UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM F-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

Siyata Mobile Inc.

(Exact Name of Registrant as Specified in its Charter)

 

British Columbia   4812   N/A

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification No.)

 

Marc Seelenfreund

1001 Lenoir St Suite A-414

Montreal, QC H4C 2Z6

514-500-1181

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

 

Siyata Mobile Inc.

1001 Lenoir St Suite A-414

Montreal, QC H4C 2Z6

514-500-1181

 

Copies to:

Joseph Lucosky

Lucosky Brookman LLP

101 Wood Avenue South

Woodbridge, New Jersey 08830

(732) 395-4400

 

Mitchell Nussbaum, Esq.

Angela Dowd, Esq.

Loeb & Loeb LLP

345 Park Ave.

New York, NY 10154

(212) 407-4000

 

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Approximate date of commencement of proposed sale to the public: As soon as practicable after effectiveness of this registration statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 

 

CALCULATION OF REGISTRATION FEE

 

Title of each Class of Security being registered   Proposed Maximum Aggregate Offering Price(1)(2)     Amount of Registration Fee(3)  
Units, each consisting of one Common Share, no par value per share, and one Warrants to purchase Common Shares     -       -  
Common Shares included as part of the Units (7)                
Warrants to purchase Common Shares included as part of the Units (2)   $ 10,000,000     $ 1,298  
Common Shares issuable upon exercise of the Warrants (3)(4)(7)   $ 10,000,000     $ 1,298  
Representatives Warrants (5)             -  
Common Shares issuable upon exercise of Representative’s Warrants (6)(7)   $ 550,000     $ 71.39  
Total   $ 20,550,000     $ 2,667.39  

  

 

(1) Includes Common Shares to cover the exercise of the over-allotment option granted to the underwriter.
   
(2) In accordance with Rule 457(i) under the Securities Act, because the Common Shares underlying the Warrants are registered hereby, no separate registration fee is required with respect to the Warrants registered hereby
   
(3) The warrants are exercisable at a per share price of      % of the price per Unit in this offering.
   
(4) Includes common shares which may be issued upon exercise of additional warrants which may be issued upon exercise of the over-allotment option granted to the underwriter.
   
(5) No additional registration fee is payable pursuant to Rule 457(g) under the Securities Act.
   
(6)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The warrants, or the Representative’s Warrants, are exercisable at a per share exercise price equal to 110% of the public offering price. As estimated solely for the purpose of recalculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the Representative’s Warrants is equal to 110% of US$500,000 (which is equal to 5% of $10,000,000).  

   
(7)

Pursuant to Rule 416 of the Securities Act, the securities being registered hereunder include such additional securities as may be issued after the date hereof as a result of share splits, share dividends or similar transactions.

 

The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

 

 

 

 

 

  

The information in this prospectus is not complete and may be changed. We may not sell the securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting any offer to buy these securities in any jurisdiction where such offer or sale is not permitted.

 

SUBJECT TO COMPLETION DATED AUGUST 24, 2020

 

PRELIMINARY PROSPECTUS

 

Siyata Mobile Inc.

 

 

 

Units

Each Unit Consisting of

One Share of Common Shares and

One Warrant to Purchase Common Shares

  

 

 

This is the initial public offering in the United States of ___________ units (the “Units”) of Siyata Mobile Inc., a British Columbia corporation. Each Unit consists of one common share, no par value, which we refer to as the “Common Shares”, and one warrant (the “Warrant”) to purchase Common Shares at an exercise price of $ per share (with an exercise price no less than 100% of the price of each Unit sold in this offering). The Units have no stand-alone rights and will not be certified or issued as stand-alone securities. The Common Shares and Warrants are immediately separable and will be issued separately in this offering. Each warrant offered hereby is immediately exercisable on the date of issuance and will expire five years from the date of issuance.

 

Our Common Shares are currently trading on the TSX Venture Exchange (the “TSXV”) under the symbol “SIM”, the OTCQX under the symbol “SYATF,” and the Frankfurt Stock Exchange (the “FRA”) under the symbol “WK3D”. We currently expect the initial public offering price to be between        and         per Unit.

 

We have applied to list our Common Shares and Warrants on the Nasdaq Capital Market under the symbols “SYAT” and “SYATW”, respectively. There can be no assurance that we will be successful in listing our Common Shares and Warrants on the Nasdaq Capital Market.

 

The share and per share information in this prospectus reflects, other than in our Financial Statements and the Notes thereto, a proposed reverse stock split of the authorized and outstanding common stock of ___-for-1 to occur immediately following the effective date but prior to the closing of the offering.

 

Investing in our securities involves a high degree of risk, including the risk of losing your entire investment. See “Risk Factors” beginning on page 9 to read about factors you should consider before buying our securities.

 

We are an “emerging growth company” as defined under the federal securities laws and may elect to comply with reduced public company reporting requirements. Please read “Implications of Our Being an Emerging Growth Company” beginning on page 4 of this prospectus for more information.

 

   

Per Unit(3)

    Total  
Offering price   $            $         
Underwriter’s discounts and commissions(1)   $       $    
Proceeds to our company before expenses (2)   $       $    

 

(1) We have also agreed to issue warrants to purchase       common shares to the representative of the underwriters and to reimburse the representative of the underwriters for certain expenses. See “Underwriting” for additional information regarding total underwriter compensation.
   
(2)

The amount of offering proceeds to us presented in this table does not give effect to any exercise of the: (i) over-allotment option (if any) we have granted to the representative of the underwriters as described below and (ii) warrants being issued to the representative of the underwriters in this offering.

 

(3) The public offering price and underwriting discount in respect of the Units corresponds to (i) a public offering price per share of common shares of $           and (ii) a public offering price per warrant of $        . Each Unit consists of one  common share and one warrant to purchase common shares.

 

Neither the Securities and Exchange Commission nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

We have granted a 45-day option to the representative of the underwriters, exercisable one or more times in whole or in part, to purchase up to an additional Common Shares and/or up to an additional _____-_warrants at a price from us at the public offering price per share of Common Shares and per Warrant, respectively, less, in each case, the underwriting discounts payable by us, solely to cover over-allotments, if any. 

 

The underwriters expect to deliver the securities against payment in New York, New York on or about               , 2020.

 

Sole Book-Running Manager

 

Maxim Group LLC

 

 

 

TABLE OF CONTENTS

 

    Page
PROSPECTUS SUMMARY   1
THE OFFERING   6
SUMMARY FINANCIAL DATA   8
RISK FACTORS   9
DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS   37
ENFORCEABILITY OF CIVIL LIABILITIES   38
USE OF PROCEEDS   39
DIVIDEND POLICY   40
CAPITALIZATION   41
DILUTION   42
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   43
BUSINESS   57
MANAGEMENT   64
EXECUTIVE COMPENSATION   69
PRINCIPAL SHAREHOLDERS   72
RELATED PARTY TRANSACTIONS   73
DESCRIPTION OF SHARE CAPITAL   74
SELECTED FINANCIAL DATA    
SHARES ELIGIBLE FOR FUTURE SALE   79
MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES TO U.S. HOLDERS   80
MATERIAL CANADIAN FEDERAL INCOME TAX CONSIDERATIONS   83
UNDERWRITING   86
EXPENSES RELATING TO THIS OFFERING   89
LEGAL MATTERS   90
EXPERTS   91
WHERE YOU CAN FIND ADDITIONAL INFORMATION   91
INDEX TO FINANCIAL STATEMENTS   F-1

 

i

 

 

Neither we nor any of the underwriters have authorized anyone to provide you with any information or to make any representations other than as contained in this prospectus or in any free writing prospectuses we have prepared. Neither we nor the underwriters take responsibility for, and provide no assurance about the reliability of, any information that others may give you. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of the securities. Our business, financial condition, results of operations and prospects may have changed since that date.

 

Unless otherwise indicated, all references in this prospectus to “Siyata,” the “Company,” “we,” “our,” “us” or similar terms refer to Siyata Mobile Inc. and its subsidiaries.

 

No action is being taken in any jurisdiction outside the U.S. to permit a public offering of our securities or possession or distribution of this prospectus in any such jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the U.S. are required to inform themselves about and to observe any restrictions about this offering and the distribution of this prospectus applicable to those jurisdictions.

  

We obtained statistical data, market data and other industry data and forecasts used in this prospectus from market research, publicly available information and industry publications. While we believe that the statistical data, industry data and forecasts and market research are reliable, we have not independently verified the data.

 

ii

 

 

PRESENTATION OF FINANCIAL INFORMATION

 

The financial information contained in this prospectus derives from our audited consolidated financial statements as of December 31, 2018 and 2019. These financial statements and related notes included elsewhere in this prospectus are collectively referred to as our audited consolidated financial statements herein and throughout this prospectus. Our audited consolidated financial statements are prepared in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB. Our fiscal year ends on December 31 of each year, so all references to a particular fiscal year are to the applicable year ended December 31. Following the completion of this offering, we will be required to file annual reports on Form 20-F with the Securities and Exchange Commission, or the SEC, under United States Securities Exchange Act of 1934, as amended, or the Exchange Act, and although not required under the Exchange Act, we expect to publish unaudited condensed consolidated interim financial statements on a quarterly basis.

 

iii

 

 

 

PROSPECTUS SUMMARY

 

The following summary is qualified in its entirety by, and should be read in conjunction with, the more detailed information and financial statements included elsewhere in this prospectus. In addition to this summary, we urge you to read the entire prospectus carefully, especially the risks of investing in our securities, discussed under “Risk Factors,” before deciding whether to buy our securities.

 

Overview

 

Siyata Mobile Inc. (the “Company,” “Siyata,” “Siyata Mobile,” “we,” “us,” or “our”) is a global developer of a vehicle mounted, cellular based communications platform over advanced 4G mobile networks under the Uniden® Cellular and Siyata brands. Siyata commercial vehicle devices are specifically designed for professional vehicles such as trucks, vans, buses, emergency service vehicles, government cars and more. Our innovative platform is designed to facilitate replacement of the current in vehicle, multi-device status quo with a single device (the flagship Uniden® UV350 4G device) that incorporates voice, Push-to-Talk over Cellular (“PoC”), data fleet management solutions and more. The UV350 also supports Band 14, a nationwide, high-quality cellular spectrum set aside by the US government for FirstNet compatibility which is the U.S. First Responders 4G LTE network with PoC capabilities that aims to replace aging two-way radio systems currently in use.

 

Our customer base includes cellular network operators and their dealers, as well as commercial vehicle technology distributors for fleets of all sizes in the United States, Canada, Europe, Australia and the Middle East.

 

We have integrated our flagship 4G UV350 commercial vehicle smartphone device with several leading cellular carriers and their distributors, including Bell Mobility in Q4 2018, AT&T and their first responder cellular network FirstNet in Q2 2019, Rogers Wireless in Q4 2019 and with Verizon Wireless in Q4 2019. These are significant milestones for us following our seven years of experience developing in-vehicle cellular based technology, vehicle installations, software integration with various Push-to-Talk (“PTT”) solutions and intensive carrier certifications.

 

With an estimated 17 million commercial vehicles as well as 3.5 million first responder vehicles, we view the U.S market as our largest opportunity with, according to the U.S. Department of Transportation, an estimated total addressable market of over $17 billion. The Tier 1 cellular carriers that we work with have expressed interest in marketing and selling the UV350 as it would allow for new SIM card activations in commercial vehicles and increased average revenue per user from existing customers with corporate and first responder fleets while targeting new customers with a unique, dedicated, multi-purpose in-vehicle smartphone.

 

We have launched the CP250 tablet/DVR connected vehicle 4G device, which is built for cellular voice calls, PoC, data, and navigation with a built-in DVR camera, available exclusively for markets outside North America. This device was designed to be installed on the dash or mounted on a windshield, specifically for lighter commercial vehicles such as taxis, vans and delivery trucks. The 5” wide screen display tablet-based design ensures better communication capabilities for professional drivers. Sales of this product are focused primarily in the Middle East, EU and Australia.

 

In addition to our connected vehicle product portfolio, we develop, manufacture, market, and sell 4G/LTE PoC rugged smartphone devices for industrial users. These rugged B2B (business to business) environments include first responders, construction workers, security guards, government agencies and various mobile workers in multiple industries. This product portfolio compliments our connected vehicle devices as it is targeted at similar enterprise customers.

 

We also manufacture, market, and sell Uniden® cellular signal boosters and accessories for homes, buildings, manufacturing facilities and vehicles with poor cell coverage across Canada and the United States. The vehicle vertical in this portfolio complements the UV350 commercial vehicle smartphone as we begin to generate sales of the UV350 bundled with the Uniden® vehicle boosters, providing stronger cellular coverage inside commercial vehicles.

 

1

 

 

Competitive Strengths

 

We believe that the following competitive strengths contribute to our success and differentiate us from our competitors:

 

   Our innovative technology and integration approach with minimal known competition.

 

   Our reputation and recognition achieved from our previous success in this space.

 

 

Our experienced management team.

 

  Our relationships and device approvals with leading North American wireless networks.

 

Growth Strategies

 

We intend to further grow our business by pursuing the following strategies:

 

 

Ramp up sales with our North American and global cellular carrier partners.

 

  Entering new customer bases and markets.

 

 

Implementing effective resources management to improve operational efficiency and boost core competency.

 

  Designing new products and improving our existing products for our current and future customer base.

 

Our Challenges

 

We face challenges, risks and uncertainties in realizing our business objectives and executing our strategies, including those relating to our ability to:

 

  Grow our market share in the United States which is a new, large scale market for us.

 

  Navigate in the fast-changing regulatory environment.

 

  Maintain and improve our relationship with leading cellular carriers and business partners.

 

  Recruit and retain qualified personnel.

 

  Manage our growth effectively and efficiently.

 

  Enhance our product lines in a cost-effective manner.

 

Please see “Risk Factors” and other information included in this prospectus for a discussion of these and other risks and uncertainties that we face.

 

2

 

 

Risk Factors Summary

 

Investing in our securities involves substantial risk. The risks described under the heading “Risk Factors” immediately following this summary may cause us to not realize the full benefits of our strengths or may cause us to be unable to successfully execute all or part of our strategy. Some of the more significant challenges include the following:

 

our reliance on our channel partners to generate a substantial majority of our revenues;

 

our materially dependence on the adoption of our solutions by both the industrial enterprise and public sector markets;

 

our participation in a competitive industry;

 

risks relating to defects that may be found in our products;

 

our ability to manage our growth effectively;

 

our dependence on third-party suppliers for key components of our products;

 

our dependence on the continued services and performance of a concentrated group of senior management and other key personnel;

 

our ability to sell our solutions into new markets;

 

risks related to the Novel Coronavirus; and

 

risks related to the wide range of product regulatory and safety, consumer, worker safety and environmental laws and regulation that we are subject to.

 

Recent Developments

 

  The Company has experienced an increase of sales of its cellular boosters as more people are working remotely as a result of the COVID-19 pandemic but its overall sales during the pandemic have remained similar to its sales in 2019 during this time period with a shift towards increased sales in North America in the first responder market. It is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or ability to raise funds. The Company plans to address any going concerns from the pandemic by continuing to increase its sales in North America which is a substantial larger market than the Company has sold in the past. In addition, its cellular distribution business shall remain strong during this time since more individuals will continue to work from home. The Company also expect that the proceeds from this offering will allow to cover any shortfall that the Company may incur until the pandemic is no longer a worldwide issue. In addition, the Company believes that its cellular booster business remains strong during the COVID-19 pandemic as more individuals continue to work from home, requiring improved cellular reception.
     

 

 

Subsequent to the year end, the Company entered into a non-brokered private placement financing agreement with Accel Telecom Inc., a reporting insider. Accel subscribed for 1,330 senior unsecured 10% convertible debentures maturing one year from the issue date at an issue price of CDN$1,000 per Convertible Debenture for aggregate gross proceeds of approximately USD$1,000,000 (the “Convertible Debenture Offering”). Each Convertible Debenture is convertible, at the option of the holder, into 3,333 common shares in the capital of the Company at a price of CDN$0.30 per Common Share, subject to adjustment in certain events and are redeemable at 101% of the face value at any time after the closing date. Accel also received 1,330,000 non-transferrable common share purchase warrants (each, a “Debenture Warrant”). Each Debenture Warrant entitles the holder to acquire one Common Share (each, a “Debenture Warrant Share”) at an exercise price of CDN$0.30 per Debenture Warrant Share for a period of twelve (12) months after the date of issue.

 

  The Company entered into an agreement with an existing arm’s-length debenture holder to amend the terms of its outstanding convertible debentures due June 28, 2020 on equivalent terms as the Convertible Debentures Offering in the amount of CDN$250,000. No finders’ fees were paid in conjunction with the Convertible Debenture Offering.
     
  On August 4, 2020, the Company completed a non-brokered private placement raising aggregate gross proceeds of $2,150,000 through the issuance of 21,500,000 units (the “August 2020 Units”) at a price of $0.10 per August 2020 Unit. Each August 2020 Unit consisted of one common share in the capital of the Company and one-half of one common share purchase warrant (each, a “August 2020 Warrant”). Each whole August 2020 Warrant is exercisable at a price of $0.18 for a period of two years. The Company paid a cash commission of $24,681.60 and issued 246,816 agent options on the same terms as the August 2020 Warrants to certain finders (collectively, the “August 2020 Financing”).
     
    On July 28, 2020, our shareholders approved a for 1 reverse stock split of our Common Shares, subject to and effective immediately prior to the completion of this offering. Unless otherwise indicated, all Common Share amounts in this prospectus are reflected on a post-split basis.

  

Going Concern

 

Our auditor has included a “going concern” explanatory paragraph in its report on our consolidated financial statements for the fiscal year ended December 31, 2019, expressing substantial doubt about our ability to continue as an ongoing business for the next twelve months. Our consolidated financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we cannot secure the financing needed to continue as a viable business, our shareholders may lose some or all of their investment in us.

 

3

 

 

Corporate Information

 

Our principal executive offices and headquarters are located at 1001 Lenoir Street, Suite A-414, Montreal, Quebec H4C 2Z6 and our phone number is +1-514-500-1181. We maintain a corporate website at www.siyatamobile.com. The information contained in, or accessible from, our website or any other website does not constitute a part of this prospectus.

 

Corporate History and Structure

 

The Company was incorporated on October 15, 1986 as Big Rock Gold Ltd. as a corporation under the Business Company Act of British Columbia. On April 5, 1988, the Company changed its name to International Cruiseshipcenters Corp. On June 24, 1991, the Company changed its name to Riley Resources Ltd. Effective January 23, 1998, the Company consolidated its share capital on an eight to one basis and changed its name to International Riley Resources Ltd. Effective November 22, 2001, the Company consolidated its share capital on a five-to-one basis and changed its name to Wind River Resources Ltd. On January 3, 2008, the Company changed its name to Teslin River Resources Corp. On July 24, 2015, Teslin River Resources Corp. completed a reverse acquisition by way of a three-cornered amalgamation, pursuant to which the Company acquired certain telecom operations of an Israel-based cellular technology company and changed its name to Siyata Mobile Inc.

 

The Company is registered with the TSXV under the symbol SIM, commenced trading on OTCQX under the symbol SYATF on May 11, 2017 and trades on the FRA under the symbol WK3D.

 

The following diagram illustrates our corporate structure as of the date of this prospectus:

 

 

Implications of Our Being an “Emerging Growth Company”

 

As a company with less than $1.07 billion in revenue during our last fiscal year, we qualify as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An “emerging growth company” may take advantage of reduced reporting requirements that are otherwise applicable to larger public companies. In particular, as an emerging growth company, we:

 

  may present only two years of audited financial statements and only two years of related Management’s Discussion and Analysis of Financial Condition and Results of Operations, or “MD&A”;

 

  are not required to provide a detailed narrative disclosure discussing our compensation principles, objectives and elements and analyzing how those elements fit with our principles and objectives, which is commonly referred to as “compensation discussion and analysis”;

 

  are not required to obtain an attestation and report from our auditors on our management’s assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002;

 

4

 

 

  are not required to obtain a non-binding advisory vote from our shareholders on executive compensation or golden parachute arrangements (commonly referred to as the “say-on-pay,” “say-on frequency” and “say-on-golden-parachute” votes);

 

  are exempt from certain executive compensation disclosure provisions requiring a pay-for-performance graph and chief executive officer pay ratio disclosure;

 

  are eligible to claim longer phase-in periods for the adoption of new or revised financial accounting standards under §107 of the JOBS Act; and

 

  will not be required to conduct an evaluation of our internal control over financial reporting.

 

We intend to take advantage of all of these reduced reporting requirements and exemptions, including the longer phase-in periods for the adoption of new or revised financial accounting standards under §107 of the JOBS Act. Our election to use the phase-in periods may make it difficult to compare our financial statements to those of non-emerging growth companies and other emerging growth companies that have opted out of the phase-in periods under §107 of the JOBS Act.

 

Under the JOBS Act, we may take advantage of the above-described reduced reporting requirements and exemptions until we no longer meet the definition of an emerging growth company. The JOBS Act provides that we would cease to be an “emerging growth company” at the end of the fiscal year in which the fifth anniversary of our initial sale of common equity pursuant to a registration statement declared effective under the Securities Act of 1933, as amended, herein referred to as the Securities Act, occurred, if we have more than $1.07 billion in annual revenues, have more than $700 million in market value of our Common Shares held by non-affiliates, or issue more than $1 billion in principal amount of non-convertible debt over a three-year period.

 

Foreign Private Issuer Status

 

We are a foreign private issuer within the meaning of the rules under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As such, we are exempt from certain provisions applicable to United States domestic public companies. For example:

 

  we are not required to provide as many Exchange Act reports, or as frequently, as a domestic public company;
     
  for interim reporting, we are permitted to comply solely with our home country requirements, which are less rigorous than the rules that apply to domestic public companies;
     
  we are not required to provide the same level of disclosure on certain issues, such as executive compensation;
     
  we are exempt from provisions of Regulation FD aimed at preventing issuers from making selective disclosures of material information;
     
  we are not required to comply with the sections of the Exchange Act regulating the solicitation of proxies, consents, or authorizations in respect of a security registered under the Exchange Act; and
     
  we are not required to comply with Section 16 of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and establishing insider liability for profits realized from any “short-swing” trading transaction.

 

5

 

 

THE OFFERING

 

Issuer   Siyata Mobile Inc.
     
Securities offered by us             Units, each Unit consisting of one Common Share and one warrant to purchase Common Shares. Each warrant will have an exercise price of $         per share (with an exercise price no less than 100% of the public offering price of one Unit), is exercisable immediately and will expire five (5) years from the date of issuance.  The Units will not be certificated or issued in stand-alone form. The Common Shares and the warrants comprising the Units are immediately separable upon issuance and will be issued separately in this offering.
     
Over-allotment option   We have granted a 45-day option to the representative of the underwriters to purchase up to  additional _____ common shares at a price of $              per share and/or up to an  additional ________warrants at a price of $              per warrant less, in each case, the underwriting discounts payable by us, in any combination solely to cover over-allotments, if any. If the representative of the underwriters exercises the option in full, the total underwriting discounts and commissions payable by us will be $             and the total proceeds to us, before expenses, will be $            .
     
Common Shares outstanding prior to this offering  

146,914,485

     
Common Shares to be outstanding after this offering                 shares (or                shares if the underwriters exercise their option to purchase additional Common Shares in full).
     
Use of proceeds   We estimate that the net proceeds to us from this offering will be approximately $       million, or approximately $      million if the underwriters exercise their over-allotment option to purchase additional Common Shares and Warrants in full, assuming an offering price of $      per share (which is the midpoint of the price range set forth on the cover page of this prospectus), after deducting underwriting discounts and commissions and estimated offering expenses payable by us.
     
    We intend to use the net proceeds of this offering primarily for general corporate purposes, including working capital, expanded sales and marketing activities, increased research and development expenditures and funding our growth strategies. See “Use of Proceeds” for additional information.
     
Description of the warrants  

The exercise price of the warrants is $             per share (with an exercise price no less than 100% of the public offering price of one Unit). Each warrant is exercisable for one common share, subject to adjustment in the event of stock dividends, stock splits, stock combinations, reclassifications, reorganizations or similar events affecting our common shares as described herein. A holder may not exercise any portion of a warrant to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would own more than 4.99% of the outstanding common shares after exercise, as such percentage ownership is determined in accordance with the terms of the warrants, except that upon notice from the holder to us, the holder may waive such limitation up to a percentage, not in excess of 9.99%. Each warrant will be exercisable immediately upon issuance and will expire five years after the initial issuance date. The terms of the warrants will be governed by a Warrant Agreement, dated as of the effective date of this offering, between us and Computershare Limited as the warrant agent (the “Warrant Agent”). This prospectus also relates to the offering of the Common Shares issuable upon exercise of the warrants. For more information regarding the warrants, you should carefully read the section titled “Description of Share Capital —Warrants” in this prospectus.

     
Representative’s Warrant   The registration statement of which this prospectus is a part also registers for sale warrants (the “Representative’s Warrants”) to purchase common shares to the underwriters, as a portion of the underwriting compensation payable in connection with this offering. The Representative’s Warrants will be exercisable at any time, and from time to time, in whole or in part, during the four and half year period commencing 180 days following the effective date of the registration statement of which this prospectus is a part at an exercise price of $               (110% of the public offering price of the Units). Please see “Underwriting—Representative’s Warrants” for a description of these warrants.
     
Proposed Nasdaq Capital Market Trading Symbol and Listing   We have applied to list our Common Shares and Warrants on the Nasdaq Capital Market under the symbol “SYAT” and “SYATW” respectively. No assurance can be given that such listing will be approved or that a liquid trading market will develop for our Common Shares and Warrants.
     
Lock-up   We, our directors, executive officers, and shareholder who own 5% or more of  our outstanding common shares have agreed with the underwriters not to offer for sale, issue, sell, contract to sell, pledge or otherwise dispose of any of our common shares or securities convertible into common shares for a period of ninety (90) days commencing on the date of this prospectus. See “Underwriting” for additional information.
     
Transfer Agent and Registrar   Computershare Limited
     
Risk Factors   See “Risk Factors” for a discussion of risks you should carefully consider before investing in our securities.

  

6

 

  

The number of shares of our common shares to be outstanding after this offering is based on ________ shares of our common shares outstanding as of ________, 2020 and excludes:

 

_________ shares of our common shares issuable upon the exercise of stock options outstanding as of _____, 2020 under our 2016 Stock Option Plan, with a weighted-average exercise price of $____ per share

 

_________ common shares reserved for future issuance under our 2016 Stock Option Plan;

 

_________ common shares issuable upon the exercise of outstanding warrants with a weighted average exercise price of $___ per share;

 

__________common shares issuable upon the exercise of $_________ aggregate principal amount of outstanding convertible debentures with a conversion price of $___ per share;

 

up to _________ common shares issuable upon the exercise of the Warrants included in the Units offered hereby; and

 

up to _________common shares issuable upon exercise of warrants to be issued to the underwriter in connection with this offering, which will have an exercise price per share equal to 110% of the initial public offering price per share in this offering

 

Unless we specifically state otherwise, the information in this prospectus assumes no exercise by the underwriter of the over-allotment option.

 

On July 28, 2020, our shareholders a for 1 reverse stock split of our Common Shares, subject to and effective immediately prior to the completion of this offering. Unless otherwise indicated, all Common Share amounts in this prospectus are reflected on a post-split basis.

 

7

 

 

SUMMARY FINANCIAL DATA

 

The following summary consolidated statements of income for the years ended December 31, 2019 and 2018 and the summary consolidated balance sheet data as of December 31, 2019 and 2018.

 

Our management believes that the assumptions underlying our financial statements and the above allocations are reasonable. Our financial statements, however, may not necessarily reflect our results of operations, financial position and cash flows as if we had operated as a separate, stand-alone company during the periods presented. You should not view our historical results as an indicator of our future performance.

 

 

 Selected Consolidated Statement of Income and Comprehensive Income

(In Canadian dollars, except number of shares)

  

    As of
December 31,
2019
(in thousands)

    As of
December 31,
2018
(in thousands)
 
Net sales   $ 13,020     $ 14,221  
Gross Margin   $ 3,287     $ 2,059  
Income (loss) from operations   $ (8,712 )   $ (10,080 )
Income (loss) from continuing operations   $ (10,160 )   $ (11,528 )
Net income (loss)   $ (10,160 )   $ (11,528 )
Net income (loss) from operations per share   $ (0.09 )   $ (0.12 )
 Capital; including the formula used for any adjustments to dividends declared;   $ 11,044     $ 9,030  
Dividends declared per share in both the currency of the financial statements and the host country currency     -       -  
Diluted net income per share   $ (0.09 )   $ (0.12 )
 Income (loss) from continuing operations per share   $ (0.09 )   $ (0.12 )
Weighted Average number of shares outstanding   $ 117,154     $ 95,376  

  

The following table presents our summary consolidated balance sheet data as of December 31, 2019 and 2018.

(In Canadian dollars, except number of shares)

 

    As of December 31,
2019
(in thousands)
   

As of December 31,
2018

(in thousands)

 
Cash   $ 3,465     $ 2,420  
Current Assets   $ 10,986     $ 9,219  
Intangible Assets   $ 9,446     $ 8,511  
Other Assets   $ 579     $ 54  
Total Assets   $ 21,011     $ 17,784  
Working Capital   $ 6,705     $ 4,565  
Bank loan   $ 42       -  
Current Liabilities (excluding current portion of long term debt)   $ 2,860     $ 4,619  
Long term debt/convertible debt (including current portion)   $ 6,832     $ 4,135  
Total liabilities   $ 9,966     $ 8,754  
Shareholders’ Equity   $ 11,044     $ 9,030  
Share Capital 125,247,819(1) common shares   $ 37,346     $ 27,638  
Reserves(2)   $ 6,603     $ 3,751  
Accumulated other comprehensive income (losses)   $ (125 )   $ 260  
Deficit   $ (32,780 )   $ (22,619 )

 

(1) Represents Company shares outstanding as of December 31, 2019
   
(2)

The purpose of our Reserve account is to track the valuation of equity instruments issued other than common shares (i.e. the value of stock options, warrants, and equity components of convertible debt). This value of these equity instruments is recorded in Reserves until the instrument is exercised into common shares, at which time the original value of the instrument is re-classified into share capital. This presentation is common under IFRS, and similar to the usage of Additional Paid-In-Capital in the United States. Because the Company’s shares do not have a par value, all valuations of equity instruments other than common shares get booked into the Reserve account.

 

8

 

  

RISK FACTORS

 

An investment in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks described below, together with all of the other information set forth in this prospectus, including the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operation” and our consolidated financial statements and related notes. If any of these risks actually occurs, our business, financial condition, results of operations or cash flow could be materially and adversely affected, which could cause the trading price of our securities to decline, resulting in a loss of all or part of your investment..

 

Risks Related to Our Business

 

We have a history of operating losses and we may never achieve or maintain profitability.

 

We have a limited operating history and a history of losses from operations. As of December 31, 2019, we had an accumulated deficit of $32,779,519. Even assuming the sale of the common shares in this offering, without additional capital our existing cash and cash equivalents will be insufficient to fully fund our business plan. Our ability to achieve profitability will depend on whether we can obtain additional capital when we need it, complete the development of our technology, obtain required regulatory approvals and continue to develop arrangements with channel partners. There can be no assurance that we will ever achieve profitability.

 

Our independent registered public accounting firm, in its report on our financial statements for the year ended December 31, 2019, has raised substantial doubt about our ability to continue as a going concern.

 

We rely on our channel partners to generate a substantial majority of our revenues. If these channel partners fail to perform or if we cannot enter into agreements with channel partners on favorable terms, our operating results could be significantly harmed.

 

More than 60% of our revenues are generated through sales by our channel partners, which are primarily wireless carriers who sell our devices through their sales channels. To the extent our channel partners are unsuccessful in selling or do not promote our products, or we are unable to obtain and retain a sufficient number of high-quality channel partners, our business and operating results could be significantly harmed. Our channel partners are wireless carriers who have direct and indirect sales channels which we are leveraging to get to their customers. Our wireless carrier channel partners currently include:

 

AT&T, in USA

 

FirstNet, in USA

 

Verizon, in USA

 

Bell Mobility, in Canada

 

Rogers, in Canada

 

Motorola Solutions Israel

 

Pelephone, in Israel

 

Partner Communications, in Israel

 

Cellcom, in Israel

 

Saudi Telecom Company, in Saudi Arabia

 

While these arrangements are typically long term, they generally do not contain any firm purchase volume commitments. As a result, our channel partners are not contractually obligated to purchase from us any minimum number of products. We are generally required to satisfy any and all purchase orders delivered to us within specified delivery windows, with limited exceptions (such as orders significantly in excess of forecasts). If we are unable to efficiently manage our supply and satisfy purchase orders on a timely basis to our channel partners, we may be in breach of our sales arrangements and lose potential sales. If a technical issue with any of our covered products exceeds certain present failure thresholds for the relevant performance standard or standards, the channel partner typically has the right to cease selling the product, cancel open purchase orders and levy certain monetary penalties. If our products suffer technical issues or failures following sales to our channel partners, we may be subject to significant monetary penalties and our channel partners may cease making purchase orders, which would significantly harm our business and results of operations. In addition, our channel partners retain sole discretion in which of their stocked products to offer their customers. While we may offer limited customer incentives, we generally have limited to no control over which products our channel partners decide to offer or promote, which directly impacts the number of products that our partners will purchase from us.

 

9

 

 

Our channel partners may be unsuccessful in marketing, selling and supporting our solutions. They may also market, sell and support solutions that are competitive with ours, and may devote more resources to the marketing, sales and support of such products. They may have incentives to promote our competitors’ products in lieu of our products, particularly for our competitors with larger volumes of orders, more diverse product offerings and a longer relationship with our channel partners. As a result, our channel partners may stop selling our products completely. While we employ a small direct sales force, our channel partners have significantly larger sales teams who are not contractually obligated to promote any of our devices and often have multiple competing devices in stock to offer their customers. In addition, downstream sales by our channel partners often succeed due to attractive device prices and monthly rate plans, which we do not control. In certain cases, we may promote our own devices through customer incentives, however, there can be no assurance that any such incentives would contribute to increased purchases of our products. Further, given the impact of attractive pricing on ultimate sales, we generally must offer increased promotional funding or price reductions for our more expensive products. This promotional funding or price reductions operate to reduce our margins and significantly impact our profitability.

 

New sales channel partners may take several months or more to achieve significant sales. Our channel partner sales structure could subject us to lawsuits, potential liability and reputational harm if, for example, any of our channel partners misrepresents the functionality of our products or services to their customers, or violate laws or our corporate policies.

 

If we fail to effectively manage our existing or future sales channel partners, our channel partners fail to promote our products effectively, we are unable to meet our obligations under our sales arrangements or future agreements that we may enter into with wireless carrier customers have terms that are more favorable to the customer, our business and results of operations would be harmed.

 

We are materially dependent on the adoption of our solutions by both the industrial enterprise and public sector markets, and if end customers in those markets do not purchase our solutions, our revenues will be adversely impacted, and we may not be able to expand into other markets.

 

Our revenues have been primarily in the industrial enterprise market, and we are materially dependent on the adoption of our solutions by both the industrial enterprise and public sector markets. End customers in the public sector market may remain, for reasons outside our control, tied to Land Mobile Radio (LMR) solutions or other competitive alternatives to our phones. Sales of our products to these buyers may also be delayed or limited by these competitive conditions. If our products are not widely accepted by buyers in those markets, we may not be able to expand sales of our products into new markets, and our business, results of operations and financial condition may be adversely impacted.

 

We participate in a competitive industry, which may become more competitive. Competitors with greater resources and significant experience in high-volume product manufacturing may be able to respond more quickly and cost-effectively than we can to new or emerging technologies and changes in customer requirements.

 

We face significant competition in developing and selling our solutions. Our primary competitors in the non-rugged mobile device market include LG Corporation, Apple Inc. and Samsung Electronics Co. Ltd. Our primary competitors in the rugged mobile device market include Sonim Technologies Inc., Bullitt Mobile Ltd., and Kyocera Corporation. We also face competition from large system integrators and manufacturers of private and public wireless network equipment and devices. Competitors in this space include Harris Corporation, JVC KENWOOD Corporation, Motorola Solutions, Inc., or MSI, and Tait International Limited. Within the Cellular Booster category, we have several direct competitors, including Wilson Electronics, LLC (“Wilson Electronics”), Nextivity, Inc. and SureCall Company.

 

We cannot assure we will be able to compete successfully against current or future competitors. Increased competition in mobile computing platforms, data capture products, or related accessories and software developments may result in price reductions, lower gross profit margins, and loss of market share, and could require increased spending on research and development, sales and marketing, and customer support. Some competitors may make strategic acquisitions or establish cooperative relationships with suppliers or companies that produce complementary products, which may create additional pressures on our competitive position in the marketplace.

 

Most of our competitors have longer operating histories, greater name recognition, larger customer bases and significantly greater financial, technical, sales, marketing and other resources and experience than we do. In addition, because of the higher volume of components that many of our competitors purchase from their suppliers, they are able to keep their supply costs relatively low and, as a result, may be able to recognize higher margins on their product sales than we do. Many of our competitors may also have existing relationships with the channel partners who we use to sell our products, or with our potential customers. This competition may result in reduced prices, reduced margins and longer sales cycles for our products. Our competitors may also be able to more quickly and cost-effectively respond to new or emerging technologies and changes in customer requirements. The combination of brand strength, extensive distribution channels and financial resources of the larger vendors could cause us to lose market share and could reduce our margins on our products. If any of our larger competitors were to commit greater technical, sales, marketing and other resources to our markets, our ability to compete would be adversely impacted. If we are unable to successfully compete with our competitors, our sales would suffer and as a result our financial condition will be adversely impacted.

  

10

 

 

Defects in our products could reduce demand for our products and result in a loss of sales, delay in market acceptance and injury to our reputation, which would adversely impact our business.

 

Complex software, as well as multiple components, displays, plastics and assemblies used in our products may contain undetected defects that are subsequently discovered at any point in the life of the product. Defects in our products may result in a loss of sales, product malfunction, delay in market acceptance and potential injuries to our customers which can bring to injury in our reputation and increased warranty costs.

 

Additionally, our software may contain undetected errors, defects or bugs. Although we have not suffered significant harm from any errors, defects or bugs to date, we may discover significant errors, defects, or bugs in the future that we may not be able to correct or correct in a timely manner. It is possible that errors, defects or bugs will be found in our existing or future software and/or hardware products and related services with the potential for delays in, or loss of market acceptance of, our products and services, diversion of our resources, injury to our reputation, increased service and warranty expenses, and payment of damages.

 

Further, errors, defects or bugs in our solutions could be exploited by hackers or could otherwise result in an actual or perceived breach of our information systems. Alleviating any of these problems could require significant expense and could cause interruptions, delays or cessation of our product licensing, which would reduce demand for our products and result in a loss of sales, delay in market acceptance and injure our reputation and could adversely impact our business, results of operations and financial condition.

 

Our independent registered public accountants have identified two material weaknesses in our internal controls over financial reporting. If we are unable to remediate these material weaknesses, we may not be able to report our financial results accurately, prevent fraud or file our periodic reports as a public company in a timely manner.

 

In connection with the audit of our consolidated financial statements for the years ended December 31, 2019 and 2018, our independent registered public accountants identified two material weaknesses in our internal control over financial reporting. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

 

The first material weakness related to insufficient audit support being available to support journal entry testing. specifically relating to an exchange of products initially sold in the 2017 fiscal year. The second material weakness is regarding informal policies surrounding internal controls and financial reporting for product returns

and intercompany transactions

 

We have taken steps to remediate these material weaknesses, and to further strengthen our accounting staff and internal controls, as follows:

 

- The Company engaged an independent valuator annually to determine the present value of future cash flows in the determination according to IAS38 if an intangible asset meets the criteria for capitalization and subsequent expense of any costs in excess.

 

- The Company has brought on a full-time CFO in its Israel office to review its internal controls and financial reporting process. In 2017, when the first material weakness discussed above occurred, the Company had not had a full-time CFO to review its financial reporting process. The Company believes that the full-time CFO in Israel will remedy these issues going forward.

 

- The Company has improved its internal financial reporting communication process. The Company has streamlined the communications between the Company’s Israel and Canadian-based financial reporting groups. Furthermore, the Company’s Audit Committee adopted a policy requiring the Company’s Canadian CFO to meet with the Company’s Israel-based reporting group at least twice a year to ensure that the Israel reporting group’s policies and procedures are consistent with those in Canada and that all the inventory is properly tracked and procedures for intercompany transactions must follow our existing formal standard procedures.

 

- The Audit Committee will ensure that at the quarterly financial meetings, there will be an agenda item to discuss policies and procedures in place in ensure internal control compliance with respect to intercompany transactions and returns so that all documentation is clear, consistent and that they are recorded in a timely manner and the pricing policy is consistent.

 

11

 

 

We cannot be certain that these measures will successfully remediate the material weaknesses or that other material weaknesses and control deficiencies will not be discovered in the future. If our efforts are not successful or other material weaknesses or control deficiencies occur in the future, we may be unable to report our financial results accurately on a timely basis or help prevent fraud, which could cause our reported financial results to be materially misstated and result in the loss of investor confidence or delisting and cause the market price of our common shares to decline.

 

When we become listed on NASDAQ, we will be required to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting for the first fiscal year beginning after the effective date of this offering. Whether or not our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm may issue a report that is qualified if it is not satisfied with our controls or the level at which our controls are documented, designed, operated or reviewed. However, our independent registered public accounting firm will not be required to attest formally to the effectiveness of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act until the later of the year following our first annual report required to be filed with the SEC or the date we are no longer an “emerging growth company” as defined in the JOBS Act. Accordingly, you will not be able to depend on any attestation concerning our internal control over financial reporting from our independent registered public accountants for the foreseeable future.

 

If our business does not grow as we expect, or if we fail to manage our growth effectively, our operating results and business would suffer.

 

Our ability to successfully grow our business depends on a number of factors including our ability to:

 

  accelerate the adoption of our solutions by new end customers;

 

  expand into new vertical markets;

 

  develop and deliver new products and services;

 

  increase awareness of the benefits that our solutions offer; and

 

  expand our domestic and international footprint.

 

As usage of our solutions grows, we will need to continue to make investments to develop and implement new or updated solutions, software, technologies, security features and cloud-based infrastructure operations. In addition, we will need to appropriately scale our internal business systems and our services organization, including the suppliers of our products and customer support services, to serve our growing customer base. Any failure of, or delay in, these efforts could impair the performance of our solutions and reduce customer satisfaction.

 

Further, our growth could increase quickly and place a strain on our managerial, operational, financial and other resources, and our future operating results depend to a large extent on our ability to successfully manage our anticipated expansion and growth. To manage our growth successfully, we will need to continue to invest in sales and marketing, research and development, and general and administrative functions and other areas. We are likely to recognize the costs associated with these investments earlier than receiving some of the anticipated benefits, and the return on these investments may be lower, or may develop more slowly, than we expect, which could adversely impact our operating results.

 

If we are unable to manage our growth effectively, we may not be able to take advantage of market opportunities or develop new solutions or upgrades to our existing solutions, satisfy customer requirements, maintain the quality and security of our solutions or execute on our business plan, any of which could harm our business, operating results and financial condition.

 

12

 

 

As we work with multiple vendors for our components, if we fail to adequately forecast demand for our inventory and supply needs, we could incur additional costs or experience manufacturing delays, which could reduce our gross margin or cause us to delay or even lose sales.

 

Because our production volumes are based on a forecast of channel partner demand rather than purchase commitments from our major customers, there is a risk that our forecasts could be inaccurate and that we will be unable to sell our products at the volumes and prices we expect, which may result in excess inventory. We provide, and will continue to provide, forecasts of our demand to our third-party suppliers prior to the scheduled delivery of products to our channel partners. If we overestimate our requirements, our contract manufacturers may have excess component inventory, which could increase our costs. If we underestimate our requirements, our contract manufacturers may have inadequate component inventory, which could interrupt the manufacturing of our products and result in delays in shipments and revenues or even lost sales, or could incur unplanned overtime costs to meet our requirements, resulting in significant cost increases. For example, certain materials and components used to manufacture our products may reach end of life during any of our product’s life cycles, following which suppliers no longer provide such expired materials and components. This would require us to either source and qualify an alternative component, which could require a re-certification of the device by the wireless carriers and/or regulatory agencies, or forecast product demand for a final purchase of such materials and components that may reach end of life to ensure that we have sufficient product inventory through a product’s life cycle. If we overestimate forecasted demand, we would hold excess end-of-life materials and components resulting in increased costs. If we underestimate forecasted demand, we could experience delays in shipments and loss of revenues.

 

In addition, if we underestimate our requirements and the applicable supplier becomes insolvent or is no longer able to timely supply our needs in a cost-efficient manner or at all, we may be required to acquire components, which may need to be customized for our products, from alternative suppliers, including at significantly higher costs. If we cannot source alternative suppliers and/or alternative components, we may suffer delays in shipments or lost sales. Similarly, credit constraints at our suppliers could require us to accelerate payment of our accounts payable, impacting our cash flow. Further, lead times for materials and components that we order vary significantly and depend on factors such as the specific supplier, contract terms, customization needed for any particular component and demand for each component at a given time. Any such failure to accurately forecast demand and manufacturing and supply requirements, and any need to obtain alternative supply sources, could materially harm our business, results of operations and financial condition.

 

We may not be able to continue to develop solutions to address user needs effectively in an industry characterized by ongoing change and rapid technological advances.

 

To be successful, we must adapt to rapidly changing technological and application needs by continually improving our products, as well as introducing new products and services, to address user demands.

 

Our industry is characterized by:

 

  evolving industry standards;

 

  frequent new product and service introductions;

 

  increasing demand for customized product and software solutions;

 

  rapid competitive developments;

 

  changing customer demands; and

 

  evolving distribution channels.

 

Future success will depend on our ability to effectively and economically adapt in this evolving environment. We could incur substantial costs if we must modify our business to adapt to these changes, and may even be unable to adapt to these changes.

 

The markets for our devices and related accessories may not develop as quickly as we expect, or may not develop at all. Our dependence on our cellular carrier channel partners and their success in promoting Push to Talk over Cellular to their client base is key for the success of the business.

 

Our future success is substantially dependent upon continued adoption of devices and related accessories in the industrial enterprise and public sector markets, including the transition from LMR to Push to Talk over LTE networks. These market developments and transitions may take longer than we expect or may not occur at all, and may not be as widespread as we expect. If the market does not develop as we expect, our business, operating results and financial condition would be significantly harmed.

 

13

 

 

Our dependence on third-party suppliers for key components of our products could delay shipment of our products and reduce our sales.

 

We depend on certain suppliers for the delivery of components used in the assembly of our products. Our reliance on third-party suppliers creates risks related to our potential inability to obtain an adequate supply of components and reduced control over pricing and timing of delivery of components. In particular, we have little to no control over the prices at which our suppliers sell materials and components to us. Certain supplies of our components are available only from a single source or limited sources and we may not be able to diversify sources in a timely manner. We have experienced shortages in the past that have negatively impacted our results of operations and may experience such shortages in the future.

 

We also do not have long-term supply agreements with any of our suppliers. Our current contracts with certain suppliers may be canceled or not extended by such suppliers and, therefore, do not afford us with sufficient protection against a reduction or interruption in supplies. Moreover, in the event any of these suppliers breach their contracts with us, our legal remedies associated with such a breach may be insufficient to compensate us for any damages we may suffer.

 

Any interruption of supply for any material components of our products, or inability to obtain required components from our third-party suppliers, could significantly delay the production and shipment of our products and harm our revenues, profitability and financial condition.

 

Our future success is dependent on our ability to create independent brand awareness for our company and products with end customers, and our inability to achieve such brand awareness could limit our prospects.

 

We depend on wireless carriers to promote and distribute our products. While we intend to ramp up direct marketing and end-customer brand awareness initiatives in the future, our sales and marketing efforts have historically been predominantly focused on channel partners. To increase end-customer brand awareness, we intend to develop sales tools for key verticals within are target markets, increase usage of social media and expand product training efforts, among other things. As a result, we expect our sales and marketing expenses to increase in the future, primarily from increased sales personnel expenses, which will require us to cost-efficiently ramp up our sales and marketing capabilities and effectively target end customers. However, there can be no assurance that we will successfully increase our brand awareness or do so in a cost-efficient manner while maintaining market share within our existing sales channels. Our failure to establish stand-alone brand awareness with end customers of our products will leave us vulnerable to the marketing and selling success of others, including our channel partners, and these developments could have an adverse impact on our prospects. If we are unable to significantly increase the awareness of our brand and solutions with end customers in a cost-efficient manner, we will remain significantly dependent on our channel partners for sales of our products, and our business, financial condition and results of operations could be adversely impacted.

 

We are dependent on the continued services and performance of a concentrated group of senior management and other key personnel, the loss of any of whom could adversely impact our business.

 

Our future success depends in large part on the continued contributions of a concentrated group of senior management and other key personnel. In particular, the leadership of key management personnel is critical to the successful management of our company, the development of our solutions and our strategic direction. We also depend on the contributions of key technical personnel. Our senior management and key personnel are all employed on an at-will basis, which means that they could terminate their employment with us at any time, for any reason and without notice. The loss of any of our key personnel could significantly delay or prevent the achievement of our development and strategic objectives and harm our business.

 

We compete in a rapidly evolving market, and the failure to respond quickly and effectively to changing market requirements could cause our business and operating results to decline.

 

The mobile device market is characterized by rapidly changing technology, changing customer needs, evolving industry standards and frequent introductions of new products and services. In order to deliver a competitive mobile device, our solutions must be capable of operating in an increasingly complex network environment. As new wireless phones are introduced and standards in the mobile device market evolve, we may be required to modify our phones and services to make them compatible with these new products and standards. Likewise, if our competitors introduce new devices and services that compete with ours, we may be required to reposition our solutions or introduce new phones and solutions in response to such competitive pressure. We may not be successful in modifying our current devices or introducing new ones in a timely or appropriately responsive manner, or at all. If we fail to address these changes successfully, our business and operating results could be significantly harmed.

 

Because we rely on a small number of channel partners/customers for a large portion of our revenue, the loss of any of these customers would have a material adverse effect on our operating results and cash flows.

 

In 2019, we derived 49% of our revenue from a four customers/channel partners. Any termination of a business relationship with, or a significant sustained reduction in business from, one or more of these channel partners/customers could have a material adverse effect on our operating results and cash flows.

 

14

 

 

If dedicated public safety LTE networks are not deployed at the rate we anticipate or at all, demand for our solutions may not grow as expected.

 

A key part of our strategy is to further expand the use of our solutions over dedicated LTE networks in the public safety market. If the deployment of dedicated LTE networks is delayed or such networks are not adopted at the rate we anticipate, demand for our solutions may not develop as we anticipate, which would have a negative effect on our revenues.

 

If we are unable to sell our solutions into new markets, our revenues may not grow.

 

Any new market into which we attempt to sell our solutions may not be receptive. Our ability to penetrate new markets depends on the quality of our solutions, the continued adoption of our public safety solution by first responders, the perceived value of our solutions as a risk management tool and our ability to design our solutions to meet the demands of our customers. If the markets for our solutions do not develop as we expect, our revenues may not grow.

 

Our ability to successfully face these challenges depends on several factors, including increasing the awareness of our solutions and their benefits, the effectiveness of our marketing programs, the costs of our solutions, our ability to attract, retain and effectively train sales and marketing personnel, and our ability to develop relationships with wireless carriers and other partners. If we are unsuccessful in developing and marketing our solutions into new markets, new markets for our solutions might not develop or might develop more slowly than we expect, either of which would harm our revenues and growth prospects.

 

If we are unable to attract, integrate and retain additional qualified personnel, including top technical talent, our business could be adversely impacted.

 

Our future success depends in part on our ability to identify, attract, integrate and retain highly skilled technical, managerial, sales and other personnel. We face intense competition for qualified individuals from numerous other companies, including other software and technology companies, many of whom have greater financial and other resources than we do. Some of these characteristics may be more appealing to high-quality candidates than those we have to offer. In addition, new hires often require significant training and, in many cases, take significant time before they achieve full productivity. We may incur significant costs to attract and retain qualified personnel, including significant expenditures related to salaries and benefits and compensation expenses related to equity awards, and we may lose new employees to our competitors or other companies before we realize the benefit of our investment in recruiting and training them. Moreover, new employees may not be or become as productive as we expect, as we may face challenges in adequately or appropriately integrating them into our workforce and culture. If we are unable to attract, integrate and retain suitably qualified individuals who are capable of meeting our growing technical, operational and managerial requirements on a timely basis or at all, our business will be adversely impacted.

 

Volatility or lack of positive performance in our stock price may also affect our ability to attract and retain our key employees. Many of our senior management personnel and other key employees have become, or will soon become, vested in a substantial amount of stock or stock options. Employees may be more likely to leave us if the shares they own or the shares underlying their vested options have significantly appreciated in value relative to the original purchase prices of the shares or the exercise prices of the options, or, conversely, if the exercise prices of the options that they hold are significantly above the market price of our Common Shares. If we are unable to appropriately incentivize and retain our employees through equity compensation, or if we need to increase our compensation expenses in order to appropriately incentivize and retain our employees, our business, operating results and financial condition would be adversely impacted.

 

15

 

 

The application development ecosystem supporting our devices and related accessories is new and evolving.

 

The application development ecosystem supporting our devices and related accessories is new and evolving. Specifically, the number of application developers in the ecosystem supporting our devices and accessories is small. If the market or the application development ecosystem does not develop, timely or at all, demand for our products may be limited, and our business and results of operations will be significantly harmed.

 

The impact of potential changes in customs, tariffs, and trade policies in the United States and the potential corresponding actions by other countries, including recent trade initiatives announced by the U.S. presidential administration against China, in which we do business could adversely impact our financial performance.

 

The U.S. government has made proposals that are intended to address trade imbalances, which include encouraging increased production in the United States. These proposals could result in increased customs duties and tariffs, and the renegotiation of some U.S. trade agreements. We import a significant percentage of our products into the United States, and an increase in customs duties and tariffs with respect to these imports could negatively impact our financial performance. If such customs duties and tariffs are implemented, it also may cause U.S. trading partners to take actions with respect to U.S. imports or U.S. investment activities in their respective countries. Any potential changes in trade policies in the United States and the potential corresponding actions by other countries in which we do business could adversely impact our financial performance. Given the level of uncertainty over which provisions will be enacted, we cannot predict with certainty the impact of the proposals.

 

For example, in 2018, the U.S. presidential administration and Chinese government imposed significant tariffs on exports between the two countries. This evolving policy dispute between China and the United States is likely to have significant impact on the industries in which we participate, directly and indirectly, and no assurance can be given that any individual customer or significant groups of companies or a particular industry, will not be adversely impacted by any governmental actions taken by either China or the United States. In addition, we manufacture our mobile phones at our facility in Shenzhen, China, which could result in significant additional costs to us when shipping our products to various customers in the United States. It is not possible to predict with any certainty the outcome of the trade dispute between the United States and China, and prolonged or increased tariffs on imports from China to the United States would adversely impact our business, results of operations and financial condition.

 

Our products are subject to risks associated with sourcing and manufacturing.

 

We do not own or operate any of the manufacturing facilities for our products and rely on a concentrated number of independent suppliers to manufacture all of the products we sell. For our business to be successful, our suppliers must provide us with quality products in substantial quantities, in compliance with regulatory requirements, at acceptable costs and on a timely basis. Our ability to obtain a sufficient selection or volume of merchandise on a timely basis at competitive prices could suffer as a result of any deterioration or change in our supplier relationships or events that adversely affect our suppliers.

 

There can be no assurance we will be able to detect, prevent or fix all defects that may affect our products manufactured by our suppliers. Failure to detect, prevent or fix defects, or the occurrence of real or perceived quality or safety problems or material defects in our current and future products, could result in a variety of consequences, including a greater number of product returns than expected from customers and our wholesale partners, litigation, product recalls and credit, warranty or other claims, among others, which could harm our brand, results of operations and financial condition. Such problems could hurt our brand image, which is critical to maintaining and expanding our business. Any negative publicity or lawsuits filed against us related to the perceived quality and safety of our products could harm our brand and decrease demand for our products.

 

If one or more of our significant suppliers were to sever their relationship with us or significantly alter the terms of our relationship, including due to changes in applicable trade policies, we may not be able to obtain replacement products in a timely manner, which could have a material adverse effect on our business, results of operations and financial condition.

 

In addition, if any of our primary suppliers fail to make timely shipments, do not meet our quality standards or otherwise fail to deliver us product in accordance with our plans, there could be a material adverse effect on our results of operations.

 

16

 

 

Our contractors and suppliers buy raw materials and are subject to wage rates that are oftentimes regulated by the governments of the countries in which our products are manufactured. The raw materials used to manufacture our products are subject to availability constraints and price volatility. There could be a significant disruption in the supply of raw materials from current sources or, in the event of a disruption, our suppliers might not be able to locate alternative suppliers of materials of comparable quality at an acceptable price or at all. Our business is dependent upon the ability of our unaffiliated suppliers to locate, train, employ and retain adequate personnel. Our unaffiliated suppliers have experienced, and may continue to experience in the future, unexpected increases in work wages, whether government-mandated or otherwise. Our suppliers may increase their pricing if their raw materials became more expensive. Our suppliers may pass the increase in sourcing costs to us through price increases, thereby impacting our margins. Material changes in the pricing practices of our suppliers could negatively impact our profitability.

 

In addition, we cannot be certain that our unaffiliated suppliers will be able to fill our orders in a timely manner. If we experience significant increases in demand, or reductions in the availability of materials, or need to replace an existing supplier, there can be no assurance additional supplies of raw materials or additional manufacturing capacity will be available when required on terms acceptable to us, or at all, or that any supplier would allocate sufficient capacity to us in order to meet our requirements. In addition, even if we are able to expand existing or find new manufacturing or sources of materials, we may encounter delays in production and added costs as a result of the time it takes to train suppliers in our methods, products, quality control standards and labor, health and safety standards. Any delays, interruption or increased costs in labor or wages, or the supply of materials or manufacture of our products, could have an adverse effect on our ability to meet wholesale partner and customer and consumer demand for our products and result in lower revenue and net income both in the short and long term.

 

Events that adversely impact our suppliers could impair our ability to obtain adequate and timely supplies. Such events include, among others, difficulties or problems associated with our suppliers’ business, the financial instability and labor problems of suppliers, merchandise quality and safety issues, natural or man-made disasters, inclement weather conditions, war, acts of terrorism and other political instability, economic conditions, transportation delays and shipment issues. Our suppliers may be forced to reduce their production, shut down their operations or file for bankruptcy. Our suppliers may consolidate, increasing their market power. The occurrence of one or more of these events could impact our ability to get products to our customers and/or wholesale partners, result in disruptions to our operations, increase our costs and decrease our profitability.

 

Global sourcing and foreign trade involve numerous factors and uncertainties beyond our control, including:

 

  increased shipping costs;

 

  the imposition of additional import or trade restrictions;

 

  legal or economic restrictions on overseas suppliers’ ability to produce and deliver products;

 

  increased custom duties and tariffs;

 

  unforeseen delays in customs clearance of goods;

 

  more restrictive quotas;

 

  loss of a most favored nation trading status;

 

  currency exchange rates;

 

  transportation delays;

 

  port of entry issues; and

 

  foreign government regulations, political instability and economic uncertainties in the countries from which we or our suppliers source our products.

  

17

 

 

 Our sourcing operations may also be hurt by health concerns regarding the outbreak of viruses, widespread illness, infectious diseases, contagions and the occurrence of unforeseen epidemics (including the outbreak of the coronavirus and its potential impact on our financial results) in countries in which our merchandise is produced. Moreover, negative press or reports about internationally manufactured products may sway public opinion, and thus customer confidence, away from our products. Furthermore, changes in U.S. trade policies, including new restrictions, tariffs or other changes could lead to additional costs, delays in shipments, embargos and other uncertainties that could negatively impact our relationships with our international suppliers and materially adversely affect our business. These and other issues affecting our international suppliers or internationally manufactured merchandise could have a material adverse effect on our business, results of operations and financial condition.

 

In addition, some of our suppliers may not have the capacity to supply us with sufficient merchandise to keep pace with our growth plans, especially if we need significantly greater amounts of inventory. In such cases, our ability to pursue our growth strategy will depend in part upon our ability to develop new supplier relationships.

 

A security breach or other significant disruption of our IT systems or those of our partners, suppliers or manufacturers, caused by cyberattacks or other means, could have a negative impact on our operations, sales, and operating results.

 

All IT systems are potentially vulnerable to damage, unauthorized access or interruption from a variety of sources, including but not limited to, cyberattacks, cyber intrusions, computer viruses, security breaches, energy blackouts, natural disasters, terrorism, sabotage, war, insider trading and telecommunication failures. A cyberattack or other significant disruption involving our IT systems or those of our outsource partners, suppliers or manufacturers could result in the unauthorized release of proprietary, confidential or sensitive information of ours or result in virus and malware installation on our devices. Such unauthorized access to, or release of, this information or other security breaches could: (i) allow others to unfairly compete with us, (ii) compromise safety or security, (iii) subject us to claims for breach of contract, tort, and other civil claims, and (iv) damage our reputation. Any or all of the foregoing could have a negative impact on our business, financial condition and results of operations.

 

We experience lengthy sales cycles for our products and the delay of an expected large order could result in a significant unexpected revenue shortfall.

 

The purchase of our products is often an enterprise-wide decision for prospective customers, which requires us to engage in sales efforts over an extended period of time and provide a significant level of education to prospective customers regarding the uses and benefits of such devices. Prospective customers, especially the wireless carriers that sell our products, often undertake a prolonged evaluation process that may take from several months to several years in certain cases. Consequently, if our forecasted sales from a specific customer are not realized, we may not be able to generate revenues from alternative sources in time to compensate for the shortfall. The loss or delay of an expected large order could also result in a significant unexpected revenue shortfall. Moreover, to the extent we enter into and deliver our products pursuant to significant contracts earlier than we expected, our operating results for subsequent periods may fall below expectations. We may spend substantial time, effort and money on our sales and marketing efforts without any assurance that our efforts will produce any sales. If we are unable to succeed in closing sales with new and existing customers, our business, operating results and financial condition will be harmed.

 

18

 

 

We have a limited history of high-volume commercial production of our devices, and we may face manufacturing capacity constraints.

 

We have limited history and experience in high-volume commercial production of our devices. Because of this limited production history, we face challenges in predicting our business and evaluating its prospects, which may result in breakdowns of our ability to timely supply our devices to our customers. Moreover, we face manufacturing capacity constraints that present further risks to our business. If overall demand of our devices increases in the future, we will need to expand our manufacturing capacity in a cost-efficient manner. Failing to meet customer demand due to our failure to successfully address these risks and challenges could adversely impact our reputation and future sales, which would significantly harm our business, results of operations and financial condition.

 

The unfavorable outcome of any future litigation, arbitration or administrative action could have a significant adverse impact on our financial condition or results of operations.

 

From time to time we are a party to litigation, arbitration, or administrative actions. Our financial results and reputation could be negatively impacted by unfavorable outcomes to any future litigation or administrative actions, including those related to the Foreign Corrupt Practices Act, the U.K. Bribery Act, or other anti-corruption laws. There can be no assurances as to the favorable outcome of any litigation or administrative proceedings. In addition, it can be very costly to defend litigation or administrative proceedings and these costs could negatively impact our financial results.

 

The nature of our business may result in undesirable press coverage or other negative publicity, which would adversely impact our brand identity, future sales and results of operations.

 

Our solutions are used to assist law enforcement and other public safety personnel in situations involving public safety. The incidents in which our solutions are deployed may involve injury, loss of life and other negative outcomes, and such events are likely to receive negative publicity. Such negative publicity could have an adverse impact on new sales or renewals or expansions of coverage areas by existing customers, which would adversely impact our financial results and business.

 

Changes in the availability of federal funding to support local public safety or other public sector efforts could impact our opportunities with public sector end customers.

 

Many of our public sector end customers rely to some extent on funds from the U.S. federal government in order to purchase and pay for our solutions. Any reduction in federal funding for local public safety or other public sector efforts could result in our end customers having less access to funds required to continue, renew, expand or pay for our solutions. For example, changes in policies with respect to “sanctuary cities” may result in a reduction in federal funds available to our current or potential end customers. Additionally, the recent U.S. government partial shutdown, and any future U.S. government shutdowns, could result in delayed public safety spending or re-allocation of funding into other areas of public safety. If federal funding is reduced or eliminated and our end customers cannot find alternative sources of funding to purchase our solutions, our business will be harmed.

 

19

 

 

Economic uncertainties or downturns, or political changes, could limit the availability of funds available to our customers and potential customers, which could significantly adversely impact our business.

 

Current or future economic uncertainties or downturns could adversely impact our business and operating results. Negative conditions in the general economy both in the United States and abroad, including conditions resulting from changes in gross domestic product growth, financial and credit market fluctuations, political deadlock, natural catastrophes, warfare and terrorist attacks in North America, Europe, the Asia Pacific region or elsewhere, could cause a decrease in funds available to our customers and potential customers and negatively affect the growth rate of our business.

 

These economic conditions may make it extremely difficult for our customers and us to forecast and plan future budgetary decisions or business activities accurately, and they could cause our customers to reevaluate their decisions to purchase our solutions, which could delay and lengthen our sales cycles or result in cancellations of planned purchases. Furthermore, during challenging economic times or as a result of political changes, our customers may tighten their budgets and face constraints in gaining timely access to sufficient funding or other credit, which could result in an impairment of their ability to make timely payments to us. In turn, we may be required to increase our allowance for doubtful accounts, which would adversely impact our financial results.

 

We cannot predict the timing, strength or duration of any economic slowdown, instability or recovery, generally or within any particular industry, or the impact of political changes. If the economic conditions of the general economy or industries in which we operate worsen from present levels, or if recent political changes result in less funding being available to purchase our solutions, our business, operating results and financial condition could be adversely impacted.

 

Failure of our suppliers, subcontractors, distributors, resellers, and representatives to use acceptable legal or ethical business practices, or to fail for any other reason, could negatively impact our business.

 

We do not control the labor and other business practices of our suppliers, subcontractors, distributors, resellers and third-party sales representatives, or TPSRs, and cannot provide assurance that they will operate in compliance with applicable rules, and regulations regarding working conditions, employment practices, environmental compliance, anti-corruption, and trademark a copyright and patent licensing. If one of our suppliers, subcontractors, distributors, resellers, or TPSRs violates labor or other laws or implements labor or other business practices that are regarded as unethical, the shipment of finished products to us could be interrupted, orders could be canceled, relationships could be terminated, and our reputation could be damaged. If one of our suppliers or subcontractors fails to procure the necessary license rights to trademarks, copyrights or patents, legal action could be taken against us that could impact the saleability of our products and expose us to financial obligations to a third party. Any of these events could have a negative impact on our sales and results of operations.

 

Moreover, any failure of our suppliers, subcontractors, distributors, resellers and TPSRs, for any reason, including bankruptcy or other business disruption, could disrupt our supply or distribution efforts and could have a negative impact on our sales and results of operations.

 

Natural or man-made disasters and other similar events may significantly disrupt our business, and negatively impact our operating results and financial condition.

 

Any of our facilities may be harmed or rendered inoperable by natural or man-made disasters, including earthquakes, tornadoes, hurricanes, wildfires, floods, nuclear disasters, acts of terrorism or other criminal activities, infectious disease outbreaks, and power outages, which may render it difficult or impossible for us to operate our business for some period of time. Our facilities would likely be costly to repair or replace, and any such efforts would likely require substantial time. Any disruptions in our operations could negatively impact our business and operating results, and harm our reputation. In addition, we may not carry business insurance or may not carry sufficient business insurance to compensate for losses that may occur. Any such losses or damages could have a significant adverse impact on our business, operating results and financial condition. In addition, the facilities of significant vendors may be harmed or rendered inoperable by such natural or man-made disasters, which may cause disruptions, difficulties or significant adverse impact on our business.

 

20

 

 

We are exposed to risks associated with strategic acquisitions and investments.

 

We may consider strategic acquisitions of companies with complementary technologies or intellectual property in the future. Acquisitions hold special challenges in terms of successful integration of technologies, products, services and employees. We may not realize the anticipated benefits of these acquisitions or the benefits of any other acquisitions we have completed or may complete in the future, and we may not be able to incorporate any acquired services, products or technologies with our existing operations, or integrate personnel from the acquired businesses, in which case our business could be harmed.

 

Acquisitions and other strategic decisions involve numerous risks, including:

 

  problems integrating and divesting the operations, technologies, personnel, services or products over geographically disparate locations;

 

  unanticipated costs, taxes, litigation and other contingent liabilities;

 

  continued liability for discontinued businesses and pre-closing activities of divested businesses or certain post-closing liabilities which we may agree to assume as part of the transaction in which a particular business is divested;

 

  adverse impacts on existing business relationships with suppliers and customers;

 

  cannibalization of revenues as customers may seek multi-product discounts;

 

  risks associated with entering into markets in which we have no, or limited, prior experience;

 

  incurrence of significant restructuring charges if acquired products or technologies are unsuccessful;

 

  significant diversion of management’s attention from our core business and diversion of key employees’ time and resources;

 

  licensing, indemnity or other conflicts between existing businesses and acquired businesses;

 

  inability to retain key customers, distributors, suppliers, vendors and other business relations of the acquired business; and

 

  potential loss of our key employees or the key employees of an acquired organization or as a result of discontinued businesses.

 

Financing for future acquisitions may not be available on favorable terms, or at all. If we identify an appropriate acquisition candidate for any of our businesses, we may not be able to negotiate the terms of the acquisition successfully, finance the acquisition or integrate the acquired business, products, service offerings, technologies or employees into our existing business and operations. Future acquisitions and divestitures may not be well-received by the investment community, which may cause the value of our stock to fall. We cannot ensure that we will be able to identify or complete any acquisition, divestiture or discontinued business in the future. Further, the terms of our indebtedness constrain our ability to make and finance additional acquisitions or divestitures.

 

If we acquire businesses, new products, service offerings or technologies in the future, we may incur significant acquisition-related costs. In addition, we may be required to amortize significant amounts of finite-lived intangible assets and we may record significant amounts of goodwill or indefinite-lived intangible assets that would be subject to testing for impairment. We have in the past and may in the future be required to write off all or part of the intangible assets or goodwill associated with these investments that could harm our operating results. If we consummate one or more significant future acquisitions in which the consideration consists of stock or other securities, our existing stockholders’ ownership could be significantly diluted. If we were to proceed with one or more significant future acquisitions in which the consideration included cash, we could be required to use a substantial portion of our cash and investments. Acquisitions could also cause operating margins to fall depending on the businesses acquired.

 

Our strategic investments may involve joint development, joint marketing, or entry into new business ventures, or new technology licensing. Any joint development efforts may not result in the successful introduction of any new products or services by us or a third party, and any joint marketing efforts may not result in increased demand for our products or services. Further, any current or future strategic acquisitions and investments by us may not allow us to enter and compete effectively in new markets or enhance our business in our existing markets and we may have to impair the carrying amount of our investments.

 

21

 

 

We could be adversely impacted by changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters.

 

Generally accepted accounting principles and related accounting pronouncements, implementation guidelines, and interpretations with regard to a wide range of matters that are relevant to our businesses, including, but not limited to, revenue recognition, asset impairment, inventories, customer rebates and other customer consideration, tax matters, and litigation and other contingent liabilities are highly complex and involve many subjective assumptions, estimates and judgments. Changes in these rules or their interpretation or changes in underlying assumptions, estimates or judgments could significantly change our reported or expected financial performance or financial condition. New accounting guidance may also require systems and other changes that could increase our operating costs and/or change our financial statements. For example, implementing future accounting guidance related to revenue, accounting for leases and other areas could require us to make significant changes to our accounting systems, impact existing debt agreements and result in adverse changes to our financial statements.

 

We face risks related to Novel Coronavirus (COVID-19) which could significantly disrupt our research and development, operations, sales, and financial results.

 

Our business will be adversely impacted by the effects of the Novel Coronavirus (COVID-19). In addition to global macroeconomic effects, the Novel Coronavirus (COVID-19) outbreak and any other related adverse public health developments will cause disruption to our operations, research and development, and sales activities. Our third-party manufacturers, third-party distributors, and our customers have been and will be disrupted by worker absenteeism, quarantines and restrictions on employees’ ability to work, office and factory closures, disruptions to ports and other shipping infrastructure, border closures, or other travel or health-related restrictions. Depending on the magnitude of such effects on our activities or the operations of our third-party manufacturers and third-party distributors, the supply of our products will be delayed, which could adversely affect our business, operations and customer relationships. In addition, the Novel Coronavirus (COVID-19) or other disease outbreak will in the short-run and may over the longer term adversely affect the economies and financial markets of many countries, resulting in an economic downturn that will affect demand for our products and impact our operating results. There can be no assurance that any decrease in sales resulting from the Novel Coronavirus (COVID-19) will be offset by increased sales in subsequent periods. Although the magnitude of the impact of the Novel Coronavirus (COVID-19) outbreak on our business and operations remains uncertain, the continued spread of the Novel Coronavirus (COVID-19) or the occurrence of other epidemics and the imposition of related public health measures and travel and business restrictions will adversely impact our business, financial condition, operating results and cash flows. In addition, we have experienced and will experience disruptions to our business operations resulting from quarantines, self-isolations, or other movement and restrictions on the ability of our employees to perform their jobs that may impact our ability to develop and design our products in a timely manner or meet required milestones or customer commitments.

 

22

 

 

Risks Related to Government Regulation

 

We are subject to anti-corruption, anti-bribery, anti-money laundering, economic sanctions, export control, and similar laws. Non-compliance with such laws can subject us to criminal or civil liability and harm our business, revenues, financial condition and results of operations.

 

We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C. § 201, the U.S. Travel Act, and other anti-bribery and anti-money laundering laws in the countries in which we conduct activities. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years and are interpreted broadly to generally prohibit companies and their employees and third-party intermediaries from authorizing, offering, or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector. As we increase our international presence, we may engage with distributors and third-party intermediaries to market our solutions and to obtain necessary permits, licenses, and other regulatory approvals. In addition, we or our third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities. We can be held liable for the corrupt or other illegal activities of these third-party intermediaries, our employees, representatives, contractors, partners and agents, even if we do not explicitly authorize such activities.

 

The United States has imposed economic sanctions that affect transactions with designated foreign countries, nationals and others. In particular, the United States prohibits U.S. persons from engaging with individuals and entities identified as “Specially Designated Nationals,” such as terrorists and narcotics traffickers. These prohibitions are administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control, or OFAC. OFAC rules prohibit U.S. persons from engaging in, or facilitating a foreign person’s engagement in, transactions with or relating to the prohibited individual, entity or country, and require the blocking of assets in which the individual, entity or country has an interest. Blocked assets (e.g., property or bank deposits) cannot be paid out, withdrawn, set off or transferred in any manner without a license from OFAC. Other countries in which we operate, including Canada and the United Kingdom, also maintain economic and financial sanctions regimes.

 

Some of our solutions, including software updates and third-party accessories, may be subject to U.S. export control laws, including the Export Administration Regulations; however, the vast majority of our products are non-U.S.-origin items, developed and manufactured outside of the United States, and therefore not subject to these laws. For third-party accessories, we rely on manufactures to supply the appropriate export control classification numbers that determine our obligations under these laws.

 

23

 

 

We cannot assure you that our employees and agents will not take actions in violation of our policies and applicable law, for which we may be ultimately held responsible. As we increase our international presence, our risks under these laws, rules, and regulations may increase. Further, any change in the applicability or enforcement of these laws, rules, and regulations could adversely impact our business operations and financial results.

 

Detecting, investigating and resolving actual or alleged violations can require a significant diversion of time, resources, and attention from senior management. In addition, noncompliance with anti-corruption, anti-bribery, anti-money laundering, or economic sanctions laws, rules, and regulations could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension and/or debarment from contracting with certain persons, the loss of export privileges, reputational harm, adverse media coverage, and other collateral consequences. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our business, revenues, financial condition, and results of operations would be significantly harmed. In addition, responding to any action will likely result in a significant diversion of management’s attention and resources and significant defense costs and other professional fees. Enforcement actions and sanctions could further harm our business, financial condition and results of operations.

 

We are subject to a wide range of product regulatory and safety, consumer, worker safety and environmental laws and regulations.

 

Our operations and the products we manufacture and/or sell are subject to a wide range of product regulatory and safety, consumer, worker safety and environmental laws and regulations. Compliance with such existing or future laws and regulations could subject us to future costs or liabilities, impact our production capabilities, constrict our ability to sell, expand or acquire facilities, restrict what solutions we can offer and generally impact our financial performance. Our products are designed for use in potentially explosive or hazardous environments. If our product design fails for any reason in such environments, we may be subject to product liabilities and future costs. In addition, some of these laws are environmental and relate to the use, disposal, remediation, emission and discharge of, and exposure to hazardous substances. These laws often impose liability and can require parties to fund remedial studies or actions regardless of fault. Environmental laws have tended to become more stringent over time and any new obligations under these laws could have a negative impact on our operations or financial performance.

 

24

 

 

Laws focused on the energy efficiency of electronic products and accessories, recycling of both electronic products and packaging, reducing or eliminating certain hazardous substances in electronic products, and the transportation of batteries continue to expand significantly. Laws pertaining to accessibility features of electronic products, standardization of connectors and power supplies, the transportation of lithium-ion batteries, and other aspects are also proliferating. There are also demanding and rapidly changing laws around the globe related to issues such as product safety, radio interference, radio frequency radiation exposure, medical related functionality, and consumer and social mandates pertaining to use of wireless or electronic equipment. These laws, and changes to these laws, could have a substantial impact on whether we can offer certain products, solutions, and services, and on what capabilities and characteristics our products or services can or must include.

 

These laws and regulations impact our products and could negatively impact our ability to manufacture and sell products competitively. In addition, we anticipate that we will see increased demand to meet voluntary criteria related to reduction or elimination of certain constituents from products, increasing energy efficiency and providing additional accessibility.

 

Changes in laws and regulations concerning the use of telecommunication bandwidth could increase our costs and adversely impact our business.

 

Our business depends on our ability to sell devices that use telecommunication bandwidth allocated to licensed and unlicensed wireless services, and that use of that bandwidth is subject to laws and regulations that are subject to change over time. Changes in the permitted uses of telecommunication bandwidth, reallocation of such bandwidth to different uses, and new or increased regulation of the capabilities, manufacture, importation, and use of devices that depend on such bandwidth could increase our costs, require costly modifications to our products before they are sold, or limit our ability to sell those products in to our target markets. In addition, we are subject to regulatory requirements for certification and testing of our products before they can be marketed or sold. Those requirements may be onerous and expensive. Changes to those requirements could result in significant additional costs and could adversely impact our ability to bring new products to market in a timely fashion.

 

We are subject to a wide range of privacy and data security laws, regulations and other legal obligations.

 

Personal privacy and information security are significant issues in the United States and the other jurisdictions in which we operate or make our products and applications available. The legislative and regulatory framework for privacy and security issues worldwide is rapidly evolving and is likely to remain uncertain for the foreseeable future. Our handling of data is subject to a variety of laws and regulations, including regulation by various government agencies, including the U.S. Federal Trade Commission, or FTC, and various state, local and foreign agencies. We may collect personally identifiable information, or PII, and other data from our customers. We use this information to provide services to our customers and to support, expand and improve our business. We may also share customers’ PII with third parties as allowed by applicable law and agreements and authorized by the customer or as described in our privacy policy.

 

25

 

 

The U.S. federal and various state and foreign governments have adopted or proposed limitations on the collection, distribution, transfer, use and storage of PII. In the United States, the FTC and many state attorneys general are applying federal and state consumer protection laws as imposing standards for the online collection, use and dissemination of data. Many foreign countries and governmental bodies, including Canada, the European Union and other relevant jurisdictions, have laws and regulations concerning the collection and use of PII obtained from their residents or by businesses operating within their jurisdiction. These laws and regulations often are more restrictive than those in the United States. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, disclosure and security of data that identifies or may be used to identify or locate an individual, such as names, email addresses and, in some jurisdictions, Internet Protocol, or IP, addresses. Within the European Union, legislators have adopted the General Data Protection Regulation, or GDPR, effective May 2018 which may impose additional obligations and risk upon our business and which may increase substantially the penalties to which we could be subject in the event of any non-compliance. We may incur substantial expense in complying with the obligations imposed by the governments of the foreign jurisdictions in which we do business or seek to do business and we may be required to make significant changes in our business operations, all of which may adversely impact our revenues and our business overall.

 

Although we are working to comply with those federal, state, and foreign laws and regulations, industry standards, contractual obligations and other legal obligations that apply to us, those laws, regulations, standards and obligations are evolving and may be modified, interpreted and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another, other requirements or legal obligations, our practices or the features of our products or applications. At state level, lawmakers continue to pass new laws concerning privacy and data security. Particularly notable in this regard is the California Consumer Privacy Act, or CCPA, which became effective on January 1, 2020. The CCPA will introduce significant new disclosure obligations and provide California consumers with significant new privacy rights. Any failure or perceived failure by us to comply with federal, state or foreign laws or regulations, industry standards, contractual obligations or other legal obligations, or any actual or suspected security incident, whether or not resulting in unauthorized access to, or acquisition, release or transfer of PII or other data, may result in governmental enforcement actions and prosecutions, private litigation, fines and penalties or adverse publicity and could cause our customers to lose trust in us, which could have an adverse impact on our reputation and business. Any inability to adequately address privacy and security concerns, even if unfounded, or comply with applicable laws, regulations, policies, industry standards, contractual obligations, or other legal obligations could result in additional cost and liability to us, damage our reputation, inhibit sales and adversely impact our business.

 

We also expect that there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection and information security in the United States, the European Union and other jurisdictions, and we cannot yet determine the impact such future laws, regulations and standards may have on our business. New laws, amendments to or re-interpretations of existing laws and regulations, industry standards, contractual obligations and other obligations may require us to incur additional costs and restrict our business operations. Such laws and regulations may require companies to implement privacy and security policies, permit users to access, correct and delete personal information stored or maintained by such companies, inform individuals of security breaches that affect their personal information, and, in some cases, obtain individuals’ consent to use PII for certain purposes. In addition, a foreign government could require that any PII collected in a country not be disseminated outside of that country, and we are not currently equipped to comply with such a requirement.

 

The effects of the Tax Cuts and Jobs Act on our business have not yet been fully analyzed and could harm our results of operations.

 

On December 22, 2017, U.S. President Donald Trump signed into law the Tax Act that significantly reforms the Code. The Tax Act, among other things, includes changes to U.S. federal corporate income tax rate, imposes significant additional limitations on the deductibility of interest, allows for the accelerated expensing of capital expenditures, and puts into effect the migration from a “worldwide” system of taxation to a territorial system. We continue to analyze the impact that the Tax Act may have on our business. Notwithstanding the reduction in the U.S federal corporate income tax rate, the overall impact of the Tax Act is uncertain, and our business and financial condition could be harmed.

 

26

 

 

Risks Related to Our Intellectual Property

 

If we are unable to successfully protect our intellectual property, our competitive position may be harmed.

 

Our ability to compete is heavily affected by our ability to protect our intellectual property. We rely on a combination of patent licenses, confidentiality procedures and contractual provisions to protect our proprietary rights. We also enter, and plan to continue to enter, into confidentiality, invention assignment or license agreements with our employees, consultants and other parties with whom we contract, and control access to and distribution of our software, documentation and other proprietary information. The steps we take to protect our intellectual property may be inadequate, and it is possible that some or all of our confidentiality agreements will not be honored and certain contractual provisions may not be enforceable. Existing trade secret, trademark and copyright laws offer only limited protection. Unauthorized parties may attempt to copy aspects of our products or obtain and use information which we regard as proprietary. Policing unauthorized use of our products is difficult, time consuming and costly, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the United States. We cannot assure you that our means of protecting our proprietary rights will be adequate or that our competitors will not independently develop similar technology, the effect of either of which would harm our competitive position in the market. Furthermore, disputes can arise with our strategic partners, customers or others concerning the ownership of intellectual property.

 

Others may claim that we infringe on their intellectual property rights, which may result in costly and time-consuming litigation and could delay or otherwise impair the development and commercialization of our products.

 

In recent years, there has been a significant increase in litigation in the United States involving patents and other intellectual property rights, and because our products are comprised of complex technology, we are often involved in or impacted by assertions, including both requests to take licenses and litigation, regarding infringement of patent and other intellectual property rights of third parties. Third parties have asserted, and in the future may assert, intellectual property infringement claims against us and against our channel partners, end customers and suppliers. For example, we have been approached by Wilson Electronics about potential infringement of several of their patents involving cellphone boosters. Many of these assertions are brought by non-practicing entities whose principal business model is to secure patent licensing revenues from product manufacturing companies. Claims for alleged infringement and any resulting lawsuit, if successful, could subject us to significant liability for damages and invalidation of our intellectual property rights. Defending any such claims, with or without merit, including pursuant to indemnity obligations, could be time consuming, expensive, cause product shipment delays or require us to enter into a royalty or licensing agreement, any of which could delay the development and commercialization of our products or reduce our margins. If we are unable to obtain a required license, our ability to sell or use certain products may be impaired. In addition, if we fail to obtain a license, or if the terms of the license are burdensome to us, our operations could be significantly harmed.

 

Our use of open source software could subject us to possible litigation or otherwise impair the development of our products.

 

A portion of our technologies incorporates open source software, including open source operating systems such as Android, and we expect to continue to incorporate open source software into our platform in the future. Few of the licenses applicable to open source software have been interpreted by courts, and their application to the open source software integrated into our proprietary technology platform may be uncertain. If we fail to comply with these licenses, then pursuant to the terms of these licenses, we may be subject to certain requirements, including requirements that we make available the source code for our software that incorporates the open source software. We cannot assure you that we have not incorporated open source software in our software in a manner that is inconsistent with the terms of the applicable licenses or our current policies and procedures. If an author or other third party that distributes such open source software were to allege that we had not complied with the conditions of one or more of these licenses, we could incur significant legal expenses defending against such allegations. Litigation could be costly for us to defend, have a negative effect on our operating results and financial condition or require us to devote additional research and development resources to change our technology platform.

 

With respect to open source operating systems, if third parties cease continued development of such operating systems or restrict our access to such operating system, our business and financial results could be adversely impacted. We are dependent on third parties’ continued development of operating systems, software application ecosystem infrastructures, and such third parties’ approval of our implementations of their operating and system and associated applications. If such parties cease to continue development or support of such operating systems or restrict our access to such operating systems, we would be required to change our strategy for our devices. As a result, our financial results could be negatively impacted because a resulting shift away from the operating systems we currently use and the associated applications ecosystem could be costly and difficult.

 

Our inability to obtain and maintain any third-party license required to develop new products and product enhancements could seriously harm our business, financial condition and results of operations.

 

From time to time, we are required to license technology from third parties to develop new products or product enhancements. Third-party licenses may not be available to us on commercially reasonable terms, or at all. If we fail to renew any intellectual property license agreements on commercially reasonable terms, or any such license agreements otherwise expire or terminate, we may not be able to use the patents and technologies of these third parties in our products, which are critical to our success. We cannot assure you that we will be able to effectively control the level of licensing and royalty fees paid to third parties, and significant increase in such fees could have a significant and adverse impact on our future profitability. Seeking alternative patents and technologies may be difficult and time-consuming, and we may not be successful in finding alternative technologies or incorporating them into our products. Our inability to obtain any third-party license necessary to develop new products or product enhancements could require us to obtain substitute technology of lower quality or performance standards, or at greater cost, which could seriously harm our business, financial condition and results of operations.

 

27

 

 

Risks relating to our locations in Israel and Canada and our international operations

 

Conditions in Israel could materially and adversely affect our business.

 

A number of our officers and directors are residents of Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly affect our business and operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its neighboring countries, as well as terrorist acts committed within Israel by hostile elements. Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its trading partners could adversely affect our operations and results of operations. During the summer of 2006, Israel was engaged in an armed conflict with Hezbollah, a Lebanese Islamist Shiite militia group and political party. In December 2008 and January 2009 there was an escalation in violence among Israel, Hamas, the Palestinian Authority and other groups, as well as extensive hostilities along Israel’s border with the Gaza Strip, which resulted in missiles being fired from the Gaza Strip into Southern Israel. During November 2012 and from July through August 2014, Israel was engaged in an armed conflict with a militia group and political party who controls the Gaza Strip, which resulted in missiles being fired from the Gaza Strip into Southern Israel, as well as at areas more centrally located near Tel Aviv and at areas surrounding Jerusalem. These conflicts involved missile strikes against civilian targets in various parts of Israel, including areas in which our employees and some of our consultants are located, and negatively affected business conditions in Israel. Since February 2011, Egypt has experienced political turbulence and an increase in terrorist activity in the Sinai Peninsula. Such political turbulence and violence may damage peaceful and diplomatic relations between Israel and Egypt, and could affect the region as a whole. Similar civil unrest and political turbulence has occurred in other countries in the region, including Syria, which shares a common border with Israel, and is affecting the political stability of those countries. Since April 2011, internal conflict in Syria has escalated and chemical weapons have been used in the region. Foreign actors have intervened and may continue to intervene in Syria. This instability and any intervention may lead to deterioration of the political and economic relationships that exist between the State of Israel and some of these countries and may lead to additional conflicts in the region. In addition, Iran has threatened to attack Israel and may be developing nuclear weapons. Iran also has a strong influence among extremist groups in the region, including Hamas in Gaza, Hezbollah in Lebanon and various rebel militia groups in Syria. These situations have escalated at various points in recent years and may escalate in the future to more violent events, which may affect Israel and us. Any armed conflicts, terrorist activities or political instability in the region could adversely affect business conditions and could harm our results of operations and could make it more difficult for us to raise capital. Parties with whom we do business have sometimes declined to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements when necessary in order to meet our business partners face to face. In addition, the political and security situation in Israel may result in parties with whom we have agreements involving performance in Israel claiming that they are not obligated to perform their commitments under those agreements pursuant to force majeure provisions in such agreements.

 

Further, in the past, the State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business with the State of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating results, financial condition or the expansion of our business. A campaign of boycotts, divestment and sanctions has been undertaken against Israel, which could also adversely impact our business.

 

In addition, many Israeli citizens are obligated to perform several days, and in some cases more, of annual military reserve duty each year until they reach the age of 40 (or older, for reservists who are military officers or who have certain occupations) and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military reservists. It is possible that there will be military reserve duty call-ups in the future. Our operations could be disrupted by such call-ups, which may include the call-up of members of our management. Such disruption could materially adversely affect our business, prospects, financial condition and results of operations.

 

28

 

 

It may be difficult to enforce a U.S. judgment against us, our officers and directors named in this prospectus in Israel or the United States, or to assert U.S. securities laws claims in Israel or serve process on our officers and directors.

 

Not all of our directors or officers are residents of the United States and most of their and our assets are located outside the United States. Service of process upon us or our non-U.S. resident directors and officers may be difficult to obtain within the United States. We have been informed by our legal counsel in Israel that it may be difficult to assert claims under U.S. securities laws in original actions instituted in Israel or obtain a judgment based on the civil liability provisions of U.S. federal securities laws. Israeli courts may refuse to hear a claim based on a violation of U.S. securities laws against us or our non-U.S. officers and directors because Israel may not be the most appropriate forum to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact, which can be a time-consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel addressing the matters described above. Additionally, Israeli courts might not enforce judgments obtained in the United States against us or our non-U.S. our directors and executive officers, which may make it difficult to collect on judgments rendered against us or our non-U.S. officers and directors.

 

Moreover, an Israeli court will not enforce a non-Israeli judgment if it was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases), if its enforcement is likely to prejudice the sovereignty or security of the State of Israel, if it was obtained by fraud or in the absence of due process, if it is at variance with another valid judgment that was given in the same matter between the same parties, or if a suit in the same matter between the same parties was pending before a court or tribunal in Israel at the time the foreign action was brought. For more information, see “Enforceability of Civil Liabilities.”

 

Because we are a corporation incorporated in British Columbia and some of our directors and officers are resident in Canada, it may be difficult for investors in the United States to enforce civil liabilities against us based solely upon the federal securities laws of the United States. Similarly, it may be difficult for Canadian investors to enforce civil liabilities against our directors and officers residing outside of Canada.

 

We are a corporation incorporated under the laws of British Columbia with our principal place of business in Montreal, Canada. Some of our directors and officers and the auditors or other experts named herein are residents of Canada and all or a substantial portion of our assets and those of such persons are located outside the United States. Consequently, it may be difficult for U.S. investors to effect service of process within the United States upon us or our directors or officers or such auditors who are not residents of the United States, or to realize in the United States upon judgments of courts of the United States predicated upon civil liabilities under the Securities Act. Investors should not assume that Canadian courts: (1) would enforce judgments of U.S. courts obtained in actions against us or such persons predicated upon the civil liability provisions of the U.S. federal securities laws or the securities or blue sky laws of any state within the United States or (2) would enforce, in original actions, liabilities against us or such persons predicated upon the U.S. federal securities laws or any such state securities or blue sky laws.

 

Similarly, some of our directors and officers are residents of countries other than Canada and all or a substantial portion of the assets of such persons are located outside Canada. As a result, it may be difficult for Canadian investors to initiate a lawsuit within Canada against these non-Canadian residents. In addition, it may not be possible for Canadian investors to collect from these non-Canadian residents judgments obtained in courts in Canada predicated on the civil liability provisions of securities legislation of certain of the provinces and territories of Canada. It may also be difficult for Canadian investors to succeed in a lawsuit in the United States, based solely on violations of Canadian securities laws.

 

We have operations in China, which exposes us to risks inherent in doing business there.

 

We use multiple third-party suppliers and manufacturers based primarily in China. With the rapid development of the Chinese economy, the cost of labor has increased and may continue to increase in the future. Furthermore, pursuant to Chinese labor laws, employers in China are subject to various requirements when signing labor contracts, paying remuneration, determining the term of employees’ probation and unilaterally terminating labor contracts. Our results of operations will be materially and adversely affected if the labor costs of our third-party suppliers and manufacturers increase significantly. In addition, we and our manufacturers and suppliers may not be able to find a sufficient number of qualified workers due to the intensely competitive and fluid market for skilled labor in China.

 

29

 

 

Operating in China exposes us to political, legal and economic risks. In particular, the political, legal and economic climate in China, both nationally and regionally, is fluid and unpredictable. Our ability to operate in China may be adversely affected by changes in U.S. and Chinese laws and regulations such as those related to, among other things, taxation, import and export tariffs, environmental regulations, land use rights, intellectual property, currency controls, network security, employee benefits, hygiene supervision and other matters. In addition, we may not obtain or retain the requisite legal permits to continue to operate in China, and costs or operational limitations may be imposed in connection with obtaining and complying with such permits. In addition, Chinese trade regulations are in a state of flux, and we may become subject to other forms of taxation, tariffs and duties in China. Furthermore, the third parties we rely on in China may disclose our confidential information or intellectual property to competitors or third parties, which could result in the illegal distribution and sale of counterfeit versions of our products. If any of these events occur, our business, financial condition and results of operations could be materially and adversely affected.

 

The impact of potential changes in customs, tariffs, and trade policies in the United States and the potential corresponding actions by other countries, including recent trade initiatives announced by the U.S. presidential administration against China, in which we do business could adversely impact our financial performance.

 

The U.S. government has made proposals that are intended to address trade imbalances, which include encouraging increased production in the United States. These proposals could result in increased customs duties and tariffs, and the renegotiation of some U.S. trade agreements. We import a significant percentage of our products into the United States, and an increase in customs duties and tariffs with respect to these imports could negatively impact our financial performance. If such customs duties and tariffs are implemented, it also may cause U.S. trading partners to take actions with respect to U.S. imports or U.S. investment activities in their respective countries. Any potential changes in trade policies in the United States and the potential corresponding actions by other countries in which we do business could adversely impact our financial performance. Given the level of uncertainty over which provisions will be enacted, we cannot predict with certainty the impact of the proposals.

 

For example, in 2018, the U.S. presidential administration and Chinese government imposed significant tariffs on exports between the two countries. This evolving policy dispute between China and the United States is likely to have significant impact on the industries in which we participate, directly and indirectly, and no assurance can be given that any individual customer or significant groups of companies or a particular industry, will not be adversely impacted by any governmental actions taken by either China or the United States. In addition, we manufacture our mobile phones at our facility in Shenzhen, China, which could result in significant additional costs to us when shipping our products to various customers in the United States. It is not possible to predict with any certainty the outcome of the trade dispute between the United States and China, and prolonged or increased tariffs on imports from China to the United States would adversely impact our business, results of operations and financial condition.

 

Operating outside of the United States presents specific risks to our business, and we have substantial operations outside of the United States.

 

Most of our employee base and operations are located outside the United States, primarily in Canada and Israel. Most of our software development, third-party contract manufacturing, and product assembly operations are conducted outside the United States.

 

Risks associated with operations outside the United States include:

 

  effectively managing and overseeing operations that are distant and remote from corporate headquarters may be difficult and may impose increased operating costs;

 

  fluctuating foreign currency rates could restrict sales, increase costs of purchasing, and impact collection of receivables outside of the United States;

 

30

 

 

  volatility in foreign credit markets may affect the financial well-being of our customers and suppliers;

 

  violations of anti-corruption laws, including the Foreign Corrupt Practices Act and the U.K. Bribery Act could result in large fines and penalties;

 

  violations of privacy and data security laws could result in large fines and penalties; and

 

  tax disputes with foreign taxing authorities, and any resultant taxation in foreign jurisdictions associated with operations in such jurisdictions, including with respect to transfer pricing practices associated with such operations.

 

Foreign currency fluctuations may reduce our competitiveness and sales in foreign markets.

 

The relative change in currency values creates fluctuations in product pricing for international customers. These changes in foreign end-customer costs may result in lost orders and reduce the competitiveness of our products in certain foreign markets. These changes may also negatively impact the financial condition of some foreign customers and reduce or eliminate their future orders of our products.

 

  adverse changes in, or uncertainty of, local business laws or practices, including the following:

 

  foreign governments may impose burdensome tariffs, quotas, taxes, trade barriers, or capital flow restrictions;

 

  restrictions on the export or import of technology may reduce or eliminate the ability to sell in or purchase from certain markets;

 

  political and economic instability, including deterioration of political relations between the United States and other countries, may reduce demand for our solutions or put our non-U.S. assets at risk;

 

  potentially limited intellectual property protection in certain countries may limit recourse against infringing on our solutions or cause us to refrain from selling in certain geographic territories;

 

  staffing may be difficult along with higher turnover at international operations;

 

  a government-controlled exchange rate and limitations on the convertibility of currencies, including the Chinese yuan;

 

  transportation delays and customs related delays that may affect production and distribution of our products; and

 

  integration and enforcement of laws vary significantly among jurisdictions and may change significantly over time.

 

Our failure to manage any of these risks successfully could harm our international operations and adversely impact our business, operating results and financial condition.

 

Risks Related to this Offering and Our Securities

 

We do not know whether an active, liquid and orderly trading market will develop for our common shares or what the market price of our common shares will be and as a result it may be difficult for you to sell your common shares.

 

Prior to this offering there has been no public market for our common shares in the United States. Although we have applied to list our common shares on The Nasdaq Capital Market, or Nasdaq, an active trading market for our shares may never develop or be sustained following this offering. You may not be able to sell your shares quickly or at the market price if trading in our common shares is not active. The initial public offering price for our common shares will be determined through negotiations with the underwriters, and the negotiated price may not be indicative of the market price of the common shares after the offering. As a result of these and other factors, you may be unable to resell your common shares at or above the initial public offering price. Further, an inactive market may also impair our ability to raise capital by selling our common shares and may impair our ability to enter into strategic partnerships or acquire companies or products by using our common shares as consideration.

 

31

 

 

We expect that our stock price will fluctuate significantly, and you may not be able to resell your shares at or above the initial public offering price.

 

The trading price of our common shares is likely to be volatile and subject to wide price fluctuations in response to various factors, including:

 

  market conditions in the broader stock market in general, or in our industry in particular;

 

  actual or anticipated fluctuations in our quarterly financial and operating results;

 

  introduction of new products and services by us or our competitors;

 

  sales, or anticipated sales, of large blocks of our stock;

 

  issuance of new or changed securities analysts’ reports or recommendations;

 

  failure of industry or securities analysts to maintain coverage of our company, changes in financial estimates by any industry or securities analysts that follow our company, or our failure to meet such estimates;

 

  additions or departures of key personnel;

 

  regulatory or political developments;

 

  changes in accounting principles or methodologies;

 

  acquisitions by us or by our competitors;

 

  litigation and governmental investigations; and

 

  economic, political and geopolitical conditions or events.

 

These and other factors may cause the market price and demand for our common shares to fluctuate substantially, which may limit or prevent investors from readily selling their common shares and may otherwise negatively affect the liquidity of our common shares. If the market price of our common shares after this offering does not exceed the initial public offering price, you may not realize any return on your investment in us and may lose some or all of your investment. In addition, in the past, when the market price of a stock has been volatile, holders of that stock have often instituted securities class action litigation against the company that issued the stock. If any of our stockholders brought a lawsuit against us, we could incur substantial costs defending the lawsuit. Such a lawsuit could also divert the time and attention of our management from our business.

 

Warrants are speculative in nature. 

 

The warrants offered in this offering do not confer any rights of common share ownership on their holders, such as voting rights or the right to receive dividends, but rather merely represent the right to acquire common shares at a fixed price for a limited period of time. Specifically, commencing on the date of issuance, holders of the warrants may exercise their right to acquire the common shares and pay an exercise price of $  per share (with an exercise price no less than 100% of the public offering price of a Unit), prior to five years from the date of issuance, after which date any unexercised warrants will expire and have no further value. In addition, there is no established trading market for the warrants and we do not expect a market to develop.

 

Holders of the warrants will have no rights as a common shareholder until they acquire our common shares.

 

Until holders of the warrants acquire common shares upon exercise of the warrants, the holders will have no rights with respect to the common shares issuable upon exercise of the warrants. Upon exercise of the warrants, the holder will be entitled to exercise the rights of a common shareholder as to the security exercised only as to matters for which the record date occurs after the exercise. 

 

There is no established market for the warrants to purchase our common shares being offered in this offering.

 

There is no established trading market for the warrants and we do not expect a market to develop. Although we have applied to list the warrants on the Nasdaq Capital Market there can be no assurance that there will be an active trading market for the warrants. Without an active trading market, the liquidity of the warrants will be limited.

 

Provisions of the warrants offered by this prospectus could discourage an acquisition of us by a third party.

 

In addition to the discussion of the provisions of our governing organizational documents, certain provisions of the warrants offered by this prospectus could make it more difficult or expensive for a third party to acquire us. The warrants prohibit us from engaging in certain transactions constituting “fundamental transactions” unless, among other things, the surviving entity assumes our obligations under the warrants. These and other provisions of the warrants offered by this prospectus could prevent or deter a third party from acquiring us even where the acquisition could be beneficial to you. 

 

32

 

 

Our planned __ for 1 reverse stock split may decrease the liquidity of our Common Sshares.

 

The liquidity of our Common Shares may be affected adversely by the reverse stock split given the reduced number of Common Shares that will be outstanding following the reverse stock split. In addition, the reverse stock split may increase the number of stockholders who own odd lots (less than 100 shares) of our Common Shares, creating the potential for such stockholders to experience an increase in the cost of selling their Common Shares and greater difficulty effecting such sales.

 

Following the reverse stock split, the resulting market price of our Common Shares may not attract new investors, including institutional investors, and may not satisfy the investing requirements of those investors. Consequently, the trading liquidity of our Common Shares may not improve.

 

Although we believe that a higher market price of our Common Shares may help generate greater or broader investor interest, there can be no assurance that the reverse stock split will result in a Common Share price that will attract new investors, including institutional investors. In addition, there can be no assurance that the market price of our Common Shares will satisfy the investing requirements of those investors.

 

We may require additional capital to fund our business and support our growth, and our inability to generate and obtain such capital on acceptable terms, or at all, could harm our business, operating results, financial condition and prospects.

 

We intend to continue to make substantial investments to fund our business and support our growth. In addition, we may require additional funds to respond to business challenges, including the need to develop new features or enhance our solutions, improve our operating infrastructure or acquire or develop complementary businesses and technologies. As a result, in addition to the revenues we generate from our business and the proceeds from this offering, we may need to engage in additional equity or debt financings to provide the funds required for these and other business endeavors. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our Common Shares. Any debt financing that we may secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain such additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges could be significantly impaired, and our business may be adversely impacted. In addition, our inability to generate or obtain the financial resources needed may require us to delay, scale back, or eliminate some or all of our operations, which may have a significant adverse impact on our business, operating results and financial condition.

 

Because we are a foreign private issuer and are exempt from certain Nasdaq corporate governance standards applicable to U.S. issuers, you will have less protection than you would have if we were a domestic issuer.

 

Nasdaq Listing Rules require listed companies to have, among other things, a majority of its board members be independent. As a foreign private issuer, however, we are permitted to, and we may follow home country practice in lieu of the above requirements, or we may choose to comply with the above requirement within one year of listing. The corporate governance practice in our home country does not require a majority of our board to consist of independent directors. Thus, although a director must act in the best interests of the Company, it is possible that fewer board members will be exercising independent judgment and the level of board oversight on the management of our company may decrease as a result. In addition, Nasdaq Listing Rules also require foreign private issuers to have a compensation committee, a nominating/corporate governance committee composed entirely of independent directors, and an audit committee with a minimum of three members. We, as a foreign private issuer, are not subject to these requirements. Nasdaq Listing Rules may require shareholder approval for certain corporate matters, such as requiring that shareholders be given the opportunity to vote on all equity compensation plans and material revisions to those plans, certain common share issuances. We intend to comply with the requirements of Nasdaq Listing Rules in determining whether shareholder approval is required on such matters and to appoint a nominating and corporate governance committee. We may, however, consider following home country practice in lieu of the requirements under Nasdaq Listing Rules with respect to certain corporate governance standards which may afford less protection to investors.

 

Although as a Foreign Private Issuer we are exempt from certain corporate governance standards applicable to US issuers, if we cannot satisfy, or continue to satisfy, the initial listing requirements and other rules of the Nasdaq Capital Market, our securities may not be listed or may be delisted, which could negatively impact the price of our securities and your ability to sell them.

 

We will seek to have our securities approved for listing on the Nasdaq Capital Market upon consummation of this offering. We cannot assure you that we will be able to meet those initial listing requirements at that time. Even if our securities are listed on the Nasdaq Capital Market, we cannot assure you that our securities will continue to be listed on the Nasdaq Capital Market.

 

In addition, following this offering, in order to maintain our listing on the Nasdaq Capital Market, we will be required to comply with certain rules of the Nasdaq Capital Market, including those regarding minimum shareholders’ equity, minimum share price, minimum market value of publicly held shares, and various additional requirements. Even if we initially meet the listing requirements and other applicable rules of the Nasdaq Capital Market, we may not be able to continue to satisfy these requirements and applicable rules. If we are unable to satisfy the Nasdaq Capital Market criteria for maintaining our listing, our securities could be subject to delisting.

 

33

 

 

If the Nasdaq Capital Market does not list our securities, or subsequently delists our securities from trading, we could face significant consequences, including:

 

  a limited availability for market quotations for our securities;
     
  reduced liquidity with respect to our securities;
     
  a determination that our Common Share is a “penny stock,” which will require brokers trading in our Common Share to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our Common Share;
     
  limited amount of news and analyst coverage; and
     
  a decreased ability to issue additional securities or obtain additional financing in the future.

 

If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired.

 

After the closing of this offering, we will be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, the Sarbanes-Oxley Act and the rules and regulations of Nasdaq. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal controls over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with accounting principles generally accepted in the U.S.. Commencing with our fiscal year ending December 31, 2020, we must perform system and process evaluation and testing of our internal controls over financial reporting to allow management to report on the effectiveness of our internal controls over financial reporting in our Form 20-F filing for that year, as required by Section 404 of the Sarbanes-Oxley Act. This will require that we incur substantial additional professional fees and internal costs to expand our accounting and finance functions and that we expend significant management efforts. Prior to this offering, we have never been required to test our internal controls within a specified period, and, as a result, we may experience difficulty in meeting these reporting requirements in a timely manner.

 

During the evaluation and testing process of our internal controls, if we identify one or more material weaknesses in our internal control over financial reporting, we will be unable to assert that our internal control over financial reporting is effective. We cannot assure you that there will not be material weaknesses or significant deficiencies in our internal control over financial reporting in the future. Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition or results of operations. If we are unable to conclude that our internal control over financial reporting is effective, or if our independent registered public accounting firm determines we have a material weakness or significant deficiency in our internal control over financial reporting, we could lose investor confidence in the accuracy and completeness of our financial reports, the market price of our common shares could decline, and we could be subject to sanctions or investigations by Nasdaq, the Securities and Exchange Commission, or the SEC, or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets.

 

We will incur significant increased costs as a result of operating as a public company in the United States, and our management will be required to devote substantial time to new compliance initiatives.

 

As a public company in the United States, we will incur significant legal, accounting and other expenses that we did not incur previously. We will be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, which will require, among other things, that we file with the SEC annual, quarterly and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and Nasdaq to implement provisions of the Sarbanes-Oxley Act, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive-compensation-related provisions in the Dodd-Frank Act that require the SEC to adopt additional rules and regulations in these areas. Recent legislation permits emerging growth companies to implement many of these requirements over a longer period and up to five years from the pricing of this offering. We intend to take advantage of this new legislation, but cannot assure you that we will not be required to implement these requirements sooner than planned and thereby incur unexpected expenses. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.

 

We expect the rules and regulations applicable to public companies to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other business concerns, they could have a material adverse effect on our business, financial condition and results of operations. The increased costs will decrease our net income or increase our consolidated net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain the same or similar coverage. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.

 

34

 

 

Our executive officers and directors, and their affiliated entities, along with our two other largest stockholders, own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.

 

Upon consummation of this offering (based on shares outstanding as of           , 2020), our executive officers and directors, together with entities affiliated with such individuals, along with our two other largest stockholders, will beneficially own approximately     % of our Common Shares (approximately    % if the underwriters’ over-allotment option is exercised in full). Accordingly, these stockholders may, as a practical matter, continue to be able to control the election of a majority of our directors and the determination of all corporate actions after this offering. This concentration of ownership could delay or prevent a change in control of the Company.

 

New investors in our securities will experience immediate and substantial dilution after this offering.

 

The initial public offering price of our Units will be substantially higher than the pro forma net tangible book value per share of the outstanding common shares immediately after this offering. Based on an assumed initial public offering price of $         per Unit (which is the midpoint of the price range set forth on the cover of this prospectus) and our net tangible book value as of December 31, 2019, if you purchase our common shares in this offering you will pay more for your shares than the amounts paid by our existing stockholders for their shares and you will suffer immediate dilution of approximately $            per share in pro forma net tangible book value. As a result of this dilution, investors purchasing common shares in this offering may receive significantly less than the full purchase price that they paid for the shares purchased in this offering in the event of a liquidation.

 

Immediately prior to the consummation of this offering, we expect to have approximately                outstanding stock options to purchase our common shares with exercise prices that are below the assumed initial public offering price of our common shares. To the extent that these options are exercised, there will be further dilution.

 

If a substantial number of shares become available for sale and are sold in a short period of time, the market price of our common shares could decline.

 

If our existing stockholders sell substantial amounts of our common shares in the public market following this offering and the expiration of the lock-up agreements, the market price of our common shares could decrease significantly. The perception in the public market that our existing stockholders might sell Common Shares could also depress our market price. Upon completion of this offering, we will have outstanding            common shares, assuming no exercise by the underwriters of their option to purchase additional shares, and options to purchase of our common shares, based on our shares and options to be outstanding as of immediately prior to the consummation of this offering. Our directors, executive officers and other holders of our common shares will be subject to the lock-up agreements described in “Underwriting” and the Rule 144 holding period requirements described in “Shares Eligible for Future Sale.” After all of these lock-up periods have expired and the holding periods have elapsed, up to            additional shares will be eligible for sale in the public market.

 

In addition, the holders of               common shares will have the right, subject to certain exceptions and conditions, to require us to register their common shares under the Securities Act, and they will have the right to participate in future registrations of securities by us. Registration of any of these outstanding common shares would result in such shares becoming freely tradable without compliance with Rule 144 upon effectiveness of the registration statement. A decline in the price of shares of our common shares might impede our ability to raise capital through the issuance of additional shares of our common shares or other equity securities.

 

35

 

  

Since we do not expect to pay any cash dividends for the foreseeable future, investors in this offering may be forced to sell their stock in order to obtain a return on their investment.

 

We do not anticipate declaring or paying in the foreseeable future any cash dividends on our capital stock. Instead, we plan to retain any earnings to finance our operations and growth plans discussed elsewhere or incorporated by reference in this prospectus. Accordingly, investors must rely on sales of their Common Shares after price appreciation, which may never occur, as the only way to realize any return on their investment. As a result, investors seeking cash dividends should not purchase our Common Shares.

 

We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.

 

As discussed above, we are a foreign private issuer, and therefore, we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act. In the future, we would lose our foreign private issuer status if (1) more than 50% of our outstanding voting securities are owned by U.S. residents and (2) a majority of our directors or executive officers are U.S. citizens or residents, or we fail to meet additional requirements necessary to avoid loss of foreign private issuer status. If we lose our foreign private issuer status, we will be required to file with the SEC periodic reports and registration statements on U.S. domestic issuer forms, which are more detailed and extensive than the forms available to a foreign private issuer. We will also have to mandatorily comply with U.S. federal proxy requirements, and our officers, directors and principal shareholders will become subject to the short-swing profit disclosure and recovery provisions of Section 16 of the Exchange Act. In addition, we will lose our ability to rely upon exemptions from certain corporate governance requirements under the listing rules of the New York Stock Exchange. As a U.S. listed public company that is not a foreign private issuer, we will incur significant additional legal, accounting and other expenses that we will not incur as a foreign private issuer.

 

We have broad discretion in the use of the net proceeds from this offering and may not use them effectively.

 

Our management will have broad discretion in the application of the net proceeds from this offering, including for any of the purposes described in the section entitled “Use of Proceeds,” and you will not have the opportunity as part of your investment decision to assess whether the net proceeds will be used appropriately. Because of the number and variability of factors that will determine our use of the net proceeds from this offering, their ultimate use may vary substantially from their currently intended use. Our management might not apply our net proceeds in ways that ultimately increase the value of your investment. We currently intend to use the net proceeds from this offering to expand marketing and brand enhancement related to our products, to fund our ongoing research and development activities, for personnel development and training and for resource management software development.

 

Our expected use of net proceeds from this offering represents our current intentions based upon our present plans and business condition. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering, or the amounts that we will actually spend on the uses set forth above. The amounts and timing of our actual use of the net proceeds will vary depending on numerous factors, including the commercial success of our systems and the costs of our research and development activities, as well as the amount of cash used in our operations. As a result, our management will have broad discretion in the application of the net proceeds, and investors will be relying on our judgment regarding the application of the net proceeds of this offering.

 

The failure by our management to apply these funds effectively could harm our business. Pending their use, we may invest the net proceeds from this offering in short-term, investment-grade, interest-bearing securities. These investments may not yield a favorable return to our stockholders. If we do not invest or apply the net proceeds from this offering in ways that enhance stockholder value, we may fail to achieve expected financial results, which could cause our stock price to decline.

 

If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.

 

The trading market for our securities will depend in part on the research and reports that securities or industry analysts publish about us or our business. Securities and industry analysts do not currently, and may never, publish research on our company. If no securities or industry analysts commence coverage of our company, the trading price for our securities would likely be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who covers us downgrades our stock or publishes inaccurate or unfavourable research about our business, our stock price may decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our securities could decrease, which might cause our stock price and trading volume to decline.

 

36

 

 

DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS

 

This prospectus contains forward-looking statements that reflect our current expectations and views of future events, all of which are subject to risks and uncertainties. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. You can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions in this prospectus. These statements are likely to address our growth strategy, financial results and product and development programs. You must carefully consider any such statements and should understand that many factors could cause actual results to differ from our forward-looking statements. These factors may include inaccurate assumptions and a broad variety of other risks and uncertainties, including some that are known and some that are not. No forward-looking statement can be guaranteed and actual future results may vary materially. Factors that could cause actual results to differ from those discussed in the forward-looking statements include, but are not limited to:

 

  the size and growth potential of the markets for our products, and our ability to serve those markets;

 

  the rate and degree of market acceptance of our products;

  

  our ability to expand our sales organization to address effectively existing and new markets that we intend to target;

  

  impact from future regulatory, judicial, and legislative changes or developments in the U.S. and foreign countries;

  

  our ability to compete effectively in a competitive industry;

  

  our ability to obtain funding for our operations;

  

  our ability to attract collaborators and strategic partnerships;

  

  our ability to meet the NASDAQ, TSXV and FRA requirements;

  

  our ability to meet our other financial operating objectives;

  

  the availability of qualified employees for our business operations;

  

  general business and economic conditions;

  

  our ability to meet our financial obligations as they become due;

 

  positive cash flows and financial viability of our operations and new business opportunities;

 

  ability to secure intellectual property rights over our proprietary products or enter into license agreements to secure the legal use of certain patents an intellectual property;

 

  our ability to be successful in new markets;

 

  our ability to avoid infringement of intellectual property rights; and

 

  the positive cash flows and financial viability of our operations and new business opportunities

 

We describe certain material risks, uncertainties, and assumptions that could affect our business, including our financial condition and results of operations, under “Risk Factors.” We base our forward-looking statements on our management’s beliefs and assumptions based on information available to our management at the time the statements are made. We caution you that actual outcomes and results may, and are likely to, differ materially from what is expressed, implied or forecast by our forward-looking statements. Accordingly, you should be careful about relying on any forward-looking statements. Except as required under the federal securities laws, we do not have any intention or obligation to update publicly any forward-looking statements after the distribution of this prospectus, whether as a result of new information, future events, changes in assumptions, or otherwise.

 

Industry Data and Forecasts

 

This prospectus contains data related to the vehicle communications industry in the United States. These industry data include projections that are based on a number of assumptions which have been derived from industry and government sources which we believe to be reasonable. The vehicle communications industry may not grow at the rate projected by industry data, or at all. The failure of the industry to grow as anticipated is likely to have a material adverse effect on our business and the market price of our Common Shares. In addition, the rapidly changing nature of the vehicle communications industry subjects any projections or estimates relating to the growth prospects or future condition of our industries to significant uncertainties. Furthermore, if any one or more of the assumptions underlying the industry data turns out to be incorrect, actual results may, and are likely to, differ from the projections based on these assumptions.

 

37

 

 

ENFORCEABILITY OF CIVIL LIABILITIES

 

We are incorporated under the laws of British Columbia. Some of our directors and officers, and some of the experts named in this prospectus, are residents of Canada, Israel or otherwise reside outside of the United States, and all or a substantial portion of their assets, and all or a substantial portion of our assets, are located outside of the United States. We have appointed an agent for service of process in the United States, but it may be difficult for shareholders who reside in the United States to effect service within the United States upon those directors, officers and experts who are not residents of the United States. It may also be difficult for shareholders who reside in the United States to realize in the United States upon judgments of courts of the United States predicated upon our civil liability and the civil liability of our directors, officers and experts under the United States federal securities laws. Furthermore, because substantially all of our assets and substantially all of our directors and officers are located outside the United States, any judgment obtained in the United States against us or any of our directors and officers may not be collectible within the United States. There can be no assurance that U.S. investors will be able to enforce against us, members of our board of directors, officers or certain experts named herein who are residents of Canada, Israel or other countries outside the United States, any judgments in civil and commercial matters, including judgments under the federal securities laws.

 

Service of process upon directors and officers which reside in Israel may be difficult to obtain within the United States. Furthermore, because substantially all of our assets and substantially all of our Israeli directors and officers are located outside the United States, any judgment obtained in the United States against us or any of our Israeli directors and officers may not be collectible within the United States.

 

We have been informed by our legal counsel in Israel, Naschitz, Brandes, Amir & Co., Advocates, our legal counsel in Israel that it may be difficult to assert U.S. securities laws claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based on a violation of U.S. securities laws because Israel is not the most appropriate forum in which to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact which can be a time-consuming and costly process. Matters of procedure will also be governed by Israeli law.

 

Subject to specified time limitations and legal procedures, Israeli courts may enforce a U.S. judgment in a civil matter which is non-appealable, provided that, among other things:

 

  the judgment was rendered by a court of competent jurisdiction, according to the laws of the state in which the judgment is given;
     
  the judgment is enforceable according to the laws of Israel and according to the law of the foreign state in which the relief was granted; and
     
  the judgment is not contrary to public policy of Israel.

 

Even if such conditions are met, an Israeli court may not declare a foreign civil judgment enforceable if:

 

  the prevailing law of the foreign state in which the judgment is rendered does not allow for the enforcement of judgments of Israeli courts (subject to exceptional cases);
     
  the defendant did not have a reasonable opportunity to be heard and to present his or her evidence, in the opinion of the Israeli court;
     
  the enforcement of the civil liabilities set forth in the judgment is likely to impair the security or sovereignty of Israel;
     
  the judgment was obtained by fraud;
     
  the judgment was rendered by a court not competent to render it according to the rules of private international law prevailing in Israel;
     
  the judgment conflicts with any other valid judgment in the same matter between the same parties; or
     
  an action between the same parties in the same matter was pending in any Israeli court or tribunal at the time at which the lawsuit was instituted in the foreign court.

 

If a foreign judgment is enforced by an Israeli court, it generally will be payable in Israeli currency, which can then be converted into non-Israeli currency and transferred out of Israel. The usual practice in an action before an Israeli court to recover an amount in a non-Israeli currency is for the Israeli court to issue a judgment for the equivalent amount in Israeli currency at the rate of exchange in force on the date of the judgment, but the judgment debtor may make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated in Israeli currency ordinarily will be linked to the Israeli consumer price index plus interest at the annual statutory rate set by Israeli regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates.

 

38

 

 

USE OF PROCEEDS

 

Based upon an assumed initial public offering price of $         per Unit (the mid-point of the range set forth on the cover page of this prospectus), we estimate that we will receive net proceeds from this offering, after deducting the underwriting discounts, non-accountable expense allowance and the estimated offering expenses payable by us, of approximately $       assuming the Underwriter does not exercise its over-allotment option.

 

We plan to use the net proceeds we receive from this offering, and any proceeds from the exercise of warrants, for the following purposes:

 

    Use of Net Proceeds Approximately in US$ 1,000  
Marketing and Brand Enhancing 35%   $    
Resource Management Software Development 15%   $    
Research and Development 20%   $    
Personnel Training and Recruitment 30%   $    

 

The foregoing represents our current intentions based upon our present plans and business conditions to use and allocate the net proceeds of this offering. Our management, however, will have some flexibility and discretion to apply the net proceeds of this offering. If an unforeseen event occurs or business conditions change, we may use the proceeds of this offering differently than as described in this prospectus. To the extent that the net proceeds we receive from this offering are not immediately used for the above purposes, we intend to invest our net proceeds in short-term, interest-bearing bank deposits or debt instruments.

 

39

 

 

DIVIDEND POLICY

 

We have never declared or paid any dividends on our common shares. We do not anticipate paying any dividends in the foreseeable future. We currently intend to retain any future earnings to fund business development and growth, and we do not expect to pay any dividends in the foreseeable future. Any future determination to declare cash dividends will be made at the discretion of our board of directors, subject to applicable laws, and will depend on a number of factors, including our financial condition, results of operations, capital requirements, contractual restrictions, general business conditions and other factors that our board of directors may deem relevant.

 

40

 

  

CAPITALIZATION

 

The following table sets forth our capitalization as of December 31, 2019:

 

  on an actual as-reported basis;
     
 

on a pro forma basis to reflect the Company on June 23, 2020 entering into a new debenture private placement of $1,580,000 with a 12% coupon with a maturity of June 22, 2021 (“June 2020 Private Placement Financing” ); and on August 4, 2020, concluding a non-brokered private placement raising aggregate gross proceeds of $2,150,000 through the issuance of 21,500,000 units (the “August 2020 Private Placement Financing”).

     
  on a pro forma as adjusted basis to reflect the issuance and sale of the Units by us in this offering at the initial public offering price of $        per Unit, the midpoint of the range set forth on the cover page of this prospectus, after deducting the estimated discounts, non-accountable expense allowance and the estimated offering expenses payable by us.

 

You should read this capitalization table in conjunction with “Use of Proceeds,” “Selected Consolidated Financial and Operating Data,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated financial statements and the related notes appearing elsewhere in this prospectus.

  

    As Reported (Canadian $)     Pro Forma as Adjusted for June 2020 Private Placement Financing and August 2020 Private Placement Financing(1)     Pro Forma as Adjusted for IPO  
                   
Cash and cash equivalents                  
Total Outstanding Long-Term Debt    $

7,085

    $

7,302

         
Stockholders’ Equity                        
Common shares, no par value: unlimited shares authorized; 125,247,819  shares, actual, 146,914,485  shares, as adjusted                        
Preferred shares, no par value, unlimited shares authorized, 0 shares actual 0 shares, as adjusted                        
Additional paid-in-capital   $ 37,346     $ 39,866      $                          
Reserves(2)   $ 6,603     $ 6,603      $      
Accumulated Other Comprehensive Income (loss)   $ (125 )   $ (125 )        
Shareholders’ Deficit   $ (32,780 )   $ (32,780 )    $      
Total Shareholders’ Equity   $ 11,044     $ 13,564      $    
Total Capitalization                        

 

(1) Such amount includes the Company’s June 2020 Private Placement Financing and August 2020 Private Placement Financing
(2) The purpose of our Reserve account is to track the valuation of equity instruments issued other than common shares (i.e. the value of stock options, warrants, and equity components of convertible debt). This value of these equity instruments is recorded in Reserves until the instrument is exercised into common shares, at which time the original value of the instrument is re-classified into share capital. This presentation is common under IFRS, and similar to the usage of Additional Paid-In-Capital in the United States. Because the Company’s shares do not have a par value, all valuations of equity instruments other than common shares get booked into the Reserve account.

 

The number of common shares to be outstanding after this offering is based on common shares as of December 31, 2019 and excludes:

 

shares of our common shares issuable upon the exercise of stock options outstanding as of under our 2016 Stock Option Plan, with a weighted-average exercise price of $ per share

 

common shares reserved for future issuance under our 2016 Stock Option Plan;

 

__________common shares issuable upon the exercise of outstanding warrants with a weighted average exercise price of $___ per share;

 

__________common shares issuable upon the exercise of $_________ aggregate principal amount of outstanding convertible debentures with a weighted average conversion price of $___ per share ;

 

up to _________ common shares issuable upon the exercise of the Warrants included in the Units offered hereby; and

 

up to __________ common shares issuable upon exercise of warrants to be issued to the underwriter in connection with this offering, which will have an exercise price per share equal to 110% of the initial public offering price per share in this offering

 

The pro forma as adjusted information set forth in the table above assumes that the Underwriter does not exercise its over-allotment option.

 

41

 

 

DILUTION

 

If you invest in our Units in this offering, your interest will be diluted to the extent of the difference between the public offering price per share of common shares that is part of the Unit and the as adjusted net tangible book value per share of common share immediately after this offering.

 

Our historical net tangible book value as of December 31, 2019 was $___ million, or $___ per common share. Our historical net tangible book value is the amount of our total tangible assets less our liabilities. Historical net tangible book value per common share is our historical net tangible book value divided by the number of outstanding common shares as of December 31, 2019.

 

The pro forma net tangible book value of our ordinary shares as of December 31, 2019 was $_____per common share Pro forma net tangible book value per share represents our total tangible assets less our total liabilities, divided by the number of outstanding common shares, after giving effect to the pro forma adjustments referenced under “Capitalization.”

 

After giving effect to the sale of the Units that we are offering (attributing no value to the warrants) at an assumed initial public offering price of $       per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our net tangible book value on a pro forma as adjusted basis as of December 31, 2019 would have been $      per common share. This amount represents an immediate increase in net tangible book value of $      per common share to our existing shareholders and an immediate dilution of $      per common share to new investors purchasing common shares in this offering. We determine dilution by subtracting the pro forma as adjusted net tangible book value per share after this offering from the amount of cash that a new investor paid for an common share.

 

The following table illustrates this dilution:

 

Assumed initial public offering price per share (attributing no value to the warrants) $ ​ ​
As adjusted net tangible book value per share as of $ ​ ​
Increase per share attributable to this offering   ​ ​
As adjusted net tangible book value per share after this offering   ​ ​
Dilution per share to new investors in this offering $ ​ ​

 

A $         increase (decrease) in the assumed initial public offering price of $      per common share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the as adjusted net tangible book value per share by $        , and increase (decrease) dilution to new investors by $        per share, in each case assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.

 

The foregoing discussion and table do not take into account further dilution to new investors that could occur upon the exercise of outstanding warrants having a per share exercise or conversion price less than the per share offering price to the public in this offering.

 

If the underwriters exercise in full their option to purchase additional common shares in this offering, the as adjusted net tangible book value after the offering would be $      per share, the increase in net tangible book value to existing shareholders would be $      per share, and the dilution to new investors would be $      per share, in each case assuming an initial public offering price of $      per share, which is the midpoint of the price range set forth on the cover page of this prospectus.

 

The number of common shares of our common shares to be outstanding after this offering is based on _____ common shares as of December 31, 2019 and excludes:

 

_________ shares of our common shares issuable upon the exercise of stock options outstanding as of _____, 2020 under our 2016 Stock Option Plan, with a weighted-average exercise price of $____ per share

 

_________ common shares reserved for future issuance under our 2016 Stock Option Plan;

 

__________common shares issuable upon the exercise of outstanding warrants with a weighted average exercise price of $___ per share;

 

__________common shares issuable upon the exercise of $_________ aggregate principal amount of outstanding convertible debentures with a weighted average conversion price of $___ per share ;

 

up to _________ common shares issuable upon the exercise of the Warrants included in the Units offered hereby; and

 

up to _________common shares issuable upon exercise of warrants to be issued to the underwriter in connection with this offering, which will have an exercise price per share equal to 110% of the initial public offering price per share in this offering.

 

42

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes included elsewhere in this prospectus. This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. See “Disclosure Regarding Forward-Looking Statements” for a discussion of the uncertainties, risks, and assumptions associated with these statements. Actual results and the timing of events could differ materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under “Risk Factors” and elsewhere in this prospectus

 

CORPORATE Overview

 

Siyata Mobile Inc. is a leading global developer of innovative cellular based communications solutions over advanced 4G mobile networks under the Uniden® Cellular and Siyata brands. Siyata’s three product categories include In-Vehicle communications solutions for commercial fleet vehicles, rugged handheld mobile devices for industrial workers, and cellular amplifiers to boost the cellular signal inside homes, buildings, and vehicles.

 

Siyata In-Vehicle communications devices are specifically designed for professional vehicles such as trucks, vans, buses, emergency service vehicles, government cars and more. The Company’s innovative platform is designed to facilitate replacement of the current in vehicle, multi-device status quo with a single device (the flagship Uniden® UV350 4G device) that incorporates voice, Push-to- Talk over Cellular (“PoC”), data fleet management solutions and more. The UV350 also supports band 14 for FirstNet compatibility which is the US First Responders 4G LTE network with PoC capabilities that aims to replace aging two-way radio systems currently in use.

 

Siyata’s customer base includes cellular network operators and their dealers, as well as commercial vehicle technology distributors for fleets of all sizes in the U.S., Canada, Europe, Australia and the Middle East.

 

Siyata launched its flagship 4G UV350 commercial vehicle smartphone device with Bell Mobility in late Q4 2018, with AT&T as well as with their first responder cellular network FirstNet in late Q2 and with Rogers Wireless and Verizon Wireless in Q4 2019. These are major milestones for the Company following Siyata’s seven years of experience perfecting in-vehicle cellular based technology, vehicle installations, software integration with various PTT solutions and intensive carrier certifications.

 

The two U.S Tier 1 cellular carriers that Siyata are working with, have distribution and sales channels many times larger than the existing sales channels of the Company. With an estimated 20 million commercial vehicles including 3.5 million first responder vehicles, according to the United States Department of Transportation, the Company sees the U.S market as its largest opportunity with a total addressable market over $20 billion. These Tier 1 cellular carriers have a keen interest in launching the UV350 as it allows for new SIM card activations in commercial vehicles and increased ARPU from existing customers with corporate and first responder fleets while targeting new customers with a unique, dedicated, multi-purpose in-vehicle smartphone.

 

In Q1 2020 Siyata Mobile Inc. signed a supply agreement with a leading global Land Mobile Radio (“LMR”) provider as an additional major channel for sales of the UV350.

 

Siyata launched the innovative CP250 tablet/DVR connected vehicle 4G device, which is built for cellular voice calls, Push-to-Talk Over Cellular (“PoC”), data, and navigation with a built-in DVR camera and more. This device was designed to be installed on the dash or mounted on a windshield, specifically for lighter commercial vehicles such as taxis, vans and delivery trucks. The 5” wide screen display tablet-based design ensures better communication capabilities for professional drivers. Sales of the CP250 device are focused in Europe, Australia and the Middle East.

 

In addition to its connected vehicle product portfolio, the Company develops, manufactures, markets, and sells 4G/LTE rugged handheld Push to Talk smartphone devices for industrial users. These rugged B2B environments are focused towards similar enterprise customers that Siyata sells its connected vehicle devices to and include first responders, construction workers, security guards, government agencies and various mobile workers in multiple industries.

 

Siyata also manufactures, markets, and sells Uniden® cellular signal boosters and accessories for homes, buildings, manufacturing facilities and vehicles with poor cell coverage across Canada and the United States. The vehicle vertical in this portfolio well complements the UV350 vehicle smartphone as the company begins to get sales of the UV350 bundled with its Uniden vehicle boosters.

 

The Company’s shares are listed on Tier 1 of the TSX Venture Exchange (“TSX-V”) under the symbol SIM, and as of July 25, 2017 on the NASDAQ Over the Counter Venture Exchange (“OTCQX”) under the symbol SYATF.

 

The corporate office of the Company is located at 1001 Lenoir Street, Montreal, Quebec H4C 2Z6 and the registered and records office is located at 2200 - 885 West Georgia Street, Vancouver, BC V6C 3E8.

 

43

 

 

Year ended December 31, 2019 compared to year ended December 31, 2018

 

Results of Operations

 

The following table sets forth a summary of the consolidated results of operations of the Company for the periods indicated, both in absolute amount and as a percentage of its total revenues.

 

    2019   2018   2017
Revenues   $ 13,019,792     $ 14,220,542     $ 17,753,006  
Comprehensive Loss for the year     (10,545,572 )     (10,658,899 )     (5,218,304 )
Net loss for the year     (10,160,351 )     (11,527,981 )     (5,058,495 )
Net loss per share                        
Basic   $ (0.09 )   $ (0.12 )   $ (0.06 )
Diluted   $ (0.09 )   $ (0.12 )   $ (0.06 )
Total Assets     21,010,797       17,784,342       21,877,613  
Total non-current financial liabilities(1)     7,258,370       4,564,831       4,639,682  
Cash dividends declared in all classes of shares     -       -       -  

 

(1) Includes current and long-term debts and future purchase consideration

 

SIGNIFICANT HIGHLIGHTS

 

The following highlights and developments for the year ended December 31, 2019 and to the date of this MD&A: During the period reflected, the Company achieved various milestones such as:

 

  Siyata announced the Uniden ® UV350 in-vehicle mounted tablet was certified by AT&T as well as FirstNet Ready, making it tested and approved for use with services on the FirstNet communications platform. FirstNet was built with AT&T in a public-private partnership with the First Responder Network Authority (FirstNet Authority) – an independent agency within the federal government. It’s designed for first responders and those critical to their emergency response.

 

  Siyata has received a purchase order from its first US customer to equip their fleet of yellow school buses with its Uniden® UV350, bringing the total order to over $1MM.

 

  Siyata launched the new Push-to-Talk Over Cellular (“PoC”) LTE Uniden® UV350 in-vehicle device with Rogers Wireless, the largest provider of wireless communications services in Canada. The launch includes integration with Nova Talk, a leading enterprise “PoC” solution for instant communication of their operating fleets of vehicles.

 

  Siyata announced its collaboration with Tango Tango, a FirstNet Certified™ Push-to-Talk application and communications service provider, to offer the Uniden® UV350 dedicated in-vehicle device to its first responder customers in the United States.

 

  Siyata announced it has launched the Company’s flagship Push-to Talk LTE Uniden® UV350 in-vehicle cellular IoT device with Verizon Wireless.

 

  Siyata finalized integration with AT&Ts Workforce Manager enterprise application which is now available on the UV350.

 

  Siyata launched its UV350 Desktop Dispatch Unit (DDU) which is an ultimate solution for enterprise PoC dispatchers.

 

  Siyata won an initial $200,000 contract to supply its Uniden(R) UV350 in-vehicle smartphones to one of Canada’s largest heavy civil construction companies.

 

  Siyata announced that the Company has signed a multi-year supply agreement with a global Land Mobile Radio (“LMR”) and software vendor (the “Vendor”). The agreement outlines that Siyata Mobile will supply the Uniden® UV350 in-vehicle IoT device to the Vendor, for resale to its first responder and commercial fleet customers looking to replace or augment its current in-vehicle communication hardware with next generation IoT solutions.

 

  Siyata announced the launch of the 4G/LTE UR5 Push to Talk rugged device for the first responder and enterprise mobile workforce. The UR5 is “Rugged and Ready” to handle the vigorous work environments encountered by enterprise workers and first responders on the front line of defense.

 

  Siyata announced the Company has partnered with TASSTA, a global mission critical push-to-talk (MCPTT) software provider and end-to-end solution for critical communications with initial opportunities to work together in Southeast Asia.

 

  Siyata appointed Jason Depue as US VP Sales to Lead sales at AT&T and FirstNet. Mr. DePue is an experienced sales executive with a demonstrated history across carrier, OEM and industrial segments in the wireless telecommunications industry.

 

  Siyata announced that it launched the next generation line of 4G LTE Uniden cellular signal boosters, helping families and businesses improve network connectivity for work, school and entertainment purposes.

 

44

 

 

Licensing Agreement with Uniden® America Corp

 

Siyata Mobile has exclusive rights in North America to market and distribute their innovative devices under the Uniden® brand in categories of cellular amplifiers, connected vehicle cellular devices and rugged cellular products. Uniden brings strong brand recognition for Siyata’s devices and introduces a more unified brand to the current dealers, operators and future customers in North America.

 

The Company’s current license agreement with Uniden (the “Uniden Agreement”) has a 3-year term, commencing on January 1, 2020 and expiring on December 31, 2022. Minimum annual payments under the Uniden Agreement are $108,000 USD in 2020 and $120,000 USD in 2021 and 2022 (the “Minimum Royalty Payments”). At the end of each fiscal year, Siyata will pay Uniden 3% of any sales from the licensed products under the Uniden Agreement that exceeds the Minimum Royalty Payments for the fiscal year.

 

Licensing Agreement with Via Licensing

 

Effective June 8, 2018, the Company entered into two separate licensing agreements with Via Licensing Corporation to utilize worldwide patents related to the coding and decoding of “android” software as well as access and download within the “LTE/ 4G” network (the “Via Licensing Agreements”). This patent is for an initial period of 5 years and can be extended for a further 5-year term. Under the Via Licensing Agreement, the Company has the right at any time during the term on any extension hereof, to terminate these agreements upon providing 60 days advanced notice of termination. Under the Via Licensing Agreements, the quarterly royalty fees are based solely on product sales and is a percentage formula based upon the number of units sold, the country manufactured and the country location of the end customer. There are no minimum royalty fees payable under the Via Licensing Agreements.

 

Licensing Agreement with Wilson Electronics, LLC

 

Siyata entered into a royalty agreement with Wilson Electronics LLC on November 30, 2017, effective January 1, 2018 (the “Wilson Agreement”). Under the Wilson Agreement, we have licensed a patent for its cellular booster portfolio of products from Wilson Electronics, LLC, for the rights to the stand-alone cell phone radio signal booster on a worldwide basis. The Wilson Agreement shall remain in force until the expiration of all of the patents under the Wilson Agreement expire. Under the Wilson Agreement, Siyata will pay a royalty to Wilson Electronics LLC of 4.5% of the sales of booster products, payable quarterly.

 

Financing Initiatives

 

On August 29, 2019, Siyata completed a non-brokered private placement raising gross proceeds of $3,000,000 through the issuance of 7,500,000 units at a price of $0.40 per unit. Each unit consisted of one common share and one half share purchase warrant. Each warrant is exercisable at a price of $0.60 for a period of two years. In conjunction with the placement, the Company was not required to pay agent’s fees.

 

On December 23, 2019, Siyata Entered into a brokered private placement financing raising CDN$7,866,000.00 through the issuance of 7,866,000 unsecured 12% per annum convertible debentures (the “Convertible Debentures”) maturing on December 23, 2021 at a price of CDN$1.00 (the “Issue Price”) per Convertible Debenture (the “Offering”). The Offering was completed through a syndicate with co-lead agents, PI Financial Corp. and Canaccord Genuity Corp. (collectively, the “Co-Lead Agents”), and with Paradigm Capital Inc. and Beacon Securities Limited (together with the Co-Lead Agents, the “Agents”). Each $1,000 of Convertible Debenture will be convertible into 2,222 common shares in the capital of the Company (“Common Shares” and each is a “Common Share”) representing approximately CDN$0.45 (the “Conversion Price”) per Common Share, subject to adjustment in certain events. These convertible debentures are redeemable by the Company at 101% of the face value at any time after December 23, 2020. These debentures are convertible into Common Shares at the Conversion Price at the option of the holder at any time prior to the close of business on the earlier of: (i) the last business day immediately preceding the Maturity Date, and (ii) the date fixed for redemption in the event of a change of control. Each purchaser also received one (1) non-transferrable share purchase warrant (each, a “Warrant”) for each CDN $1.00 principal amount of Convertible Debentures purchased by such purchaser. Each Warrant will entitle the holder to acquire one further Common Share (each, a “Warrant Share”) at an exercise price of CDN $0.45 per Warrant Share. The Warrants will expire on December 23, 2022.

 

Subsequent to the year end, the Company entered into a demand line of credit arrangement with the TD Bank to a maximum of $1,500,000. This line of credit is secured by a $4,000,000 first ranking lien on its wholly owned subsidiary, Signifi Mobile Inc.’s assets. Interest rate on the loan is TD Bank’s Canadian prime rate + 1.25%. The loan is further limited to the lessor of $1,500,000 or by the borrowing base which is 90% of insured receivables under 90 days, plus 80% of receivables over 90 days, plus 30% of inventory (up to a maximum of up to $400,000). A financial covenant requires that net tangible net worth cannot be less than $1,500,000 in Signifi Mobile Inc.

 

On June 23, 2020, the Company entered into a non-brokered private placement financing agreement with Accel Telecom Inc., a reporting insider. Accel subscribed for 1,330 senior unsecured 10% convertible debentures maturing one year from the issue date at an issue price of CDN$1,000 per Convertible Debenture for aggregate gross proceeds of approximately USD$1,000,000 (the “Convertible Debenture Offering”). Each Convertible Debenture is convertible, at the option of the holder, into 3,333 common shares in the capital of the Company at a price of CDN$0.30 per Common Share, subject to adjustment in certain events and are redeemable at 101% of the face value at any time after the closing date. Accel also received 1,330,000 non-transferrable common share purchase warrants (each, a “Debenture Warrant”). Each Debenture Warrant entitles the holder to acquire one Common Share (each, a “Debenture Warrant Share”) at an exercise price of CDN$0.30 per Debenture Warrant Share for a period of twelve (12) months after the date of issue. 

 

45

 

  

The Company entered into an agreement with an existing arm’s-length debenture holder to amend the terms of its outstanding convertible debentures due June 28, 2020 on equivalent terms as the Convertible Debentures Offering in the amount of CDN$250,000. No finders’ fees were paid in conjunction with the Convertible Debenture Offering.

 

On August 4, 2020, the Company completed a non-brokered private placement raising aggregate gross proceeds of $2,150,000 through the issuance of 21,500,000 units (the “August 2020 Units”) at a price of $0.10 per August 2020 Unit. Each August 2020 Unit consisted of one common share in the capital of the Company and one-half of one common share purchase warrant (each, a “August 2020 Warrant”). Each whole August 2020 Warrant is exercisable at a price of $0.18 for a period of two years. The Company paid a cash commission of $24,681.60 and issued 246,816 broker warrants on the same terms as the August 2020 Warrants to certain finders.

 

OUTLOOK

 

The Company is a global developer and provider of a vehicle mounted communications platform over advanced mobile networks. Customers include cellular operators and their dealers, commercial vehicle technology distributors and fleets of all sizes in Canada, Europe, Australia and the Middle East. The Company’s “Connected-Vehicle” devices and various accessories are specifically designed for enterprise customers and professional fleets such as trucks, vans, buses, ambulances, government cars and more. The Company aims to provide greater mobile connectivity for professional drivers and facilitate replacement of the current in-vehicle, multi device status quo with a single device that incorporates voice, data and fleet management solutions with the new suite of 4G UV350 and UV250 products. In addition, the Company develops, markets and sells rugged Push to Talk mobile devices, cellular amplifiers and various accessories for both consumer and enterprise customers with sales across North America, Europe and the Middle East to multiple retailers, distributors and cellular dealers.

 

Siyata has received device approval for its Uniden® UV350 from AT&T, Verizon and FirstNet in the US as well as at Tier 1 Canadian carriers, Bell Mobility and Rogers Wireless. Siyata offers a complete product offering including the UV350 device and multiple accessory peripherals as well as integration with multiple fleet applications which has resulted in initial purchase orders in the USA and Canada.

 

With over 20 million commercial and first responder vehicles in North America, per the U.S. Department of Transportation, this represents a multi-billion-dollar opportunity for Siyata which it began aggressively pursuing and capturing in 2019 and continues to do so. In addition, Siyata is working closely with Motorola’s Push to Talk software subsidiary Kodiak. The company already launched the UV350 in partnership with Motorola and plans to sell this device to multiple Kodiak partners in North America and globally. Siyata’s management believes that these key partnerships that have unlocked large scale sales opportunities for its products which it expects will continue in the coming years and will also result in a paradigm shift in our revenue base to predominantly the North American market.

 

In March 2020 the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, potentially leading to an economic downturn.

 

The Company has experienced an increase of sales of its cellular boosters as more people are working remotely as a result of the COVID-19 pandemic but its overall sales during the pandemic have remained similar to its sales in 2019 during this time period with a shift towards increased sales in North America in the first responder market. It is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or ability to raise funds. The Company plans to address any going concerns from the pandemic by continuing to increase its sales in North America which is a substantial larger market than the Company has sold in the past. In addition, its cellular distribution business shall remain strong during this time since more individuals will continue to work from home. The Company also expect that the proceeds from this offering will allow to cover any shortfall that the Company may incur until the pandemic is no longer a worldwide issue. In addition, the Company believes that its cellular booster business remains strong during the COVID-19 pandemic as more individuals continue to work from home, requiring improved cellular reception.

 

Critical Accounting Policies, Judgments and Estimates

 

Statement of compliance

 

The accompanying consolidated financial statements, including comparatives, have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and Interpretations of the International Financial Reporting Interpretations Committee (“IFRIC”).

 

Basis of consolidation and presentation

 

The accompanying consolidated financial statements of the Company have been prepared on the historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.

 

The accompanying consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. The consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.

 

46

 

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:

 

Name of Subsidiary   Place of Incorporation   Ownership
Queensgate Resources Corp.   British Columbia, Canada     100 %
Queensgate Resources US Corp.   Nevada, USA     100 %
Siyata Mobile (Canada) Inc.   British Columbia, Canada     100 %
Siyata Mobile Israel Ltd.   Israel     100 %
Signifi Mobile Inc.   Quebec, Canada     100 %

 

The accompanying consolidated financial statements of the Company are presented in Canadian dollars, which is the functional currency of the Company.

 

Foreign currency translation

 

Items included in the Company’s accompanying financial statements of each entity in the Company are measured using the currency of the primary economic environment in which the entity operates (the “functional currency”) and has been determined for each entity within the Company. The functional currency of Siyata Mobile Inc. is the Canadian dollar which is also the functional currency of all its subsidiaries except Siyata Mobile Israel Ltd. which is the United States dollar. The functional currency determinations were conducted through an analysis of the consideration factors identified in IAS

 

The Effects of Changes in Foreign Exchange Rates.

 

Assets and liabilities of entities with a functional currency other than the Canadian dollar are translated into Canadian dollars at period end exchange rates. Income and expenses, and cash flows are translated into Canadian dollars using the average exchange rate. Exchange differences resulting from the translation of United States operations are recognized in other comprehensive income (loss) and accumulated in equity.

 

Transactions in currencies other than the entity’s functional currency are translated at the exchange rates in effect on the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the rate of exchange in effect as at the statement of financial position date. Non-monetary assets and liabilities denominated in foreign currencies are translated at the exchange rates prevailing at the time of the acquisition of the assets or assumption of the liabilities. Foreign currency differences arising on translation are recognized in the statement of loss and comprehensive loss.

.

Use of estimates and judgements

 

The preparation of the Company’s accompanying consolidated financial statements in conformity with IFRS requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.

 

  i) Critical accounting estimates

 

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected. Information about critical estimates in applying accounting policies that have the most significant effect on the amounts recognized in the consolidated financial statements are, but not limited to the following:

 

  Income taxes - Tax provisions are based on enacted or substantively enacted laws. Changes in those laws could affect amounts recognized in profit or loss both in the period of change, which would include any impact on cumulative provisions, and future periods. Deferred tax assets, if any, are recognized to the extent it is considered probable that those assets will be recoverable. This involves an assessment of when those deferred tax assets are likely to reverse.

 

  Fair value of stock options and warrants - Determining the fair value of warrants and stock options requires judgments related to the choice of a pricing model, the estimation of stock price volatility, the expected forfeiture rate and the expected term of the underlying instruments. Any changes in the estimates or inputs utilized to determine fair value could have a significant impact on the Company’s future operating results or on other components of shareholders’ equity.

 

  Capitalization of development costs and their amortization rate – Development costs are capitalized in accordance with the accounting policy. To determine the amounts earmarked for capitalization, management estimates the cash flows which are expected to be derived from the asset for which the development is carried out and the expected benefit period.

 

  Inventory - Inventory is valued at the lower of cost and net realizable value. Cost of inventory includes cost of purchase (purchase price, import duties, transport, handling, and other costs directly attributable to the acquisition of inventories), cost of conversion, and other costs incurred in bringing the inventories to their present location and condition. Net realizable value for inventories is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Provisions are made in profit or loss of the current period on any difference between book value and net realizable value.

 

  Estimated product returns - Revenue from product sales is recognized net of estimated sales discounts, credits, returns, rebates and allowances. The return allowance is determined based on an analysis of the historical rate of returns, industry return data, and current market conditions, which is applied directly against sales.

 

47

 

 

  Impairment of non-financial assets - The Company assesses impairment at each reporting date by evaluating conditions specific to the Company that may lead to asset impairment. The recoverable amount of an asset or a cash-generating unit (“CGU”) is determined using the greater of fair value less costs to sell and value in use which requires the use of various judgments, estimates, and assumptions. The Company identifies CGUs as identifiable groups of assets that are largely independent of the cash inflows from other assets or groups of assets. Value in use calculations require estimations of discount rates and future cash flows derived from revenue growth, gross margin and operating costs. Fair value less costs to sell calculations require the Company to estimate fair value of an asset or a CGU using market values of similar assets as well as estimations of the related costs to sell.

    

  Useful life of intangible assets – The Company estimates the useful life used to amortize intangible assets which relates to the expected future performance of the assets acquired based on management estimate of the sales forecast.

 

  Future purchase consideration - In a business combination, the Company recognizes a contingent consideration at fair value at the acquisition date. Contingent consideration classified as an asset or liability that is a financial instrument and within the scope of IAS 39 Financial Instruments: Recognition and Measurement, is measured at fair value with changes in fair value recognized either in profit or loss, or as a change to other comprehensive income (“OCI”). If the contingent consideration is not within the scope of IAS 39, it is measured at fair value in accordance with the appropriate IFRS. Contingent consideration that is classified as equity is not re-measured and subsequent settlement is accounted for within equity.

 

  Contingent consideration from an asset acquisition is recognized when: the conditions associated with the contingency are met; the Company has a present legal or constructive obligation that can be estimated reliably; and it is probably that an outflow of economic benefits will be required to settle the obligation.

 

  ii) Critical accounting judgments

 

Information about critical judgments in applying accounting policies that have the most significant effect on the amounts recognized in the consolidated financial statements are, but are not limited to, the following:

 

  Deferred income taxes – judgments are made by management to determine the likelihood of whether deferred income tax assets at the end of the reporting period will be realized from future taxable earnings. To the extent that assumptions regarding future profitability change, there can be an increase or decrease in the amounts recognized in respect of deferred tax assets as well as the amounts recognized in profit or loss in the period in which the change occurs.

 

  Functional currency - The functional currency for the Company and each of its subsidiaries is the currency of the primary economic environment in which the respective entity operates. The Company has determined the functional currency of each entity to be the Canadian dollar with the exception of Siyata Mobile Israel Ltd. which has the functional currency of the US dollar. Such determination involves certain judgments to identify the primary economic environment. The Company reconsiders the functional currency of its subsidiaries if there is a change in events and/or conditions which determine the primary economic environment.

 

  Going concern – As disclosed in Note 1 to the accompanying consolidated financial statements.

 

New accounting pronouncements

 

The following new accounting policies were adopted by the Company during the year ended December 31, 2019:

 

As of January 1, 2019, the Company adopted the following new accounting standards and interpretations on a modified retrospective approach:

 

IFRS 16, Leases

 

IFRS 16, Leases (“IFRS 16”), specifies how to recognize, measure, present, and disclose leases. The standard provides a single-lessee accounting model, requiring lessees to recognize a right-of-use asset representing its right to use the underlying asset and a liability representing its obligation to make lease payments (“lease obligation”), for all leases unless the Company elects to exclude leases when the lease term is twelve months or less, or the underlying asset has a low monetary value. Lessors continue to classify leases as operating or finance, with IFRS 16’s approach to lessor accounting substantially unchanged from its predecessor, IAS 17, Leases (“IAS 17”). The Company’s accounting policy under IFRS 16 is as follows:

 

At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company adopted IFRS 16 using the modified retrospective approach and therefore, the comparative information has not been restated and continues to be reported under IAS 17 Leases and IFRIC 4 to determine whether an arrangement contains a lease.

 

The Company as a lessee

 

The Company recognizes a right-of-use (“ROU”) asset and a lease liability at the lease commencement date. The ROU asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received.

 

48

 

 

The ROU asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the ROU asset or the lease term. The lease term includes consideration of an option to renew or to terminate if the Company is reasonably certain to exercise that option. Current office and car lease terms range from 6 months to 22 months. In addition, the ROU asset is periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability.

 

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate. Lease payments include fixed, or in substance fixed, payments and variable lease payments that depend on an index or a rate. Variable lease payments that do not depend on an index or rate are not included in the measurement of the lease liability. The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, or if the Company changes its assessment of whether it will exercise a purchase, extension, or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the ROU asset, or is recorded in profit or loss if the carrying amount of the ROU asset has been reduced to zero.

 

Effective January 1, 2019 (date of initial application), the Company adopted IFRS 16 using the modified retrospective transition approach. Accordingly, comparative figures as at and for the year ended December 31, 2018 have not been restated and continue to be reported under IAS 17 and IFRIC 4, Determining Whether an Arrangement Contains a Lease (“IFRIC 4”).

 

The Company has elected to apply the practical expedient to grandfather the assessment of which transactions are leases on the date of initial application, as previously assessed under IAS 17 and IFRIC 4. The Company applied the definition of a lease under IFRS 16 to contracts entered into or modified on or after January 1, 2019.

 

At transition, the Company used the following practical expedients when applying IFRS 16 to leases previously classified as operating leases under IAS 17: applied a single discount rate to a portfolio of leases with similar characteristics; recognition exemption of short-term leases; recognition exemption of low-value leases; and used hindsight when determining the lease term if the contract contained options to extend or terminate the lease.

 

When applying the modified retrospective transition approach, for leases previously classified as operating leases under IAS 17 and IFRIC 4, on initial application, a lessee is permitted to measure the ROU asset, on a lease-by-lease basis, using one of two methods: (1) as if IFRS 16 had always been applied, using the incremental borrowing rate at the date of initial application; or (2) at an amount equal to the lease liability (subject to certain adjustments). For all leases, the Company applied the second method and recognized the ROU assets based on the corresponding lease liability. As at January 1, 2019, the Company recorded lease obligations of $407,776 and ROU assets of $407,776. When measuring lease liabilities, the Company discounted future lease payments using its incremental borrowing rate as at January 1, 2019. The weighted-average rate applied was 7.5%. During the year ended December 31, 2019, the Company recorded $147,946 of depreciation of ROU assets, and $14,827 of interest accretion on discounted lease obligations as a result of the adoption of IFRS 16.

 

The following table reconciles the Company’s operating lease commitments as at December 31, 2018, as previously disclosed in the Company’s annual audited consolidated financial statements, to the lease obligations recognized on initial application of IFRS 16 on January 1, 2019:

 

As at January 1, 2019   Previously Reported under IAS 17   IFRS 16 Transition Adjustments   As report under
IFRS 16
Right of use Assets   $ -     $ 407,776     $ 407,776  
Lease Obligation   $ -     $ 407,776     $ 407,776  

 

RESULTS OF OPERATIONS FOR YEAR ENDED DECEMBER 31, 2019

 

The following table sets forth a summary of its results of operations for the periods indicated, both in absolute amount and as a percentage of its total revenues.

 

    December 31, 2019  

December 31, 2018

Revenues   $ 13,019,792     $ 14,220,542  
                 
Comprehensive Loss for the year     (10,545,572 )     (10,658,899 )
Net loss for the year     (10,160,351 )     (11,527,981 )
Net loss per share                
Basic   $ (0.09 )   $ (0.12 )
Diluted   $ (0.09 )   $ (0.12 )
Total Assets     21,010,797       17,784,342  
Total non-current financial liabilities(1)     7,258,370       4,564,831  
Cash dividends declared in all classes of shares     -       -  

 

(1) Includes current and long-term debts and future purchase consideration

 

49

 

 

The following is an analysis of the Company’s operating results for the year ended December 31, 2019 and includes a comparison against the year ended December 31, 2018.

 

Revenues

 

Revenues for the year ended December 31, 2019 were $13,019,792 compared to $14,220,542 for the same period in the previous year. This negative variance of ($1,200,750) (-8.4%) is due to the $1,154,000 in increase of sales in North America (representing a year over year increase of 32%) resulting from initial demand for our Uniden® UV350 4G In-vehicle product in North America in 2019 as a direct result of certification with Tier One mobile operators offset by the $2,441,000 decrease in sales in Europe and the Middle East, representing a 23% decrease year over year of Siyata’s 3G legacy products.

 

Since January 1, 2020, Siyata has grown its sales pipeline of opportunities for our 4G flagship UV350 device to include potential customers from many different vertical markets including school bus operators, utilities, First responder agencies, municipal vehicles, construction companies, transportation companies, and more. As of July 2020, we have proof of concept trials in progress with approximately 40 different companies which if we won every opportunity would equate to revenue of up to $20 million. We do not believe that we will win every opportunity, nor that every opportunity will deploy their entire fleet all at once, but we see growing demand for UV350 as we encourage more and more potential customers to begin proof of concept trials. We expect this demand will more than offset the decline in sales from our 3G legacy devices. 

 

Costs of Goods Sold

 

Cost of sales for the year ended December 31, 2019 were $9,732,577 compared to $12,161,044 for the same period in the previous year. The gross margin dollars for this period was $3,287,215 (25.26% of sales) compared to $2,059,498 (14.5%) of sales in the previous year, a positive variance of $1,227,717. The increase in gross margin dollars is due to the higher overall margins in the North American marketplace a result of sales of the Uniden® UV350 4G In-vehicle sold in 2019 offset by the lower sales volume of 8.4%.

 

Amortization and Depreciation

 

Amortization and depreciation costs for the year ended December 31, 2019 was $1,550,607 compared to $704,749 for the same period in the previous year. The negative variance of ($845,858) relates to the amortization required under IFRS 16 of $136,946 in 2019, not applied prior to 2019, as well as the increase in depreciation in the year in the UV350 on the new portfolio of 4G as well as the increase in amortization of the 3G remaining products in the amount of $88,005.

 

The amortization of product development costs of $950,383 over a 5-6 year useful life is broken down into three categories. The first category involves product development costs from the Company’s products that are not commercially ready for sale (4G products). These costs have not been amortized in 2019 and involve a total capitalized intangible cost of $1,800,377. The second category involves product development cost of fully amortized 3G products amounting to $2,924,423. No amortization was taken in the second category in 2019. The third category involves product development costs of 3G and 4G products that were amortized in 2019. The cost of these products totalled $7,094,605 in 2019; with $226,007 and $6,868,598 for 3G and 4G products, respectively. The amortization amount in 2019 was $950,383 consisting of $115,585 for 3G products with only two years left on the 5-year amortization and product development cost amortization for 4G products in 2019 of $834,798, based upon each of their useful lives of either 5- or 6-years.

 

Selling and Marketing Costs

 

(in thousands)

  December 31,
2019
 

December 31,
2018

Salaries and related expenses   $ 2,063     $ 1,519  
Advertising and marketing     2,256       3,545  
Travel and conferences     404       385  
Total   $ 4,723     $ 5,449  

 

50

 

  

Selling and marketing costs for the year ended December 31, 2019 were $4,723,236 compared to $5,449,031 for the same period in the previous year. This positive variance of $725,795 is due to an increase in selling salaries and commissions on the suite of new products in the amount of $544,000, the decrease in additional advertising and marketing costs of $1,289,000 due to the engaging of salaried employees to promote the new products in North America and globally including trial samples, tradeshows and targeted promotional activities and a marginal increase of $19,000 in travel related costs.

 

General and Administrative Costs

 

(in thousands)

 

December 31, 2019

 

December 31, 2018

Salaries and related expenses   $ 540     $ 306  
Professional services     269       397  
Consulting and director fees     1,278       828  
Management fees     170       570  
Travel     106       94  
Office and general     353       384  
Regulatory and filing fees     62       25  
Shareholder relations     304       325  
Total   $ 3,082     $ 2,929  

 

General and administrative costs for the year ended December 31, 2019 of $3,081,966 compared to $2,929,277 for the same period in the previous year. This negative variance of $152,689 relate to the negative variance in salaries in the year of $234,000 related to the increase in direct hires offset by the positive variance in lower management fees of $400,000, a negative variance in the increase in director and consulting fees of $450,000 in the year for management salaries and increase in the number of Directors, the positive variance in professional services of $128,000 relating to less consultants in the year, the slight negative variance in G&A travel of $12,000, the positive variance in office and general of $29,000 related to cost rationalization, a negative variance in regulatory and filing fees of $37,000 related to costs for both TSX.V and OTCQX additional fees, and a positive variance of $21,000 related to shareholder relations resulting from costs rationalization.

 

Research and Development

 

Research and Development costs for the year ended December 31, 2019 were 1,005,000 compared to zero in 2018. The Company engaged an independent outside valuator to measure the Recoverable Amount of the Intangibles. As a result of their findings, management expensed certain development costs incurred in the year so as not to exceed the net recoverable amount..

 

Impairment in Intangible Assets

 

Impairment in intangible resulted in $147,977 in Q4 2019 on the impairment of the E-wave license as compared to a $1,954,000 impairment in the prior year on the write down of the CP-200 rugged phone, a positive variance of $1,806,023.

 

Share-based Payments

 

Share-based payments for the year ended December 31, 2019 was $1,490,313 compared to $1,102,313 for the same period in the previous year which is a negative variance of $388,000 which relates to the valuation of stock options vested during the period.

 

Finance Expense

 

Finance expense for the year ended December 31, 2019 was $1,276,827 compared to an expense of compared to $975,468 for the same period in the previous year for a negative variance of $301,359. This negative variance resulted from the loss of $176,737 on the rollover of the 10.5% debenture, included in finance expenses, as well as the additional accrual in Q4 2019 on the 12% debenture of $41,923, plus the increase in amortization of the 10.5% debenture of an additional $82,699 in 2019.

 

Foreign Exchange Loss

 

Foreign exchange loss (income) for the year ended December 31, 2019 of $141,640 compared to foreign exchange income of ($46,507) for the same period in the previous year for a negative variance of ($188,147). This variance resulted from foreign currency fluctuations in the period.

 

Accreditation and Change in Value of Future Contingent Consideration

 

Accretion and change in value of future contingent consideration resulted in an expense for the year ended December 31, 2019 of $30,000 versus an expense of $519,148 for the same period in 2018, a positive variance of $489,148 which results that as of the end of Q2 2019, the Company did not have any contingent consideration and therefore had no accretion expense compared to a large accretion expense due to a fluctuating stock price in 2018 required for the future purchase consideration.

 

51

 

 

Net income (loss) for the period

 

The Company experienced a net loss for the year ended December 31, 2019 of ($10,160,351) as compared to net loss of ($11,527,981) for the same period in the previous year representing a positive variance of $1,367,630. This positive variance is due to the positive variances in gross margin of $1,227,717. Selling expenses of $725,795, accretion of $489,148 and impairment in the value of intangible assets of $1,806,023 offset by negative variances in, amortization of ($845,858), development costs of ($1,005,000), G&A of $152,689, share based compensation of ($388,000), finance expenses of ($301,359), and foreign exchange of ($188,147).

 

Loss and comprehensive loss for the period

 

As a result of the activities discussed above, the Company experienced a comprehensive loss for the year ended December 31, 2019 of ($10,545,572) as compared to a comprehensive loss of ($10,658,899) for the same period in the previous year representing a positive variance of $113,327.

 

Adjusted EBITDA

 

For the year ended December 31, 2019 the adjusted EBITDA is negative ($4,517,987) versus negative ($6,318,810) in the same period in 2018 a positive variance of $1,800,823. Adjusted EBITDA is defined as the EBITDA adding back the share based compensation expense, the impairment of intangible assets and product development expenses.

 

The Company defines capital as consisting of shareholder’s equity (comprised of issued share capital, reserves, accumulated translation differences and deficit). The Company manages its capital structure to maximize its financial flexibility making adjustments to it in response to changes in economic conditions and the risk characteristics of the underlying assets and business opportunities. The Company does not presently utilize any quantitative measures to monitor its capital, but rather relies on the expertise of the Company’s management to sustain the future development of the business. Management reviews its capital management approach on an ongoing basis and believes that this approach, given the relative size of the Company, is reasonable. As at December 31, 2019, the Company is only subject to externally imposed capital requirements arising from the quarterly payments of interest on the debenture, and the monthly principal and interest payments from the BDC loan. The Company is also subject to a debt covenant in relation to the factoring agreement. At no time during the year was the Company in breach of the covenant.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Siyata Mobile Israel has a factoring facility with Israeli banks whereby the Bank advances funds to Siyata Mobile Israel and charges a fluctuating interest rate on the advanced funds until it is repaid by the borrowers’ customers. The Bank has a lien on these receivables. The factored receivables are all required to be insured in case of customer default with a financial institution.

 

The Company’s objective in managing liquidity risk is to maintain sufficient liquidity in order to meet operational and investing requirements at any point in time. The Company has historically financed its operations primarily through a combination of demand loans and the sale of share capital by way of private placements.

 

As at December 31, 2019 the Company had a cash balance of $3,465,371, compared to $2,420,205 in December 31, 2018. As at December 31, 2019, the Company had an accumulated deficit of $32,779,519, compared to $22,619,168 as of December 31, 2018, and working capital of $6,704,651, compared to $4,565,215 as of December 31, 2018.

 

52

 

 

The following table sets forth a summary of its cash flows for the periods indicated:

 

    As of
December 31,
2019
  As of
December 31,
2018
Net cash used in operating activities     (8,544,227 )     (2,996,235 )
Net cash used in investing activities     (3,020,880 )     (2,879,193 )
Net cash from financing activities     12,569,404       3,813,315  

 

Cash (used in) provided by operating activities

 

Net cash flows used in operating activities for the year ended December 31, 2019 were ($8,544,227) compared with cash used of ($2,996,235) in the same period of the prior year. The increase in cash used of $5,547,992 in operating activities was primarily due to the increase in the non-cash working capital items by $6,132,430 consisting of an increase in trade and other receivables, prepaids, and advances to suppliers of $3,582,935, accounts payable and accrued liabilities of $2,338,667, due to related party of $1,064,675 net of inventory of negative $853,847 offset by the decrease in the loss net of non-cash items of $584,438.

 

Cash (used in) provided by investing activities

 

Net cash flows used in investing activities for the year ended December 31, 2019 was $3,020,880 compared with $2,879,193 in the prior year, a negative variance of $141,687. This variance relates primarily to costs incurred for testing with multiple carriers in order to obtain device approval on their networks.

 

Cash used in financing activities:

 

    December 31,
2019
  December 31,
2018
Financing activities:                
Proceeds of loans     3,778,634       250,000  
Repayment of loans     (34,000 )     (20,000 )
Lease payments     (165,584 )     -  
Private placement     3,000,000       2,080,710  
Share issue costs     (243,379 )     (375,423 )
Bank loan     42,230       -  
Exercise of stock options     -       410,000  
Exercise of warrants     5,862,745       1,324,464  
Exercise of agents’ options     328,758       143,564  
Net cash from financing activities     12,569,404       3,813,315  

 

Net cash provided by financing activities for the year ended December 31, 2019 was $12,569,404 compared to $3,813,315 in December 31, 2018. This positive variance of $8,756,089 relates to the proceeds received from the issuance of the 12% convertible debenture for net proceeds of $3,778,634, exercise of 11,725,490 share purchase warrants for proceeds of $5,862,745 for the year end December 31, 2019, compared to $1,324,464 in the prior year, plus the proceeds received from the 7,500,000 share non-brokered private placement in the amount of $3,000,000, plus the exercise of 821,896 agents’ options for proceeds of $328,758, compared to proceeds of $143,564 in December 31, 2018, offset by issue costs of $243,379 (2018-$375,423), offset by the proceeds from the exercise of stock options in the prior year of $410,000, ( 2019-$0) and offset by the proceeds of the BDC loan in the prior year of $250,000 and BDC principal payment increase of $14,000 over the prior year.

 

The future success of the Company is now dependent on the continued success of its vehicle mounted communications products, its mobile rugged phones and its Booster systems in the market together with the ability to finance the necessary working capital, at agreeable terms, to support the growth of the business.

 

The Company had a debenture maturity balloon payment of $1,445,000 which was repaid on June 28, 2020. On June 23, 2020 the Company entered into a new debenture private placement of $1,580,000 with a 12% coupon with a maturity of June 22, 2021 which was used to pay off the above balloon payment. Of the total proceeds from this new debenture, $250,000 was related to one of the old debenture holders, re-investing their investment into the new debenture and thus this portion was deemed a non-cash transaction. The Company plans on using part of the proceeds of this offering, as well as its working capital to repay these debentures prior to maturity as well as any other material debt that the Company currently has outstanding.

 

53

 

 

Financial Instruments

 

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values.

 

Financial instruments measured at fair value are classified into three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are:

 

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities;

Level 2 – Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly;

Level 3 – Inputs that are not based on observable market data.

 

The fair values of the Company’s cash, trade and other receivables, due from related party, and accounts payable and accrued liabilities approximate carrying value, which is the amount recorded on the consolidated statement of financial position.

 

The following table illustrates the classification of the Company’s financial instruments within the fair value hierarchy as at December 31, 2019 and December 31, 2018:

 

    Level 1   Level 2   Level 3
             
December 31, 2018:                        
Future purchase consideration   $ 430,000     $ -     $ -  
                         
December 31, 2019:                        
Future purchase consideration   $ -     $ -     $ -  

 

The balance of future purchase consideration above is the current portion, plus the present value of the non-current portion presented on the consolidated statements of financial position.

 

The input used in Level 1 for the year ended and for the year ended December 31, 2018 is either the cash the Company is obligated to pay as an anniversary payment or the Company’s share price quoted on active markets, or a combination thereof, depending on which payment form is considered most probable to be chosen by the vendor.

 

The Company is exposed to varying degrees to a variety of financial instrument related risks:

 

Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company places its cash with institutions of high credit worthiness. Management has assessed there to be a low level of credit risk associated with its cash balances.

 

The Company’s exposure to credit risk is influenced by the individual characteristics of each customer. However, management also considers the demographics of the Company’s customer base, including the default risk of the industry and country in which customers operate, as these factors may have an influence on credit risk. Approximately 15% of the Company’s revenues for 2019 (2018- 29%) are attributable to sales transactions with a single customer.

 

The Company has established a credit policy under which each new customer is analyzed individually for creditworthiness before the Company’s standard payment and delivery terms and conditions are offered. The Company’s review includes external ratings, when available, and in some cases bank references. Purchase limits are established for each customer, which represent the maximum open amount without requiring approval from the Risk Management Committee; these limits are reviewed quarterly. Customers that fail to meet the Company’s benchmark creditworthiness may transact with the Company only on a prepayment basis.

 

54

 

 

More than 80% of the Company’s customers have been active with the Company for over four years, and no impairment loss has been recognized against these customers. In monitoring customer credit risk, customers are grouped according to their credit characteristics, including whether they are an individual or legal entity, whether they are a wholesale, retail or end-user customer, geographic location, industry, aging profile, maturity and existence of previous financial difficulties. Trade and other receivables relate to the Company’s wholesale customers. Customers that are graded as “high risk” are placed on a restricted customer list and monitored by the Company, and future sales are made on a prepayment basis.

 

The carrying amount of financial assets represents the maximum credit exposure, notwithstanding the carrying amount of security or any other credit enhancements.

 

The maximum exposure to credit risk for trade and other receivables at the reporting date by geographic region was as follows:

 

(in thousands)

 

 

December 31, 2019

 

 

December 31, 2018

Israel   $ 754     $ 626  
Europe     39       25  
North America     1,151       274  
Total   $ 1,944     $ 925  

 

Liquidity risk

 

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The Company’s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation.

 

The Company examines current forecasts of its liquidity requirements so as to make certain that there is sufficient cash for its operating needs, and it is careful at all times to have enough unused credit facilities so that the Company does not exceed its credit limits and is in compliance with its financial covenants (if any). These forecasts take into consideration matters such as the Company’s plan to use debt for financing its activity, compliance with required financial covenants, compliance with certain liquidity ratios, and compliance with external requirements such as laws or regulation.

 

The Company uses activity-based costing to cost its products and services, which assists it in monitoring cash flow requirements and optimizing its cash return on investments. Typically, the Company ensures that it has sufficient cash on demand to meet expected operational expenses for a period of 90 days, including the servicing of financial obligations; this excludes the potential impact of extreme circumstances that cannot reasonably be predicted, such as natural disasters.

 

The Company has a factoring agreement with external funding. The increase in days-sales-outstanding in our trade receivables is due to a factoring arrangement which we use to expedite collection in Israel, where no such arrangement is in place for sales in North America. Receivables in Israel are collected 80-85% up-front from the factoring company, which are then presented on a net basis in the financial statements in accordance with IAS 32. In 2019, sales in the North American market increased to 36% of our sales, from 25% in the prior year, which accordingly increased our collection period due to the lack of a factoring arrangement for those receivables.

 

With the exception of employee benefits, the Company’s accounts payable and accrued liabilities have contractual terms of 90 days. The employment benefits included in accrued liabilities have variable maturities within the coming year.

 

55

 

 

Currency Risk

 

Currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. The functional currency of Siyata Israel is the US dollar (“USD”). Revenues are predominantly incurred in the US dollar with expenses in the Israeli New Sheqel (“NIS”). As at December 31, 2019, the Company’s exposure to foreign currency risk with respect to financial instruments is as follows:

 

(in CAD thousands)

  USD   NIS   CAD   Total
Financial assets and financial liabilities:            
             
Current assets                                
Cash     175       1,273       2,017       3,465  
Trade and other receivables     1,019       889       36       1,944  
Due from director     260       -       -       260  
Current liabilities                                
Bank Loan     -       (42 )     -       (42 )
Accounts payable and accrued liabilities     (448 )     (1,393 )     (725 )     (2,566 )
Due to related party     -       (100 )             (100 )
Convertible debentures                     (6,636 )     (6,636 )
Long term debt     -       -       (196 )     (196 )
Total     1,006       627       (5,504 )     (3,871 )

 

Interest Rate Risk

 

Interest rate risk is the risk that the fair value of future cash flows will fluctuate as a result of changes in interest rates. The Company’s sensitively to interest rates is currently immaterial as the Company’s debt bears interest at fixed rates.

 

Price Risk

 

The Company is exposed to price risk with respect to equity prices. Equity price risk is defined as the potential adverse impact on the Company’s earnings due to movements in individual equity prices or general movements in the level of the stock market. The Company closely monitors individual equity movements, and the stock market to determine the appropriate course of action to be taken by the Company.

 

Off-Balance Sheet Arrangements

 

The Company has no off-balance sheet arrangements, including arrangements that would affect its liquidity, capital resources, market risk support, and credit risk support or other benefits.

 

Contractual Obligations

 

The following table summarized the contractual obligations of the Company as of December 31, 2019:

 

    Less than one year   1-3 years   3-5 years   Over 5 years   Total
                     
Capital lease obligations     151,437       101,582       -       -       253,019  
Long Term Debt     60,000       136,000       -       -       196,000  
Debentures     1,455,000       7,866,000       -       -       9,321,000  
Other Long term Liabilities     -       173,044       -       -       173,044  
Commitments by date due     1,666,437       8,276,626       -       -       9,943,063  

 

Future Financings

 

The Company may sell its common shares in order to fund its business growth. Issuances of additional shares will result in dilution to existing shareholders. There is no assurance that the Company will achieve sales of the equity securities or arrange for debt or other financing to fund its growth in case it is necessary, or if the Company is able to do so, there is no guarantee that existing shareholders will not be substantially diluted. 

 

56

 

 

BUSINESS

 

The Problem

 

Businesses and organizations that rely on commercial vehicle fleets to carry out critical business functions and operations have historically used two-way radios (“Land Mobile Radios” or “LMR”) to communicate between drivers and headquarters. LMR communication devices have historically encountered several challenges. These devices are typically expensive, generally consisting of older and outdated technology. LMR devices are also limited in their range of communication, as local radio bandwidth is limited. Most devices are restricted to communications in one metro areas with limited connectivity with neighboring areas, agencies or companies, hindering headquarters’ ability to communicate with their vehicles. Occasionally, vehicles communicating through LMR will often encounter a communication “dead zone”, thus hindering these vehicles’ abilities to communicate during times of emergencies. They are single-purpose devices, allowing for communications through “push-to-talk” (“PTT”) broadcasting with limited additional features.

 

UV350 In-Vehicle Solution

 

 

 

The Uniden® UV350 (the “UV350”) is the world’s first and only smartphone with 4G/LTE capabilities specifically designed for in-vehicle usage, optimizing mobile communications for on the road commercial fleet vehicles. Unlike existing Land Mobile Radio (LMR) technology, that operates over radio signals, the UV350 operates over standard 4G cellular networks. The UV350 received United States Federal Communications Commission’s approval as a cellular device, Industry Canada’s approval, certification of PCS Type Certification Review Board (“PTCRB”), Google GMS certification, and Conformité Européenne (“CE”) and Emark certification. The UV350 and has been certified or approved for manufacturing or sale by several North American wireless carriers, or our “channel partners”, including AT&T, Bell Mobility, Rogers, Motorola Solutions and Verizon. The UV350’s reputation and approvals from industry leaders represent a barrier to entry for potential direct competitive devices, with North American carrier for in-vehicle devices for fleet communication.

 

AT&T, our largest channel partner, represented 15% of our revenues in 2019. AT&T did not enter into a master services agreement with the Company, but rather, enters into standard purchase order forms on a per order basis. We do does not obligate AT&T to fulfill any required minimum purchase orders. Our typical purchase order contracts with AT&T involve standard warranties and indemnification, insurance requirement and delivery terms. Each separate purchase order agreement can be terminated by AT&T within ten (10) days notice upon notice of and failure to cure any breach by the Company of such agreement.

 

The UV350 contains several unique features, including:

 

  Android Operating System Compatibility. Android compatibility allows customers to download apps such as a PTT app and have it configured by the wireless carrier to ensure your workers can communicate one-to-one, or in a full group call. Because virtually any Android fleet application can be downloaded, this enables customers to eliminate redundant single-purpose hardware in their fleet vehicles.

 

  Noise Cancelation. Best-in-class loud and clear audio in noisy commercial vehicles. Our bundled kit includes a dedicated loud speaker and microphone for both phone calls and Push To Talk (PTT) calls.

 

  Economic. Far lower price to customers compared to using multiple single purpose devices which can cost thousands of dollars to purchase, and lots of time to install and maintain. With our UV350, the truck only needs one sim card with a voice and data plan as opposed to using multiple devices with multiple sims and plans. This allows lower monthly fees per vehicle.

 

57

 

 

  Safety. With its large display a dedicated palm mic and one-touch buttons for key driver tasks, the UV350 is safe for drivers, allowing them to keep their eyes on the road and hands on the wheel.

 

  Wi-Fi Hotspot. Customers can connect up to five devices to the UV350 via Wi-Fi, giving the customers added connectivity options.

 

  Always Powered. The UV350 is powered by the vehicle’s battery so it automatically powers on when the vehicle is started up, and it defaults to turn off automatically when the vehicle is turned off. This default setting can be changed for customers who need the device to stay on after the vehicle is shut off. The device is designed to operate properly in any extreme temperature situation.

 

  4G/LTE. The UV350 works on the multiple wireless carrier networks which provide the best nation-wide coverage options for customers and is compatible with high speed 4G data networks.

 

  Accessories. In addition to the UV350 standard bundle kit which includes everything that customers need to get started, Siyata also offers optional PTT accessories such as a Wired Palm Mic which most PTT customers prefer. For customers whose fleet vehicles travel into areas with limited cellular reception, Siyata offers an outdoor, roof mounted antenna as well as an optional in-line cellular booster to amplify the cellular signal so that fleet vehicles can maintain connection when they are further away from cellular tower sites.

 

Our Rugged Handheld Solution

 

Siyata has entered into supply agreements with several North American wireless carriers. The Company believes that additional complementary PTT devices can be offered by Siyata to these wireless carriers. The rugged handheld market, smartphones designed specifically to withstand hardship and exposure, have relatively few competitors, and wireless carriers appear poised to expand their offerings in this category.

 

Siyata currently offers a rugged handheld clamshell device (UR7) outside of North America for customers who demand a cost-effective high performing PTT device. We recently launched an additional rugged device (UR5) which is intended to complement our commercial vehicle devices for the North American and international markets and will support popular Push-to-Talk apps. Key vertical markets for rugged handheld devices are construction job sites, warehouses, factories, hotels, retail stores, schools, landscaping crews, special events. Customers who would consider our rugged handheld devices are looking to increase the worker’s productivity, and to reduce their total cost of ownership compared to other devices.

 

  Tough & Rugged. Our rugged devices meet the industry standards for ruggedness and water resistance.

 

  Large PTT Button. With a large dedicated PTT Button, this makes it easy for customers to use for PTT, as opposed to having to hold down a virtual button on the screen.

 

  Loud and Clear. Its powerful speakers ensure loud, clear audio sound quality.

 

  Large optional extended. Long lasting battery to keep working for several days, in most customer use cases. The battery can be easily and quickly replaced on short notice.

 

  SOS Button. Workers can alert supervisors of emergency situations that occur on the job.

 

58

 

 

Our Cellular Booster Solution

 

We offer a full line of cellular boosters, a device intended to form a wireless system to boost cellular reception, under the brand name Uniden®. We have entered into a partnership whereby Uniden America Corporation has granted the exclusive license to Siyata Mobile to market cellular signal boosters under the Uniden® brand name within the U.S. and Canada. As a world-wide leader in wireless communications, Uniden America Corporation, the North American subsidiary of Japan-based Uniden Corporation, manufactures and markets wireless consumer electronic products. Based in Fort Worth, Texas, Uniden sells its products through dealers and distributors throughout North, Central and South America. Uniden Cellular booster kits solve issues of poor reception, dropped calls, lost data and transmission quality issues that users routinely experience on every cellular network. These easy-to-install cellular booster kits are designed for homes, cabins, offices, and buildings to improve the cellular signal reception indoors, allowing people to use their cellular phones indoors where they previously could not do so. We also offer models designed for vehicles, both wired and wireless boosters, to improve the cellular reception inside a vehicle that is driving in a weak cellular signal area. Uniden cellular signal boosters offer kits designed to offer cellphone coverage for difference distances, including kits for a small area of 1 or 2 rooms, and more expansive solutions that will cover over 100,000 sq. ft. Our cellular signal boosters are carrier agnostic to ensure the best signal integrity, supporting 2G, 3G, 4G and soon 5G (in development) technologies on all carriers operating in North America.

 

The Uniden® U60C 4G Cellular Booster and Uniden® U65C 4G Cellular Booster are user friendly devices that simply require plugging it into a power source and turning it on. The device will automatically adjust to provide the user with a boosted cellular signal in their trouble zone. These devices range in price starting from a retail price of $347 USD and up. The Uniden® U60P Cellular Booster, Uniden® U65P Cellular Booster, and Uniden® U70P Cellular Booster and available in 3G and 4G versions. These devices are just as easy to install as the consumer boosters but include additional features, such as manual gain control override, LCD status display and input signal display.

 

The Uniden® Link 4G Cradle Style Cellular Booster is used for single use case, Uniden® UM50 4G Cellular Booster works great in cars, vans, first responders, and any situation on the go where you need to expand your coverage zone. The Uniden® UM2M 4G Cellular Booster is our direct connect unit that works in vehicles connected to your in-vehicle phone or your cellular modem. These devices range in price starting from a retail price of $197 USD and up.

 

The Uniden® UM2M 4G Cellular Booster is our newest product in our line up and one of the most promising. We are very excited to launch this item as it is not only great for machine to machine application such as in vending and ATM machines, but this booster perfectly complements the company’s Uniden® UV350 In Vehicle Smartphone. This booster connects directly to the Uniden® UV350 In Vehicle Smartphone giving the device a much-expanded coverage zone. This is a complete solution that many customers need. The combination of Uniden® UV350 and Uniden® M2M 4G Cellular Booster gives our customer the ultimate enterprise class solution to enjoy crystal clear phone calls and lightning fast data speeds.

 

Industry

 

Communication, productivity and safety among task workers are the central requirements in business-critical and mission-critical environments. Organizations with remote and disparate workers—from police and firefighters to construction, oil rigs and manufacturing workers—require extremely durable communication solutions that provide reliable and secure voice, data and workflow applications.

 

The types of vehicles that we provide communication solutions to include school buses, utilities, oil and gas, waste management, snow plows, transportation, construction vehicles, and first responder vehicles. In North America there are, according to the United States Department of Transportation, over 20 million of such vehicles, representing a significant potential customer base for Siyata. Each of these types of vehicles demands superior in-vehicle communications solutions.

 

A cost-effective solution is essential for both government fleets, such as first responder police vehicles, and commercial enterprises, including construction companies. These industries are concerned with managing and controlling their capital expenditures and operating expenses and they adopt such mindset with their selection of communication devices for their staff and fleets.

 

59

 

 

These industries are also required to adhere to the current safety and operational requirements, while maintaining the flexibility to adjust to meet future relevant requirements. For example, currently, the fleet managers may only require PTT communications with the drivers, and the ability to track the location of their vehicles. However, latest industry trends require that drivers possess a driver emergency safety app or a workforce automation solution. A communications solution based on the UV350 contains built-in flexibility to adapt with customer demand. The UV350 is a highly connected Internet of Things (IoT) platform which supports downloadable Android apps for future functionality.

 

There is a demand within our targeted vertical markets to be connected with the First Responder Network Authority (FirstNet). FirstNet is a nationwide high-speed broadband wireless network providing a single interoperable platform for law enforcement, firefighters, paramedics and other public safety officials in every state, county, locality and tribal area. AT&T has developed a 4G network for organizations or agencies in times of emergencies to communicate and coordinate response efforts. AT&T’s FirstNet network is reserved for “primary” first responder users such as police, fire, and ambulance, and it includes “extended primary” users such as utilities, snow plows, and yellow school buses, who are occasionally summoned for emergencies. The United States Government is increasingly encouraging first-responder organizations and agencies to transition to a FirstNet-based communications network to facilitate communications and coordination during emergencies.

 

According to the Smithsonian Institute, there approximately 500,000 yellow school buses in the United States. School buses primarily communicate through the existing legacy technology of two-way radios (LMR). Many county school districts own both their own fleet of buses and their own radio towers with two-way radio service coverage that is restricted to within in their county. However, occasionally, when school buses transport students outside their county for field trips and sports events, the drivers are unable to communicate with their dispatchers. The UV350 device addresses this problem since it uses the nationwide cellular networks. Moving from a solely PTT to a cellular-based system also precludes the necessity for counties and school districts to maintain older radio towers.

 

Our Strategy

 

Siyata’s primary focus is to increase sales of our UV350 In-Vehicle device in North America. With approximately 20 million potential commercial vehicles to pursue in North America, per the United States Department of Transportation, Siyata believes there is large growth potential in this market. Our strategy is to continue to partner with North American wireless carriers in order to interface with new potential customers and expand our customer base. Siyata sales are B2B and we will sell the hardware to the wireless carrier (or their distributors), who will in turn sell the hardware to the fleet vehicle customer.

 

Siyata already has established distribution relationships with several North American carriers and is also generating revenue from selected countries outside of North America. Siyata will continue to be strategic in selecting geographic markets with strong demand for our existing solutions. We will identify key distributors in those new markets who can assist us with establishing a market presence.

 

Siyata is also willing to consider strategic moves such as acquiring a complementary company if the right opportunity presents itself.

 

Our Pricing

 

For wireless carriers, they are free to price the device how they choose. In most cases for significant sales opportunities the carriers are willing to subsidize the cost of the device in order to secure the new activations with the associated monthly Average Revenue Per User (ARPU).

 

Even our unsubsidized full price is competitive compared to other hardware solutions, but when our device is subsidized, the capital and operational expense benefits to customers compared to other solutions are even greater.

 

60

 

 

Target Markets

 

Yellow School Buses

 

There are currently approximately 500,000 active yellow school buses in North America, per the Smithsonian Institute. The majority of these use a two-way LMR radio for voice communications between their dispatchers and the bus drivers. A small percentage of yellow school buses also use a tracking system so that the fleet manager at the local school district headquarters can identify where the buses are at any time. Challenges for school districts include controlling costs, maintaining legacy two-way radio devices and networks, and also the lack of communication with their drivers when buses are beyond the county borders for field trips and sports events. The US Government is also encouraging school districts to incorporate technology that is compatible with FirstNet. Siyata believes that UV350 In-Vehicle device with a Push-to-Talk over Cellular app, a Mobile Device Management (MDM) app, and an emergency response app such as CrisisGo, combined with Siyata’s Wired Palm Mic, Roof Mounted Antenna and In-line Cellular Booster provides a solution to these school districts. This will result in lower Capex and Opex, as well as increased driver safety, increased functionality, and much improved cellular coverage. If the School District selects FirstNet as its wireless carrier partner, then drivers can be assured of communicating with their dispatchers and with neighboring agencies in times of emergencies. This availability of the new FirstNet network is causing many school districts to reconsider their communications solutions, which will benefit Siyata. Siyata is conducting multiple trials and has already commenced sales in this sector.

 

Utility ‘Bucket Trucks’

 

Utility businesses in North America operate hundreds of thousands of vehicles, including bucket trucks used by workers to fix or install hydro-lines on utility poles. These trucks require the ability for their dispatchers to communicate with the workers in the truck. These trucks currently primarily incorporate a mix of two-way LMR radio and Push-to-Talk over Cellular (PoC) to communicate. Many bucket trucks also utilize a second weatherproof speaker mounted in the back of the truck in order for dispatchers to communicate with elevated workers operating on hydro lines. Communicating with and relaying important information to workers operating on hydro lines can be challenging. Siyata has developed a custom solution for dispatchers to communicate with the truck, and also an extra amplifier which can power the Utility’s pre-installed second speaker, connected by a simple toggle switch. Siyata has conducted trials with this product with several utility trucks.

 

First Responder Vehicles

 

According to the Smithsonian Institute, there are approximately 3 million active First Responder vehicles in the US. Most police vehicles contain “P25” two-way radio devices for PTT voice communication. P25 devices are expensive, with each device costing thousands of USD, along with a ruggedized laptop computer for database lookups which can cost over $2,000 USD. The opportunity for Siyata in the near term is to augment, rather than to replace the P25 in vehicle two-way radio. Police agencies are traditionally less willing to abandon their legacy two-way radio technology. With the launch and growth of FirstNet, police agencies are beginning to adopt FirstNet compatible PTT over cellular devices to enable neighboring agencies to communicate during emergencies. While it is possible to enable P25 two-way radios to talk with PTT over cellular devices, the UV350 is a dedicated PTT over cellular solution which delivers strong audio quality and dependability for first responders. Siyata recognizes opportunities with police agencies in smaller rural communities where two-way radio coverage is more challenging. With Siyata’s roof mounted antenna and in-line cellular booster, the UV350 device can be the solution that allows rural police vehicles to communicate efficiently. Siyata is also currently conducting trials with several ambulance agencies.

 

Construction Vehicles

 

Construction companies present a strong customer base for Siyata’s suite of products. Companies operating trucks that deliver gravel or remove soil from construction sites traditionally have used commercial grade two-way LMR radios for voice communication. These vehicles occasionally also integrate technologies such as Automatic Vehicle Location devices so that headquarters can monitor the locations of their trucks. For metro-wide two-way radio coverage, these construction companies are typically paying a small two-way radio company between $20 and $40 USD per month per truck for the use of their towers and repeaters for voice communications between headquarters and their drivers. If the trucks need to travel outside the metro region then they are unable to communicate. The UV350 device delivers loud and clear audio communications while its relatively small footprint fits securely in vehicles. The UV350 can replace the two-way radio devices used in construction company vehicles to make driving simpler and safer. Siyata is currently conducting trials with several construction companies and has already begun sales in this vertical.

 

61

 

 

Competition

 

We do not believe that we have any direct competitors within the in-vehicle market category and we believe that no other Company offers an In-Vehicle Smartphone that is approved for sale in North America by wireless carriers. To date, we are not aware of any directly competing devices that are in development.

 

We have several indirect competitors. Customers could choose a handheld phone along with a professionally installed third party car kit. There are car kit providers who attempt to make their car kits compatible with popular handheld phone models. By comparison, the UV350 device offers enhanced audio quality, safety, and reception. Furthermore, the UV350 is always active and can be used in temperature extremes. Furthermore, the UV350 kit is one complete solution from one supplier, as opposed to buying separately from two different companies and assembling a phone and a car kit that offers no proven compatibility.

 

Our second indirect competitor are rugged tablets that can be placed in a mount. The UV350 device offers better audio quality, better safety, better cellular reception, and it is always on and ready to be used. Also, compared to a tablet, the UV350 can also make cellular calls including emergency 911 calls whereas the tablet cannot as it is a data only device.

 

Our third indirect competitor is an In-Vehicle Two-way Radio (LMR). Not only can the UV350 make phone calls which the LMR radio cannot, but the UV350 offers much better coverage due to using the cellular network as opposed to a limited two-way radio network. And the UV350 can support downloadable Android apps and can serve as a modem for IoT devices and as a Wi-Fi hotspot for further connectivity options and more.

 

Our fourth indirect competition is that Motorola Solutions has recently announced the TLK 150 In-Vehicle device which is a Push to Talk over Cellular device, compatible only with Motorola’s Wave PTT application and does not feature any downloadable apps (fleet management, GPS tracking, live video feed, etc) nor the ability to make a phone call over the wireless network. Motorola Solutions sells the TLK 150 In-Vehicle devices directly to customers and through its dealer channel, but not through wireless carriers

 

Within the Ruggedized handheld phone category, we have a few direct competitors, including Sonim Technologies, Inc., Kyocera Corporation and Bullet Mobile using the CAT brand who produce rugged handheld devices. Samsung Electronics Co. Ltd. also offer some of their consumer cellular devices in a more rugged form factor. There are also several Chinese companies who manufacture rugged devices but are less active in the North American markets.

 

Within the Cellular Booster category, we have several direct competitors, including Wilson Electronics, LLC, Nextivity Inc., and SureCall Company.

 

Employees

 

As of December 31, 2019, we had 20 full-time employees and no part-time employees. Ten (10) of our employees are located in Israel, with three performing sales functions, four performing research and development functions, and four performing operations. The other ten (10) employees are located in Canada, with six performing sales functions and four performing operations functions.

 

On December 31, 2018, we had 21 full-time employees and zero part-time employees. 10 of our employees are located in Israel, with three performing sales functions, two performing logistic functions, four performing operations and two performing marketing. 10 of our employees are located in Canada, with six performing sales functions and four performing operations functions. We enter into employment contracts with some of our full-time employees. In addition to salaries and benefits, we provide performance-based bonuses for some of our full-time employees.

 

Intellectual Property

 

We do not currently own any intellectual property, however the Company has entered into several licensing agreements for the use of a trademark and certain patents.

 

Uniden America Corporation

 

In December 2012, Signifi Mobile, the Company’s wholly-owned subsidiary entered into a license agreement with Uniden America Corporation, as amended (the “Uniden Agreement”). The Uniden Agreement provides for the Company to use the trademark “Uniden®”, along with associated designs and trade dress to distribute, market and sell its In-Vehicle device, cellular signal booster and accessories during its term in North America. The agreement includes renewal options up to December 31, 2022 and is subject to certain minimum royalties. The license agreement is amortized on a straight-line basis over its five-year term.

 

62

 

  

Wilson Electronics LLC

 

Effective January 1, 2018, Signifi Mobile Inc., the Company’s wholly-owned subsidiary, entered into an agreement with Wilson Electronics, LLC to permit the Company to utilize several of Wilson Electronics’ patents related to cellphone boosters (the “Wilson Agreement”). The Wilson Agreement grants the Company an indefinite right to utilize its cellphone booster-related patents in exchange for paying Wilson Electronics, LLC a royalty fee for boosters sold by the Company. The Wilson Agreement remains in force until the Wilson patents on the Booster products expire.

 

Via Licensing Corporation

 

Effective June 8, 2018, the Company entered into two separate licensing agreements with Via Licensing Corporation to utilize worldwide patents related to the coding and decoding of “android” software as well as access and download within the “LTE/ 4G” network. This patent is for an initial period of 5 years and can be extended for a further 5-year term. The Company has the right at any time during the term on any extension hereof, to terminate these agreements upon providing 60 days advanced notice of termination. The quarterly royalty fees are based solely on product sales and is a percentage formula based upon the number of units sold, the country manufactured and the country location of the end customer. There are no minimum royalty fees payable according to the agreement.

 

eWave Mobile Ltd.

 

Effective October 1, 2017, the Company entered into an Asset Purchase Agreement with eWave Mobile Ltd. (“eWave”) for the purchase of certain distribution rights and contracts in connection with the right to sell and distribute in Israel certain cellular devices for the push to talk market (the “eWave Supplies”) in exchange for $700,000 and the Company issuing an amount equal to USD$700,000 to the Company. Additionally, the Company shall pay eWave 50% of the net profit from all sales the Company earns from the eWave Supplies from 2017 – 2018, and then 25% thereafter.

 

Seasonality

 

The Company does not experience any effects of seasonality it its business. Our products are designed to function at full capacity under all weather conditions and therefore, we do not experience any shifts in our sales patterns.

 

Facilities

 

The Company’s headquarters are located at 1001 Lenoir Street, Suite A-414, Montreal, QC H4C 2Z6, with approximately 4,472 square feet of space. The Company entered into a lease agreement for its property for a five-year term, beginning on July 1, 2020 (the “Lease). The Lease is set to expire on May 31, 2024. Under the Lease, the Company pays Net Rent of $12.00 per square foot per annum, approximately $53,664 annum, payable in monthly equal installments.

 

Legal Proceedings

 

From time to time, we are involved in litigation or other legal proceedings incidental to our business. We are not currently a party to any litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business, operating results, cash flows or financial condition.

 

63

 

 

MANAGEMENT

 

Set forth below is information concerning our directors, executive officers, and other key employees.

 

Name   Age   Position(s)
Marc Seelenfreund   50   Chief Executive Officer and Chairman of the Board of Directors
Gerald Bernstein   57   Chief Financial Officer
Glenn Kennedy   53   Vice President of Sales
Steven Ospalak   52   Director
Gidi Bracha   43   Vice President of Technology and Product Development
Michael Kron   57   Director
Richard Hoy   57   Director
Brian Budd   52   Director

 

Marc Seelenfreund

 

Marc Seelenfreund is the Founder and CEO of Siyata Mobile Inc. since July 2015, when the reverse takeover of Teslin Resources created Siyata Mobile Inc. Marc Seelenfreund has over 20 years experience in the telecom and cellular arena as founder of a leading telecom distribution company representing multiple global telecom vendors. From August 2004 to July 2015 he was the CEO of Accel Telecom Inc. a key importer and integrator of advanced telecom equipment into the Israeli telecom market. Accel Telecom Inc’s products and services included importing and distribution of mobile devices, including smartphones and feature phones, integration of cloud software, and distribution and integration of networking equipment including routers and mobile broadband solutions. Marc Seelenfreund received a law degree from Bar Ilan University and is Chairman of Ono College.

 

Gerald Bernstein

 

Gerald Bernstein has been CFO of the Company since July 2016. Mr. Bernstein was previously the VP Finance from July 2015 until June 2016 of Pazazz Printing Inc. a printing and fulfillment service to ensure a seamless flow throughout projects including printing, graphic design, direct marketing, fulfillment and logistics. Previously, Mr. Bernstein served as the VP Finance from July 2013 until February 2015 of Amcor Holdings Inc., an international real estate development and management company. From September 2003 until July 2015, Mr. Bernstein was a self-employed certified public accountant consultant, working on various mandates in mortgage financing, tax planning, turnaround, process re-engineering and private equity due diligence. Mr. Bernstein holds a Bachelor of Commerce Degree and a Graduate Diploma in Public Accountancy from McGill University. Mr. Bernstein has been a member of the Canadian Institute of Chartered Professional Accountants since 1987.

 

Glenn Kennedy

 

Mr. Kennedy has over 25 years of sales experience in the telecommunications industry where he has managed sales nationally for Motorola Canada, HTC Communications Canada and Sonim Technologies; Glenn Kennedy is the VP Sales of Siyata Mobile Inc. since January 2017 including product certification, sales training and education to the marketplace. Previously Mr. Kennedy severed as the Director of Carrier Sales for Sonim Technologies working exclusively on the Rogers Wireless account from October 2015 until December 2016. Mr. Kennedy was the National Account Manager for HTC Communications Canada, working exclusively on the Bell Mobility account from August 2011 until August 2015. From April 2003 until May 2011, Mr. Kennedy was the National Account Manager for Motorola Mobility, working specifically on the Telus account. Mr. Kennedy has earned a Bachelor of Arts in Honors Business Administration from the Richard Ivey School of Business at the University of Western Ontario.

 

Gidi Bracha

 

Mr. Bracha has served as VP of Technology since 2011 and has spearheaded the development of Siyata’s various cellular products. Mr. Bracha has over 15 years of technological experience in the telecommunications industry. Mr. Bracha has served in various key positions at Cellcom, Israel’s leading cellular provider, including Head of Car Mobility Products and as a Director of Type Approvals. Mr. Bracha has served as an engineer in the Anti-Aircraft division of the air force in the IDF. Mr. Bracha holds a Bachelor’s degree in Engineering and Business Management from the University of Derby.

 

Michael Kron

 

Michael Kron combines over twelve years in the communications industry. Mr. Krin has been the director of the Company since July 27, 2015. Since May 2017, Mr. Kron has been the Chairman and CEO of AnywhereCommerce Inc, where he works closely with technology start-ups serving as an incubator. Previously, he held the role of CFO at Anywhere Commerce Inc. since June 2008. He currently holds one public company board seat being Siyata. He is a Chartered Professional Accountant and has a B.Com. from Concordia University.

 

64

 

 

Stephen Ospalak

 

Mr. Stephen Ospalak combines over twenty-one years of experience in the communications industry. Mr. Ospalak has been the director of the Company since July 27, 2015. Mr. Ospalak has been a Managing Director of Breen Management Group, Inc. (BMG) since January 2009. Previously, Mr. Ospalak was the Vice President of Products and Service Marketing at TELUS Communications Inc. from September 1999 until November 2008. Mr. Ospalak we received a Bachelor of Science from the University of Toronto and an Honors Bachelor of Commerce from the University of Windsor.

 

Richard Hoy

 

Mr. Hoy combines over 30 years of experience in Telecom in senior management roles in sales, operations and marketing. Richard Hoy has been a director of Siyata Mobile Inc. since December 1, 2019. Since May 2019, Mr. Hoy has been the President of Catax Inc. Catax Inc. specialize in the areas of tax incentives, specifically SR&ED. From November 2014 to February 2019, Mr. Hoy served as the SVP of Operations for Ledcor, Inc., a diversified construction company working to design, build, transport, operate, and maintain projects all over North America. From May 2012 until October 2014, Mr. Hoy was the Managing Director and VP of Sales at TELUS, a Canadian national telecommunications company that provides a wide range of telecommunications products and services including internet access, voice, entertainment, healthcare, video, and IPTV television one of the largest wireless telecom providers in Canada. From May 2007 to April 2012 Richard was CEO of CompassPeak Inc. enabling organizations to achieve their business growth aspiration by defining the strategy, to developing the customer’s existing talent, through to taking full responsibility for the execution of targets via outsourced sales and management.

 

Brian Budd

 

Mr. Budd has extensive management and corporate development background with over 25 years of entrepreneurial and sales leadership experience in high tech and resource industries. Mr. Budd has been the director of the Company since July 27, 2015. Mr. Budd has been the managing director of Live Well Exercise Clinic since April 2018. From March 2009 until December 2015, Mr. Budd served as the VP Investor Relations, Director and President of North Country Gold, where he was responsible for fundraising activities, executing overall strategy and reporting progress to the board of directors. From January 2012 to April 2013, Mr. Budd was the CEO of Altiplano Minerals, an exploration company seeking assets in Mexico and South America. Mr. Budd has held several board of director positions in the past. He has been a member of the board of directors of Graphite One Resources Inc. (TSXV: GPH | OTCQXL GPHOF) since 2012. Mr. Budd received his B.A. from the University of British Columbia.

 

Family Relationships

 

None of our directors or executive officers has a family relationship as defined in Item 401 of Regulation S-K.

 

Involvement in Certain Legal Proceedings

 

To the best of our knowledge, none of our directors or executive officers has, during the past 10 years, been involved in any legal proceedings described in subparagraph (f) of Item 401 of Regulation S-K.

 

Board of Directors

 

Our board of directors will consist of five directors upon closing of this offering, three of whom shall be “independent” within the meaning of Section 5605(a)(2) of the NASDAQ Listing Rules and will meet the criteria for independence set forth in Rule 10A-3 of the Exchange Act.

 

Terms of Directors and Executive Officers

 

Each of our directors holds office until a successor has been duly elected and qualified unless the director was appointed by the board of directors, in which case such director holds office until the next following annual meeting of shareholders at which time such director is eligible for re-election. All of our executive officers are appointed by and serve at the discretion of our board of directors.

 

65

 

 

Qualification

 

There is currently no shareholding qualification for directors, although a shareholding qualification for directors may be fixed by our shareholders by ordinary resolution.

 

Insider Participation Concerning Executive Compensation

 

Marc Seelenfreund has been involved in all determinations regarding executive officer compensation since the inception of the Company. He will continue to make such decisions until the Compensation Committee is established immediately prior to the consummation of this offering.

 

Committees of the Board of Directors

 

We have established three committees under the board of directors: an audit committee, a compensation committee, and a nominating and corporate governance committee. We will adopt a formal charter for each of the three committees prior to the closing of this offering. We have determined that Stephen Ospalak, Michael Kron, Richard Hoy and Brian Budd will satisfy the “independence” requirements of Section 5605(a)(2) of the Nasdaq Listing Rules and Rule 10A-3 under the Securities Exchange Act. Each committee’s members and functions are described below.

 

Audit Committee. Our audit committee consists of Stephen Ospalak, Michael Kron and Brian Budd. Michael Kron is the chairperson of our audit committee. Our board also has determined that Michael Kron qualifies as an audit committee financial expert within the meaning of the SEC rules or possesses financial sophistication within the meaning of the Nasdaq Listing Rules. The audit committee oversees our accounting and financial reporting processes and the audits of the financial statements of our company. The audit committee is responsible for, among other things:

 

  appointing the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors;
     
  reviewing with the independent auditors any audit problems or difficulties and management’s response;
     
  discussing the annual audited financial statements with management and the independent auditors;
     
  reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures and any steps taken to monitor and control major financial risk exposures;
     
  reviewing and approving all proposed related party transactions;
     
  meeting separately and periodically with management and the independent auditors; and
     
  monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance.

 

66

 

 

Compensation Committee. Our compensation committee consists of Stephen Ospalak, Michael Kron and Brian Budd. Stephen Ospalak is the chairperson of our compensation committee. The compensation committee assists the board in reviewing and approving the compensation structure, including all forms of compensation, relating to our directors and executive officers. Our chief executive officer may not be present at any committee meeting during which his compensation is deliberated. The compensation committee is responsible for, among other things:

 

  reviewing and approving the total compensation package for our most senior executive officers;
     
  approving and overseeing the total compensation package for our executives other than the most senior executive officers;
     
  reviewing and recommending to the board with respect to the compensation of our directors;
     
  reviewing periodically and approving any long-term incentive compensation or equity plans;
     
  selecting compensation consultants, legal counsel or other advisors after taking into consideration all factors relevant to that person’s independence from management; and
     
  reviewing programs or similar arrangements, annual bonuses, employee pension and welfare benefit plans.

 

Nominating and Corporate Governance Committee. Our nominating and corporate governance committee consists of Stephen Ospalak, Michael Kron, and Brian Budd. Brian Budd is the chairperson of our nominating and corporate governance committee. The nominating and corporate governance committee assists the board of directors in selecting individuals qualified to become our directors and in determining the composition of the board and its committees. The nominating and corporate governance committee are responsible for, among other things:

 

  identifying and recommending nominees for election or re-election to our board of directors or for appointment to fill any vacancy;
     
  reviewing annually with our board of directors its current composition in light of the characteristics of independence, age, skills, experience and availability of service to us;
     
  identifying and recommending to our board the directors to serve as members of committees;
     
  advising the board periodically with respect to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to our board of directors on all matters of corporate governance and on any corrective action to be taken; and
     
  monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance.

 

Code of Business Conduct and Ethics

 

Our board of directors has not yet adopted a code of business conduct and ethics because none of the markets that our Common shares is registered under requires us to have one. We plan on adopting a code of business conduct and ethics prior to this registration statement becoming effective.

 

67

 

 

Non-Employee Director Compensation

 

Prior to the closing of this offering, we expect to implement a formal policy pursuant to which our non-employee directors will be eligible to receive compensation for service on our board of directors and committees of our board of directors.

 

The following table sets forth information regarding compensation earned during the year ended December 31, 2019 by our non-employee directors who served as directors during such year. Mr. Seelenfreund, our Chief Executive Officer, serves on our board of directors but did not receive compensation for his service as a director and the compensation paid to Mr. Seelenfreund as a consultant during the year ended December 31, 2019 is set forth in the “Executive Compensation” section below.

 

Name   Fees Earned or
Paid in Cash
    Option
Awards(1)
    Total  
Brian Budd   $ 38,000     $       $ 38,000  
Stephen Ospalak     75,835             $ 75,835  
Michael Kron     72,225               72,225  
Richard Hoy     7,000       69,665 (1)     76,665  

 

(1) On December 1, 2019, our board of directors approved a grant to Richard Hoy as a new non-employee Director 450,000 stock options, with an exercise price per share of $0.50 per share. 37,500 of the options vested on December 1, 2019, and the remaining options shall vest quarterly over the following thirty-three-month period in eleven equal tranches, with the first tranche vesting on March 1, 2020. The options expire if unexercised on December 1, 2023.

 

68

 

 

EXECUTIVE COMPENSATION

 

Summary Compensation Table

 

The following table sets forth certain information with respect to compensation for the years ended December 31, 2019 and 2018, earned by or paid to our chief executive officer and principal executive officer, our principal financial officer, and our other most highly compensated executive officers whose total compensation exceeded US$100,000 (the “named executive officers”).

 

Name and Principal Position   Year   Salary (CDN$)     Bonus (CDN$)   Stock Awards (CDN$)     Option Awards (CDN$)(1)     Non-Equity Incentive Plan Compensation
($)
    Non-Equity Incentive Plan Compensation
($)
    Deferred Compensation Earnings
($)
    Other
($)
    Total
($)
 
                                                         
Marc Seelenfreund   2019     400,629       150,420     0       0       0       0       0       0       551,049  
CEO   2018     389,122       92,000     0       0       0       0       0       0       481,122  
Gerald Bernstein   2019     144,768       65,000     0       0       0       0       0       0       209,768  
CFO   2018     135,465       30,000     0       139,193 (2)     0       0       0       0       304,658  
Glenn Kennedy   2019     174,000                                                             174,000  
VP Sales   2018     174,000       0     0       0       0       0       0       0       174,000  

  

(1) Represents the aggregate grant date fair value computed in accordance with IFRS 2 Share-based payments. The price for each amount is based on the closing price of the Company’s stock trading on the TSXV on the date of grant.
   
(2) Effective as of December 24, 2018, Mr. Bernstein was granted an award of 360,000 stock options, with an exercise price of $0.50 per share, pursuant to his Amended and Restated Employment Agreement, dated as of July 1, 2018. See below table “Outstanding Equity Awards at Fiscal Year Ended” for the description of the vesting and lock-up conditions applicable to such grant.

 

69

 

 

Name   Number of securities underlying unexercised options (#) exercisable     Number of securities underlying unexercised options (#) unexercisable     Equity incentive plan awards: Number of securities underlying unexercised unearned options (#)     Option exercise price ($)     Option expiration date   Number of shares or units of stock that have not vested (#)     Market value of shares of units of stock that have not vested ($)     Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested (#)     Equity incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested ($)  
Marc Seelenfreund     1,062,000 (1)     0       118,000 (1)   $ 0.55     3/21/24     -       -       -       -  
      2,000,000 (2)     0       0     $ 0.30     7/23/20     -       -       -       -  
Gerald Bernstein     180,000 (3)     0       180,000 (3)   $ 0.50     12/24/23     -       -       -       -  
      360,000 (4)     0       0     $ 0.36     01/11/22     -       -       -       -  
Glenn Kennedy     320,000 (5)     0       0     $ 0.36     01/01/22     -       -       -       -  
Stephen Ospalak     200,000 (6)     0       0     $ 0.69     7/24/22     -       -       -       -  
      250,000 (7)     0       0     $ 0.50     12/24/23     -       -       -       -  
      250,000 (8)     0       0     $ 0.30     7/23/20     -       -       -       -  
Gidi Bracha     200,000       0       0     $ 0.30     7/23/20                                
      200,000       0       0     $ 0.69     7/20/23                                
      150,000       0       210,000     $ 0.55     3/21/22                                
Brian Budd     100,000 (9)     0       0     $ 0.69     7/20/23     -       -       -       -  
      75,000 (8)     0       0     $ 0.30     7/23/20     -       -       -       -  
      75,000 (8)     0       0     $ 0.60     7/23/20     -       -       -       -  
      250,000 (7)     0       0     $ 0.50     12/24/23     -       -       -       -  
Michael Kron     200,000 (6)     0       0     $ 0.69     7/24/22     -       -       -       -  
      75,000 (8)     0       0     $ 0.60     7/23/20     -       -       -       -  
      75,000 (8)     0       0     $ 0.30     7/23/20     -       -       -       -  
      250,000 (7)     0       0     $ 0.50     12/24/23     -       -       -       -  
Richard Hoy     75,000 (10)     0       375,000 (10)   $ 0.50     12/01/23     -       -       -       -  

 

2019 Outstanding Option Awards at Fiscal Year Ended

 

(1) 590,000 of the options shall vest in five equal tranches over a 15-month period, with the first tranche beginning on March 22, 2019. The options expire on March 22, 2024.

 

(2) The options shall vest monthly over a 24-month period and shall expire, if unexercised, on July 23, 2020.

 

(3) 350,000 of the options (the “2018 Bernstein Options”) vest in 1/12th increments every three months for a three-year period from December 24, 2018, subject to Mr. Bernstein’s continued employment by us on each such vesting date. Each tranche of the options shall become exercisable on the date of grant and expire at the end of the Bernstein 2018 Option Term.

 

(4) 270,000 of the 2017 options vest on a quarterly basis in tranches of 30,000, with the first tranche vesting on April 13, 2017. The options expire if unexercised on April 13, 2022.

 

(5) The options shall vest over a 24-month period, with 40,000 of the options vesting on December 6, 2016, and then quarterly for an additional 23 months.

 

(6) The options shall vest quarterly in eight (8) equal installments over a 24-month period and shall expire, if unexercised, on July 1, 2022.

 

(7) 125,000 of the options vested on December 24, 2018, with the remaining options vesting quarterly over a fifteen-month period in five equal tranches, with the first tranche vesting on March 24, 2019. The options expire if unexercised on December 24, 2023.

 

(8) The options shall vest quarterly over a 24-month period and are exercisable until July 23, 2020.

 

(9) The options vested quarterly over a 24-month period, with eight (8) tranches, with the first tranche vesting on July 24, 2017. The options shall expire on July 24, 2022.

 

(10) The options will vest on a quarterly basis over a 36-month period in equal tranches, with the first tranche vesting on December 1, 2019, and shall expire if unexercised at the end of the Term.

 

70

 

 

Agreements with Named Executive Officers

 

Effective July 1, 2018, the Company entered into a consulting agreement with BSD Ltd. and Marc Seelenfreund (the “Seelenfreund Consulting Agreement”) pursuant to which Marc Seelenfreund, as CEO, will be paid an initial base salary approximately $293,501 USD (NIS 90,000 per month). The Seelenfreund Consulting Agreement also contains change of control provisions such that if the Seelenfreund Consulting Agreement is terminated by the Company without good cause or Marc Seelenfreund is constructively dismissed by the Company within six months of a change of control, Marc Seelenfreund will receive a lump-sum payment equal to thirty-six months’ worth of salary in addition to the continuing payment of a quarterly bonus equal to 5% of the Company’s EBITDA for three years following the termination or constructive dismissal, as applicable. In the event of a hostile change of control, Marc Seelenfreund will be entitled to elect to terminate the Seelenfreund Consulting Agreement and will thereafter be entitled to receive a lump-sum payment equal to thirty-six months’ worth of salary in addition to the continuing payment of a quarterly bonus equal to 5% of the Company’s EBITDA for three years following the election.

 

Effective July 1, 2018, the Company entered into an amended and restated employment agreement with Gerald Bernstein (the “Bernstein Employment Agreement”) pursuant to which Gerald Bernstein, as CFO, will be paid an initial base salary of $140,000 per year. The Bernstein Employment Agreement also contains change of control provisions such that if the Bernstein Employment Agreement is terminated without good cause by the Company or Gerald Bernstein is constructively dismissed within six months of a change of control, Gerald Bernstein will receive a lump-sum payment equal to two years’ worth of salary.

 

Effective November 26, 2018, the Company entered into a consulting agreement with Glenn Kennedy (the “Kennedy Consulting Agreement) pursuant to which Glenn Kennedy, as Vice President of Sales, North America, will be paid an annual fee of $150,000. Additionally, Mr. Kennedy will receive commission of 1.5% on all North American sales of the Company’s products exceeding $5,000,000 but less than $18,500,00, and commission of 0.75% on sales exceeding $18,500,000. The Kennedy Consulting Agreement can be terminated without good cause by either the Company or Kennedy upon 90 days’ notice.

 

71

 

 

PRINCIPAL SHAREHOLDERS

 

Except as specifically noted, the following table sets forth information with respect to the beneficial ownership of our Common Shares as of the date of this prospectus by:

 

  each of our directors and executive officers; and

 

  each person known to us to beneficially own more than 5% of our Common Shares on an as-converted basis.

 

The calculations in the table below are based on 124,312,602 common shares on an as-converted basis outstanding as of the date of this prospectus, issued and outstanding immediately after the completion of this offering, assuming the underwriters do not exercise their over-allotment option.

 

Beneficial ownership is determined in accordance with the rules and regulations of the SEC. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, we have included shares that the person has the right to acquire within 60 days, including through the exercise of any option, warrant or other right or the conversion of any other security. These shares, however, are not included in the computation of the percentage ownership of any other person.

 

    Total Common Shares Beneficially Owned on an as-Converted Basis     % of Beneficial Ownership     % of Aggregate Voting Power  
Directors and Executive Officers:                  
Marc Seelenfreund      3,180,000 (1) (2)     2.56       2.56  
Gerald Bernstein     720,000 (3)      *        *  
Glenn Kennedy     320,000 (4)      *        *  
Brian Budd     500,000 (5)      *        *  
Stephen Ospalak     750,000 (6)      *        *  
Michael Kron     743,500 (7)      *        *  
Richard Hoy     450,000 (8)      *        *  
All Directors and Executive Officers as a Group (7 persons)     6,663,500       5.36       5.36  
                         
Principal Shareholders:                        
Accel Telecom Ltd. (9)     22,233,333       17.89       17.89  

 

* Less than 1%

 

(1) Accel Telecom Ltd. is the holder of 3,000,000 of which Mr. Seelenfreund receives a pecuniary interest. Accel Telecom Ltd. retains full ability to vote and dispose on such shares.
   
(2) Represents 3,180,000 options convertible to Common Shares held by Mr. Seelenfreund. For additional information about the options, please see the section of this prospectus titled “2019 Outstanding Option Awards at Fiscal Year Ended” beginning on page 70.
   
(3) Represents 720,000 options convertible to Common Shares held by Mr. Bernstein. For additional information about the options, please see the section of this prospectus titled “2019 Outstanding Option Awards at Fiscal Year Ended” beginning on page 70.
   
(4) Represents 320,000 options convertible to Common Shares held by Mr. Kennedy. For additional information about the options, please see the section of this prospectus titled “2019 Outstanding Option Awards at Fiscal Year Ended” beginning on page 70.
   
(5) Represents 500,000 options convertible to Common Shares held by Mr. Budd. For additional information about the options, please see the section of this prospectus titled “2019 Outstanding Option Awards at Fiscal Year Ended” beginning on page 70.
   
(6) Represents 750,000 options convertible to Common Shares held by Mr. Ospalak. For additional information about the options, please see the section of this prospectus titled “2019 Outstanding Option Awards at Fiscal Year Ended” beginning on page 70.
   
(7) Includes 600,000 options convertible to Common Shares held by Mr. Kron. For additional information about the options, please see the section of this prospectus titled “2019 Outstanding Option Awards at Fiscal Year Ended” beginning on page 70.
   
(8) Includes 450,000 options convertible to Common Shares held by Mr. Hoy. For additional information about the options, please see the section of this prospectus titled “2019 Outstanding Option Awards at Fiscal Year Ended” beginning on page 70.
   
(9) Accel Telecom Ltd.’s sole director is Meir Jacobson.

 

72

 

 

RELATED PARTY TRANSACTIONS

 

Other than as disclosed below, and except for the regular salary and bonus payments made to our directors and officers in the ordinary course of business as described in “Executive Compensation”, there have been no transactions since January 1, 2018, or any currently proposed transaction or series of similar transactions to which the Company was or is to be a party, in which the amount involved exceeds $120,000 and in which any current or former director or officer of the Company, any 5% or greater shareholder of the Company or any member of the immediate family of any such persons had or will have a direct or indirect material interest.

 

Loan to Seelenfreund

 

On April 1, 2019 the Company and BSD Capital Ltd, an entity controlled by Marc Seelenfreund, the CEO and a Director of the Company, entered into a Loan Agreement, whereby the Company issued a promissory note in the amount of $200,000 USD to BSD Capital Ltd (the “Promissory Note”). This promissory note is due in five years with interest charged at the rate of 7% per annum payable quarterly. There are no principal repayment requirements until the end of the term when a balloon payment of the principal balance is required.

 

On January 1, 2020 the Company, BSD Capital Ltd., and Basad Partners Ltd. entered into an assignment and amending agreement whereby BSD Capital Ltd assigned its right, title and interest in Basad Partners Ltd. in the Promissory Note and that the interest rate of the note shall be increased to 12.5% per annum.

 

Balances and transactions with Accel Telecom Ltd.

 

Until September 30, 2018, the Company had a management agreement with a related company, Accel Solutions Ltd., a leading Israeli telecom distribution company (“Accel”). Shamrock Israel Fund is a major indirect shareholder in Siyata via its ownership in Accel. As part of the agreement, the Company paid Accel $US25,000 per month for management services (including services related to office space rent, insurance, accounting services, general operations, administration, and other). From October 1, 2018 the monthly fee was reduced to $US11,000 per month (2017 – 12 months at $US 25,000). Included in due to related party as at December 31, 2019 is a balance payable to Accel of $100,0791 (December 31, 2018 balance due of $198,000). The balance is non-interest bearing.

 

Non-Exclusive Distribution Agreement with Accel Solutions Ltd.

 

In November 2019 Signifi entered into a nonexclusive distribution agreement with Accel. During 2019, the Company sold $259,600 USD worth of merchandise to Accel Solutions Ltd at a fair market value price consistent with arm’s length transactions.

 

Convertible Debenture with Accel Solutions Ltd.

 

On June 23, 2020, the Company entered into an agreement with Accel in connection with a non-brokered private placement financing (the “Convertible Debentures Offering”) pursuant to which Accel subscribed for 1,330 senior unsecured convertible debentures (the “Convertible Debentures”) at an issue price of CDN$1,000 per Convertible Debenture for aggregate gross proceeds of approximately USD$1,000,000. Each Convertible Debenture is convertible, at the option of the holder, into 3,333 Common Shares at a price of CDN$0.30 (the “Conversion Price”) per Common Share, subject to adjustment in certain events. Each Convertible Debenture will bear interest at a rate of 10.0% per annum from the date of issue, payable in cash quarterly in arrears. Any unpaid interest payments will accrue and be added to the principal amount of the Convertible Debenture. The Convertible Debentures will mature twelve (12) months (the “Maturity Date”) after the date of issuance and are redeemable at 101% of the face value at any time after the closing date. Accel also received 1,330,000 common share purchase warrant (each, a “Warrant”). Each Warrant entitles the holder to acquire one Common Share at an exercise price of CDN$0.30 per share for a period of twelve (12) months after the date of issue.

 

Purchase of Units by Marc Seelenfruend

 

Marc Seelenfruend, CEO and director of the Company, purchased an aggregate of 360,000 August 2020 Units in connection with the Company’s August 2020 Financing

 

73

 

 

DESCRIPTION OF SHARE CAPITAL

 

The following description of our share capital and provisions of our memorandum and articles of association are summaries and do not purport to be complete. Reference is made to our memorandum and articles of association, which will become effective upon or before the completion of this offering, copies of which are filed as an exhibit to the registration statement of which this prospectus is a part (and which is referred to in this section as, respectively, the “memorandum” and the “articles”).

 

Common Shares

 

All of our issued and outstanding Common Shares are fully paid and non-assessable. Our Common Shares are issued in registered form, and are issued when registered in our register of members. Unless the board of directors determine otherwise, each holder of our Common Shares will not receive a certificate in respect of such Common Shares. Our shareholders who are non-residents of British Columbia may freely hold and vote their Common Shares.

 

We are authorized to issue an unlimited amount of Common Shares with no par value per share. Subject to the provisions of the Business Corporations Act (British Columbia) (“Business Corporations Act”) and our articles regarding redemption and purchase of the shares, the directors have general and unconditional authority to allot (with or without confirming rights of renunciation), grant options over or otherwise deal with any unissued shares to such persons, at such times and on such terms and conditions as they may decide. Such authority could be exercised by the directors to allot shares which carry rights and privileges that are preferential to the rights attaching to Common Shares. No share may be issued at a discount except in accordance with the provisions of the Business Corporations Act. The directors may refuse to accept any application for shares, and may accept any application in whole or in part, for any reason or for no reason.

 

On July 28, 2020, our shareholders approved a                       for 1 reverse stock split of our Common Shares, subject to and effective immediately prior to the completion of this offering.

 

Warrants

  

Overview. The following summary of certain terms and provisions of the warrants offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions of the warrant agency agreement between us and the Warrant Agent, and the form of warrant, both of which are filed as exhibits to the registration statement of which this prospectus is a part. Prospective investors should carefully review the terms and provisions set forth in the warrant agency agreement, including the annexes thereto, and form of warrant.

 

The warrants issued in this offering entitle the registered holder to purchase common shares at a price equal to $ per share, subject to adjustment as discussed below, immediately following the issuance of such warrant and terminating at 5:00 p.m., New York City time, five years after the closing of this offering.

 

The exercise price and number of common shares issuable upon exercise of the warrants may be adjusted in certain circumstances, including in the event of a stock dividend or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of common shares at prices below its exercise price.

 

Exercisability. The warrants are exercisable at any time after their original issuance and at any time up to the date that is five (5) years after their original issuance. The warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the Warrant Agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price, by certified or official bank check payable to us, for the number of warrants being exercised. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common shares issuable upon exercise of the warrants until the expiration of the warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common shares issuable upon exercise of the warrants, the holders of the warrants shall have the right to exercise the warrants solely via a cashless exercise feature provided for in the warrants, until such time as there is an effective registration statement and current prospectus.

 

Exercise Limitation. A holder may not exercise any portion of a warrant to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would own more than 4.99% of the outstanding common shares after exercise, as such percentage ownership is determined in accordance with the terms of the warrant, except that upon prior notice from the holder to us, the holder may waive such limitation up to a percentage not in excess of 9.99%.

 

Exercise Price. The exercise price per whole share of common share purchasable upon exercise of the warrants is no less than 100% of public offering price of the Units. The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting our common shares and also upon any distributions of assets, including cash, stock or other property to our stockholders. 

 

74

 

 

Fractional Shares. No fractional common shares will be issued upon exercise of the warrants. As to any fraction of a share which the holder would otherwise be entitled to purchase upon such exercise, the Company will round up or down, as applicable, to the nearest whole share.

 

Transferability. Subject to applicable laws, the warrants may be offered for sale, sold, transferred or assigned without our consent.

  

Warrant Agent; Global Certificate. The warrants will be issued in registered form under a warrant agency agreement between the Warrant Agent and us. The warrants shall initially be represented only by one or more global warrants deposited with the Warrant Agent, as custodian on behalf of The Depository Trust Company (DTC) and registered in the name of Cede & Co., a nominee of DTC, or as otherwise directed by DTC.

 

Fundamental Transactions. In the event of a fundamental transaction, as described in the warrants and generally including any reorganization, recapitalization or reclassification of our common shares, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding common shares, or any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding common shares, the holders of the warrants will be entitled to receive the kind and amount of securities, cash or other property that the holders would have received had they exercised the warrants immediately prior to such fundamental transaction.

 

Rights as a Stockholder. The warrant holders do not have the rights or privileges of holders of common shares or any voting rights until they exercise their warrants and receive common shares. After the issuance of common shares upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.

 

Governing Law. The warrants and the warrant agency agreement are governed by New York law.

 

Representative’s Warrants. The registration statement of which this prospectus is a part also registers for sale the Representative’s Warrants, as a portion of the underwriting compensation payable to the Representative in connection with this offering. The Representative’s Warrants will be exercisable for a four and half year period commencing 180 days following the effective date of the registration statement of which this prospectus is a part at an exercise price of $______ (110% of the public offering price of the Units). Please see “Underwriting—Representative’s Warrants” for a description of the warrants we have agreed to issue to the Representative in this offering, subject to the completion of the offering.

  

Listing

 

We applied to list the Common Shares and Common Shares Purchase Warrants on the Nasdaq Capital Market under the symbol “SYAT and SYATW”, respectively.”

 

Transfer Agent

 

The transfer agent for the Common Shares is Computershare Limited, 8th Floor, 100 University Avenue, Toronto Ontario M5J2Y1.

 

Dividends

 

Subject to the provisions of the Business Corporations Act and any rights attaching to any class or classes of shares under and in accordance with the articles:

 

  (a) the directors may declare dividends or distributions out of our funds which are lawfully available for that purpose; and

 

  (b) our shareholders may, by ordinary resolution, declare dividends but no such dividend shall exceed the amount recommended by the directors.

 

Unless provided by the rights attached to a share, no dividend shall bear interest.

 

Voting Rights

 

Subject to any rights or restrictions as to voting attached to any shares, unless any share carries special voting rights, on a show of hands every shareholder who is present in person and every person representing a shareholder by proxy shall have one vote per Common Shares. During a shareholder vote, every shareholder who is present in person and every person representing a shareholder by proxy shall have one vote for each share of which he or the person represented by proxy is the holder. In addition, all shareholders holding shares of a particular class are entitled to vote at a meeting of the holders of that class of shares. Votes may be given either personally or by proxy.

 

75

 

 

Variation of Rights of Shares

 

Whenever our capital is divided into different classes of shares, the rights attaching to any class of share (unless otherwise provided by the terms of issue of the shares of that class) may be varied either with the consent in writing of the holders of not less than two-thirds of the issued shares of that class, or with the sanction of a resolution passed by a majority of not less than two-thirds of the holders of shares of the class present in person or by proxy at a separate general meeting of the holders of shares of that class.

 

Unless the terms on which a class of shares was issued state otherwise, the rights conferred on the shareholder holding shares of any class shall not be deemed to be varied by the creation or issue of further shares ranking pari passu with the existing shares of that class.

 

Alteration of Share Capital

 

Subject to the Business Corporations Act, the Company may, by ordinary resolution:

 

(1) create one or more classes or series of shares or, if none of the shares of a class or series of shares are allotted or issued, eliminate that class or series of shares;

 

(2) increase, reduce or eliminate the maximum number of shares that the Company is authorized to issue out of any class or series of shares or establish a maximum number of shares that the Company is authorized to issue out of any class or series of shares for which no maximum is established;

 

(3) subdivide or consolidate all or any of its unissued, or fully paid issued, shares;

 

(4) if the Company is authorized to issue shares of a class of shares with par value:

 

  (a) decrease the par value of those shares; or

 

  (b) if none of that class of shares are allotted or issued, increase the par value of those shares;

 

(5) change all or any of its unissued, or fully paid issued, shares with par value into shares without par value or any of its unissued shares without par value into shares with par value;

 

(6) alter the identifying name of any of its shares; or

 

(7) otherwise alter its shares or authorized share structure when required or permitted to do so by the Business Corporations Act.

 

Inspection of Books and Records

 

Holders of our Common Shares will have no general right under the Business Corporations Act to inspect or obtain copies of our register of members or our corporate records.

 

General Meetings

 

Under the Business Corporations Act, the Company must hold its first annual general meeting within 18 months after the date on which it was incorporated or otherwise recognized, and after that much hold an annual general meeting at least once in each calendar year and not more than 15 months after the last annual reference date at such time and place as may be determined by the directors.

 

76

 

 

If all the shareholders who are entitled to vote at an annual general meeting consent by a unanimous resolution to all of the business that is required to be transacted at that annual general meeting, the annual general meeting is deemed to have been held on the date of the unanimous resolution. The shareholders much, in any unanimous resolution, select as the Company’s annual reference date, a date that would be appropriate for the holding of the applicable annual general meeting.

 

The directors also may whenever think fit, call a meeting of the shareholders.

 

A general meeting of the Company may be held anywhere in North America, as determined by the directors.

 

The Company must send notice of the date, time and location of any meeting of shareholders in the manner provided in the Business Corporations Act to each shareholder entitled to attend the meeting and to each director of the Company if and for so long as the Company is a public company, twenty-one days, and otherwise ten days.

 

The directors may set a date as the record date for the purpose of determining shareholders entitled to, or the non-receipt of any notice by, any of the persons entitled to notice does not invalidate any proceeding at that meeting. Any persons entitled to notice of a meeting of shareholders may, in writing or otherwise, waive or reduce the period of notice of such meeting.

 

Accidental omission to send notice of any meeting of shareholder to, or the non-receipt of any notice by, any of the persons entitled to notice does not invalidate any proceeding at that meeting. Any person entitled to notice of a meeting of shareholders may, in writing or otherwise, waive or reduce the period of notice of such meeting.

 

If a meeting of shareholders is to consider special business, as defined in the Company’s Articles of Incorporation, the notice of meeting must:

(1) state the general nature of the special business;

 

(2) if the special business includes considering, approving, ratifying, adopting or authorizing any document or the signing of or giving of effect to any document, have attached to it a copy of the document or state that a copy of the document will be available for inspection by shareholders:

 

(a) at the Company’s record office, or at such other reasonably accessible location in British Columbia as is specified in the notice; and

 

(b) during statutory business hours on any one or more specified days before the day set for the holding of the meeting.

 

A shareholder may participate in a meeting of the shareholders in person or by telephone if all shareholders participate in the meeting, whether in person or by telephone or other communications medium, are able to communicate with each other and if all shareholders who wish to participate in the meeting agree to such participation.

 

The quorum for the transaction of business at a meeting of shareholders is two persons, who are or representing by proxy, shareholders holding, in the aggregate, at least five percent of the issued shares entitled to be voted at the meeting. On a show of hands, every person present who is a shareholder or proxy holder entitled to vote on the matter has one vote.

 

Directors

 

Under the Business Corporations Act, as a publicly traded company, the Company must have at least three directors, and as many directors as set by ordinary resolution. The shareholders may elect or appoint the directors needed to fill any vacancies in the board of directors up to the number of opened vacancies. A director is entitled to remuneration for acting as directors.

 

77

 

 

At every annual general meeting, the shareholder entitled to vote must elect, or in the unanimous resolution, appoint, a board of directors consisting of the number of directors for the time being

 

The shareholding qualification for directors may be fixed by our shareholders by ordinary resolution and unless and until so fixed no share qualification shall be required.

 

Each director holds office for the term, if any, fixed by the terms of his appointment or until his earlier death, bankruptcy, insanity, resignation or removal. If no term is fixed on the appointment of a director, the director serves indefinitely until his earlier death, bankruptcy, insanity, resignation or removal.

 

A director may be removed by ordinary resolution.

 

A director may at any time resign or retire from office by giving us notice in writing. Unless the notice specifies a different date, the director shall be deemed to have resigned on the date that the notice is delivered to us.

 

Subject to the provisions of the articles, the office of a director may be terminated forthwith if:

 

  (a) he resigns his office by notice to us;

 

  (b) he only held office as a director for a fixed term and such term expires;

 

  (c) he dies; or

 

  (h) he is removed pursuant to the articles of the Company.

 

Each of the compensation committee and the nominating and corporate governance committee shall consist of at least three directors and the majority of the committee members are independent within the meaning of Section 5605(a)(2) of the NASDAQ Listing Rules. The audit committee consists of at least three directors, all of whom are independent within the meaning of Section 5605(a)(2) of the NASDAQ Listing Rules and meet the criteria for independence set forth in Rule 10A-3 or Rule 10C-1 of the Exchange Act.

 

Powers and Duties of Directors

 

Subject to the provisions of the Business Corporations Act and our articles of association, our business shall be managed by the directors, who may exercise all our powers. No prior act of the directors shall be invalidated by any subsequent alteration of our articles of association. To the extent allowed by the Business Corporations Act, however, shareholders may by special resolution validate any prior or future act of the directors which would otherwise be in breach of their duties.

 

The directors may delegate any of their powers to any person to be the attorney of the Company.

 

The board of directors may establish any local or divisional board of directors or agency and delegate to it its powers and authorities (with power to sub-delegate) for managing any of our affairs.

 

The directors may from time to time and at any time by power of attorney or in any other manner they determine appoint any person, either generally or in respect of any specific matter, to be our agent with or without authority for that person to delegate all or any of that person’s powers.

 

The directors may from time to time and at any time by power of attorney or in any other manner appoint any person, whether nominated directly or indirectly by the directors, to be our attorney or our authorized signatory and for such period and subject to such conditions as they may think fit. The powers, authorities and discretions, however, must not exceed those vested in, or exercisable, by the directors under the articles.

 

The board of directors may remove any person so appointed and may revoke or vary the delegation.

 

A director may, as a director, vote (and be counted in the quorum) in respect of any contract, transaction, arrangement or proposal in which he has an interest which is not a material interest. However, a director who holds a disclosable interest in a contract or transaction win which the Company has entered or proposes to enter is not entitled to vote on any directors’ resolutions to approve the contract or transaction, unless the directors have disclosable interest in that contract or transaction, in which case any or all of those directors may vote on such resolution. Such director who holds a disclosable interest that is present for a meeting of directors may be counted in the quorum at the meeting, whether or not the director votes on any or all of the resolutions considered at the meeting.

 

78

 

 

SHARES ELIGIBLE FOR FUTURE SALE

 

Future sales of substantial amounts of our common shares in the public market could adversely affect prevailing market prices. Furthermore, since only a limited number of shares will be available for sale shortly after the offering because of contractual and legal restrictions on resale described below, sales of substantial amounts of common shares in the public market after the restrictions lapse could adversely affect the prevailing market price for shares of our common shares as well as our ability to raise equity capital in the future.

 

Upon completion of this offering, we will have            common shares issued and outstanding (or shares if the underwriters exercise in full their option to purchase additional shares of our common shares).

 

Of these shares, the            common shares sold in this offering (or          shares, if the underwriters exercise in full their option to purchase additional shares of our Common Shares) will be freely tradable without further restriction or registration under the Securities Act, except that any shares purchased by our affiliates may generally only be sold in compliance with Rule 144, which is described below. The remaining              common shares will be deemed “restricted securities” under the Securities Act. Restricted securities may be sold in the public market only if they are registered under the Securities Act or if they qualify for an exemption from registration under Rules 144 or 701 under the Securities Act, which are discussed below.

 

Lock-up Agreements

 

We, each of our executive officers and directors of our common shares (including securities convertible into or exchangeable for shares of our common shares) anticipate on entering into lock-up agreements under which these parties have agreed not to sell or otherwise transfer their shares for a period of ninety (90)   days after the date of this prospectus. These lock-up restrictions are subject to certain exceptions and may be waived by the representatives of the underwriters at any time. As a result of these contractual restrictions, shares of our common shares subject to lock-up agreements will not be eligible for sale, including pursuant to Rules 144 or 701 under the Securities Act as discussed below, until these agreements expire or the restrictions are waived by the representatives of the underwriters.

 

See “Underwriting” for a more complete description of the lock-up agreements.

 

Rule 144

 

In general, Rule 144 provides that once we have been subject to the public company reporting requirements of Section 13 or Section 15(d) of the Exchange Act for at least 90 days, a person who is not deemed to have been one of our affiliates for purposes of the Securities Act at any time during the 90 days preceding a sale and who has beneficially owned the shares of our common shares proposed to be sold for at least six months is entitled to sell those shares without complying with the manner of sale, volume limitation, or notice provisions of Rule 144, subject to compliance with the public information requirements of Rule 144. If such a person has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than our affiliates, then that person would be entitled to sell those shares without complying with any of the requirements of Rule 144.

 

In general, Rule 144 provides that our affiliates or persons selling shares of our common shares on behalf of our affiliates are entitled to sell upon expiration of the market standoff agreements and lock-up agreements described above, within any three-month period, a number of shares of our common shares that does not exceed the greater of: 

 

  1% of the number of shares of our common shares then outstanding, which will equal shares            immediately after the completion of this offering; or
     
  the average weekly trading volume of our common shares during the four calendar weeks preceding the filing of a notice on Form 144 with respect to that sale.

 

Rule 701

 

Rule 701 generally allows a stockholder who purchased shares of our capital stock pursuant to a written compensatory plan or contract and who is not deemed to have been an affiliate of our company during the immediately preceding 90 days to sell these shares in reliance upon Rule 144, but without being required to comply with the public information, holding period, volume limitation, or notice provisions of Rule 144. Rule 701 also permits affiliates of our company to sell their Rule 701 shares under Rule 144 without complying with the holding period requirements of Rule 144. All holders of Rule 701 shares, however, are required to wait until 180 days after the date of this prospectus before selling those shares pursuant to Rule 701.

 

Registration Statement on Form S-8

 

We intend to file with the SEC one or more registration statements on Form S-8 covering the common shares reserved for issuance under our incentive plans. These registration statements are expected to be filed and become effective as soon as practicable after completion of this offering. Upon effectiveness, the common shares covered by these registration statements will generally be eligible for sale in the public market, subject to the lock-up agreements described above.

 

79

 

 

MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES TO U.S. HOLDERS

 

The following discussion describes the material United States federal income tax consequences to a United States Holder (as defined herein) of the purchase, ownership and disposition of our voting shares as of the date hereof. This discussion deals only with voting shares that are held as capital assets by a United States Holder. In addition, the discussion set forth below is applicable only to United States Holders (i) who are residents of the United States for purposes of the current United States—Canada Income Tax Convention (the “Treaty”), (ii) whose voting shares are not, for purposes of the Treaty, effectively connected with a permanent establishment in Canada and (iii) who otherwise qualify for the full benefits of the Treaty.

 

As used herein, the term “United States Holder” means a beneficial owner of our voting shares that is, for United States federal income tax purposes, any of the following:

 

  an individual citizen or resident of the United States;
     
  a corporation (or other entity treated as a corporation for United States federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia;
     
  an estate the income of which is subject to United States federal income taxation regardless of its source; or
     
  a trust if it (1) is subject to the primary supervision of a court within the United States and one or more United States persons have the authority to control all substantial decisions of the trust or (2) has a valid election in effect under applicable United States Treasury regulations to be treated as a United States person.

 

This discussion is based upon provisions of the Internal Revenue Code of 1986, as amended (the “Code”), and regulations, rulings and judicial decisions thereunder as of the date hereof. Those authorities may be changed, perhaps retroactively, so as to result in United States federal income tax consequences different from those summarized below.

 

This discussion does not represent a detailed description of the United States federal income tax consequences applicable to you if you are subject to special treatment under the United States federal income tax laws, including if you are:

 

  a dealer in securities or currencies;
     
  a financial institution;
     
  a regulated investment company;
     
  a real estate investment trust;
     
  an insurance company;
     
  a tax-exempt organization;
     
  a person holding our voting shares as part of a hedging, integrated or conversion transaction, a constructive sale or a straddle;
     
  a trader in securities that has elected the mark-to-market method of tax accounting for your securities;
     
  a person liable for alternative minimum tax;
     
  a person who owns or is deemed to own 10% or more of our stock (by vote or value);
     
  a partnership or other pass-through entity for United States federal income tax purposes;
     
  a person required to accelerate the recognition of any item of gross income with respect to our voting shares as a result of such income being recognized on an applicable financial statement; or
     
  a person whose “functional currency” is not the United States dollar.

 

If a partnership (or other entity treated as a partnership for United States federal income tax purposes) holds our voting shares, the tax treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. If you are a partner of a partnership holding our voting shares, you should consult your tax advisors.

 

80

 

 

This discussion does not contain a detailed description of all the United States federal income tax consequences to you in light of your particular circumstances and does not address the Medicare tax on net investment income or the effects of any state, local or non-United States tax laws. If you are considering the purchase of our voting shares, you should consult your own tax advisors concerning the particular United States federal income tax consequences to you of the purchase, ownership and disposition of our voting shares, as well as the consequences to you arising under other United States federal tax laws and the laws of any other taxing jurisdiction.

 

This discussion assumes that we are not, and will not become, a passive foreign investment company, as described below.

 

Taxation of Dividends

 

The gross amount of distributions on the voting shares (including any amounts withheld to reflect Canadian withholding taxes) will be taxable as dividends to the extent paid out of our current or accumulated earnings and profits, as determined under United States federal income tax principles. To the extent that the amount of any distribution exceeds our current and accumulated earnings and profits for a taxable year, the distribution will first be treated as a tax-free return of capital, causing a reduction in the tax basis of the voting shares, and to the extent the amount of the distribution exceeds your tax basis, the excess will be taxed as capital gain recognized on a sale or exchange. We do not, however, expect to determine earnings and profits in accordance with United States federal income tax principles. Therefore, you should expect that a distribution will generally be treated as a dividend.

 

Any dividends that you receive (including any withheld taxes) will be includable in your gross income as ordinary income on the day actually or constructively received by you. Such dividends will not be eligible for the dividends received deduction allowed to corporations under the Code.

 

With respect to non-corporate United States Holders, certain dividends received from a qualified foreign corporation may be subject to reduced rates of taxation. A qualified foreign corporation includes a non-U.S. corporation that is eligible for the benefits of a comprehensive income tax treaty with the United States which the United States Treasury Department determines to be satisfactory for these purposes and which includes an exchange of information provision. The United States Treasury Department has determined that the Treaty meets these requirements, but we may not be eligible for the benefits of the Treaty. However, a non-U.S. corporation is also treated as a qualified foreign corporation with respect to dividends paid by that corporation on shares that are readily tradable on an established securities market in the United States. United States Treasury Department guidance indicates that our voting shares, which will be listed on the NASDAQ, will be readily tradable on an established securities market in the United States. There can be no assurance, however, that our voting shares will be considered readily tradable on an established securities market in later years. Non-corporate holders that do not meet a minimum holding period requirement during which they are not protected from the risk of loss or that elect to treat the dividend income as “investment income” pursuant to Section 163(d)(4) of the Code will not be eligible for the reduced rates of taxation regardless of our status as a qualified foreign corporation. In addition, the rate reduction will not apply to dividends if the recipient of a dividend is obligated to make related payments with respect to positions in substantially similar or related property. This disallowance applies even if the minimum holding period has been met. You should consult your own tax advisors regarding the application of these rules to your particular circumstances.

 

The amount of any dividend paid in Canadian dollars will equal the United States dollar value of the Canadian dollars received calculated by reference to the exchange rate in effect on the date the dividend is received by you, regardless of whether the Canadian dollars are converted into United States dollars. If the Canadian dollars received as a dividend are converted into United States dollars on the date they are received, you generally will not be required to recognize foreign currency gain or loss in respect of the dividend income. If the Canadian dollars received as a dividend are not converted into United States dollars on the date of receipt, you will have a basis in the Canadian dollars equal to their United States dollar value on the date of receipt. Any gain or loss realized on a subsequent conversion or other disposition of the Canadian dollars will be treated as United States source ordinary income or loss.

 

81

 

 

Subject to certain conditions and limitations, Canadian withholding taxes on dividends may be treated as foreign taxes eligible for credit against your United States federal income tax liability. For purposes of calculating the foreign tax credit, dividends paid on the voting shares will be treated as income from sources outside the United States and will generally constitute passive category income. However, in certain circumstances, if you have held the voting shares for less than a specified minimum period during which you are not protected from risk of loss, or are obligated to make payments related to the dividends, you will not be allowed a foreign tax credit for Canadian withholding taxes imposed on dividends paid on the voting shares. If you do not elect to claim a United States foreign tax credit, you may instead claim a deduction for Canadian income tax withheld, but only for a taxable year in which you elect to do so with respect to all foreign income taxes paid or accrued in such taxable year. The rules governing the foreign tax credit are complex. You are urged to consult your tax advisors regarding the availability of the foreign tax credit under your particular circumstances.

 

Passive Foreign Investment Company

 

We do not believe that we are, for United States federal income tax purposes, a passive foreign investment company (a “PFIC”), and we expect to operate in such a manner so as not to become a PFIC. If, however, we are or become a PFIC, you could be subject to additional United States federal income taxes on gain recognized with respect to the voting shares and on certain distributions, plus an interest charge on certain taxes treated as having been deferred under the PFIC rules.

 

Taxation of Capital Gains

 

For United States federal income tax purposes, you will recognize taxable gain or loss on any sale or exchange of the voting shares in an amount equal to the difference between the amount realized for the voting shares and your tax basis in the voting shares. Such gain or loss will generally be capital gain or loss and will generally be long-term capital gain or loss if you have held the voting shares for more than one year. Long-term capital gains of non-corporate United States Holders (including individuals) are eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations. Any gain or loss recognized by you will generally be treated as United States source gain or loss. Consequently, you may not be able to use the foreign tax credit arising from any Canadian tax imposed on the disposition of voting shares unless such credit can be applied (subject to applicable limitations) against tax due on other income treated as derived from foreign sources.

 

Information Reporting and Backup Withholding

 

In general, information reporting will apply to dividends in respect of our voting shares and the proceeds from the sale, exchange or other disposition of our voting shares that are paid to you within the United States (and in certain cases, outside the United States), unless you are an exempt recipient. A backup withholding tax may apply to such payments if you fail to provide a taxpayer identification number or certification of exempt status or fail to report in full dividend and interest income.

 

Backup withholding is not an additional tax and any amounts withheld under the backup withholding rules will be allowed as a refund or a credit against your United States federal income tax liability provided the required information is timely furnished to the Internal Revenue Service.

 

Reporting Obligations for Specified Foreign Financial Assets

 

United States Holders who are individuals (and certain entities) are required to report on Internal Revenue Service Form 8938 specified foreign financial assets that they own if the aggregate value of those assets exceeds certain threshold amounts. Specified foreign financial assets may include stock of a foreign issuer such as the voting shares if not held through a financial account maintained at a United States “financial institution,” as defined in the applicable rules. United States Holders should consult their own tax advisors as to the possible application of this reporting obligation under their particular circumstances.

 

82

 

 

MATERIAL CANADIAN FEDERAL INCOME TAX CONSIDERATIONS

 

The following summary describes, as of the date hereof, the principal Canadian federal income tax considerations under the Income Tax Act (Canada) (the “Tax Act”) generally applicable to a holder who acquires, as beneficial owner, Common Shares pursuant to this Offering, who has not elected to report its Canadian tax results in a currency other than the Canadian currency, and who deals at arm’s length with the Company and the underwriters for purposes of the Tax Act (a “Holder”).

 

This summary is based on the provisions of the Tax Act and the regulations thereunder (the “Regulations”) in force as of the date hereof, all specific proposals to amend the Tax Act and the Regulations that have been publicly announced prior to the date hereof (the “Proposed Amendments”), and our understanding of the current published administrative policies and practices of the Canada Revenue Agency. This summary assumes that the Proposed Amendments will be enacted in the form proposed; however, no assurance can be given that the Proposed Amendments will be enacted in the form proposed, if at all. This summary is not exhaustive of all possible Canadian federal income tax considerations and, except for the Proposed Amendments, does not take into account any changes in law, whether by legislative, governmental or judicial action, nor does it take into account provincial, territorial or foreign tax considerations, which may differ from those discussed herein.

 

This summary is of a general nature only and is not intended to be, nor should it be construed to be, legal or tax advice to any particular Holder, and no representations with respect to the income tax consequences to any Holder are made. Consequently, Holders and prospective holders of Common Shares should consult their own tax advisors for advice with respect to the tax consequences to them of acquiring such shares pursuant to this offering, having regard to their particular circumstances. This summary does not address any tax considerations applicable to persons other than Holders and such persons should consult their own tax advisors regarding the consequences of acquiring, holding and disposing of Common Shares under the Tax Act and any jurisdiction in which they may be subject to tax.

 

Foreign Exchange

 

For purposes of the Tax Act, all amounts expressed in a currency other than Canadian dollars relating to the acquisition, holding or disposition of Common Shares, including dividends, adjusted cost base and proceeds of disposition, must be determined in Canadian dollars using the relevant rate of exchange required under the Tax Act.

 

Residents of Canada

 

The following portion of this summary is generally applicable to a Holder who, at all relevant times for purposes of the Tax Act (a) is, or is deemed to be, resident in Canada, (b) holds Common Shares as “capital property”, and (c) is not affiliated with the Company or the underwriters (a “Resident Holder”). Generally, Common Shares will be considered to be capital property to a Resident Holder unless they are held in the course of carrying on a business or as part of an adventure or concern in the nature of trade. Certain Resident Holders whose Common Shares do not otherwise qualify as capital property may, in certain circumstances, make an irrevocable election in accordance with subsection 39(4) of the Tax Act to have their Common Shares and every other “Canadian security” (as defined in the Tax Act) owned by such holder in the taxation year of the election and in all subsequent taxation years deemed to be capital property. Resident Holders are advised to consult their own tax advisors to determine whether such an election is available and desirable in their particular circumstances.

 

This summary is not applicable to a Resident Holder: (i) that is a “financial institution” for the purposes of the “mark-to-market” rules contained in the Tax Act; (ii) that is a “specified financial institution”; (iii) an interest in which would be a “tax shelter investment”; or (iv) that enters into a “derivative forward agreement” in respect of Common Shares, as each of those terms is defined in the Tax Act. This summary does not address the possible application of the “foreign affiliate dumping” rules that may be applicable to a Resident Holder that is a corporation resident in Canada (for the purposes of the Tax Act) and is, or becomes, or does not deal at arm’s length with a corporation resident in Canada that is, or that becomes, as part of a transaction or event or series of transactions or events that includes the acquisition of the Common Shares, controlled by a non-resident corporation, individual, trust or a group of any combination of non-resident individuals, trusts, and/or corporations who do not deal with each other at arm’s length for purposes of the rules in section 212.3 of the Tax Act. Any such Resident Holder should consult its own tax advisor with respect to an investment in Common Shares.

 

83

 

 

Dividends

 

In the case of a Resident Holder who is an individual (other than certain trusts), dividends received or deemed to be received on the Common Shares will be included in computing the Resident Holder’s income and will be subject to the gross-up and dividend tax credit rules that apply to taxable dividends received from taxable Canadian corporations. Provided that appropriate designations are made by the Company, such dividend will be treated as an “eligible dividend” for the purposes of the Tax Act and a Resident Holder who is an individual will be entitled to an enhanced dividend tax credit in respect of such dividend. There may be limitations on the Company’s ability to designate dividends and deemed dividends as eligible dividends.

 

Dividends received or deemed to be received on the Common Shares by a Resident Holder that is a corporation will be required to be included in computing the corporation’s income for the taxation year in which such dividends are received, but such dividends will generally be deductible in computing the corporation’s taxable income. In certain circumstances, subsection 55(2) of the Tax Act will treat a taxable dividend received by a Resident Holder that is a corporation as proceeds of disposition or a capital gain. Resident Holders that are corporations should consult their own tax advisors having regard to their own circumstances.

 

A Resident Holder that is a “private corporation” or a “subject corporation” (each as defined in the Tax Act) may be liable under Part IV of the Tax Act to pay a refundable tax on dividends received or deemed to be received on the Common Shares to the extent that such dividends are deductible in computing the Resident Holder’s taxable income for the taxation year.

 

Dividends received by a Resident Holder who is an individual (including certain trusts) may result in such Resident Holder being liable for alternative minimum tax under the Tax Act. Resident Holders who are individuals should consult their own tax advisors in this regard.

 

Dispositions of Common Shares

 

A disposition or deemed disposition of a Common Share by a Resident Holder will generally result in the Resident Holder realizing a capital gain (or capital loss) equal to the amount by which the proceeds of disposition of the Common Share, net of any reasonable costs of disposition, are greater (or less) than the Resident Holder’s adjusted cost base of the Common Shares. Such capital gain (or capital loss) will be subject to the tax treatment described below under “—Taxation of Capital Gains and Capital Losses.”

 

The adjusted cost base to the Resident Holder of a voting share acquired pursuant to this offering will, at any particular time, be determined in accordance with certain rules in the Tax Act by averaging the cost of such share with the adjusted cost base of all Common Shares owned by the Resident Holder as capital property at that time, if any.

 

Taxation of Capital Gains and Capital Losses

 

Generally, one-half of any capital gain (a “taxable capital gain”) realized by a Resident Holder in a taxation year must be included in computing the Resident Holder’s income for the year, and one-half of any capital loss (an “allowable capital loss”) realized by a Resident Holder in a taxation year must be deducted from taxable capital gains realized by the Resident Holder in that year. Allowable capital losses for a taxation year in excess of taxable capital gains for that year generally may be carried back and deducted in any of the three preceding taxation years or carried forward and deducted in any subsequent taxation year against net taxable capital gains realized in such years, to the extent and under the circumstances described in the Tax Act.

 

84

 

 

The amount of any capital loss realized by a Resident Holder that is a corporation on the disposition of a Common Share may be reduced by the amount of any dividends received or deemed to have been received on such Common Share (or on a share for which such Common Share has been substituted) to the extent and under the circumstances described in the Tax Act. Analogous rules apply to a partnership or trust of which a corporation, trust or partnership is a member or beneficiary. Resident Holders should consult their own tax advisors in this regard.

 

Taxable capital gains realized by a Resident Holder who is an individual (including certain trusts) may give rise to liability for alternative minimum tax as calculated under the detailed rules set out in the Tax Act. A Resident Holder that is a “Canadian-controlled private corporation” (as defined in the Tax Act) may be liable to pay an additional refundable tax on certain investment income, including taxable capital gains.

 

Eligibility for Investment

 

At the time of closing of the offering the Common Shares will be a qualified investment under the Tax Act and the regulations thereunder for trusts governed by registered retirement savings plans, registered retirement income funds, registered education savings plans, registered disability savings plans, tax-free savings accounts (collectively “Registered Plans”) and deferred profit sharing plans (“DPSPs)”, all as defined in the Tax Act, provided that at the time of closing of the offering the Common Shares are listed on a “designated stock exchange” as defined in the Tax Act (which includes the TSXV) or the Company is a “public corporation” (other than a mortgage investment corporation) as defined in the Tax Act.

 

Notwithstanding the foregoing, the holder of, subscriber or annuitant under, a Registered Plan (the “Controlling Individual”) will be subject to a penalty tax in respect of Common Shares acquired by the Registered Plan if such shares are a prohibited investment for the particular Registered Plan. A Common Share generally will not be a “prohibited investment” for a Registered Plan provided the Controlling Individual deals at arm’s length with the Company for the purposes of the Tax Act and the Controlling Individual does not have a “significant interest” (as defined in subsection 207.01(4) the Tax Act) in the Company.

 

Prospective investors who intend to hold Common Shares in a Registered Plan or DPSP are advised to consult their personal tax advisors.

 

Non-Residents of Canada

 

The following portion of this summary is generally applicable to a Holder who, at all relevant times for purposes of the Tax Act and any applicable tax treaty or convention (a) is not, and is not deemed to be, resident in Canada, and (b) does not use or hold, and is not deemed to use or hold, Common Shares in the course of carrying on a business in Canada (a “Non-Resident Holder”). Special rules which are not discussed in this summary may apply to a Non-Resident Holder that is an insurer which carries on an insurance business in Canada and elsewhere.

 

Dividends

 

Dividends paid or credited or deemed to be paid or credited to a Non-Resident Holder by the Company on Common Shares are subject to Canadian withholding tax at the rate of 25% on the gross amount of the dividend unless such rate is reduced by the terms of an applicable tax treaty. For example, under the Canada – United States Tax Convention (1980), as amended (the “Treaty”), the rate of withholding tax on dividends paid or credited to a Non-Resident Holder who is a resident of the United States for purposes of the Treaty and who is fully entitled to the benefits of the Treaty (a “U.S. Holder”) is generally limited to 15% of the gross amount of the dividend (or 5% in the case of a U.S. Holder that is a company that beneficially owns at least 10% of the Company’s Common Shares). Non-Resident Holders should consult their own tax advisors to determine their entitlement to relief under any applicable income tax treaty.

 

Dispositions of Common Shares

 

A Non-Resident Holder will not be subject to tax under the Tax Act in respect of a capital gain realized on the disposition or deemed disposition of a voting share unless the voting share constitutes “taxable Canadian property” to the Non-Resident Holder for purposes of the Tax Act and the Non-Resident Holder is not entitled to relief under the terms of an applicable tax treaty between Canada and the Non-Resident Holder’s jurisdiction of residence.

 

Provided the Common Shares are listed on a “designated stock exchange”, as defined in the Tax Act (which currently includes the TSXV) at the time of disposition, the Common Shares will generally not constitute taxable Canadian property of a Non-Resident Holder at that time unless, at any time during the 60-month period immediately preceding the disposition, the following two conditions are satisfied: (i) (a) the Non-Resident Holder, (b) persons with whom the Non-Resident Holder did not deal at arm’s length for purposes of the Tax Act, (c) partnerships in which the Non-Resident Holder or a person described in (b) holds a membership interest directly or indirectly through one or more partnerships, or (d) any combination of the persons and partnerships described in (a) through (c), owned 25% or more of the issued shares of any class or series of shares of the Company, and (ii) more than 50% of the fair market value of the Common Shares was derived directly or indirectly from one or any combination of: real or immovable property situated in Canada, “Canadian resource properties”, “timber resource properties” (each as defined in the Tax Act), and options in respect of, or interests in or for civil law rights in, such properties, whether or not the property exits. Notwithstanding the foregoing, the shares may also be deemed to be taxable Canadian property to a Non-Resident Holder under other provisions of the Tax Act.

 

Non-Resident Holders who may hold Common Shares as taxable Canadian property should consult their own tax advisors.

 

85

 

 

UNDERWRITING

 

Maxim Group LLC (“Maxim”) is acting as sole book-runner and as representative of the underwriters (the “Representative”). Subject to the terms and conditions of an underwriting agreement between us and the Representative, we have agreed to sell to each underwriter named below, and each underwriter named below has severally agreed to purchase, at the public offering price less the underwriting discounts set forth on the cover page of this prospectus, the number of Units listed next to its name in the following table:

 

Name of Underwriter   Number of Units  
         
         
Total        

 

The underwriting agreement provides that the obligation of the underwriters to purchase all of the Units being offered to the public is subject to specific conditions, including the absence of any material adverse change in our business or in the financial markets and the receipt of certain legal opinions, certificates and letters from us, our counsel and the independent auditors. The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-defaulting underwriters may be increased or the offering may be terminated. Subject to the terms of the underwriting agreement, the underwriters will purchase all of the Units being offered to the public, other than those covered by the over-allotment option described below, if any of these Units are purchased.

   

The underwriters are offering the Units, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel and other conditions specified in the underwriting agreement. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part.

 

Over-Allotment Option

 

We have granted to the Representative an option, exercisable one or more times in whole or in part, not later than 45 days after the date of this prospectus, to purchase from us (i) up to an additional ______ common shares at a price of $      per share and/or (ii) up to an additional _______-warrants to purchase common shares at a price of $              per warrant , in each case, less the underwriting discounts and commissions set forth on the cover of this prospectus in any combination thereof to cover over-allotments, if any. To the extent that the Representative exercises this option, each of the underwriters will become obligated, subject to conditions, to purchase approximately the same percentage of these additional common shares and/or warrants as the number of Units to be purchased by it in the above table bears to the total number of Units offered by this prospectus. We will be obligated, pursuant to the option, to sell these additional common shares and/or warrants to the underwriters to the extent the option is exercised. If any additional common shares and/or warrants are purchased, the underwriters will offer the additional common shares and/or warrants on the same terms as those on which the other Units are being offered hereunder. If this option is exercised in full, the total offering price to the public will be $ and the total net proceeds, before expenses and after the credit to the underwriting commissions described below, to us will be $         .  

 

Discounts and Commissions

 

The following table shows the public offering price, underwriting discount and proceeds, before expenses, to us. The information assumes either no exercise or full exercise by the Representative of the over-allotment option. 

 

    Per Unit     Total
(No Exercise)
    Total
(Full Exercise)
 
Public offering price   $           $           $        
Underwriting discounts and commissions (8%)                        
Proceeds, before expenses, to us   $     $     $  

 

The underwriters propose to offer the Units offered by us to the public at the public offering price per Unit set forth on the cover of this prospectus. In addition, the underwriters may offer some of the Units to other securities dealers at such price less a concession of $ per Unit. After the initial offering, the public offering price and concession to dealers may be changed.

 

We have agreed to pay the underwriters a cash fee equal to eight percent (8%) of the aggregate gross proceeds.

 

The Representative has advised us that the underwriters propose to offer the shares directly to the public at the public offering price set forth on the cover of this prospectus. In addition, the representative may offer some of the shares to other securities dealers at such price less a concession of up to $        per share of our common shares. After the offering to the public, the offering price and other selling terms may be changed by the Representative without changing the Company’s proceeds from the underwriters’ purchase of the shares.

  

86

 

 

We have agreed to reimburse Maxim for its out of pocket accountable expenses, including Maxim’s legal fees up to a maximum of $100,000, in connection with the offering. Maxim’s total out of pocket accountable expenses shall not exceed $125,000. We have paid $25,000 to Maxim as an advance to be applied towards reasonable out-of-pocket expenses, or the Advance. Any portion of the Advance shall be returned back to us to the extent not actually incurred. We estimate that the total expenses of the offering, including registration, filing and listing fees, printing fees and legal and accounting expenses, but excluding underwriting discounts and commissions, will be approximately          , all of which are payable by us.

 

Representative’s Warrants

 

We have agreed to issue to the Representative (or its permitted assignees) warrants to purchase up to a total of common shares (5% of the common shares included in the Units). The Representative’s Warrant will have a term of five years from the effective date of this prospectus and an exercise price per share equal to 110% of the public offering per share price. Pursuant to FINRA Rule 5110(g), the Representative’s Warrant and any shares issued upon exercise of the Representative’s Warrant shall not be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness or commencement of sales of this offering, except the transfer of any security: (i) by operation of law or by reason of our reorganization; (ii) to any FINRA member firm participating in the offering and the officers or partners thereof, if all securities so transferred remain subject to the lock-up restriction set forth above for the remainder of the time period; (iii) if the aggregate amount of our securities held by the underwriter or related persons does not exceed 1% of the securities being offered; (iv) that is beneficially owned on a pro rata basis by all equity owners of an investment fund, provided that no participating member manages or otherwise directs investments by the fund and the participating members in the aggregate do not own more than 10% of the equity in the fund; or (v) the exercise or conversion of any security, if all securities remain subject to the lock-up restriction set forth above for the remainder of the time period. The Representative’s Warrant will provide for cashless exercise.

 

Lock-Up Agreements

 

We and each of our officers, directors and 5% or more holders of our outstanding common shares have agreed, subject to certain exceptions, not to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any shares of our common shares or other securities convertible into or exercisable or exchangeable for our common shares for a period of 90 days after this offering is completed without the prior written consent of Maxim.

 

Maxim may in its sole discretion and at any time without notice release some or all of the shares subject to lock-up agreements prior to the expiration of the lock-up period. When determining whether or not to release shares from the lock-up agreements, the representative will consider, among other factors, the security holder’s reasons for requesting the release, the number of shares for which the release is being requested and market conditions at the time.

 

Right of First Refusal

 

We have granted the Representative a right of first refusal, for a period of  twelve (12) months from the commencement of sales of this offering, to act as sole underwriter and sole book running manager and/or sole placement agent for any and all public and private equity, equity-linked, convertible or debt offerings of the Company.

 

Indemnification

 

We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, and to contribute to payments that the underwriters may be required to make for these liabilities.

 

87

 

 

Price Stabilization, Short Positions, and Penalty Bids

 

In connection with this offering, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of our securities. Specifically, the underwriters may over-allot in connection with this offering by selling more securities than are set forth on the cover page of this prospectus. This creates a short position in our securities for its own account. The short position may be either a covered short position or a naked short position. In a covered short position, the number of securities over-allotted by the underwriters is not greater than the number of securities that they may purchase in the over-allotment option. In a naked short position, the number of securities involved is greater than the number of shares common shares in the over-allotment option. To close out a short position, the underwriters may elect to exercise all or part of the over-allotment option. The underwriters may also elect to stabilize the price of our securities or reduce any short position by bidding for, and purchasing, securities in the open market.

 

The underwriters may also impose a penalty bid. This occurs when a particular underwriter or dealer repays selling concessions allowed to it for distributing a security in this offering because the underwriter repurchases that security in stabilizing or short covering transactions.

 

Finally, the underwriters may bid for, and purchase, securities in market making transactions, including “passive” market making transactions as described below.

 

These activities may stabilize or maintain the market price of our securities at a price that is higher than the price that might otherwise exist in the absence of these activities. The underwriters are not required to engage in these activities, and may discontinue any of these activities at any time without notice.

 

In connection with this offering, the underwriters and selling group members, if any, or their affiliates may engage in passive market making transactions in our common shares immediately prior to the commencement of sales in this offering, in accordance with Rule 103 of Regulation M under the Exchange Act. Rule 103 generally provides that:

 

  a passive market maker may not effect transactions or display bids for our securities in excess of the highest independent bid price by persons who are not passive market makers;
     
  net purchases by a passive market maker on each day are generally limited to 30% of the passive market maker’s average daily trading volume in our securities during a specified two-month prior period or 200 shares, whichever is greater, and must be discontinued when that limit is reached; and
     
  passive market making bids must be identified as such.

 

Electronic Distribution

 

A prospectus in electronic format may be made available on a website maintained by the representatives of the underwriters and may also be made available on a website maintained by other underwriters. The underwriters may agree to allocate a number of shares to underwriters for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives of the underwriters to underwriters that may make Internet distributions on the same basis as other allocations. In connection with the offering, the underwriters or syndicate members may distribute prospectuses electronically. No forms of electronic prospectus other than prospectuses that are printable as Adobe® PDF will be used in connection with this offering.

 

The underwriters have informed us that they do not expect to confirm sales of shares offered by this prospectus to accounts over which they exercise discretionary authority.

 

Other than the prospectus in electronic format, the information on any underwriter’s website and any information contained in any other website maintained by an underwriter is not part of the prospectus or the registration statement of which this prospectus forms a part, has not been approved and/or endorsed by us or any underwriter in its capacity as underwriter and should not be relied upon by investors.

 

Selling Restrictions

 

Other than in the United States, no action has been taken by us or the Underwriter in any jurisdiction that would permit a public offering of the securities offered by this prospectus, or the possession, circulation or distribution of this prospectus or any other material relating to us or the securities, where action for that purpose is required. Accordingly, the securities may not be offered or sold, directly or indirectly, and neither this prospectus nor any other offering material or advertisements in connection with the securities may be distributed or published, in or from any country or jurisdiction except in compliance with any applicable rules and regulations of any such country or jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.

 

88

 

 

EXPENSES RELATING TO THIS OFFERING

 

Set forth below is an itemization of the total expenses, excluding Underwriting discounts, expected to be incurred in connection with this offering by us. With the exception of the SEC registration fee, the FINRA filing fee, and the Nasdaq Capital Market listing fee, all amounts are estimates.

 

SEC registration fee   $    *  
FINRA filing fee   $ 2,300  
Nasdaq Capital Market Listing Fee   $ *  
Transfer agent fees and expenses   $ *  
Printer fees and engraving expenses   $ *  
Legal fees and expenses   $ *  
Accounting fees and expenses   $ *  
Miscellaneous   $ *  
Total   $ *  

* To be filed by amendment

 

89

 

 

LEGAL MATTERS

 

The validity of the Common Shares offered in this offering and certain other legal matters as to British Columbia law will be passed upon for us by Cassels Brock & Blackwell LLP, our counsel as to British Columbia law. Legal matters as to Israeli law will be passed upon for us by Naschitz, Brandes, Amir & Co., Advocates, our counsel as to Israeli law. Matters related to the laws of the United States will be passed upon for us by Lucosky Brookman LLP, Woodbridge, New Jersey. Loeb & Loeb LLP, New York, New York, is representing the underwriters in this offering.

 

90

 

 

EXPERTS

 

The consolidated financial statements for the years ended December 31, 2019 and 2018, included in this prospectus will been so included in reliance on the report of our accountants, Davidson & Company, LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.

 

WHERE YOU CAN FIND ADDITIONAL INFORMATION

 

We have filed with the SEC a registration statement on Form F-1, including relevant exhibits and schedules under the Securities Act, covering the Common Shares offered by this prospectus. You should refer to our registration statements and their exhibits and schedules if you would like to find out more about us and about the Common Shares. This prospectus summarizes material provisions of contracts and other documents that we refer you to. Since the prospectus may not contain all the information that you may find important, you should review the full text of these documents.

 

Immediately upon the completion of this offering, we will be subject to periodic reporting and other informational requirements of the Exchange Act, as applicable to foreign private issuers. Accordingly, we will be required to file reports, including annual reports on Form 20-F, and other information with the SEC. As a foreign private issuer, we are exempt from the rules of the Exchange Act prescribing the furnishing and content of proxy statements to shareholders under the federal proxy rules contained in Sections 14(a), (b) and (c) of the Exchange Act, and our executive officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.

 

The registration statements, reports and other information so filed can be inspected and copied at the public reference facilities maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549. You can request copies of these documents upon payment of a duplicating fee, by writing to the SEC. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference rooms. The SEC also maintains a website that contains reports, proxy statements and other information about issuers, such as us, who file electronically with the SEC. The address of that website is http://www.sec.gov. The information on that website is not a part of this prospectus.

 

No dealers, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus. You must not rely on any unauthorized information or representations. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date.

 

91

 

 

 

 

 

 

 

 

 

 

 

SIYATA MOBILE INC.

 

 

Consolidated Financial Statements

(Expressed in Canadian Dollars)

 

As at and for the years ended December 31, 2019 and 2018

 

 

 

 

 

 

 

 

 

 

 

SIYATA MOBILE INC.

 

INDEX TO FINANCIAL STATEMENTS

 

Audited Consolidated Financial Statements for the Fiscal Years Ended December 31, 2019 and 2018  
   
  Page
Consolidated Balance Sheets as of December 31, 2019 and 2018 F-3
   
Consolidated Statements of Operations and Comprehensive Income for the years ended December 31, 2019 and 2018 F-4
   
Consolidated Statements of Changes in Stockholders’ Deficit for the years ended December 31, 2019 and 2018 F-5
   
Consolidated Statements of Cash Flows for the years ended December 31, 2019 and 2018 F-6
   
Notes to Consolidated Financial Statements F-7

 

F-1

 

 

 

Report of Independent Registered Public Accounting Firm

  

To the Shareholders and Directors of

Siyata Mobile Inc.

  

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of Siyata Mobile Inc. (the “Company”), as of December 31, 2019 and 2018, and the related consolidated statements of loss and comprehensive loss, changes in shareholders’ equity, and cash flows for the years ended December 31, 2019 and 2018, and the related notes (collectively referred to as the “financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of Siyata Mobile Inc. as of December 31, 2019 and 2018, and the results of its operations and its cash flows for the years ended December 31, 2019 and 2018, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.

 

Restatement of Previously Issued Financial Statements

 

As discussed in Note 24 to the consolidated financial statements, the previously issued December 31, 2019 and 2018 financial statements have been restated to correct a misstatement.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has suffered recurring losses from operations and has a net capital deficiency that raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatements of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

We have served as the Company’s auditor since 2016.

  

“DAVIDSON & COMPANY LLP”

  

Vancouver, Canada   Chartered Professional Accountants
     
August 6, 2020    

 

F-2

 

 

Siyata Mobile Inc.

Consolidated Statements of Financial Position

(Expressed in Canadian dollars)

As at December 31, 2019 and 2018

 

    December 31,
2019
   

December 31,

2018

 
ASSETS            
Current            
Cash   $ 3,465,371     $ 2,420,205  
Trade and Other Receivables (Note 4)     1,943,828       925,355  
Prepaid expenses     329,234       413,114  
Inventory (Note 5)     4,400,623       4,981,467  
Advance to suppliers     847,198       478,517  
      10,986,254       9,218,658  
Right of Use Assets (Note 6)     266,830       -  
Loan to Director (Note 19)     260,400       -  
Equipment     51,750       54,392  
Intangible assets (Note 7)     8,423,294       7,489,023  
Goodwill     1,022,269       1,022,269  
Total assets   $ 21,010,797     $ 17,784,342  
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY                
Current                
Bank Loan   $ 42,230     $ -  
Accounts payable and accrued liabilities     2,565,802       3,991,081  
Due to Related Party (Note 19)     100,079       198,362  
Lease Obligations (Note 8)     151,437       -  
Future Purchase Consideration (Note 9)     -       430,000  
Current portion of Convertible Debenture (Note 11)     1,364,055       -  
Current portion of long term debt (Note 10)     58,000       34,000  
      4,281,603       4,653,443  
Lease Obligation (Note 8)     101,582       -  
Other payables     173,044       -  
Convertible Debenture (Note 11)     5,272,252       3,904,831  
Long Term Debt (Note 10)     138,000       196,000  
      5,684,878       4,100,831  
Total Liabilities     9,966,481       8,754,274  
Shareholders’ equity                
Share capital (Note 12)     37,346,168       27,638,100  
Reserves     6,602,751       3,750,999  
Accumulated other comprehensive income ( loss)     (125,084 )     260,137  
Deficit     (32,779,519 )     (22,619,168 )
      11,044,316       9,030,068  
Total liabilities and shareholders’ equity   $ 21,010,797     $ 17,784,342  

 

Nature of operations and going concern (Note 1)

Subsequent events (Note 23)

 

The accompanying notes are an integral part of these consolidated financial statements.

  

Approved on August 6, 2020 on behalf of the Board:
 
“Michael Kron”   “Marc Seelenfreund”  
Michael Kron – Director   Marc Seelenfreund - Director  

 

F-3

 

 

Siyata Mobile Inc.

Consolidated Statements of Loss and Comprehensive Loss

(Expressed in Canadian dollars)

For the years ended December 31, 2019 and 2018

 

    2019
Restated (Note 24)
  2018
Restated (Note 24)
Revenue   $ 13,019,792     $ 14,220,542  
Cost of Sales (Note 13)     (9,732,577 )     (12,161,044 )
Gross profit     3,287,215       2,059,498  
                 
EXPENSES                
Amortization and Depreciation (Note 6,7)     1,550,607       704,749  
Selling and marketing (Note 14)     4,723,236       5,449,031  
General and administrative (Note 15)     3,081,966       2,929,277  
Product Development (Note 7)     1,005,000       —    
Impairment of intangible assets (Note 7)     147,977       1,954,000  
Share-based payments (Note 12)     1,490,313       1,102,313  
Total Operating Expenses     11,999,099       12,139,370  
Net operating income (loss)     (8,711,884 )     (10,079,872 )
                 
OTHER EXPENSES                
Finance expense (income)     1,276,827       975,468  
Foreign exchange     141,640       (46,507 )
Accretion and change in value of future purchase consideration (Note 9)     30,000       519,148  
Total other expenses     1,448,467       1,448,109  
Net loss for the year     (10,160,351 )     (11,527,981 )
                 
Other comprehensive income (loss)                
Items that may be subsequently reclassified to profit and loss:                
Translation Adjustment     (385,221 )     869,082  
Comprehensive loss for the year   $ (10,545,572 )   $ (10,658,899 )
Weighted Average Shares     117,153,662       95,375,747  
                 
Basic and diluted loss per share   ($ 0.09 )   ($ 0.12 )

 

The accompanying notes are an integral part of these consolidated financial statements.

  

F-4

 

 

Siyata Mobile Inc.

Consolidated Statement of Changes in Shareholders’ Equity

(Expressed in Canadian dollars)

For the years ended December 31, 2019 and 2018

  

    Number of Common Shares    

 

Share Capital Amount

    Reserves     Accumulated other comprehensive Income (loss)     Deficit     Total Shareholders’ Equity  
                                     
Balance, December 31, 2017     93,749,535     $ 23,336,596     $ 2,996,875     $ (608,945 )   $ (11,091,187 )   $ 14,633,339  
Private placement     4,623,800       2,080,710       -       -       -       2,080,710  
Share issue costs     -       (375,423 )     -       -       -       (375,423 )
Exercise of warrants     2,648,928       1,324,464       -       -       -       1,324,464  
Exercise of stock options     1,300,000       682,442       (272,442 )     -       -       410,000  
Exercise of agents’ options     396,242       219,311       (75,747 )     -       -       143,564  
Shares issued on acquisition of Signifi     1,000,000       370,000       -       -       -       370,000  
Share-based payments     -       -       1,102,313       -       -       1,102,313  
Translation adjustment     -       -       -       869,082       -       869,082  
Loss for the year     -       -       -       -       (11,527,981 )     (11,527,981 )
Balance, December 31, 2018     103,718,505       27,638,100       3,750,999       260,137       (22,619,168 )   $ 9,030,068  
Exercise of Warrants     11,725,490       5,862,745       -       -       -       5,862,745  
Shares issued on acquisition of Signifi     1,000,000       460,000       -       -       -       460,000  
Exercise of agents’ options     821,896       458,885       (130,128 )     -       -       328,757  
Non-brokered private placement     7,500,000       3,000,000       -       -       -       3,000,000  
Share Issuance costs on capital raise             (243,379 )             -               (243,379 )
Shares issued as agent compensation for debenture     481,928       154,217       -       -       -       154,217  
Expiry of agent’s options     -       15,600       (15,600 )     -       -       -  
Equity portion of the debenture bifurcated     -       -       578,903       -       -       578,903  
Issuance of agents’ warrants     -       -       61,407       -       -       61,407  
Issuance of warrants to debentureholders     -       -       866,857       -       -       866,857  
Share based payments     -       -       1,490,313       -       -       1,490,313  
Translation adjustment     -       -       -       (385,221 )     -       (385,221 )
Loss for the period     -       -       -       -       (10,160,351 )     (10,160,351 )
Balance, December 31, 2019     125,247,819     $ 37,346,168     $ 6,602,751     $ (125,084 )   $ (32,779,519 )   $ 11,044,316  

 

The accompanying notes are an integral part of these consolidated financial statements.

  

F-5

 

 

Siyata Mobile Inc.

Consolidated Statements of Cash Flows

(Expressed in Canadian dollars)

For the years ended December 31, 2019 and 2018

 

    2019     2018  
             
Cash provided by / (used for):            
             
Operating activities:            
Net loss for the year   $ (10,160,351 )   $ (11,527,981 )
Items not affecting cash:                
Amortization and depreciation     1,550,607       704,749  
Accretion and change in value of future purchase consideration     30,000       519,148  
Accretion of convertible debentures included in finance expense     437,487       350,930  
Lease liability finance expense accretion     14,827       -  
Impairment of Intangibles     147,977       1,954,000  
Loss on debt modification     176,737       -  
Share-based payments     1,490,313       1,102,313  
Net change in non-cash working capital items:                
Trade and other receivables, prepaids, and advances to suppliers     (1,371,383 )     2,211,552  
Inventory     372,624       (481,223 )
Accounts payable and accrued liabilities     (1,142,752 )     1,195,915  
Due to/from related party     (90,313 )     974,362  
Net cash used in operating activities     (8,544,227 )     (2,996,235 )
                 
Investing activities:                
Acquisition of equipment     (2,605 )     (4,264 )
Loan to director     (260,400 )     -  
Future purchase consideration             (804,929 )
Development costs included in intangible assets     (2,757,875 )     (2,070,000 )
Net cash used in investing activities     (3,020,880 )     (2,879,193 )
                 
Financing activities:                
Proceeds of loans     3,778,634       250,000  
Repayment of loans     (34,000 )     (20,000 )
Lease payments     (165,584 )     -  
Private placement     3,000,000       2,080,710  
Share issue costs     (243,379 )     (375,423 )
Bank loan     42,230       -  
Exercise of stock options     -       410,000  
Exercise of warrants     5,862,745       1,324,464  
Exercise of agents’ options     328,758       143,564  
Net cash from financing activities     12,569,404       3,813,315  
                 
Effect of foreign exchange on cash     40,869       97,722  
Change in cash for the year     1,045,166       (1,964,391 )
Cash, beginning of year     2,420,205       4,384,596  
Cash, end of year     3,465,371     $ 2,420,205  

 

Supplemental disclosure with respect to cash flows (Note 22)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

  

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

1. NATURE OF OPERATIONS AND GOING CONCERN

 

Siyata Mobile Inc. (“Siyata” or the “Company”) was incorporated under the Business Corporations Act, British Columbia on October 15, 1986. The Company’s shares are listed on Tier 1 of the TSX Venture Exchange (“TSX-V”) under the symbol SIM. As at December 31, 2019, the Company’s principal activity is the sale of vehicle mounted, cellular based communications platforms over advanced 4G mobile networks. The corporate office of the Company is located at 1001 Lenoir Street Suite A-414, Montreal, Quebec, Canada H4C-2Z6, and the registered and records office is located at 2200 - 885 West Georgia Street, Vancouver, BC V6C 3E8.

 

On June 7, 2016, the Company acquired all of the issued and outstanding shares of Signifi Mobile Inc. (“Signifi”).

 

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business rather than a process of forced liquidation. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

The Company incurred a net loss of $10,160,351 during the year ended December 31, 2019 (year ended December 31, 2018- ($11,527,981) and, as of that date, the Company’s total deficit was $32,779,519. The Company’s continuation as a going concern is dependent upon the success of the Company’s sale of inventory, the existing cash flows, and the ability of the Company to obtain additional debt or equity financing, all of which are uncertain. These material uncertainties, along with those discussed in Note 23(a), may cast significant doubt on the Company’s ability to continue as a going concern.

 

2. BASIS OF PREPARATION

 

Statement of compliance

 

These consolidated financial statements, including comparatives, have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”) and Interpretations of the International Financial Reporting Interpretations Committee (“IFRIC”).

 

Basis of consolidation and presentation

 

These consolidated financial statements of the Company have been prepared on the historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.

 

These consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. The consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.

 

F-7

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

  

2. BASIS OF PREPARATION (cont’d)

 

Basis of consolidation and presentation (cont’d)

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:

 

Name of Subsidiary   Place of Incorporation   Ownership
Queensgate Resources Corp.   British Columbia, Canada   100%
Queensgate Resources US Corp.   Nevada, USA   100%
Siyata Mobile (Canada) Inc.   British Columbia, Canada   100%
Siyata Mobile Israel Ltd.   Israel   100%
Signifi Mobile Inc.   Quebec, Canada   100%

 

These consolidated financial statements of the Company are presented in Canadian dollars, which is the functional currency of the Company.

 

Foreign currency translation

Items included in the financial statements of each entity in the Company are measured using the currency of the primary economic environment in which the entity operates (the “functional currency”) and has been determined for each entity within the Company. The functional currency of Siyata Mobile Inc. is the Canadian dollar which is also the functional currency of all its subsidiaries except Siyata Mobile Israel Ltd. which is the United States dollar. The functional currency determinations were conducted through an analysis of the consideration factors identified in IAS 21 The Effects of Changes in Foreign Exchange Rates.

 

Assets and liabilities of entities with a functional currency other than the Canadian dollar are translated into Canadian dollars at period end exchange rates. Income and expenses, and cash flows are translated into Canadian dollars using the average exchange rate. Exchange differences resulting from the translation of United States operations are recognized in other comprehensive income (loss) and accumulated in equity.

 

Transactions in currencies other than the entity’s functional currency are translated at the exchange rates in effect on the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the rate of exchange in effect as at the statement of financial position date. Non-monetary assets and liabilities denominated in foreign currencies are translated at the exchange rates prevailing at the time of the acquisition of the assets or assumption of the liabilities. Foreign currency differences arising on translation are recognized in the statement of loss and comprehensive loss.

.

Use of estimates and judgements

 

The preparation of the consolidated financial statements in conformity with IFRS requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.

 

F-8

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

2. BASIS OF PREPARATION (cont’d)

 

Use of estimates and judgements (cont’d)

 

i) Critical accounting estimates

 

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected. Information about critical estimates in applying accounting policies that have the most significant effect on the amounts recognized in the consolidated financial statements are, but not limited to the following:

 

Income taxes - Tax provisions are based on enacted or substantively enacted laws. Changes in those laws could affect amounts recognized in profit or loss both in the period of change, which would include any impact on cumulative provisions, and future periods. Deferred tax assets, if any, are recognized to the extent it is considered probable that those assets will be recoverable. This involves an assessment of when those deferred tax assets are likely to reverse.

 

Fair value of stock options and warrants - Determining the fair value of warrants and stock options requires judgments related to the choice of a pricing model, the estimation of stock price volatility, the expected forfeiture rate and the expected term of the underlying instruments. Any changes in the estimates or inputs utilized to determine fair value could have a significant impact on the Company’s future operating results or on other components of shareholders’ equity.

 

Capitalization of development costs and their amortization rate – Development costs are capitalized in accordance with the accounting policy. To determine the amounts earmarked for capitalization, management estimates the cash flows which are expected to be derived from the asset for which the development is carried out and the expected benefit period.

 

Inventory - Inventory is valued at the lower of cost and net realizable value. Cost of inventory includes cost of purchase (purchase price, import duties, transport, handling, and other costs directly attributable to the acquisition of inventories), cost of conversion, and other costs incurred in bringing the inventories to their present location and condition. Net realizable value for inventories is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Provisions are made in profit or loss of the current period on any difference between book value and net realizable value.

 

Estimated product returns - Revenue from product sales is recognized net of estimated sales discounts, credits, returns, rebates and allowances. The return allowance is determined based on an analysis of the historical rate of returns, industry return data, and current market conditions, which is applied directly against sales.

 

Impairment of non-financial assets - The Company assesses impairment at each reporting date by evaluating conditions specific to the Company that may lead to asset impairment. The recoverable amount of an asset or a cash-generating unit (“CGU”) is determined using the greater of fair value less costs to sell and value in use which requires the use of various judgments, estimates, and assumptions. The Company identifies CGUs as identifiable groups of assets that are largely independent of the cash inflows from other assets or groups of assets. Value in use calculations require estimations of discount rates and future cash flows derived from revenue growth, gross margin and operating costs. Fair value less costs to sell calculations require the Company to estimate fair value of an asset or a CGU using market values of similar assets as well as estimations of the related costs to sell.

 

F-9

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

2. BASIS OF PREPARATION (cont’d)

 

Use of estimates and judgements (cont’d)

 

Useful life of intangible assets – The Company estimates the useful life used to amortize intangible assets which relates to the expected future performance of the assets acquired based on management estimate of the sales forecast.

 

Future purchase consideration - In a business combination, the Company recognizes a contingent consideration at fair value at the acquisition date. Contingent consideration classified as an asset or liability that is a financial instrument and within the scope of IAS 39 Financial Instruments: Recognition and Measurement, is measured at fair value with changes in fair value recognized either in profit or loss, or as a change to other comprehensive income (“OCI”). If the contingent consideration is not within the scope of IAS 39, it is measured at fair value in accordance with the appropriate IFRS. Contingent consideration that is classified as equity is not re-measured and subsequent settlement is accounted for within equity.

 

Contingent consideration from an asset acquisition is recognized when: the conditions associated with the contingency are met; the Company has a present legal or constructive obligation that can be estimated reliably; and it is probably that an outflow of economic benefits will be required to settle the obligation.

 

ii) Critical accounting judgments

 

Information about critical judgments in applying accounting policies that have the most significant effect on the amounts recognized in the consolidated financial statements are, but are not limited to, the following:

 

Deferred income taxes – judgments are made by management to determine the likelihood of whether deferred income tax assets at the end of the reporting period will be realized from future taxable earnings. To the extent that assumptions regarding future profitability change, there can be an increase or decrease in the amounts recognized in respect of deferred tax assets as well as the amounts recognized in profit or loss in the period in which the change occurs.

 

Functional currency - The functional currency for the Company and each of its subsidiaries is the currency of the primary economic environment in which the respective entity operates. The Company has determined the functional currency of each entity to be the Canadian dollar with the exception of Siyata Mobile Israel Ltd. which has the functional currency of the US dollar. Such determination involves certain judgments to identify the primary economic environment. The Company reconsiders the functional currency of its subsidiaries if there is a change in events and/or conditions which determine the primary economic environment.

 

Going concern – As disclosed in Note 1 to the consolidated financial statements.

 

3. SIGNIFICANT ACCOUNTING POLICIES

 

(a) Impairment of long lived assets

 

The carrying amounts of the Company’s non-financial assets, other than deferred tax assets if any, are reviewed at each reporting date to determine whether there is any indication of impairment. If any such indication exists, then the asset’s recoverable amount is estimated.

 

F-10

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

3. SIGNIFICANT ACCOUNTING POLICIES (cont’d)

 

(a) Impairment of long lived assets (cont’d)

 

For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (the “cash-generating unit” or “CGU”). The recoverable amount of an asset or CGU is the greater of its value in use and its fair value less costs to sell. In assessing the value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.

 

(b) Impairment of long lived assets (cont’d)

 

If there is an indication that a corporate asset may be impaired, then the recoverable amount is determined for the CGU to which the corporate asset belongs.

 

An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its estimated recoverable amount. Impairment losses are recognized in profit or loss.

 

Impairment losses recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed if there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized. A reversal of an impairment loss is recognized immediately in profit or loss.

 

(c) Intangible assets

 

i) Research and development

 

Expenditure on research activities, undertaken with the prospect of gaining new scientific or technical knowledge and understanding, is recognized in profit or loss when incurred.

 

Development activities involve a plan or design for the production of new or substantially improved products and processes. Development expenditure is capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and Siyata has the intention and sufficient resources to complete development and to use or sell the asset. The expenditure capitalized in respect of development activities includes the cost of materials, direct labor and overhead costs that are directly attributable to preparing the asset for its intended use, and capitalized borrowing costs. Other development expenditure is recognized in profit or loss as incurred.

 

In subsequent periods, capitalized development expenditure is measured at cost less accumulated amortization and accumulated impairment losses.

 

ii) Subsequent expenditure

 

Subsequent expenditure is capitalized only when it increases the future economic benefits embodied in the specific asset to which it relates. All other expenditure, including expenditure on internally generated goodwill and brands, is recognized in profit or loss as incurred.

 

F-11

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

3. SIGNIFICANT ACCOUNTING POLICIES (cont’d)

 

(d) Intangible assets (cont’d)

 

iii) Amortization

 

Amortization is a systematic allocation of the amortizable amount of an intangible asset over its useful life. The amortizable amount is the cost of the asset less its estimated residual value.

 

Amortization is recognized in profit or loss on a straight line basis over the estimated useful lives of the intangible assets from the date they are available for use. See Note 7 for amortization rates and methods applied to each class of intangible assets. An annual review of the useful life of the intangibles asset are made by management and any changes in useful life are reflected prospectively.

 

Internally generated intangible assets are not systematically amortized as long as they are not available for use (i.e. they have not completed certifications and/or are in working condition for their intended use). Accordingly, these intangible assets, such as development costs, are tested for impairment at least once a year, until such date as they are available for use.

 

(e) Business Combinations

 

Business combinations are accounted for using the acquisition method. The cost of the acquisition is measured at the aggregate of the fair values at the date of acquisition, of assets transferred, liabilities incurred or assumed, and equity instruments issued by the Company. The acquiree’s identifiable assets and liabilities assumed are recognized at their fair value at the acquisition date. Acquisition-related costs are recognized in earnings as incurred. The excess of the consideration over the fair value of the net identifiable assets and liabilities acquired is recorded as goodwill. Any gain on a bargain purchase is recorded in profit or loss immediately. Transaction costs are expensed as incurred, except if related to the issue of debt or equity securities. Any goodwill that arises is tested annually for impairment.

 

(f) Goodwill

 

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the Company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognized at the date of acquisition. Goodwill is initially recognized as an asset at cost and is subsequently measured at cost less any accumulated impairment losses. Goodwill is not subject to amortization but is tested for impairment annually.

 

(g) Inventory

 

Inventories are measured at the lower of cost and net realizable value. The cost of inventories is based on the first-in first-out (FIFO) principle, and includes expenditure incurred in acquiring the inventories and the costs incurred in bringing them to their existing location and condition. In the case of manufactured inventories and work in progress, cost includes an appropriate share of production overheads based on normal operating capacity. Net realizable value is the estimated selling price in the ordinary course of business, less the estimated costs of completing and selling expenses.

 

F-12

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

3. SIGNIFICANT ACCOUNTING POLICIES (cont’d)

 

(h) Revenues

 

Revenue from the sale of goods, in the ordinary course of business is measured at the fair value of the consideration received or receivable, net of returns, trade discounts and volume rebates. When the credit period is short and constitutes the accepted credit in the industry, the future consideration is not discounted.

 

Revenue is recognized when persuasive evidence exists (usually in the form of an executed sales agreement), that the significant risks and rewards of ownership have been transferred to the buyer, recovery of the consideration is probable, the associated costs and possible return of goods can be estimated reliably, there is no continuing management involvement with the goods, and the amount of revenue can be measured reliably. If it is probable that discounts will be granted and the amount can be measured reliably, then the discount is recognized as a reduction of revenue as the sales are recognized.

 

Transfers of risks and rewards vary depending on the individual terms of the contract of sale. For sales on products in Israel, transfer usually occurs when the product is received at the customer’s warehouse, but  for some international shipments transfer occurs upon loading the goods onto the relevant carrier.

 

(i) Financial Instruments

 

Financial assets

 

On initial recognition, financial assets are recognized at fair value and are subsequently classified and measured at: (i) amortized cost; (ii) fair value through other comprehensive income (“FVOCI”); or (iii) fair value through profit or loss (“FVTPL”). The classification of financial assets is generally based on the business model in which a financial asset is managed and its contractual cash flow characteristics. A financial asset is measured at fair value net of transaction costs that are directly attributable to its acquisition except for financial assets at FVTPL where transaction costs are expensed. All financial assets not classified and measured at amortized cost or FVOCI are measured at FVTPL. On initial recognition of an equity instrument that is not held for trading, the Company may irrevocably elect to present subsequent changes in the investment’s fair value in other comprehensive.

 

The classification determines the method by which the financial assets are carried on the balance sheet subsequent to inception and how changes in value are recorded. The Company has classified its cash and trade and other receivables at amortized cost.

 

Impairment

 

An ‘expected credit loss’ impairment model applies which requires a loss allowance to be recognized based on expected credit losses. The estimated present value of future cash flows associated with the asset is determined and an impairment loss is recognized for the difference between this amount and the carrying amount as follows: the carrying amount of the asset is reduced to estimated present value of the future cash flows associated with the asset, discounted at the financial asset’s original effective interest rate, either directly or through the use of an allowance account and the resulting loss is recognized in profit or loss for the period.

 

F-13

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018 

 

3. SIGNIFICANT ACCOUNTING POLICIES (cont’d)

 

(i) Financial Instruments (cont’d)

 

In a subsequent period, if the amount of the impairment loss related to financial assets measured at amortized cost decreases, the previously recognized impairment loss is reversed through profit or loss to the extent that the carrying amount of the investment at the date the impairment is reversed does not exceed what the amortized cost would have been had the impairment not been recognized.

 

Financial liabilities

 

Financial liabilities are designated as either: (i) fair value through profit or loss; or (ii) other financial liabilities. All financial liabilities are classified and subsequently measured at amortized cost except for financial liabilities at FVTPL.

 

The classification determines the method by which the financial liabilities are carried on the balance sheet subsequent to inception and how changes in value are recorded. The Company has classified its bank loan, accounts payable and accrued liabilities, due to related party, convertible debentures and long term debt as other financial liabilities and carried on the balance sheet at amortized cost. Future purchase consideration is classified as FVTPL.

 

As at December 31, 2019, the Company does not have any derivative financial liabilities.

 

(j) Loss per share

 

The Company presents basic and diluted loss per share data for its common shares. Basic loss per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period, adjusted for own shares held. Diluted loss per share is calculated by dividing the loss by the weighted average number of common shares outstanding assuming that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at the average market price during the period. In the Company’s case diluted loss per share is the same as basic loss per share, as the effect of outstanding share options and warrants on loss per share would be anti-dilutive.

 

(k) Share-based payments

 

The stock option plan allows Company employees and consultants to acquire shares of the Company. The fair value of options granted is recognized as a share-based payment expense with a corresponding increase in equity. An individual is classified as an employee when the individual is an employee for legal or tax purposes (direct employee) or provides services similar to those performed by a direct employee. Consideration paid on the exercise of stock options is credited to share capital and the fair value of the option is reclassified from share-based payment reserve to share capital.

 

In situations where equity instruments are issued to non-employees and some or all of the services received by the entity as consideration cannot be specifically identified, they are all measured at the fair value of the share-based payment, otherwise, share-based payments are measured at the fair value of the services received.

 

F-14

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

3. SIGNIFICANT ACCOUNTING POLICIES (cont’d)

 

(k) Share-based payments (cont’d)

 

The fair value is measured at grant date at each tranche is recognized over the period during which the options vest. The fair value of the options granted is measured using the Black-Scholes option pricing model taking into account the terms and conditions upon which the options were granted. At each reporting date, the amount recognized as an expense is adjusted to reflect the number of stock options that are expected to vest.

 

(l) Provisions

 

Provisions are recognized when the Company has a present obligation (legal or constructive), as a result of past events, and it is probable that an outflow of resources that can be reliably estimated will be required to settle the obligation. The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks and uncertainties surrounding the obligation. Where the effect is material, the provision is discounted to net present value using an appropriate current market-based pre-tax discount rate and the unwinding of the discount is included in profit or loss as interest expense from discounting obligations.

 

(m) Income taxes

 

Current tax is the expected tax payable or receivable on the taxable income or loss for the year using tax rates enacted or substantially enacted at the reporting date, and any adjustment to tax payable in respect of previous years.

 

Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable operations, and differences relating to investments in subsidiaries and jointly controlled entities to the extent that it is probable that they will not reverse in the foreseeable future. In addition, deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date.

 

Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax assets and liabilities, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously. A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized.

 

(n) Deferred charges

 

Costs directly identifiable with the raising of capital will be charged against the related capital stock.  Costs related to shares not yet issued are recorded as deferred financing costs.  These costs will be deferred until the issuance of the shares to which the costs relate, at which time the costs will be charged against the related capital stock or charged to operations if the shares are not issued.

 

F-15

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

3. SIGNIFICANT ACCOUNTING POLICIES (cont’d)

 

(o) New accounting pronouncements

 

The following new accounting policies were adopted by the Company during the year ended December 31, 2019:

 

As of January 1, 2019, the Company adopted the following new accounting standards and interpretations on a modified retrospective approach:

 

IFRS 16, Leases

 

IFRS 16, Leases (“IFRS 16”), specifies how to recognize, measure, present, and disclose leases. The standard provides a single-lessee accounting model, requiring lessees to recognize a right-of-use asset representing its right to use the underlying asset and a liability representing its obligation to make lease payments (“lease obligation”), for all leases unless the Company elects to exclude leases when the lease term is twelve months or less, or the underlying asset has a low monetary value. Lessors continue to classify leases as operating or finance, with IFRS 16’s approach to lessor accounting substantially unchanged from its predecessor, IAS 17, Leases (“IAS 17”). The Company’s accounting policy under IFRS 16 is as follows:

 

At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company adopted IFRS 16 using the modified retrospective approach and therefore, the comparative information has not been restated and continues to be reported under IAS 17 Leases and IFRIC 4 to determine whether an arrangement contains a lease.

 

The Company as a lessee

 

The Company recognizes a right-of-use (“ROU”) asset and a lease liability at the lease commencement date. The ROU asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received.

 

The ROU asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the ROU asset or the lease term. The lease term includes consideration of an option to renew or to terminate if the Company is reasonably certain to exercise that option. Current office and car lease terms range from 6 months to 22 months. In addition, the ROU asset is periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability.

 

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate. Lease payments mainly include fixed, or in substance fixed, payments and variable lease payments that depend on an index or a rate. Variable lease payments that do not depend on an index or rate are not included in the measurement of the lease liability. The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, or if the Company changes its assessment of whether it will exercise a purchase, extension, or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the ROU asset, or is recorded in profit or loss if the carrying amount of the ROU asset has been reduced to zero.

 

F-16

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

3. SIGNIFICANT ACCOUNTING POLICIES (cont’d)

 

(o) New accounting pronouncements (cont’d)

 

Effective January 1, 2019 (date of initial application), the Company adopted IFRS 16 using the modified retrospective transition approach. Accordingly, comparative figures as at and for the year ended December 31, 2018 have not been restated and continue to be reported under IAS 17 and IFRIC 4, Determining Whether an Arrangement Contains a Lease (“IFRIC 4”).

 

The Company has elected to apply the practical expedient to grandfather the assessment of which transactions are leases on the date of initial application, as previously assessed under IAS 17 and IFRIC 4. The Company applied the definition of a lease under IFRS 16 to contracts entered into or modified on or after January 1, 2019.

 

At transition, the Company used the following practical expedients when applying IFRS 16 to leases previously classified as operating leases under IAS 17: applied a single discount rate to a portfolio of leases with similar characteristics; recognition exemption of short-term leases; recognition exemption of low-value leases; and used hindsight when determining the lease term if the contract contained options to extend or terminate the lease.

 

When applying the modified retrospective transition approach, for leases previously classified as operating leases under IAS 17 and IFRIC 4, on initial application, a lessee is permitted to measure the ROU asset, on a lease-by-lease basis, using one of two methods: (1) as if IFRS 16 had always been applied, using the incremental borrowing rate at the date of initial application; or (2) at an amount equal to the lease liability (subject to certain adjustments). For all leases, the Company applied the second method and recognized the ROU assets based on the corresponding lease liability. As at January 1, 2019, the Company recorded lease obligations of $407,776 and ROU assets of $407,776. When measuring lease liabilities, the Company discounted future lease payments using its incremental borrowing rate as at January 1, 2019. The weighted-average rate applied was 7.5%. During the year ended December 31, 2019, the Company recorded $147,946 of depreciation of ROU assets, and $14,827 of interest accretion on discounted lease obligations as a result of the adoption of IFRS 16.

 

The following table reconciles the Company’s operating lease commitments as at December 31, 2018, as previously disclosed in the Company’s annual audited consolidated financial statements, to the lease obligations recognized on initial application of IFRS 16 on January 1, 2019:

 

As at January 1, 2019   Previously Reported under IAS 17     IFRS 16 Transition Adjustments     As report under
IFRS 16
 
Right of use Assets   $      Nil     $ 407,776     $ 407,776  
Lease Obligation   $      Nil     $ 407,776     $ 407,776  

  

F-17

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

4. TRADE AND OTHER RECEIVABLES

 

    December 31,
2019
    December 31,
2018
 
Trade receivables   $ 1,510,915     $ 479,156  
Taxes receivable     144,150       315,047  
Other receivables     288,763       131,152  
Total   $ 1,943,828     $ 925,355  

 

Siyata Mobile Israel (“SMI”) has a factoring agreement on its trade receivables, whereby invoices are fully assigned to a funding entity in return for 80%-85% of the total sale to be paid to SMI by the funding entity in advance. The remaining 15-20% is paid to SMI when the funding entity receives payment from the customer.

 

SMI incurs a financing charge of 3.1% – 3.5% on advances received and is subject to certain covenants.

 

The 80-85% received upfront remains a liability from SMI to the funding entity until final settlement, however all such balances are fully insured in case of non-payment. As SMI has both the legally enforceable right and the intention to settle the receivable and liability on a net basis in accordance with IAS 32, trade receivables are presented net of the liability for amounts advanced. As at December 31, 2019 the total offset for amounts extended by the funding entity was $2,455,000 (December 31, 2018 - $1,178,841).

 

5. INVENTORY

 

    December 31,
2019
    December 31,
2018
 
Finished products   $ 3,584,263     $ 4,124,977  
Accessories and spare parts     816,360       856,490  
Total   $ 4,400,623     $ 4,981,467  

 

6. RIGHT OF USE ASSETS

 

    Office     Vehicle     Total  
Balance Jan 1, 2019     -       -       -  
Addition in the year     100,134       307,642       407,776  
Translation adjustment     -       (4,000 )     (4,000 )
Amortization in the year     (57,908 )     (79,038 )     (136,946 )
Balance December 31, 2019     42,226       224,604       266,830  

 

F-18

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

7. INTANGIBLE ASSETS

  

    Development Costs     Uniden License     E-Wave License     Total  
                         
Cost:                        
Balance at December 31, 2017     6,770,255       148,592       1,681,959       8,600,806  
Additions     2,070,265       -       -       2,070,265  
Translation adjustment     644,442       -       -       644,442  
Balance at December 31, 2018     9,484,962       148,592       1,681,959       11,315,513  
Additions     2,757,875       -       -       2,757,875  
Translation adjustment     (423,432 )     -       -       (423,432 )
Balance at December 31, 2019     11,819,405       148,592       1,681,959       13,649,956  
                                 
Accumulated Amortization:                                
Balance at December 31, 2017     980,000       42,876       -       1,022,876  
Additions     249,000       26,745       420,490       696,235  
Impairment     1,954,000       -       -       1,954,000  
Translation adjustment     153,380       -       -       153,380  
Balance at December 31, 2018     3,336,380       69,621       420,490       3,826,491  
Additions     950,383       27,320       420,492       1,398,195  
Impairment     -       -       147,977       147,977  
Translation adjustment     (146,001 )     -       -       (146,001 )
Balance at December 31, 2019     4,140,762       96,941       988,959       5,226,662  
                                 
Net Book Value:                                
Balance at December 31, 2018   $ 6,148,582     $ 78,971     $ 1,261,469     $ 7,489,023  
Balance at December 31, 2019   $ 7,678,643     $ 51,651     $ 693,000     $ 8,423,294  

 

Development Costs

 

Development costs are internally generated and are capitalized in accordance with the IAS 38.

 

On an annual basis, the Company assesses capitalized development costs for indicators of impairment or when facts or circumstances suggest the carrying amount may exceed its recoverable amount.

 

The Company engaged a third-party valuator to determine the recoverable amount of the development costs. The recoverable amount was equal or in excess to the carrying amount and therefore no impairment was taken on development costs in 2019 (2018 - $1,954,000 impairment on legacy 3G products due to obsolescence, the majority of sales moving forwards would be 4G technology).

 

F-19

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

7. INTANGIBLE ASSETS (cont’d)

 

Development Costs (cont’d)

 

As part of the valuation process, the Company reduced the estimated useful life of certain products. This was considered to be a change in estimate and applied prospectively. As follows:

 

Intangible Asset   Useful Economic Life 2018   Useful Economic Life 2019   Amortization Method
4G Devices   7 years   5 - 6 years   Straight line
3G Devices   11 years   5 years   Straight line

 

During the year ended December 31, 2019 the Company incurred $1,005,000 (2018 - $Nil) product development costs which did not satisfy the criteria for capitalization and were recorded in profit and loss. The product development costs recorded were for the following products: UR-7 $285,000, CP-100 $101,000 and UR-5 $619,000.

 

Uniden License

 

During 2016, the Company acquired a license agreement with Uniden America Corporation (“Uniden”). The agreement provides for the Company to use the trademark “Uniden”, along with associated designs and trade dress to distribute, market and sell its cellular signal booster and accessories during its term.  The agreement includes renewal options up to December 31, 2022 and is subject to certain minimum royalties.  The license agreement is amortized on a straight-line basis over its five year term. Based on the valuation report, the Company has determined that there is no impairment in the year.

 

E-Wave License

 

On an annual basis, the Company assesses its E-Wave License for indicators of impairment or when facts or circumstances suggest the carrying amount may exceed its recoverable amount. Indicators of impairment relating to the E-Wave License included a decline in demand for the products in the exclusive license agreement.

 

The Company engaged a third-party valuator to determine the recoverable amount of the E-Wave License, which was completed using value in use (“VIU”).

 

Value in use is an estimate that involves (a) estimating the future cash inflows and the outflows to be derived from continuing use of the asset and from its ultimate disposal and (b) applying the appropriate pre-tax discount rate to those future cash flows after considering and reflecting elements outlined in IAS 36.30.

 

The key assumptions used in the calculation of the recoverable amount include forecasting the next twelve months:

 

i) Revenues; and
ii) Normalized Operating Expenses;

 

VIU is determined with reference to risk adjusted cash flows and a discount rate of 35% based on individual characteristics of the Company’s CGU, the risk-free rate of return and other economic and operating factors.

 

The result is that the carrying amount of intangible assets relating to the E-Wave License exceeded their recoverable amount and as a result the Company recorded an impairment charge in the amount of $147,977.

 

F-20

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

8. LEASE OBLIGATIONS

 

Lease Obligations   Total  
Balance Jan 1, 2019   -  
Addition in the year     407,776  
interest expense     14,827  
Translation adjustment     (4,000 )
lease payments     (165,584 )
Balance December 31, 2019     253,019  
         
Lease obligations Maturity Schedule:        
2020     151,437  
2021     82,282  
2022     19,300  
Total lease obligations     253,019  

 

During the year ended December 31, 2019 the Company did not incur any expense related to short-term or low value leases exempt for IFRS 16 requirements.

 

9. FUTURE PURCHASE CONSIDERATION

 

    December 31,
2019
    December 31, 2018  
Balance, beginning of the period   $ 430,000     $ 1,085,781  
E-wave future purchase consideration paid     -       (804,929 )
Signifi future purchase consideration paid     (460,000 )     (370,000 )
Accretion and change in value of future purchase consideration     30,000       519,148  
Balance, end of the period   $ -     $ 430,000  
                 
Classification:                
Short-term (payable within one year)   $ -     $ 430,000  

 

Future Purchase Consideration Signifi

 

On June 7, 2016, the Company acquired all of the issued and outstanding shares of Signifi Mobile Inc. In connection with the acquisition of Signifi, the Company agreed to pay, on each of the three anniversaries of the transaction at the option of the vendors

 

a) 1,000,000 In common shares; or
b) $150,000 in cash
c) $75,000 in cash and 500,000 common shares.

 

On June 7, 2019 the Company issued 1,000,000 common shares at a value of $460,000. The estimated future purchase consideration was estimated at that date at $430,000, resulting in a change in value of the future purchase consideration on the income statement in the amount of $30,000 loss. As at December 31, 2019 the Company has completed its obligations.

 

F-21

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

10. LONG TERM DEBT

 

On June 28, 2018 Signifi borrowed $250,000 from the Business Development Bank of Canada (“BDC”) for a term of four years, payable in monthly instalments of principal and interest. This loan bears interest at the bank’s base rate + 3.2%. The loan must be fully repaid by July 23, 2022. The loan is secured by the assets of Signifi and a guarantee by the Company and its Canadian subsidiaries.

 

    December 31,
2019
    December 31,
2018
 
Balance, Beginning of Year   $ 230,000     $ -  
Loan proceeds from the BDC     -       250,000  
Capital repayments in the year     (34,000 )     (20,000 )
    $ 196,000     $ 230,000  
Less: current portion of long term debt     (58,000 )     (34,000 )
Long Term Debt, End of Year   $ 138,000     $ 196,000  

 

11. CONVERTIBLE DEBENTURES

 

    December 31,
2019
    December 31,
2018
 
Balance, Beginning of Year   $ 3,904,831     $ 3,553,901  
Interest and accretion expense     920,487       833,930  
Interest paid or accrued     (483,000 )     (483,000 )
Rollover to the 12% convertible debenture     (2,978,263 )     -  
Issuance of the 12% convertible debenture     5,272,252       -  
    $ 6,636,307     $ 3,904,831  
Due within one year     (1,364,055 )     -  
Balance, End of Year   $ 5,272,252     $ 3,904,831  

 

(a) On December 28, 2017 the Company issued 46,000 unsecured convertible debentures at a price of $1,000 per unit, convertible into 1,667 common shares of the Company at $0.60 (the “Conversion Price”) per common share.

 

Each Convertible Debenture unit bears an interest rate of 10.5% per annum from the date of issue, payable in cash quarterly in arrears. Any unpaid interest payments will accrue and be added to the principal amount of the Convertible Debenture. During the year ended December 31, 2019 the Company paid or accrued $483,000 (year ended December 31, 2018-$483,000) in interest related to the convertible debentures, included within finance expense in profit and loss.

 

On December 22, 2019, a portion of the 10.5% debentureholders rolled over the net present value of their holdings totaling $2,978,263 with a maturity value of $3,155,000 into $3,319,000 of face value 12% convertibles debentures as more fully described below.

 

The exchange of debt instruments between the debenture holders and the Company satisfied the criteria under IFRS 9 as a substantial modification, and therefore was treated as an extinguishment of the previous debt and a recognition of a new financial liability. In connection, a loss of $176,737 was recorded within finance expense (income) in profit or loss, as the difference between the carrying amount of the financial liability extinguished and the consideration paid, which is comprised of the newly issued debentures.

 

F-22

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

11. CONVERTIBLE DEBENTURES (cont’d)

 

The remaining portion of the 10.5% Convertible Debentures will mature on June 28, 2020 (the “Maturity Date”) and are convertible into common shares at the Conversion Price, at the option of the holder, at any time prior to the close of business on the earlier of: (i) the last business day immediately preceding the Maturity Date, and (ii) the date fixed for redemption in the event of a change of control. The face value of the 10.5% convertible debenture maturing on June 28, 2020 is $1,445,000.

 

(b) On December 23, 2019 the Company issued 7,866,000 unsecured convertible debentures at a price of $1.00 per unit, convertible into 2.222 common shares of the Company at $0.45 (the “Conversion Price”) per common share. The discounted liability for this convertible debenture at December 23, 2019 is $5,272,252. The amount allocated to contributed surplus is $578,903 and the balance of $2,014,845 is the transaction costs incurred.

 

Each Convertible Debenture unit bears an interest rate of 12% per annum from the date of issue, payable in cash quarterly in arrears. Any unpaid interest payments will accrue and be added to the principal amount of the Convertible Debenture.

 

The Convertible Debentures will mature on December 23, 2021 (the “Maturity Date”) and are convertible into common shares at the Conversion Price, at the option of the holder, at any time prior to the close of business on the earlier of: (i) the last business day immediately preceding the Maturity Date, and (ii) the date fixed for redemption in the event of a change of control.

 

The Company has the right to repay the convertible debenture at 101% of face value anytime after December 23, 2020.

 

12. SHARE CAPITAL

 

(a) Authorized    Unlimited number of common shares without par value
      Unlimited number of preferred shares without par value

 

As at December 31, 3019, the Company had 125,247,819 common shares issued and outstanding.

 

(b) Common share transactions

 

Transactions for the year ended December 31, 2019 are as follows:

 

i) Issued 821,896 common shares in connection with exercised of agents’ options for proceeds of $328,757.
     
ii) Issued 11,725,490 common shares in connection with exercise of warrants for proceeds of $5,862,745.
     
iii) Issued 1,000,000 common shares in connection with purchase consideration for Signifi (Note 9) with the value of the shares as $460,000.
     
iv) On August 29, 2019 the Company completed a non-brokered private placement of 7,500,000 units at a price of $0.40 per unit for gross proceeds of $3,000,000. Each unit consisted of one common share and one half share purchase warrant. Each warrant is exercisable at a price of $0.60 for a period of two years. In conjunction with the placement, the Company incurred share issuance costs of $243,379.
     
v) On December 23, 2019, the Company issued 481,928 common shares as compensation to the agents’ in connection to the issuance of the convertible debentures (Note 11)

  

F-23

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

12. SHARE CAPITAL (cont’d)

 

(b) Common share transactions (cont’d)

 

Transactions for the year ended December 31, 2018 are as follows:

 

vi) Issued 396,242 common shares in connection with exercised of agents’ options for proceeds of $143,564.
     
vii) Issued 1,000,000 common shares in connection with purchase consideration for Signifi (Note 9) with the value of the shares as $370,000.
     
viii) Issued 2,648,948 common shares in connection with exercise of warrants for proceeds of $1,324,464.
     
ix) Issued 1,300,000 common shares in connection with the exercise of options for proceeds of $410,000.
     
x) Closed a private placement of 4,623,800 units at a price of $0.45 per unit for gross proceeds of $2,080,710. Each unit consisted of one common share and one share purchase warrant. Each warrant is exercisable at a price of $0.60 for a period of three years. In conjunction with the placement, the Company incurred finders’ fees and other cash share issuance costs of $375,423 and issued 227,976 agents’ options exercisable at a price of $0.60 per common share for a period of three years.

 

(c) Stock options

 

The Company has a shareholder approved “rolling” stock option plan (the “Plan”) in compliance with TSX-V policies. Under the Plan the maximum number of shares reserved for issuance may not exceed 10% of the total number of issued and outstanding common shares at the time of granting. The exercise price of each stock option shall not be less than the market price of the Company’s stock at the date of grant, less a discount of up to 25%. Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted.

 

A summary of the Company’s stock option activity is as follows:

 

    Number of Stock Options    

Weighted Average

Exercise Price

 
Outstanding options, December 31, 2017     8,580,000       0.42  
Granted     2,210,000       0.50  
Exercised     (1,300,000 )     0.32  
Outstanding options, December 31, 2018     9,490,000     $ 0.44  
Granted     2,560,000       0.54  
Expired     (75,000 )     0.60  
Outstanding options, December 31, 2019     11,975,000     $ 0.47  

 

F-24

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

12. SHARE CAPITAL (cont’d)

 

(c) Stock options (cont’d)

 

At December 31, 2019 stock options outstanding are as follows:

 

Grant Date   Number of options outstanding     Number of options exercisable     Weighted Average Exercise Price     Expiry date   Remaining contractual life (years)  
July 24, 2015     400,000       400,000     $ 0.30     July 23, 2020     0.56  
July 24, 2015     150,000       150,000       0.60     July 23, 2020     0.56  
July 28, 2015     250,000       250,000       0.30     July 28, 2020     0.58  
August 10, 2015     425,000       425,000       0.30     August 7, 2020     0.60  
September 30, 2015     2,700,000       2,700,000       0.30     July 23, 2020     0.56  
January 1, 2017     320,000       320,000       0.36     January 1, 2022     2.01  
January 11, 2017     360,000       360,000       0.36     January 11, 2022     2.03  
April 4, 2017     1,000,000       1,000,000       0.45     April 4, 2022     2.27  
July 24, 2017     1,600,000       1,600,000       0.69     July 24, 2022     2.56  
December 24, 2018     2,210,000       1,283,335       0.50     December 24, 2023     3.98  
January 15, 2019     320,000       106,668       0.50     January 15, 2024     4.04  
March 21, 2019     1,790,000       1,147,333       0.55     March 21, 2024     4.22  
December 1, 2019     450,000       37,500       0.50     December 1, 2023     3.92  
Total     11,975,000       9,779,836     $ 0.47           2.10  

 

During the year ended December 31, 2019, the Company recorded share-based payments expense of $1,490,313 (year ended December 31, 2018- $1,102,313) in relation to options vesting.

 

The following weighted average assumptions have been used for the Black-Scholes valuation for the stock options granted:

 

    2019     2018  
Stock price   $ 0.50     $ 0.43  
Risk-free interest rate     1.5 %     1.9 %
Expected life     4.8       5  
Annualized volatility     143 %     148 %
Dividend rate     0.00 %     0.00 %

 

F-25

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

12. SHARE CAPITAL (cont’d)

 

(d) Agents’ options

 

A summary of the Company’s agents’ options activity is as follows:

 

    Number of
options
    Weighted average
exercise price
 
Outstanding agent options, December 31, 2017     1,390,950       0.39  
Granted     227,976       0.60  
Exercised     (396,242 )     0.36  
Expired     (55,443 )     0.35  
Outstanding agent options, December 31, 2018     1,167,241     $ 0.45  
Granted     728,615       0.42  
Exercised     (821,896 )     0.40  
Expired     (117,369 )     0.48  
Outstanding agent options, December 31, 2019     956,591     $ 0.46  

 

At December 31, 2019 agents’ options outstanding are as follows:

 

Grant Date   Number of options outstanding     Number of options exercisable     Weighted Average Exercise Price     Expiry date   Remaining contractual life (years)  
December 24, 2018     227,976       227,976       0.60     December 24, 2021     1.98  
December 23, 2019     728,615       728,615       0.42     December 23, 2021     1.98  
Total     956,591       956,591     $ 0.46           1.98  

 

(e) Share purchase warrants

 

A summary of the Company’s warrant activity is as follows:

 

    Number of
warrants
    Weighted average
exercise price
 
             
Outstanding, December 31, 2017     25,078,307       0.54  
Granted     4,623,800       0.60  
Exercised     (2,648,928 )     0.50  
Expired     (5,350,430 )     0.50  
Outstanding, December 31, 2018     21,702,749     $ 0.56  
Granted     11,616,000       0.50  
Exercised     (11,725,490 )     0.50  
Expired     (5,353,459 )     (0.67 )
Outstanding, December 31, 2019     16,239,800     $ 0.53  

 

F-26

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

12. SHARE CAPITAL (cont’d)

 

(e) Share purchase warrants (cont’d)

 

At December 31, 2019, share purchase warrants outstanding and exercisable are as follows:

 

Grant Date   Number of Warrants outstanding and exercisable     Exercise Price     Expiry date
December 24, 2018     4,623,800     $ 0.60     December 24, 2021
August 29, 2019     3,750,000     $ 0.60     August 29, 2021
December 23, 2019     7,866,000     $ 0.45     December 23, 2022

 

13. COST OF SALES

  

 

(in thousands)

 

Dec 31,

2019

   

Dec 31,

2018

 
Materials and merchandise   $ 7,282     $ 11,199  
Royalties     427       338  
Other expenses     1,082       1,444  
Change in inventory     941       (820 )
Total   $ 9,732     $ 12,161  

 

14. SELLING AND MARKETING EXPENSES

 

 

(in thousands)

 

Dec 31,

2019

   

Dec 31,

2018

 
Salaries and related expenses   $ 2,063     $ 1,519  
Advertising and marketing     2,256       3,545  
Travel and conferences     404       385  
Total   $ 4,723     $ 5,449  

 

F-27

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

15. GENERAL AND ADMINISTRATIVE EXPENSES

 

 

(in thousands)

 

Dec 31,

2019

   

Dec 31,

2018

 
Salaries and related expenses   $ 540     $ 306  
Professional services     269       397  
Consulting and director fees     1,278       828  
Management fees     170       570  
Travel     106       94  
Office and general     353       384  
Regulatory and filing fees     62       25  
Shareholder relations     304       325  
Total   $ 3,082     $ 2,929  

 

16. INCOME TAXES

  

The reconciliation of income taxes at statutory rates is as follows:

 

    December 31,
2019
   

December 31,
2018

 
             
Net loss before taxes   $ 10,160,351     $ 11,527,981  
                 
Expected income tax (recovery)     (2,743,000 )     (3,113,000 )
Impact of difference in statutory tax rates on earnings of subsidiaries     89,000       96,000  
Impact of future income tax rates applied versus current statutory rate and changes in future tax rate from prior year     -       56,000  
Permanent differences     410,000       (117,000 )
Unrecognized (recognized) benefit of operating loss carry-forwards     2,156,000       2,580,000  
Impact of convertible debenture     142,000       -  
Share issue costs and transaction costs     (66,000 )     (94,000 )
Adjustment to prior years provision versus statutory tax returns and expiry of non-capital losses     12,000       592,000  
Total income tax expense (recovery)   $ -     $ -  
                 
Current income tax   $ -     $ -  
Deferred tax recovery   $ -     $ -  

 

F-28

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

16. INCOME TAXES (cont’d)

 

The significant components of the Company’s deductible temporary differences, unused tax credits and unused tax losses that have not been included on the consolidated statement of financial position are as follows:

 

    2019     Expiry Date Range   2018     Expiry Date Range
Temporary Differences                    
Property, plant, and equipment and intangibles     2,002,000     No expiry date     250,000     No expiry date
Share issue costs and transaction costs for convertible note     1,787,000     No expiry date     1,525,000     No expiry date
Allowable capital losses     50,000     No expiry date     254,000     No expiry date
Non-capital losses available for future period     26,895,000     See below     19,940,000     See below

 

The Company has approximately $26,895,000 (2018 - $19,940,000) of operating tax loss carry-forwards. Of these, $13.7 million arise from Israel (2018 - $10.6 million) which do not expire, and the remaining balance arise from Canada which expire through to 2039.

 

17. CAPITAL MANAGEMENT

 

The Board of Directors has overall responsibility for the establishment and oversight of the Company’s risk management framework.

 

The Company defines capital as consisting of shareholder’s equity. The Company’s objectives when managing capital are to support the creation of shareholder value, as well as to ensure that the Company is able to meet its financial obligations as they become due.

 

The Company manages its capital structure to maximize its financial flexibility making adjustments in response to changes in economic conditions and the risk characteristics of the underlying assets and business opportunities. The Company does not presently utilize any quantitative measures to monitor its capital, but rather relies on the expertise of the Company’s management to sustain the future development of the business. Management reviews its capital management approach on an ongoing basis and believes that this approach, given the relative size of the Company, is reasonable.

 

As at December 31, 2019, the Company is only subject to externally imposed capital requirements arising from the quarterly payments of interest on the debenture as described in Note 9, and the monthly principal and interest payments from the BDC loan described in Note 10. SMI is also subject to a debt covenant in relation to the factoring agreement described in Note 4. At no time during the year was the Company in breach of the covenant.

 

Management reviews its capital management approach on an ongoing basis and believes that this approach, given the relative size of the Company, is reasonable.

 

F-29

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

18. FINANCIAL INSTRUMENTS

  

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values.

 

Financial instruments measured at fair value are classified into three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are:

 

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities;

 

Level 2 – Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly;

 

Level 3 – Inputs that are not based on observable market data.

 

The fair values of the Company’s cash, trade and other receivables, due to/from related party, accounts payable and accrued liabilities, long term debt, and convertible debentures approximate carrying value, which is the amount recorded on the consolidated statement of financial position.

 

The following table illustrates the classification of the Company’s financial instruments within the fair value hierarchy as at December 31, 2019 and December 31, 2018:

 

    Level 1     Level 2     Level 3  
                   
December 31, 2019:                  
Future purchase consideration   $ -     $ -       -  
                         
December 31, 2018:                        
Future purchase consideration   $ 430,000     $ -       -  

 

The balance of future purchase consideration above is the current portion, plus the present value of the non-current portion presented on the consolidated statements of financial position.

 

The input used in Level 1 for the year ended December 31, 2018 is either the cash the Company is obligated to pay as an anniversary payment or the Company’s share price quoted on active markets, or a combination thereof, depending on which payment form is considered most probable to be chosen by the vendor (Note 9). The Company is exposed to varying degrees to a variety of financial instrument related risks:

 

Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company places its cash with institutions of high credit worthiness. Management has assessed there to be a low level of credit risk associated with its cash balances.

 

The Company’s exposure to credit risk is influenced mainly by the individual characteristics of each customer. However, management also considers the demographics of the Company’s customer base, including the default risk of the industry and country in which customers operate, as these factors may have an influence on credit risk. Approximately 15% of the Company’s revenue for the year ended December 31, 2019 (2018 -29%) is attributable to sales transactions with a single customer.

 

F-30

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

18. FINANCIAL INSTRUMENTS (cont’d)

 

Credit risk (cont’d)

 

The Company has established a credit policy under which each new customer is analyzed individually for creditworthiness before the Company’s standard payment and delivery terms and conditions are offered. The Company’s review includes external ratings, when available, and in some cases bank references. Purchase limits are established for each customer, which represent the maximum open amount without requiring approval from the Risk Management Committee; these limits are reviewed quarterly. Customers that fail to meet the Company’s benchmark creditworthiness may transact with the Company only on a prepayment basis.

 

More than 80% of the Company’s customers have been active with the Company for over four years, and no impairment loss has been recognized against these customers. In monitoring customer credit risk, customers are grouped according to their credit characteristics, including whether they are an individual or legal entity, whether they are a wholesale, retail or end-user customer, geographic location, industry, aging profile, maturity and existence of previous financial difficulties. Trade and other receivables relate mainly to the Company’s wholesale customers. Customers that are graded as “high risk” are placed on a restricted customer list and monitored by the Company, and future sales are made on a prepayment basis.

 

The carrying amount of financial assets represents the maximum credit exposure, notwithstanding the carrying amount of security or any other credit enhancements.

 

The maximum exposure to credit risk for trade and other receivables at the reporting date by geographic region was as follows:

 

 

(in thousands)

 

December 31,
2019

   

December 31, 2018

 
Israel   $ 754     $ 626  
Europe     39       25  
North America     1,151       274  
Total   $ 1,944     $ 925  

 

Liquidity risk

 

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The Company’s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation.

 

The Company examines current forecasts of its liquidity requirements so as to make certain that there is sufficient cash for its operating needs, and it is careful at all times to have enough unused credit facilities so that the Company does not exceed its credit limits and is in compliance with its financial covenants (if any). These forecasts take into consideration matters such as the Company’s plan to use debt for financing its activity, compliance with required financial covenants, compliance with certain liquidity ratios, and compliance with external requirements such as laws or regulation.

 

F-31

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

18. FINANCIAL INSTRUMENTS (cont’d)

 

Liquidity risk (cont’d)

 

The Company uses activity-based costing to cost its products and services, which assists it in monitoring cash flow requirements and optimizing its cash return on investments. Typically, the Company ensures that it has sufficient cash on demand to meet expected operational expenses for a period of 90 days, including the servicing of financial obligations; this excludes the potential impact of extreme circumstances that cannot reasonably be predicted, such as natural disasters.

 

The Company has a factoring agreement with external funding (Note 4).

 

With the exception of employee benefits, the Company’s accounts payable and accrued liabilities have contractual terms of 90 days. The employment benefits included in accrued liabilities have variable maturities within the coming year.

 

Market risk

 

a) Currency Risk

 

Currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. The functional currency of Siyata Israel is the US dollar (“USD”). Revenues are predominantly incurred in the US dollar with expenses in the Israeli New Sheqel (“NIS”). As at December 31, 2019 the Company’s exposure to foreign currency risk with respect to financial instruments is as follows:

 

 

(in CAD thousands)

  USD     NIS     CAD     Total  
Financial assets and financial liabilities:                        
                   
Current assets                        
Cash     175       1,273       2,017       3,465  
Trade and other receivables     1,019       889       36       1,944  
Due from director     260       -       -       260  
Current liabilities                                
Bank loan     -       (42 )     -       (42 )
Accounts payable and accrued liabilities     (448 )     (1,393 )     (725 )     (2,566 )
Due to related party     -       (100 )             (100 )
Convertible debentures                     (6,636 )     (6,636 )
Long term debt     -       -       (196 )     (196 )
Total     1,006       627       (5,504 )     (3,871 )

 

F-32

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

18. FINANCIAL INSTRUMENTS (cont’d)

 

Market risk (cont’d)

 

b) Interest Rate Risk

 

Interest rate risk is the risk that the fair value of future cash flows will fluctuate as a result of changes in interest rates. The Company’s sensitively to interest rates is limited to the BDC loan, and is therefore currently immaterial as the rest of the Company’s debt bears interest at fixed rates.

 

c) Price Risk

 

The Company is exposed to price risk with respect to equity prices. Equity price risk is defined as the potential adverse impact on the Company’s earnings due to movements in individual equity prices or general movements in the level of the stock market. The Company closely monitors individual equity movements, and the stock market to determine the appropriate course of action to be taken by the Company.

 

19. RELATED PARTY TRANSACTIONS

 

Key Personnel Compensation

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. The Company has determined that key management personnel consists of executive and non-executive members of the Company’s Board of Directors and corporate officers. The remuneration of directors and key management personnel is as follows:

 

    2019     2018  
             
Payments to key management personnel:            
Salaries, consulting and directors’ fees   $ 1,232,208     $ 943,568  
Share-based payments     871,634       280,003  
Total   $ 2,103,842     $ 1,223,571  

 

Other related party transactions are as follows:

 

        (in thousands)  
Type of Service   Nature of Relationship   2019     2018  
Sales   Accel Solutions (common directors)   $ 361     $ 233  
Selling and marketing expenses   VP Technology     278       136  
General and administrative expense   Accel Telecom (common directors)     170       132  
General and administrative expense   Companies controlled by the CEO, and Directors     953       838  

 

F-33

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

19. RELATED PARTY TRANSACTIONS (cont’d)

 

Loan to Director

 

On April 1, 2019 the Company loaned to a Director $200,000 USD. This loan is for a term of 5 years with interest charged at rate of 7% per annum payable quarterly. As of January 1, 2020 the interest rate on the loan has been increased to 12% per annum. There are no capital repayment requirements until the end of the term when a balloon payment of the principal balance is required.

 

Balances and transactions with Accel Telecom Ltd.

 

Until December 31, 2018, the Company had a management agreement with a related company, Accel Telecom Ltd. (“Accel”). As part of the agreement, the Company paid Accel $US 25,000 per month for management services (including services related to finance, general operations, insurance, administration, and other). From October 1, 2018 the monthly fee was reduced to $US 11,000 per month. In 2019 the management fee was $170,000 Canadian.

 

Included in due to related party as at December 31, 2019 is a balance payable to Accel of $100,079 (December 31, 2018 - balance payable to Accel of $198,362). The balance is non-interest bearing.

 

20. SEGMENTED INFORMATION

 

The Company is domiciled in Canada and it operates and produces its income primarily in Israel, Europe and North America.

 

In presenting information on the basis of geographical segments, segment revenue is based on the geographical location of the customers and is as follows:

 

 

External Revenues (in thousands)

  December 31,
2019
    December 31,
2018
 
EMEA   $ 8,134     $ 10,575  
USA     3,104       1,375  
Canada     1,635       2,219  
Australia and New Zealand     147       52  
Total   $ 13,020     $ 14,221  

 

21. MAJOR CUSTOMERS

 

Revenues from four customers of the Company for the year ended December 31, 2019 represent approximately $6,380,000 or 49% of the Company’s total revenues (year ended December 31, 2018 is four customers representing $10,493,000 or 74% of total revenues).

 

22. SUPPLEMENTAL INFORMATION WITH RESPECT TO CASH FLOWS

 

During the year ended December 31, 2019, the Company paid $483,000 (2018 - $494,307) in interest and $Nil (2018 - $Nil) in income taxes.

 

During the year ended December 31, 2019 the Company incurred the following non-cash investing or financing activities:

 

a) Reclassified $130,128 from reserves to share capital as the fair value of agents’ options exercised during the period.

 

F-34

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

22. SUPPLEMENTAL INFORMATION WITH RESPECT TO CASH FLOWS (cont’d)

  

b) Reclassified $15,600 from reserves to share capital as the fair value of agents’ options that expired in the period.

 

c) Recognized $437,487 of accretion of the convertible debentures and classified $58,000 of long-term debt as current.

 

During the year ended December 31, 2018, the Company incurred the following non-cash investing or financing activities:

 

a) Issued 1,000,000 common shares as purchase consideration for Signifi with a value of $370,000.

 

b) Reclassified $75,747 from reserves to share capital as the fair value of agents’ options exercised during the year.

 

c) Reclassified $272,442 from reserves to share capital as the fair value of stock options exercised during the year.

 

d) Reclassified $130,852 of long term debt to current, and classified $34,000 of long term debt as current.

 

23. SUBSEQUENT EVENTS

 

(a) In March 2020 the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, potentially leading to an economic downturn. It is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or ability to raise funds.

 

The Company is taking measures in order to mitigate such adverse effects, by reducing its expenses, specifically temporary salary reductions to management and directors in addition to permanent lay-offs across the company.

 

(b) The Company received a demand line of credit from the TD Bank to a maximum of $1,500,000 CAD.

This line of credit is secured by certain assets, including accounts receivables and inventory of our subsidiary, Signifi Mobile Inc. The lien on those assets is for a total of $4,000,000 CAD. The BDC gave a cessation of rank on their loan in priority to the TD Bank.

  

(c) The Company entered into a non-brokered private placement financing agreement on June 23, 2020 for 1,580 senior unsecured 10% convertible debentures maturing one year from the issue date at an issue price of CDN$1,000 per Convertible Debenture for aggregate gross proceeds of CAD$1,580,000 which includes $250,000 that was rolled over from the convertible debenture that came due on June 28, 2020 for net proceeds of $1,330,000 which was received from Accel Telecom Inc., a reporting insider. Each Convertible Debenture is convertible, at the option of the holder, into 3,333 common shares in the capital of the Company at a price of CDN$0.30 per Common Share, subject to adjustment in certain events and are redeemable at 101% of the face value at any time after the closing date. The convertible debenture holders’ received one (1) non-transferrable common share purchase warrant (each, a “Warrant”) for each CDN$1.00 principal amount of the Convertible Debentures purchased. Each Warrant will entitle the holder to acquire one Common Share (each, a “Warrant Share”) at an exercise price of CDN$0.30 per Warrant Share for a period of twelve (12) months after the date of issue.

 

F-35

 

 

Siyata Mobile Inc.

Notes to the Consolidated Financial Statements

(Expressed in Canadian dollars)

As at and for the years ended December 31, 2019 and 2018

 

23. SUBSEQUENT EVENTS (cont’d)

 

(d) The Company completed a two part non-brokered private placement totalling 21,500,000 units at a price of $0.10 per unit for gross proceeds of $2,150,000. Each unit consisted of one common share and one half share purchase warrant. Each warrant is exercisable at a price of $0.18 for a period of two years.

 

(e) Stock options totalling 3,500,000 with an average exercise price of $0.31 expired.

 

(f) Subsequent to the year end, The Company issued 166,666 common shares as a result of a subscriber converting of 370 convertible debentures at $1,000 per debenture at a price of $0.45 per share;

 

(g) Subsequent to the year end, the Company issued 390,000 stock options exercisable at $0.50 that expires on December 31, 2023;

 

(h) Subsequent to the year end, the Company issued 246,816 agent’s options exercisable at $0.18 with an expiry date of two years from the date of issuance.

 

24. RESTATEMENT

 

Subsequent to the issuance of the financial statements on June 11, 2020, the Company re-assessed its presentation of the impairment of intangible assets on the Consolidated Statements of Loss and Comprehensive Loss and determined that it should be presented as part of operating income (loss) instead of an item within other expenses, in accordance with IAS 1. This correction was made by reclassifying impairment losses of $147,977 and $1,954,000 into operating income (loss) instead of other expenses for the years ended December 31, 2019 and 2018 respectively. There was no impact on net loss for the year as a result of this restatement.

 

F-36

 

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 6. Indemnification of Directors and Officers.

 

Section 124 of the CBCA authorizes companies to indemnify past and present directors, officers and certain other individuals for the liabilities incurred in connection with their services as such (including costs, expenses and settlement payments) unless such individual did not act honestly and in good faith with a view to the best interests of the company and, in the case of a criminal or administrative action or proceeding that is enforced by a monetary penalty, if such individual did not have reasonable grounds for believing his or her conduct was lawful. In the case of a suit by or on behalf of the corporation, a court must approve the indemnification.

 

Upon completion of this offering, our articles will provide that we shall indemnify directors and officers to the extent required or permitted by law.

 

Prior to the completion of this offering, we intend to enter into agreements with our directors and certain officers (each an “Indemnitee” under such agreements) to indemnify the Indemnitee, to the fullest extent permitted by law and subject to certain limitations, against all liabilities, costs, charges and expenses reasonably incurred by an Indemnitee in an action or proceeding to which the Indemnitee was made a party by reason of the Indemnitee being an officer or director of (i) our company or (ii) an organization of which our company is a shareholder or creditor if the Indemnitee serves such organization at our request.

 

We maintain insurance policies relating to certain liabilities that our directors and officers may incur in such capacity.

 

Item 7. Recent sales of unregistered securities.

 

During the past three years, we have issued the following securities. We believe that each of the following issuances was exempt from registration under the Securities Act pursuant to Section 4(2) of the Securities Act regarding transactions not involving a public offering or in reliance on Regulation S under the Securities Act regarding sales by an issuer in offshore transactions. No underwriters were involved in these issuances of securities.

 

On August 4, 2020, the Company completed a non-brokered private placement raising aggregate gross proceeds of $2,150,000 through the issuance of 21,500,000 units (the “August 2020 Units”) at a price of $0.10 per August 2020 Unit. Each August 2020 Unit consisted of one common share in the capital of the Company and one-half of one common share purchase warrant (each, a “August 2020 Warrant”). Each whole August 2020 Warrant is exercisable at a price of $0.18 for a period of two years. The Company paid a cash commission of $24,681.60 and issued 246,816 broker warrants on the same terms as the August 2020 Warrants to certain finders. The purchasers of the August 2020 Units consisted of a group of accredited investors.

 

On June 23, 2020 the Company consummated a new debenture private placement of $1,580,000 with a 12% coupon with a maturity of June 22, 2021. The investors consisted a group of accredited investors, including Accel Telecom, Ltd. purchasing $1,330,000 Units

 

On December 23, 2019, Siyata consummated a brokered private placement financing raising CDN$7,866,000.00 through the issuance of 7,866,000 unsecured 12% per annum convertible debentures (the “Convertible Debentures”) maturing on December 23, 2021 at a price of CDN$1.00 (the “Issue Price”) per Convertible Debenture, with each $1,000 of Convertible Debenture will be convertible into 2,222 common shares in the capital of the Company representing approximately CDN$0.45 per Common Share, subject to adjustment in certain events. The purchasers of the Convertible Debentures consisted of a group of accredited investors.

 

On December 23, 2019, the Company issued 481,928 common shares as compensation to the agents’ in connection to the issuance of the convertible debentures

 

On August 29, 2019, Siyata completed a non-brokered private placement to a group of accredited investors raising gross proceeds of $3,000,000 through the issuance of 7,500,000 units at a price of $0.40 per unit. Each unit consisted of one common share and one half share purchase warrant. Each warrant is exercisable at a price of $0.60 for a period of two years. In conjunction with the placement, the Company was not required to pay agent’s fees.

 

On June 7, 2019 the Company issued 1,000,000 common shares at a value of $460,000 to Justin Goldenblatt to complete the purchase of its acquisition of all of the issued and outstanding shares of Signif Mobile, Inc. (“Signifi”).

 

On March 19, 2019, the Company issued 821,896 common shares in connection with exercised of agents’ options for proceeds of $328,757.

 

On March 19, 2019, the Company issued 11,725,490 common shares in connection with exercise of warrants by the general public for proceeds of $5,862,745.

 

On December 21, 2018, the Company closed a private placement for the sale of 4,623,800 units to a group of accredited investors at a price of $0.45 per unit for gross proceeds of $2,080,710. Each unit consisted of one common share and one share purchase warrant. Each warrant is exercisable at a price of $0.60 for a period of three years. In conjunction with the placement, the Company incurred finders’ fees and other cash share issuance costs of $375,423 and issued 227,976 agents’ options exercisable at a price of $0.60 per common share for a period of three years.

 

On November 30, 2018, the Company issued 2,648,948 common shares in connection with exercise of warrants by the general public for proceeds of $1,324,464.

 

On September 26, 2018, the Company issued 1,300,000 common shares in connection with the exercise of options by Gil Gurfinkel and Paradox IR Services for proceeds of $410,000.

 

On June 8, 2018, the Company issued 1,000,000 common shares to Justin Goldblatt on June 8, 2018 in connection with purchase consideration for Signifi with the value of the shares as $370,000.

 

On March 19, 2018, the Company issued 396,242 common shares in connection with exercised of agents’ options for proceeds of $143,564.

 

On December 15, 2017, the Company issued 100,00 common shares in connection with exercises of warrants by the general public for proceeds of $50,000.

 

II-1

 

 

On December 7, 2017, the Company issued 44,823 common shares in connection with exercises of agents’ options for proceeds of $17,929.

 

On November 14, 2017, the Company issued 174,500 common shares in connection with the exercise of stock options for proceeds of $555,350 to certain directors, officers and consultant as a group.

 

Since August 23, 2017, the Company has granted to its employees and others options to purchase an aggregate of 5,150,000 common shares under its equity compensation plans at a weighted average exercise price of $0.53 per share, with a range of 0.50 to 0.64.

 

Item 8. Exhibits and Financial Statement Schedules

 

(a) The following documents are filed as part of this registration statement:

 

EXHIBIT INDEX

 

The following documents are filed as part of this registration statement:

 

Exhibit Number   Description
1.1+   Form of Underwriting Agreement
     
3.1*   Articles of Association of the Company
     
4.1+   Form of the Representative’s Warrant (Included in Exhibit 1.1)
     
4.2*   Form of Convertible Debenture Indenture
     
4.3*   Form of Warrant Certificate
     
4.4*   Unsecured Convertible Debenture, dated June 22, 2020, by and between the Company and Accel Telecom Ltd.
     
4.5+   Form of Warrant for the Purchase of Shares of Common Shares
     
4.6+   Form of Warrant Agency Agreement
     
4.7+   Form of Representative’s Warrant (Included in Exhibit 1.1)
     
5.1+   Opinion of Cassels Brock & Blackwell LLP
     
10.1*   Consulting Agreement, dated July 1, 2018, by and between the Company, BSD, Ltd. and Marc Seelenfreund
     
10.2*   License Agreement, dated December 1, 2012, by and between Uniden America Corporation, Inc. & affiliates and Signifi Mobile.
     
10.3*   Parent License Agreement, dated November 30, 2017, by and between Wilson Electronics, LLC and Signifi Mobile Inc.
     
10.4*   2016 Siyata Mobile Inc. Stock Option Plan
     
10.5*  

Demand Operating Facility Agreement, dated March 3, 2020, by and between The Toronto-Dominion Bank and Signifi Mobile Inc./Mobile Signifi Inc.

     
10.6*   Amended and Restated Employment Agreement, dated July 1, 2018, by and between the Company and Gerald Bernstein
     
10.7*   Consulting Agreement, dated November 26, 2018, by and between the Company, Glenn Kennedy Sales Agency and Glenn Kennedy
     
10.8*   LTE Standard Patent Licensing Agreement, dated June 5, 2018, by and between the Company and Via Licensing Corporation
     
10.9*   AAC Standard Patent Licensing Agreement, dated June 5, 2018, by and between the Company and Via Licensing Corporation
     
10.10*   Loan Agreement, dated April 1, 2019, by and between the Company and BSD Capital, LTD.
     
10.11*   Assignment and Amending Agreement, dated January 1, 2020, by and between the Company, BSD Capital, LTD. and Basad Partners LTD.
     
10.12+   Asset Purchase Agreement, dated October 1, 2017, by and between the Company and eWave Mobile Ltd.
     
21.1*   Subsidiaries of the Registrant.
     
23.1*   Consent of Davidson & Company LLP
     
23.2+   Consent of Cassels Brock & Blackwell LLP (included in Exhibit 5.1)
     
24*   Power of Attorney (included on the signature page of this registration statement)
     
101.CAL+   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF+   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB+   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE+   XBRL Taxonomy Extension Presentation Linkbase Document

 

* Filed herewith.

 

+ To be filed upon amendment.

 

II-2

 


 


ITEM 9. UNDERTAKINGS.

 

The undersigned registrant hereby undertakes to provide to the Underwriter at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the Underwriter to permit prompt delivery to each purchaser.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described in Item 6, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

The undersigned registrant hereby undertakes that:

 

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

i. To include any prospectus required by Section 10(a)(3) of the Securities Act;

 

ii. To reflect in the prospectus any facts or events arising after the effective date of the registration statement(or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement;

 

iii. To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

 

(2) For the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof;

 

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering

 

(4) To file a post-effective amendment to the registration statement to include any financial statements required by “Item 8.A. of Form 20-F (17 CFR 249.220f)” at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements.

 

(5) For the purpose of determining liability under the Securities Act of 1933 to any purchaser, if the registrant is relying on Rule 430B, each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement

 

II-3

 

 

(6) For the purposes of determining liability under the Securities Act of 1933 to any purchaser in the initial distributions of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

 

(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

 

(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

 

(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

 

(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

 

The undersigned registrant hereby undertakes that:

 

(1) For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

 

(2) For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

II-4

 

 

(6) That, for the purpose of determining liability under the Securities Act to any purchaser:

 

Each prospectus filed by the Registrant pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the small business issuer pursuant to the foregoing provisions, or otherwise, the small business issuer has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the small business issuer of expenses incurred or paid by a director, officer or controlling person of the small business issuer in the successful defence of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the small business issuer will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

(7) For the purposes of determining liability under the Securities Act of 1933 to any purchaser in the initial distributions of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

 

(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

 

(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

 

(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

 

(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

 

II-5

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Siyata Mobile Inc.

 

Signature   Title   Date
         
/s/ Marc Seelenfreund   Chief Executive Officer and Director  

August 21, 2020

Name: Marc Seelenfreund   (Principal Executive Officer)    
         
/s/ Gerald Bernstein   Chief Financial Officer   August 21, 2020
Name: Gerald Bernstein   (Principal Accounting and Financial Officer)    

 

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Marc Seelenfreund as his true and lawful attorney-in-fact and agent, with the full power of substitution, for him and in his name, place or stead, in any and all capacities, to sign any and all amendments to this registration statement (including post-effective amendments), and to sign any registration statement for the same offering covered by this registration statement that is to be effective upon filing pursuant to Rule 462 promulgated under the Securities Act, and all post-effective amendments thereto, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

By: /s/ Steven Ospalak         
  Steven Ospalak   Chairman   August 21, 2020
         
By: /s/ Michael Kron         
  Michael Kron   Director   August 21, 2020
           
By: /s/ Brian Budd        
  Brian Budd   Director   August 21, 2020
         
By: /s/ Richard Hoy         
  Richard Hoy   Director   August 21, 2020

 

 

II-6

 

 

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

 

Pursuant to the Securities Act of 1933 as amended, the undersigned, the duly authorized representative in the United States of America of Siyata Mobile Inc., has signed this registration statement on August 21, 2020.

 

Siyata Mobile Inc.

 

/s/ Lucosky Brookman LLP

 

 

II-7

 

 

 

 

 

 

 

 

 

______________ Units

Each Unit Consisting of

One Share of Common Shares and

One Warrant to Purchase Share of Common Shares

 

 

 

 

 

PROSPECTUS

 

 

 

 

 

 

  Sole Book-Running Manager

   

Maxim Group LLC

 

 

 

 

 

 

______, 2020 

 

 

 

 

Through and including ______, 2020 (the 25th day after the date of this prospectus), all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer’s obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.

 

 

 

 

 

 

 

 

 

 

Exhibit 3.1

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

Incorporation Number : BC0316008

 

TESLIN RIVER RESOURCES CORP.

(the “Company”)

ARTICLES

 

1. INTERPRETATION 1
2. SHARES AND SHARE CERTIFICATES 1
3. ISSUE OF SHARES 3
4. SECURITIES REGISTERS 3
5. SHARE TRANSFERS 4
6. TRANSMISSION OF SHARES 5
7. PURCHASE OF SHARES 5
8. BORROWING POWERS 6
9. ALTERATIONS 6
10. MEETINGS OF SHAREHOLDERS 7
11 PROCEEDINGS AT MEETINGS OF SHAREHOLDERS 8
12 VOTES OF SHAREHOLDERS 12
13 DIRECTORS 15
14 ELECTION AND REMOVAL OF DIRECTORS 16
15 ALTERNATE DIRECTORS 18
16 POWERS AND DUTIES OF DIRECTORS 19
17 DISCLOSURE OF INTEREST OF DIRECTORS 20
18 PROCEEDINGS OF DIRECTORS 21
19 EXECUTIVE AND OTHER COMMITTEES 23
20 OFFICERS 24
21 INDEMNIFICATION 25
22 DIVIDENDS 26
23 DOCUMENTS, RECORDS AND REPORTS 27
24 NOTICES 27
25 SEAL 29
26 PROHIBITIONS 29

  

i

 

 

1. INTERPRETATION

 

1.1 Definitions

 

In these articles, unless the context otherwise requires:

 

(1) “board of directors”, “directors” and “board” mean the directors or sole director of the Company for the time being;

 

(2) “Business Corporations Act” means the Business Corporations Act (British Columbia) from time to time in force and all amendments thereto and includes all regulations and amendments thereto made pursuant to the Act;

 

(3) “Interpretation Act” means the Interpretation Act (British Columbia) from time to time in force and all amendments thereto and includes all regulations and amendments thereto made pursuant to the Act;

 

(4) “legal personal representative” means the personal or other legal representative of the shareholder;

 

(5) “registered address” of a shareholder means the shareholder’s address as recorded in the central securities register;

 

(6) “seal” means the seal of the Company;

 

1.2 Business Corporations Act and Interpretation Act Definitions Applicable

 

The definitions in the Business Corporations Act and the definitions and rules of construction in the Interpretation Act, with the necessary changes, and unless the context requires otherwise, apply to these Articles as if the Articles were an enactment. If there is a conflict between a definition in the Business Corporations Act and a definition or rule in the Interpretation Act relating to a term in these Articles, the definition in the Business Corporations Act will prevail in relation to the use of the term in these Articles. If there is a conflict between these Articles and the Business Corporations Act, the Business Corporations Act will prevail

 

2. SHARES AND SHARE CERTIFICATES

 

2.1 Authorized Share Structure

 

The authorized share structure of the Company consists of shares of the class or classes and series, if any described in the Notice of Articles of the Company.

 

2.2 Use of Uncertificated Shares and Electronic Record Keeping Systems for Shares

 

Notwithstanding any other provisions in these Articles relating to the issuance, transfer or cancellation of physical share certificates or the maintenance of a physical record keeping system for the Company’s shares, the directors or the Company may authorize the issuance of uncertificated shares by the Company and permit the use by the Company of an electronic record keeping system for its shares subject to the provisions of the Business Corporations Act relating to uncertificated shares and electronic record keeping systems.

 

2.3 Form of Share Certificate

 

Each share certificate issued by the Company must comply with, and be signed as required by, the Business Corporations Act.

  

1

 

 

2.4 Shareholder Entitled to Share Certificate or Acknowledgement

 

Each shareholder is entitled, without charge, to (a) one share certificate representing the shares of each class or series of shares registered in the shareholder’s name or (b) a non-transferable written acknowledgement of the shareholder’s right to obtain such a share certificate, provided that in respect of a share held jointly by several persons, the Company is not bound to issue more than one share certificate and delivery of a share certificate or acknowledgment for a share to one of several joint shareholders or to one of the shareholders’ duly authorized agents will be sufficient for delivery to all.

 

2.5 Delivery by Mail

 

Any share certificate or non-transferable written acknowledgment of a shareholder’s right to obtain a share certificate may be by mail at the shareholder’s registered address and neither the Company nor any director, officer or agent of the Company is liable for any loss to the shareholder because the share certificate or acknowledgement is lost in the mail or stolen.

 

2.6 Replacement of Worn Out or Defaced Share Certificate or Acknowledgement

 

If the directors are satisfied that a share certificate or a non-transferable written acknowledgment of the shareholder’s right to obtain a share certificate is worn out or defaced, the director must, on production of the share certificate or acknowledgement, as the case may be, and on such other terms, if any, as the directors think fit:

 

(1) order the share certificate or acknowledgment, as the case may be, to be cancelled; and

 

(2) issue a replacement share certificate or acknowledgement, as the case may be.

 

2.7 Replacement of Lost, Stolen or Destroyed Share Certificate or Acknowledgement

 

If a share certificate or a non-transferable written acknowledgment of a shareholder’s right to obtain a share certificate is lost, stolen or destroyed, a replacement share certificate or acknowledgement, as the case may be, must be issued to the person entitled to that share certificate or acknowledgment, as the case may be, if the directors receive:

 

(1) proof satisfactory to the directors that the share certificate or acknowledgement is lost, stolen or destroyed; and

 

(2) any indemnity the directors consider adequate.

 

2.8 Splitting Share Certificates

 

If a shareholder surrenders a share certificate to the Company with a written request that the Company issue in the shareholder’s name two or more share certificates, each representing a specified number of shares and in the aggregate representing the same number of shares as the share certificate so surrendered, the Company must cancel the surrendered share certificate and issue replacement share certificates in accordance with that request.

 

2.9 Share Certificate Fee

 

There must be paid to the Company, in relation to the issue of any share certificate under Articles 2.5, 2.6 or 2.7, the amount, if any and which must not exceed the amount prescribed under the Business Corporations Act, determined by the directors.

 

2.10 Recognition of Trusts

 

Except as required by law or statute or these Articles, no person will be recognized by the Company as holding any share upon any trust, and the Company is not bound by or compelled in any way to recognize (even when having notice thereof) any equitable, contingent, future or partial interest in any share or fraction of a share or (except as by law or statute or these Articles provided or as ordered by a court of competent jurisdiction) any other rights in respect of any share except an absolute right to the entirety thereof in the shareholder.

 

2

 

 

3. ISSUE OF SHARES

 

3.1 Directors Authorized

 

Subject to the Business Corporations Act and the rights of the holders of issued shares of the Company, the Company may issue, allot, sell or otherwise dispose of the unissued shares, and issued shares held by the Company, at the times, to the persons, including directors, in the manner, on the terms and conditions and for the issue prices (including any premium at which shares with par value may be issued) that the directors may determine. The issue price for a share with par value must be equal to or greater than the par value of the share.

 

3.2 Commissions and Discounts

 

The Company may at any time, pay a reasonable commission or allow a reasonable discount to any person in consideration of that person purchasing or agreeing to purchase shares of the Company from the Company or any other person or procuring or agreeing to procure purchasers for shares of the Company.

 

3.3 Brokerage

 

The Company may pay such brokerage fee or other consideration as may be lawful for or in connection with the sale or placement of its securities.

 

3.4 Conditions of Issue

 

Except as provided for by the Business Corporations Act, no share may be issued until it is fully paid. A share is fully paid when:

 

(1) consideration is provided to the Company for the issue of the share by one or more of the following:

 

(a) past services performed for the Company;

 

(b) property;

 

(c) money; and

 

(2) the value of the consideration received by the Company equals or exceeds the issue price set for the share under Article 3.1.

 

3.5 Share Purchase Warrants and Rights

 

Subject to the Business Corporations Act, the Company may issue share purchase warrants, options and rights upon such terms and conditions as the directors determine, which share purchase warrants, options and rights may be issued alone or in conjunction with debentures, debenture stock, bonds, shares or any other securities issued or created by the Company from time to time.

 

4. SECURITIES REGISTERS

 

4.1 Central Securities Register

 

As required by and subject to the Business Corporations Act, the Company must maintain in British Columbia a central securities register. The directors may, subject to the Business Corporations Act, appoint an agent to maintain the central securities register. The directors may also appoint one or more agents, including the agent which keeps the central securities register, as transfer agent for its shares or any class or series of its shares, as the case may be, and the same or another agent as registrar for its shares or such class or series of its shares, as the case may be. The directors may terminate such appointment of any agent at any time and may appoint another agent in its place.

 

3

 

  

4.2. Closing Register

 

The Company must not at any time close its central securities register.

 

5. SHARE TRANSFERS

 

5.1 Registering Transfers

 

A transfer of a share of the Company must not be registered unless:

 

(1) a duly signed instrument of transfer in respect of the share has been received by the Company;

 

(2) if a share certificate has been issued by the Company in respect of the share to be transferred, that share certificate has been surrendered to the Company; and

 

(3) if a non-transferable written acknowledgement of the shareholder’s right to obtain a share certificate has been issued by the Company in respect of the share to be transferred, that acknowledgement has been surrendered to the Company;

 

5.2 Form of Instrument of Transfer

 

The instrument of transfer in respect of any share of the Company must be either in the form, if any, on the back of the Company’s share certificates or in any other form that may be approved by the directors from time to time.

 

5.3 Transferor Remains Shareholder

 

Except to the extent that the Business Corporations Act otherwise provides, a transferor of shares is deemed to remain the holder of the shares until the name of the transferee is entered in a securities register of the Company in respect of the transfer.

 

5.4 Signing of Instrument of Transfer

 

If a shareholder, or his or her duly authorized attorney, signs an instrument of transfer in respect of shares registered in the name of the shareholder, the signed instrument of transfer constitutes a complete and sufficient authority to the Company and its directors, officers and agents to register the number of shares specified in the instrument of transfer or specified in any other manner, or, if no number is specified, all the shares represented by the share certificates or set out in the written acknowledgements deposited with the instrument of transfer:

 

(1) in the name of the person named as transferee in that instrument of transfer; or

 

(2) if no person is named as transferee in that instrument of transfer, in the name of the person on whose behalf the instrument is deposited for the purpose of having the transfer registered.

 

5.5 Enquiry as to Title Not Required

 

Neither the Company nor any director, officer or agent of the Company is bound to inquire into title of the person named in the instrument of transfer as transferee or, if no person is named as transferee in the instrument of transfer, of the person on whose behalf the instrument is deposited for the purpose of having the transfer registered or is liable for any claim related to registering the transfer by the shareholder or by any intermediate owner or holder of the shares, of any interest in the shares, of any share certificate representing such shares or of any written acknowledgement of a right to obtain a share certificate for such shares. 

 

4

 

 

5.6 Transfer Fee

 

There must be paid to the Company, in relation to the registration of any transfer, the amount, if any, determined by the directors.

 

6. TRANSMISSION OF SHARES

 

6.1 Legal Personal Representative Recognized on Death

 

In the case of the death of a shareholder, the legal personal representative, or if the shareholder was a joint holder, the surviving joint holder, will be the only person recognized by the Company as having any title to the shareholder’s interest in the shares. Before recognizing a person as a legal personal representative, the director may require proof of appointment by a court of competent jurisdiction, a grant of letters probate, letters of administration or such other evidence or documents as the directors consider appropriate.

 

6.2 Rights of Legal Personal Representative

 

The legal personal representative of a shareholder has the same rights, privileges and obligations that attach to the shares held by the shareholder, including the right to transfer the shares in accordance with these Articles, provided the documents required by the Business Corporations Act and the directors have been deposited with the Company.

 

7. PURCHASE OF SHARES

 

7.1 Company Authorized to Purchase Shares

 

Subject to Article 7.2, the special rights and restrictions attached to the share of any class or series and the Business Corporations Act, the Company may, if authorized by the directors, purchase or otherwise acquire any of its shares at the price and upon the terms specified in such resolution.

 

7.2 Purchase When Insolvent

 

The Company must not make a payment or provide any other consideration to purchase or otherwise acquire any of its shares if there are reasonable grounds for believing that:

 

(1) the Company is insolvent; or

 

(2) making the payment or providing the consideration would render the Company insolvent.

 

7.3 Sale and Voting of Purchased Shares

 

If the Company retains a share redeemed, purchased or otherwise acquired by it, the Company may sell, gift or otherwise dispose of the share, but, while such share is held by the Company, it:

 

(1) is not entitled to vote the share at a meeting of its shareholders;

 

(2) must not pay a dividend in respect of the share; and

 

(3) must not make any other distribution in respect of the share.

  

5

 

 

8. BORROWING POWERS

 

The Company, if authorized by the directors, may:

 

(1) borrow money in the manner and amount, on the security, from the sources and on the terms and conditions that the directors consider appropriate;

 

(2) issue bonds, debentures and other debt obligations either outright or as security for any liability or obligation of the Company or any other person and at such discounts or premiums and on such other terms as the directors consider appropriate;

 

(3) guarantee the repayment of money by any other person or the performance of any obligation of any other person; and

 

(4) mortgage, charge, whether by way of specific or floating charge, grant a security interest in, or give other security on, the whole or any part of the present and future assets and undertaking of the Company.

 

9. ALTERATIONS

 

9.1 Alteration of Authorized Share Structure

 

Subject to Article 9.2 and the Business Corporations Act, the Company may by ordinary resolution:

 

(1) create one or more classes or series of shares or, if none of the shares of a class or series of shares are allotted or issued, eliminate that class or series of shares;

 

(2) increase, reduce or eliminate the maximum number of shares that the Company is authorized to issue out of any class or series of shares or establish a maximum number of shares that the Company is authorized to issue out of any class or series of shares for which no maximum is established;

 

(3) subdivide or consolidate all or any of its unissued, or fully paid issued, shares;

 

(4) if the Company is authorized to issue shares of a class of shares with par value:

 

(a) decrease the par value of those shares; or

 

(b) if none of the shares of that class of shares are allotted or issued, increase the par value of those shares;

 

(5) change all or any of its unissued, or fully paid issued, shares with par value into shares without par value or any of its unissued shares without par value into shares with par value;

 

(6) alter the identifying name of any of its shares; or

 

(7) otherwise alter its shares or authorized share structure when required or permitted to do so by the Business Corporations Act.

 

9.2 Special Rights and Restrictions

 

The Company may be special resolution:

 

(1) create special rights or restrictions for, and attach those special rights or restrictions to, the shares of any class or series of shares, whether or not any or all of those shares have been issued; or

 

(2) vary or delete any special rights or restrictions attached to the shares of any class or series of shares, whether or not any or all of those shares have been issued.

 

6

 

 

9.3 Change of Name

 

The Company may by directors’ resolution or ordinary resolution authorize an alteration of its Notice of Articles in order to change its name.

 

9.4 Other Alterations

 

If the Business Corporations Act does not specify the type of resolution and these Articles do not specify another type of resolution, the Company may by ordinary resolution alter these Articles.

 

10. MEETINGS OF SHAREHOLDERS

 

10.1 Annual General Meetings

 

Unless an annual general meeting is deferred or waived in accordance with the Business Corporations Act, the Company must hold its first annual general meeting within 18 months after the date on which it was incorporated or otherwise recognized, and after that must hold an annual general meeting at least once in each calendar year and not more than 15 months after the last annual reference date at such time and place as may be determined by the directors.

 

10.2 Resolution Instead of Annual General Meeting

 

If all the shareholders who are entitled to vote at an annual general meeting consent by a unanimous resolution to all of the business that is required to be transacted at that annual general meeting, the annual general meeting is deemed to have been held on the date of the unanimous resolution. The shareholders must, in any unanimous resolution passed under this Article 10.2, select as the Company’s annual reference date, a date that would be appropriate for the holding of the applicable annual general meeting.

 

10.3 Calling of Meetings of Shareholders

 

The directors may, whenever the directors think fit, call a meeting of shareholders.

 

10.4 Location of Meeting

 

A general meeting of the Company may be held anywhere in North America, as determined by the directors.

 

10.5 Notice of Meeting of Shareholders

 

The Company must send notice of the date, time and location of any meeting of shareholders, in the manner provided in these Articles, or in such other manner, if any, as may be prescribed by ordinary resolution (whether previous notice of the resolution has been given or not), to each shareholder entitled to attend the meeting, to each director of the Company, unless these Articles otherwise provide, at least the following number of days before the meeting:

 

(1) if and for so long as the Company is a public company, twenty-one days;

 

(2) otherwise, ten days.

 

7

 

 

10.6 Record Date for Notice

 

The directors may set a date as the record date for the purpose of determining shareholders entitled to notice of any meeting of shareholders. The record date must not precede the date on which the meeting is to be held by more than two months or, in the case of a general meeting requisitioned by shareholders under the Business Corporations Act, by more than four months. The record date must not precede the date on which the meeting is held by fewer than:

 

(1) if and for so long as the Company is a public company, twenty-one days;

 

(2) otherwise ten days.

 

10.7 Record Date for Voting

 

The directors may set a date as the record date for the purpose of determining shareholders entitled to vote at any meeting of shareholders. The record date must not precede the date on which the meeting is to be held by more than two months, or , in the case of a general meeting requisitioned by shareholders under the Business Corporations Act, by more than four months. If no record date is set, the record date is 5:00 p.m. on the date immediately preceding the first date on which the notice is sent or, if no notice is sent, the beginning of the meeting.

 

10.8 Failure to Give Notice and Waiver of Notice

 

The accidental omission to send notice of any meeting of shareholders to, or the non-receipt of any notice by, any of the persons entitled to notice does not invalidate any proceedings at that meeting. Any persons entitled to notice of a meeting of shareholders may, in writing or otherwise, waive or reduce the period of notice of such meeting.

 

10.9 Notice of Special Business at Meetings of Shareholders

 

If a meeting of shareholders is to consider special business within the meaning of Article 11.1, the notice of meeting must:

 

(1) state the general nature of the special business; and

 

(2) if the special business includes considering, approving, ratifying, adopting or authorizing any document or the signing of or giving of effect to any document, have attached to it a copy of the document or state that a copy of the document will be available for inspection by shareholders:

 

(a) at the Company’s records office, or at such other reasonably accessible location in British Columbia as is specified in the notice; and

 

(b) during statutory business hours on any one or more specified days before the day set for the holding of the meeting.

 

10.10 Meetings by Telephone or Other Communications Medium

 

A shareholder may participate in a meeting of the shareholders in person or by telephone, if all shareholders participating in the meeting, whether in person or by telephone or other communications medium, are able to communicate with each other and if all shareholders who wish to participate in the meeting agree to such participation. A shareholder who participates in a meeting in a manner contemplated by this Article 10.10 is deemed for all purposes of the Business Corporations Act and these Articles to be present at the meeting and to have agreed to participate in that manner,

 

11 PROCEEDINGS AT MEETINGS OF SHAREHOLDERS

 

11.1 Special Business

 

At a meeting of shareholders, the following business is special business:

 

(1) at a meeting of shareholders that is not an annual general meeting, all business is special business except business relating to the conduct of or voting at the meeting;

  

8

 

 

(2) at an annual general meeting, all business is special business except for the following:

 

(a) business relating to the conduct of or voting at the meeting;

 

(b) consideration of any financial statements of the Company presented to the meeting;

 

(c) consideration of any reports of the directors or auditor;

 

(d) the setting or changing of the number of directors;

 

(e) the election or appointment of directors;

 

(t) the appointment of an auditor;

 

(g) the setting of the remuneration of an auditor;

 

(h) business arising out of a report of the directors not requiring the passing of a special resolution or an exceptional resolution;

 

(i) any other business which, under these Articles or the Business Corporations Act, may be transacted at a meeting of shareholders without prior notice of the business being given to the shareholders.

 

11.2 Special Majority

 

The majority of votes required for the Company to pass a special resolution at a meeting of shareholders is two-thirds, of the votes cast on the resolution.

 

11.3 Quorum

 

Subject to the special rights and restrictions attached to the shares of any class or series of shares, the quorum for the transaction of business at a meeting of shareholders is two persons who are, or represent by proxy, shareholders holding, in the aggregate, at least five percent of the issued shares entitled to be voted at the meeting.

 

11.4 One Shareholder May Constitute Quorum

 

If there is only one shareholder entitled to vote at a meeting of shareholders:

 

(1) the quorum is one person who is, or who represents by proxy, that shareholder, and

 

(2) that shareholder, present in person or by proxy, may constitute the meeting.

 

11.5 Other Persons May Attend

 

The directors, the president (if any), the secretary (if any), the assistant secretary (if any), the auditor of the Company and any other persons invited by the directors are entitled to attend any meeting of shareholders, but if any of those persons does attend a meeting of shareholders, that person is not to be counted in the quorum and is not entitled to vote at the meeting unless that person is a shareholder or proxy holder entitled to vote at the meeting.

 

11.6 Requirement of Quorum

 

No business, other than the election of a chair of the meeting and the adjournment of the meeting, may be transacted at any meeting of shareholders unless a quorum of shareholders entitled to vote is present at the commencement of the meeting, but such quorum need not be present throughout the meeting. 

 

9

 

 

11.7 Lack of Quorum

 

If, within 1/2 hour from the time set for the holding of a meeting of shareholders, a quorum is not present:

 

(1) in the case of a general meeting requisitioned by shareholders, the meeting is dissolved, and

 

(2) in the case of any other meeting of shareholders, the meeting stands adjourned to the same day in the next week at the same time and place.

 

11.8 Lack of Quorum at Succeeding Meeting

 

If, at the meeting to which the meeting referred to in Article 11.8(2) was adjourned, a quorum is not present within 1/2 hour from the time set for the holding of the meeting, the person or persons present and being, or representing by proxy, one or more shareholders entitled to attend and vote at the meeting constitute a quorum.

 

11.9 Chair

 

The following individual is entitled to preside as chair at a meeting of shareholders:

 

(1) the chair of the board, if any; or

 

(2) if the chair of the board is absent or unwilling to act as chair of the meeting, the president, if any.

 

11.10 Selection of Alternate Chair

 

If, at any meeting of shareholders, there is no chair of the board or president present within fifteen minutes after the time set for holding the meeting, or if the chair of the board and the president have advised the secretary, if any, or any director present at the meeting, that the chair of the board and the president will not be present at the meeting, the directors present must choose one of their number to be chair of the meeting or if all of the directors present decline to take the chair or fail to so choose or if no director is present, the shareholders entitled to vote at the meeting who are present in person or by proxy may choose any person present at the meeting to chair the meeting.

 

11.11 Adjournments

 

The chair of a meeting of shareholders may, and if so directed by the meeting must, adjourn the meeting from time to time and from place to place, but no business may be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment took place.

 

11.12 Notice of Adjourned Meeting

 

It is not necessary to give any notice of an adjourned meeting or of the business to be transacted at an adjourned meeting of shareholders except that, when a meeting is adjourned for thirty days or more, notice of the adjourned meeting must be given as in the case of the original meeting.

 

11.13 Decision by Show of Hands or Poll

 

Every motion put to a vote at a meeting of shareholders will be decided on a show of hand unless a poll, before or on the declaration of the result of the vote by show of hands, is directed by the chair or demanded by at least one shareholder entitled to vote who is present in person or by proxy.

 

11.14 Declaration of Result

 

The chair of a meeting of shareholders must declare to the meeting the decision on every question in accordance with the result of the show of hands or the poll, as the case may be, and that decision must be entered in the minutes of the meeting. A declaration of the chair that a resolution is carried by the necessary majority or is defeated is, unless a poll is directed by the chair or demanded under Article 11.13, conclusive evidence without proof of the number or proportion of the votes recorded in favour of or against the resolution.

 

10

 

 

11.15 Motion Need Not be Seconded

 

No motion proposed at a meeting of shareholders need be seconded unless the chair of the meeting rules otherwise, and the chair of any meeting of shareholders is entitled to propose or second a motion.

 

11.16 Casting Vote

 

In case of an equality of votes, the chair of a meeting of shareholders does not, either on a show of hands or on a poll, have a second or casting vote in addition to the vote or votes to which the chair may be entitled as a shareholder.

 

11.17 Manner of Taking Poll

 

Subject to Article 11.19, if a poll is duly demanded at a meeting of shareholders:

 

(1) the poll must be taken:

 

(a) at the meeting, or within seven days after the date of the meeting, as the chair of the meeting directs; and

 

(b) in the manner, at the time and at the place that the chair of the meeting directs.

 

(2) the result of the poll is deemed to be the decision of the meeting at which the poll is demanded; and

 

(3) the demand for the poll may be withdrawn by the person who demanded it.

 

11.18 Demand for Poll on Adjournment

 

A poll demanded at a meeting of shareholders on a question of adjournment must be taken immediately at the meeting.

 

11.19 Chair Must Resolve Dispute

 

In the case of any dispute as to the admission or rejection of a vote given on a poll, the chair of a meeting of the shareholders must determine the dispute, and his or her determination made in good faith is final and conclusive.

 

11.20 Casting of Votes

 

On a poll, a shareholder is not entitled to more than one vote by which a chair of a meeting of shareholders is elected.

 

11.21 Poll not Available in respect of Election of Chair

 

No poll may be demanded in respect of the vote by which a chair of a meeting of shareholders is elected.

 

11.22 Demand for Poll Not to Prevent Continuance of Meeting

 

The demand for a poll at a meeting of shareholders does not, unless the chair of the meeting so rules, prevent the continuation of a meeting for the transaction of any business other than the question on which a poll has been demanded.

 

11.23 Retention of Ballots and Proxies

 

The Company must, for at least three months after a meeting of shareholders, keep each ballot cast on a poll and each proxy at the meeting, and, during that period, make such ballots and proxies available for inspection during normal business hours by any shareholder or proxyholder entitled to vote at the meeting. At the end of such three-month period, the Company may destroy such ballots and proxies.

 

11

 

  

12 VOTES OF SHAREHOLDERS

 

12.1 Number of Votes by Shareholder or by Shares

 

Subject to any special rights or restrictions attached to any shares and to the restrictions imposed on joint shareholders under Article 12.3:

 

(1) on a vote by show of hands, every person present who is a shareholder or proxy holder and entitled to vote on the matter has one vote; and

 

(2) on a poll, every shareholder entitled to vote on the matter has one vote in respect of each share entitled to be voted on the matter and held by that shareholder and may exercise that vote either in person or by proxy.

 

12.2 Votes of Persons in Representative Capacity

 

A person who is not a shareholder may vote at a meeting of shareholders, whether on a show of hands or on a poll, and may appoint a proxy holder to act at the meeting, if, before doing so, the person satisfies the chair of the meeting, or the directors, that the person is a legal personal representative or a trustee in bankruptcy for a shareholder who is entitled to vote at the meeting.

 

12.3 Votes by Joint Holders

 

If there are joint shareholders registered in respect of any share:

 

(1) any one of the joint shareholders may vote at any meeting of shareholders, either personally or by proxy, in respect of the share as if that joint shareholder were solely entitled to it; or

 

(2) if more than one of the joint shareholders is present at any meeting of shareholders, personally or by proxy, and more than one of the joint shareholders votes in respect of that share, then only the vote of the joint shareholder present whose name stands first in the central securities register in respect of the share will be counted.

 

12.4 Legal Personal Representatives as Joint Shareholders

 

Two or more legal personal representatives of a shareholder in whose sole name any share is registered are, for the purposes of Article 12.3, deemed to be joint shareholders.

 

12.5 Representative of a Corporate Shareholder

 

If a corporation, that is not a subsidiary of the Company, is a shareholder, that corporation may appoint a person to act as its representative at any meeting of shareholders of the Company, and:

 

(1) for that purpose, the instrument appointing a representative must:

 

(a) be received at the registered office of the Company or at any other place specified, in the notice calling the meeting, for the receipt of proxies, at least the number of business days specified in the notice for the receipt of proxies, or if no number of days is specified, two business days before the day set for the holding of the meeting; or

 

(b) be provided at the meeting, to the chair of the meeting or to a person designated by the chair of the meeting.

 

12

 

  

(2) if a representative is appointed under this Article 12.5:

 

(a) the representative is entitled to exercise in respect of and at that meeting the same rights on behalf of the corporation that the representative represents as that corporation could exercise if it were a shareholder who is an individual, including, without limitation, the right to appoint a proxy holder; and

 

(b) the representative, if present at the meeting, is to be counted for the purpose of forming a quorum and is deemed to be a shareholder present in person at the meeting.

 

Evidence of the appointment of any such representative may be sent to the Company by written instrument, fax or any other method of transmitting legibly recorded messages.

 

12.6 Proxy Provisions do not Apply to Public Companies

 

Articles 12.7 to 12.15 apply to the Company only insofar as they are not inconsistent with any applicable securities legislation and any regulations and rules made and promulgated under such legislation and all administrative policy statements, blanket orders and rulings, notices and other administrative directions issued by securities commissions or similar authorities appointed under that legislation.

 

12.7 Appointment of Proxy Holders

 

Every shareholder of the Company, including a corporation that is a shareholder but not a subsidiary of the Company, entitled to vote at a meeting of shareholders of the Company may, by proxy, appoint one or more (but not more than five) proxy holders to attend and act at the meeting in the manner, to the extent and with the powers conferred by the proxy.

 

12.8 Alternate Proxy Holders

 

A shareholder may appoint one or more proxy holders to act in the place of an absent proxy holder.

 

12.9 When Proxy Holder Need Not be Shareholder

 

A person must not be appointed as proxy holder unless the person is a shareholder, although a person who is not a shareholder may be appointed as a proxy holder if:

 

(1) the person appointing the proxy holder is a corporation or a representative of a corporation appointed under Article 12.5;

 

(2) the Company has at the time of the meeting for which the proxy holder is to be appointed only one shareholder entitled to vote at the meeting; or

 

(3) the shareholders present in person or by proxy at and entitled to vote at the meeting for which the proxy holder is to be appointed, by a resolution on which the proxy holder is not entitled to vote but in respect of which the proxy holder is to be counted in the quorum, permit the proxy holder to attend and vote at the meeting.

 

12.10 Deposit of Proxy

 

A proxy for a meeting of shareholders must:

 

(1) be received at the registered office of the Company or at any other place specified, in the notice calling the meeting, for the receipt of proxies, at least the number of business days specified in the notice, or if no number of days is specified, two business days before the day set for the holding of the meeting; or

 

13

 

 

(2) unless the notice provides otherwise, be provided, at the meeting, to the chair of the meeting or to a person designated by the chair of the meeting.

 

A proxy may be sent to the Company by written instrument, fax or any other method of transmitting legibly recorded messages.

 

12.11 Validity of Proxy Vote

 

A vote given in accordance with the terms of a proxy is valid notwithstanding the death or incapacity of the shareholder giving the proxy and despite the revocation of the proxy or the revocation of the authority under which the proxy is given, unless notice in writing of that death, incapacity or revocation is received:

 

(1) at the registered office of the Company, at any time up to and including the last business day before the day set for the holding of the meeting at which the proxy is to be used; or

 

(2) by the chair of the meeting, before the vote is taken.

 

12.12 Form of Proxy

 

A proxy, whether for a specified meeting or otherwise, must be either in the following form or in any other form approved by the directors or the chair of the meeting:

 

[name of the company]

 

(the “Company”)

 

The undersigned, being a shareholder of the Company, hereby appoint [name] or, failing that person, [name], as proxy holder for the undersigned to attend, act and vote for and on behalf of the undersigned at the meeting of shareholders of the Company to be held on [month, day, year] and at any adjournment of that meeting.

 

Number of shares in respect of which this proxy is given (if no number is specified, then this proxy if given in respect of all shares registered in the name of the shareholder): _________________________

 

Signed [month, day, year]

 

____________________________________ 

Signature of shareholder

 

 

____________________________________

Name of shareholder – [printed]

 

12.13 Revocation of Proxy

 

Subject to Article 12.14, every proxy may be revoked by an instrument in writing that is:

 

(1) received at the registered office of the Company at any time up to and including the last business day before the day set for the holding of the meeting at which the proxy is to be used; or

 

(2) provided, at the meeting, to the chair of the meeting.

 

14

 

  

12.14 Revocation of Proxy Must be Signed

 

An instrument referred to in Article 12.13 must be signed as follows:

 

(1) if the shareholder for whom the proxy holder is appointed is an individual, the instrument must be signed by the shareholder or his or her legal personal representative or trustee in bankruptcy;

 

(2) if the shareholder for whom the proxy holder is appointed is a corporation, the instrument must be signed by the corporation or by a representative appointed for the corporation under Article 12.5.

 

12.15 Production of Evidence of Authority to Vote

 

The chair of any meeting of shareholders may, but need not, inquire into the authority of any person to vote at the meeting and may, but need not, demand from that person production of evidence as to the existence of the authority to vote.

 

13 DIRECTORS

 

13.1 First Directors; Number of Directors

 

The first directors are the persons designated as directors of the Company in the Notice of Articles that applies to the Company when it is recognized under the Business Corporations Act. The number of directors, excluding additional directors appointed under Article 14.8, is set at:

 

(1) subject to paragraphs (2) and (3), the number of directors that is equal to the number of the Company’s first directors;

 

(2) if the Company is a public company, the greater of three and the most recently set of:

 

(a) the number of directors set by ordinary resolution (whether or not previous notice of the resolution was given); and

 

(b) the number of directors set under Article 14.4;

 

(3) if the Company is not a public company, the most recently set of:

 

(a) the number of directors set by ordinary resolution (whether or not previous notice of the resolution was given); and

 

(b) the number of directors set under Article 14.4;

 

13.2 Change in Number of Directors

 

If the number of directors is set under Articles 13.1(2)(a) or 13.1(3)(a):

 

(1) the shareholders may elect or appoint the directors needed to fill any vacancies in the board of directors up to that number;

 

(2) if the shareholders do not elect or appoint the directors needed to fill any vacancies in the board of directors up to that number contemporaneously with the setting of that number, then the directors may appoint, or the shareholders may elect or appoint, directors to fill those vacancies.

 

13.3 Directors’ Acts Valid Despite Vacancy

 

An act or proceeding of the directors is not invalid merely because fewer than the number of directors set or otherwise required under these Articles is in office.

 

15

 

 

13.4 Qualifications of Directors

 

A director is not required to hold a share in the capital of the Company as qualification for his or her office but must be qualified as required by the Business Corporations Act to become, act or continue to act as a director.

 

13.5 Remuneration of Directors

 

The directors are entitled to the remuneration for acting as directors, if any, as the directors may from time to time determine. If the directors so decide, the remuneration of the directors, if any, will be determined by the shareholders. That remuneration may be in addition to any salary or other remuneration paid to any officer or employee of the Company as such, who is also a director.

 

13.6 Reimbursement of Expenses of Directors

 

The Company must reimburse each director for the reasonable expenses that he or she may incur in and about the business of the Company.

 

13.7 Special Remuneration for Directors

 

If any director performs any professional or other services for the Company that in the opinion of the directors are outside the ordinary duties of a director, or if any director is otherwise specially occupied in or about the Company’s business, he or she may be paid remuneration fixed by the directors, or, at the option of that director, fixed by ordinary resolution, and such remuneration may be either in addition to, or in substitution for, any other remuneration that he or she may be entitled to receive.

 

13.8 Gratuity, Pension or Allowance on Retirement of Director

 

Unless otherwise determined by ordinary resolution, the directors on behalf of the Company may pay a gratuity or pension or allowance on retirement to any director who held any salaried office or place of profit with the Company or to his or her spouse or dependants and may make contributions to any fund and pay premium for the purchase or provision of any such gratuity, pension or allowance.

 

14 ELECTION AND REMOVAL OF DIRECTORS

 

14.1 Election at Annual General Meeting

 

At every annual general meeting and in every unanimous resolution contemplated by Article 10.2:

 

(1) the shareholders entitled to vote at the annual general meeting for the election of directors must elect, or in the unanimous resolution appoint, a board of directors consisting of the number of directors for the time being set under these Articles; and

 

(2) all the directors cease to hold office immediately before the election or appointment of directors under paragraph (1), but are eligible for re-election or re-appointment.

 

14.2 Consent to be a Director

 

No election, appointment or designation of an individual as a director is valid unless:

 

(1) that individual consents to be a director in the manner provided for in the Business Corporations Act;

 

(2) that individual is elected or appointed at a meeting at which the individual does not refuse, at the meeting, to be a director; or

 

(3) with respect to first directors, the designation is otherwise valid under the Business Corporations Act.

 

16

 

 

14.3 Failure to Elect or Appoint Directors

 

If:

 

(1) the Company fails to hold an annual general meeting, and all the shareholders who are entitled to vote at an annual general meeting fail to pass the unanimous resolution contemplated by Article 10.2, on or before the date by which the annual general meeting is required to be held under the Business Corporations Act; or

 

  (2) the shareholders fail, at the annual general meeting or in the unanimous resolution contemplated by Article 10.2, to elect or appoint any directors.

 

then each of the directors then in office continues to hold office until the earlier of:

 

(3) the date on which his or her successor is elected or appointed; and

 

(4) the date on which he or she otherwise ceases to hold office under the Business Corporations Act or these Articles.

 

14.4 Places of Retiring Directors Not Filled

 

If, at any meeting of shareholders at which there should be an election of directors, the places of any of the retiring directors are not filled by that election, those retiring directors who are not reelected and who are asked by the newly elected directors to continue in office will, if willing to do so, continue in office to complete the number of directors for the time being set pursuant to these Articles until further new directors are elected at a meeting of shareholders convened for that purpose. If any such election or continuance of directors does not result in the election or continuance of the number of directors for the time being set pursuant to these Article, the number of directors of the Company is deemed to be set at the number of directors actually elected or continued in office.

 

14.5 Directors May Fill Casual Vacancies

 

Any casual vacancy occurring in the board of directors may be filled by the directors.

 

14.6 Remaining Directors Power to Act

 

The directors may act notwithstanding any vacancy in the board of directors, but if the Company has fewer directors in office than the number set pursuant to these Articles as the quorum of directors, the directors may only act for the purpose of appointing directors up to that number or of summoning a meeting of shareholders for the purpose of filling any vacancies on the board of directors or, subject to the Business Corporations Act, for any other purpose.

 

14.7 Shareholders May Fill Vacancies

 

If the Company has no directors or fewer directors in office than the number set pursuant to these Articles as the quorum of directors, the shareholders may elect or appoint directors to fill any vacancies on the board of directors.

 

14.8 Additional Directors

 

Notwithstanding Article 13.1 and 13.2, between annual general meetings or unanimous resolutions, contemplated by Article 10.2, the directors may appoint one or more additional directors, but the number of additional directors appointed under this Article 14.8 must not at any time exceed:

 

(1) one-third of the number of first directors, if, at the time of the appointments, one or more of the first directors have not yet completed their first term of office; or

 

17

 

 

(2) in any other case, one-third of the number of the current directors who were elected or appointed as directors other than pursuant to this Article 14.8.

 

Any director so appointed ceases to hold office immediately before the next election or appointment of directors under Article 14.1(1), but is eligible for re-election or re-appointment.

 

14.9 Ceasing to be a Director

 

A director ceases to be a director when:

 

(1) the term of office of the director expires;

 

(2) the director dies;

 

(3) the director resigns as a director by notice in writing provided to the Company or a lawyer for the Company; or

 

(4) the director is removed from office pursuant to Articles 14.10 or 14.11.

 

14.10 Removal of Director by Shareholders

 

The Company may remove any director before the expiration of his or her term of office by ordinary resolution. In that event, the shareholders may elect, or appoint by ordinary resolution, a director to fill the resulting vacancy. If the shareholders do not elect or appoint a director to fill the resulting vacancy contemporaneously with the removal, then the directors may appoint or the shareholders may elect, or appoint by ordinary resolution, a director to fill that vacancy.

 

14.11 Removal of Director by Directors

 

The directors may remove any director before the expiration of his or her term of office if the director is convicted of an indictable offence, or if the director ceases to be qualified to act as a director of a company and does not promptly resign, and the directors may appoint a director to fill the resulting vacancy.

 

15 ALTERNATE DIRECTORS

 

15.1 Appointment of Alternate Director

 

Any director (an “appointor”) may by notice in writing received by the Company appoint any person (an “appointee”) who is qualified to act as a director to be his or her alternate to act in his or her place at meetings of the directors or committees of the directors at which the appointor is not present unless (in the case of an appointee who is not a director) the directors have reasonably disapproved the appointment of such person as an alternate director and have given notice to that effect to his or her appointor within a reasonable time after the notice of appointment is received by the Company.

 

15.2 Notice of Meetings

 

Every alternate director so appointed is entitled to notice of meetings of the directors and of committees of the directors of which his or her appointor is a member and to attend and vote as a director at any such meetings at which his or her appointor is not present.

 

18

 

 

15.3 Alternate for More than One Director Attending Meetings

 

A person may be appointed as an alternate director by more than one director, and an alternate director:

 

(1) will be counted in determining the quorum for a meeting of directors once for each of his or her appointors and, in the case of an appointee who is also a director, once more in that capacity;

 

(2) has a separate vote at a meeting of directors for each of his or her appointors and, in the case of an appointee who is also a director, an additional vote in that capacity;

 

(3) will be counted in determining the quorum for a meeting of a committee of directors once for each of his or her appointors who is a member of that committee and, in the case of an appointee who is also a member of that committee as a director, once more in that capacity;

 

(4) has a separate vote at a meeting of a committee of directors for each of his or her appointors who is a member of that committee and, in the case of an appointee who is also a member of that committee as a director, an additional vote in that capacity.

 

15.4 Consent Resolutions

 

Every alternate director, if authorized by the notice appointing him or her, may sign in place of his or her appointor any resolutions to be consented to in writing.

 

15.5 Alternate Director Not an Agent

 

Every alternate director is deemed not to be the agent of his or her appointor.

 

15.6 Revocation of Appointment of Alternate Director

 

An appointor may at any time, by notice in writing received by the Company, revoke the appointment of an alternate director appointed by him or her.

 

15.7 Ceasing to be an Alternate Director

 

The appointment of an alternate director ceases when:

 

  (1) his or her appointor ceases to be a director and is not promptly re-elected or re-appointed;

 

  (2) the alternate director dies;

 

  (3) the alternate director resigns as an alternate director by notice in writing provided to the Company or a lawyer for the Company;

 

  (4) the alternate director ceases to be qualified to act as a director; or

 

  (5) his or her appointor revokes the appointment of the alternate director.

 

15.8 Remuneration of Expenses of Alternate Director

 

The Company may reimburse an alternate director for the reasonable expenses that would be properly reimbursed if he or she were a director, and the alternate director is entitled to receive from the Company, such proportion, if any, of the remuneration otherwise payable to the appointor as the appointor may from time to time direct.

 

16 POWERS AND DUTIES OF DIRECTORS

 

16.1 Powers of Management

 

The directors, must, subject to the Business Corporations Act and these Articles, manage or supervise the management of the business and affairs of the Company and have the authority to exercise all such powers of the Company as are not, by the Business Corporations Act or by these Articles, required to be exercised by the shareholders of the Company.

 

19

 

 

16.2 Appointment of Attorney of Company

 

The directors may from time to time, by power of attorney or other instrument, under seal if so required by law, appoint any person to be the attorney of the Company for such purposes, and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the directors under these Articles and excepting the power to fill vacancies in the board of directors, to remove a director, to change the membership of, or fill vacancies in, any committee of the directors, to appoint or remove officers appointed by the directors and to declare dividends) and for such period, and with such remuneration and subject to such conditions as the directors may think fit. Any such power of attorney may contain such provisions for the protection or convenience of persons dealing with such attorney as the directors think fit. Any such attorney may be authorized by the directors to sub-delegate all or any of the powers, authorities and discretions for the time being vested in him or her.

 

17 DISCLOSURE OF INTEREST OF DIRECTORS

 

17.1 Obligation to Account for Profits

 

A director or senior officer who holds a disclosable interest (as that term is defined in the Business Corporations Act) in a contract or transaction into which the Company has entered or proposes to enter is liable to account to the Company for any profit that accrues to the director or senior officer under or as a result of the contract or transaction only if and to the extent provided in the Business Corporations Act.

 

17.2 Restrictions on Voting by Reason of Interest

 

A director who holds a disclosable interest in a contract or transaction into which the Company has entered or proposes to enter is not entitled to vote on any directors’ resolution to approve that contract or transaction, unless all the directors have disclosable interest in that contract or transaction, in which case any or all of those directors may vote on such resolution.

 

17.3 Interested Director Counted in Quorum

 

A director who holds a disclosable interest in a contract or transaction into which the Company has entered or proposes to enter and who is present at the meeting of directors at which the contract or transaction is considered for approval may be counted in the quorum at the meeting whether or not the director votes on any or all of the resolutions considered at the meeting.

 

17.4 Disclosure of Conflict of Interest or Property

 

A director or senior officer who holds any office or possesses any property, right or interest that could result directly or indirectly, in the creation of a duty or interest that materially conflicts with that individual’s duty or interest as a director or senior officer, must disclose the nature and extent of the conflict as required by the Business Corporations Act.

 

17.5 Director Holding Other Office in the Company

 

A director may hold any office or place of profit with the Company, other than the office of auditor of the Company, in addition to his or her office of director for the period and on the terms (as to remuneration or otherwise) that the directors may determine.

 

20

 

 

17.6 No Disqualification

 

No director or intended director is disqualified by his or her office from contracting with the Company either with regard to the holding of any office or place of profit the director holds with the Company or as vendor, purchaser or otherwise, and no contract or transaction entered into by or on behalf of the Company in which a director is in any way interested is liable to be voided for that reason.

 

17.7 Professional Services by Director or Officer

 

Subject to the Business Corporations Act, a director or officer, or any person in which a director or officer has an interest, may act in a professional capacity for the Company, except as auditor of the Company, and the director or officer or such person is entitled to remuneration for professional services as if that director or officer were not a director or officer.

 

17.8 Director of Officer in Other Corporations

 

A director or officer may be or become a director, officer or employee of, or otherwise interested in, any person in which the Company may be interested as a shareholder or otherwise, and subject to the Business Corporations Act, the director or officer is not accountable to the Company for any remuneration or other benefits received by him or her as director, officer or employee of, or from his or her interest in, such other person.

 

18 PROCEEDINGS OF DIRECTORS

 

18.1 Meetings of Directors

 

The directors may meet together for the conduct of business, adjourn and otherwise regulate their meetings as they think fit, and meetings of the directors held at regular intervals may be held at the place, at the time and on the notice, if any, as the directors may from time to time determine.

 

18.2 Voting at Meetings

 

Questions arising at any meeting of directors are to be decided by a majority of votes and, in the case of an equality of votes, the chair of the meeting does not have a second or casting vote.

 

18.3 Chair of Meetings

 

The following individual is entitled to preside as chair at a meeting of directors:

 

(1) the chair of the board, if any;

 

(2) in the absence of the chair of the board, the president, if any, if the president is a director; or

 

(3) any other director chosen by the directors if:

 

(a) neither the chair of the board nor the president, if a director, is present at the meeting within 15 minutes after the time set for holding the meeting;

 

(b) neither the chair of the board nor the president, if a director, is willing to chair the meeting; or

 

(c) the chair of the board and the president, if a director, have advised the secretary, if any, or any other director, that they will not be present at the meeting;

 

18.4 Meetings by Telephone or Other Communications Medium

 

A director may participate in a meeting of the directors or of any committee of the directors by a communications medium other than telephone if all directors participating in the meeting, whether in person or by telephone or other communications medium, are able to communicate with each other and if all directors who wish to participate in the meeting agree to such participation. A director who participates in a meeting in a manner contemplated by this Article 18.4 is deemed for all purposes of the Business Corporations Act and these Articles to be present at the meeting and to have agreed to participate in that manner,

 

21

 

 

18.5 Calling of Meetings

 

A director may, and the secretary or an assistant secretary of the Company if any, on the request of a director must, call a meeting of the directors at any time.

 

18.6 Notice of Meetings

 

Other than for meetings held at regular intervals as determined by the directors pursuant to Article 18.1, reasonable notice of each meeting of the directors, specifying the place, day and time of that meeting must be given to each of the directors and the alternate directors by any method set out in Article 24.1 or orally or by telephone.

 

18.7 When Notice not Required

 

It is not necessary to give notice of a meeting of the directors to a director or an alternate director if:

 

(1) the meeting is to be held immediately following a meeting of shareholders at which that director was elected or appointed, or is the meeting of the directors at which that director is appointed; or

 

(2) the director or alternate director, as the case may be, has waived notice of the meeting.

 

18.8 Meeting Valid Despite Failure to Give Notice

 

The accidental omission to give notice of any meeting of directors to, or the non-receipt of any notice by, any director or alternate director, does not invalidate any proceedings at that meeting.

 

18.9 Waiver of Notice of Meetings

 

Any director or alternate director may send to the Company a document signed by him or her waiving notice of any past, present or future meeting or meetings of the directors and may at any time withdraw that waiver with respect to meetings held after that withdrawal. After sending a waiver with respect to all future meetings and until that waiver is withdrawn, no notice of any meeting of the directors need be given to that director and, unless the director otherwise requires by notice in writing to the Company, to his or her alternate director, and all meetings of the directors so held are deemed not to be improperly called or constituted by reason of notice not having been given to such director or alternate director.

 

18.10 Quorum

 

The quorum necessary for the transaction of the business of the directors may be set by the directors and, if not so set, is deemed to be set at two directors or, if the number of directors is set at one, is deemed to be set at one director, and that director may constitute a meeting.

 

18.11 Validity of Acts Where Appointment Defective

 

Subject to the Business Corporations Act, an act of a director or officer is not invalid merely because of an irregularity in the election or appointment or a defect in the qualification of that director or officer.

 

18.12 Consent Resolution in Writing

 

A resolution of the directors or of any committee of the directors consented to in writing by all of the directors entitled to vote on it, whether by signed document, fax, email or any other method of transmitting legibly recorded messages, is as valid and effective as if it had been passed at a meeting of the directors or of the committee of the directors duly called and held. Such resolution may be in two or more counterparts which together are deemed to constitute one resolution in writing. A resolution passed in that manner is effective on the date stated in the resolution or on the latest date stated on any counterpart. A resolution of the directors or any committee of the directors passed in accordance with this Article 18.12 is deemed to be a proceeding at a meeting of directors or of the committee of the directors and to be as valid and effective as if it has been passed at a meeting of the directors or of the committee of the directors that satisfies all the requirements of the Business Corporations Act and all the requirements of these Articles relating to meetings of the directors or of a committee of the directors.

 

22

 

  

19 EXECUTIVE AND OTHER COMMITTEES

 

19.1 Appointment and Powers of Executive Committee

 

The directors may, by resolution, appoint an executive committee consisting of the director or directors that they consider appropriate, and this committee has, during the intervals between meetings of the board of directors, all of the director’s powers, except:

 

(1) the power to fill vacancies in the board of directors;

 

(2) the power to remove a director;

 

(3) the power to change the membership of, or fill vacancies in, any committee of the directors; and

 

(4) such other powers, if any, as may be set out in the resolution or any subsequent directors’ resolution.

 

19.2 Appointment and Powers of Other Committees

 

The directors may, by resolution:

 

(1) appoint one or more committees (other than the executive committee) consisting of the director or directors that they consider appropriate;

 

(2) delegate to a committee appointed under paragraph (1) any of the directors’ powers, except:

 

(a) the power to fill vacancies in the board of directors;

 

(b) the power to remove a director;

 

(c) the power to change the membership of, or fill vacancies in, any committee of the directors; and

 

(d) the power to appoint or remove officers appointed by the directors; and

 

(3) make any delegation referred to in paragraph (2) subject to the conditions set out in the resolution or any subsequent directors’ resolution.

 

19.3 Obligations of Committees

 

Any committee appointed under Articles 19.1 or 19.2, in the exercise of the powers delegated to it, must:

 

(1) conform to any rules that may from time to time be imposed on it by the directors; and

 

(2) report every act or thing done in exercise of those powers at such times as the directors may require.

 

23

 

 

19.4 Powers of Board

 

The directors may, at any time, with respect to a committee appointed under Articles 19.1 or 19.2:

 

(1) revoke or alter the authority given to the committee, or override a decision made by the committee, except as to acts done before such revocation, alteration or overriding;

 

(2) terminate the appointment of, or change the membership of, the committee; and

 

(3) fill vacancies in the committee.

 

19.5 Committee Meetings

 

Subject to Article 19.3(1) and unless the directors otherwise provide in the resolution appointing the committee or in any subsequent resolution, with respect to a committee appointed under Articles 19.1 or 19.2:

 

(1) the committee may meet and adjourn as it thinks proper;

 

(2) the committee may elect a chair of its meeting but, if no chair of a meeting is elected, or if at a meeting the chair of the meeting is not present within 15 minutes after the time set for holding the meeting, the directors present who are members of the committee may choose one of their number to chair the meeting;

 

(3) a majority of the members of the committee constitutes a quorum of the committee; and

 

(4) questions arising at any meeting of the committee are determined by a majority of votes of the members present, and in the case of an equality of votes, the chair of the meeting does not have a second or casting vote.

 

20 OFFICERS

 

20.1 Directors May Appoint Officers

 

The directors, may, from time to time, appoint such officers, if any, as the directors determine and the directors may, at any time, terminate any such appointment.

 

20.2 Functions, Duties and Powers of Officers

 

The directors may, for each officer:

 

(1) determine the functions and duties of the officer;

 

(2) entrust to and confer on the officer any of the powers exercisable by the directors on such terms and conditions and with such restrictions as the directors think fit; and

 

(3) revoke, withdraw, alter or vary all or any of the functions, duties and powers of the officer.

 

20.3 Qualifications

 

No officers may be appointed unless that officer is qualified in accordance with the Business Corporations Act. One person may hold more than one position as an officer of the Company. Any person appointed as the chair of the board or as a managing director must be a director. Any other officer need not be a director.

 

20.4 Remuneration and Terms of Appointment

 

All appointments of officers are to be made on the terms and conditions and at the remuneration (whether by way of salary, fee, commission, participation in profits or otherwise) that the directors think fit and are subject to termination at the pleasure of the directors, and an officer may in addition to such remuneration be entitled to receive, after he or she ceases to hold such office or leaves the employment of the Company, a pension or gratuity. 

 

24

 

 

21 INDEMNIFICATION

 

21.1 Definitions

 

In this Article 21:

 

(1) “eligible penalty” means a judgment, penalty or fine awarded or imposed in, or an amount paid in settlement of, an eligible proceeding;

 

(2) “eligible proceeding” means a legal proceeding or investigative action, whether current or threatened, pending or completed, in which a director, former director or alternate director of the Company (an “eligible party”) or any of the heirs and legal personal representatives of the eligible party, by reason of the eligible party being or having been a director or alternate director of the Company:

 

(a) is or may be joined as a party; or

 

(b) is or may be liable for or in respect of a judgment, penalty or tine in , or expenses related to, the proceeding;

 

(3) “expenses” has the meaning set out in the Business Corporations Act.

 

21.2 Mandatory Indemnification of Directors and Former Directors

 

Subject to the Business Corporations Act, the Company must indemnify a director, former director or alternate director of the Company and his or her heirs and legal personal representatives against all eligible penalties to which such person is or may be liable, and the Company must, after the final disposition of an eligible proceeding, pay the expenses actually and reasonably incurred by such person in respect of that proceeding. Each director and alternate director is deemed to have contracted with the Company on the terms of the indemnity contained in this Article 21.2

 

21.3 Indemnification of Other Persons

 

Subject to any restrictions in the Business Corporations Act, the Company may indemnify any person.

 

21.4 Non-Compliance with Business Corporations Act

 

The failure of a director, alternate director or officer of the Company to comply with the Business Corporations Act or these Articles does not invalidate any indemnity to which he or she is entitled under this Part.

 

21.5 Company May Purchase Insurance

 

The Company may purchase and maintain insurance for the benefit of any person (or his or her heirs or legal personal representatives) who:

 

(1) is or was a director, alternate director, officer, employee or agent of the Company;

 

(2) is or was a director, alternate director, officer, employee or agent of a corporation at a time when the corporation is or was an affiliate of the Company;

 

(3) at the request of the Company, is or was a director, alternate director, officer, employee or agent of a corporation or of a partnership, trust, joint venture or other unincorporated entity;

 

(4) at the request of the Company, holds or held a position equivalent to that of a director, alternate director or officer of a partnership, trust or joint venture or other unincorporated entity;

 

against any liability incurred by him or her as such director, alternate director, officer, employee or agent or person who holds or held such equivalent position. 

 

25

 

 

22 DIVIDENDS

 

22.1 Payment of Dividends Subject to Special Rights

 

The provisions of this Article 22 are subject to the rights, if any, of shareholders holding shares with special rights as to dividends.

 

22.2 Declaration of Dividends

 

Subject to the Business Corporations Act, the directors may from time to time declare and authorize payment of such dividends as they may deem advisable.

 

22.3 No Notice Required

 

The directors need not give notice to any shareholder of any declaration under Article 22.2.

 

22.4 Record Date

 

The directors may set a date as the record date for the purpose of determining shareholders entitled to receive a payment of a dividend. The record date must not precede the date on which the dividend is to be paid by more than two months. If no record date is set, the record date is 5 p.m. on the date on which the directors pass the resolution declaring the dividend.

 

22.5 Manner of Paying Dividend

 

A resolution declaring a dividend may direct payment of the dividend wholly or partly by the distribution of specific assets or of fully paid shares or of bonds, debentures or other securities of the Company, or in any one or more of those ways.

 

22.6 Settlement of Difficulties

 

If any difficulty arises in regard to a distribution under Article 22.5, the directors may settle the difficulty as they deem advisable, and, in particular, may:

 

(1) set the value for distribution of specific assets;

 

(2) determine that cash payments in substitution for all or any part of the specific assets to which any shareholders are entitled may be made to any shareholders on the basis of the value so fixed in order to adjust the rights of all parties; and

 

(3) vest any such specific assets in trustees for the persons entitled to the dividend.

 

22.7 When Dividend Payable

 

Any dividend may be made payable on such date as is fixed by the directors.

 

22.8 Dividends to be Paid in Accordance with Number of Shares

 

Subject to the rights of shareholders, if any, holding shares with special rights as to dividends, all dividends on shares of any class or series of shares must be declared and paid according to the number of such shares held.

 

22.9 Receipt by Joint Shareholders

 

If several persons are joint shareholders of any share, any one of them may give an effective receipt for any dividend, bonus or other money payable in respect of the share. 

 

26

 

 

22.10 Dividend Bears No Interest

 

No dividend bears interest against the Company.

 

22.11 Fractional Dividends

 

If a dividend to which a shareholder is entitled includes a fraction of the smallest monetary unit of the currency of the dividend, that fraction may be disregarded in making payment of the dividend and that payment represents full payment of the dividend.

 

22.12 Payment of Dividends

 

Any dividend or other distribution payable in cash in respect of shares may be paid by cheque, made payable to the order of the person to whom it is sent, and mailed to the address of the shareholder, or in the case of joint shareholders, to the address of the joint shareholder who is first named on the central securities register, or to the person and to the address the shareholder or joint shareholders may direct in writing. The mailing of such cheque will, to the extent of the sum represented by the cheque (plus the amount of the tax required by law to be deducted), discharge all liability for the dividend unless such cheque is not paid on presentation or the amount of tax so deducted is not paid to the appropriate taxing authority.

 

22.13 Capitalization of Surplus

 

Notwithstanding anything contained in these Articles, the directors may from time to time capitalize any surplus of the Company and may from time to time issue, as fully paid, shares or any bonds, debentures, or other securities of the Company as a dividend representing the surplus or any part of the surplus.

 

23 DOCUMENTS, RECORDS AND REPORTS

 

23.1 Recording of Financial Affairs

 

The directors must cause adequate accounting records to be kept to record properly the financial affairs and condition of the Company and to comply with the Business Corporations Act.

 

23.2 Inspection of Accounting Records

 

Unless the directors determine otherwise, or unless otherwise determined by ordinary resolution, no shareholder of the Company is entitled to inspect or obtain a copy of any accounting records of the Company.

 

24 NOTICES

 

24.1 Method of Giving Notice

 

Unless the Business Corporations Act or these Articles provide otherwise, a notice, statement, report or other record required or permitted by the Business Corporations Act or these Articles to be sent by or to a person may be sent by any one of the following methods:

 

(1) mailing addressed to the person at the applicable address for that person as follows:

 

(a) for a record mailed to a shareholder, the shareholder’s registered address;

 

(b) for a record mailed to a director or officer, the prescribed address for mailing shown for the director or officer in the records kept by the Company or the mailing address provided by the recipient for the sending of that record or records of that class;

  

27

 

 

(c) in any other case, the mailing address of the intended recipient;

 

(2) delivery at the applicable address for that person, as follows, addressed to the person:

 

(a) for a record delivered to a shareholder, the shareholder’s registered address;

 

(b) for a record delivered to a director or officer, the prescribed address for delivery shown for the director or officer in the records kept by the Company or the delivery address provided by the recipient for the sending of that record or records of that class;

 

(c) in any other case, the delivery address of the intended recipient;

 

(3) sending the record by fax to the fax number provided by the intended recipient for the sending of that record or records of that class;

 

(4) sending the record by email to the email address provided by the intended recipient for the sending of that record or records of that class;

 

(5) physical delivery to the intended recipient.

 

24.2 Deemed Receipt of Mailing

 

A record that is mailed to a person by ordinary mail to the applicable address for that person referred to in Article 24.1 is deemed to be received by the person to whom it was mailed on the day, Saturdays, Sundays and holidays excepted, following the date of mailing.

 

24.3 Certificate of Sending

 

A certificate signed by the secretary, if any, or other officer of the Company or of any other corporation acting in that behalf for the Company stating that a notice, statement, report or other record was addressed as required by Article 24.1, prepaid and mailed or otherwise sent as permitted by Article 24.1 is conclusive evidence of that fact.

 

24.4 Notice to Joint Shareholders

 

A notice, statement, report or other record may be provided by the Company to the joint shareholders of a share by providing the notice to the joint shareholder first named in the central securities register in respect of the share.

 

24.5 Notice to Trustees

 

A notice, statement, report or other record may be provided by the Company to the persons entitled to a share in consequence of the death, bankruptcy or incapacity of a shareholder by:

 

(1) mailing the record addressed to them:

 

(a) by name, by the title of the legal personal representative of the deceased or incapacitated shareholder, by the title of trustee of the bankrupt shareholder or by any similar description; and

 

(b) at the address, if any, supplied to the Company for that purpose by the persons claiming to be so entitled; or

 

(2) if an address referred to in paragraph (I)(b) has not been supplied to the Company, by giving the notice in a manner in which it might have been given if the death, bankruptcy or incapacity had not occurred.

 

28

 

 

25 SEAL

 

25.1 Who May Attest to Seal

 

Except as provided in Articles 25.2 and 25.3, the Company’s seal, if any, must not be impressed on any record except when that impression is attested by the signatures of:

 

(1) any two directors;

 

(2) any officer, together with any director;

 

(3) if the Company only has one director, that director; or

 

(4) any one or more directors or officers or persons as may be determined by the directors.

 

25.2 Sealing Copies

 

For the purposes of certifying under seal a certificate of incumbency of the directors or officers of the Company or a true copy of any resolution or other document, despite Article 25.1, the impression of the seal may be attested by the signature of any director or officer.

 

25.3 Mechanical Reproduction of Seal

 

The directors may authorize the seal to be impressed by third parties on share certificates or bonds, debentures or other securities of the Company as they may determine appropriate from time to time. To enable the seal to be impressed on any share certificates or bonds, debentures or other securities of the Company, whether in definitive or interim form, on which facsimiles of any of the signatures of the directors or officers of the Company, are, in accordance with the Business Corporations Act or these Articles, printed or otherwise mechanically reproduced, there may be delivered to the person employed to engrave, lithograph or print such definitive or interim share certificate or bonds, debentures or other securities one or more unmounted dies reproducing the seal and the chair of the board or any senior officer together with the secretary, treasurer, secretary-treasurer may in writing authorize such person to cause the seal to be impressed on such definitive or interim share certificates or bonds, debentures or other securities by the use of such dies. Share certificates or bonds, debentures or other securities to which the seal has been so impressed are for all purposes deemed to be under and to bear the seal impressed on them.

 

26 PROHIBITIONS

 

26.1 Definitions

 

In this Article 26:

 

(1) “designated securities” means:

 

(a) a voting security of the Company;

 

(b) a security of the Company that is not a debt security and that carries a residual right to participate in the earnings of the Company or, on the liquidation or winding up of the Company, in its assets; or

 

(c) a security of the Company convertible, directly or indirectly, into a security described in paragraph (a) or (b);

 

(2) “security” has the meaning assigned in the Securities Act (British Columbia);

  

29

 

 

(3) “voting security” means a security of the Company that:

 

(a) is not a debt security, and

 

(b) carries a voting right either under all circumstances or under some circumstances that have occurred and are continuing.

 

26.2 Application

 

Article 26.3 does not apply to the Company if and for so long as it is public company or a pre-existing reporting company which has the Statutory Reporting Company Provisions as part of its Articles or to which the Statutory Reporting Company Provisions apply.

 

26.3 Consent Required for Transfer of Shares or Designated Securities

 

No share or designated security may be sold, transferred or otherwise disposed of without the consent of the directors and the directors are not required to give any reason for refusing to consent to any such sale, transfer or other disposition.

 

Full name and signature of director   Date of Signing
     
/s/ John Icke   June 29, 2011
(Signature of director)  
     
John Icke    
Name of Director    

 

30

Exhibit 4.2

 

CONVERTIBLE DEBENTURE INDENTURE

 

Made as of December 23, 2019

 

Between

 

SIYATA MOBILE INC.

 

and

 

 

 

TABLE OF CONTENTS

 

ARTICLE 1 – INTERPRETATION 1
Section 1.1 Definitions 1
Section 1.2 Meaning of “Outstanding” 6
Section 1.3 Interpretation 7
Section 1.4 Headings, Etc. 7
Section 1.5 Time of Essence 7
Section 1.6 Monetary References 7
Section 1.7 Invalidity, Etc. 8
Section 1.8 Language 8
Section 1.9 Successors and Assigns 8
Section 1.10 Severability 8
Section 1.11 Entire Agreement 8
Section 1.12 Benefits of Indenture 8
Section 1.13 Applicable Law and Attornment 8
Section 1.14 Currency of Payment 9
Section 1.15 Non-business Days 9
Section 1.16 Accounting Terms 9
Section 1.17 Calculations 9
Section 1.18 Schedules 9
ARTICLE 2 – THE DEBENTURES 9
Section 2.1 Limit of Debentures 9
Section 2.2 Terms of Debentures of Any Series 10
Section 2.3 Form of Debentures 11
Section 2.4 Form and Terms of the Issued Debentures 11
Section 2.5 Issue of Global Debenture 16
Section 2.6 Certification and Delivery of Additional Debentures 16
Section 2.7 Non-certificated Deposit 17
Section 2.8 Execution of Debentures 19
Section 2.9 Certification 19
Section 2.10 Interim Debentures or Certificates 20
Section 2.11 Mutilation, Loss, Theft or Destruction 20
Section 2.12 Concerning Interest 20
Section 2.13 Ranking of Debentures 20
Section 2.14 Payments of Amounts Due On Maturity 21
Section 2.15 Payment of Interest 21
Section 2.16 Prepayment

  

i -

 

 

ARTICLE 3 – REGISTRATION, TRANSFER, EXCHANGE AND OWNERSHIP 22
Section 3.1 Fully Registered Debentures 22
Section 3.2 Global Debentures 22
Section 3.3 Transferee Entitled to Registration 24
Section 3.4 No Notice of Trusts 24
Section 3.5 Registers Open for Inspection 24
Section 3.6 Exchanges of Debentures 24
Section 3.7 Closing of Registers 25
Section 3.8 Charges for Registration, Transfer and Exchange 25
Section 3.9 Ownership of Debentures 26
ARTICLE 4 – REDEMPTION AND PURCHASE OF DEBENTURES 26
Section 4.1 Applicability of Article 26
Section 4.2 Notice of Redemption 26
Section 4.3 Debentures Due On Redemption Dates 27
Section 4.4 Deposit of Redemption Monies 27
Section 4.5 Failure to Surrender Debentures Called for Redemption 27
Section 4.6 Cancellation of Debentures Redeemed 28
Section 4.7 Purchase of Debentures by the Corporation 28
Section 4.8 Deposit of Maturity Monies 28
ARTICLE 5 – SUBORDINATION OF DEBENTURES 29
Section 5.1 Applicability of Article 29
Section 5.2 Order of Payment 29
Section 5.3 Subrogation to Rights of Holders of Secured Indebtedness 30
Section 5.4 Obligation to Pay Not Impaired 30
Section 5.5 No Payment If Secured Indebtedness in Default 31
Section 5.6 Payment On Debentures Permitted 31
Section 5.7 Confirmation of Subordination 31
Section 5.8 Knowledge of Trustee 32
Section 5.9 Trustee May Hold Secured Indebtedness 32
Section 5.10 Rights of Holders of Secured Indebtedness Not Impaired 32
Section 5.11 Altering the Secured Indebtedness 32
Section 5.12 Additional Indebtedness 32
Section 5.13 Right of Debentureholder to Convert Not Impaired 33
Section 5.14 Invalidated Payments 33
Section 5.15 Contesting Security 33

 

ii -

 

 

ARTICLE 6 – CONVERSION OF DEBENTURES 33
Section 6.1 Applicability of Article 33
Section 6.2 Revival of Right to Convert 33
Section 6.3 Manner of Exercise of Right to Convert 34
Section 6.4 Adjustment of Conversion Price 35
Section 6.5 No Requirement to Issue Fractional Common Shares 39
Section 6.6 Corporation to Reserve Common Shares 40
Section 6.7 Cancellation of Converted Debentures 40
Section 6.8 Certificate as to Adjustment 40
Section 6.9 Notice of Special Matters 40
Section 6.10 Protection of Trustee 41
ARTICLE 7 – COVENANTS OF THE CORPORATION 41
Section 7.1 to Pay Principal, Premium (if Any) and Interest 41
Section 7.2 to Pay Trustee’s Remuneration 41
Section 7.3 to Give Notice of Default 41
Section 7.4 Preservation of Existence, Etc. 41
Section 7.5 Keeping of Books 42
Section 7.6 Annual Certificate of Compliance 42
Section 7.7 Performance of Covenants by Trustee 42
Section 7.8 Maintain Listing 42
Section 7.9 No Dividends On Common Shares If Event of Default 42
Section 7.10 Withholding Matters 43
Section 7.11 Sec Reporting Status 43
ARTICLE 8 – DEFAULT 43
Section 8.1 Events of Default 43
Section 8.2 Notice of Events of Default 45
Section 8.3 Waiver of Default 45
Section 8.4 Enforcement by the Trustee 46
Section 8.5 No Suits by Debentureholders 47
Section 8.6 Application of Monies by Trustee 47
Section 8.7 Notice of Payment by Trustee 48
Section 8.8 Trustee May Demand Production of Debentures 48
Section 8.9 Remedies Cumulative 48
Section 8.10 Immunity of Directors, Officers and Others 49

 

iii -

 

 

ARTICLE 9 – SATISFACTION AND DISCHARGE 49
Section 9.1 Cancellation and Destruction 49
Section 9.2 Non-presentation of Debentures 49
Section 9.3 Repayment of Unclaimed Monies 49
Section 9.4 Discharge 50
Section 9.5 Satisfaction 50
Section 9.6 Continuance of Rights, Duties and Obligations 51
ARTICLE 10 – SUCCESSORS 52
Section 10.1 Corporation May Consolidate, Etc., Only On Certain Terms 52
Section 10.2 Successor Substituted 53
ARTICLE 11 – COMPULSORY ACQUISITION 53
Section 11.1 Definitions in This Article: 53
Section 11.2 Offer for Debentures 54
Section 11.3 Offeror’s Notice to Dissenting Shareholders 54
Section 11.4 Delivery of Debenture Certificates 55
Section 11.5 Payment of Consideration to Trustee 55
Section 11.6 Consideration to be Held in Trust 55
Section 11.7 Completion of Transfer of Debentures to Offeror 55
Section 11.8 Communication of Offer to the Corporation 56
ARTICLE 12 – MEETINGS OF DEBENTUREHOLDERS 56
Section 12.1 Right to Convene Meeting 56
Section 12.2 Notice of Meetings 56
Section 12.3 Chairman 57
Section 12.4 Quorum 57
Section 12.5 Power to Adjourn 58
Section 12.6 Show of Hands 58
Section 12.7 Poll 58
Section 12.8 Voting 58
Section 12.9 Proxies 59
Section 12.10 Persons Entitled to Attend Meetings 59
Section 12.11 Powers Exercisable by Extraordinary Resolution 59
Section 12.12 Meaning of “Extraordinary Resolution” 61
Section 12.13 Powers Cumulative 61
Section 12.14 Minutes 62
Section 12.15 Instruments in Writing 62
Section 12.16 Binding Effect of Resolutions 62
Section 12.17 Evidence of Rights of Debentureholders 62
Section 12.18 Concerning Serial Meetings 62

 

iv -

 

 

ARTICLE 13 – NOTICES 63
Section 13.1 Notice to Corporation 63
Section 13.2 Notice to Debentureholders 63
Section 13.3 Notice to Trustee 63
Section 13.4 Mail Service Interruption 64
ARTICLE 14 – CONCERNING THE TRUSTEE 64
Section 14.1 No Conflict of Interest 64
Section 14.2 Replacement of Trustee 64
Section 14.3 Duties of Trustee 65
Section 14.4 Reliance Upon Declarations, Opinions, Etc. 65
Section 14.5 Evidence and Authority to Trustee, Opinions, Etc. 65
Section 14.6 Officer’s Certificates Evidence 66
Section 14.7 Experts, Advisers and Agents 66
Section 14.8 Trustee May Deal in Debentures 67
Section 14.9 Investment of Monies Held by Trustee 67
Section 14.10 Trustee Not Ordinarily Bound 67
Section 14.11 Trustee Not Required to Give Security 67
Section 14.12 Trustee Not Bound to Act On Trust’s Request 67
Section 14.13 Conditions Precedent to Trustee’s Obligations to Act Hereunder 68
Section 14.14 Authority to Carry On Business 68
Section 14.15 Compensation and Indemnity 68
Section 14.16 Acceptance of Trust 69
Section 14.17 Third Party Interests 69
Section 14.18 Anti-money Laundering 69
Section 14.19 Privacy Laws 69
Section 14.20 Force Majeure 70
ARTICLE 15 – SUPPLEMENTAL INDENTURES 70
Section 15.1 Supplemental Indentures 70
ARTICLE 16 – EXECUTION AND FORMAL DATE 71
Section 16.1 Execution 71
Section 16.2 Formal Date 71
SCHEDULE A – FORM OF DEBENTURE A-1
SCHEDULE B – FORM OF REDEMPTION NOTICE B-1
SCHEDULE C – FORM OF NOTICE OF CONVERSION C-1

 

v -

 

  

CONVERTIBLE DEBENTURE INDENTURE

 

This Agreement is made as of December 23, 2019, between

 

SIYATA MOBILE INC.

 

a corporation existing under the laws of the Province of British Columbia and having its head office in the City of Vancouver, in the Province of British Columbia (the “Corporation”)

 

AND

 

a trust company existing under the laws of Canada and registered to carry on business in the Province of British Columbia

 

(the “Trustee”)

 

RECITALS

 

WHEREAS the Corporation wishes to create and issue the Debentures (as defined herein) in the manner and subject to the terms and conditions of this Indenture;

 

FOR VALUE RECEIVED, the parties agree as follows:

 

Article 1 – INTERPRETATION

 

Section 1.1 Definitions

 

In this Indenture and in the Debentures, unless there is something in the subject matter or context inconsistent therewith, the expressions following shall have the following meanings, namely:

 

(1) “1933 Act” means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder;

 

(2) “90% Redemption Right” has the meaning ascribed thereto in Section 2.4(11)(b);

 

(3) “this Indenture”, “hereto”, “herein”, “hereby”, “hereunder”, “hereof” and similar expressions refer to this Indenture and not to any particular Article, Section, subsection, clause, subdivision or other portion hereof and include any and every instrument supplemental or ancillary hereto;

 

(4) “Additional Debentures” means Debentures of any one or more series, other than the Issued Debentures, issued under this Indenture;

 

(5) “Applicable Securities Legislation” means applicable securities laws (including rules, regulations, policies and instruments) in each of the applicable provinces and territories of Canada;

 

(6) “Approved Bank” has the meaning ascribed thereto in Section 14.9.

 

(7) “Auditors of the Corporation” means an independent firm of chartered accountants duly appointed as auditors of the Corporation;

 

 

 

(8) “Beneficial Holder” means any person who holds a beneficial interest in a Debenture that is represented by a Debenture Certificate or an Uncertificated Debenture registered in the name of such person’s nominee;

 

(9) “Board of Directors” means the board of directors of the Corporation or any committee thereof;

 

(10) “Business Day” means any day other than a Saturday, Sunday or any other day that the Trustee in the City of Toronto, Ontario and in the City of Vancouver, British Columbia is not generally open for business;

 

(11) “Change of Control” means (i) any event as a result of or following which any person, or group of persons “acting jointly or in concert” within the meaning of Applicable Securities Legislation, beneficially owns or exercises control or direction over an aggregate of more than 50% of the then outstanding Common Shares; or (ii) the sale or other transfer of all or substantially all of the consolidated assets of the Corporation. A Change of Control will not include a sale, merger, reorganization or other similar transaction if the previous holders of the Common Shares hold at least 50% of the voting shares of such merged, reorganized or other continuing entity;

 

(12) “Change of Control Notice” has the meaning ascribed thereto in Section 2.4(11)(a);

 

(13) “Change of Control Purchase Date” has the meaning ascribed thereto in Section 2.4(11)(a);

 

(14) “Change of Control Purchase Option” has the meaning ascribed thereto in Section 2.4(11)(a);

 

(15) “Change of Control Purchase Price” has the meaning ascribed thereto in Section 2.4(11)(a);

 

(16) “Common Shares” means the common shares in the capital of the Corporation, as such common shares are constituted on the date of execution and delivery of this Indenture; provided that in the event of a change or a subdivision, revision, reduction, combination or consolidation thereof, any reclassification, capital reorganization, consolidation, amalgamation, arrangement, merger, sale or conveyance or liquidation, dissolution or winding- up, or such successive changes, subdivisions, redivisions, reductions, combinations or consolidations, reclassifications, capital reorganizations, consolidations, amalgamations, arrangements, mergers, sales or conveyances or liquidations, dissolutions or windings-up, then, subject to adjustments, if any, having been made in accordance with the provisions of Section 6.4, “Common Shares” shall, as the context may require, mean the shares or other securities or property resulting from such change, subdivision, redivision, reduction, combination or consolidation, reclassification, capital reorganization, consolidation, amalgamation, arrangement, merger, sale or conveyance or liquidation, dissolution or winding-up;

 

(17) “Conversion Price” means the dollar amount for which each Common Share may be issued from time to time upon the conversion of Debentures or any series of Debentures which are by their terms convertible in accordance with the provisions of Article 6;

 

(18) “Corporation” means Siyata Mobile Inc. and includes any successor to or of the Corporation which shall have complied with the provisions of Article 10;

 

(19) “Counsel” means a barrister or solicitor or firm of barristers or solicitors retained or employed by the Trustee or retained or employed by the Corporation and reasonably acceptable to the Trustee;

 

(20) “Current Market Price” means, generally, the VWAP of the Common Shares on the TSXV, if the Common Shares are listed on the TSXV, for the 20 consecutive trading days ending on the date immediately preceding the applicable date. If the Common Shares are not listed on the TSXV, reference shall be made for the purpose of the above calculation to the principal securities exchange or market on which the Common Shares are listed or quoted or if no such prices are available “Current Market Price” shall be the fair value of a Common Share as reasonably determined by the Board of Directors;

 

- 2 -

 

 

(21) “Date of Conversion” has the meaning ascribed thereto in Section 6.3(2);

 

(22) “Debenture Certificate” means a certificate evidencing Debentures substantially in the form attached as Schedule A hereto;

 

(23) “Debenture Liabilities” has the meaning ascribed thereto in Section 5.1;

 

(24) “Debentureholders” or “holders” means the Persons for the time being entered in the register for Debentures as registered holders of Debentures or any transferees of such Persons by endorsement or delivery;

 

(25) “Debentures” means the debentures, notes or other evidence of indebtedness of the Corporation issued and certified hereunder, or deemed to be issued and certified hereunder, including, without limitation, the New Debentures and Existing Debentures, and for the time being outstanding, whether in definitive, uncertificated or interim form;

 

(26) “Defeased Debentures” has the meaning ascribed thereto in Section 9.6(2);

 

(27) “Depository” or “CDS” means CDS Clearing and Depository Services Inc. and its successors in interest;

 

(28) “Depository Participant” means a broker, dealer, bank, other financial institution or other person for whom from time to time, a Depository effects book entries for a Global Debenture deposited with the Depository;

 

(29) “Distributed Securities” has the meaning ascribed thereto in Section 6.4(1)(e);

 

(30) “Event of Default” has the meaning ascribed thereto in Section 8.1;

 

(31) “Existing Debentures” has the meaning ascribed thereto in Section 2.4(2);

 

(32) “Expiration Date” has the meaning ascribed thereto in Section 6.4(1)(f);

 

(33) “Expiration Time” has the meaning ascribed thereto in Section 6.4(1)(f);

 

(34) “Extraordinary Resolution” has the meaning ascribed thereto in Section 12.12;

 

(35) “Fully Registered Debentures” means Debentures registered as to both principal and interest;

 

(36) “Global Debenture” means a Debenture that is issued to and registered in the name of the Depository, or its nominee, pursuant to Section 2.5 for purposes of being held by or on behalf of the Depository as custodian for participants in the Depository’s book-based system;

 

(37) “Government Obligations” means securities issued or guaranteed by the Government of Canada or any province thereof;

 

(38) “Ineligible Consideration” shall have the meaning ascribed to it in Section 6.4(1)(n);

 

- 3 -

 

 

(39) “IFRS” means International Financial Reporting Standards issued by the International Accounting Standards Board (including as further described in Section 1.16);

 

(40) “Interest Payment Date” means a date specified in a Debenture as the date on which the interest of such Debenture is due and payable;

 

(41) “Internal Procedures” means in respect of the making of any one or more entries to, changes in or deletions of any one or more entries in the register of Debentureholders at any time (including without limitation, original issuance or registration of transfer of ownership) the minimum number of the Trustee’s internal procedures customary at such time for the entry, change or deletion made to be complete under the operating procedures followed at the time by the Trustee, it being understood that neither preparation and issuance shall constitute part of such procedures for any purpose of this definition;

 

(42) “Issued Debentures” has the meaning ascribed thereto in Section 2.4(2);

 

(43) “Material Subsidiary” means any Subsidiary of the Corporation which has consolidated assets equal to or greater than 5% of the consolidated assets of the Corporation and its Subsidiaries;

 

(44) “Maturity Account” means an account or accounts required to be established by the Corporation (and which shall be maintained by and subject to the control of the Trustee) for each series of Debentures issued pursuant to and in accordance with this Indenture;

 

(45) “Maturity Date” means December 23, 2021;

 

(46) “Merger Event” has the meaning ascribed thereto in Section 6.4(1)(d);

 

(47) “New Debentures” has the meaning ascribed thereto in Section 2.4(1);

 

(48) “NI 62-104” means National Instrument 62-104 — Take-Over Bids and Issuer Bids;

 

(49) “Offering” means the brokered private placement of up to $10,000,000 in unsecured convertible debenture units at a price of $1,000 per debenture unit, with each such unit consisting of one unsecured convertible debenture of the Corporation at an issue price of $950.00 per $1,000 principal amount and one Warrant for each $1.00 principal amount of the Debenture purchased by such purchaser and includes an option granted to the agents of the Offering to increase the size of the Offering by up to 15%;

 

(50) “Offeror’s Notice” has the meaning ascribed thereto in Section 11.3;

 

(51) “Officer’s Certificate” means a certificate of the Corporation signed by any authorized officer or director of the Corporation, in their capacity as an officer or director of the Corporation, and not in their personal capacity;

 

(52) “Participant” means a Person recognized by CDS as a participant in the non-certificated inventory system administered by CDS;

 

(53) “Periodic Offering” means an offering of Debentures of a series from time to time, the specific terms of which Debentures, including, without limitation, the rate or rates of interest, if any, thereon, the stated maturity or maturities thereof and the redemption provisions, if any, with respect thereto, are to be determined by the Corporation upon the issuance of such Debentures from time to time;

 

- 4 -

 

 

(54) “Person” includes an individual, corporation, company, partnership, joint venture, association, trust, trustee, unincorporated organization or government or any agency or political subdivision thereof (and for the purposes of the definition of “Change of Control”, in addition to the foregoing, “Person” shall include any syndicate or group that would be deemed to be a “Person” under NI 62-104);

 

(55) “Privacy Laws” has the meaning ascribed thereto in Section 14.19;

 

(56) “Purchased Common Shares” has the meaning ascribed thereto in Section 6.4(1)(f);

 

(57) “Qualified Institutional Buyer” means a “qualified institutional buyer” as such term is defined in Rule 144A under the 1933 Act;

 

(58) “Redemption Date” has the meaning ascribed thereto in Section 4.2(1);

 

(59) “Redemption Notice” has the meaning ascribed thereto in Section 4.2(1);

 

(60) “Redemption Price” means, in respect of a Debenture, 101% of the outstanding principal amount and any and all accrued and unpaid interest up to and including the Redemption Date fixed for such Debenture, payable on the Redemption Date;

 

(61) “SEC” has the meaning ascribed thereto in Section 7.11;

 

(62) “Secured Creditor” means a holder or holders of Secured Indebtedness and includes any representative or representatives, agent or agents or trustee or trustees of any such holder or holders;

 

(63) “Secured Indebtedness” means the principal of, the premium (if any) and interest and other obligations on secured indebtedness, statutory liens (other than statutory liens where the party is defending same in good faith), secured bank or other institutional indebtedness, and secured project indebtedness, in each case owing by the Corporation, or renewals, extensions and refunding of such indebtedness, including, without limitation: (a) obligations of the Corporation or its Subsidiaries under any swap, hedging or other similar contracts or arrangements; (b) all costs and expenses incurred by or on behalf of the holder of any Secured Indebtedness in enforcing payment or collection of any such Secured Indebtedness, including enforcing any security interest securing the same. “Secured Indebtedness” shall not include any indebtedness that would otherwise be Secured Indebtedness if it is expressly stated to be subordinate to or rank pari passu with the Debentures;

 

(64) “Serial Meeting” has the meaning ascribed thereto in Section 12.2(2)(a);

 

(65) “Subsidiary” has the meaning ascribed thereto in the Securities Act (British Columbia);

 

(66) “Tax Act” means the Income Tax Act (Canada), as amended;

 

(67) “Time of Expiry” means the time of expiry of certain rights with respect to the conversion of Debentures under Article 6 which is to be set forth separately in the form and terms for each series of Debentures which by their terms are to be convertible, and has the meaning ascribed thereto in Section 2.4(7) with respect to the Issued Debentures;

 

(68) “trading day” means, with respect to the TSXV or other market for securities, any day on which such exchange or market is open for trading or quotation;

 

(69) “Trustee” means , or its successor or successors for the time being as trustee hereunder;

 

- 5 -

 

 

(70) “TSXV” means the TSX Venture Exchange;

 

(71) “Uncertificated Debenture” means any Debenture which is not issued as part of a Debenture Certificate, including DRS Advices;

 

(72) “Unclaimed Funds Return Date” has the meaning ascribed thereto in Section 2.4(11)(g);

 

(73) “United States” or “U.S.” means the United States of America, its territories and possessions, any state of the United States and the District of Columbia;

 

(74) “U.S. Securities Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended from time to time, and the rules and regulations promulgated thereunder.

 

(75) “VWAP” means the per share volume weighted average trading price of the Common Shares for the applicable period (which must be calculated utilizing days in which the Common Shares actually trade) on the TSXV (or if the Common Shares are no longer traded on the TSXV, on such other exchange as the Common Shares are then traded);

 

(76) “Warrants” mean the Common Share purchase warrants of the Corporation, each entitling the holder thereof to acquire one Common Share at an exercise price of $0.45 per Common Share for a period of three years following the date hereof, subject to adjustment and acceleration in certain events;

 

(77) “Withholding Taxes” has the meaning ascribed to it in Section 7.10; and

 

(78) “Written Direction of the Corporation” means an instrument in writing signed by any one officer or director of the Corporation.

 

Section 1.2 Meaning of “Outstanding”

 

Every Debenture certified and delivered by the Trustee or every Uncertificated Debenture authenticated by the Trustee by completing its Internal Procedures hereunder shall be deemed to be outstanding until it is cancelled, converted or redeemed or delivered to the Trustee for cancellation, conversion or redemption for monies and/or Common Shares, as the case may be, or the payment thereof shall have been set aside under Section 9.2, provided that:

 

(a) Debentures which have been partially redeemed, purchased or converted shall be deemed to be outstanding only to the extent of the unredeemed, unpurchased or unconverted part of the principal amount thereof;

 

(b) when a new Debenture has been issued in substitution for a Debenture which has been lost, stolen or destroyed, only one of such Debentures shall be counted for the purpose of determining the aggregate principal amount of Debentures outstanding; and

 

(c) for the purposes of any provision of this Indenture entitling holders of outstanding Debentures to vote, sign consents, requisitions or other instruments or take any other action under this Indenture, or to constitute a quorum of any meeting of Debentureholders, Debentures owned directly or indirectly, legally or equitably, by the Corporation shall be disregarded except that:

 

  (i) for the purpose of determining whether the Trustee shall be protected in relying on any such vote, consent, requisition or other instrument or action, or on the holders of Debentures present or represented at any meeting of Debentureholders, only the Debentures which the Trustee knows are so owned shall be so disregarded; and

 

  (ii) Debentures so owned which have been pledged in good faith other than to the Corporation shall not be so disregarded if the pledgee shall establish to the satisfaction of the Trustee the pledgee’s right to vote such Debentures, sign consents, requisitions or other instruments or take such other actions in his discretion free from the control of the Corporation or a Subsidiary of the Corporation.

 

- 6 -

 

 

Section 1.3 Interpretation

 

In this Indenture:

 

(a) words importing the singular number or masculine gender shall include the plural number or the feminine or neuter genders, and vice versa;

 

(b) all references to Articles and Schedules refer, unless otherwise specified, to articles of and schedules to this Indenture;

 

(c) all references to Sections, subsections or clauses refer, unless otherwise specified, to Sections, subsections or clauses of this Indenture;

 

(d) words and terms denoting inclusiveness (such as “include” or “includes” or “including”), whether or not so stated, are not limited by and do not imply limitation of their context or the words or phrases which precede or succeed them;

 

(e) reference to any agreement or other instrument in writing means such agreement or other instrument in writing as amended, modified, replaced or supplemented from time to time;

 

(f) unless otherwise indicated, reference to a statute shall be deemed to be a reference to such statute as amended, re-enacted or replaced from time to time; and

 

(g) unless otherwise indicated, time periods within which a payment is to be made or any other action is to be taken hereunder shall be calculated by including the day on which the period commences and excluding the day on which the period ends.

 

Section 1.4 Headings, etc.

 

The division of this Indenture into Articles and Sections, the provision of a Table of Contents and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation of this Indenture or of the Debentures.

 

Section 1.5 Time of Essence

 

Time shall be of the essence of this Indenture.

 

Section 1.6 Monetary References

 

Whenever any amounts of money are referred to herein, such amounts shall be deemed to be in lawful money of Canada unless otherwise expressed.

 

- 7 -

 

 

Section 1.7 Invalidity, etc.

 

Any provision hereof which is prohibited or unenforceable shall be ineffective only to the extent of such prohibition or unenforceability, without invalidating the remaining provisions hereof.

 

Section 1.8 Language

 

Each of the parties hereto hereby acknowledges that it has consented to and requested that this Indenture and all documents relating hereto, including, without limiting the generality of the foregoing, the Schedules to this Indenture, be drawn up in the English language only.

 

Section 1.9 Successors and Assigns

 

All covenants and agreements of the Corporation in this Indenture and the Debentures shall bind its successors and assigns, whether so expressed or not. All covenants and agreements of the Trustee in this Indenture shall bind its successors.

 

Section 1.10 Severability

 

In case any provision in this Indenture or in the Debentures shall be invalid, illegal or unenforceable, such provision shall be deemed to be severed herefrom or therefrom and the validity, legality and enforceability of the remaining provisions shall not in any way be affected, prejudiced or impaired thereby.

 

Section 1.11 Entire Agreement

 

This Indenture and all supplemental indentures and Schedules hereto and thereto, and the Debentures issued hereunder and thereunder, together constitute the entire agreement between the parties hereto with respect to the indebtedness created hereunder and thereunder and under the Debentures and supersedes as of the date hereof all prior memoranda, agreements, negotiations, discussions and term sheets, whether oral or written, with respect to the indebtedness created hereunder or thereunder and under the Debentures.

 

Section 1.12 Benefits of Indenture

 

Nothing in this Indenture or in the Debentures, express or implied, shall give to any Person, other than the parties hereto and their successors hereunder, any paying agent, the holders of Debentures, the Secured Creditors (to the extent provided in Article 5 only) and, to the extent provided by Section 8.10, the holders of Common Shares, any benefit or any legal or equitable right, remedy or claim under this Indenture.

 

Section 1.13 Applicable Law and Attornment

 

This Indenture, any supplemental indenture and the Debentures shall be governed by and interpreted in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein and shall be treated in all respects as British Columbia contracts, with respect to any suit, action or proceedings relating to this Indenture, any supplemental indenture or any Debenture, the Corporation, the Trustee and each holder irrevocably submit and attorn to the non-exclusive jurisdiction of the courts of the Province of British Columbia.

 

- 8 -

 

 

Section 1.14 Currency of Payment

 

Unless otherwise indicated in a supplemental indenture with respect to any particular series of Debentures, all payments to be made under this Indenture or a supplemental indenture shall be made in Canadian dollars.

 

Section 1.15 Non-Business Days

 

Whenever any payment to be made hereunder shall be due, any period of time would begin or end, any calculation is to be made or any other action is to be taken on, or as of, or from a period ending on, a day other than a Business Day, such payment shall be made, such period of time shall begin or end, such calculation shall be made and such other action shall be taken, as the case may be, unless otherwise specifically provided herein, on or as of the next succeeding Business Day without any additional interest, cost or charge to the Corporation.

 

Section 1.16 Accounting Terms

 

Except as hereinafter provided or as otherwise indicated in this Indenture, all calculations required or permitted to be made hereunder pursuant to the terms of this Indenture shall be made in accordance with IFRS. For greater certainty, IFRS shall include any accounting standards that may from time to time be approved for general application by the Canadian Institute of Chartered Accountants.

 

Section 1.17 Calculations

 

The Corporation shall be responsible for making all calculations called for hereunder including, without limitation, calculations of Current Market Price. The Corporation shall make such calculations in good faith and, absent manifest error, the Corporation’s calculations shall be final and binding on holders and the Trustee. The Corporation will provide a schedule of its calculations to the Trustee and the Trustee shall be entitled to rely conclusively on the accuracy of such calculations without independent verification.

 

Section 1.18 Schedules

 

(1) The following Schedules are incorporated into and form part of this Indenture:

 

Schedule A – Form of Debenture

Schedule B – Form of Redemption Notice

Schedule C – Form of Notice of Conversion

 

(2) In the event of any inconsistency between the provisions of any Section of this Indenture and the provisions of the Schedules which form a part hereof, the provisions of this Indenture shall prevail to the extent of the inconsistency.

 

Article 2 – THE DEBENTURES

 

Section 2.1 Limit of Debentures

 

The aggregate principal amount of Debentures authorized to be issued under this Indenture is unlimited, but Debentures may be issued only upon and subject to the conditions and limitations herein set forth.

 

- 9 -

 

 

Section 2.2 Terms of Debentures of any Series

 

(1) The Debentures may be issued in one or more series. There shall be established herein or in or pursuant to one or more indentures supplemental hereto, prior to the initial issuance of Debentures of any particular series:

 

(a) the designation of the Debentures of the series (which need not include the term Debentures), which shall distinguish the Debentures of the series from the Debentures of all other series;

 

(b) any limit upon the aggregate principal amount of the Debentures of the series that may be certified and delivered under this Indenture (except for Debentures certified and delivered upon registration of, transfer of, amendment of, or in exchange for, or in lieu of, other Debentures of the series pursuant to Section 2.10, Section 2.11, Section 3.1, Section 3.6, Article 4 and Article 6);

 

(c) the date or dates on which the principal of the Debentures of the series is payable;

 

(d) the rate or rates at which the Debentures of the series shall bear interest, if any, the date or dates from which such interest shall accrue, on which such interest shall be payable and on which record date, if any, shall be taken for the determination of holders to whom such interest shall be payable and/or the method or methods by which such rate or rates or date or dates shall be determined;

 

(e) the place or places where the principal of and any interest on Debentures of the series shall be payable or where any Debentures of the series may be surrendered for registration of transfer or exchange;

 

(f) the right, if any, of the Corporation to redeem Debentures of the series, in whole or in part, at its option and the period or periods within which, the price or prices at which and any terms and conditions upon which, Debentures of the series may be so redeemed;

 

(g) the obligation, if any, of the Corporation to redeem, purchase or repay Debentures of the series pursuant to any mandatory redemption, sinking fund or analogous provisions or at the option of a holder thereof and the price or prices at which, the period or periods within which, the date or dates on which, and any terms and conditions upon which, Debentures of the series shall be redeemed, purchased or repaid, in whole or in part, pursuant to such obligations;

 

(h) if other than denominations of $1,000 and any integral multiple thereof, the denominations in which Debentures of the series shall be issuable;

 

(i) subject to the provisions of this Indenture, any trustee, Depositories, authenticating or paying agents, transfer agents or registrars or any other agents with respect to the Debentures of the series;

 

(j) any other events of default or covenants with respect to the Debentures of the series;

 

(k) whether and under what circumstances the Debentures of the series will be convertible into or exchangeable for securities of any Person;

 

- 10 -

 

 

(l) the form and terms of the Debentures of the series;

 

(m) if applicable, that the Debentures of the series shall be issuable in certificated or uncertificated form;

 

(n) if other than Canadian currency, the currency in which the Debentures of the series are issuable; and

 

(o) any other terms of the Debentures of the series (which terms shall not be inconsistent with the provisions of this Indenture).

 

(2) All Debentures of any one series shall be substantially identical, except as may otherwise be established herein or in an indenture supplemental hereto. All Debentures of any one series need not be issued at the same time and may be issued from time to time, including pursuant to a Periodic Offering, consistent with the terms of this Indenture, if so provided herein, or in an indenture supplemental hereto.

 

Section 2.3 Form of Debentures

 

Except in respect of the Issued Debentures, the form of which is provided for herein, the Debentures of each series shall be substantially in such form or forms (not inconsistent with this Indenture) as shall be established herein or in one or more indentures supplemental hereto, in each case with such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Indenture or an indenture supplemental hereto, and may have imprinted or otherwise reproduced thereon such legend or legends or endorsements, not inconsistent with the provisions of this Indenture or an indenture supplemental hereto, as may be required to comply with any law or with any rules or regulations pursuant thereto or with any rules or regulations of any securities exchange or securities regulatory authority or to conform to general usage, all as may be determined by the directors or officers of the Corporation executing such Debentures on behalf of the Corporation, as conclusively evidenced by their execution of such Debentures.

 

Section 2.4 Form and Terms of the Issued Debentures

 

(1) The Corporation has entered into subscription agreements for the issuance of up to 1,500 12% unsecured convertible debentures (“New Debentures”) of the Corporation at a purchase price of $950 per $1,000 principal amount for each New Debenture for aggregate gross proceeds to the Corporation of $10,925,000.

 

(2) In addition, the Corporation has authorized for issuance a principal amount of up to $4,842,106 in Debentures (the “Restructuring Debentures” and together with the New Debentures the “Issued Debentures”) in connection with a restructuring of certain outstanding convertible Debentures due June 28, 2020 (the “Existing Debentures” ).

 

(3) The Issued Debentures shall be dated as of the date of closing of the Offering and shall mature on December 23, 2021 (the “Maturity Date” for the Issued Debentures).

 

(4) The Issued Debentures shall bear interest from the date of issue at the rate of 12% per annum, payable in cash, quarterly, in arrears following their date of issue. The first interest payment will be made on Monday, March 23, 2020 and will include interest payable from the date of issue. Interest will be computed on the basis of a 365-day year. Any payment required to be made on any day that is not a Business Day will be made on the next succeeding Business Day. The record date for the payment of interest on the Issued Debentures will be that date which is five Business Days prior to each Interest Payment Date.

 

- 11 -

 

 

(5) The Issued Debentures will be redeemable in accordance with the terms of Article 4, provided that the Issued Debentures will not be redeemable before December 23, 2020, except in the event of the satisfaction of certain conditions after a Change of Control has occurred as provided herein. On and after December 23, 2020 and at any time prior to the Maturity Date, the Issued Debentures may be redeemed at the option of the Corporation in whole or in part from time to time, on 30 days advance notice at the Redemption Price. The Redemption Notice for the Issued Debentures shall be substantially in the form of Schedule B.

 

(6) The Issued Debentures will rank pari passu with each other series of Debentures issued under this Indenture or under indentures supplemental to this Indenture (regardless of their actual date or terms of issue) and, except as prescribed by law, with all other existing and future unsecured indebtedness of the Corporation, other than Secured Indebtedness.

 

(7) Upon and subject to the provisions and conditions of Article 5 and Section 3.7 and the approval of the TSXV, the holder of each Issued Debenture shall have the right at such holder’s option, at any time prior to the close of business on the earliest of (i) the close of business on the Maturity Date; (ii) if the Issued Debentures are called for redemption, on the Business Day immediately preceding the date specified by the Corporation for redemption of the Issued Debentures; or (iii) if subject to repurchase pursuant to a Change of Control, on the Business Day immediately preceding the payment date, subject to the satisfaction of certain conditions, by notice to the holders of Issued Debentures in accordance with Section 4.2(1) (the earlier of which will be the “Time of Expiry” for the purposes of Article 6 in respect of the Issued Debentures), to convert any part, being $1,000 or an integral multiple thereof, of the principal amount of a Debenture into Common Shares at the Conversion Price in effect on the Date of Conversion. To the extent a redemption is a redemption in part only of the Issued Debentures, such right to convert, if not exercised prior to the applicable Time of Expiry, shall survive as to any Issued Debentures not redeemed or converted and be applicable to the next succeeding Time of Expiry. Notwithstanding the foregoing, no Issued Debentures may be converted on an Interest Payment Date or during the five Business Days preceding each Interest Payment Date.

 

(8) The Conversion Price in effect on the date hereof for each Common Share to be issued upon the conversion of Issued Debentures shall be equal to $0.45 such that approximately 2,222 Common Shares shall be issued for each $1,000 principal amount of Issued Debentures so converted. Except as provided below, no adjustment in the number of Common Shares to be issued upon conversion will be made for dividends or distributions on Common Shares issuable upon conversion, the record date for the payment of which precedes the date upon which the holder becomes a holder of Common Shares in accordance with Article 6, or for interest accrued on Issued Debentures surrendered. No fractional Common Shares will be issued, and the number of Common Shares so issuable will be rounded down to the nearest whole number. The Conversion Price applicable to, and the Common Shares, securities or other property receivable on the conversion of, the Issued Debentures is subject to adjustment pursuant to the provisions of Section 6.4. Holders converting their Issued Debentures will receive, in addition to the applicable number of Common Shares, accrued and unpaid interest (less any taxes required to be deducted) in respect of the Issued Debentures surrendered for conversion up to but excluding the Date of Conversion from, and including, the most recent Interest Payment Date. The Conversion Price will not be adjusted for accrued interest.

 

Notwithstanding any other provisions of this Indenture, if a Debenture is surrendered for conversion on an Interest Payment Date or during the five preceding Business Days, the Person or Persons entitled to receive Common Shares in respect of the Debenture so surrendered for conversion shall not become the holder or holders of record of such Common Shares until the Business Day following such Interest Payment Date and, for clarity, any interest payable on such Debentures will be for the account of the holder of record of such Debentures at the close of business on the relevant record date.

 

- 12 -

 

 

(9) The Issued Debentures shall be issued in denominations of $1,000 and integral multiples of $1,000. Each Issued Debenture and the certificate of the Trustee endorsed thereon shall be issued in substantially the form set out in Schedule A, with such insertions, omissions, substitutions or other variations as shall be required or permitted by this Indenture, and may have imprinted or otherwise reproduced thereon such legend or legends or endorsements, not inconsistent with the provisions of this Indenture, as may be required to comply with any law or with any rules or regulations pursuant thereto or with any rules or regulations of any securities exchange or securities regulatory authority or to conform with general usage. Each Issued Debenture shall additionally bear such distinguishing letters and numbers as the Trustee shall approve. Notwithstanding the foregoing, an Issued Debenture may be in such other form or forms as may, from time to time, be approved by a resolution of the Board of Directors, or as specified in an Officer’s Certificate. The Issued Debentures may be engraved, lithographed, printed, mimeographed or typewritten or partly in one form and partly in another.

 

(10) The Issued Debentures may be issued in the form of one or more Debenture Certificates or Global Debentures, substantially in the form set out in Schedule “A” hereto or as Uncertificated Debentures. Global Debentures will be registered in the name of the Depository, which, as of the date hereof, shall be CDS (or any nominee of the Depository) and, if applicable, be designated by a CUSIP number. No Beneficial Holder will receive definitive certificates representing its interest in Global Debentures except as provided in Section 3.2. A Global Debenture may be exchanged for Debentures in registered form that are not Global Debentures, or transferred to and registered in the name of a Person other than the Depository for such Global Debentures or a nominee thereof as provided in Section 3.2.

 

(11) Within 30 days following a Change of Control, and subject to the provisions and conditions of this Section 2.4(11), the Corporation shall be obligated to offer to purchase or convert all of the Issued Debentures then outstanding, subject to the exercise of conversion rights of holders in accordance with Section 2.4(7) and Article 6. The terms and conditions of such obligation are set forth below:

 

(a) Not more than 30 days following the occurrence of a Change of Control, the Corporation shall deliver to the Trustee, and the Trustee shall promptly deliver to the holders of the Issued Debentures, a notice stating that there has been a Change of Control and specifying the date on which such Change of Control occurred and the circumstances or events giving rise to such Change of Control (a “Change of Control Notice”). Prior to the Change of Control Purchase Date (as defined below), the Debentureholders shall, in their sole discretion, have the right to require the Corporation to, either: (i) purchase the Debentures (the “Change of Control Purchase Option”) for an amount equal to 100% of the principal amount thereof plus unpaid interest to, but excluding, the Change of Control Purchase Date (the “Change of Control Purchase Price”); or (ii) convert the Debentures at the Conversion Price. The “Change of Control Purchase Date” shall be the date that is 30 Business Days after the date of the Change of Control Notice is delivered to holders of Issued Debentures.

 

(b) If 90% or more in aggregate principal amount of Issued Debentures outstanding on the date the Corporation provides the Change of Control Notice to holders of the Issued Debentures have been surrendered for purchase pursuant to the Change of Control Purchase Option on the expiration thereof, the Corporation has the right, upon written notice provided to the Trustee within 10 days following the expiration of the Change of Control Purchase Option, to redeem all the Issued Debentures remaining outstanding on the expiration of the Change of Control Purchase Option at the Change of Control Purchase Price as at the Change of Control Purchase Date (the “90% Redemption Right”).

 

- 13 -

 

 

(c) Upon receipt of notice that the Corporation has exercised or is exercising the 90% Redemption Right and is acquiring the remaining Issued Debentures, the Trustee shall promptly provide written notice to each Debentureholder that did not previously accept the Change of Control Purchase Option that:

 

(i) the Corporation has exercised the 90% Redemption Right and is purchasing all outstanding Issued Debentures effective on the expiry of the Change of Control Purchase Option at the Change of Control Purchase Price, and shall include a calculation of the amount payable to such holder as payment of the Change of Control Purchase Price as at the Change of Control Purchase Date;

 

  (ii) each such holder must transfer their Issued Debentures to the Trustee on the same terms as those holders that accepted the Change of Control Purchase Option and must send their respective Issued Debentures, duly endorsed for transfer, to the Trustee within 10 Business Days after the sending of such notice; and

 

  (iii) the rights of such holder under the terms of the Issued Debentures and this Indenture cease effective as of the date of expiry of the Change of Control Purchase Option provided the Corporation has, on or before the time of notifying the Trustee of the exercise of the 90% Redemption Right, paid the aggregate Change of Control Purchase Price to, or to the order of, the Trustee and thereafter the Issued Debentures shall not be considered to be outstanding and the holder shall not have any right except to receive such holder’s Change of Control Purchase Price upon surrender and delivery of such holder’s Issued Debentures in accordance with this Indenture.

 

(d) The Corporation shall, on or before 11:00 a.m. (Vancouver time) on the Business Day immediately prior to the Change of Control Purchase Date, deposit with the Trustee or any paying agent to the order of the Trustee, such sums of money as may be sufficient to pay the aggregate Change of Control Purchase Price of the Issued Debentures to be purchased or redeemed by the Corporation on the Change of Control Purchase Date (less any tax required by law to be deducted in respect of accrued and unpaid interest), provided the Corporation may elect to satisfy this requirement by providing the Trustee with a certified cheque or wire transfer for such amounts required under this Section 2.4(11)(d) post-dated to the date of expiry of the Change of Control Purchase Option. The Corporation shall also deposit with the Trustee a sum of money sufficient to pay any reasonable charges or expenses which may be incurred by the Trustee in connection with such purchase. Every such deposit shall be irrevocable. From the sums so deposited, the Trustee shall pay or cause to be paid to the holders of such Issued Debentures, the Change of Control Purchase Price to which they are entitled (less any tax required by law to be deducted in respect of accrued and unpaid interest) on the Corporation’s purchase.

 

(e) In the event that one or more of such Issued Debentures being purchased in accordance with this Section 2.4(11) becomes subject to purchase in part only, upon surrender of such Issued Debentures for payment of the Change of Control Purchase Price, the Corporation shall execute and the Trustee shall certify and deliver without charge to the holder thereof or upon the holder’s order, one or more new Issued Debentures for the portion of the principal amount of the Issued Debentures not purchased.

 

- 14 -

 

 

(f) Issued Debentures for which holders have accepted the Change of Control Purchase Option and Issued Debentures which the Corporation has elected to redeem in accordance with this Section 2.4(11) shall become due and payable at the Change of Control Purchase Price on the Change of Control Purchase Date, in the same manner and with the same effect as if it were the date of maturity specified in such Issued Debentures, anything therein or herein to the contrary notwithstanding, and, from and after the Change of Control Purchase Date, if the money necessary to purchase or redeem, or the Common Shares necessary to purchase or redeem, the Issued Debentures shall have been deposited as provided in this Section 2.4(11) and affidavits or other proofs satisfactory to the Trustee as to the publication and/or mailing of such notices shall have been lodged with it, interest on the Issued Debentures shall cease. If any question shall arise as to whether any notice has been given as above provided and such deposit made, such question shall be decided by the Trustee whose decision shall be final and binding upon all parties in interest.

 

(g) In case the holder of any Issued Debenture to be purchased or redeemed in accordance with this Section 2.4(11) shall fail on or before the Change of Control Purchase Date to so surrender such holder’s Issued Debenture or shall not within such time accept payment of the monies payable, to take delivery of certificates representing such Common Shares issuable in respect thereof, or give such receipt therefor, if any, as the Trustee may require, such monies may be set aside in trust, or such certificates may be held in trust, without interest, either in the deposit department of the Trustee or in a chartered bank, and such setting aside shall for all purposes be deemed a payment to the Debentureholder of the sum or the Common Shares so set aside and the Debentureholder shall have no other right except to receive payment of the monies so paid and deposited, or take delivery of the certificates so deposited, or both, upon surrender and delivery of such holder’s Issued Debenture. In the event that any money or certificates representing Common Shares required to be deposited hereunder with the Trustee or any depository or paying agent on account of principal, premium, if any, or interest, if any, on Issued Debentures issued hereunder shall remain so deposited for a period of six years from the Change of Control Purchase Date, then such monies, or certificates representing Common Shares, or any distributions paid thereon, shall at the end of such period be paid over or delivered over by the Trustee or such depository or paying agent to the Corporation and the Trustee shall not be responsible to Debentureholders for any amounts owing to them. Notwithstanding the foregoing, the Trustee will pay any remaining funds deposited hereunder on that date which is six years after the Change of Control Purchase Date (the “Unclaimed Funds Return Date”) to the Corporation upon receipt from the Corporation of a letter of credit from a financial institution in an amount equal to or in excess of the amount of the remaining funds. If the remaining funds are paid to the Corporation prior to the Unclaimed Funds Return Date, the Corporation shall reimburse the Trustee for any amounts required to be paid by the Trustee to a holder of a Debenture pursuant to the Change of Control Purchase Option after the date of such payment of the remaining funds to the Corporation but prior to the Unclaimed Funds Return Date.

 

(h) Subject to the provisions above related to Issued Debentures purchased in part, all Issued Debentures redeemed and paid under this Section 2.4(11) shall forthwith be delivered to the Trustee and cancelled and no Issued Debentures shall be issued in substitution therefor.

 

- 15 -

 

 

Section 2.5 Issue of Global Debenture

 

(1) The Corporation may specify that the Debentures of a series are to be issued in whole or in part as one or more Global Debentures, that may or may not be book based only debentures, registered in the name of a Depositary, or its nominee, designated by the Corporation in the Written Direction of the Corporation delivered to the Trustee at the time of issue of such Debentures, and in such event the Corporation shall execute and the Debenture Trustee shall certify and deliver one or more Global Debentures which, if applicable, shall be designated by CUSIP number, and that shall:

 

(a) represent an aggregate amount equal to the principal amount of the outstanding Debentures to be represented by one or more Global Debentures;

 

(b) be delivered to such Depository or pursuant to such Depository’s instructions; and

 

(2) Each Depository designated for a Global Debenture must, at the time of its designation and at all times while it serves as such Depository, be a clearing agency registered or designated under the securities legislation of the jurisdiction where the Depository has its principal offices.

 

(3) Global Debentures shall bear a legend substantially to the following effect, or as may otherwise be required by the Depositary:

 

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF CDS CLEARING AND DEPOSITORY SERVICES INC. (“CDS”) TO SIYATA MOBILE INC. (THE “ISSUER”) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IN RESPECT THEREOF IS REGISTERED IN THE NAME OF CDS & CO., OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF CDS (AND ANY PAYMENT IS MADE TO CDS & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF CDS), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED HOLDER HEREOF, CDS & CO., HAS A PROPERTY INTEREST IN THE SECURITIES REPRESENTED BY THIS CERTIFICATE HEREIN AND IT IS A VIOLATION OF ITS RIGHTS FOR ANOTHER PERSON TO HOLD, TRANSFER OR DEAL WITH THIS CERTIFICATE.

 

(4) Unless otherwise provided in this Indenture, the Debenture Trustee shall not issue any unlegended Debenture until it has received an Officers’ Certificate from the Corporation directing it to do so.

 

Section 2.6 Certification and Delivery of Additional Debentures

 

The Corporation may from time to time request the Trustee to certify and deliver Additional Debentures of any series by delivering to the Trustee the documents referred to below in this Section 2.6 whereupon the Trustee shall certify such Debentures and cause the same to be delivered in accordance with the Written Direction of the Corporation referred to below or pursuant to such procedures acceptable to the Trustee as may be specified from time to time by a Written Direction of the Corporation. The maturity date, issue date, interest rate (if any) and any other terms of the Debentures of such series shall be set forth in or determined by or pursuant to such Written Direction of the Corporation and procedures. In certifying such Debentures, the Trustee shall be entitled to receive and shall be fully protected in relying upon, unless and until such documents have been superseded or revoked:

 

  (a) an Officer’s Certificate and/or executed supplemental indenture by or pursuant to which the form and terms of such Additional Debentures were established;

 

- 16 -

 

 

  (b) a Written Direction of the Corporation requesting certification and delivery of such Additional Debentures and setting forth delivery instructions, provided that, with respect to Debentures of a series subject to a Periodic Offering:

 

  (i) such Written Direction of the Corporation may be delivered by the Corporation to the Trustee prior to the delivery to the Trustee of such Additional Debentures of such series for certification and delivery;

 

  (ii) the Trustee shall certify and deliver Additional Debentures of such series for original issue from time to time, in an aggregate principal amount not exceeding the aggregate principal amount, if any, established for such series, pursuant to a Written Direction of the Corporation or pursuant to procedures acceptable to the Trustee as may be specified from time to time by a Written Direction of the Corporation;

 

  (iii) the maturity date or dates, issue date or dates, interest rate or rates (if any) and any other terms of Additional Debentures of such series shall be determined by an executed supplemental indenture or by Written Direction of the Corporation or pursuant to such procedures; and

 

  (iv) if provided for in such procedures, such Written Direction of the Corporation may authorize certification and delivery pursuant to oral or electronic instructions from the Corporation which oral or electronic instructions shall be promptly confirmed in writing;

 

  (c) an opinion of Counsel, in form and substance satisfactory to the Trustee, acting reasonably, to the effect that all requirements imposed by this Indenture and by law in connection with the proposed issue of Additional Debentures have been complied with, subject to the delivery of certain documents or instruments specified in such opinion; and

 

  (d) an Officer’s Certificate certifying that the Corporation is not in default under this Indenture, that the terms and conditions for the certification and delivery of Additional Debentures (including those set forth in Section 14.5), have been complied with subject to the delivery of any documents or instruments specified in such Officer’s Certificate and that no Event of Default exists or will exist upon such certification and delivery.

 

Section 2.7 Non-Certificated Deposit

 

(1) Subject to the provisions hereof, at the Corporation’s option, Debentures may be issued and registered in the name of CDS or its nominee and:

 

(a) the deposit of which may be confirmed electronically by the Trustee to a particular Participant through CDS; and

 

(b) shall be identified by a specific CUSIP/ISIN as requested by the Corporation from CDS to identify each specific series of Debentures and the Issued Debentures shall be identified by either CUSIP – 83013QAA1 or ISIN – CA83013QAA19.

 

(2) If the Corporation issues Debentures in a non-certificated format, Beneficial Holders of such Debentures registered and deposited with CDS shall not receive Debenture Certificates in definitive form and shall not be considered owners or holders thereof under this Indenture or any supplemental indenture. Beneficial interests in Debentures registered and deposited with CDS will be represented only through the non-certificated inventory system administered by CDS. Transfers of Debentures registered and deposited with CDS between Participants shall occur in accordance with the rules and procedures of CDS. Neither the Corporation nor the Trustee shall have any responsibility or liability for any aspects of the records relating to or payments made by CDS or its nominee, on account of the beneficial interests in Debentures registered and deposited with CDS. Nothing herein shall prevent the Beneficial Holders of Debentures registered and deposited with CDS from voting such Debentures using duly executed proxies or voting instruction forms.

 

- 17 -

 

 

(3) All references herein to actions by, notices given or payments made to, Debentures shall, where Debentures are held through CDS, refer to actions taken by, or notices given or payments made to, CDS upon instruction from the Participants in accordance with its rules and procedures. For the purposes of any provision hereof requiring or permitting actions with the consent of or the direction of Debentureholders evidencing a specified percentage of the aggregate Debentures outstanding, such direction or consent may be given by Beneficial Holders acting through CDS and the Participants owning Debentures evidencing the requisite percentage of the Debentures. The rights of a Beneficial Holder whose Debentures are held established by law and agreements between such holders and CDS and the Participants upon instructions from the Participants. Each Trustee and the Corporation may deal with CDS for all purposes (including the making of payments) as the authorized representative of the respective Debentures and such dealing with CDS shall constitute satisfaction or performance, as applicable, of their respective obligations hereunder.

 

(4) For so long as Debentures are held through CDS, if any notice or other communication is required to be given to Debentureholders, the Trustee will give such notices and communications to CDS.

 

(5) If CDS resigns or is removed from its responsibility as Depository and the Corporation is unable or does not wish to locate a qualified successor, CDS shall provide the Trustee with instructions for registration of Debentures in the names and in the amounts specified by CDS, and the Corporation shall issue and the Trustee shall certify and deliver the aggregate number of Debentures then outstanding in the form of definitive Debentures Certificates representing such Debentures.

 

(6) The rights of Beneficial Holders who hold securities entitlements in respect of the Debentures through non-certificated inventory system administered by CDS shall be limited to those established by applicable law and agreements between the Depository and the Participants and between such Participants and the Beneficial Holders who hold securities entitlements in respect of the Debentures through the non-certificated inventory system administered by CDS, and such rights must be exercised through a Participant in accordance with the rules and procedures of the Depository.

 

(7) Notwithstanding anything herein to the contrary, none of the Corporation or the Trustee or any agent thereof shall have any responsibility or liability for:

 

(a) the electronic records maintained by the Depository relating to any ownership interests or other interests in the Debentures or the depository system maintained by the Depository, or payments made on account of any ownership interest or any other interest of any Person in any Debenture represented by an electronic position in the non-certificated inventory system administered by CDS (other than Depository or its nominee);

 

(b) for maintaining, supervising or reviewing any records of the Depository or any Participant relating to any such interest; or

 

(c) any advice or representation made or given by the Depository or those contained herein that relate to the rules and regulations of the Depository or any action to be taken by the Depository on its own direction or at the direction of any Participant.

 

- 18 -

 

 

(8) The Corporation may terminate the application of this Section 2.7 in its sole discretion in which case all Debentures shall be evidenced by Debenture Certificates registered in the name of a Person other than the Depository.

 

Section 2.8 Execution of Debentures

 

All Debentures shall be signed (either manually or by facsimile or other electronic signature) by any one authorized director or officer of the Corporation holding office at the time of signing. A facsimile or electronic signature upon a Debenture shall for all purposes of this Indenture be deemed to be the signature of the person whose signature it purports to be. Notwithstanding that any person whose signature, either manual or in facsimile or electronic form, appears on a Debenture as a director or officer may no longer hold such office at the date of the Debenture or at the date of the certification and delivery thereof, such Debenture shall be valid and binding upon the Corporation and entitled to the benefits of this Indenture.

 

Section 2.9 Certification

 

(1) No Debenture shall be issued or, if issued, shall be obligatory or shall entitle the holder to the benefits of this Indenture, until it has been certified by or on behalf of the Trustee substantially in the form set out in this Indenture, in the relevant supplemental indenture, or in some other form approved by the Trustee. Such certification of any Debenture shall be conclusive evidence that such Debenture is duly issued, is a valid obligation of the Corporation and the holder is entitled to the benefits hereof.

 

(2) The certificate of the Trustee signed on the Debentures, or interim Debentures hereinafter mentioned, shall not be construed as a representation or warranty by the Trustee as to the validity of this Indenture or of the Debentures or interim Debentures or as to the issuance of the Debentures or interim Debentures and the Trustee shall in no respect be liable or answerable for the use made of the Debentures or interim Debentures or any of them or the proceeds thereof. The certificate of the Trustee on the Debentures or interim Debentures shall, however, be a representation and warranty by the Trustee that the Debentures or interim Debentures have been duly certified by or on behalf of the Trustee pursuant to the provisions of this Indenture.

 

(3) The Trustee shall certify Uncertificated Debentures (whether upon original issuance, exchange, registration of transfer or otherwise) by completing its Internal Procedures and the Corporation shall, and hereby acknowledges that it shall, thereupon be deemed to have duly and validly issued such Uncertificated Debentures have been duly issued hereunder and that the holder or holders are entitled to the benefits of this Indenture. The register shall be final and conclusive evidence as to all matters relating to Uncertificated Debentures with respect to which this Indenture requires the Trustee to maintain records or accounts. In case of differences between the register at any time and any other time the register at the later time shall be controlling, absent manifest error and such Uncertificated Debentures are binding on the Corporation.

 

- 19 -

 

 

Section 2.10 Interim Debentures or Certificates

 

Pending the delivery of definitive Debentures of any series to the Trustee, the Corporation may issue and the Trustee certify in lieu thereof interim Debentures in such forms and in such denominations and signed in such manner as provided herein, entitling the holders thereof to definitive Debentures of the series when the same are ready for delivery; or the Corporation may execute and the Trustee certify a temporary Debenture for the whole principal amount of Debentures of the series then authorized to be issued hereunder and deliver the same to the Trustee and thereupon the Trustee may issue its own interim certificates in such form and in such amounts, not exceeding in the aggregate the principal amount of the temporary Debenture so delivered to it, as the Corporation and the Trustee may approve entitling the holders thereof to definitive Debentures of the series when the same are ready for delivery; and, when so issued and certified, such interim or temporary Debentures or interim certificates shall, for all purposes but without duplication, rank in respect of this Indenture equally with Debentures duly issued hereunder and, pending the exchange thereof for definitive Debentures, the holders of the interim or temporary Debentures or interim certificates shall be deemed without duplication to be Debentureholders and entitled to the benefit of this Indenture to the same extent and in the same manner as though the said exchange had actually been made. Forthwith after the Corporation shall have delivered the definitive Debentures to the Trustee, the Trustee shall cancel such temporary Debentures, if any, and shall call in for exchange all interim Debentures or certificates that shall have been issued and forthwith after such exchange shall cancel the same. No charge shall be made by the Corporation or the Trustee to the holders of such interim or temporary Debentures or interim certificates for the exchange thereof. All interest paid upon interim or temporary Debentures or interim certificates shall be noted thereon as a condition precedent to such payment unless paid by cheque to the registered holders thereof.

 

Section 2.11 Mutilation, Loss, Theft or Destruction

 

In case any of the Debentures issued hereunder shall become mutilated or be lost, stolen or destroyed, the Corporation shall issue, and thereupon the Trustee shall certify and deliver, a new Debenture upon surrender and cancellation of the mutilated Debenture, or in the case of a lost, stolen or destroyed Debenture, in lieu of and in substitution for the same, and the substituted Debenture shall be in a form approved by the Trustee and shall be entitled to the benefits of this Indenture and rank equally in accordance with its terms with all other Debentures issued or to be issued hereunder. In case of loss, theft or destruction, the applicant for a substituted Debenture shall furnish to the Corporation and to the Trustee such evidence of the loss, theft or destruction of the Debenture as shall be satisfactory to them in their discretion, acting reasonably, and shall also furnish an indemnity and surety bond satisfactory to them in their discretion, acting reasonably. The applicant shall pay all reasonable expenses incidental to the issuance of any substituted Debenture.

 

Section 2.12 Concerning Interest

 

(1) All Debentures issued hereunder, whether originally or upon exchange or in substitution for previously issued Debentures which are interest bearing, shall bear interest (i) from and including their issue date, or (ii) from and including the last Interest Payment Date to which interest shall have been paid or made available for payment on the outstanding Debentures of that series, whichever shall be the later, or, in respect of Debentures subject to a Periodic Offering, from and including their issue date or from and including the last Interest Payment Date to which interest shall have been paid or made available for payment on such Debentures, in all cases, to and excluding the next Interest Payment Date.

 

Section 2.13 Ranking of Debentures

 

The Debentures will be direct unsecured obligations of the Corporation. Each Debenture of the same series of Debentures will rank pari passu with each other Debenture of the same series (regardless of their actual date or terms of issue) and, subject to statutory preferred exceptions, with all other previously existing and future unsecured indebtedness of the Corporation.

 

- 20 -

 

 

Section 2.14 Payments of Amounts Due on Maturity

 

Except as may otherwise be provided herein or in any supplemental indenture in respect of any series of Debentures, payments of amounts due upon maturity of the Debentures will be made in the following manner. The Corporation will establish and maintain with the Trustee a Maturity Account for each series of Debentures. Each such Maturity Account shall be maintained by and be subject to the control of the Trustee for the purposes of this Indenture. On or before 11:00 a.m. (Vancouver time) not less than five Business Days immediately prior to each Maturity Date for Debentures outstanding from time to time under this Indenture, the Corporation will deliver to the Trustee a certified cheque or wire transfer for deposit in the applicable Maturity Account in an amount sufficient to pay the cash amount payable in respect of such Debentures (including the principal amount together with any accrued and unpaid interest thereon less any tax required by law to be deducted). The Trustee, on behalf of the Corporation, will pay to each holder entitled to receive payment the principal amount of and premium (if any) and accrued and unpaid interest on the Debenture, upon surrender of the Debenture at any branch of the Trustee designated for such purpose from time to time by the Corporation and the Trustee. The delivery of such funds to the Trustee for deposit to the applicable Maturity Account will satisfy and discharge the liability of the Corporation for the Debentures to which the delivery of funds relates to the extent of the amount delivered (plus the amount of any tax deducted as aforesaid) and such Debentures will thereafter to that extent not be considered as outstanding under this Indenture and such holder will have no other right in regard thereto other than to receive out of the money so delivered or made available the amount to which it is entitled. Interest shall cease to accrue on the Debentures upon the Maturity Date provided the Trustee has received, by the Maturity Date, from the Corporation all the funds due and payable on the Debentures.

 

Section 2.15 Payment of Interest

 

The following provisions shall apply to Debentures, except as otherwise provided in Section 2.4(4) or: (i) with respect to minor administrative matters or typographical errors, as specified in a resolution of the Board of Directors, an Officer’s Certificate, or (ii) as otherwise specified in a supplemental indenture relating to a particular series of Additional Debentures:

 

(a) As interest becomes due on each Debenture (except, subject to certain exceptions set forth herein including in Section 2.4(4), on conversion or on redemption, when interest may at the option of the Corporation be paid upon surrender of such Debenture), the Corporation, either directly or through the Trustee or any agent of the Trustee, shall send or forward by prepaid ordinary mail, electronic transfer of funds or such other means as may be agreed to by the Trustee, payment of such interest (less any tax required to be withheld therefrom) to the order of the registered holder of such Debenture appearing on the registers maintained by the Trustee at the close of business on the record date prior to the applicable Interest Payment Date and addressed to the holder at the holder’s last address appearing on the register, unless such holder otherwise directs. If payment is made by cheque, such cheque shall be forwarded at least three days prior to each date on which interest becomes due, and if payment is made by other means (such as electronic transfer of funds), the Trustee must receive confirmation of receipt of funds prior to being able to forward funds or cheques to holders) and such payment shall be made in a manner whereby the holder receives credit for such payment on the date such interest on such Debenture becomes due. The mailing of such cheque or the making of such payment by other means shall, to the extent of the sum represented thereby, plus the amount of any tax withheld as aforesaid, satisfy and discharge all liability for interest on such Debenture, unless in the case of payment by cheque, such cheque is not paid at par on presentation. In the event of non-receipt of any cheque for or other payment of interest by the person to whom it is so sent as aforesaid, the Corporation will issue to such person a replacement cheque or other payment for a like amount upon being furnished with such evidence of non-receipt as it shall reasonably require and upon being indemnified to its satisfaction. Notwithstanding the foregoing, if the Corporation is prevented by circumstances beyond its control (including, without limitation, any interruption in mail service) from making payment of any interest due on each Debenture in the manner provided above, the Corporation may make payment of such interest or make such interest available for payment in any other manner acceptable to the Trustee with the same effect as though payment had been made in the manner provided above.

 

- 21 -

 

 

(b) Notwithstanding Section 2.15(1)(a), if the Debentures are represented by a Global Debenture or otherwise registered in the name of CDS or its nominee, then all payments of interest on such Global Debentures shall be made on such Interest Payment Date by wire transfer or cheque made payable to the Depository or its nominee for subsequent payment to Beneficial Holders of interests in the applicable Global Debenture, unless the Corporation and the Depository otherwise agree. If the Corporation wishes to have the Trustee act as interest paying agent, funds must be delivered to the Trustee no later than the Business Day prior to the day interest is payable to the Depository. None of the Corporation, the Debenture Trustee or any agent of the Debenture Trustee for any Debenture issued as a Global Debenture will be liable or responsible to any person for any aspect of the records related to or payments made on account of beneficial interests in any Global Debenture or for maintaining, reviewing, or supervising any records relating to such beneficial interests.

 

Article 3 – REGISTRATION, TRANSFER, EXCHANGE AND OWNERSHIP

 

Section 3.1 Fully Registered Debentures

 

(1) With respect to each series of Debentures issuable as Fully Registered Debentures, the Corporation shall cause to be kept by and at the principal office of the Trustee in Vancouver, British Columbia and by the Trustee or such other registrar as the Corporation, with the approval of the Trustee, may appoint at such other place or places, if any, as may be specified in the Debentures of such series or as the Corporation may designate with the approval of the Trustee, a register in which shall be entered the names and addresses of the holders of Fully Registered Debentures and particulars of the Debentures held by them respectively and of all transfers of Fully Registered Debentures. Such registration shall be noted on the Debenture register by the Trustee or other registrar unless a new Debenture shall be issued upon such transfer.

 

(2) No transfer of a Fully Registered Debenture shall be valid unless made on such register referred to in Section 3.1(1) by the registered holder or such holder’s executors, administrators or other legal representatives or an attorney duly appointed by an instrument in writing in form and executed in a manner satisfactory to the Trustee or other registrar upon surrender of the Debentures together with a duly executed form of transfer acceptable to the Trustee upon compliance with such other reasonable requirements as the Trustee or other registrar may prescribe, or unless the name of the transferee shall have been noted on the Debenture by the Trustee or other registrar.

 

Section 3.2 Global Debentures

 

(1) With respect to the Debentures issuable in whole or in part as one or more Global Debentures, the Corporation shall cause to be kept by and at the offices of the Trustee in Vancouver, British Columbia and by the Trustee or such other registrar as the Corporation, with the approval of the Trustee, may appoint at such other place or places, if any, as the Corporation may designate with the approval of the Trustee, a register in which shall be entered the name and address of the holder of each such Global Debenture (being the Depository, or its nominee, for such Global Debenture) as holder thereof and particulars of the Global Debenture held by it, and of all transfers thereof. If the Debentures are at any time not Global Debentures, the provisions of Section 3.1 shall govern with respect to registrations and transfers of such Debentures.

 

- 22 -

 

 

(2) Notwithstanding any other provision of this Indenture, a Global Debenture may not be transferred by the registered holder thereof and accordingly, no definitive certificates shall be issued to Beneficial Holders of Debentures, except in the following circumstances or as otherwise specified in a resolution of the Directors, an Officer’s Certificate or supplemental indenture relating to the Debentures.

 

(3) Global Debentures may be transferred by a Depository to a nominee of such Depository or by a nominee of a Depository to such Depository or to another nominee of such Depository or by a Depository or its nominee to a successor Depository or its nominee.

 

(4) Global Debentures may be transferred at any time after the Depository for such Global Debentures (i) has notified the Corporation that it is unwilling or unable to continue as Depository in connection with Global Debentures, or (ii) if at any time the Depository ceases to be a clearing agency or otherwise ceases to be eligible to be a Depository under Section 2.5(2) and the Corporation has not appointed a successor Depository for such Global Debentures.

 

(5) Global Debentures may be transferred at any time after the Corporation has determined, in its sole discretion, to terminate the book-based system in respect of such Global Debentures and has communicated such determination to the Trustee in writing.

 

(6) Global Debentures may be transferred at any time after an Event of Default has occurred and is continuing with respect to the Debentures issued as a Global Debenture, provided that Beneficial Holders of the Debentures representing, in the aggregate, not less than 25% of the aggregate principal amount of the Debentures advise the Depository in writing, through the Depository Participants, that the continuation of the book-based system for the Debentures is no longer in their best interest and also provided that at the time of such transfer the Trustee has not waived the Event of Default pursuant to Section 8.3.

 

(7) Global Debentures may be transferred if required by applicable law.

 

(8) Global Debentures may be transferred if the book-based system ceases to exist.

 

(9) With respect to the Global Debentures, unless and until definitive certificates have been issued to Beneficial Holders pursuant to Section 3.2(2):

 

(a) the Corporation and the Trustee may deal with the Depository for all purposes (including paying interest on the Debentures) as the sole holder of the Debentures and the authorized representative of the Beneficial Holders;

 

(b) the rights of the Beneficial Holders shall be exercised only through the Depository and shall be limited to those established by applicable law and agreements between such Beneficial Holders and the Depository or the Depository Participants;

 

(c) the Depository will make book-based transfers among the Depository Participants; and

 

(d) whenever this Indenture requires or permits actions to be taken based upon instructions or directions of Debentureholders evidencing a specified percentage of the outstanding Debentures, the Depository shall be deemed to be counted in that percentage only to the extent that it has received instructions to such effect from the Beneficial Holders or the Depository Participant, and has delivered such instructions to the Trustee.

 

(10) Whenever a notice or other communication is required to be provided to Debentureholders, unless and until definitive certificate(s) have been issued to Beneficial Holders pursuant to this Section 3.2, the Debenture Trustee shall provide all such notices and communications to the Depository and the Depository shall deliver such notices and communications to such Beneficial Holders in accordance with Applicable Securities Legislation. Upon the termination of the book-based system with respect to the Debentures issued hereunder, the Trustee shall notify all applicable Depository Participants and Beneficial Holders, through the Depository, of the availability of definitive Debenture certificates. Upon surrender by the Depository of the certificate(s) representing the Global Debentures and receipt of new registration instructions from the Depository, the Trustee shall deliver the definitive Debenture Certificates for such Debentures to the holders thereof in accordance with the new registration instructions and thereafter, the registration and transfer of such Debentures will be governed by Section 3.1 and the remaining Sections of this Article 3.

 

- 23 -

 

 

Section 3.3 Transferee Entitled to Registration

 

The transferee of a Debenture shall be entitled, after the appropriate form of transfer is lodged with the Trustee or other registrar and upon compliance with all other conditions in that behalf required by this Indenture or by law, to be entered on the register as the owner of such Debenture free from all equities or rights of set-off or counterclaim between the Corporation and the transferor or any previous holder of such Debenture, save in respect of equities of which the Corporation is required to take notice by statute or by order of a court of competent jurisdiction. Upon surrender for registration of transfer of Debentures, the Corporation shall issue and thereupon the Trustee shall certify and deliver a new Debenture Certificate or confirm the electronic deposit of Uncertificated Debentures of like tenor in the name of the designated transferee and register such transfer in accordance with Section 3.1. If less than all the Debentures evidenced by the Debenture Certificate(s) or Uncertificated Debentures so surrendered are transferred, the transferor shall be entitled to receive, in the same manner, a new Debenture Certificate or electronically deposited Uncertificated Debentures registered in his name evidencing the Debentures not transferred.

 

Section 3.4 No Notice of Trusts

 

Neither the Corporation nor the Trustee nor any registrar shall be bound to take notice of or see to the execution of any trust (other than that created by this Indenture) whether express, implied or constructive, in respect of any Debenture, and may transfer the same on the direction of the person registered as the holder thereof, whether named as trustee or otherwise, as though that person were the beneficial owner thereof.

 

Section 3.5 Registers Open for Inspection

 

The registers referred to in Section 3.1 shall at all reasonable times be open for inspection by the Corporation, the Trustee or any Debentureholder. Every registrar, including the Trustee, shall from time to time when requested so to do by the Corporation, in writing, furnish the Corporation with a list of names and addresses of holders of registered Debentures entered on the register kept by them and showing the principal amount and serial numbers of the Debentures held by each such holder.

 

Section 3.6 Exchanges of Debentures

 

(1) Subject to Section 3.1 and Section 3.7, Debentures in any authorized form or denomination, other than Global Debentures, may be exchanged for Debentures in any other authorized form or denomination, of the same series and date of maturity, bearing the same interest rate and of the same aggregate principal amount as the Debentures so exchanged.

 

(2) In respect of exchanges of Debentures permitted by Section 3.6(1), Debentures of any series may be exchanged only at the principal offices of the Trustee in the city of Vancouver, British Columbia or at such other place or places, if any, as may be specified in the Debentures of such series and at such other place or places as may from time to time be designated by the Corporation with the approval of the Trustee. Any Debentures surrendered for exchange shall be surrendered to the Trustee. The Corporation shall execute and the Trustee shall certify all Debentures necessary to carry out exchanges as aforesaid. All Debentures surrendered for exchange shall be cancelled.

 

(3) Debentures issued in exchange for Debentures which at the time of such issue have been selected or called for redemption at a later date shall be deemed to have been selected or called for redemption in the same manner and shall have noted thereon a statement to that effect.

 

- 24 -

 

 

Section 3.7 Closing of Registers

 

(1) Neither the Corporation nor the Trustee nor any registrar shall be required to:

 

(a) make transfers or exchanges or convert any Fully Registered Debentures on any Interest Payment Date for such Debentures or during the five preceding Business Days;

 

(b) make transfers or exchanges of, or convert any Debentures on the day of any selection by the Trustee of Debentures to be redeemed or during the ten preceding Business Days;

 

(c) make conversions of Debentures or any Interest Payment Date or during the five preceding Business Days;

 

(d) make exchanges of any Debentures which will have been selected or called for redemption unless upon due presentation thereof for redemption such Debentures shall not be redeemed, as the register for the applicable series of Debentures shall be closed in respect of such actions on such dates; or

 

(e) make conversions of any Debentures the Business Day immediately preceding the Maturity Date for such Debentures or during such greater period prior to an applicable maturity date as directed in writing by the Corporation (which period shall not exceed the five Business Days preceding the applicable date of maturity).

 

(2) Subject to any restriction herein provided, the Corporation with the approval of the Trustee may at any time close any register for any series of Debentures, other than those kept at the principal offices of the Trustee in Vancouver, British Columbia, and transfer the registration of any Debentures registered thereon to another register (which may be an existing register) and thereafter such Debentures shall be deemed to be registered on such other register. Notice of such transfer shall be given to the holders of such Debentures.

 

Section 3.8 Charges for Registration, Transfer and Exchange

 

For each Debenture exchanged, registered, transferred or discharged from registration, the Trustee or other registrar, except as otherwise herein provided, may make a reasonable charge for its services and in addition may charge a reasonable sum for each new Debenture issued (such amounts to be agreed upon from time to time by the Trustee and the Corporation), and payment of such charges and reimbursement of the Trustee or other registrar for any stamp taxes or governmental or other charges required to be paid shall be made by the party requesting such exchange, registration, transfer or discharge from registration as a condition precedent thereto. Notwithstanding the foregoing provisions, no charge shall be made to a Debentureholder hereunder:

 

(a) for any exchange, registration, transfer or discharge from registration of any Debenture applied for within a period of two months from the date of the first delivery of Debentures of that series or, with respect to Debentures subject to a Periodic Offering, within a period of two months from the date of delivery of any such Debenture;

 

- 25 -

 

 

(b) for any exchange of any interim or temporary Debenture or interim certificate that has been issued under Section 2.10 for a definitive Debenture; or

 

for any exchange of a Global Debenture as contemplated in Section 3.2.

 

Section 3.9 Ownership of Debentures

 

(1) Unless otherwise required by law, the person in whose name any registered Debenture is registered shall for all purposes of this Indenture be and be deemed to be the owner thereof and payment of or on account of the principal of and premium, if any, on such Debenture and interest thereon shall be made to such registered holder.

 

(2) The registered holder for the time being of any registered Debenture shall be entitled to the principal, premium, if any, and/or interest evidenced by such instruments, respectively, free from all equities or rights of set-off or counterclaim between the Corporation and the original or any intermediate holder thereof and all persons may act accordingly and the receipt of any such registered holder for any such principal, premium or interest shall be a good discharge to the Trustee, any registrar and to the Corporation for the same and none shall be bound to inquire into the title of any such registered holder.

 

(3) Where Debentures are registered in more than one name, the principal, premium, if any, and interest from time to time payable in respect thereof may be paid to the order of all such holders, failing written instructions from them to the contrary, and the receipt of any one of such holders therefor shall be a valid discharge, to the Trustee, any registrar and to the Corporation.

 

(4) In the case of the death of one or more joint holders of any Debenture the principal, premium, if any, and interest from time to time payable thereon may be paid to the order of the survivor or survivors of such registered holders and the receipt of any such survivor or survivors therefor shall be a valid discharge to the Trustee and any registrar and to the Corporation.

 

Article 4 – REDEMPTION AND PURCHASE OF DEBENTURES

 

Section 4.1 Applicability of Article

 

Subject to regulatory approval, Section 2.4(5) and Article 6, and provided no Event of Default has occurred and is continuing, the Corporation shall have the right at its option to redeem all Debentures outstanding hereunder, including all principal amounts and accrued interest thereunder, by payment of money in accordance with Section 2.4(5), at any time on or after December 23, 2020, on not greater than 60 days’ and not less than 30 days’ notice.

 

Section 4.2 Notice of Redemption

 

(1) Notice of redemption (the “Redemption Notice”) of any series of Debentures shall be given to the holders of the Debentures so to be redeemed not more than 60 days nor less than 30 days prior to the date fixed for redemption (the “Redemption Date”) in the manner provided in Section 13.2. Every such notice shall specify the aggregate principal amount of Debentures called for redemption, the Redemption Date, the Redemption Price and the places of payment and shall state that interest upon the principal amount of Debentures called for redemption shall cease to be payable from and after the Redemption Date. In addition, unless all the outstanding Debentures are to be redeemed, the Redemption Notice shall specify:

 

(a) the distinguishing letters and numbers of the registered Debentures which are to be redeemed (or of such thereof as are registered in the name of such Debentureholder);

 

- 26 -

 

 

(b) in the case of a published notice, the distinguishing letters and numbers of the Debentures which are to be redeemed or, if such Debentures are selected by terminal digit or other similar system, such particulars as may be sufficient to identify the Debentures so selected;

 

(c) in the case of a Global Debenture, that the redemption will take place in such manner as may be agreed upon by the Depository, the Trustee and the Corporation; and

 

(d) in all cases, the principal amounts of such Debentures or, if any such Debenture is to be redeemed in part only, the principal amount of such part.

 

Section 4.3 Debentures Due on Redemption Dates

 

Notice having been given as aforesaid, all the Debentures so called for redemption shall thereupon be and become due and payable at the Redemption Price, together with accrued interest up to and including the Redemption Date, on the Redemption Date specified in such notice, in the same manner and with the same effect as if it were the date of maturity specified in such Debentures, anything therein or herein to the contrary notwithstanding, and from and after such Redemption Date, if the monies necessary to redeem such Debentures shall have been deposited as provided in Section 4.4 and affidavits or other proof satisfactory to the Trustee, acting reasonably, as to the publication and/or mailing of such notices shall have been lodged with it, interest upon the Debentures shall cease. If any question shall arise as to whether any notice has been given as above provided and such deposit made, such question shall be decided by the Trustee whose decision shall be final and binding upon all parties in interest.

 

Section 4.4 Deposit of Redemption Monies

 

Redemption of Debentures shall be provided for by the Corporation depositing with the Trustee or any paying agent to the order of the Trustee, on or before 11:00 a.m. (Vancouver time) on the Business Day immediately prior to the Redemption Date specified in such notice, such sums of money as may be sufficient to pay the Redemption Price of the Debentures so called for redemption. The Corporation shall also deposit with the Trustee a sum of money sufficient to pay any charges or expenses which may be incurred by the Trustee in connection with such redemption. Every such deposit shall be irrevocable. From the sums so deposited, the Trustee shall pay or cause to be paid to the holders of such Debentures so called for redemption, upon surrender of such Debentures, the principal, premium (if any) and interest (if any) to which they are respectively entitled on redemption.

 

Section 4.5 Failure to Surrender Debentures Called for Redemption

 

In case the holder of any Debenture so called for redemption shall fail on or before the Redemption Date to so surrender such holder’s Debenture, or shall not within such time accept payment of the redemption monies payable, or give such receipt therefor, if any, as the Trustee may require, such redemption monies may be set aside in trust, either in the deposit department of the Trustee or in a chartered bank, and such setting aside shall for all purposes be deemed a payment to the Debentureholder of the sum so set aside and, to that extent, the Debenture shall thereafter not be considered as outstanding hereunder and the Debentureholder shall have no other right except to receive payment out of the monies so paid and deposited, upon surrender and delivery of such holder’s Debenture, plus any accrued but unpaid interest thereon up to and including the Redemption Date. In the event that any money required to be deposited hereunder with the Trustee or any depository or paying agent on account of principal, premium, if any, or interest, if any, on Debentures issued hereunder shall remain so deposited for a period of six years from the Redemption Date, then such monies, shall at the end of such period be paid over or delivered over by the Trustee or such depository or paying agent to the Corporation on its demand, and thereupon the Trustee shall not be responsible to Debentureholders for any amounts owing to them and subject to applicable law, thereafter the holder of a Debenture in respect of which such money was so repaid to the Corporation shall have no rights in respect thereof except to obtain payment of the money due from the Corporation, subject to any limitation period provided by the laws of British Columbia. Notwithstanding the foregoing, the Trustee will pay any remaining funds prior to the expiry of six years after the Redemption Date to the Corporation upon receipt from the Corporation, of a letter of credit from a financial institution in an amount equal to or in excess of the amount of the remaining funds. If the remaining funds are paid to the Corporation prior to the expiry of six years after the Redemption Date, the Corporation shall reimburse the Trustee for any amounts required to be paid by the Trustee to a holder of a Debenture pursuant to the redemption after the date of such payment of the remaining funds to the Corporation but prior to six years after the redemption.

 

- 27 -

 

 

Section 4.6 Cancellation of Debentures Redeemed

 

Subject to the provisions of Section 4.7 as to Debentures redeemed or purchased in part, all Debentures redeemed and paid under this Article 4 shall forthwith be delivered to the Trustee and cancelled and no Debentures shall be issued in substitution for those redeemed.

 

Section 4.7 Purchase of Debentures by the Corporation

 

(1) Unless otherwise specifically provided with respect to a particular series of Debentures, the Corporation may, if it is not at the time in default hereunder, at any time and from time to time, purchase Debentures in the market (which shall include purchases from or through an investment dealer or a firm holding membership on a recognized stock exchange) or by tender or by contract, at any price. All Debentures so purchased will be delivered to the Trustee and shall be cancelled and no Debentures shall be issued in substitution therefor.

 

(2) If, upon an invitation for tenders, more Debentures are tendered at the same lowest price than the Corporation is prepared to accept, the Debentures to be purchased by the Corporation shall be selected by the Trustee on a pro rata basis from the Debentures tendered by each tendering Debentureholder who tendered at such lowest price. For this purpose the Trustee may make, and from time to time amend, regulations with respect to the manner in which Debentures may be so selected, and regulations so made shall be valid and binding upon all Debentureholders, notwithstanding the fact that as a result thereof one or more of such Debentures become subject to purchase in part only. The holder of a Debenture of which a part only is purchased, upon surrender of such Debenture for payment, shall be entitled to receive, without expense to such holder, one or more new Debentures for the unpurchased part so surrendered, and the Trustee shall certify and deliver such new Debenture or Debentures upon receipt of the Debenture so surrendered or, with respect to a Global Debenture, the Depository shall make notations on the Global Debenture of the principal amount thereof so purchased.

 

Section 4.8 Deposit of Maturity Monies

 

Payment on maturity of Debentures shall be provided for by the Corporation depositing with the Trustee or any paying agent to the order of the Trustee, on or before 11:00 a.m. (Toronto time) not less than five Business Days immediately prior to the Maturity Date such sums of money as may be sufficient to pay all accrued and unpaid interest thereon up to and excluding the Maturity Date, provided the Corporation may elect to satisfy this requirement by providing the Trustee with a certified cheque or wire transfer for such amounts required under this Section 4.8. The Corporation shall also deposit with the Trustee a sum of money sufficient to pay any charges or expenses which may be incurred by the Trustee in connection therewith. Every such deposit shall be irrevocable. From the sums so deposited, the Trustee shall pay or cause to be paid to the holders of such Debentures, upon surrender of such Debentures, the principal and interest to which they are respectively entitled on the Maturity Date.

 

- 28 -

 

 

Article 5 – SUBORDINATION OF DEBENTURES

 

Section 5.1 Applicability of Article

 

The indebtedness, liabilities and obligations of the Corporation hereunder (except as provided in Section 14.15) or under the Debentures, whether on account of principal, premium, if any, interest or otherwise, but excluding the issuance of Common Shares upon any conversion pursuant to Article 6, upon any purchase pursuant to Article 4, or at maturity pursuant to Section 2.14 (collectively, the “Debenture Liabilities”), shall be subordinated and postponed and subject in right of payment, to the extent and in the manner hereinafter set forth in the following Sections of this Article 5, to the full and final payment of all Secured Indebtedness, and each holder of any such Debenture by his acceptance thereof agrees to and shall be bound by the provisions of this Article 5.

 

Section 5.2 Order of Payment

 

(1) In the event of any insolvency or bankruptcy proceedings, or any receivership, liquidation, reorganization or other similar proceedings relative to the Corporation, or to its property or assets, or in the event of any proceedings for voluntary liquidation, dissolution or voluntary winding-up of the Corporation, whether or not involving insolvency or bankruptcy, or any marshalling of the assets and liabilities of the Corporation:

 

(a) all Secured Indebtedness shall first be paid in full, or provision made for such payment, before any payment is made on account of Debenture Liabilities;

 

(b) any payment or distribution of assets of the Corporation, whether in cash, property or securities, to which the holders of the Debentures or the Trustee on behalf of such holders would be entitled except for the provisions of this Article 5, shall be paid or delivered by the trustee in bankruptcy, receiver, assignee for the benefit of creditors, or other liquidating agent making such payment or distribution, directly to the holders of Secured Indebtedness or their representative or representatives, or to the trustee or trustees under any indenture pursuant to which any instruments evidencing any of such Secured Indebtedness may have been issued, to the extent necessary to pay all Secured Indebtedness in full after giving effect to any concurrent payment or distribution, or provision therefor, to the holders of such Secured Indebtedness; and

 

(c) the Secured Creditors or a receiver or a receiver-manager of the Corporation or of all or part of its assets or any other enforcement agent may sell, mortgage, or otherwise dispose of the Corporation’s assets in whole or in part, free and clear of all Debenture Liabilities and without the approval of the Debentureholders or the Trustee.

 

(2) The rights and priority of the Secured Indebtedness and the subordination pursuant hereto shall not be affected by:

 

(a) the time, sequence or order of creating, granting, executing, delivering of, or registering, perfecting or failing to register or perfect any security notice, caveat, financing statement or other notice in respect of any security securing the Secured Indebtedness (the “Senior Security”);

 

(b) the time or order of the attachment, perfection or crystallization of any security constituted by the Senior Security;

 

- 29 -

 

 

(c) the taking of any collection, enforcement or realization proceedings pursuant to the Senior Security;

 

(d) the date of obtaining of any judgment or order of any bankruptcy court or any court administering bankruptcy, insolvency or similar proceedings as to the entitlement of the Secured Creditors, or any of them or the Debentureholders or any of them to any money or property of the Corporation;

 

(e) the failure to exercise any power or remedy reserved to the Secured Creditors under the Senior Security or to insist upon a strict compliance with any terms thereof;

 

(f) whether any Senior Security is now perfected, hereafter ceases to be perfected, is avoidable by any trustee in bankruptcy or like official or is otherwise set aside, invalidated or lapses;

 

(g) the date of giving or failing to give notice to or making demand upon the Corporation; or

 

(h) any other matter whatsoever.

 

Section 5.3 Subrogation to Rights of Holders of Secured Indebtedness

 

(1) Subject to the prior payment in full of all Secured Indebtedness, the holders of the Debentures shall be subrogated to the rights of the holders of Secured Indebtedness to receive payments or distributions of assets of the Corporation to the extent of the application thereto of such payments or other assets which would have been received by the holders of the Debentures but for the provisions hereof until the principal of, premium, if any, and interest on the Debentures shall be paid in full, and no such payments or distributions to the holders of the Debentures of cash, property or securities, which otherwise would be payable or distributable to the holders of the Secured Indebtedness, shall, as between the Corporation, its creditors other than the holders of Secured Indebtedness, and the holders of Debentures, be deemed to be a payment by the Corporation to the holders of the Secured Indebtedness or on account of the Secured Indebtedness, it being understood that the provisions of this Article 5 are and are intended solely for the purpose of defining the relative rights of the holders of the Debentures, on the one hand, and the holders of Secured Indebtedness, on the other hand.

 

(2) The Trustee, for itself and on behalf of each of the Debentureholders, hereby waives any and all rights to require a Secured Creditor to pursue or exhaust any rights or remedies with respect to the Corporation or any property and assets subject to any Senior Security or in any other manner to require the marshalling of property, assets or security in connection with the exercise by the Secured Creditors of any rights, remedies or recourses available to them.

 

Section 5.4 Obligation to Pay Not Impaired

 

Nothing contained in this Article 5 or elsewhere in this Indenture or in the Debentures is intended to or shall impair, as between the Corporation, its creditors other than the holders of Secured Indebtedness, and the holders of the Debentures, the obligation of the Corporation, which is absolute and unconditional, to pay to the holders of the Debentures the principal of, premium, if any, and interest on the Debentures, as and when the same shall become due and payable in accordance with their terms, or affect the relative rights of the holders of the Debentures and creditors of the Corporation other than the holders of the Secured Indebtedness, nor shall anything herein or therein prevent the Trustee or the holder of any Debenture from exercising all remedies otherwise permitted by applicable law upon default under this Indenture, subject to the rights, if any, under this Article 5 of the holders of Secured Indebtedness in respect of cash, property or securities.

 

- 30 -

 

 

Section 5.5 No Payment if Secured Indebtedness in Default

 

(1) Upon the maturity of any Secured Indebtedness by lapse of time, acceleration or otherwise, or any other enforcement of any Secured Indebtedness, then, except as provided in Section 5.8, all such Secured Indebtedness shall first be paid in full, or shall first have been duly provided for, before any payment is made on account of the Debenture Liabilities.

 

(2) In case of a circumstance constituting a default or event of default with respect to any Secured Indebtedness permitting (whether at that time or upon notice, lapse of time, or satisfaction of any other condition precedent) a Secured Creditor to demand payment or accelerate the maturity thereof where the notice of such default or event of default has been given by or on behalf of the holders of Secured Indebtedness to the Corporation or the Corporation otherwise has knowledge thereof, unless and until such default or event of default shall have been cured or waived or shall have ceased to exist, no payment (by purchase of Debentures or otherwise) shall be made by the Corporation (except as provided in Section 5.8) with respect to the Debenture Liabilities and neither the Trustee nor the holders of Debentures shall be entitled to demand, institute proceedings for the collection of (which shall, for certainty include proceedings related to an adjudication or declaration as to the insolvency or bankruptcy of the Corporation and other similar creditor proceedings), or receive any payment or benefit (including without limitation by set-off, combination of accounts or otherwise in any manner whatsoever) on account of the Debentures after the happening of such a default or event of default (except as provided in Section 5.8), and unless and until such default or event of default shall have been cured or waived or shall have ceased to exist, such payments shall be held in trust for the benefit of, and, if and when such Secured Indebtedness shall have become due and payable, shall be paid over to, the holders of the Secured Indebtedness or their representative or representatives or to the trustee or trustees under any indenture under which any instruments evidencing an amount of the Secured Indebtedness remaining unpaid until all such Secured Indebtedness shall have been paid in full, after giving effect to any concurrent payment or distribution to the holders of such Secured Indebtedness.

 

(3) The fact that any payment hereunder is prohibited by this Section 5.5 shall not prevent the failure to make such payment from being an Event of Default hereunder.

 

Section 5.6 Payment on Debentures Permitted

 

Nothing contained in this Article 5 or elsewhere in this Indenture, or in any of the Debentures, shall affect the obligation of the Corporation to make, or prevent the Corporation from making, at any time except as prohibited by Section 5.2 or Section 5.5, any payment of principal of or, premium, if any, or interest on the Debentures. The fact that any such payment is prohibited by Section 5.2 or Section 5.5 shall not prevent the failure to make such payment from being an Event of Default hereunder. Nothing contained in this Article 5 or elsewhere in this Indenture, or in any of the Debentures, shall prevent the conversion of the Debentures or, except as prohibited by Section 5.2 or Section 5.5, the application by the Trustee of any monies deposited with the Trustee hereunder for the purpose, to the payment of or on account of the Debenture Liabilities.

 

Section 5.7 Confirmation of Subordination

 

Each holder of Debentures by his acceptance thereof authorizes and directs the Trustee on his behalf to take such action as may be necessary or appropriate to effect the subordination as provided in this Article 5 and appoints the Trustee his attorney-in-fact for any and all such purposes. Upon request of the Corporation, and upon being furnished an Officer’s Certificate stating that one or more named Persons are Secured Creditors and specifying the amount and nature of the Secured Indebtedness of such Secured Creditor, the Trustee shall enter into a written agreement or agreements with the Corporation and the Person or Persons named in such Officer’s Certificate providing that such Person or Persons are entitled to all the rights and benefits of this Article 5 as a Secured Creditor and for such other matters, such as an agreement not to amend the provisions of this Article 5 and the definitions herein without the consent of such Secured Creditor, as the Secured Creditor may reasonably request. Such agreement shall be conclusive evidence that the indebtedness specified therein is Secured Indebtedness; however, nothing herein shall impair the rights of any Secured Creditor who has not entered into such an agreement.

 

- 31 -

 

 

Section 5.8 Knowledge of Trustee

 

Notwithstanding the provisions of this Article 5 or any provision in this Indenture or in the Debentures contained, the Trustee will not be charged with knowledge of any Secured Indebtedness or of any default in the payment thereof, or of the existence of any Event of Default or any other fact that would prohibit the making of any payment of monies to or by the Trustee, or the taking of any other action by the Trustee, unless and until the Trustee has received written notice thereof from the Corporation, any Debentureholder or any Secured Creditor.

 

Section 5.9 Trustee May Hold Secured Indebtedness

 

The Trustee is entitled to all the rights set forth in this Article 5 with respect to any Secured Indebtedness at the time held by it, to the same extent as any other holder of Secured Indebtedness, and nothing in this Indenture deprives the Trustee of any of its rights as such holder.

 

Section 5.10 Rights of Holders of Secured Indebtedness Not Impaired

 

No right of any present or future holder of any Secured Indebtedness to enforce the subordination herein will at any time or in any way be prejudiced or impaired by any act or failure to act on the part of the Corporation or by any non-compliance by the Corporation with the terms, provisions and covenants of this Indenture, regardless of any knowledge thereof which any such holder may have or be otherwise charged with.

 

Section 5.11 Altering the Secured Indebtedness

 

The holders of the Secured Indebtedness have the right to extend, renew, modify or amend the terms of the Secured Indebtedness or any security therefor and to release, sell or exchange such security and otherwise to deal freely with the Corporation, all without notice to or consent of the Debentureholders or the Trustee and without affecting the liabilities and obligations of the parties to this Indenture or the Debentureholders.

 

Section 5.12 Additional Indebtedness

 

This Indenture does not restrict the Corporation from incurring additional indebtedness for borrowed money or other obligations or liabilities (including Secured Indebtedness) or mortgaging, pledging or charging its properties to secure any indebtedness or liabilities. Except for Secured Indebtedness, any additional indebtedness for borrowed money or other obligations or liabilities or other debts will be subordinated to the Debentures, provided that any indebtedness provided by any officer, director or other Person holding or otherwise controlling (directly or indirectly) more than 10% of the Common Shares will rank pari passu with the Debentures and with the obligations of the Corporation under the Debentures.

 

- 32 -

 

 

Section 5.13 Right of Debentureholder to Convert Not Impaired

 

The subordination of the Debentures to the Secured Indebtedness and the provisions of this Article 5 do not impair in any way the right of a Debentureholder to convert its Debentures pursuant to Article 6 provided that there is no continuing default or event under Secured Indebtedness or acceleration of Secured Indebtedness that has not been rescinded and provided that such conversion does not result in a payment that could reasonably be expected to cause a default or event of default under any Secured Indebtedness.

 

Section 5.14 Invalidated Payments

 

In the event that any of the Secured Indebtedness shall be paid in full and subsequently, for whatever reason, such formerly paid or satisfied Secured Indebtedness becomes unpaid or unsatisfied, the terms and conditions of this Article 5 shall be reinstated and the provisions of this Article shall again be operative until all Secured Indebtedness is repaid in full, provided that such reinstatement shall not give the Secured Creditors any rights or recourses against the Trustee or the Debentureholders for amounts paid to the Debentureholders subsequent to such payment or satisfaction in full and prior to such reinstatement.

 

Section 5.15 Contesting Security

 

The Trustee, for itself and on behalf of the Debentureholders, agrees that it shall not contest or bring into question the validity, perfection or enforceability of any of the Secured Indebtedness, the Senior Security or the relative priority of the Senior Security.

 

Article 6 – CONVERSION OF DEBENTURES

 

Section 6.1 Applicability of Article

 

(1) Any Debentures issued hereunder of any series which by their terms are convertible (subject, however, to any applicable restriction of the conversion of Debentures of such series) will be convertible into Common Shares or other securities of the Corporation, at such conversion rate or rates, and on such date or dates and in accordance with such other provisions as shall have been determined at the time of issue of such Debentures and shall have been expressed in this Indenture (including Section 2.4(7) and Section 3.7 hereof), in such Debentures, in an Officer’s Certificate, or in a supplemental indenture authorizing or providing for the issue thereof.

 

(2) Such right of conversion shall extend only to the maximum number of whole Common Shares into which the aggregate principal amount of the Debenture or Debentures surrendered for conversion at any one time by the holder thereof may be converted. Fractional interests in Common Shares shall be adjusted for the manner provided in Section 6.5.

 

Section 6.2 Revival of Right to Convert

 

If the redemption of any Debenture called for redemption by the Corporation is not made or the payment of the purchase price of any Debenture which has been tendered in acceptance of an offer by the Corporation to purchase Debentures for cancellation is not made, in the case of a redemption upon due surrender of such Debenture or in the case of a purchase on the date on which such purchase is required to be made, as the case may be, then, provided the Time of Expiry has not passed, the right to convert such Debentures shall revive and continue as if such Debenture had not been called for redemption or tendered in acceptance of the Corporation’s offer, respectively.

 

- 33 -

 

 

Section 6.3 Manner of Exercise of Right to Convert

 

(1) The holder of a Debenture desiring to convert such Debenture in whole or in part into Common Shares shall surrender such Debenture to the Trustee at its principal offices in Vancouver, British Columbia together with a conversion notice in the form attached hereto as Schedule C duly executed by the holder or his or her executors or administrators or other legal representatives or his, her or their attorney duly appointed by an instrument in writing in form and executed in a manner satisfactory to the Trustee, exercising his or her right to convert such Debenture in accordance with the provisions of this Article 6; provided that with respect to a Global Debenture, the obligation to surrender a Debenture to the Trustee shall be satisfied if the Trustee makes notation on the Global Debenture of the principal amount thereof so converted and the Trustee is provided with all other documentation which it may request. Thereupon, subject to payment of all applicable stamp or security transfer, income, withholding or other taxes or other governmental charges and compliance with all reasonable requirements of the Trustee, the Conversion Price shall have been paid and such Debentureholder or his or her nominee(s) or assignee(s) shall be entitled to be entered in the books of the Corporation on the Business Day immediately after the Date of Conversion, as the holder of the number of Common Shares into which such Debenture is convertible, in accordance with the provisions of this Article and, as soon as practicable thereafter, the Corporation shall: (i) deliver or cause to be delivered to the Debentureholder, or subject as aforesaid, his or her nominee(s) or assignee(s) such certificate or certificates for such Common Shares; and (ii) make or cause to be made any payment of interest to which such holder is entitled in accordance with Section 6.3(5).

 

(2) For the purposes of this Article, a Debenture shall be deemed to be surrendered for conversion on the date on which it is so surrendered in proper form when the register of the Trustee is open and in accordance with the provisions of this Article or, in the case of a Global Debenture, on the date on which the Trustee received notice of and all necessary documentation in respect of the exercise of the conversion rights and, in the case of a Debenture so surrendered by post or other means of transmission, on the date on which it is received in proper form by the Trustee at its office specified in Section 6.3(1); provided that if a Debenture is surrendered for conversion on a day on which the register of Common Shares is closed, the Person or Persons entitled to receive Common Shares shall become the holder or holders of record of such Common Shares as at the date on which such registers are next reopened (in each case the “Date of Conversion”).

 

(3) Any part, being $1,000 or an integral multiple thereof, of a Debenture in a denomination in excess of $1,000 may be converted as provided in this Article and all references in this Indenture to conversion of Debentures shall be deemed to include conversion of such parts.

 

(4) The holder of any Debenture of which only a part is converted shall, upon the exercise of his right of conversion surrender such Debenture to the Trustee in accordance with Section 6.3(1), and the Trustee shall cancel the same and shall without charge forthwith certify and deliver to the holder a new Debenture or Debentures in an aggregate principal amount equal to the unconverted part of the principal amount of the Debenture so surrendered or, with respect to a Global Debenture, the Depository shall make notations on the Global Debentures of the principal amount thereof so converted.

 

(5) Except as may be otherwise expressly provided for at the time of issue of such Debentures, as expressed in this Indenture, in such Debentures, in an Officer’s Certificate, or in a supplemental indenture authorizing or providing for the issue thereof, the holder of a Debenture surrendered for conversion in accordance with this Section 6.3 shall be entitled (subject to any applicable restriction on the right to receive interest on conversion of Debentures of any series) to receive accrued and unpaid interest in respect thereof, in cash, up to but excluding the Date of Conversion and the Common Shares issued upon such conversion shall rank only in respect of distributions or dividends declared in favour of shareholders of record on and after the Date of Conversion or such later date as such holder shall become the holder of record of such Common Shares pursuant to Section 6.3(1), from which applicable date they will for all purposes be and be deemed to be issued and outstanding as fully paid and non-assessable Common Shares.

 

- 34 -

 

 

Section 6.4 Adjustment of Conversion Price

 

The Conversion Price in effect at any date shall be subject to adjustment from time to time as set forth below.

 

(a) If and whenever at any time prior to the Time of Expiry the Corporation shall

 

    (i) subdivide or redivide the outstanding Common Shares into a greater number of shares,

 

    (ii) reduce, combine or consolidate the outstanding Common Shares into a smaller number of shares, or

 

    (iii) issue Common Shares to the holders of all or substantially all of the outstanding Common Shares or other securities of the Corporation by way of a dividend or distribution (other than the issue of Common Shares to holders of Common Shares who have elected to receive dividends or distributions in the form of Common Shares in lieu of cash dividends or cash distributions paid in the ordinary course on the Common Shares),

 

  the Conversion Price in effect on the effective date of such subdivision, redivision, reduction, combination or consolidation or on the record date for such issue of Common Shares by way of a dividend or distribution, as the case may be, shall in the case of any of the events referred to in (i) and (iii) above be decreased in proportion to the number of outstanding Common Shares resulting from such subdivision, redivision or dividend, or shall, in the case of any of the events referred to in (ii) above, be increased in proportion to the number of outstanding Common Shares resulting from such reduction, combination or consolidation. Such adjustment shall be made successively whenever any event referred to in this Section 6.4(1)(a) shall occur. Any such issue of Common Shares by way of a dividend or distribution shall be deemed to have been made on the record date for the dividend or distribution for the purpose of calculating the number of outstanding Common Shares under subsections (c) and (d) of this Section 6.4.

 

(b) If and whenever at any time prior to the Time of Expiry the Corporation shall fix a record date for the payment of a cash dividend or distribution to the holders of all or substantially all of the outstanding Common Shares or other securities of the Corporation, the Conversion Price shall be adjusted immediately after such record date so that it shall be equal to the price determined by multiplying the Conversion Price in effect on such record date by a fraction, of which the denominator shall be the Current Market Price on such record date and of which the numerator shall be the Current Market Price on such record date minus the amount in cash per Common Share or other securities distributed to holders of such securities. Such adjustment shall be made successively whenever such a record date is fixed. To the extent that any such cash dividend or distribution is not paid, the Conversion Price shall be re-adjusted to the Conversion Price which would then be in effect if such record date had not been fixed.

 

- 35 -

 

 

(c) If and whenever at any time prior to the Time of Expiry the Corporation shall fix a record date for the issuance of options, rights or warrants to all or substantially all the holders of its outstanding Common Shares or other securities entitling them, for a period expiring not more than 45 days after such record date, to subscribe for or purchase Common Shares (or securities convertible into Common Shares) at a price per share (or having a conversion or exchange price per share) less than 95% of the Current Market Price on such record date, the Conversion Price shall be adjusted immediately after such record date so that it shall equal the price determined by multiplying the Conversion Price in effect on such record date by a fraction, of which the numerator shall be the total number of Common Shares outstanding on such record date plus a number of Common Shares equal to the number arrived at by dividing the aggregate price of the total number of additional Common Shares offered for subscription or purchase (or the aggregate conversion or exchange price of the convertible securities so offered) by such Current Market Price, and of which the denominator shall be the total number of Common Shares outstanding on such record date plus the total number of additional Common Shares offered for subscription or purchase (or into which the convertible securities so offered are convertible). Such adjustment shall be made successively whenever such a record date is fixed. To the extent that any such options, rights or warrants are not so issued or any such options, rights or warrants are not exercised prior to the expiration thereof, the Conversion Price shall be re-adjusted to the Conversion Price which would then be in effect if such record date had not been fixed or to the Conversion Price which would then be in effect based upon the number of Common Shares (or securities convertible into Common Shares) actually issued upon the exercise of such options, rights or warrants were included in such fraction, as the case may be.

 

(d) Subject to Section 2.4(11), if and whenever at any time prior to the Time of Expiry, there is a reclassification of the Common Shares or a capital reorganization of the Corporation other than as described in Section 6.4 or a consolidation, amalgamation, arrangement, share exchange, merger of the Corporation with or into any other Person or other entity or acquisition of the Corporation or other combination pursuant to which the Common Shares are converted into or acquired for cash, securities or other property; or a sale or conveyance of the property and assets of the Corporation as an entirety or substantially as an entirety to any other Person (other than a direct or indirect wholly-owned Subsidiary of the Corporation) or other entity or a liquidation, dissolution or winding-up of the Corporation (any such event, a “Merger Event”), any holder of a Debenture who has not exercised its right of conversion prior to the effective date of such reclassification, capital reorganization, consolidation, amalgamation, arrangement, merger, share exchange, acquisition, combination, sale or conveyance or liquidation, dissolution or winding-up, upon the exercise of such right thereafter, shall be entitled to receive and shall accept, in lieu of the number of Common Shares then sought to be acquired by it, such amount of cash or the number of shares or other securities or property of the Corporation or of the Person or other entity resulting from such merger, amalgamation, arrangement, acquisition, combination or consolidation, or to which such sale or conveyance may be made or which holders of Common Shares receive pursuant to such liquidation, dissolution or winding-up, as the case may be, that such holder of a Debenture would have been entitled to receive on such reclassification, capital reorganization, consolidation, amalgamation, arrangement, merger, share exchange, acquisition, combination, sale or conveyance or liquidation, dissolution or winding-up, if, on the record date or the effective date thereof, as the case may be, the holder had been the registered holder of the number of Common Shares sought to be acquired by it and to which it was entitled to acquire upon the exercise of the conversion right, subject to Section 6.4(1)(m). If determined appropriate by the Board of Directors, to give effect to or to evidence the provisions of this Section 6.4(1)(d), the Corporation, its successor, or such purchasing Person or other entity, as the case may be, shall, prior to or contemporaneously with any such reclassification, capital reorganization, consolidation, amalgamation, arrangement, merger, share exchange, acquisition, combination, sale or conveyance or liquidation, dissolution or winding-up, enter into an indenture which shall provide, to the extent possible, for the application of the provisions set forth in this Indenture with respect to the rights and interests thereafter of the holder of Debentures to the end that the provisions set forth in this Indenture shall thereafter correspondingly be made applicable, as nearly as may reasonably be, with respect to any cash, shares or other securities or property to which a holder of Debentures is entitled on the exercise of its acquisition rights thereafter. Any indenture entered into between the Corporation and the Trustee pursuant to the provisions of this Section 6.4(1)(d) shall be a supplemental indenture entered into pursuant to the provisions of 15. Any indenture entered into between the Corporation, any successor to the Corporation or such purchasing Person or other entity and the Trustee shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided in this Section 6.4(1)(d) and which shall apply to successive reclassifications, capital reorganizations, amalgamations, consolidations, mergers, share exchanges, acquisitions, combinations, sales or conveyances. For greater certainty, nothing in this Section 6.4(1)(d) shall affect or reduce the requirement for any Person to make a Change of Control Offer, and notice of any transaction to which this Section 6.4(1)(d) applies shall be given in accordance with Section 6.10.

 

- 36 -

 

 

(e) If the Corporation shall make a distribution to all or substantially all of the holders of shares in the capital of the Corporation, other than Common Shares, or evidences of indebtedness or other assets of the Corporation, including securities (but excluding (i) any issuance of rights or warrants for which an adjustment was made pursuant to Section 6.4(1)(d) and (ii) any dividend or distribution paid exclusively in cash (the “Distributed Securities”), then in each such case (unless the Corporation distributes such Distributed Securities to the holders of Debentures on such dividend or distribution date (as if each holder had converted such Debenture into Common Shares immediately preceding the record date with respect to such distribution)) the Conversion Price in effect immediately preceding the record date fixed for the determination of shareholders entitled to receive such dividend or distribution shall be adjusted so that the same shall equal the price determined by multiplying the Conversion Price in effect immediately preceding such record date by a fraction of which the denominator shall be the Current Market Price per Common Share on such record date and of which the numerator shall be the Current Market Price per Common Share on such record date less the fair market value (as determined by the Board of Directors, whose determination shall be conclusive evidence of such fair market value, subject to approval by the TSXV (or such other recognized stock exchange on which the Common Shares are listed for trading) and which shall be evidenced by an Officer’s Certificate delivered to the Trustee) on such record date of the portion of the Distributed Securities so distributed applicable to one Common Share (determined on the basis of the number of Common Shares outstanding at the close of business on such record date). Such adjustment shall be made successively whenever any such distribution is made and shall become effective immediately after the record date for the determination of shareholders entitled to receive such distribution. In the event that such dividend or distribution is not so paid or made, the Conversion Price shall again be adjusted to be the Conversion Price that would then be in effect if such dividend or distribution had not been declared. If the then fair market value (as so determined) of the portion of the Distributed Securities so distributed applicable to one Common Share is equal to or greater than the Current Market Price per Common Share on such record date, in lieu of the foregoing adjustment, adequate provision shall be made so that each holder of a Debenture shall have the right to receive upon conversion the amount of Distributed Securities so distributed that such holder would have received had such holder converted each Debenture on such record date. If the Board of Directors determines the fair market value of any distribution for purposes of this clause (e) of Section 6.4 by reference to the actual or when issued trading market for any securities, it must in doing so consider the prices in such market over the same period used in computing the Current Market Price of the Common Shares.

 

Notwithstanding the foregoing, if the securities distributed by the Corporation to all holders of its Common Shares consist of capital stock of, or similar equity interests in, a Subsidiary or other business of the Corporation (the “Spinoff Securities”), the Conversion Price shall be adjusted, unless the Corporation makes an equivalent distribution to the holders of Debentures, so that the same shall be equal to the rate determined by multiplying the Conversion Price in effect on the record date fixed for the determination of shareholders entitled to receive such distribution by a fraction, the denominator of which shall be the sum of: (A) the weighted average trading price of one Common Share over the 20 consecutive trading day period (the “Spinoff Valuation Period”) commencing on and including the fifth trading day after the date on which ex-dividend trading commences for such distribution on the TSXV (or such other exchange on which the Common Shares are then listed); and (B) the product of: (i) the weighted average trading price (calculated in substantially the same way as the Current Market Price is calculated for the Common Shares) over the Spinoff Valuation Period of the Spinoff Securities or, if no such prices are available, the fair market value of the Spinoff Securities as reasonably determined by the Board of Directors (which determination shall be conclusive and shall be evidenced by an Officer’s Certificate delivered to the Trustee) multiplied by; (ii) the number of Spinoff Securities distributed in respect of one Common Share and the numerator of which shall be the weighted average trading price of one Common Share over the Spinoff Valuation Period, such adjustment to become effective immediately preceding the opening of business on the 25th trading day after the date on which ex-dividend trading commences; provided, however, that the Corporation may in lieu of the foregoing adjustment elect to make adequate provision so that each holder of Debentures shall have the right to receive upon conversion thereof the amount of such Spinoff Securities that such holder of Debentures would have received if such Debentures had been converted on the record date with respect to such distribution.

 

- 37 -

 

 

(f) If any issuer bid made by the Corporation or any of its Subsidiaries for all or any portion of Common Shares shall expire, then, if the issuer bid shall require the payment to shareholders of consideration per Common Share having a fair market value (determined as provided below) that exceeds the Current Market Price on the last date (the “Expiration Date”) tenders could have been made pursuant to such issuer bid (as it may be amended) (the last time at which such tenders could have been made on the Expiration Date is hereinafter sometimes called the “Expiration Time”), the Conversion Price shall be adjusted so that the same shall equal the rate determined by multiplying the Conversion Price in effect immediately preceding the close of business on the Expiration Date by a fraction of which (i) the denominator shall be the sum of (A) the fair market value of the aggregate consideration (the fair market value as determined by the Board of Directors, whose determination shall be conclusive evidence of such fair market value and which shall be evidenced by an Officer’s Certificate delivered to the Trustee) payable to shareholders based on the acceptance (up to any maximum specified in the terms of the issuer bid) of all Common Shares validly tendered and not withdrawn as of the Expiration Time (the Common Shares deemed so accepted, up to any such maximum, being referred to as the “Purchased Common Shares”) and (B) the product of the number of Common Shares outstanding (less any Purchased Common Shares and excluding any Common Shares held in the treasury of the Corporation) at the Expiration Time and the Current Market Price on the Expiration Date and (ii) the numerator of which shall be the product of the number of Common Shares outstanding (including Purchased Common Shares but excluding any Common Shares held in the treasury of the Corporation) at the Expiration Time multiplied by the Current Market Price on the Expiration Date, such increase to become effective immediately preceding the opening of business on the day following the Expiration Date. In the event that the Corporation is obligated to purchase Common Shares pursuant to any such issuer bid, but the Corporation is permanently prevented by applicable law from effecting any or all such purchases or any or all such purchases are rescinded, the Conversion Price shall again be adjusted to be the Conversion Price which would have been in effect based upon the number of Common Shares actually purchased, if any. If the application of this clause (f) of Section 6.4 to any issuer bid would result in a decrease in the Conversion Price, no adjustment shall be made for such issuer bid under this clause (f).

 

For purposes of this Section 6.4(1)(f), the term “issuer bid” shall mean an issuer bid under Applicable Securities Legislation or a take-over bid under Applicable Securities Legislation by a Subsidiary of the Corporation for the Common Shares and all references to “purchases” of Common Shares in issuer bids (and all similar references) shall mean and include the purchase of Common Shares in issuer bids and all references to “tendered Common Shares” (and all similar references) shall mean and include Common Shares tendered in issuer bids.

 

(g) In any case in which this Section 6.4 shall require that an adjustment shall become effective immediately after a record date for an event referred to herein, the Corporation may defer, until the occurrence of such event, issuing to the holder of any Debenture converted after such record date and before the occurrence of such event the additional Common Shares issuable upon such conversion by reason of the adjustment required by such event before giving effect to such adjustment; provided, however, that the Corporation shall deliver to such holder an appropriate instrument evidencing such holder’s right to receive such additional Common Shares upon the occurrence of the event requiring such adjustment and the right to receive any distributions made on such additional Common Shares declared in favour of holders of record of Common Shares on and after the Date of Conversion or such later date as such holder would, but for the provisions of this Section 6.4(1)(g), have become the holder of record of such additional Common Shares pursuant to Section 6.3(1).

 

(h) The adjustments provided for in this Section 6.4 are cumulative and shall apply to successive subdivisions, redivisions, reductions, combinations, consolidations, distributions, issues or other events resulting in any adjustment under the provisions of this Section, provided that, notwithstanding any other provision of this Section, no adjustment of the Conversion Price shall be required unless such adjustment would require an increase or decrease of at least 1% in the Conversion Price then in effect; provided however, that any adjustments which by reason of this Section 6.4(1)(h) are not required to be made shall be carried forward and taken into account in any subsequent adjustment.

 

- 38 -

 

 

(i) For the purpose of calculating the number of Common Shares outstanding, Common Shares owned by or for the benefit of the Corporation shall not be counted.

 

(j) In the event of any question arising with respect to the adjustments provided in this Section 6.4, such question shall be conclusively determined by the Board of Directors, and in the event holders of not less than 25% of the principal amount of the Debentures then outstanding notify the Trustee that they do not agree with such determination within 14 days of such determination being communicated to all the holders, such determination shall be made by a firm of nationally recognized chartered accountants appointed by the Corporation and acceptable to the Trustee (who may be the Auditors of the Corporation); such accountants shall have access to all necessary records of the Corporation and such determination shall be binding upon the Corporation, the Trustee, and the Debentureholders. In the absence of notice by holders of not less than 25% of the principal amount of the Debentures then outstanding of their disagreement as aforesaid, the determination of the Board of Directors shall be binding.

 

(k) In case the Corporation shall take any action affecting the Common Shares other than action described in this Section 6.4, which in the opinion of the Board of Directors, would materially affect the rights of Debentureholders, the Conversion Price shall be adjusted in such manner and at such time, by action of the Board of Directors, as the Board of Directors, in their sole discretion may determine to be equitable in the circumstances. Failure of the directors to make such an adjustment shall be conclusive evidence that they have determined that it is equitable to make no adjustment in the circumstances.

 

(l) No adjustment in the Conversion Price shall be made in respect of any event described in Section 6.4(1)(a), Section 6.4(1)(b), Section 6.4(1)(c), Section 6.4(1)(e) or Section 6.4(1)(f) other than the events described in Section 6.4(1)(a)(i) or Section 6.4(1)(a)(ii) if the holders of the Debentures are entitled to participate in such event on the same terms mutatis mutandis as if they had converted their Debentures prior to the effective date or record date, as the case may be, of such event.

 

(m) Except as stated above in this Section 6.4, no adjustment will be made in the Conversion Price for any Debentures as a result of the issuance of Common Shares at less than the Current Market Price on the date of issuance or the then applicable Conversion Price.

 

(n) Notwithstanding any of the foregoing in this Section 6.4, if a holder of a Debenture would otherwise be entitled to receive, upon conversion of the Debenture, any property (including cash) or securities that would not constitute “prescribed securities” for the purposes of clause 212(1)(b)(vii)(E) of the Tax Act as it applied on December 31, 2007 (“Ineligible Consideration”), such holder of a Debenture shall not be entitled to receive such Ineligible Consideration and the Corporation or the successor or acquirer, as the case may be, shall have the right (at the sole option of the Corporation or the successor or acquirer, as the case may be) to deliver to such holder “prescribed securities” for the purposes of clause 212(1)(b)(vii)(E) of the Tax Act as it applied on December 31, 2007 with a market value (as conclusively determined by the Board of Directors) equal to the market value of such Ineligible Consideration.

 

Section 6.5 No Requirement to Issue Fractional Common Shares

 

The Corporation shall not be required to issue fractional Common Shares upon the conversion of Debentures pursuant to this Article. If more than one Debenture shall be surrendered for conversion at one time by the same holder, the number of whole Common Shares issuable upon conversion thereof shall be computed on the basis of the aggregate principal amount of such Debentures to be converted. If any fractional interest in a Common Share would, except for the provisions of this Section, be deliverable upon the conversion of any principal amount of Debentures, the number of Common Shares so issuable shall be rounded down to the nearest whole number.

 

- 39 -

 

 

Section 6.6 Corporation to Reserve Common Shares

 

The Corporation covenants with the Trustee that it will at all times reserve and keep available out of its authorized Common Shares (if the number thereof is or becomes limited), solely for the purpose of issue upon conversion of Debentures as in this Article provided, and conditionally allot to Debentureholders who may exercise their conversion rights hereunder, such number of Common Shares as shall then be issuable upon the conversion of all outstanding Debentures. The Corporation covenants with the Trustee that all Common Shares which shall be so issuable shall be duly and validly issued as fully-paid and non-assessable.

 

Section 6.7 Cancellation of Converted Debentures

 

Subject to the provisions of Section 6.3 as to Debentures converted in part, all Debentures converted in whole or in part under the provisions of this Article shall be forthwith delivered to and cancelled by the Trustee and no Debenture shall be issued in substitution for those converted.

 

Section 6.8 Certificate as to Adjustment

 

The Corporation shall from time to time immediately after the occurrence of any event which requires an adjustment or readjustment as provided in Section 6.4, deliver an Officer’s Certificate to the Trustee specifying the nature of the event requiring the same and the amount of the adjustment necessitated thereby and setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based, which certificate and the amount of the adjustment specified therein shall be verified by advice of a firm of nationally recognized chartered accountants appointed by the Corporation and acceptable to the Trustee (who may be the Auditors of the Corporation) and shall be conclusive and binding on all parties in interest. When so approved, the Corporation shall, except in respect of any subdivision, redivision, reduction, combination or consolidation of the Common Shares, forthwith give notice to the Debentureholders in the manner provided in Section 13.2 specifying the event requiring such adjustment or readjustment and the results thereof, including the resulting Conversion Price; provided that, if the Corporation has given notice under this Section 6.8 covering all the relevant facts in respect of such event and if the Trustee approves, no such notice need be given under this Section 6.8.

 

Section 6.9 Notice of Special Matters

 

(1) The Corporation covenants with the Trustee that so long as any Debenture remains outstanding, it will give notice to the Trustee, and to the Debentureholders in the manner provided in Section 13.2 of its intention to fix a record date for any event referred to in Section 6.4(1)(a), Section 6.4(1)(b), Section 6.4(1)(c), Section 6.4(1)(d) or Section 6.4(1)(e) (other than the subdivision, redivision, reduction, combination or consolidation of its Common Shares) which may give rise to an adjustment in the Conversion Price, and, in each case, such notice shall specify the particulars of such event and the record date and the effective date for such event; provided that the Corporation shall only be required to specify in such notice such particulars of such event as shall have been fixed and determined on the date on which such notice is given. Such notice shall be given not less than 14 days in each case prior to such applicable record date.

 

(2) In addition, the Corporation covenants with the Trustee that so long as any Debenture remains outstanding, it will give notice to the Trustee, and to the Debentureholders in the manner provided in Section 13.2 at least 30 days prior to the (i) effective date of any transaction referred to in Section 6.4(1)(d) stating the consideration into which the Debentures will be convertible after the effective date of such transaction, and (ii) Expiration Date of any transaction referred to in Section 6.4(1)(f) stating the consideration paid per Common Share in such transaction.

 

- 40 -

 

 

Section 6.10 Protection of Trustee

 

The Trustee:

 

(a) shall not at any time be under any duty or responsibility to any Debentureholder to determine whether any facts exist which may require any adjustment in the Conversion Price, or with respect to the nature or extent of any such adjustment when made, or with respect to the method employed in making the same;

 

(b) shall not be accountable with respect to the validity or value (or the kind or amount) of any Common Shares or of any shares or other securities or property which may at any time be issued or delivered upon the conversion of any Debenture; and

 

(c) shall not be responsible for any failure of the Corporation to make any cash payment or to issue, transfer or deliver Common Shares or share certificates upon the surrender of any Debenture for the purpose of conversion, or to comply with any of the covenants contained in this Article.

 

Article 7 – COVENANTS OF THE CORPORATION

 

The Corporation hereby covenants and agrees with the Trustee for the benefit of the Trustee and the Debentureholders, that so long as any Debentures remain outstanding:

 

Section 7.1 To Pay Principal, Premium (if any) and Interest

 

The Corporation will duly and punctually pay or cause to be paid to every Debentureholder the principal of, premium (if any) and interest accrued on the Debentures of which it is the holder on the dates, at the places and in the manner mentioned herein and in the Debentures.

 

Section 7.2 To Pay Trustee’s Remuneration

 

The Corporation will pay the Trustee reasonable remuneration for its services as Trustee hereunder and will repay to the Trustee on demand all monies which shall have been paid by the Trustee in connection with the execution of the trusts hereby created and such monies including the Trustee’s remuneration, shall be payable out of any funds coming into the possession of the Trustee in priority to payment of any principal of the Debentures or interest or premium thereon. Such remuneration shall continue to be payable until the trusts hereof be finally wound up and whether or not the trusts of this Indenture shall be in the course of administration by or under the direction of a court of competent jurisdiction.

 

Section 7.3 To Give Notice of Default

 

The Corporation shall notify the Trustee immediately upon obtaining knowledge of any Event of Default hereunder.

 

Section 7.4 Preservation of Existence, etc.

 

Subject to the express provisions hereof, the Corporation will carry on and conduct its activities, and cause its Subsidiaries to carry on and conduct their businesses, in a business-like manner and in accordance with good business practices, and, subject to the express provisions hereof, it will do or cause to be done all things necessary to preserve and keep in full force and effect its existence and rights; provided that the foregoing covenant shall not prevent or restrict the Corporation from completing a transaction to which Article 10 would apply if carried out in accordance with Article 10.

 

- 41 -

 

 

Section 7.5 Keeping of Books

 

The Corporation will keep or cause to be kept proper books of record and account, in which full and correct entries shall be made of all financial transactions and the assets and business of the Corporation in accordance with generally accepted accounting principles.

 

Section 7.6 Annual Certificate of Compliance

 

The Corporation shall deliver to the Trustee, within 120 days after the end of each calendar year, (and at any reasonable time upon demand by the Trustee) an Officer’s Certificate as to the knowledge of such officers of the Corporation who execute the Officer’s Certificate of the Corporation’s compliance with all conditions and covenants in this Indenture certifying that after reasonable investigation and inquiry, the Corporation has complied with all covenants, conditions or other requirements contained in this Indenture, the non-compliance with which would, with the giving of notice, lapse of time or otherwise, constitute an Event of Default hereunder, or if such is not the case, setting forth with reasonable particulars the circumstances of any failure to comply and steps taken or proposed to be taken to eliminate such circumstances and remedy such Event of Default, as the case may be.

 

Section 7.7 Performance of Covenants by Trustee

 

If the Corporation shall fail to perform any of its covenants contained in this Indenture, the Trustee may notify the Debentureholders of such failure on the part of the Corporation or may itself perform any of the covenants capable of being performed by it, but shall be under no obligation to do so or to notify the Debentureholders All sums so expended or advanced by the Trustee shall be repayable as provided in Section 7.2. No such performance, expenditure or advance by the Trustee shall be deemed to relieve the Corporation of any default hereunder.

 

Section 7.8 Maintain Listing

 

The Corporation will use reasonable commercial efforts to maintain the listing of the Common Shares on the TSXV, and to maintain the Corporation’s status as a “reporting issuer” not in default of the requirements of the Applicable Securities Legislation; provided that the foregoing covenant shall not prevent or restrict the Corporation from carrying out a transaction to which Article 10 would apply if carried out in compliance with Article 10 even if as a result of such transaction the Corporation ceases to be a “reporting issuer” in all or any of the provinces of Canada or the Common Shares cease to be listed on the TSXV or any other stock exchange.

 

Section 7.9 No Dividends on Common Shares if Event of Default

 

The Corporation shall not declare or pay any dividend to the holders of its issued and outstanding Common Shares after the occurrence of an Event of Default unless and until such default shall have been cured or waived or shall have ceased to exist.

 

- 42 -

 

 

Section 7.10 Withholding Matters

 

All payments made by or on behalf of the Corporation under or with respect to the Debentures (including, without limitation, any penalties, interest and other liabilities related thereto) will be made free and clear of and without withholding, or deduction for, or on account of, any present or future tax, duty, levy, impost, assessment or other governmental charge (including, without limitation, penalties, interest and other liabilities related hereto) imposed or levied by or on behalf of the Government of Canada or the United States or elsewhere, or of any province or territory thereof or by any authority or agency therein or thereof having power to tax (“Withholding Taxes”), unless the Corporation is required by law or the interpretation or administration thereof, to withhold or deduct any amounts for, or on account of Withholding Taxes. If the Corporation is so required to withhold or deduct any amount for, or on account of, Withholding Taxes from any payment made under or with respect to the Debentures, the Corporation shall deduct and withhold such Withholding Taxes from any payment to be made or with respect to the Debentures and, provided that the Corporation forthwith remits such amount to the relevant governmental authority or agency, the amount of any such deduction or withholding will be considered an amount paid in satisfaction of the Corporation’s obligations under the Debentures. There is no obligation on the Corporation to gross-up or pay additional amounts to a holder of Debentures in respect of such deductions or withholdings. For greater certainty, if any amount is required to be deducted or withheld in respect of Withholding Taxes upon a conversion of a Debenture, the Corporation shall be entitled to liquidate such number of Common Shares (or other securities) issuable as a result of such conversion as shall be necessary in order to satisfy such requirement. The Corporation shall provide the Trustee with copies of receipts or other communications relating to the remittance of such withheld amount or the filing of any forms received from such government authority or agency promptly after receipt thereof.

 

Section 7.11 SEC Reporting Status

 

The Corporation confirms that, as at the date of execution of this Indenture, it does not have a class of securities registered pursuant to Section 12 of the U.S. Securities Exchange Act or have a reporting obligation pursuant to Section 15(d) of the U.S. Securities Exchange Act.

 

The Corporation covenants that in the event that (i) any class of its securities shall become registered pursuant to Section 12 of the U.S. Securities Exchange Act or the Corporation shall incur a reporting obligation pursuant to Section 15(d) of the U.S. Securities Exchange Act, or (ii) any such registration or reporting obligation shall be terminated by the Corporation in accordance with the U.S. Securities Exchange Act, such Corporation shall promptly deliver to the Trustee an Officers’ Certificate (in a form provided by the Trustee and reasonably acceptable to the Corporation) notifying the Trustee of such registration or termination and such other information as the Trustee may reasonably require at the time. The Corporation acknowledges that the Trustee is relying upon the foregoing confirmation and covenant in order to meet certain obligations of the Trustee with respect to those clients who are reporting with the U.S. Securities and Exchange Commission (the “SEC”).

 

Article 8 – DEFAULT

 

Section 8.1 Events of Default

 

(1) Each of the following events constitutes, and is herein sometimes referred to as, an “Event of Default”:

 

(a) failure to pay interest on the Debentures when due, which default continues for 10 days;

 

(b) failure to pay principal or premium (whether by way of payment of cash or delivery of Common Shares), if any, when due on the Debentures whether at maturity, upon redemption or a Change of Control, by declaration or otherwise;

 

(c) default in the delivery, when due, of any Common Shares or other consideration, payable on conversion with respect to the Debentures, which default continues for 15 days;

 

- 43 -

 

 

(d) default in the observance or performance of any covenant or condition of this Indenture by the Corporation and the failure to cure (or obtain a waiver for) such default for a period of 30 days after notice in writing has been given by the Trustee or from holders of not less than 25% in aggregate principal amount of the Debentures to the Corporation specifying such default and requiring the Corporation to rectify such default or obtain a waiver for same;

 

(e) if a decree or order of a Court having jurisdiction is entered adjudging the Corporation or any Material Subsidiary a bankrupt or insolvent under the Bankruptcy and Insolvency Act (Canada) or any other bankruptcy, insolvency or analogous laws, or issuing sequestration or process of execution against, or against any substantial part of, the property of the Corporation or any Material Subsidiary, or appointing a receiver of, or of any substantial part of, the property of the Corporation or any Material Subsidiary or ordering the winding-up or liquidation of its affairs, and any such decree or order continues unstayed and in effect for a period of 60 days;

 

(f) if the Corporation or any Material Subsidiary institutes proceedings to be adjudicated a bankrupt or insolvent, or consents to the institution of bankruptcy or insolvency proceedings against it under the Bankruptcy and Insolvency Act (Canada) or any other bankruptcy, insolvency or analogous laws, or consents to the filing of any such petition or to the appointment of a receiver of, or of any substantial part of, the property of the Corporation or any Material Subsidiary or makes a general assignment for the benefit of creditors, or admits in writing its inability to pay its debts generally as they become due;

 

(g) if a resolution is passed for the winding-up or liquidation of the Corporation or any Material Subsidiary except in the course of carrying out or pursuant to a transaction in respect of which the conditions of Section 10.1 are duly observed and performed;

 

(h) if, after the date of this Indenture, any proceedings with respect to the Corporation or any Material Subsidiary are taken with respect to a compromise or arrangement, with respect to creditors of the Corporation or any Material Subsidiary generally, under the applicable legislation of any jurisdiction; or

 

(i) the occurrence of any default or event of default under the debenture indenture dated December 23, 2019 between the Corporation and the Trustee.

 

then: (i) in each and every such event listed above, the Trustee may, in its discretion, but subject to the provisions of this section, and shall, upon receipt of a request in writing signed by the holders of not less than 25% in principal amount of the Debentures then outstanding (or if the Event of Default shall exist only in respect of one or more series of the Debentures then outstanding, then upon receipt of a request in writing signed by the holders of not less than 25% in principal amount of the Debentures of such series then outstanding), subject to the provisions of Section 8.3, by notice in writing to the Corporation declare the principal of and interest and premium, if any, on all Debentures then outstanding and all other monies outstanding hereunder to be due and payable and the same shall thereupon forthwith become immediately due and payable (or, if the Event of Default shall exist only in respect of one or more series of the Debentures then outstanding, then the Trustee may declare due and payable the principal and interest and premium, if any, only with respect to such Debentures in respect of which there is an Event of Default) to the Trustee, and (ii) on the occurrence of an Event of Default under Section 8.1(1)(e), Section 8.1(1)(f) or Section 8.1(1)(g), the principal of and interest and premium, if any, on all Debentures then outstanding hereunder and all other monies outstanding hereunder, shall automatically without any declaration or other act on the part of the Trustee or any Debentureholder become immediately due and payable to the Trustee and, in either case, upon such amounts becoming due and payable in either (i) or (ii) above, the Corporation shall forthwith pay to the Trustee for the benefit of the Debentureholders such principal, accrued and unpaid interest and premium, if any, and interest on amounts in default on such Debenture and all other monies outstanding hereunder, together with subsequent interest at the rate borne by the Debentures on such principal, interest, premium and such other monies from the date of such declaration or event until payment is received by the Trustee, such subsequent interest to be payable at the times and places and in the manner mentioned in and according to the tenor of the Debentures. Such payment when made shall be deemed to have been made in discharge of the Corporation’s obligations hereunder and any monies so received by the Trustee shall be applied in the manner provided in Section 8.6.

 

- 44 -

 

 

(2) For greater certainty, for the purposes of this Section 8.1, a series of Debentures shall be in default in respect of an Event of Default if such Event of Default relates to a default in the payment of principal, premium, if any, or interest on the Debentures of such series in which case references to Debentures in this Section 8.1 refer to Debentures of that particular series.

 

(3) For purposes of this Article 8, where the Event of Default refers to an Event of Default with respect to a particular series of Debentures as described in this Section 8.1, then this Article 8 shall apply mutatis mutandis to the Debentures of such series and references in this Article 8 to the Debentures shall mean Debentures of the particular series and references to the Debentureholders shall refer to the Debentureholders of the particular series, as applicable.

 

Section 8.2 Notice of Events of Default

 

If an Event of Default shall occur and be continuing the Trustee shall, within 15 days after it receives written notice of the occurrence of such Event of Default, give notice of such Event of Default to the Debentureholders in the manner provided in Section 13.2, provided that notwithstanding the foregoing, unless the Trustee shall have been requested to do so by the holders of at least 25% of the principal amount of the Debentures then outstanding, the Trustee shall not be required to give such notice if the Trustee in good faith shall have determined that the withholding of such notice is in the best interests of the Debentureholders and shall have so advised the Corporation in writing.

 

When notice of the occurrence of an Event of Default has been given and the Event of Default is thereafter cured, notice that the Event of Default is no longer continuing shall be given by the Trustee to the Debentureholders within 15 days after the Trustee becomes aware the Event of Default has been cured.

 

Section 8.3 Waiver of Default

 

(1) Upon the happening of any Event of Default hereunder:

 

(a) the holders of the Debentures shall have the power (in addition to the powers exercisable by Extraordinary Resolution as hereinafter provided) by requisition in writing by the holders of more than 50% of the principal amount of Debentures then outstanding, to instruct the Trustee to waive any Event of Default and to cancel any declaration made by the Trustee pursuant to Section 8.1 and the Trustee shall thereupon waive the Event of Default and cancel such declaration, or either, upon such terms and conditions as shall be prescribed in such requisition; provided that notwithstanding the foregoing if the Event of Default has occurred by reason of the non-observance or non-performance by the Corporation of any covenant applicable only to one or more series of Debentures, then the holders of more than 50% of the principal amount of the outstanding Debentures of that series shall be entitled to exercise the foregoing power and the Trustee shall so act and it shall not be necessary to obtain a waiver from the holders of any other series of Debentures; and

 

(b) the Trustee, so long as it has not become bound to declare the principal and interest on the Debentures then outstanding to be due and payable, or to obtain or enforce payment of the same, shall have power to waive any Event of Default if, in the Trustee’s opinion, the same shall have been cured or adequate satisfaction made therefor, and in such event to cancel any such declaration theretofore made by the Trustee in the exercise of its discretion, upon such terms and conditions as the Trustee may deem advisable.

 

- 45 -

 

 

(2) No such act or omission either of the Trustee or of the Debentureholders shall extend to or be taken in any manner whatsoever to affect any subsequent Event of Default or the rights resulting therefrom.

 

Section 8.4 Enforcement by the Trustee

 

(1) Subject to the provisions of Section 8.3 and to the provisions of any Extraordinary Resolution that may be passed by the Debentureholders, if the Corporation shall fail to pay to the Trustee, forthwith after the same shall have been declared to be due and payable under Section 8.1, the principal of and interest on all Debentures then outstanding, together with any other amounts due hereunder, the Trustee may in its discretion and shall upon receipt of a request in writing signed by the holders of not less than 25% in principal amount of the Debentures then outstanding and upon being funded and indemnified to its reasonable satisfaction against all costs, expenses and liabilities to be incurred, proceed in its name as trustee hereunder to obtain or enforce payment of such principal and interest on all the Debentures then outstanding together with any other amounts due hereunder by such proceedings authorized by this Indenture or by law or equity as the Trustee in such request shall have been directed to take, or if such request contains no such direction, or if the Trustee shall act without such request, then by such proceedings authorized by this Indenture or by suit at law or in equity as the Trustee shall deem expedient.

 

(2) The Trustee shall be entitled and empowered, either in its own name or as trustee of an express trust, or as attorney-in-fact for the holders of the Debentures, or in any one or more of such capacities, to file such proof of debt, amendment of proof of debt, claim, petition or other document as may be necessary or advisable in order to have the claims of the Trustee and of the holders of the Debentures allowed in any insolvency, bankruptcy, liquidation or other judicial proceedings relative to the Corporation or its creditors or relative to or affecting its property. The Trustee is hereby irrevocably appointed (and the successive respective holders of the Debentures by taking and holding the same shall be conclusively deemed to have so appointed the Trustee) the true and lawful attorney-in-fact of the respective holders of the Debentures with authority to make and file in the respective names of the holders of the Debentures or on behalf of the holders of the Debentures as a class, subject to deduction from any such claims of the amounts of any claims filed by any of the holders of the Debentures themselves, any proof of debt, amendment of proof of debt, claim, petition or other document in any such proceedings and to receive payment of any sums becoming distributable on account thereof, and to execute any such other papers and documents and to do and perform any and all such acts and things for and on behalf of such holders of the Debentures, as may be necessary or advisable in the opinion of the Trustee, in order to have the respective claims of the Trustee and of the holders of the Debentures against the Corporation or its property allowed in any such proceeding, and to receive payment of or on account of such claims; provided, however, that subject to Section 8.3, nothing contained in this Indenture shall be deemed to give to the Trustee, unless so authorized by Extraordinary Resolution, any right to accept or consent to any plan of reorganization or otherwise by action of any character in such proceeding to waive or change in any way any right of any Debentureholder.

 

- 46 -

 

 

(3) The Trustee shall also have the power at any time and from time to time to institute and to maintain such suits and proceedings as it may be advised shall be necessary or advisable to preserve and protect its interests and the interests of the Debentureholders.

 

(4) All rights of action hereunder may be enforced by the Trustee without the possession of any of the Debentures or the production thereof on the trial or other proceedings relating thereto.

 

(5) Any such suit or proceeding instituted by the Trustee shall be brought in the name of the Trustee as trustee of an express trust, and any recovery of judgment shall be for the rateable benefit of the holders of the Debentures subject to the provisions of this Indenture. In any proceeding brought by the Trustee (and also any proceeding in which a declaratory judgment of a court may be sought as to the interpretation or construction of any provision of this Indenture, to which the Trustee shall be a party) the Trustee shall be held to represent all the holders of the Debentures, and it shall not be necessary to make any holders of the Debentures parties to any such proceeding.

 

Section 8.5 No Suits by Debentureholders

 

Subject to any rights or remedies available to the Trustee and the Debentureholders under applicable law or otherwise, no holder of any Debenture shall have any right to institute any action, suit or proceeding at law or in equity for the purpose of enforcing payment of the principal of or interest on the Debentures or for the execution of any trust or power hereunder or for the appointment of a liquidator or receiver or for a receiving order under the Bankruptcy and Insolvency Act (Canada) or to have the Corporation wound up or to file or prove a claim in any liquidation or bankruptcy proceeding or for any other remedy hereunder, unless: (a) such holder shall previously have given to the Trustee written notice of the happening of an Event of Default hereunder; and (b) the Debentureholders by Extraordinary Resolution or by written instrument signed by the holders of at least 25% in principal amount of the Debentures then outstanding shall have made a request to the Trustee and the Trustee shall have been afforded reasonable opportunity either itself to proceed to exercise the powers hereinbefore granted or to institute an action, suit or proceeding in its name for such purpose; and (c) the Debentureholders or any of them shall have furnished to the Trustee, when so requested by the Trustee, sufficient funds and security and indemnity satisfactory to it against the costs, expenses and liabilities to be incurred therein or thereby; (d) the Trustee shall have failed to act within a reasonable time after such notification, request and offer of indemnity; and (e) no direction inconsistent with such request has been received by the Trustee from holders of a majority in principal amount of the outstanding Debentures, and such notification, request and offer of indemnity are hereby declared in every such case, at the option of the Trustee, to be conditions precedent to any such proceeding or for any other remedy hereunder by or on behalf of the holder of any Debentures.

 

Section 8.6 Application of Monies by Trustee

 

(1) Except as herein otherwise expressly provided, any monies received by the Trustee from the Corporation pursuant to the foregoing provisions of this Article 8, or as a result of legal or other proceedings or from any trustee in bankruptcy or liquidator of the Corporation, shall be applied, together with any other monies in the hands of the Trustee available for such purpose, as follows:

 

(a) first, in payment or in reimbursement to the Trustee of its compensation, costs, charges, expenses, borrowings, advances or other monies furnished or provided by or at the instance of the Trustee in or about the execution of its trusts under, or otherwise in relation to, this Indenture, with interest thereon as herein provided;

 

(b) second, but subject as hereinafter in this Section 8.6 provided, in payment, rateably and proportionately to the holders of Debentures, of the principal and accrued and unpaid interest and interest on amounts in default on the Debentures which shall then be outstanding in the priority of principal first and then premium and then accrued and unpaid interest and interest on amounts in default unless otherwise directed by Extraordinary Resolution and in that case in such order or priority as between principal and interest as may be directed by such resolution; and

 

- 47 -

 

 

(c) third, in payment of the surplus, if any, of such monies to the Corporation or its assigns;

 

provided, however, that no payment shall be made pursuant to clause (b) above in respect of the principal or interest on any Debenture held, directly or indirectly, by or for the benefit of the Corporation or any Subsidiary (other than any Debenture pledged for value and in good faith to a person other than the Corporation or any Subsidiary but only to the extent of such person’s interest therein) except subject to the prior payment in full of the principal and interest (if any) on all Debentures which are not so held.

 

(2) The Trustee shall not be bound to apply or make any partial or interim payment of any monies coming into its hands if the amount so received by it, after reserving thereout such amount as the Trustee may think necessary to provide for the payments mentioned in Section 8.6(1), is insufficient to make a distribution of at least 2% of the aggregate principal amount of the outstanding Debentures, but it may retain the money so received by it and invest or deposit the same as provided in Section 14.9 until the money or the investments representing the same, with the income derived therefrom, together with any other monies for the time being under its control shall be sufficient for the said purpose or until it shall consider it advisable to apply the same in the manner hereinbefore set forth. The foregoing shall, however, not apply to a final payment in distribution hereunder.

 

Section 8.7 Notice of Payment by Trustee

 

Not less than 15 days’ notice shall be given in the manner provided in Section 13.2 by the Trustee to the Debentureholders of any payment to be made under this Article 8. Such notice shall state the time when and place where such payment is to be made and also the liability under this Indenture to which it is to be applied. After the day so fixed, unless payment shall have been duly demanded and have been refused, the Debentureholders will be entitled to interest only on the balance (if any) of the principal monies, and interest due (if any) to them, respectively, on the Debentures, after deduction of the respective amounts payable in respect thereof on the day so fixed.

 

Section 8.8 Trustee May Demand Production of Debentures

 

The Trustee shall have the right to demand production of the Debentures in respect of which any payment of principal, interest or premium required by this Article 8 is made and may cause to be endorsed on the same a memorandum of the amount so paid and the date of payment, but the Trustee may, in its discretion, dispense with such production and endorsement, upon such indemnity being given to it and to the Corporation as the Trustee shall deem sufficient.

 

Section 8.9 Remedies Cumulative

 

No remedy herein conferred upon or reserved to the Trustee, or upon or to the holders of Debentures is intended to be exclusive of any other remedy, but each and every such remedy shall be cumulative and shall be in addition to every other remedy given hereunder or now existing or hereafter to exist by law or by statute.

 

- 48 -

 

 

Section 8.10 Immunity of Directors, Officers and Others

 

The Debentureholders and the Trustee hereby waive and release any right, cause of action or remedy now or hereafter existing in any jurisdiction against any past, present or future officer, director or employee of the Corporation or holder of Common Shares of the Corporation or of any successor for the payment of the principal of or premium or interest on any of the Debentures or on any covenant, agreement, representation or warranty by the Corporation contained herein or in the Debentures.

 

Article 9 – SATISFACTION AND DISCHARGE

 

Section 9.1 Cancellation and Destruction

 

All Debentures shall forthwith after payment thereof be delivered to the Trustee and cancelled by it. All Debentures cancelled or required to be cancelled under this or any other provision of this Indenture shall be destroyed by the Trustee and, if required by the Corporation, the Trustee shall furnish to it a destruction certificate setting out the designating numbers of the Debentures so destroyed.

 

Section 9.2 Non-Presentation of Debentures

 

In case the holder of any Debenture shall fail to present the same for payment on the date on which the principal of or the interest thereon or represented thereby becomes payable either at maturity or otherwise or shall not accept payment on account thereof and give such receipt therefor, if any, as the Trustee may require:

 

  (a) the Corporation shall be entitled to pay or deliver to the Trustee and direct it to set aside; or

 

  (b) in respect of monies in the hands of the Trustee which may or should be applied to the payment of the Debentures, the Corporation shall be entitled to direct the Trustee to set aside; or

 

  (c) if the redemption was pursuant to notice given by the Trustee, the Trustee may itself set aside;

 

the monies in trust to be paid to the holder of such Debenture upon due presentation or surrender thereof in accordance with the provisions of this Indenture; and thereupon the principal of, or the interest payable on, or represented by each Debenture in respect whereof such monies have been set aside shall be deemed to have been paid and the holder thereof shall thereafter have no right in respect thereof except that of receiving delivery and payment of the monies so set aside by the Trustee upon due presentation and surrender thereof, subject always to the provisions of Section 9.3.

 

Section 9.3 Repayment of Unclaimed Monies

 

Subject to applicable law, any monies set aside under Section 9.2 and not claimed by and paid to holders of Debentures as provided in Section 9.2 within six years after the date of such setting aside shall be repaid and delivered to the Corporation by the Trustee and thereupon the Trustee shall be released from all further liability with respect to such monies and thereafter the holders of the Debentures in respect of which such monies were so repaid to the Corporation shall have no rights in respect thereof except to obtain payment and delivery of the monies from the Corporation subject to any limitation provided by the laws of the Province of British Columbia. Notwithstanding the foregoing, the Trustee will pay any remaining funds prior to the expiry of six years after the setting aside described in Section 9.2 to the Corporation upon receipt from the Corporation, of an unconditional letter of credit from a Canadian chartered bank in an amount equal to or in excess of the amount of the remaining funds. If the remaining funds are paid to the Corporation prior to the expiry of six years after such setting aside, the Corporation shall reimburse the Trustee for any amounts so set aside which are required to be paid by the Trustee to a holder of a Debenture after the date of such payment of the remaining funds to the Corporation but prior to six years after such setting aside.

 

- 49 -

 

 

Section 9.4 Discharge

 

The Trustee shall at the written request of the Corporation release and discharge this Indenture and execute and deliver such instruments as it shall be advised by Counsel are requisite for that purpose and to release the Corporation from its covenants herein contained (other than the provisions relating to the indemnification of the Trustee), upon proof being given to the reasonable satisfaction of the Trustee that the principal of, and interest (including interest on amounts in default, if any), on all the Debentures and all other monies payable hereunder have been paid or satisfied or that all the Debentures having matured or having been duly called for redemption, payment of the principal of and interest (including interest on amounts in default, if any) on such Debentures and of all other monies payable hereunder has been duly and effectually provided for in accordance with the provisions hereof.

 

Section 9.5 Satisfaction

 

(1) The Corporation shall be deemed to have fully paid, satisfied and discharged all of the outstanding Debentures of any series and the Trustee, at the expense of the Corporation, shall execute and deliver proper instruments acknowledging the full payment, satisfaction and discharge of such Debentures, when, with respect to all of the outstanding Debentures or all of the outstanding Debentures of any series, as applicable:

 

(a) the Corporation has deposited or caused to be deposited with the Trustee as trust funds or property in trust for the purpose of making payment on such Debentures, an amount in money sufficient to pay, satisfy and discharge the entire amount of principal of, and interest, if any, to maturity, or any repayment date or Redemption Dates, or any Change of Control Purchase Date, or upon conversion or otherwise as the case may be, of such Debentures;

 

(b) the Corporation has deposited or caused to be deposited with the Trustee as trust property in trust for the purpose of making payment on such Debentures:

 

  (i) if the Debentures are issued in Canadian dollars, such amount in Canadian dollars of direct obligations of, or obligations the principal and interest of which are guaranteed by, the Government of Canada; or

 

  (ii) if the Debentures are issued in a currency or currency unit other than Canadian dollars, cash in the currency or currency unit in which the Debentures are payable and/or such amount in such currency or currency unit of direct obligations of, or obligations the principal and interest of which are guaranteed by, the Government of Canada or the government that issued the currency or currency unit in which the Debentures are payable;

 

as will be sufficient to pay and discharge the entire amount of principal of, and accrued and unpaid interest to maturity or any repayment date, as the case may be, of all such Debentures; or

 

(c) all Debentures authenticated and delivered (other than (A) Debentures which have been destroyed, lost or stolen and which have been replaced or paid as provided in Section 2.9 and (B) Debentures for whose payment has been deposited in trust and thereafter repaid to the Corporation as provided in Section 9.3) have been delivered to the Trustee for cancellation;

 

- 50 -

 

 

so long as in any such event:

 

(d) the Corporation has paid, caused to be paid or made provisions to the satisfaction of the Trustee for the payment of all other sums payable or which may be payable with respect to all of such Debentures (together with all applicable expenses of the Trustee in connection with the payment of such Debentures); and

 

(e) the Corporation has delivered to the Trustee an Officer’s Certificate stating that all conditions precedent herein provided relating to the payment, satisfaction and discharge of all such Debentures have been complied with.

 

Any deposits with the Trustee referred to in this Section 9.5 shall be irrevocable, subject to Section 9.6, and shall be made under the terms of an escrow and/or trust agreement in form and substance satisfactory to the Trustee and which provides for the due and punctual payment of the principal of and interest on the Debentures being satisfied.

 

(2) Upon the satisfaction of the conditions set forth in this Section 9.5 with respect to all the outstanding Debentures, or all the outstanding Debentures of any series, as applicable, the terms and conditions of the Debentures, including the terms and conditions with respect thereto set forth in this Indenture (other than those contained in Article 2 and Article 4 and the provisions of Article 1 pertaining to Article 2 and Article 4) shall no longer be binding upon or applicable to the Corporation.

 

(3) Any funds or obligations deposited with the Trustee pursuant to this Section 9.5 shall be denominated in the currency or denomination of the Debentures in respect of which such deposit is made.

 

(4) If the Trustee is unable to apply any money or securities in accordance with this Section 9.5 by reason of any legal proceeding or any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Corporation’s obligations under this Indenture and the affected Debentures shall be revived and reinstated as though no money or securities had been deposited pursuant to this Section 9.5 until such time as the Trustee is permitted to apply all such money or securities in accordance with this Section 9.5, provided that if the Corporation has made any payment in respect of principal of, or interest on Debentures or, as applicable, other amounts because of the reinstatement of its obligations, the Corporation shall be subrogated to the rights of the holders of such Debentures to receive such payment from the money or securities held by the Trustee.

 

Section 9.6 Continuance of Rights, Duties and Obligations

 

(1) Where trust funds or trust property have been deposited pursuant to Section 9.5, the holders of Debentures and the Corporation shall continue to have and be subject to their respective rights, duties and obligations under Article 2 and Article 4.

 

(2) In the event that, after the deposit of trust funds or trust property pursuant to Section 9.5 in respect of a series of Debentures (the “Defeased Debentures”), any holder of any of the Defeased Debentures from time to time converts its Debentures to Common Shares or other securities of the Corporation in accordance with Section 2.4(7) (in respect of Issued Debentures or the comparable provision of any other series of Debentures), Article 6 or any other provision of this Indenture, the Trustee shall upon receipt of a Written Direction of the Corporation return to the Corporation from time to time the proportionate amount of the trust funds or other trust property deposited with the Trustee pursuant to Section 9.5 in respect of the Defeased Debentures which is applicable to the Defeased Debentures so converted (which amount shall be based on the applicable principal amount of the Defeased Debentures being converted in relation to the aggregate outstanding principal amount of all the Defeased Debentures).

 

- 51 -

 

 

(3) In the event that, after the deposit of trust funds or trust property pursuant to Section 9.5, the Corporation is required to purchase any outstanding Debentures pursuant to Section 2.4(11) (in respect of Issued Debentures or the comparable provision of any other series of Debentures), in relation to Issued Debentures or to make an offer to purchase Debentures pursuant to any other similar provisions relating to any other series of Debentures, the Corporation shall be entitled to use any trust money or trust property deposited with the Trustee pursuant to Section 9.5 for the purpose of paying to any holders of Defeased Debentures who have accepted any such offer of the Corporation the Change of Control Purchase Price payable to such holders in respect of such Change of Control Purchase Option in respect of Issued Debentures (or the total offer price payable in respect of an offer relating to any other series of Debentures). Upon receipt of a Written Direction from the Corporation, the Trustee shall be entitled to pay to such holder from such trust money or trust property deposited with the Trustee pursuant to Section 9.5 in respect of the Defeased Debentures which is applicable to the Defeased Debentures held by such holders who have accepted any such offer to the Corporation (which amount shall be based on the applicable principal amount of the Defeased Debentures held by accepting offerees in relation to the aggregate outstanding principal amount of all the Defeased Debentures).

 

Article 10 – SUCCESSORS

 

Section 10.1 Corporation may Consolidate, etc., Only on Certain Terms

 

(1) The Corporation may not, without the consent of the holders of the Debentures by Extraordinary Resolution hereunder, consolidate with or amalgamate or merge with or into any Person (other than a directly or indirectly wholly-owned Subsidiary of the Corporation) or sell, convey, transfer or lease all or substantially all of the properties and assets of the Corporation to another Person (other than a directly or indirectly wholly-owned Subsidiary of the Corporation) unless:

 

(a) the Person formed by such consolidation or into which the Corporation is amalgamated or merged, or the Person which acquires by sale, conveyance, transfer or lease all or substantially all of the properties and assets of the Corporation is a corporation, organized and existing under the laws of Canada or any province or territory thereof or the laws of the United States or any state thereof and such corporation (if other than the Corporation or the continuing corporation resulting from the amalgamation of the Corporation with another corporation under the laws of Canada or any province or territory thereof) expressly assumes, by an indenture supplemental hereto, executed and delivered to the Trustee, in form satisfactory to the Trustee, the obligations of the Corporation under the Debentures and this Indenture and the performance or observance of every covenant and provision of this Indenture and the Debentures required on the part of the Corporation to be performed or observed and the conversion rights shall be provided for in accordance with Article 5, by supplemental indenture satisfactory in form to the Trustee, executed and delivered to the Trustee, by the Person (if other than the Corporation or the continuing corporation resulting from the amalgamation of the Corporation with another corporation under the laws of Canada or any province or territory thereof) formed by such consolidation or into which the Corporation shall have been merged or by the Person which shall have acquired the Corporation’s assets;

 

- 52 -

 

 

(b) after giving effect to such transaction, no Event of Default, and no event which, after notice or lapse of time or both, would become an Event of Default, shall have occurred and be continuing; and

 

(c) if the Corporation or the continuing corporation resulting from the amalgamation or merger of the Corporation with another Person under the laws of Canada or any province or territory thereof or the laws of the United States or any state thereof will not be the resulting, continuing or surviving corporation, the Corporation shall have, at or prior to the effective date of such consolidation, amalgamation, merger or sale, conveyance, transfer or lease, delivered to the Trustee an Officer’s Certificate and an opinion of Counsel, each stating that such consolidation, merger or transfer complies with this Article and, if a supplemental indenture is required in connection with such transaction, such supplemental indenture complies with this Article, and that all conditions precedent herein provided for relating to such transaction have been complied with.

 

(2) For purposes of the foregoing, the sale, conveyance, transfer or lease (in a single transaction or a series of related transactions) of the properties or assets of one or more Subsidiaries of the Corporation (other than to the Corporation or another wholly-owned Subsidiary of the Corporation), which, if such properties or assets were directly owned by the Corporation, would constitute all or substantially all of the properties and assets of the Corporation and its Subsidiaries, taken as a whole, shall be deemed to be the sale, conveyance, transfer or lease of all or substantially all of the properties and assets of the Corporation.

 

Section 10.2 Successor Substituted

 

Upon any consolidation of the Corporation with, or amalgamation or merger of the Corporation into, any other Person or any sale, conveyance, transfer or lease of all or substantially all of the properties and assets of the Corporation and its Subsidiaries, taken as a whole, in accordance with Section 10.1, the successor Person formed by such consolidation or into which the Corporation is amalgamated or merged or to which such sale, conveyance, transfer or lease is made shall succeed to, and be substituted for, and may exercise every right and power of, the Corporation under this Indenture with the same effect as if such successor Person had been named as the Corporation herein, and thereafter, except in the case of a lease, and except for obligations the predecessor Person may have under a supplemental indenture entered into pursuant to Section 10.1(1)(c), the predecessor Person shall be relieved of all obligations and covenants under this Indenture and the Debentures.

 

Article 11 – COMPULSORY ACQUISITION

 

Section 11.1 Definitions In this Article:

 

(1) “Affiliate” and “Associate” shall have their respective meanings set forth in the Securities Act (British Columbia);

 

(2) “Dissenting Debentureholders” means a Debentureholder who does not accept an Offer referred to in Section 11.2 and includes any assignee of the Debenture of a Debentureholder to whom such an Offer is made, whether or not such assignee is recognized under this Indenture;

 

(3) “Offer” means an offer to acquire outstanding Debentures, which is a takeover bid for Debentures within the meaning ascribed thereto in NI 62-104 Corporate Glossary and the Securities Act (British Columbia), whereas of the date of the offer to acquire, the Debentures that are subject to the offer to acquire, together with the Offeror’s Debentures, constitute in the aggregate 20% or more of the outstanding principal amount of the Debentures;

 

- 53 -

 

 

(4) “offer to acquire” includes an acceptance of an offer to sell;

 

(5) “Offeror” means a person, or two or more persons acting jointly or in concert, who make an Offer to acquire Debentures;

 

(6) “Offeror’s Debentures” means Debentures beneficially owned, or over which control or direction is exercised, on the date of an Offer by the Offeror, any Affiliate or Associate of the Offeror or any person or company acting jointly or in concert with the Offeror; and

 

(7) “Offeror’s Notice” means the notice described in Section 11.3.

 

Section 11.2 Offer for Debentures

 

If an Offer for all of the outstanding Debentures (other than Debentures held by or on behalf of the Offeror or an Affiliate or Associate of the Offeror) is made and:

 

(a) within the time provided in the Offer for its acceptance or within 120 days after the date the Offer is made, whichever period is the shorter, the Offer is accepted by Debentureholders representing at least 90% of the outstanding principal amount of the Debentures, other than the Offeror’s Debentures;

 

(b) the Offeror is bound to take up and pay for, or has taken up and paid for the Debentures of the Debentureholders who accepted the Offer;

 

(c) the Offeror complies with Section 11.3 and Section 11.5; and

 

(d) the Offer complies with applicable securities laws (including any applicable requirements of the U.S. Securities Exchange Act).

 

the Offeror is entitled to acquire, and the Dissenting Debentureholders are required to sell to the Offeror, the Debentures held by the Dissenting Debentureholder for the same consideration per Debenture payable or paid, as the case may be, under the Offer.

 

Section 11.3 Offeror’s Notice to Dissenting Shareholders

 

Where an Offeror is entitled to acquire Debentures held by Dissenting Debentureholders pursuant to Section 11.2 and the Offeror wishes to exercise such right, the Offeror shall send by registered mail within 30 days after the date of termination of the Offer a notice (the “Offeror’s Notice”) to each Dissenting Debentureholder stating that:

 

(a) Debentureholders holding at least 90% of the principal amount of all outstanding Debentures, other than Offeror’s Debentures, have accepted the Offer;

 

(b) the Offeror is bound to take up and pay for, or has taken up and paid for, the Debentures of the Debentureholders who accepted the Offer;

 

(c) Dissenting Debentureholders must transfer their respective Debentures to the Offeror on the terms on which the Offeror acquired the Debentures of the Debentureholders who accepted the Offer within 21 days after the date of the sending of the Offeror’s Notice; and

 

(d) Dissenting Debentureholders must send their respective Debenture certificate(s) to the Trustee within 21 days after the date of the sending of the Offeror’s Notice.

 

- 54 -

 

 

Section 11.4 Delivery of Debenture Certificates

 

A Dissenting Debentureholder to whom an Offeror’s Notice is sent pursuant to Section 11.3 shall, within 21 days after the sending of the Offeror’s Notice, send his or her Debenture certificate(s) to the Trustee duly endorsed for transfer.

 

Section 11.5 Payment of Consideration to Trustee

 

Within 21 days after the Offeror sends an Offeror’s Notice pursuant to Section 11.3, the Offeror shall pay or transfer to the Trustee, or to such other person as the Trustee may direct, the cash or other consideration that is payable to Dissenting Debentureholders pursuant to Section 11.2. The acquisition by the Offeror of all Debentures held by all Dissenting Debentureholders shall be effective as of the time of such payment or transfer.

 

Section 11.6 Consideration to be held in Trust

 

The Trustee, or the person directed by the Trustee, shall hold in trust for the Dissenting Debentureholders the cash or other consideration they or it receives under Section 11.5. The Trustee, or such persons, shall deposit cash in a separate account in a Canadian chartered bank, or other body corporate, any of whose deposits are insured by the Canada Deposit Insurance Corporation, and shall place other consideration in the custody of a Canadian chartered bank or such other body corporate.

 

Section 11.7 Completion of Transfer of Debentures to Offeror

 

Within 30 days after the date of the sending of an Offeror’s Notice pursuant to Section 11.3 the Trustee, if the Offeror has complied with Section 11.5, shall:

 

(a) do all acts and things and execute and cause to be executed all instruments as in the Trustee’s opinion may be necessary or desirable to cause the transfer of the Debentures of the Dissenting Debentureholders to the Offeror;

 

(b) send to each Dissenting Debentureholder who has complied with Section 11.4 the consideration to which such Dissenting Debentureholder is entitled under this Article 11 (net of applicable withholdings); and

 

(c) send to each Dissenting Debentureholder who has not complied with Section 11.4 a notice stating that:

 

  (i) his or her Debentures have been transferred to the Offeror;

 

  (ii) the Trustee or some other person designated in such notice are holding in trust the consideration for such Debentures; and

 

  (iii) the Trustee, or such other person, will send the consideration to such Dissenting Debentureholder as soon as possible after receiving such Dissenting Debentureholder’s Debenture certificate(s) or such other documents as the Trustee or such other person may require in lieu thereof;

 

and the Trustee is hereby appointed the agent and attorney of the Dissenting Debentureholders for the purposes of giving effect to the foregoing provisions including, without limitation, the power and authority to execute such transfers as may be necessary or desirable in respect of the book-entry only registration systems of the Depository (as applicable).

 

- 55 -

 

 

Section 11.8 Communication of Offer to the Corporation

 

An Offeror cannot make an Offer for Debentures unless, concurrent with the communication of the Offer to any Debentureholder, a copy of the Offer is provided to the Corporation.

 

Article 12 – MEETINGS OF DEBENTUREHOLDERS

 

Section 12.1 Right to Convene Meeting

 

The Trustee or the Corporation may at any time and from time to time, and the Trustee shall, on receipt of a Written Direction of the Corporation or a written request signed by the holders of not less than 25% of the principal amount of the Debentures then outstanding and upon receiving funding and being indemnified to its reasonable satisfaction by the Corporation or by the Debentureholders signing such request against the costs which may be incurred in connection with the calling and holding of such meeting, convene a meeting of the Debentureholders. In the event of the Trustee failing, within 30 days after receipt of any such request and such funding of indemnity, to give notice convening a meeting, the Corporation or such Debentureholders, as the case may be, may convene such meeting. Every such meeting shall be held in the City of Vancouver or at such other place as may be approved or determined by the Corporation and the Trustee.

 

Section 12.2 Notice of Meetings

 

(1) At least 21 days’ notice of any meeting shall be given to the Debentureholders in the manner provided in Section 13.2 and a copy of such notice shall be sent by post to the Trustee, unless the meeting has been called by it. Such notice shall state the time when and the place where the meeting is to be held and shall state briefly the general nature of the business to be transacted thereat and it shall not be necessary for any such notice to set out the terms of any resolution to be proposed or any of the provisions of this Article. The accidental omission to give notice of a meeting to any holder of Debentures shall not invalidate any resolution passed at any such meeting. A holder may waive notice of a meeting either before or after the meeting.

 

(2) If the business to be transacted at any meeting by Extraordinary Resolution or otherwise, or any action to be taken or power exercised by instrument in writing under Section 12.15 especially affects the rights of holders of Debentures of one or more series in a manner or to an extent differing in any material way from that in or to which the rights of holders of Debentures of any other series are affected (determined as provided in Section 12.2(3) and Section 12.2(4), then:

 

(a) a reference to such fact, indicating each series of Debentures in the opinion of the Trustee so especially affected (hereinafter referred to as the “especially affected series”) shall be made in the notice of such meeting, and in any such case the meeting shall be and be deemed to be and is herein referred to as a “Serial Meeting”; and

 

(b) the holders of Debentures of an especially affected series shall not be bound by any action taken at a Serial Meeting or by instrument in writing under Section 12.15 unless in addition to compliance with the other provisions of this Article 12:

 

  (i) at such Serial Meeting: (I) there are Debentureholders present in person or by proxy and representing at least 25% in principal amount of the Debentures then outstanding of such series, subject to the provisions of this Article 12 as to quorum at adjourned meetings; and (II) the resolution is passed by the affirmative vote of the holders of more than 50% (or in the case of an Extraordinary Resolution not less than 66 2/3%) of the principal amount of the Debentures of such series then outstanding voted on the resolution; or

 

- 56 -

 

 

  (ii) in the case of action taken or power exercised by instrument in writing under Section 12.15, such instrument is signed in one or more counterparts by the holders of not less than 66 2/3% in principal amount of the Debentures of such series then outstanding.

 

(3) Subject to Section 12.2(4), the determination as to whether any business to be transacted at a meeting of Debentureholders, or any action to be taken or power to be exercised by instrument in writing under Section 12.15, especially affects the rights of the Debentureholders of one or more series in a manner or to an extent differing in any material way from that in or to which it affects the rights of Debentureholders of any other series (and is therefore an especially affected series) shall be determined by an opinion of Counsel, which shall be binding on all Debentureholders, the Trustee and the Corporation for all purposes hereof.

 

(4) A proposal:

 

(a) to extend the maturity of Debentures of any particular series or to reduce the principal amount thereof, the rate of interest or redemption premium thereon or to impair any conversion right thereof;

 

(b) to modify or terminate any covenant or agreement which by its terms is effective only so long as Debentures of a particular series are outstanding; or

 

(c) to reduce with respect to Debentureholders of any particular series any percentage stated in this Section 12.2 or Section 12.4, Section 12.12 and Section 12.15;

 

shall be deemed to especially affect the rights of the Debentureholders of such series in a manner differing in a material way from that in which it affects the rights of holders of Debentures of any other series, whether or not a similar extension, reduction, modification or termination is proposed with respect to Debentures of any or all other series.

 

Section 12.3 Chairman

 

Some person, who need not be a Debentureholder, nominated in writing by the Corporation (in case it convenes the meeting) or by the Trustee (in any other case) shall be chairman of the meeting and if no person is so nominated, or if the person so nominated is not present within 15 minutes from the time fixed for the holding of the meeting, a majority of the Debentureholders present in person or by proxy shall choose some person present to be chairman.

 

Section 12.4 Quorum

 

Subject to the provisions of Section 12.12, at any meeting of the Debentureholders a quorum shall consist of Debentureholders present in person or by proxy and representing at least 25% in principal amount of the outstanding Debentures and, if the meeting is a Serial Meeting, at least 25% of the Debentures then outstanding of each especially affected series. If a quorum of the Debentureholders shall not be present within 30 minutes from the time fixed for holding any meeting, the meeting, if summoned by the Debentureholders or pursuant to a request of the Debentureholders, shall be dissolved, but in any other case the meeting shall be adjourned to the same day in the next week (unless such day is not a Business Day in which case it shall be adjourned to the next following Business Day thereafter) at the same time and place to the extent possible and no notice shall be required to be given in respect of such adjourned meeting. At the adjourned meeting, the Debentureholders present in person or by proxy shall form a quorum and may transact the business for which the meeting was originally convened, notwithstanding that they may not represent 25% of the principal amount of the outstanding Debentures or of the Debentures then outstanding of each especially affected series. Any business may be brought before or dealt with at an adjourned meeting which might have been brought before or dealt with at the original meeting in accordance with the notice calling the same. No business shall be transacted at any meeting unless the required quorum is present at the commencement of business.

 

- 57 -

 

 

Section 12.5 Power to Adjourn

 

The chairman of any meeting at which a quorum of the Debentureholders is present may, with the consent of the holders of a majority in principal amount of the Debentures represented thereat, adjourn any such meeting and no notice of such adjournment need be given except such notice, if any, as the meeting may prescribe.

 

Section 12.6 Show of Hands

 

Every question submitted to a meeting shall, subject to Section 12.7, be decided in the first place by a majority of the votes given on a show of hands except that votes on Extraordinary Resolutions shall be given in the manner hereinafter provided. At any such meeting, unless a poll is duly demanded as herein provided, a declaration by the chairman that a resolution has been carried or carried unanimously or by a particular majority or lost or not carried by a particular majority shall be conclusive evidence of the fact. The chairman of any meeting shall be entitled, both on a show of hands and on a poll, to vote in respect of the Debentures, if any, held by him.

 

Section 12.7 Poll

 

On every Extraordinary Resolution, and on any other question submitted to a meeting when demanded by the chairman or by one or more Debentureholders or proxies for Debentureholders, a poll shall be taken in such manner and either at once or after an adjournment as the chairman shall direct. Questions other than Extraordinary Resolutions shall, if a poll be taken, be decided by the votes of the holders of a majority in principal amount of the Debentures and of each especially affected series, if applicable, represented at the meeting and voted on the poll.

 

Section 12.8 Voting

 

On a show of hands every person who is present and entitled to vote, whether as a Debentureholder or as proxy for one or more Debentureholders or both, shall have one vote. On a poll each Debentureholder present in person or represented by a proxy duly appointed by an instrument in writing shall be entitled to one vote in respect of each $1,000 principal amount of Debentures of which he shall then be the holder. In the case of any Debenture denominated in a currency or currency unit other than Canadian dollars, the principal amount thereof for these purposes shall be computed in Canadian dollars on the basis of the conversion of the principal amount thereof at the applicable spot buying rate of exchange for such other currency or currency unit as reported by the Bank of Canada at the close of business on the Business Day next preceding the meeting. Any fractional amounts resulting from such conversion shall be rounded to the nearest $100. A proxy need not be a Debentureholder. In the case of joint holders of a Debenture, any one of them present in person or by proxy at the meeting may vote in the absence of the other or others but in case more than one of them be present in person or by proxy, they shall vote together in respect of the Debentures of which they are joint holders.

 

- 58 -

 

 

Section 12.9 Proxies

 

A Debentureholder may be present and vote at any meeting of Debentureholders by an authorized representative. The Corporation (in case it convenes the meeting) or the Trustee (in any other case) for the purpose of enabling the Debentureholders to be present and vote at any meeting without producing their Debentures, and of enabling them to be present and vote at any such meeting by proxy and of lodging instruments appointing such proxies at some place other than the place where the meeting is to be held, may from time to time make and vary such regulations as it shall think fit providing for and governing the form of the instrument appointing a proxy, which shall be in writing, and the manner in which the same shall be executed and the production of the authority of any person signing on behalf of a Debentureholder.

 

Any regulations so made shall be binding and effective and the votes given in accordance therewith shall be valid and shall be counted. Save as such regulations may provide, the only persons who shall be recognized at any meeting as the holders of any Debentures, or as entitled to vote or be present at the meeting in respect thereof, shall be Debentureholders and persons whom Debentureholders have by instrument in writing duly appointed as their proxies.

 

Section 12.10 Persons Entitled to Attend Meetings

 

The Corporation and the Trustee, by their respective officers and directors, the Auditors of the Corporation and the legal advisors of the Corporation, the Trustee or any Debentureholder may attend any meeting of the Debentureholders, but shall have no vote as such.

 

Section 12.11 Powers Exercisable by Extraordinary Resolution

 

(1) In addition to the powers conferred upon them by any other provisions of this Indenture or by law, a meeting of the Debentureholders shall have the following powers exercisable from time to time by Extraordinary Resolution (subject in the case of the matters in paragraphs (a) – (d) and (l) to the prior approval of the TSXV (or such other recognized stock exchange on which the Common Shares are listed for trading)):

 

(a) power to authorize the Trustee to grant extensions of time for payment of any principal, premium or interest on the Debentures, whether or not the principal, premium, or interest, the payment of which is extended, is at the time due or overdue;

 

(b) power to sanction any modification, abrogation, alteration, compromise or arrangement of the rights of the Debentureholders or the Trustee (with its consent) against the Corporation, or against its property, whether such rights arise under this Indenture or the Debentures or otherwise;

 

(c) power to assent to any modification of or change in or addition to or omission from the provisions contained in this Indenture or any Debenture which shall be agreed to by the Corporation and to authorize the Trustee to concur in and execute any indenture supplemental hereto embodying any modification, change, addition or omission;

 

(d) power to sanction any scheme for the reconstruction, reorganization or recapitalization of the Corporation or for the consolidation, amalgamation, arrangement, combination or merger of the Corporation with any other Person or for the sale, leasing, transfer or other disposition of all or substantially all of the undertaking, property and assets of the Corporation or any part thereof, provided that no such sanction shall be necessary in respect of any such transaction if the provisions of Section 10.1 shall have been complied with;

 

- 59 -

 

 

(e) power to direct or authorize the Trustee to exercise any power, right, remedy or authority given to it by this Indenture in any manner specified in any such Extraordinary Resolution or to refrain from exercising any such power, right, remedy or authority;

 

(f) power to waive, and direct the Trustee to waive, any default hereunder and/or cancel any declaration made by the Trustee pursuant to Section 8.1 either unconditionally or upon any condition specified in such Extraordinary Resolution;

 

(g) power to restrain any Debentureholder from taking or instituting any suit, action or proceeding for the purpose of enforcing payment of the principal, premium or interest on the Debentures, or for the execution of any trust or power hereunder;

 

(h) power to direct any Debentureholder who, as such, has brought any action, suit or proceeding to stay or discontinue or otherwise deal with the same upon payment, if the taking of such suit, action or proceeding shall have been permitted by Section 8.5, of the costs, charges and expenses reasonably and properly incurred by such Debentureholder in connection therewith;

 

(i) power to assent to any compromise or arrangement with any creditor or creditors or any class or classes of creditors, whether secured or otherwise, and with holders of any shares or other securities of the Corporation;

 

(j) power to appoint a committee with power and authority (subject to such limitations, if any, as may be prescribed in the resolution) to exercise, and to direct the Trustee to exercise, on behalf of the Debentureholders, such of the powers of the Debentureholders as are exercisable by Extraordinary Resolution or other resolution as shall be included in the resolution appointing the committee. The resolution making such appointment may provide for payment of the expenses and disbursements of and compensation to such committee. Such committee shall consist of such number of persons as shall be prescribed in the resolution appointing it and the members need not be themselves Debentureholders. Every such committee may elect its chairman and may make regulations respecting its quorum, the calling of its meetings and the filling of vacancies occurring in its number and its procedure generally. Such regulations may provide that the committee may act at a meeting at which a quorum is present or may act by minutes signed by the number of members thereof necessary to constitute a quorum. All acts of any such committee within the authority delegated to it shall be binding upon all Debentureholders. Neither the committee nor any member thereof shall be liable for any loss arising from or in connection with any action taken or omitted to be taken by them in good faith;

 

(k) power to remove the Trustee from office and to appoint a new Trustee or Trustees provided that no such removal shall be effective unless and until a new Trustee or Trustees shall have become bound by this Indenture;

 

(l) power to sanction the exchange of the Debentures for or the conversion thereof into shares, bonds, debentures or other securities or obligations of the Corporation or of any other Person formed or to be formed;

 

- 60 -

 

 

(m) power to authorize the distribution in specie of any shares or securities received pursuant to a transaction authorized under the provisions of Section 12.11(1); and

 

(n) power to amend, alter or repeal any Extraordinary Resolution previously passed or sanctioned by the Debentureholders or by any committee appointed pursuant to Section 12.11(1)(j).

 

(2) Notwithstanding the foregoing provisions of this Section 12.11 none of such provisions shall in any manner allow or permit any amendment, modification, abrogation or addition to the provisions of Article 5 which could reasonably be expected to detrimentally affect the rights, remedies or recourse of the priority of the Secured Creditors.

 

Section 12.12 Meaning of “Extraordinary Resolution”

 

(1) The expression “Extraordinary Resolution” when used in this Indenture means, subject as hereinafter in this Article provided, a resolution proposed to be passed as an Extraordinary Resolution at a meeting of Debentureholders (including an adjourned meeting) duly convened for the purpose and held in accordance with the provisions of this Article at which the holders of not less than 25% of the principal amount of the Debentures then outstanding, and if the meeting is a Serial Meeting, at which holders of not less than 25% of the principal amount of the Debentures then outstanding of each especially affected series, are present in person or by proxy and passed by the favourable votes of the holders of not less than 66 2/3% of the principal amount of the Debentures, and if the meeting is a Serial Meeting by the affirmative vote of the holders of not less than 66 2/3% of each especially affected series, in each case present or represented by proxy at the meeting and voted upon on a poll on such resolution.

 

(2) If, at any such meeting, the holders of not less than 25% of the principal amount of the Debentures then outstanding and, if the meeting is a Serial Meeting, 25% of the principal amount of the Debentures then outstanding of each especially affected series, in each case are not present in person or by proxy within 30 minutes after the time appointed for the meeting, then the meeting, if convened by or on the requisition of Debentureholders, shall be dissolved but in any other case it shall stand adjourned to such date, being not less than 14 nor more than 60 days later, and to such place and time as may be appointed by the chairman. Not less than 10 days’ notice shall be given of the time and place of such adjourned meeting in the manner provided in Section 12.2. At the adjourned meeting, the holders present in person or by proxy representing not less than 25% of the principal amount of the Debentures then outstanding and, if the meeting is a Serial Meeting, 25% of the principal amount of the Debentures then outstanding of each especially affected series, shall form a quorum and may transact the business for which the meeting was originally convened and a resolution proposed at such adjourned meeting and passed thereat by the affirmative vote of holders of not less than 66 2/3% of the principal amount of the Debentures and, if the meeting is a Serial Meeting, by the affirmative vote of the holders of not less than 66 2/3% of the principal amount of the Debentures of each especially affected series, in each case present or represented by proxy at the meeting and voted upon on a poll shall be an Extraordinary Resolution within the meaning of this Indenture.

 

(3) Votes on an Extraordinary Resolution shall always be given on a poll and no demand for a poll on an Extraordinary Resolution shall be necessary.

 

Section 12.13 Powers Cumulative

 

Any one or more of the powers in this Indenture stated to be exercisable by the Debentureholders by Extraordinary Resolution or otherwise may be exercised from time to time and the exercise of any one or more of such powers from time to time shall not be deemed to exhaust the rights of the Debentureholders to exercise the same or any other such power or powers thereafter from time to time.

 

- 61 -

 

 

Section 12.14 Minutes

 

Minutes of all resolutions and proceedings at every meeting as aforesaid shall be made and duly entered in books to be from time to time provided for that purpose by the Trustee at the expense of the Corporation, and any such minutes as aforesaid, if signed by the chairman of the meeting at which such resolutions were passed or proceedings had, or by the chairman of the next succeeding meeting of the Debentureholders, shall be prima facie evidence of the matters therein stated and, until the contrary is proved, every such meeting, in respect of the proceedings of which minutes shall have been made, shall be deemed to have been duly held and convened, and all resolutions passed thereat or proceedings taken thereat to have been duly passed and taken.

 

Section 12.15 Instruments in Writing

 

All actions which may be taken and all powers that may be exercised by the Debentureholders at a meeting held as hereinbefore in this Article provided may also be taken and exercised by the holders of 66 2/3% of the principal amount of all the outstanding Debentures and, if the meeting at which such actions might be taken would be a Serial Meeting, by the holders of 66 2/3% of the principal amount of the Debentures then outstanding of each especially affected series, by an instrument in writing signed in one or more counterparts and the expression “Extraordinary Resolution” when used in this Indenture shall include an instrument so signed.

 

Section 12.16 Binding Effect of Resolutions

 

Every resolution and every Extraordinary Resolution passed in accordance with the provisions of this Article at a meeting of Debentureholders shall be binding upon all the Debentureholders, whether present at or absent from such meeting, and every instrument in writing signed by Debentureholders in accordance with Section 12.15 shall be binding upon all the Debentureholders, whether signatories thereto or not, and each and every Debentureholder and the Trustee (subject to the provisions for its indemnity herein contained) shall be bound to give effect accordingly to every such resolution, Extraordinary Resolution and instrument in writing.

 

Section 12.17 Evidence of Rights Of Debentureholders

 

(1) Any request, direction, notice, consent or other instrument which this Indenture may require or permit to be signed or executed by the Debentureholders may be in any number of concurrent instruments of similar tenor signed or executed by such Debentureholders.

 

(2) The Trustee may, in its discretion, require proof of execution in cases where it deems proof desirable and may accept such proof as it shall consider proper.

 

Section 12.18 Concerning Serial Meetings

 

If in the opinion of Counsel any business to be transacted at any meeting, or any action to be taken or power to be exercised by instrument in writing under Section 12.15, does not adversely affect the rights of the holders of Debentures of one or more series, the provisions of this Article 12 shall apply as if the Debentures of such series were not outstanding and no notice of any such meeting need be given to the holders of Debentures of such series. Without limiting the generality of the foregoing, a proposal to modify or terminate any covenant or agreement which is effective only so long as Debentures of a particular series are outstanding shall be deemed not to adversely affect the rights of the holders of Debentures of any other series.

 

- 62 -

 

 

Article 13 – NOTICES

 

Section 13.1 Notice to Corporation

 

Any notice to the Corporation under the provisions of this Indenture shall be valid and effective if delivered to the Corporation at: Siyata Mobile Inc., 1001 Lenoir Street, Montreal, Quebec, H4C 2Z6, Attention: Chief Executive Officer, or if given by registered letter, postage prepaid, to such offices and so addressed and if mailed, shall be deemed to have been effectively given three days following the mailing thereof. The Corporation may from time to time notify the Trustee in writing of a change of address which thereafter, until changed by like notice, shall be the address of the Corporation for all purposes of this Indenture.

 

Section 13.2 Notice to Debentureholders

 

(1) All notices to be given hereunder with respect to the Debentures shall be deemed to be validly given to the holders thereof if sent by first class mail, postage prepaid, by letter or circular addressed to such holders at their post office addresses appearing in any of the registers hereinbefore mentioned and shall be deemed to have been effectively given three days following the day of mailing. Accidental error or omission in giving notice or accidental failure to mail notice to any Debentureholder or the inability of the Corporation to give or mail any notice due to anything beyond the reasonable control of the Corporation shall not invalidate any action or proceeding founded thereon.

 

(2) If any notice given in accordance with the foregoing paragraph would be unlikely to reach the Debentureholders to whom it is addressed in the ordinary course of post by reason of an interruption in mail service, whether at the place of dispatch or receipt or both, the Corporation shall give such notice by publication at least once in the city of Vancouver (or in such of those cities as, in the opinion of the Trustee, is sufficient in the particular circumstances), each such publication to be made in a daily newspaper of general circulation in the designated city.

 

(3) Any notice given to Debentureholders by publication shall be deemed to have been given on the day on which publication shall have been effected at least once in each of the newspapers in which publication was required.

 

(4) All notices with respect to any Debenture may be given to whichever one of the holders thereof (if more than one) is named first in the registers hereinbefore mentioned, and any notice so given shall be sufficient notice to all holders of any persons interested in such Debenture.

 

Section 13.3 Notice to Trustee

 

Any notice to the Trustee under the provisions of this Indenture shall be valid and effective if delivered, receipt confirmed, to the Trustee at its principal office in the ; and shall be deemed to have been effectively given as of the date of such receipt confirmation or if given by registered letter, postage prepaid, to such office and so addressed and, if mailed, shall be deemed to have been effectively given three days following the mailing thereof.

 

- 63 -

 

 

Section 13.4 Mail Service Interruption

 

If by reason of any interruption of mail service, actual or threatened, any notice to be given to the Trustee would reasonably be unlikely to reach its destination by the time notice by mail is deemed to have been given pursuant to Section 13.3, such notice shall be valid and effective only if delivered at the appropriate address in accordance with Section 13.3.

 

Article 14 – CONCERNING THE TRUSTEE

 

Section 14.1 No Conflict of Interest

 

The Trustee represents to the Corporation that, to the best of its knowledge, at the date of execution and delivery by it of this Indenture, there exists no material conflict of interest in the role of the Trustee as a fiduciary hereunder but, if, notwithstanding the provisions of this Section 14.1, such a material conflict of interest exists, or hereafter arises, the validity and enforceability of this Indenture, and the Debentures issued hereunder, shall not be affected in any manner whatsoever by reason only that such material conflict of interest exists or arises but the Trustee shall, within 30 days after ascertaining that it has a material conflict of interest, either eliminate such material conflict of interest or resign in the manner and with the effect specified in Section 14.2.

 

Section 14.2 Replacement of Trustee

 

(1) The Trustee may resign its trust and be discharged from all further duties and liabilities hereunder by giving to the Corporation 90 days’ notice in writing or such shorter notice as the Corporation may accept as sufficient. If at any time a material conflict of interest exists in the Trustee’s role as a fiduciary hereunder the Trustee shall, within 30 days after ascertaining that such a material conflict of interest exists, either eliminate such material conflict of interest or resign in the manner and with the effect specified in this Section 14.2. The validity and enforceability of this Indenture and of the Debentures issued hereunder shall not be affected in any manner whatsoever by reason only that such a material conflict of interest exists. In the event of the Trustee resigning or being removed or being dissolved, becoming bankrupt, going into liquidation or otherwise becoming incapable of acting hereunder, the Corporation shall forthwith appoint a new Trustee unless a new Trustee has already been appointed by the Debentureholders. Failing such appointment by the Corporation, the retiring Trustee or any Debentureholder may apply to a Judge of the British Columbia Supreme Court, on such notice as such Judge may direct at the Corporation’s expense, for the appointment of a new Trustee but any new Trustee so appointed by the Corporation or by the Court shall be subject to removal as aforesaid by the Debentureholders and the appointment of such new Trustee shall be effective only upon such new Trustee becoming bound by this Indenture. Any new Trustee appointed under any provision of this Section 14.2 shall be a corporation authorized to carry on the business of a trust company in all of the Provinces of Canada. On any new appointment the new Trustee shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named herein as Trustee.

 

(2) Any company into which the Trustee may be merged or, with or to which it may be consolidated, amalgamated or sold, or any company resulting from any merger, consolidation, sale or amalgamation to which the Trustee shall be a party, or any company which shall purchase all or substantially all of the corporate trust book of business of the Trustee, shall be the successor trustee under this Indenture without the execution of any instrument or any further act. Nevertheless, upon the written request of the successor Trustee or of the Corporation, the Trustee ceasing to act shall execute and deliver an instrument assigning and transferring to such successor Trustee, upon the trusts herein expressed, all the rights, powers and trusts of the Trustee so ceasing to act, and, shall duly assign, transfer and deliver all property and money held by such Trustee to the successor Trustee so appointed in its place. Should any deed, conveyance or instrument in writing from the Corporation be required by any new Trustee for more fully and certainly vesting in and confirming to it such estates, properties, rights, powers and trusts, then any and all such deeds, conveyances and instruments in writing shall on request of said new Trustee, be made, executed, acknowledged and delivered by the Corporation.

 

- 64 -

 

 

Section 14.3 Duties of Trustee

 

In the exercise of the rights, duties and obligations prescribed or conferred by the terms of this Indenture, the Trustee shall act honestly and in good faith and exercise that degree of care, diligence and skill that a reasonably prudent trustee would exercise in comparable circumstances.

 

Section 14.4 Reliance Upon Declarations, Opinions, etc.

 

In the exercise of its rights, duties and obligations hereunder the Trustee may, if acting in good faith, rely, as to the truth of the statements and accuracy of the opinions expressed therein, upon statutory declarations, opinions, reports or certificates furnished pursuant to any covenant, condition or requirement of this Indenture or required by the Trustee to be furnished to it in the exercise of its rights and duties hereunder, if the Trustee examines such statutory declarations, opinions, reports or certificates and determines that they comply with Section 14.5, if applicable, and with any other applicable requirements of this Indenture. The Trustee may nevertheless, in its discretion, require further proof in cases where it deems further proof desirable. Without restricting the foregoing, the Trustee may rely on an opinion of Counsel satisfactory to the Trustee notwithstanding that it is delivered by a solicitor or firm which acts as solicitors for the Corporation.

 

Section 14.5 Evidence and Authority to Trustee, Opinions, etc.

 

(1) The Corporation shall furnish to the Trustee evidence of compliance with the conditions precedent provided for in this Indenture relating to any action or step required or permitted to be taken by the Corporation or the Trustee under this Indenture or as a result of any obligation imposed under this Indenture, including without limitation, the certification and delivery of Debentures hereunder, the satisfaction and discharge of this Indenture and the taking of any other action to be taken by the Trustee at the request of or on the application of the Corporation, forthwith if and when (a) such evidence is required by any other Section of this Indenture to be furnished to the Trustee in accordance with the terms of this Section 14.5, or (b) the Trustee, in the exercise of its rights and duties under this Indenture, gives the Corporation written notice requiring it to furnish such evidence in relation to any particular action or obligation specified in such notice.

 

(2) Such evidence shall consist of:

 

(a) a certificate made by any two officers or directors of the Corporation, stating that any such condition precedent has been complied with in accordance with the terms of this Indenture;

 

(b) in the case of a condition precedent compliance with which is, by the terms of this Indenture, made subject to review or examination by a solicitor, an opinion of Counsel that such condition precedent has been complied with in accordance with the terms of this Indenture; and

 

(c) in the case of any such condition precedent compliance with which is subject to review or examination by auditors or accountants, an opinion or report of the Auditors of the Corporation whom the Trustee for such purposes hereby approves, that such condition precedent has been complied with in accordance with the terms of this Indenture.

 

- 65 -

 

 

(3) Whenever such evidence relates to a matter other than the certificates and delivery of Debentures and the satisfaction and discharge of this Indenture, and except as otherwise specifically provided herein, such evidence may consist of a report or opinion of any solicitor, auditor, accountant, engineer or appraiser or any other person whose qualifications give authority to a statement made by him, provided that if such report or opinion is furnished by a trustee, officer or employee of the Corporation it shall be in the form of a statutory declaration. Such evidence shall be, so far as appropriate, in accordance with the immediately preceding paragraph of this Section.

 

(4) Each statutory declaration, certificate, opinion or report with respect to compliance with a condition precedent provided for in this Indenture shall include (a) a statement by the person giving the evidence that he has read and is familiar with those provisions of this Indenture relating to the condition precedent in question, (b) a brief statement of the nature and scope of the examination or investigation upon which the statements or opinions contained in such evidence are based, (c) a statement that, in the belief of the person giving such evidence, he has made such examination or investigation as is necessary to enable him to make the statements or give the opinions contained or expressed therein, and (d) a statement whether in the opinion of such person the conditions precedent in question have been complied with or satisfied.

 

(5) The Corporation shall furnish or cause to be furnished to the Trustee at any time if the Trustee reasonably so requires, its certificate that the Corporation has complied with all covenants, conditions or other requirements contained in this Indenture, the non-compliance with which would, with the giving of notice or the lapse of time, or both, or otherwise, constitute an Event of Default, or if such is not the case, specifying the covenant, condition or other requirement which has not been complied with and giving particulars of such non-compliance. The Corporation shall, whenever the Trustee so requires, furnish the Trustee with evidence by way of statutory declaration, opinion, report or certificate as specified by the Trustee as to any action or step required or permitted to be taken by the Corporation or as a result of any obligation imposed by this Indenture.

 

Section 14.6 Officer’s Certificates Evidence

 

Except as otherwise specifically provided or prescribed by this Indenture, whenever in the administration of the provisions of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or omitting any action hereunder, the Trustee, if acting in good faith, may rely upon an Officer’s Certificate.

 

Section 14.7 Experts, Advisers and Agents

 

The Trustee may:

 

(a) employ or retain and act and rely on the opinion or advice of or information obtained from any solicitor, auditor, valuer, engineer, surveyor, appraiser or other expert, whether obtained by the Trustee or by the Corporation, or otherwise, and shall not be liable for acting, or refusing to act, in good faith on any such opinion or advice and may pay proper and reasonable compensation for all such legal and other advice or assistance as aforesaid. The reasonable costs of such services shall be added to and become part of the Trustee’s remuneration hereunder; and

 

(b) employ such agents and other assistants as it may reasonably require for the proper discharge of its duties hereunder, and may pay reasonable remuneration for all services performed for it (and shall be entitled to receive reasonable remuneration for all services performed by it) in the discharge of the trusts hereof and compensation for all disbursements, costs and expenses made or incurred by it in the discharge of its duties hereunder and in the management of the trusts hereof and any solicitors employed or consulted by the Trustee may, but need not be, solicitors for the Corporation.

 

- 66 -

 

 

Section 14.8 Trustee May Deal in Debentures

 

Subject to Section 14.1 and Section 14.3, the Trustee may, in its personal or other capacity, buy, sell, lend upon and deal in the Debentures and generally contract and enter into financial transactions with the Corporation or otherwise, without being liable to account for any profits made thereby.

 

Section 14.9 Investment of Monies Held by Trustee

 

Until released in accordance with this Agreement, monies held by the Trustee shall be kept segregated in the records of the Trustee and shall be deposited in one or more interest-bearing trust accounts to be maintained by the Trustee in the name of the Trustee at one or more banks having a Standard and Poors Issuer Credit rating of AA- or above (an “Approved Bank”). All amounts held by the Trustee pursuant to this Agreement shall be held by the Trustee pursuant to the term of this Agreement and shall not give rise to a debtor-creditor or other similar relationship. The amounts held by the Trustee pursuant to this Agreement are at the sole risk of Corporation and, without limiting the generality of the foregoing, the Trustee shall have no responsibility or liability for any diminution of the monies which may result from any deposit made with an Approved Bank pursuant to this Section 14.9, including any losses resulting from a default by the Approved Bank or other credit losses (whether or not resulting from such a default) and any credit or other losses on any deposit liquidated or sold prior to maturity. The parties hereto acknowledge and agree that the Trustee will have acted prudently in depositing the monies at any Approved Bank,

 

Section 14.10 Trustee Not Ordinarily Bound

 

Except as provided in Section 8.2 and as otherwise specifically provided herein, the Trustee shall not, subject to Section 14.3, be bound to give notice to any person of the execution hereof, nor to do, observe or perform, or see to the observance or performance by the Corporation of, any of the obligations herein imposed upon the Corporation or the covenants on the part of the Corporation herein contained, nor in any way to supervise or interfere with the conduct of the Corporation’s business, unless the Trustee shall have been required to do so in writing by the holders of not less than 25% of the aggregate principal amount of the Debentures then outstanding or by any Extraordinary Resolution of the Debentureholders passed in accordance with the provisions contained in Article 12, and then only after it shall have been funded and indemnified to its satisfaction against all actions, proceedings, claims and demands to which it may render itself liable and all costs, charges, damages and expenses which it may incur by so doing.

 

Section 14.11 Trustee Not Required to Give Security

 

The Trustee shall not be required to give any bond or security in respect of the execution of the trusts and powers of this Indenture or otherwise in respect of the premises.

 

Section 14.12 Trustee Not Bound to Act on Trust’s Request

 

Except as otherwise specifically provided in this Indenture, the Trustee shall not be bound to act in accordance with any direction or request of the Corporation until a duly authenticated copy of the instrument or resolution containing such direction or request shall have been delivered to the Trustee, and the Trustee shall be empowered to act upon any such copy purporting to be authenticated and believed by the Trustee to be genuine.

 

- 67 -

 

 

Section 14.13 Conditions Precedent to Trustee’s Obligations to Act Hereunder

 

(1) The obligation of the Trustee to commence or continue any act, action or proceeding for the purpose of enforcing the rights of the Trustee and of the Debentureholders hereunder shall be conditional upon the Debentureholders furnishing when required by notice in writing by the Trustee, sufficient funds to commence or continue such act, action or proceeding and indemnity reasonably satisfactory to the Trustee to protect and hold harmless the Trustee against the costs, charges and expenses and liabilities to be incurred thereby and any loss and damage it may suffer by reason thereof.

 

(2) None of the provisions contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur financial liability in the performance of any of its duties or in the exercise of any of its rights or powers unless indemnified and funded as aforesaid.

 

(3) The Trustee may, before commencing or at any time during the continuance of any such act, action or proceeding require the Debentureholders at whose instance it is acting to deposit with the Trustee the Debentures held by them for which Debentures the Trustee shall issue receipts.

 

Section 14.14 Authority to Carry on Business

 

The Trustee represents to the Corporation that at the date of execution and delivery by it of this Indenture it is authorized to carry on the business of a trust company in each of the provinces and territories of Canada but if, notwithstanding the provisions of this Section 14.14, it ceases to be so authorized to carry on business, the validity and enforceability of this Indenture and the securities issued hereunder shall not be affected in any manner whatsoever by reason only of such event but the Trustee shall, within 90 days after ceasing to be authorized to carry on the business of a trust company in any of the provinces or territories of Canada, either become so authorized or resign in the manner and with the effect specified in Section 13.2.

 

Section 14.15 Compensation and Indemnity

 

(1) The Corporation shall pay to the Trustee, from time to time, compensation for its services hereunder as agreed separately by the Corporation and the Trustee, and shall pay or reimburse the Trustee upon its request for all reasonable expenses, disbursements and advances incurred or made by the Trustee in the administration or execution of its duties under this Indenture (including the reasonable and documented compensation and disbursements of its Counsel and all other advisers and assistants not regularly in its employ), both before any default hereunder and thereafter until all duties of the Trustee under this Indenture shall be finally and fully performed. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust.

 

(2) The Corporation hereby indemnifies and holds the Trustee and its affiliates, their successors and assigns, as well as its and their respective directors, officers, employees and agents, harmless from and against any and all claims, demands, assessments, interest, penalties, actions, suits, proceedings, liabilities, losses, damages, costs and expenses, including, without limiting the foregoing, expert, consultant and counsel fees and disbursements on a solicitor and client basis, arising from or in connection with any actions or omissions that the Trustee or they take pursuant to this Indenture, provided that the Corporation need not reimburse any cost or expense or indemnify against any loss or liability incurred by the Trustee through gross negligence or bad faith or fraud. This indemnity shall survive the resignation or removal of the Trustee and the termination or discharge of this Indenture.

 

- 68 -

 

 

(3) Notwithstanding any other provision of this Indenture, the Trustee shall not be liable for any (i) breach by any other party of the Applicable Securities Legislation, (ii) lost profits or (iii) punitive, consequential or special damages of any Person.

 

(4) The Trustee shall notify the Corporation promptly of any claim for which it may seek indemnity. The Corporation shall defend the claim and the Trustee shall co-operate in the defence. The Trustee may have separate Counsel and the Corporation shall pay the reasonable fees and expenses of such Counsel. The Corporation need not pay for any settlement made without its consent, which consent must not be unreasonably withheld.

 

Section 14.16 Acceptance of Trust

 

The Trustee hereby accepts the trusts in this Indenture declared and provided for and agrees to perform the same upon the terms and conditions herein set forth and to hold all rights, privileges and benefits conferred hereby and by law in trust for the various persons who shall, from time to time, be Debentureholders, subject to all the terms and conditions herein set forth.

 

Section 14.17 Third Party Interests

 

Each party to this Indenture (in this paragraph referred to as a “representing party”) hereby represents to the Trustee that any account to be opened by, or interest to be held by, the Trustee in connection with this Indenture, for or to the credit of such representing party, either (i) is not intended to be used by or on behalf of any third party; or (ii) is intended to be used by or on behalf of a third party, in which case such representing party hereby agrees to complete, execute and deliver forthwith to the Trustee a declaration, in the Trustee’s prescribed form or in such other form as may be satisfactory to it, as to the particulars of such third party.

 

Section 14.18 Anti-Money Laundering

 

The Trustee shall retain the right not to act and shall not be liable for refusing to act if, due to a lack of information or for any other reason whatsoever, the Trustee, in its sole judgment, acting reasonably, determines that such act might cause it to be in noncompliance with any applicable anti-money laundering or anti-terrorist or economic sanctions legislation, regulation or guideline. Further, should the Trustee, in its sole judgment, acting reasonably, determine at any time that its acting under this Indenture has resulted in its being in non-compliance with any applicable anti-money laundering or anti-terrorist or economic sanctions legislation, regulation or guideline, then it shall have the right to resign on 10 days’ prior written notice sent to the Corporation provided that (i) the Trustee’s written notice shall describe the circumstances of such non-compliance; and (ii) if such circumstances are rectified to the Trustee’s satisfaction within such 10-day period, then such resignation shall not be effective.

 

Section 14.19 Privacy Laws

 

The parties acknowledge that the Trustee may, in the course of providing services hereunder, collect or receive financial and other personal information about such parties and/or their representatives, as individuals, or about other individuals related to the subject matter hereof, and use such information for the following purposes:

 

(a) to provide the services required under this Indenture and other services that may be requested from time to time;

 

(b) to help the Trustee manage its servicing relationships with such individuals;

 

- 69 -

 

 

(c) to meet the Trustee’s legal and regulatory requirements; and

 

(d) if Social Insurance Numbers are collected by the Trustee, to perform tax reporting and to assist in verification of an individual’s identity for security purposes.

 

Each party acknowledges and agrees that the Trustee may receive, collect, use and disclose personal information provided to it or acquired by it in the course of this Indenture for the purposes described above and, generally, in the manner and on the terms described in its Privacy Code, which the Trustee shall make available on its website,  , or upon request, including revisions thereto. The Trustee may transfer personal information to other companies in or outside of Canada that provide data processing and storage or other support in order to facilitate the services it provides.

 

Further, each party agrees that it shall not provide or cause to be provided to the Trustee any personal information relating to an individual who is not a party to this Indenture unless that party has assured itself that such individual understands and has consented to the aforementioned uses and disclosures.

 

Section 14.20 Force Majeure

 

Neither party shall be liable to the other, or held in breach of this Indenture, if prevented, hindered, or delayed in the performance or observance of any provision contained herein by reason of act of God, riots, terrorism, acts of war, epidemics, governmental action or judicial order, earthquakes, or any other similar causes (including, but not limited to, mechanical, electronic or communication interruptions, disruptions or failures). Performance times under this Indenture shall be extended for a period of time equivalent to the time lost because of any delay that is excusable under this Section 14.20.

 

Article 15 – SUPPLEMENTAL INDENTURES

 

Section 15.1 Supplemental Indentures

 

From time to time the Trustee and, when authorized by a resolution of the Board of Directors of Corporation, the Corporation, may, and they shall when required by this Indenture, execute, acknowledge and deliver by their proper officers deeds or indentures supplemental hereto which thereafter shall form part hereof, for any one or more of the following purposes:

 

(a) providing for the issuance of Additional Debentures under this Indenture;

 

(b) adding to the covenants of the Corporation herein contained for the protection of the Debentureholders, or of the Debentures of any series, or providing for events of default, in addition to those herein specified;

 

(c) making such provisions not inconsistent with this Indenture as may be necessary or desirable with respect to matters or questions arising hereunder, including the making of any modifications in the form of the Debentures which do not affect the substance thereof and which in the opinion of the Trustee relying on an opinion of Counsel will not be prejudicial to the interests of the Debentureholders;

 

(d) evidencing the succession, or successive successions, of others to the Corporation and the covenants of and obligations assumed by any such successor in accordance with the provisions of this Indenture;

 

- 70 -

 

 

(e) giving effect to any Extraordinary Resolution passed as provided in Article 12; and

 

(f) for any other purpose not inconsistent with the terms of this Indenture.

 

Unless the supplemental indenture requires the consent or concurrence of Debentureholders or the holders of a particular series of Debentures, as the case may be, by Extraordinary Resolution, and provided no Event of Default has occurred and is continuing, the consent or concurrence of Debentureholders or the holders of a particular series of Debentures, as the case may be, shall not be required in connection with the execution, acknowledgement or delivery of a supplemental indenture. The Corporation and the Trustee may amend any of the provisions of this Indenture related to matters of United States law or the issuance of Debentures into the United States in order to ensure that such issuances can be made in accordance with applicable law in the United States without the consent or approval of the Debentureholders. Further, the Corporation and the Trustee may without the consent or concurrence of the Debentureholders or the holders of a particular series of Debentures, as the case may be, and provided no Event of Default has occurred and is continuing, by supplemental indenture or otherwise, make any changes or corrections in this Indenture which it shall have been advised by Counsel are required for the purpose of curing or correcting any ambiguity or defective or inconsistent provisions or clerical omissions or mistakes or manifest errors contained herein or in any indenture supplemental hereto or any Written Direction of the Corporation provided for the issue of Debentures, providing that in the opinion of the Trustee (relying upon an opinion of Counsel) the rights of the Debentureholders are in no way prejudiced thereby.

 

Article 16 – EXECUTION AND FORMAL DATE

 

Section 16.1 Execution

 

This Indenture may be simultaneously executed in several counterparts, each of which when so executed shall be deemed to be an original and such counterparts together shall constitute one and the same instrument.

 

Section 16.2 Formal Date

 

For the purpose of convenience this Indenture may be referred to as bearing the formal date of December 23, 2019 irrespective of the actual date of execution hereof.

 

[Balance of Page Left Blank]

 

- 71 -

 

 

The parties have executed this Agreement.

 

  SIYATA MOBILE INC.
       
  By:  
    Name:  
    Title:  
       
  By:  
    Name:  
    Title:  
       
  By:  
    Name:  
    Title:  

 

[Signature Page to Convertible Debenture Indenture]

 

 

 

Schedule A – Form of Debenture

 

(INSERT IF BEING ISSUED TO CDS) UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF CDS CLEARING AND DEPOSITORY SERVICES INC. (“CDS”) TO SIYATA MOBILE INC.. (THE “ISSUER”) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IN RESPECT THEREOF IS REGISTERED IN THE NAME OF CDS & CO., OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF CDS (AND ANY PAYMENT IS MADE TO CDS & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF CDS), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED HOLDER HEREOF, CDS & CO., HAS A PROPERTY INTEREST IN THE SECURITIES REPRESENTED BY THIS CERTIFICATE HEREIN AND IT IS A VIOLATION OF ITS RIGHTS FOR ANOTHER PERSON TO HOLD, TRANSFER OR DEAL WITH THIS CERTIFICATE.

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE APRIL 24, 2020.

 

(INSERT IF APPLICABLE) WITHOUT PRIOR APPROVAL OF THE EXCHANGE AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE AND THE SECURITIES ISSUABLE UPON EXERCISE THEREOF MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF THE TSX VENTURE EXCHANGE OR OTHERWISE IN CANADA OR TO OR FOR THE BENEFIT OF A CANADIAN RESIDENT UNTIL APRIL 24, 2020.

 

Certificate No. [●] C$[●]

   

CUSIP No. 83013QAA1

 

ISIN No. CA83013QAA19

 

SIYATA MOBILE INC.

 

(A corporation existing under the laws of British Colombia)

 

12.0% UNSECURED CONVERTIBLE DEBENTURE
DUE DECEMBER 23, 2021

 

Siyata Mobile Inc. (the “Corporation”) for value received hereby acknowledges itself indebted and, subject to the provisions of the convertible debenture indenture (the “Indenture”) dated as of December 23, 2019 between the Corporation and  (the “Debenture Trustee”), promises to pay to the registered holder hereof on December 23, 2021 (the “Maturity Date”) or on such earlier date as the principal amount hereof may become due in accordance with the provisions of the Indenture on presentation and surrender of this Debenture at the offices of the Debenture Trustee in Vancouver, British Columbia in accordance with the terms of the Indenture and, subject as hereinafter provided, to pay interest on the principal amount hereof from the date hereof, or from the last Interest Payment Date (as defined below) to which interest shall have been paid or made available for payment hereon, whichever is later, at the rate of 12.0% per annum, in like money, in arrears quarterly commencing on December 23, 2019 (each, an “Interest Payment Date”) and including the last payment (representing interest payable from the last Interest Payment Date to, but excluding, the Maturity Date or the earlier date of redemption) to fall due on the Maturity Date and, should the Corporation at any time make default in the payment of any principal, premium or interest, to pay interest on the amount in default at the same rate, in like money and on the same dates.

 

A-1

 

 

Reference is hereby expressly made to the Indenture for a description of the terms and conditions upon which the Debentures are or are to be issued and held and the rights and remedies of the holders of the Debentures and of the Corporation and of the Debenture Trustee, all to the same effect as if the provisions of the Indenture were herein set forth, and to all of which provisions the holder of this Debenture by acceptance hereof assents. To the extent that the terms and conditions stated in this Debenture conflict with the terms and conditions of the Indenture, the latter shall prevail. All capitalized terms used herein have the meaning ascribed thereto in the Indenture unless otherwise indicated.

 

Interest hereon shall be payable by cheque or electronic transfer of funds to the registered holder hereof or such other means provided in the Indenture and, subject to the provisions of the Indenture, the sending of such cheque or electronic transfer of funds shall, to the extent of the sum represented thereby, satisfy and discharge all liability for interest on this Debenture.

 

This Debenture is one of the Debentures of the Corporation issued under the provisions of the Indenture. Upon compliance with the provisions of the Indenture, Debentures of any denomination may be exchanged for an equal aggregate principal amount of Debentures in any other authorized denomination or denominations.

 

Any part, being C$1,000 or an integral multiple thereof, of the principal of this Debenture, provided that the principal amount of this Debenture is in a denomination in excess of C$1,000, is convertible, at the option of the holder hereof, upon surrender of this Debenture at the principal offices of the Debenture Trustee in the City of Vancouver, British Columbia, at any time prior to the close of business on the Maturity Date or, if this Debenture is called for redemption on or prior to such date, then up to but not after the close of business on the last Business Day immediately preceding the date specified for redemption of this Debenture, into Common Shares (without adjustment for interest accrued hereon at a conversion price of C$0.45 per Common Share (the “Conversion Price”)), being a conversion ratio of approximately 2,222 shares for each C$1,000 principal amount of Debentures so converted, all subject to the terms and conditions and in the manner set forth in the Indenture. The Indenture makes provision for the adjustment of the Conversion Price in the events therein specified. No fractional Common Shares will be issued, and the number of Common Shares so issuable will be rounded down to the nearest whole number.

 

This Debenture may be redeemed at the option of the Corporation on or after December 23, 2020 (except in certain limited circumstances following a Change of Control of the Corporation) on the terms and conditions set out in the Indenture at the Redemption Price therein and herein set out. In such circumstances, the Debentures will be redeemable at a price equal to their principal amount plus accrued and unpaid interest.

 

Upon the occurrence of a Change of Control of the Corporation, the Corporation is required to make an offer to purchase all of the Debentures at a price equal to 100% of the principal amount of such Debentures plus accrued and unpaid interest up to, but excluding, the date the Debentures are so repurchased (the “Change of Control Purchase Offer”). If 90% or more in aggregate principal amount of Debentures outstanding on the date the Change of Control Notice and the Change of Control Purchase Offer are delivered or mailed to holders of the Debentures have been tendered for purchase and not withdrawn pursuant to the Change of Control Purchase Offer, then the Corporation has the right upon written notice provided to the Debenture Trustee within ten (10) calendar days following the Change of Control Purchase Date to redeem all the remaining outstanding Debentures on the same date and at the same price, subject to the terms and conditions described in the Indenture.

 

A-2

 

 

If an Offer for outstanding Debentures (other than Debentures held by or on behalf of the Offeror, Associates or Affiliates of the Offeror or anyone acting jointly or in concert with the Offeror) is made and 90% or more of the outstanding principal amount of the Debentures is taken up and paid for by the Offeror, the Offeror will be entitled to acquire the Debentures of those holders who did not accept the offer on the same terms as the Offeror acquired the first 90% of the principal amount of the Debentures.

 

The indebtedness, liabilities and obligations of the Corporation under this Debenture are direct unsecured obligations of the Corporation, and will rank equally with one another and with all other unsecured and unsubordinated indebtedness of the Corporation except as prescribed by law and will rank senior to any existing or future subordinated indebtedness of the Corporation.

 

The principal hereof may become or be declared due and payable before the stated maturity in the events, in the manner, with the effect and at the times provided in the Indenture.

 

The Indenture contains provisions making binding upon all holders of Debentures outstanding thereunder resolutions passed at meetings of such holders held in accordance with such provisions and instruments signed by the holders of a specified majority of Debentures outstanding, which resolutions or instruments may have the effect of amending the terms of this Debenture or the Indenture.

 

This Debenture may only be transferred, upon compliance with the conditions prescribed in the Indenture, in one of the registers to be kept at the principal offices of the Debenture Trustee in Toronto and in such other place or places and/or by such other registrars (if any) as the Corporation with the approval of the Debenture Trustee may designate. No transfer of this Debenture shall be valid unless made on the register by the registered holder hereof and upon compliance with such reasonable requirements as the Debenture Trustee and/or other registrar may prescribe and upon surrender of this Debenture for cancellation. Thereupon a new Debenture or Debentures in the same aggregate principal amount shall be issued to the transferee in exchange hereof.

 

This Debenture shall not become obligatory for any purpose until it shall have been certified by the Debenture Trustee under the Indenture.

 

The Indenture and this Debenture shall be governed by, and construed in accordance with, the laws of the Province of British Columbia and the federal laws of Canada applicable therein.

 

Capitalized words or expressions used in this Debenture shall, unless otherwise defined herein, have the meaning ascribed thereto in the Indenture. In the event that the terms and conditions stated in this Debenture conflict, or are inconsistent, with the terms and conditions of the Indenture, the Indenture shall prevail and take priority.

 

[Remainder of page intentionally left blank. Signature page follows.] 

 

A-3

 

  

IN WITNESS WHEREOF Siyata Mobile Inc.. has caused this Debenture to be signed by its authorized signatories as of the 23rd day of December, 2019.

 

  SIYATA MOBILE INC.
       
  By:  
    Name:  
    Title:  

 

  By:  
    Name:  
    Title:  

 

A-4

 

  

TRUSTEE’S CERTIFICATE

 

This Issued Debenture is one of the 12.0% Unsecured Convertible Debentures due December 23, 2021 referred to in the Indenture within mentioned.

 

Dated: ___________________________, 20_____.

 

  By:  
    Name:  
    Title:  

 

A-5

 

  

(FORM OF REGISTRATION PANEL)

 

(No writing hereon except by Debenture Trustee or other registrar)

 

Date of Registration In Whose Name Registered Signature of Debenture Trustee or Registrar
     
     
     

 

A-6

 

  

FORM OF ASSIGNMENT

 

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto ____________, whose address, if applicable, is set forth below, these Debentures (or C$___________ principal amount hereof) of Siyata Mobile Inc. standing in the name(s) of the undersigned in the register maintained by         with respect to such Debentures and does hereby irrevocably authorize and direct the Debenture Trustee to transfer such Debentures in such register, with full power of substitution in the premises.

 

Dated:  
   
Address of Transferee:  
   
   
   
  (Street Address, City, Province and Postal Code)

 

(*) If less than the full principal amount of the within Debenture is to be transferred, indicate in the space provided the principal amount (which must be C$1,000 or an integral multiple thereof, unless you hold an Debenture in a non-integral multiple of C$1,000, in which case such Debenture is transferable only in its entirety) to be transferred.

 

Dated:   Signature(s):  

 

     
    Signature of transferring registered holder
     
Signature of Guarantor:    
     
     
Authorized Officer   Signature of transferring registered holder
     
     
Name of Institution    

  

REASON FOR TRANSFER – For US Residents only (where the individual(s) or corporation receiving the securities is a US resident). Please select only one (see instructions below).

 

Gift Estate Private Sale Other (or no change in ownership)

  

Date of Event (Date of gift, death or sale): Value per Debenture on the date of event:

 

      ☐ CAD OR USD

 

1. The signature(s) of the transferor(s) must correspond with the name(s) as written upon the face of this certificate(s), in every particular, without alteration or enlargement, or any change whatsoever. The signature(s) on this form must be guaranteed by an authorized officer of Royal Bank of Canada, Scotia Bank or TD Canada Trust whose sample signature(s) are on file with the transfer agent, or by a member of an acceptable Medallion Signature Guarantee Program (STAMP, SEMP, NYSE, MSP). Notarized or witnessed signatures are not acceptable as guaranteed signatures. The Guarantor must affix a stamp bearing the actual words: “SIGNATURE GUARANTEED”, “MEDALLION GUARANTEED” OR “SIGNATURE & AUTHORITY TO SIGN GUARANTEE”, all in accordance with the transfer agent’s then current guidelines and requirements at the time of transfer. For corporate holders, corporate signing resolutions, including certificate of incumbency, will also be required to accompany the transfer unless there is a “SIGNATURE & AUTHORITY TO SIGN GUARANTEE” Stamp affixed to the Form of Transfer obtained from an authorized officer of the Royal Bank of Canada, Scotia Bank or TD Canada Trust or a “MEDALLION GUARANTEED” Stamp affixed to the Form of Transfer, with the correct prefix covering the face value of the certificate.

 

2. The registered holder of this Issued Debenture is responsible for the payment of any documentary, stamp or other transfer taxes that may be payable in respect of the transfer of this Debenture.

 

A-7

 

 

EXHIBIT “I”

 

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF CDS CLEARING AND DEPOSITORY SERVICES INC. (“CDS”) TO SIYATA MOBILE INC. (THE “ISSUER”) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IN RESPECT THEREOF IS REGISTERED IN THE NAME OF CDS & CO., OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF CDS (AND ANY PAYMENT IS MADE TO CDS & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF CDS), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED HOLDER HEREOF, CDS & CO., HAS A PROPERTY INTEREST IN THE SECURITIES REPRESENTED BY THIS CERTIFICATE HEREIN AND IT IS A VIOLATION OF ITS RIGHTS FOR ANOTHER PERSON TO HOLD, TRANSFER OR DEAL WITH THIS CERTIFICATE.

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE APRIL 24, 2020.

 

(INSERT IF APPLICABLE) WITHOUT PRIOR APPROVAL OF THE EXCHANGE AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE AND THE SECURITIES ISSUABLE UPON EXERCISE THEREOF MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF THE TSX VENTURE EXCHANGE OR OTHERWISE IN CANADA OR TO OR FOR THE BENEFIT OF A CANADIAN RESIDENT UNTIL APRIL 24, 2020.

 

[Remainder of this page intentionally left blank]

 

A-8

 

 

TO CDS GLOBAL DEBENTURE

 

SIYATA MOVILE INC.

 

12.0% UNSECURED CONVERTIBLE DEBENTURES

 

Initial Principal Amount: C$[●]

 

CUSIP No. 83013QAA1

 

ISIN No. CA83013QAA19

 

Signature of the Debenture Trustee:

 

ADJUSTMENTS

 

Date Amount of Increase Amount of Decrease New Principal Amount Authorization
         
         
         

 

A-9

 

 

Schedule B – Form of Redemption Notice

 

TO: Holders of 12.0% Unsecured Convertible Debentures due December 23, 2021 (the “Debentures”) of Siyata Movile Inc. (the “Corporation”)

 

NOTE: All capitalized terms used herein have the meaning ascribed thereto in the Indenture (as defined herein), unless otherwise indicated.

 

Notice is hereby given pursuant to Section 4.2 of the convertible debenture indenture (the “Indenture”) dated as of December 23, 2019 between the Corporation and  Trust Company of Canada (the “Debenture Trustee”), that the aggregate principal amount of C$[●] of the C$[●] of Debentures outstanding will be redeemed as of [●], 20[●] (the “Redemption Date”), upon payment of a redemption amount of C$[●] for each C$1,000 principal amount of Debentures, being equal to the aggregate of (i) C$1,000 (the “Redemption Price”), and (ii) accrued and unpaid interest on such redeemed Debentures to and including the Redemption Date, (collectively, the “Total Redemption Price”).

 

The Total Redemption Price will be payable upon presentation and surrender of the Debentures called for redemption at the following corporate trust office:

 

The interest upon the principal amount of Debentures called for redemption shall cease to be payable from and after the Redemption Date, unless payment of the Redemption Price shall not be made on presentation for surrender of such Debentures at the above-mentioned corporate trust office on or after the Redemption Date or prior to the setting aside of the Redemption Price pursuant to the Indenture.

 

No fractional Common Shares shall be delivered upon the exercise by the Corporation of the above-mentioned redemption right. Fractional Common Shares shall be rounded down to the nearest whole number.

 

DATED: _____________________________

 

  SIYATA MOBILE INC.
     
  By:  
    Name:
    Title:

 

  (Authorized Signatory)

 

B-1

 

 

 

Schedule C – Form of Notice of Conversion

 

TO: SIYATA MOVILE INC.
   
AND TO:  
   
NOTE: All capitalized terms used herein have the meaning ascribed thereto in the Indenture (as defined herein), unless otherwise indicated.

 

The undersigned registered holder of 12.0% Unsecured Convertible Debentures in the principal amount of C$[●] irrevocably elects to convert such Debentures (or C$[●] principal amount thereof) in accordance with the terms of the Indenture referred to in such Debentures and tenders herewith the Debentures, and, if applicable, directs that the Common Shares of Siyata Mobile Inc. issuable upon a conversion be issued and delivered to the person indicated below. (If Common Shares are to be issued in the name of a person other than the holder, all requisite transfer taxes must be tendered by the undersigned and the Form of Assignment must be completed.)

 

Dated:  
      Signature of Registered Holder

 

(*) If less than the full principal amount of the Debentures, indicate in the space provided the principal amount (which must be C$1,000 or integral multiples thereof).

 

NOTE: If Common Shares are to be issued in the name of a person other than the holder, the signature must be guaranteed as follows:

 

The signature(s) of the transferor(s) must correspond with the name(s) as written upon the face of this certificate(s), in every particular, without alteration or enlargement, or any change whatsoever. The signature(s) on this form must be guaranteed by an authorized officer of Royal Bank of Canada, Scotia Bank or TD Canada Trust whose sample signature(s) are on file with the transfer agent, or by a member of an acceptable Medallion Signature Guarantee Program (STAMP, SEMP, NYSE, MSP). Notarized or witnessed signatures are not acceptable as guaranteed signatures. The Guarantor must affix a stamp bearing the actual words: “SIGNATURE GUARANTEED”, “MEDALLION GUARANTEED” OR “SIGNATURE & AUTHORITY TO SIGN GUARANTEE”, all in accordance with the transfer agent’s then current guidelines and requirements at the time of transfer. For corporate holders, corporate signing resolutions, including certificate of incumbency, will also be required to accompany the transfer unless there is a “SIGNATURE & AUTHORITY TO SIGN GUARANTEE” Stamp affixed to the Form of Transfer obtained from an authorized officer of the Royal Bank of Canada, Scotia Bank or TD Canada Trust or a “MEDALLION GUARANTEED” Stamp affixed to the Form of Transfer, with the correct prefix covering the face value of the certificate.

 

(Print name in which Common Shares are to be issued, delivered and registered)

 

Name:  
Address:  
   
   
  (Street Address, City, Province and Postal Code)
Name of guarantor  
   
Authorized Signature  
   

 

 

C-1

 

 

Exhibit 4.3

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND ANY SECURITY ISSUED ON EXERCISE HEREOF MUST NOT TRADE THE SECURITY BEFORE OCTOBER 23, 2020.

 

WITHOUT THE PRIOR WRITTEN APPROVAL OF THE TSX VENTURE EXCHANGE AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE AND ANY SECURITIES ISSUED ON EXERCISE HEREOF MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF THE EXCHANGE OR OTHERWISE IN CANADA OR TO OR FOR THE BENEFIT OF A CANADIAN RESIDENT UNTIL OCTOBER 23, 2020.

 

No. W2020.JUN.01 1,330,000

WARRANTS

 

WARRANT CERTIFICATE

 

SIYATA MOBILE INC.

Suite 2200, HSBC Building, 885 West Georgia Street
Vancouver, British Columbia, V6C 3E8

 

THIS CERTIFIES that, for value received:

 

Accel Telecom Ltd.

Meshek 43 Bene Atarot

6099100, Israel

 

(hereinafter referred to as the “Holder”)

 

is the registered holder of that number of transferable warrants (the “Warrants”) of Siyata Mobile Inc. (the “Issuer”) set forth above.

 

Underlying Securities and Exercise Terms

 

Each Warrant entitles the Holder to purchase one common share (the “Share”) of the Issuer, as constituted on June 22, 2020 (the “Closing Date”), at a price of $0.30 per Share until 4:00 pm (Vancouver Time) on June 22, 2021 (the “Expiry Date”).

 

The Warrants and Shares are collectively referred to herein as the “Securities”.

 

The Issuer covenants that the Shares, when issued upon the due exercise of the Warrants, will be fully paid and non-assessable securities, and will be free and clear of all liens, charges and encumbrances. The Issuer covenants that, until the expiry of the Warrants, it will have reserved a sufficient number of common shares to provide for the exercise of the rights represented by the Warrants.

 

THE WARRANTS ARE TRANSFERRABLE.

 

Warrant Exercise Procedure

 

The Warrants may be exercised at any time prior to the expiry thereof on the Expiry Date by surrendering to the Issuer:

 

(a) this Warrant Certificate;

 

(b) the Subscription Form attached as Schedule “A” hereto, duly completed and executed; and

 

 

 

 

(c) a certified cheque, bank draft or money order made payable to the Issuer in the aggregate amount of the exercise price,

 

at the office stated above or such other office or agency of the Issuer as it may designate by notice in writing delivered to the Holder at the Holder’s address stated above. Upon the due exercise of the Warrants, the Issuer shall issue or cause to be issued the requisite number of Shares to be issued to the Holder pursuant to said exercise, registered in the name of the Holder or such other person as may be specified in the Subscription Form, and each such person shall be deemed the holder of such Shares with effect from the date of such exercise. If Shares are to be issued to a person other than the Holder, the Holder’s signature on the Subscription Form must be guaranteed by a Canadian chartered bank, a Canadian trust company or a member firm of the TSX Venture Exchange. The Issuer will cause the certificates representing such Shares to be mailed to the Holder at the Holder’s address stated above or such other address(es) as may be specified in the Subscription Form, within ten business days of the due exercise of the Warrants.

 

Upon the due exercise of a Warrant, the Warrant Certificate in respect thereof shall be deemed tendered to the Issuer for purposes thereof by the Holder without further notice or action by the Holder, and all rights under such exercised Warrant and the Warrant Certificate, other than the right to receive certificates representing the Shares to which the Holder is entitled on such exercise, and if applicable, a certificate representing the balance of any unexercised Warrants, shall wholly cease and terminate and such Warrant and Warrant Certificate shall be void and of no further effect or value.

 

Partial Exercise, Exchange and Replacement of Certificates

 

The Warrants represented by this Warrant Certificate may be exercised in whole or in part from time to time. If the Warrants are exercised in part, the Issuer shall deliver, with the Shares issued pursuant to such exercise, a new Warrant Certificate representing the balance of the Warrants remaining unexercised.

 

This Warrant Certificate may be exchanged, upon its surrender to the Issuer for new Warrant Certificates of like tenor in denominations which in the aggregate represent the number of Warrants represented hereby. Such new Warrant Certificates will be mailed to the Holder at the Holder’s address stated above within ten business days of the surrender of the Warrant Certificate for exchange.

 

If this Warrant Certificate is lost, stolen, mutilated or destroyed, the Issuer may on such reasonable terms as it may in its discretion impose, including but not limited to the provision of any indemnity by the Holder satisfactory to the Issuer in its sole discretion, issue and countersign a new Warrant Certificate of like tenor, denomination and date as the Warrant Certificate so lost, stolen, mutilated or destroyed.

 

All Warrants shall rank pari passu, notwithstanding the actual date of issue thereof.

 

Transferable Warrants

 

The Warrants and all rights hereunder are transferable.

 

Holding of Warrants

 

The Issuer may treat the Holder as the absolute owner of the Warrants represented hereby for all purposes, and the Issuer shall not be affected by any notice or knowledge to the contrary except where the Issuer is required to take notice by statute or by order of a court of competent jurisdiction.

 

Nothing in this Warrant Certificate or in the holding of a Warrant evidenced hereby shall be construed as conferring upon the Holder any right or interest whatsoever as a shareholder of the Issuer or entitle the Holder to any right or interest in respect of any Securities except as herein expressly provided.

 

2

 

 

Resale Restrictions and Legending of Certificates

 

The Warrants have been, and the Shares will be, issued pursuant to an exemption (an “Exemption”) from the registration and prospectus requirements of applicable securities law. To the extent that the Issuer relies on such Exemption, the Securities will be subject to restrictions on resale and transferability contained in applicable securities laws.

 

In the event that any of the Securities are subject to a hold period, or any other restrictions on resale and transferability, the Issuer may place a legend on the certificates representing the Securities as may be required under applicable securities laws or the requirements of any stock exchange or other market, or as it may otherwise deem necessary or advisable.

 

Capital Adjustments

 

If at any time after the date hereof and prior to the expiry of the Warrants, and provided that any Warrants remain unexercised, there shall be:

 

(a) a reclassification of the Issuer’s common shares, a change in the Issuer’s common shares into other shares or securities, a subdivision or consolidation of the Issuer’s common shares into a greater or lesser number of common shares, or any other capital reorganization, or

 

(b) an amalgamation, merger or consolidation of the Issuer with or into any other corporation other than an amalgamation, merger or consolidation which does not result in any reclassification of the Issuer’s outstanding common shares or a change of the Issuer’s common shares into other shares or securities, a subdivision or consolidation of the Issuer’s common shares into a greater or lesser number of common shares, or any other capital reorganization,

 

(any of such events being called a “Capital Reorganization”) any Holders who thereafter exercise Warrants shall, at no additional cost to the Holder, be entitled to receive and shall accept in lieu of the Shares to which such Holder was theretofore entitled upon such exercise, the aggregate number of shares, other securities or other property which such Holder would have been entitled to receive as a result of such Capital Reorganization if, on the effective date or record date thereof as the case may be, the Holder had been the registered holder of the number of Shares to which such Holder was theretofore entitled to acquire upon such exercise. If determined appropriate by the Issuer acting reasonably, appropriate adjustments shall be made in the application of the provisions set forth herein with respect to the rights and interests of the Holder relative to a Capital Reorganization, to the end that the provisions set forth herein shall correspond as nearly as may be reasonably possible to the effect of the Capital Reorganization in relation to any shares, other securities or other property thereafter deliverable upon the exercise of any Warrants.

 

In case the Issuer, after the date hereof, shall take any action affecting any securities of the Issuer, other than as previously set out herein, which in the opinion of the directors would materially affect the rights and interests of the Holder hereunder, the number of Shares, or other securities or other property which shall be issuable on the exercise of the Warrants, shall be adjusted in such manner, if any, and at such time as the directors, in their sole discretion, may determine to be equitable in the circumstances, provided that no such adjustment will be made unless all necessary regulatory approvals, if any, have been obtained.

 

No adjustment shall be made in respect of any event described herein if the Holder is entitled to participate in such event on the same terms, without amendment, as if the Holder had exercised the Warrants prior to or on the effective date or record date of such event. The adjustments provided for herein are cumulative and such adjustments shall be made successively whenever an event referred to herein shall occur, subject to the limitations provided for herein. No adjustment shall be made in the number or kind of securities which may be acquired on the exercise of a Warrant unless it would result in a change of at least one-hundredth to such securities. Any adjustment which may by reason of this paragraph not be required to be made shall be carried forward and then taken into consideration in any subsequent adjustment.

 

Notwithstanding any adjustments provided for herein or otherwise, the Issuer shall not be required, upon the exercise of any Warrants, to issue fractional Shares or other securities in satisfaction of its obligations hereunder and, except as provided for herein, any fractions shall be eliminated. To the extent that the Holder would otherwise be entitled to acquire a fraction of a Share or other security, such right may be exercised in respect of such fraction only in combination with the exercise of other Warrants which in the aggregate entitle the Holder to acquire a whole number of Shares or other securities. The Holder shall be entitled, upon the elimination of any fraction of a Share or other security, to be paid in cash for the fair market value for the securities so eliminated, always provided that the Issuer shall not be required to make any payment if for less than $25.

 

3

 

 

In the event of any question arising with respect to any adjustment provided for herein, such question shall be conclusively determined by a firm of chartered accountants appointed by the Issuer at its sole discretion (who may be the Issuer’s auditors) and any such determination shall be binding upon the Issuer and the Holder.

 

Miscellaneous Provisions

 

Any delivery or surrender of documents shall be valid and effective if delivered personally or if sent by registered letter postage prepaid, and any notice shall be valid and effective if made in writing and transmitted as aforementioned or if transmitted by facsimile with confirmed receipt, in each case addressed to:

 

(a) if to the Issuer,

 

SIYATA MOBILE INC.

Suite 2200, HSBC Building, 885 West Georgia Street

Vancouver, British Columbia, V6C 3E8

 

(b) if to the Holder, at its address appearing in the register of holders of Warrants maintained by the Issuer,

 

and such shall be deemed to have been effectively made and received on the date of personal delivery, if delivered; on the fourth business day after the time of mailing or upon actual receipt, whichever is sooner, if sent by registered letter (except the delivery of documents to exercise the Warrants, in which case actual receipt is required); or on the first business day after the time of facsimile transmission, if sent by facsimile. In the case of a disruption in postal services, any delivery or surrender of documents or notice sent by mail shall not be deemed to have been effectively made or received until it is actually delivered. The Issuer and the Holder may from time to time change their address for service hereunder by notice in writing delivered in one of the foregoing manners.

 

Except as herein provided, any and all of the rights conferred upon the Holder herein may be enforced by the Holder through appropriate legal proceedings. No recourse under or upon any covenant, obligation or agreement herein contained shall be had against any shareholder, director, officer or agent of the Issuer, either directly or through the Issuer, it being expressly agreed and declared that the obligations under the Warrants are solely corporate obligations of the Issuer and no personal liability whatsoever shall attach to or be incurred by the shareholders, directors, officers or agents of the Issuer in respect thereof. This Warrant Certificate shall be binding upon the Issuer and its successors.

 

This Warrant Certificate shall be governed in accordance with the laws of British Columbia and the laws of Canada applicable therein. The parties hereby attorn to the jurisdiction of the courts of British Columbia in the event of any dispute hereunder. Time shall be of the essence hereof.

 

IN WITNESS WHEREOF the Issuer has caused this Warrant Certificate to be electronically signed by its duly authorized signatory as of the date first above indicated. This Warrant Certificate is electronically signed and is the only copy that will be issued and is deemed original.

 

SIYATA MOBILE INC.  
     
By:    
  Authorized Signatory  

 

4

 

 

SCHEDULE “A”

to the Warrant Certificate
of SIYATA MOBILE INC.

 

SUBSCRIPTION FORM

 

TO: SIYATA MOBILE INC.

Suite 2200, HSBC Building, 885 West Georgia Street

Vancouver, British Columbia, V6C 3E8

 

 

 

The Undersigned, being the registered holder of the attached Warrant Certificate of the Issuer, does hereby irrevocably exercise ____________________________________ of the Warrants evidenced thereby in accordance with the terms thereof, and accordingly hereby irrevocably subscribes for the Shares (as described therein), or other securities or property in substitution thereof, to be received thereon and irrevocably surrenders the Warrant Certificate to the Issuer for such purpose. The Undersigned hereby irrevocably directs that the Shares, or other securities or property in substitution thereof, to be received by the Undersigned be registered as follows:

 

Name in Full   Address   No. of
Shares
1.         
2.         
3.         
4.         

 

IF SHARES ARE TO BE ISSUED TO A PERSON OR PERSONS OTHER THAN THE UNDERSIGNED REGISTERED HOLDER, THE SIGNATURE OF THE UNDERSIGNED MUST BE MEDALLION GUARANTEED AND IT MUST PAY TO THE ISSUER ALL APPLICABLE TAXES AND OTHER DUTIES.

 

The Undersigned registered holder hereby represents, warrants and certifies that:

 

1. the Undersigned is not in the United States or a U.S. Person, and is resident in the jurisdiction indicated as its address set forth in this Subscription Form;

 

2. the Undersigned acknowledges that the Warrants and Shares (collectively, the “Securities”) have not been registered under the United States Securities Act of 1933, as amended (the “1933 Act”), or any applicable State securities laws, and may not be offered or sold in the United States or to U.S. Persons without registration under the 1933 Act and any applicable State securities laws, unless an exemption from registration is available; and

 

5

 

 

3. the Undersigned has no intention to distribute, either directly or indirectly, any of the Securities in the United States or to U.S. Persons.

 

DATED the                day of                           , 20       .      

 

    }  
    }  
Signature of Witness   } Signature of registered holder or Signatory thereof
[Please Note Instruction 2]   }  
  }  
    } If applicable, print Name and Office of Signatory
    }  
Print Name of Witness   } Print Name of registered holder as on certificate
    }  
    }  
Address of Witness   } Street Address
    }  
    }  
Occupation of Witness   } City, Province and Postal Code
    }  
    }  

 

INSTRUCTIONS:

 

1. The registered holder of the Warrant(s) may exercise its right to purchase the Shares(s) by completing and surrendering this Subscription Form and the ORIGINAL Warrant Certificate representing the Warrant(s) being exercised to the Issuer, together with the aggregate amount of the exercise price for the Share(s) as provided for in the Warrant Certificate. Certificates representing the Shares to be acquired on exercise will be sent by prepaid ordinary mail to the address(es) above within ten business days after the receipt of all required documentation.

 

2. If this Subscription Form indicates that Share(s) are to be issued to a person or persons other than the registered holder of the Warrant(s) to be exercised: (i) the signature of the registered holder on this Subscription Form must be medallion guaranteed by an authorized officer of a chartered bank, trust company or an investment dealer who is a member of a recognized stock exchange, and (ii) the registered holder must pay to the Issuer all applicable taxes and other duties.

 

3. If this Subscription Form is signed by a trustee, executor, administrator, custodian, guardian, attorney, officer of a corporation or any other person acting in a fiduciary or representative capacity, this Subscription Form must be accompanied by evidence of authority to sign satisfactory to the Issuer.

 

 

6

 

 

Exhibit 4.4

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE SHALL NOT TRADE SUCH SECURITIES BEFORE OCTOBER 23, 2020.

 

WITHOUT THE PRIOR WRITTEN APPROVAL OF THE TSX VENTURE EXCHANGE AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LEGISLATION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE AND ANY SECURITIES ISSUED ON EXERCISE HEREOF MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE TRADED ON OR THROUGH THE FACILITIES OF THE EXCHANGE OR OTHERWISE IN CANADA OR TO OR FOR THE BENEFIT OF A CANADIAN RESIDENT UNTIL OCTOBER 23, 2020.

 

Issue Date: June 22, 2020

 

Certificate No. 01

 

UNSECURED CONVERTIBLE DEBENTURE

 

FOR VALUE RECEIVED, SIYATA MOBILE INC. (the “Company”) promises to pay to Accel Telecom Ltd. of Meshek 43 Bene Atarot 6099100 Israel (the “Holder”), the principal sum of C$1,330,000 in lawful currency of Canada (the “Principal Amount”) on or before June 22, 2021 (the “Maturity Date”), subject to section 4.1 and the terms and conditions hereof. This Debenture shall bear interest calculated per annum at the Interest Rate (as defined herein).

 

This Debenture is subject to the following additional terms and conditions:

 

1. Definitions

 

1.1 For the purposes hereof, in addition to the terms defined elsewhere in this Debenture, the following terms shall have the following meanings:

 

(a) Business Day” means any day except Saturday, Sunday and any day which shall be a statutory holiday in the province of British Columbia or a day on which banking institutions in the province of British Columbia are authorized or required by law or other government action to close;

 

(b) Change of Control” means (i) any event as a result of, or following which, any person, or group of persons “acting jointly or in concert” within the meaning of applicable Canadian securities laws, beneficially owns or exercises control or direction over an aggregate of more than 50% of the then outstanding Common Shares; or (ii) the sale or other transfer of all or substantially all of the consolidated assets of the Company;

 

(c) Common Shares” means the common shares in the capital of the Company and shares of any other class into which such Common Shares may hereafter have been reclassified or changed;

 

(d) Conversion Date” has the meaning set forth in Section 3.2 hereof;

 

(e) Conversion Price” means $0.30;

 

(f) Conversion Share” means a Common Share issuable upon conversion of all or a portion of the Principal Amount;

 

(g) Debenture” means this unsecured convertible debenture;

 

(h) Exchange” means the TSX Venture Exchange;

 

(i) Interest Rate” means 10.0% per annum;

 

 

 

 

(j) Issue Date” means June 22, 2020;

 

(k) Offering” means the offering of convertible debentures and warrants by the Company for aggregate gross proceeds of up to USD$1,400,000 under which this Debenture is being issued;

 

(l) Person” means a corporation, association, partnership, organization, business, individual, government or political subdivision thereof;

 

(m) Principal Amount” means the principal amount as may be due and owing by the Company to the Holder from time to time under this Debenture; and

 

(n) Trading Day” means a day on which the Common Shares are traded on the Exchange or other trading market on which the Common Shares are then listed or quoted, provided that, in the event that the Common Shares are not listed or quoted, then Trading Day shall mean a Business Day.

 

1.2 Unless otherwise provided, all dollar amounts referred to in this Debenture are in lawful money of Canada.

 

2. Interest

 

2.1 The Principal Amount shall bear simple interest both before and after maturity, default and judgment, from and including the Issue Date to the date of repayment in full, or conversion, at the Interest Rate. Such interest will be calculated quarterly, not in advance, on the basis of a year of 365 days and payable quarterly after the Issue Date. In the event that the entire Principal Amount remaining outstanding is converted into Conversion Shares, any interest owing as of the Conversion Date (as defined below), will be paid by the Company within three Business Days of the Conversion Date.

 

3. Conversion

 

3.1 Subject to Section 4, at any time after the Issue Date until one Business Day prior to the Maturity Date, and provided that this Debenture is then outstanding, the Principal Amount then outstanding may be converted into Conversion Shares at the option of the Holder, in whole or in part, at any time and from time to time. The Holder shall convert a minimum of $6,000 of the Principal Amount for any conversion, unless there is less than $6,000 of the Principal Amount then outstanding.

 

3.2 The Holder shall effect conversions by delivering to the Company a duly completed and executed Notice of Conversion in the form attached hereto as Appendix A (a “Notice of Conversion”), specifying the aggregate amount of the Principal Amount to be converted and the date on which such conversion is to be effected (a “Conversion Date”), which date shall not be more than ten (10) days following the date of delivery of the Notice of Conversion. If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that is five (5) Business Days following the date of delivery of the Notice of Conversion. To effect conversions hereunder, the Holder shall be required to electronically surrender the Debenture to the Company.

 

3.3 Any conversions hereunder shall have the effect of lowering the outstanding Principal Amount in an amount equal to the applicable amount of the Principal Amount being converted. The Holder and the Company shall maintain records showing all Principal Amounts converted and the date of such conversions. The Company shall deliver any objection to any Notice of Conversion within five (5) Business Days of receipt of such notice. The Holder, by acceptance of this Debenture, acknowledges and agrees that, following conversion of a portion of this Debenture, the unpaid and unconverted Principal Amount will be less than the amount stated on the face hereof and a new certificate will be issued to reflect such new Principal Amount.

 

3.4 The number of Conversion Shares issuable upon any conversion shall be determined by the quotient obtained by dividing (x) by (y) where (x) is equal to the amount of the Principal Amount to be converted and (y) is the Conversion Price.

 

2

 

 

3.5 Not later than ten (10) Trading Days after any Conversion Date, the Company will deliver to the Holder a certificate representing the number of Conversion Shares being issued, which certificate shall bear such restrictive legends and trading restrictions as are required by applicable laws and by the Exchange.

 

3.6 If the Company shall at any time or from time to time, while any Principal Amount is still outstanding, effect a subdivision or consolidation of the outstanding Common Shares, the Conversion Price in effect immediately before a subdivision shall be proportionately decreased, and, conversely, the Conversion Price in effect immediately before a consolidation shall be proportionately increased. Any adjustment under this Section 3.6 shall become effective at the close of business on the date the subdivision or consolidation becomes effective.

 

3.7 If the Company at any time or from time to time while this Debenture is outstanding, issues, or fixes a record date for the determination of holders of Common Shares entitled to receive, a dividend or other distribution payable solely in Common Shares, the Conversion Price that is then in effect shall be decreased as of the time of such issuance or, in the event such record date is fixed, as of the close of business on such record date, by multiplying the Conversion Price by a fraction (i) the numerator of which is the total number of Common Shares issued and outstanding immediately prior to the time of such issuance or the close of business on such record date, and (ii) the denominator of which is the sum of the total number of Common Shares issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of Common Shares issuable in payment of such dividend or distribution; provided, however, that if such record date is fixed and such dividend is not fully paid or if such distribution is not fully made on the date fixed therefore, the Conversion Price shall be recomputed accordingly as of the close of business on such record date and thereafter the Conversion Price shall be adjusted pursuant to this Section 3.7 to reflect the actual payment of such dividend or distribution.

 

3.8 If at any time while this Debenture is outstanding, (i) the Company effects any merger or combination of the Company with or into another entity, (ii) the Company effects any sale of all or substantially all of its assets in one or more transactions, (iii) any tender offer or exchange offer (whether by the Company or another entity) is completed pursuant to which holders of Common Shares are permitted to tender or exchange their Common Shares for other securities, cash or property, or (iv) the Company effects any reclassification or recapitalization of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities, cash or property (other than a subdivision, consolidation or dividend provided for elsewhere in this Section 3) (in any such case, a “Fundamental Change”), then, upon any subsequent conversion of this Debenture, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion absent such Fundamental Change, the same kind and amount of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Change if it had been, immediately prior to such Fundamental Change, the holder of one Common Share (the “Alternate Consideration”). If holders of Common Shares are given any choice as to the securities, cash or property to be received in a Fundamental Change, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Debenture following such Fundamental Change. In the event of a Fundamental Change, the Company or the successor or purchasing entity, as the case may be, shall execute with the Holder a written agreement providing that:

 

(a) this Debenture shall thereafter entitle the Holder to purchase the Alternate Consideration; and

 

(b) in the case of any such successor or purchasing entity, upon such consolidation, merger, statutory exchange, combination, sale or conveyance, such successor or purchasing entity shall be jointly and severally liable with the Company for the performance of all of the Company’s obligations under this Debenture.

 

3.9 If, in the case of any Fundamental Change, the Alternate Consideration includes shares, other securities, other property or assets of an entity other than the Company or any such successor or purchasing entity, as the case may be, then such written agreement shall also be executed by such other entity and shall contain such additional provisions to protect the interests of the Holder as the board of directors of the Company shall reasonably consider necessary by reason of the foregoing. At the Holder’s request, any successor to the Company or surviving entity in such Fundamental Change shall issue to the Holder a new Debenture consistent with the foregoing provisions and evidencing the Holder’s right to convert such Debenture into Alternate Consideration. The terms of any agreement pursuant to which a Fundamental Change is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this Section 3 and insuring that this Debenture (or any such replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Change.

 

3

 

 

3.10 The Company covenants that it will at all times reserve and keep available out of its authorized and unissued Common Shares, Conversion Shares for the purpose of issuance upon conversion of the Debenture, free from pre-emptive rights or any other actual contingent purchase rights of Persons other than the Holder, not less than such number of Conversion Shares as shall be issuable upon the conversion of the Principal Amount. The Company covenants that all Conversion Shares that shall be so issuable shall, upon issue, be duly and validly authorized, issued and fully paid and non-assessable.

 

3.11 Upon a conversion hereunder, the Company shall not be required to issue share certificates representing fractions of Conversion Shares, and the Company shall be entitled to round the number of Conversion Shares down to the nearest whole number. The Holder agrees to waive any rights or entitlements to fractional Conversion Shares that the Holder may have in connection with a conversion hereunder.

 

3.12 In each case of an adjustment or readjustment of the Conversion Price for the number of Conversion Shares issuable upon conversion of this Debenture, the Company, at its own expense, shall cause its Secretary or other officer as directed by the board of directors of the Company to compute such adjustment or readjustment in accordance with the provisions hereof and prepare a certificate showing such adjustment or readjustment, and shall deliver such certificate to the Holder in accordance with Section 6.1. The certificate shall set forth such adjustment or readjustment, showing in detail the facts upon which such adjustment or readjustment is based. No adjustment in the Conversion Price shall be required to be made unless it would result in an increase or decrease of at least one cent, but any adjustments not made because of this sentence shall be carried forward and taken into account in any subsequent adjustment otherwise required hereunder.

 

4. Change of Control

 

4.1 Upon a Change of Control of the Company, holders of the Debentures will have the right to require the Company to repurchase their Debentures, in whole or in part, on the date that is 30 days following the giving of notice of the Change of Control, at a price equal to 100% of the Principal Amount of the Debentures then outstanding, plus accrued and unpaid interest thereon (the “Offer Price”).

 

If 90% or more of the aggregate principal amount of all debentures issued under the Offering that are outstanding on the date of the notice of the Change of Control have been tendered for redemption, the Company will have the right to redeem all of the remaining debentures (including this Debenture) at the Offer Price.

 

5. Events of Default

 

5.1 The occurrence of any of the following shall constitute an “Event of Default” under this Debenture:

 

(a) the Company failing to pay any Principal Amount or interest payment hereof on the applicable due date hereunder and such failure continuing for ten (10) days after written notice thereof is delivered to the Company;

 

(b) the Company failing to observe or perform any other covenant or agreement contained in this Debenture which failure is not cured, if possible to cure, within thirty (30) calendar days after notice of such default is sent by the Holder to the Company;

 

4

 

 

(c) the Company (i) applying for or consenting to the appointment of a receiver, trustee, liquidator or custodian of itself or of all or a substantial part of its property, (ii) being unable, or admitting in writing its inability, to pay its debts generally as they mature, (iii) making a general assignment for the benefit of its or any of its creditors, (iv) being dissolved or liquidated in full or in part (v) commencing a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or consenting to any such relief or to the appointment of or taking possession of its property by any official in an involuntary case or other proceeding commenced against it, or (vi) taking any action for the purpose of effecting any of the foregoing; and

 

(d) proceedings for the appointment of a receiver, trustee, liquidator or custodian of the Company or of all or a substantial part of the property thereof, or an involuntary case or other proceedings seeking liquidation, reorganization or other relief with respect to the Company or the debts thereof under any bankruptcy, insolvency or other similar law now or hereafter in effect being commenced and an order for relief entered or such proceeding is not dismissed or discharged within thirty (30) days of commencement.

 

5.2 Upon the occurrence or existence of any Event of Default and following the expiry of any applicable grace periods and at any time thereafter during the continuance of such Event of Default, the Holder may, by written notice to the Company, declare all outstanding amounts payable by the Company hereunder to be immediately due and payable without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived, anything contained herein to the contrary notwithstanding. Upon the occurrence or existence of any Event of Default described in subsections 5.1(c) hereof, immediately and without notice, all outstanding amounts payable by the Company hereunder shall automatically become immediately due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived, anything contained herein to the contrary notwithstanding. In addition to the foregoing remedies, upon the occurrence or existence of any Event of Default, the Holder may exercise any other right, power or remedy permitted to it by law, either by suit in equity or by action at law, or both.

 

6. Notices

 

6.1 Any notice required or permitted to be given to the Company or the Holder will be in writing and may be given by prepaid registered post, electronic transmission or other means of electronic communication capable of producing a printed copy to the address of the party set forth below or such other address as such party may specify by notice in writing to the other party, and any such notice will be deemed to have been given and received by the party to whom it was addressed if mailed, on the third day following the mailing thereof, if by electronic communication, on the date sent, or, if delivered, on delivery; but if at the time of mailing or between the time of mailing and the third Business Day thereafter there is a strike, lockout, or other labour disturbance affecting postal service, then the notice will not be effectively given until actually delivered:

 

To the Company:

 

SIYATA MOBILE INC.

2200-885 West Georgia St.

Vancouver, British Columbia, V6C 3E8

 

Attention: Gerald Bernstein

Email: gerry@siyatamobile.com

 

with an electronic copy to:

 

Attention: Jeff Durno

Email: jdurno@casselsbrock.com

 

To the Holder at the address set forth above.

 

5

 

 

7. Exchange or Replacement of Debenture

 

7.1 The Holder may, at its option, in person or by duly authorized attorney, surrender this Debenture for exchange at the principal business office of the Company and receive in exchange therefor a new Debenture in the same principal amount as the unpaid Principal Amount of this Debenture and bearing interest at the same annual rate as this Debenture, each such new Debenture to be dated as of the date of this Debenture and to be in such Principal Amount as remains unpaid and payable to such Holder.

 

7.2 Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction, or mutilation of this Debenture and (in the case of loss, theft or destruction) of an indemnity reasonably satisfactory to it, and upon surrender and cancellation of this Debenture, if mutilated, the Company will deliver a new Debenture of like tenor in lieu of this Debenture. Any Debenture delivered in accordance with the provisions of this Section 7.2 shall be dated as of the date of this Debenture.

 

8. Governing Law

 

8.1 All questions concerning the construction, validity, enforcement and interpretation of this Debenture shall be governed by and construed and enforced in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein, without regard to the principles of conflicts of law thereof.

 

9. Waivers

 

9.1 The Company hereby waives presentment, demand for payment, notice of dishonour, notice of protest and all other notices or demands in connection with the delivery, acceptance, performance or default of this Debenture. No delay by the Holder in exercising any power or right hereunder shall operate as a waiver of any power or right, nor shall any single or partial exercise of any power or right preclude other or further exercise thereof, or the exercise thereof, or the exercise of any other power or right hereunder or otherwise; and no waiver whatsoever or modification of the terms hereof shall be valid unless set forth in writing by the Holder and then only to the extent set forth therein.

 

10. Amendments

 

10.1 This Debenture may not be amended without the express written consent of both the Company and the Holder.

 

11. Severability

 

11.1 If any provision of this Debenture is invalid, illegal or unenforceable, the balance of this Debenture shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances.

 

12. Next Business Day

 

12.1 Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

 

13. Time of the Essence

 

13.1 Time will be of the essence of this Debenture.

 

[Remainder of page left intentionally blank.]

 

6

 

 

IN WITNESS WHEREOF, the Company has caused this Debenture to be electronically executed by a duly authorized officer as of the date first above indicated. This Debenture is electronically signed and is the only copy that will be issued and is deemed original

 

SIYATA MOBILE INC.

 

Per:    
  Authorized Signatory  

 

7

 

 

APPENDIX A

 

NOTICE OF CONVERSION

 

The undersigned hereby irrevocably elects to convert principal due under the attached Debenture of SIYATA MOBILE INC., a company incorporated pursuant to the laws of the province of British Columbia (the “Company”), into Conversion Shares according to the terms and conditions of the Debenture, as of the date written below. If Conversion Shares are to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates, including a medallion guarantee stock power of attorney and such opinions as reasonably requested by the Company. No fee will be charged to the Holder for any conversion, except for such transfer taxes, if any. Capitalized terms used herein and not otherwise defined shall have the meanings set out in the Debenture.

 

The undersigned agrees to comply with applicable securities laws in connection with any transfer of the aforesaid Conversion Shares.

 

Conversion Date:    
     
Conversion Price for Principal Amount:    
    $0.30
Principal Amount to be converted:    
    $
Number of Conversion Shares to be issued:    
     
Principal Amount of Debenture remaining unconverted:    
    $
Register the Conversion Shares in the following name and address:    
     
Signature of the Holder:    
     
Name:    
     
Address:    
     
Phone Number:    
     
Email:    

 

 

8

 

 

Exhibit 10.1

 

CONSULTING AGREEMENT

 

THIS AGREEMENT is dated as of July 1, 2018 (the “Effective Date”).

 

AMONG:

 

SIYATA MOBILE INC., a company existing under the laws of the Province of British Columbia and having an office at Suite A-414, 1001 Lenoir Street, Montreal, QC H4C 2Z6

 

(the “Company”)

 

AND:

 

BSD LTD., a company existing under the laws of the State of Israel and having a principal place of business at 4a Nachshon Street, Raanana, Israel

 

(the “Consultant”)

 

AND:

 

MARC SEELENFREUND., an individual residing at 4a Nachshon Street, Raanana, Israel

 

(the “Service Provider”)

 

WHEREAS:

 

A. The Consultant is in the business of providing consulting services and the Company desires to engage the Consultant to provide such services;

 

B. the Service Provider is an employee of the Consultant; and

 

C. The Company and the Consultant wish that the Consultant provide the Company such consulting services exclusively through the Service Provider, pursuant to the terms and conditions of this Agreement;

 

THEREFORE this Agreement witnesses that in consideration of the premises and mutual covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which is acknowledged by each party hereto, the parties agree as follows:

 

1. The Consulting Services.

 

1.1 During the term of this Agreement, the Consultant shall provide the Company with management services which include, without limitation, the execution of the day to day operations of the Company, carrying out the strategies and directions of its Board of Directors, other activities that would otherwise be carried out by the Company’s Chief Executive Officer including undertaking all lawful and reasonable directions, duties and instructions given to it from time to time by the Board of Directors of the Company, and serving as the Chairman of the Board of Directors of the Company including by providing all services ordinarily associated with such position. (the “Consulting Services”).

 

1

 

 

1.2 The Consultant shall provide the Consulting Services exclusively through the Service Provider, who shall devote all of his business and professional time, attention, energy, skill, learning and best efforts to the business and affairs of the Company, and the Consultant shall not engage or contract any other person or entity to perform the Consulting Services or any part thereof without the prior written consent of the Company.

 

1.3 The Consultant shall report regularly to the Company’s Board of Directors. The Consultant shall perform its duties hereunder predominantly at the Company’s facilities in Israel, but acknowledges and agrees that its duties may involve significant domestic and international travel.

 

1.4 Neither the Consultant nor the Service Provider, nor anyone acting on their behalf, without the prior written authorization of the Company’s Board of Directors, shall directly or indirectly, render services to a third party, whether as an employee or independently as an agent or consultant or in any other manner (whether for compensation or otherwise), or engage in any activities which, directly or indirectly, cause the Consultant or the Service Provider to compete with the Company. It is hereby understood that the Service Provider and Consultant may hold shares in other businesses, which do not compete with the Company and may additionally act as a director in such businesses’ board of directors and such activities shall not be deemed as a breach of this Agreement. For greater certainty, the Consultant or Service Provider may also be engaged as directors of non-profit entities, provided that such entities are unrelated to the Company’s business.

 

1.5 Neither the Consultant nor the Service Provider shall engage in any conduct that is, or may be, detrimental to the reputation, character or standing of the Company and shall not partake in any illegal or morally or ethically questionable business practices. Without derogating from the generality of the immediately preceding sentence, neither the Consultant, the Service Provider nor anyone acting on behalf of either, shall directly or indirectly, accept any payment or consideration, including without limitation, commission, rebate, discount or gratuity in cash or in kind, from any person who has or is likely to have a business relationship with the Company, or is engaged in a business competing in any aspect with the business of the Company.

 

1.6 The Company shall add the Service Provider and Consultant as an insured person under its D&O insurance policy and shall enter into an indemnification agreement with the Service Provider similar to such indemnification agreement entered into with its directors and officers.

 

1.7 The Service Provider personally undertakes in favor of the Company to comply with the restrictions and undertaking contained in this Section 1.

 

2. Consultant Representation and Warranties.

 

2.1 The Consultant represents and warrants to the Company each of the following:

 

2.1.1 This Agreement has been duly authorized, executed and delivered by the Consultant and constitutes the legal, valid and binding obligation of the Consultant, enforceable in accordance with its terms. The execution and consummation of this Agreement by the Consultant, does not and shall not constitute any breach and/or violation of any law, regulation or other agreement, obligation or undertaking to which the Consultant, and anyone acting on its behalf, is a party and there is no impediment of any kind whatsoever, preventing the Consultant from fully complying with all of the provisions of this Agreement.

  

2

 

 

2.1.2 The Consultant has full right and power to enter into and perform this Agreement without the consent of any third party.

 

2.1.3 The Service Provider has the experience and expertise required to properly render the Consulting Services.

 

3. Term of the Agreement.

 

3.1 Subject to the terms hereof, this Agreement shall enter into effect on the Effective Date and shall remain in full force and effect until January 1, 2022 (the “Term”), unless terminated hereunder.

 

3.2 Notwithstanding Section 3.1, either party may terminate this Agreement for convenience at any time and for whatever reason by giving the other party at least 365 days’ prior written notice of termination.

 

3.3 Notwithstanding the foregoing, the Company may, at any time following the Effective Date, terminate this Agreement immediately by provision of a written notice, in which case the termination of this Agreement shall be the effective date of such notice of immediate termination, in any of the following circumstances:

 

3.3.1 a final judgment convicting the Consultant or Service Provider with a criminal offence involving disgrace “Avera She’yesh Ima Kalon”);

 

3.3.2 under circumstances that, if the Service Provider or Consultant were an employee of the Company, would have denied him the right to receive severance payments under applicable law; or

 

3.3.3 the Consultant materially breached his undertakings as set forth in this Agreement (including those relating to the Services Provider), which was not cured upon 30 days prior written notice.

 

3.4 Immediately upon the termination of this Agreement, for any reason, the Consultant shall, and shall cause the Service Provider to, return to the Company all property provided to it/him by the Company and in its/his possession, including (without limitation) any vehicle, cellular phone or other equipment, document, drawings, plans, formulas, products, samples, designs and the like and all copies thereof, including any data stored on magnetic or optical media, received by Consultant and/or Service Provider in the course of the provision of services to the Company.

 

4. Change of Control.

 

4.1 In the event of a Change of Control (as defined herein) or a Hostile Change of Control (as defined herein), the Corporation agrees that it will continue to engage the Consultant for the Consulting Services and both the Company and the Consultant agree that they shall not exercise their respective rights to terminate this Agreement pursuant to Section 3.2 for a period of three (3) months following the occurrence of the Change of Control or Hostile Change of Control, as applicable (the “Transition Period”).

 

3

 

 

4.2 In the event of a Change of Control or a Hostile Change of Control and if, within the Transition Period or at any time within three (3) months following the last day of the Transition Period, the Consultant is Constructively Dismissed (as defined in Section 4.7 of this Agreement) or this Agreement is terminated by the Company, other than pursuant to Section 3.3, then:

 

4.2.1 the Company shall pay to the Consultant:

 

4.2.1.1 within ten (10) days, an amount equal to thirty-six (36) months’ Base Consideration (as that term is defined in Section 1 of Exhibit A); and

 

4.2.1.2 for a period of three (3) years following the Change of Control or Hostile Change of Control, as applicable, the quarterly Incentive Bonus (as that term is defined in Section 4 of Exhibit A), with such required annual adjustments.

 

4.2.2 if the Consultant or Service Provider hold any options, rights, warrants, or other entitlements for the purchase or acquisition of securities in the capital of the Company (collectively, the “Options”), regardless of whether such Options are then exercisable in accordance with the terms thereof and notwithstanding the terms and conditions of such Options or of any plan or other document affecting such Options, all of such Options shall thereupon be immediately fully vested and any unexercised portion of such Options shall thereafter be exercisable by the Consultant or Service Provider, as applicable.

 

4.3 In the event of a Hostile Change of Control, the Consultant may elect to terminate this Agreement on the last day of the Transition Period, and, in such circumstance:

 

4.3.1 the Company shall pay to the Consultant:

 

4.3.1.1 within ten (10) days, an amount equal to thirty-six (36) months’ Base Consideration; and

 

4.3.1.2 for a period of three (3) years following the Hostile Change of Control, the quarterly Incentive Bonus (as that term is defined in Section 4 of Exhibit A), with such required annual adjustments.

 

4.3.2 if the Consultant or Service Provider holds any Options, regardless of whether such Options are then exercisable in accordance with the terms thereof and notwithstanding the terms and conditions of such Options or of any plan or other document affecting such Options, all of such Options shall thereupon be immediately fully vested and any unexercised portion of such Options shall thereafter be exercisable by the Consultant or Service Provider, as applicable.

 

4.4 The Company agrees to, immediately prior to the occurrence of a Change of Control or a Hostile Change of Control, deposit an amount equal to thirty-six (36) months’ Base Consideration with an escrow agent, to be held in trust and payable to the Consultant only in the instance that one of Section 4.2 or 4.3 have been triggered.

 

4

 

 

4.5 For the purposes of this agreement, a “Change of Control” means any of the following:

 

4.5.1 at least 50% of the fair-market value of all the assets of the Company are sold;

 

4.5.2 there is a direct or indirect acquisition by a person or group of persons (excluding the Consultant or any person associated with the Consultant), acting jointly or in concert, of voting securities of the Company (as defined in the Securities Act (British Columbia) and as the same may be amended from time to time and any successor legislation thereto) that when taken together with any voting securities owned directly or indirectly by such person or group of persons at the time of the acquisition, constitute 20% or more of the outstanding voting securities of the Company, provided that Board of Directors has not recommended to security holders to reject the terms of such acquisition;

 

4.5.3 a liquidation, dissolution or winding-up of the Company; or

 

4.5.4 the amalgamation, merger or arrangement of the Company with or into another entity where the shareholders of the Company immediately prior to the transaction will hold less than 51% of the voting securities of the resulting entity upon completion of the transaction;

 

but does not include any transaction that may occur between the Company, any affiliate or subsidiary of the Company or, as applicable, any person associated with the Company or any affiliate or subsidiary of the Company, which, but for such relationship the transaction would otherwise constitute a Change of Control hereunder.

 

4.6 For the purposes of this agreement, a “Hostile Change of Control” means any of the following:

 

4.6.1 a majority of management’s nominees for election to the Board of Directors of the Company are not elected at any annual or special meeting of shareholders of the Company; or

 

4.6.2 there is a direct or indirect acquisition by a person or group of persons (excluding the Consultant or any person associated with the Consultant), acting jointly or in concert, of voting securities of the Company (as defined in the Securities Act (British Columbia) and as the same may be amended from time to time and any successor legislation thereto) that when taken together with any voting securities owned directly or indirectly by such person or group of persons at the time of the acquisition, constitute 20% or more of the outstanding voting securities of the Company, provided that Board of Directors has recommended to security holders to reject the terms of such acquisition.

 

5

 

 

4.7 For the purposes of this Agreement, “Constructively Dismissed” means:

 

4.7.1 the material diminution of the Consultant’s duties or the assignment to the Consultant of duties materially inconsistent with duties customarily assigned to a Chief Executive Officer;

 

4.7.2 a material breach by the Company of any terms of this Agreement (including any reduction in the compensation due to the Consultant), which breach is not cured within 30 days of written notice by the Consultant to the Company of such breach specifying in reasonable detail the provision or provisions of this Agreement allegedly being breached and the facts and circumstances surrounding such breach; or

 

4.7.3 the relocation of the Company’s principal offices to a location more than 50 miles from Raanana, Israel.

 

5. Compensation.

 

5.1 In consideration for the Consulting Services pursuant to this Agreement, the Consultant shall, as of the Effective Date, be entitled to receive compensation as set forth in Exhibit A hereto.

 

5.2 The Consultant acknowledges and agrees that the compensation payable to it pursuant to this Agreement may be made by the Company or any of its subsidiaries, including, for greater certainty, Siyata Mobile Israel Ltd.

 

6. Confidentiality and Intellectual Property Assignment.

 

6.1 Consultant hereby agrees to the provisions of the Company’s Proprietary Information, Confidentiality and Non-Competition Agreement attached in Exhibit B hereto and simultaneously herewith executes and shall cause Service Provider to execute a copy thereof.

 

7. The Nature of the Contractual Relationship.

 

7.1 The Consultant and, by countersigning below, the Service Provider, hereby declare, undertake and agree, that:

 

7.1.1 its/his relationship with the Company will be that of an independent consultant and nothing in this Agreement should be construed to create a partnership, joint venture, or employer-employee relationship between the Company and the Consultant and/or Service Provider;

 

7.1.2 it/he will not be entitled to any of the benefits that the Company may make available to its employees that are based on their compensation (such as severance payment, education funds etc.); and

 

7.1.3 no title that the Consultant and/or Service Provider shall carry while acting in the capacity of a consultant of the Company, nor any conduct by the Company, the Consultant of the Service Provider, shall derogate from this Section 7.

 

7.2 Subject to the provisions of Exhibit A hereto, Consultant will be solely responsible for all tax returns and payments required to be filed with or made to any tax authority with respect to the Consultant’s performance of the Consulting Services and receipt of fees under this Agreement. The Consultant acknowledges that the Company will not withhold or make payments for National Insurance Institute; make unemployment insurance or disability insurance contributions, or obtain worker’s compensation insurance on the Consultant’s behalf.

 

6

 

 

7.3 The Consultant shall make all payments to the National Insurance Institute required under law and any other payment imposed upon it by law as the employer of the Service Provider and it shall be solely responsible in respect thereof. The Company shall be entitled to require the Consultant to produce evidence of that payments as aforesaid have been made.

 

7.4 The Consultant hereby agrees to indemnify and defend Company against any and all such taxes or contributions, including penalties and interest, which should have been paid by Consultant as the employer of the Service Provider.

 

7.5 The Consultant and the Service Provider agree that neither they nor anyone acting on their behalf shall file a claim against the Company in connection with employer-employee relations between the Service Provider and the Company, and if they or anyone acting on their behalf does so, the Consultant and the Service Provider shall indemnify and hold the Company harmless upon its first demand for any liability and expense that may be occasioned to it in respect of or in connection with such a claim, including legal fees.

 

7.6 If for any reason whatsoever a competent authority, including a judicial body, determines that the Consultant and/or the Service Provider is the Company’s employee, or is entitled to any payment as an employee, the following provisions shall apply:

 

7.6.1 In lieu of all consideration that was paid to the Consultant by the Company from the Effective Date the Consultant shall be deemed only entitled to gross consideration equal to 60% of the consideration actually paid (the “Adjusted Consideration”).

 

7.6.2 The Consultant shall immediately refund to the Company any amount paid from the Effective Date in excess of the Adjusted Consideration, such being linked to the Israeli consumer price index (the base index - the index known on the date of each payment made under this Agreement; the new index - the index known on the date of actual refund by the Consultant).

 

8. Miscellaneous

 

8.1 Severability. In case any one or more of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein. If moreover, any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear.

 

7

 

 

8.2 Governing Law. This Agreement shall be subject solely to and interpreted in accordance with the laws of the state of Israel.

 

8.3 Arbitration. Any dispute, controversy or claim between the parties hereto, in connection with this Agreement or any amendment or modification hereof, shall be settled by arbitration, in accordance with the following:

 

8.3.1 The Parties will mutually agree upon a sole arbitrator and, if they are unable to reach an agreement within thirty (30) days, the head of the Israeli Bar Association shall appoint the sole arbitrator provided that such arbitrator will be a retired district or supreme court judge (the “Arbitrator”).

 

8.3.2 The Arbitrator shall not be bound by procedural laws or rules, including rules of evidence, however Arbitrator’s decision must be based on the application of the laws of the State of Israel.

 

8.3.3 The Arbitrator will be authorized to issue interim orders, including injunctions, enforcement orders and any other order that a court would be entitled to issue.

 

8.3.4 Decisions of the Arbitrator shall be accompanied by written justification of the Arbitrator’s decision.

 

8.3.5 The Arbitrator’s decision shall be appealable in accordance with Section 21A of the Arbitration Law 5728-1968 (the “Arbitration Law”), to a separate appellate arbitrator, who shall be chosen in accordance with the procedures set forth in Section 8.3.1 above and who shall be equally bound by the terms hereof.

 

8.3.6 Each party shall maintain all matters related to and raised in the arbitration proceedings, in strict confidence and shall not disclose to any third party any information pertaining to such proceedings or to the existence of such proceedings.

 

8.3.7 The Company shall bear all of the Arbitrator fees in connection with such proceedings, provided the Consultant waives any argument of prejudice against the Arbitrator by virtue of this provision.

 

8.3.8 This provision shall be deemed a binding arbitration agreement in accordance with the Arbitration Law.

 

8.4 No Assignment. This Agreement may not be assigned by the Consultant and/or Service Provider without Company’s prior and written consent, and any such attempted assignment shall be void and of no effect.

 

8.5 Waiver. No waiver by any party of any breach of this Agreement shall be a waiver of any preceding or succeeding breach. No waiver by any party of any right under this Agreement shall be construed as a waiver of any other right.

  

8

 

 

8.6 Entire Agreement. This Agreement and its Exhibit A hereto is the final, complete and exclusive agreement of the parties with respect to the subject matter hereof and supersedes all prior discussions and/or agreements (written or oral) between the parties. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing and signed by the party to be charged.

  

8.7 Notices. All communications under this Agreement shall be in writing and shall be delivered by hand or facsimile or mailed by registered or certified mail, postage prepaid to the address provided in the header of this Agreement or at such other address or facsimile number as the Consultant may have furnished the Company in writing. Any notice so addressed shall be deemed to be given: if delivered by hand or by facsimile, on the date of such delivery; if mailed by courier, on the first business day following the date of such mailing; and if mailed by registered or certified mail, on the third business day after the date of such mailing.

 

8.8 Survival. The following provisions shall survive termination of this Agreement: Section 3.4, Section 4, Section 6, Section 7 and Section 8 of this Agreement, and Section 6 of Exhibit A.

 

  8.9 Section Headings. The headings of the sections and subsections of this Agreement are inserted for convenience only and shall not be deemed to constitute a part thereof.

 

[Signature page follows]

 

9

 

 

IN WITNESS WHEREOF, the parties have executed this Agreement on the date first written above.

 

SIYATA MOBILE INC.   BSD LTD.  
     
By: /s/ Brain Budd   By: /s/ Marc Seelenfreund
  Name: Brain Budd     Name:
  Title: Director     Title:

 

/s/ Keren Seelenfreund   /s/ Marc Seelenfreund
Witness signature   MARC SEELENFREUND
     
Name:    
(please print) Keren Seelenfreund    
Address:      
       

 

10

 

 

Exhibit A

 

1. Compensation. In consideration for the performance of the Consulting Services in accordance with this Agreement, the Company shall pay to the Consultant NIS 90,000 (plus VAT) monthly consideration (the “Base Consideration”), upon receipt by the Company of an invoice from the Consultant. The Base Consideration shall be paid monthly in arrears. The Base Consideration shall be indexed to the average annual inflation of the State of Israel for the previous year on the first day of each new year that this Agreement is in force.

 

2. Reimbursement of Expenses. The Consultant will be authorized to incur reasonable expenses in carrying out the Consulting Services for the Company under this Agreement and shall be entitled to reimbursement of all reasonable out-of-pocket expenses incurred in connection with the performance of the Consulting Services, provided that all such expenses are expended in accordance with the Company’s then current policies.

 

2.1 Among other things, the Consultant will be authorized to incur expenses for meals and entertainment, transportation (including ride-hailing, taxis, car rentals, parking, and gasoline), office supplies, and travel.

 

2.2 The Company shall provide the Consultant with a cellular phone for the performance of its duties under this Agreement. The Company shall pay for all expenses and taxes concerning the use of said cellular phone. In addition, the Company shall reimburse the Consultant for any expense incurred in connection with one phone line installed in the Service Provider’s home including any applicable tax arising from the reimbursement under this Section.

 

2.3 Where the Service Provider is required to travel internationally in connection with the performance of the Consulting Services under this Agreement, the Consultant will be reimbursed for travel-related expenses, and when travelling via air, the Consultant is authorized to travel “business class” or, if there is no “business class” on the required flight, then the next highest class above “economy class” on that particular flight. Additionally, the Consultant will be entitled to book accommodations that have been rated with a minimum of four stars.

 

3. Paid Absence. The Consultant shall be entitled to receive full payment from the Company for up to 30 business days per year, as well as all Jewish holidays, despite the Service Provider’s absence on such days.

 

4. Incentive Bonus. The Consultant shall be entitled to an quarterly bonus equal to 5% of the Company’s EBITDA (as defined below) (the “Incentive Bonus”). The Incentive Bonus shall be payable within 15 days of the filing of the Company’s unaudited interim financial statements on SEDAR. An annual adjustment shall be completed on the Incentive Bonus 30 days of the filing of the Company’s audited annual financial statements; provided that the adjustment shall only occur if it is found that the Consultant is entitled to a greater Incentive Bonus on the year than otherwise paid. In the event of any termination of the Agreement prior to the conclusion of the relevant calendar year, except termination due to a Change of Control, the Consultant shall be entitled to the pro rata portion of the Incentive Bonus that is due with respect to the part of the year prior to the termination date.

 

4.1 For the purposes of this Agreement, “EBITDA” means earnings before interest, taxes, depreciation, and amortization of the Company, and such calculation shall be based upon the Company’s year-end audited financial statements.

 

11

 

 

4.2 The Company’s board of directors may, at its sole discretion, increase the Incentive Bonus based upon the performance of the Company’s stock, financings, and other such indicators of the Company’s success.

 

4.3 The Consultant may, at its discretion, exercise the right to have an independent firm of chartered accountants audit the records that relate to the calculation of the Incentive Bonus within six (6) months of the filing of the Company’s audited annual financial statements. At the conclusion of such audit, if the auditors determine that the calculation of the Incentive Bonus has been understated or excessive costs have been added to the calculation of the underlying EBITDA, then the costs of the audit will be borne by the Company and such costs, together with the deficiency in the amount actually paid as an Incentive Bonus as against the calculation of the Incentive Bonus by the auditors, shall be paid by the Company to the Consultant within thirty (30) days. In all other circumstances, the cost of the audit will be borne by the Holder.

 

5. VAT & Withholding. All payments to be made hereunder are exclusive of value added taxes which shall be added to such payments based on the then current value added tax rate. The Base Consideration, the Incentive Bonus, any expense reimbursement provided for hereunder shall be payable subject to receipt of and in accordance with a valid withholding tax certificate duly issued by the Israel Tax Authority (the “ITA”). Each invoiced amount shall be due and payable within five (5) days from the date of receipt thereof. The Company shall deduct from all payments due and payable hereunder any taxes and related mandatory costs that must be deducted at source or with respect to which the Company is otherwise deemed liable to pay according to applicable law or the aforementioned withholding tax certificate.

 

6. No Additional Compensation. Subject to the Agreement and, for greater certainty, Section 4 of the Agreement, the foregoing shall constitute the full and final payment for the Consulting Services rendered pursuant to this Agreement and neither the Consultant nor the Service Provider shall be entitled to any other payment in connection with the Agreement and the Consulting Services and the Company shall not be obliged to pay to the Consultant and/or Service Provider any additional consideration, fees or expense reimbursement whatsoever.

 

 

12

 

 

 

Exhibit 10.2

 

License Agreement

 

AGREEMENT entered into as of December, 2012, by and between Uniden America Corporation, Inc. & its affiliates, a Delaware Corporation, having its principal office at 4700 Amon Carter Boulevard, Fort Worth, TX 76155 (“Licensor”). and Signifi Mobile. a Canadian Corporation. having its principal office at 5005 Jean Talon Boulevard Suite 10, Montreal, Quebec, H4P1W7, Canada ( “Licensee”).

 

WHEREAS, Licensor is the owner of the trademark Uniden and associated designs and trade dress, (together, the “Trademarks’’) as shown below, and is using the Trademarks throughout the World, and

 

WHEREAS, Licensor has the right to grant Licensee the license, right and permission to use the Trademarks, and

 

WHEREAS. Licensee is in the business of manufacturing, distributing and selling articles or services described and specified hereinafter, and desires to secure the license, right and permission to use the Trademarks upon, and in connection with, the manufacturing, distributing and selling of such articles or services; and

 

WHEREAS. Licensor desires to grant to Licensee, and Licensee desires to accept from Licensor, a license to use the Trademarks in the design, manufacture, advertising, sale and promotion of product, subject to each of the terms. provisions and conditions of this Agreement

 

NOW, THEREFORE, in consideration of the premises and of the mutual agreements. covenants and provisions contained herein, the parties hereto do hereby agree as follows

 

ARTICLE 1: DEFINITIONS

 

1.1 “High End Booster” means any cellular signal booster retailing for USD$150 or more per unit

 

1.2 “High End Accessory” means all accessories for any High End Booster, without regard to the price of such assessor;

 

1.3 Licensed Items. “Licensed Items” means all High End Boosters and High End Accessories specifically listed in Appendix A, which can be modified by a writing signed by both parties. Goods eligible to be included in Appendix A include cellular signal boosters and related cellular signal booster accessories: mobile broadband antennas supporting cellular signal booster products. The parties may agree in a writing signed by both parties to include among the Licensed Items, products which are not High End Boosters or High End Accessories.

 

 

 

 

ARTICLE 2: GRANT OF LICENSE AND DESIGNATION OF LICENSED ITEMS

 

Effective upon the execution of this Agreement, Licensor hereby grants to Licensee, for the period hereinafter specified and upon the terms, provisions and conditions of this Agreement, the exclusive right and license to use the Trademark(s) within the geographic area described in Article 2 hereof, in the design, manufacture, advertising, sale and promotion of the Licensed Items.

 

Licensed Items will be as designated in Appendix A. Licensee may request in writing to add or delete a product from Appendix A. Approval of such request will be at the sole discretion of Licensor. The rights granted to Licensee herein are limited to use on or in connection with the Licensed Items and Licensee specifically agrees not to use the Trademarks in any manner or on any product. service or item, except as set forth in the Agreement

 

ARTICLE 3: GEOGRAPHIC AREA AND CHANNELS

 

The rights granted to Licensee hereunder may be exercised by Licensee within the United States and its possessions, territories. military bases and Puerto Rico, and Canada (the ‘Territory”). and Licensee shall have exclusive rights with respect to the Licensed Items. Upon Licensee’s request, Licensor may, in its discretion, extend the areas in which Licensee may exercise said rights, but any such extension shall, in each instance, be evidenced by a written and duly executed amendment to this Agreement for such periods and upon such terms and conditions as shall be determined by Licensor. Notwithstanding the foregoing, Licensee may manufacture outside the Territory for sale within the Territory.

 

The rights granted to Licensee are further limited by the Distribution Guidelines in Appendix B which can be modified by a writing signed by both parties

 

ARTICLE 4. TERM AND TERMINATION OF AGREEMENT

 

4.1 Contract Term. The Contract Term of this Agreement shall be for three (3) Contract Years commencing as of the date of execution of this Agreement and ending on December 31, 2015 at midnight Eastern Standard Time, unless sooner terminated pursuant to the terms of this Agreement

 

4.2 Extension Terms. If Licensee meets or exceeds Contract Year 3 Minimum Net Sales per Article 7.1, Licensor hereby grants to Licensee the option to extend the Contract Term of this Agreement for one (1) three (3) year period (an “Extension Term”) as follows: (i) commencing on January 1, 2016 and ending on December 31. 2018 ending at midnight Eastern Standard Time of the date of expiration thereof, unless sooner terminated pursuant to the terms of this Agreement. Such options to extend the Contract Term of this Agreement must be exercised by Licensee, if at all, by giving written notice to Licensor at least sixty (60) days prior to the expiration of the then preceding Contract Term or the First Extension Term of this Agreement.

 

2

 

 

4.3 Termination

 

4.3.1 Defaults. Except as otherwise expressly provided in this Agreement. in the event Licensee shall default in the performance of any of the terms, conditions or obligations to be performed by Licensee hereunder, and if such default involves the payment of money and same shall not be cured within ten (10) days of such default. or if such default involves performance other than the payment of money and the same is not cured within thirty (30) days after Licensor gives written notice to Licensee of such default (or if such default cannot be cured within thirty (30) days if Licensee does not commence cure within thirty (30) days and diligently completes such cure), then and in any such event, Licensor may immediately terminate this Agreement and all of the rights and obligations hereunder (except as otherwise expressly provided by this Agreement). However, if such default is a result of Licensee selling Licensed Items or any other items baring the Trademarks without first receiving full written approval from Licensor as provided in this Agreement, then Licensor may terminate this Agreement immediately.

 

4.3.2 Failure To Meet Required Minimum Net Sales. Should during two consecutive Contract Years Licensee fail to maintain the required Minimum Net Sales during any Contract Year or Extension Term Contract Year, as provided in Article 7, then Licensor may, at its option, elect to terminate this Agreement by written thirty (30) day notice delivered to Licensee within ninety (90) days after the end of such Contract Year or Extension Term Contract Year during which Licensee failed to maintain such required Minimum Net Sales Such termination shall be effective upon expiration of the thirty (30) day period set forth in said notice but shall not affect Licensee’s outstanding indebtedness to Licensor, or any of the provisions relating thereto

 

4.3.3 Bankruptcy/Receivership. In the event that a Receiver is appointed to, or one or more creditors take possession of all. or substantially all, of the assets of the Licensee, or if Licensee shall make a general assignment for the benefit of creditors. or if any action is taken or suffered by Licensee under any state or Federal insolvency or bankruptcy act, then this Agreement and all of the rights and obligations hereunder (except as otherwise expressly provided by this Agreement) shall immediately, and without notice or need of any further action by any party hereto, terminate.

 

4.3.4 Time for Performance. The time for performance of any act required of either party shall be extended by a period equal to the period during which such party was reasonably prevented from performance by fire, flood, storm, or other like casualty beyond such party’s control.

 

ARTICLE 5: EARNED ROYALTIES AND NET SALES

 

5.1 Earned Royalties Subject to Section 6.3 of Article 6 hereof, Licensee shall pay to Licensor for the rights granted hereunder a sum equal to five percent (5%) of Net Sales (the “Earned Royalties”) on Licensed Items sold at the wholesale level to all resellers except the mass retailers sales channel (as defined in Appendix “B”). and four percent (4.0%) of Net Sales on Licensed Items sold at the wholesale level for resale to the mass market retailers sales channel (as defined in Appendix “B”) whether sold by the licensor or the licensee; and four percent (4.0%) of Net Sales on Licensed Items sold by the licensee direct to end users at retail level.

 

The Earned Royalties shall be remitted in accordance with Article 6.3 of this Agreement.

 

 

3

 

 

 

5.2 Definition of Net Sales. As used throughout this Agreement. the term “Net Sales” shall mean the aggregate of the invoiced amounts of Licensed Items, sold and/or shipped by Licensee and paid for by Licensee’s customers, less (a) refunds, credits and allowances actually made or allowed to customer with respect to Licensed Items, (b) shipping and/or freight charges, whether or not charged to customers as a separate line item on the invoice. (c) promotional/new store discounts. and (d) federal and state duties, levies, sales and excise taxes (including value-added taxes).

 

ARTICLE 6: MINIMUM ROYALTIES AND ROYALTY PAYMENTS

 

6.1 Minimum Royalties. Notwithstanding anything to the contrary set forth herein, Licensee shall pay to the Licensor Minimum Royalties as follows:

 

Contract Year 1 (effective date – 12/31/2013): $30,000.00

Contract Year 2 (1/1/2014-12/3112014): $50,000.00

Contract Year 3 (1/1/2015-3/31/2015): $60,000 00

 

Extension Term

Contract Year 4 (1/1/2016-12/31/2016). $85,000.00 or 70% of Earned Royalties for Contract Year 3 whichever is greater

Contract Year 5 (1/1/2017-12/31/2017) $85,000.00 or 70% of Earned Royalties for Contract Year 3 whichever is greater

Contract Year 6 (1/1/2018-12/31/2018): $85,000.00 or 70% of Earned Royalties for Contract Year 3 whichever is greater

 

6.2 Minimum Royalty Payments The Minimum Royalty for the first Contract Year shall be paid as follows twenty-thousand dollars ($20,000.00) upon contract execution with four (4) quarterly payments of $2,500 beginning March 31, 2013 and ending December 31, 2013. The Minimum Royalty for each subsequent Contract Year of the Contract Term and/or Extension Term shall be paid in full by January 15’h of each Contract Year respectively.

 

6.3 Application of Earned Royalties. The Earned Royalties to be paid under Article 5 shall be applied against the Minimum Royalties due under this Article 6, and Licensee shall pay such Earned Royalties by the 20”’ day after the end of each Calendar quarter. Each Royalty Payment, payable in U.S currency, shall be remitted by check or wire transfer as required by Licensor in Appendix C.

 

6.4 In the event that Licensor does not comment, reject or approve the Licensed Items within 60 days of submission and in accordance with Article 8 and Article 14 of this agreement. the Licensor agrees that in effect ,the licensee will not have the ability to make sales and therefore will not have any royalties to be paid. In such a case Licensee will have the option to terminate this agreement immediately, and will not be responsible for any additional Minimum Royalty Payments. Such termination shall be effective upon expiration of the thirty (30) day period set forth in said notice but shall not affect Licensee’s outstanding indebtedness to Licensor. or any of the provisions relating thereto.

 

4

 

 

ARTICLE 7: MINIMUM NET SALES OF LICENSED ITEMS

 

7.1 Minimum Net Sales. Notwithstanding anything to the contrary set forth herein,

Licensee shall maintain minimum Net Sales during each Contract Year as follows.

 

Contract Year 1 (effective date – 12/31/2013): $650,000.00

Contract Year 2 (1/112014-1213112014): $1,300,000.00

Contract Year 3 (1/1/2015-3/31/2015): $1,700,000.00

 

Extension Term

Contract Year 4 (1/1/2016-12/31/2016): $2,125,000.00 or 70% of Net Sales for Contract Year 3 whichever is greater

Contract Year 5 (1/1/2017-12/31/2017) $2,125,000.00 or 70% of Net Sales for Contract Year 3 whichever is greater

Contract Year 6 (1/1/2018-12/31/2018): $2,125,000.00 or 70% of Net Sales for Contract Year 3 whichever is greater

 

7.2 Failure To Meet Required Minimum Net Sales. Should Licensee fail to maintain the required Minimum Net Sales for two (2) consecutive Contract Years, as provided in this Article 7, then Licensor may, at its option, elect to terminate this Agreement pursuant to Article 4.3.2.

 

ARTICLE 8: ADVERTISING AND ART WORK

 

8.1 Advance Submission. Licensee shall submit to Licensor for approval all advertising and promotional items, budgets, programs and materials relating to the Licensed Items at least thirty (30) days prior to intended usage. Licensor shall provide Licensee with written approval or disapproval within twenty (20) business days after Licensor’s receipt thereof. If Licensor fails to respond within such twenty business (20) day period, Licensee shall again submit such materials to Licensor for approval and if Licensor fails to approve or disapprove. with reasonable explanation for such disapproval, within an additional seven (7) day period, such materials shall be deemed approved pending written confirmation from Licensor. Should Licensor disapprove, its written notice shall explain in detail the reasons for disapproval so that Licensee may prepare and submit new advertising and art work and suggest to Licensee corrective measures so that the item submitted can be approved on further submission. Under no circumstances shall Licensee proceed with submissions without written approval from Licensor.

 

8.2 Art Work. Licensor shall make reasonably available to Licensee any and all necessary film, photostats, artwork and full color reproductions of its Trademarks, artwork. designs and other materials necessary for Licensee’s use in accordance with this Agreement.

 

8.3 Expense Reimbursement. Licensee shall reimburse Licensor for Licensor’s out-of-pocket expenses, including, reasonable hourly charges for creative personnel reasonably incurred by Licensor in the preparation for Licensee, when and if required, of new artwork, mechanicals, and film. All charges shall be agreed to in writing prior to the time such expenses are incurred, and all sums due to Licensor under this Article 8 shall be paid by Licensee upon receipt of an appropriate invoice.

 

5

 

 

8.4 Periodic Sales and Marketing Meeting. The parties agree that it is in the best interests of each party to meet periodically with the other to review the current and future sales and marketing of Licensed Items pursuant to this Agreement and also to explore the possibility of expanding the Territory or scope of products on which the Trademarks are used. Therefore the parties will strive to meet no less than twice a year to review current and future sales and marketing plans for Licensed Items.

 

ARTICLE 9 LICENSEE’S RECORDS

 

Licensee shall keep and maintain at its regular place of business separate and complete books and records of all business transacted by Licensee in connection with the Licensed Items, including, but not limited to, books and records relating to Net Sales and orders for Licensed Items. Such books and records shall be maintained in accordance with generally accepted accounting procedures and principles consistently applied. Licensor or its duly authorized agents or representatives shall have the right to inspect said books and records at Licensee’s premises during Licensee’s regular business hours but in any event upon prior written notice to Licensee of not less than seven (7) business days, and in no event more than once per Contract Year

 

ARTICLE 10. LICENSEE’S QUARTERLY REPORTS OF SALES AND ROYALTY PAYMENTS

 

On or before the twentieth (20th) day of each January, April, July and October during the Contract Term and any Extension Term, Licensee shall deliver to Licensor the following: (i) a written statement, certified to be true and correct by the Chief Financial Officer, or the functional equivalent, of Licensee, setting forth the quantity sold, gross sales and Net Sales for each of the Licensed Items during the preceding calendar quarter and a calculation of the Earned Royalties payable, if any, under Articles 5 and 6 of this Agreement, and (ii) a check or wire transfer payable to Licensor, according to Appendix C, in full payment of the amount due under Articles 5 and 6 of this Agreement.

 

ARTICLE 11: LICENSEE’S ANNUAL REPORTS AND ANNUAL ROYALTY PAYMENTS

 

On or before the fifteenth (15th) day of the second (2nd) month following the end of Licensee’s fiscal year, Licensee shall render to Licensor a statement certified by Licensee’s Chief Financial Officer, or functional equivalent, disclosing quantity sold, gross sales. Net Sales, Royalties due and Royalties paid for Licensee’s preceding fiscal year, and, on the last year thereof, for any Contract or Extension Term which ended within said fiscal year. If said statement discloses that the amount of Royalties paid during any period to which said statement relates was less than the amount required to be paid under the provisions of this Agreement, Licensee shall pay said deficiency, according to Appendix C. concurrent with the delivery of the statement. If said statement discloses the Licensee has paid Royalties in excess of the amounts required to be paid because of an accounting error, Licensor shall apply said excess to the next Royalty payment, or refund such excess to Licensee if no such Royalty payment is expected to be due.

 

6

 

 

ARTICLE 12: AUDIT BY LICENSOR

 

At all times during the Contract Term or any Extension Term and for twelve (12) months after the last report is rendered hereunder, Licensor, shall have the right to audit all books and records of Licensee in respect to the Licensed Items. but in any event upon prior written notice to Licensee of not less than seven (7) business days, and in no event more than once per year. Licensor’s foregoing right shall include the right to engage an independent certified public accounting firm, to audit the books and records of Licensee with regards to the Royalties due hereunder. In the event any such audit shall disclose that the Licensee has understated Net Sales or underpaid Royalties for any reporting period. Licensee shall forthwith and upon written demand of Licensor, pay the amount, if any, by which the Royalties owing exceed Royalties paid, plus interest of twelve percent (12%) per annum on such delinquent amounts, accruing from the date on which such amounts became delinquent to the date on which such delinquent amounts were paid In the event that Licensee has understated Net Sales and consequently has underpaid Royalties in excess of ten thousand dollars ($10,000) of the amount due for any Contract Term, Licensee shall forthwith and upon written demand also pay all reasonable costs, fees and expenses reasonably incurred by Licensor in conducting such audit, including, without limitation, reasonable travel expenses. Should such audit disclose that the Royalties paid exceed the Royalties due, any excess revealed by such audit will be remitted to Licensee within thirty (30) days of such finding.

 

ARTICLE 13: LICENSEE OBLIGATIONS

 

13.1 Licensee Diligence. Licensee shall design, manufacture, advertise, sell and ship the Licensed Items and shall continuously and diligently during the Contract Term hereof procure and maintain facilities and trained personnel sufficient and adequate to accomplish the foregoing, all substantially and to the commercially reasonable extent and in a manner no less thorough, diligent and professional than the same accorded by Licensee for Licensee’s most favored premium products and/or services. A cessation of the above for a continuous period of ninety (90) days shall be grounds for termination by Licensor. according to Article 4.31.

 

13.2 Licensor Inspection Rights. Licensor shall have the right to inspect any of Licensee’s facilities, including Licensee’s manufacturers and subcontractors, pertaining to the Licensed Items during regular business hours but in any event upon prior written notice to Licensee of not less than seven (7) business days but in no event more than twice per Contract Year. Licensor shall conduct such inspection in the presence of an officer, partner or authorized representative of Licensee. If Licensee’s facilities, manufacturer or subcontractor fails an inspection, then Licensee shall be given notice of default pursuant to Section 4.3.1. Once Licensee corrects such failure, Licensor may reinspect the Licensee’s facilities, manufacturer or subcontractor at Licensee’s sole cost to ensure failure has been cured.

 

13.3 Intellectual Property. It is Licensee’s sole responsibility to acquire in its own name, for its own account and at it own expense, all licenses for or similar conferment of rights to all intellectual property needed to manufacture and sell Licensed Items

 

7

 

 

13.4 Required Approvals. It is Licensee’s sole responsibility to acquire in its own name, for its own account and at its own expense, all Underwriter’s Laboratory, Federal Communications Commissions, and other required approvals of the Licensed Items.

 

13.5 Government Regulations. Licensee warrants that the Licensed Items shall be in complete and strict compliance with all applicable safety and environmental regulations and industrial standards in all the countries where the Licensed Items are sold. Further, Licensee warrants that Licensed Items comply in all material respects with federal laws and regulations applicable to the manufacture, packing, sale, shipment, exportation and importation of the Licensed Items

 

ARTICLE 14: APPROVALS AND QUALITY STANDARDS

 

14.1 Advance Approval. Prior to any use of any Trademarks, Licensee shall, at Licensee’s expense, submit to Licensor, for Licensor’s written approval the following: (a) specimens of each Licensed Item on which said Trademarks are to appear (the “Specimens”) in accordance with Appendix A, Appendix D and Appendix E of this Agreement; (b) all artwork which Licensee intends to use in connection with the Trademarks in accordance with Appendix E and (c) all packaging, advertising and promotional literature which Licensee intends to use in the marketing or merchandising of the Licensed Items in accordance with Appendix E. Licensor shall give Licensee written notice of approval or disapproval within fifteen (15) business days from its receipt of the specimens, and should Licensor disapprove or require additional information for approval, its written notice shall explain in detail the reasons for disapproval and suggest to Licensee corrective measures so that Licensee may prepare and submit new specimens and/or samples If Licensor fails to respond within such fifteen business (15) day period, Licensee shall again submit such materials to Licensor for approval and if Licensor fails to approve or disapprove, with reasonable explanation for such disapproval, within an additional fifteen (15) day period, such materials shall be deemed approved pending written confirmation from Licensor. Under no circumstances shall Licensee proceed with submissions without written approval from Licensor.

 

14.2 Standards. After Licensor has given its written approval of said specimens, then the approved product, quality, packaging, advertising and promotional literature shall be the standard for all Licensed Items produced thereafter (the “Approved Quality”).

 

14.3 Periodic Samples Thereafter, consecutively at four (4) month intervals, Licensee shall, at Licensee’s expense, submit to Licensor not less than two (2) randomly selected production run samples of the Licensed Items.

 

14.4 Approved Quality Standards. Without the prior written approval of Licensor, Licensee shall not sell or distribute any Licensed Item which deviates from the Approved Quality except for deviations which may occur as a result of normal deviations in raw material characteristics or such other minimal deviations.

 

8

 

 

14.5 Product Recall. Licensee shall not sell or distribute any sub-standard products under the Trademark. In the event that Licensee sells Licensed Items bearing the Trademark which are not in compliance with the agreed upon standards as set forth herein, Licensor may require that Licensee immediately stop selling and immediately remove all such non-compliant Licensed Items bearing the Trademarks from retails shelves, point-of-purchase displays and from the inventory of any of its customers. All reasonable costs associated with the removal of such non-compliant Licensed Items shall be borne by Licensee. If Licensee fails to remove non-compliant Licensed Items bearing the Trademark From its retail shelves or point-of-purchase displays within thirty (30) days after receipt of written notice from Licensor. Licensee’s right to continue using the Trademark shall cease immediately without any further right to cure. Licensee acknowledges and agrees that irreparable injury to Licensor would occur and that Licensor shall be entitled to temporary, preliminary and permanent injunctive relief, cost and reasonable attorneys’ fees arising from such continued violation

 

ARTICLE 15: FACTORY STANDARDS & RESTRICTIONS UPON SUBCONTRACTS

 

Licensee shall have the Licensed Items manufactured only with factories who are reputable and whose business and labor practices conform to the requirements of the applicable law of the country where the Licensed Items are manufactured. The factories must have written social compliance policies in place that ensure that all safety, health, child labor, forced labor. discrimination, working hours, wages and benefits and environmental laws and other social moral and ethical laws are followed.

 

Licensee may enter into subcontracts for the manufacture of Licensed Items without the express written consent of Licensor with subcontractors or factories of its choice so long as the quality standards set forth in this Agreement are adhered to. Licensee is responsible for the work of any subcontractor and for any debts, obligations or liabilities incurred by any such subcontractor in connection with the Licensed Items

 

Licensee shall discontinue using any factory and subcontractor who shall fail to comply with quality standards and/or delivery schedules required by Licensee or Licensor.

 

ARTICLE 16: ASSIGNMENT, TRANSFERS, SUBLICENSE

 

The parties hereby acknowledge the substantial personal service nature of Licensee’s obligations hereunder Therefore, without the prior written consent of Licensor not to be unreasonably withheld, delayed and/or conditioned, Licensee shall not voluntarily or by operation of law assign or transfer this Agreement or any of Licensee’s rights or duties hereunder or any interest of Licensee herein, nor shall Licensee enter into any sublicense for the use of the Trademarks by others.

 

Any assignment, transfer or sub-license without Licensor’s written consent shall be void and at the option of the Licensor shall constitute a default hereunder. For purposes of this Article 16. the transfer in one or more transactions, by operation of law, or otherwise of 50% or more of the outstanding voting securities of Licensee shall be deemed an attempted assignment by the Licensee of this Agreement.

 

ARTICLE 17: NO DILUTION OF TRADEMARKS OR ATTACK UPON TRADEMARKS, REPRESENTATIONS BY LICENSOR

 

17.1 Limit on Use. Licensee shall not at any time use, promote, advertise, display or otherwise publish any of the Trademarks or any material utilizing or reproducing any of the Trademarks in whole or in part. except as specifically provided in the Trademark Usage Guidelines (Appendix E) and this Agreement.

 

9

 

 

17.2 Notice. Licensee shall cause to appear on all Licensed Items and on all materials on, or in connection with which, any of the Trademarks are used, such legends, markings and notices as may be required by law to give appropriate notice of all trademarks. trade name or other rights therein or pertaining thereto.

 

17.3 Materials and Documents. Licensee shall provide all materials and execute all documents required by law incident to the maintenance and/or preservation of the Trademarks and Licensor’s rights therein with Licensor’s full cooperation where and to the extent needed.

 

17.4 No Contest of Trademark Validity. Licensee shall not contest the validity of the Trademarks or any rights of Licensor therein, nor shall Licensee willingly become an adverse party in litigation in which others shall contest the Trademarks or Licensor’s said rights. In addition thereto, Licensee shall not in any way seek to avoid its obligations hereunder because of the assertion or allegation by any persons, entities or government agencies. bureaus, or instrumentalities that the Trademarks, or any of them, are invalid or ineffective or by reason of any contest concerning the rights of Licensor therein.

 

17.5 No Other Trademark Protection. Licensee agrees not to seek any state, Federal. foreign or other statutory trademark or service mark or other protection for the Trademarks as they are used in connection with the Licensee’s goods or services and agrees that the use of the Trademarks shall be for the sole benefit of the Licensor.

 

17.6 Licensor represents and warrants to Licensee that: (i) Licensor holds all such rights in and to the Trademarks as are necessary in order to grant to Licensee the rights hereunder: (ii) Licensor has full power and authority, without the consent or approval of any other person or entity, to enter into this Agreement and to grant Licensee the rights hereunder: and (iii) to the best of Licensor’s knowledge, the Trademarks do not infringe upon any copyright, trademark, or other intellectual property right(s) or proprietary right(s) of any third party or constitute a misappropriation of any such right(s) in the Territory. The Licensor and its successors agree to indemnity, hold harmless and defend the Licensee from and against all suits, actions, claims, liabilities, costs and expenses or other damages arising out of or connected with a breach of the foregoing representations and warranties or any claim that the Trademarks infringe on the rights of any third party or any breach by the Licensor of any provision of this Agreement.

 

ARTICLE 18: INFRINGEMENT AND OTHER TRADEMARK LITIGATION

 

18.1 Trademark Defense. Licensee shall apprise Licensor immediately upon discovery of any possible infringement of the Trademarks which comes to the attention of the Licensee. Licensor, at its sole cost and expense, and in its own name, may prosecute and defend any action or proceeding which Licensor deems necessary or desirable to protect the Trademarks, including but not limited to, actions or proceedings involving their infringement. Upon written request by Licensor, Licensee shall join Licensor at Licensor’s sole expense in any such action or proceeding. However. Licensee shall not commence any action or proceeding to protect the Trademarks or any action or proceeding alleging infringement thereof without the prior written consent of Licensor Licensee may prosecute and defend, at its sole expense, and in its own name. any action or proceeding to protect its designs or styles. Any and all damages recovered in any action or proceeding commenced by Licensor shall belong solely and exclusively to Licensor

 

10

 

 

18.2 No Liability for Violation Except as otherwise set forth in Section 17 6 of this Agreement, Licensor shall have no liability to Licensee or any other person, nor shall there be any right of contribution against Licensor therefore. for any action or proceeding alleging any violation of any antitrust, trade regulation, or similar statute. or unfair competition. Furthermore, in the event of any threatened or actual action or proceeding in which Licensee and Licensor are or may be charged with jointly violating any antitrust. trade regulation or similar statute, or any law pertaining to unfair competition. Licensee may, at its option, elect to be represented in such threatened or actual action or proceeding by Licensor’s counsel at no cost to Licensee for fees, costs or expenses. Should Licensee elect in such event to be represented by Licensors counsel, then Licensee shall relinquish any right to control or direct such threatened or actual action or proceeding, and Licensor shall maintain full control thereof. Such representation of Licensee shall continue only so long as Licensors counsel, in its sole and absolute discretion. believes that it may properly and ethically represent both Licensor and Licensee. In the event that Licensor’s counsel decides that it may no longer properly and ethically represent both Licensor and Licensee, then Licensors counsel shall continue to represent Licensor only, and Licensee’s continued defense shall be at Licensee’s sole expense and shall be conducted by separate counsel.

 

18.3 Licensee Indemnification. Licensee shall indemnify and hold Licensor harmless from any and all trademark or infringement liability and/or claims for which Licensor shall become liable by reason of any actions that may be committed by Licensee in connection with Licensee’s improper use of the Trademarks

 

18.4 Limitation on Rights Licensee shall have no rights against Licensor with respect to any of the matters covered in this Article 18 except as expressly set forth above. Licensee shall under no circumstance incur legal expense on Licensors account absent prior specific written authorization from Licensor

 

18.5 Notwithstanding any of the foregoing, Licensor shall use commercially reasonable efforts to discourage any third party infringement.

 

ARTICLE 19: ADDITIONAL RESTRICTIONS UPON USE OF TRADEMARKS

 

Identification of Licensed Items. It is the intention of the parties hereto and the purpose of this Article 19 that all of the Licensed Items be identified to the general public by the Trademarks. Licensee agrees to assist Licensor in obtaining registrations for the Trademarks in the event the Trademarks are not yet registered for the Licensed Items within any part of the Territory, all at no cost whatsoever to Licensee.

 

11

 

 

ARTICLE 20 RETURN GOODS

 

Both parties acknowledge that Licensee is solely responsible for all dealing with and administering of returns, including but not limited to defective product returns. of Licensed Items from its customers and that Licensor has no obligation towards these returns. Further, both parties recognize that each party may mistakenly receive other party’s returned goods mixed in with its own product. Therefore, both parties agree:

 

a. Licensee will closely instruct its retail customers to return all Licensed Items directly to Licensee; and

b. In the case Licensor receives Licensed Items mixed in with its own goods. Licensor will ship to Licensee, at Licensee’s cost. all Licensed Items received. It is Licensee’s responsibility to notify and credit the retail customer for the Licensed Items.

C. In the case Licensee receives Licensor’s goods mixed in with Licensed Items, Licensee will ship to Licensor, at Licensor’s cost, all Licensor’s goods.

 

ARTICLE 21 CUSTOMER SERVICE

 

Both parties acknowledge that Licensee is solely responsible for providing customer service for all Licensed Items and Licensor has no obligation to provide customer service for these Licensed Items Therefore. Licensee shall:

 

a. Use reasonable efforts to ensure that each customer service experience, whether online or via the phone, is a pleasant experience with positive feedback, and ensure that any complaints received on the Licensed Product or the customer service are dealt with timely and remedied in a reasonable business manner;
b. Ensure that all packaging and other material for Licensed Items are clearly marked with the correct customer service contact information; and
c. Provide the correct customer service contact information to Licensor, so that Licensor can provide this information to consumers who contact Licensor for customer service issues on the Licensed Items.

 

ARTICLE 22 LICENSOR SALES

 

Licensee agrees that Licensor may purchase Licensed Items from Licensee to resell. Licensee agrees that it will owe all the same duties and responsibilities to Licensor for these sales as it has to any other purchaser of the Licensed Items. including but not limited to, product/technical support, customer service, product warranty, and indemnification The parties will negotiate the purchase price in good faith.

 

If Licensor chooses to purchase Licensed Items, then Licensee agrees to support Licensor’s sales by providing electronic copies of product owner’s manuals, specifications, product warranty, product images and other product related material which Licensor needs to properly advertise to and inform consumers.

 

ARTICLE 23: LICENSOR’S RIGHTS TO DESIGNS. ETC UPON TERMINATION

 

23.1 Rights Upon Termination. In the event this Agreement is terminated for any reason. or expires according to its terms, Licensee shall assign, transfer and transmit to Licensor any and all rights of Licensee in the Trademarks, including associated goodwill, and shall not thereafter manufacture. sell or use the Trademarks in any manner. Licensee may, however, dispose of its stock of Licensed Items on hand within one hundred twenty (120) days after such termination or expiration of this Agreement (the “Selloff Period”); provided, however, Licensee’s obligation to pay to Licensor all sums due to Licensor through the date of such termination or expiration shall survive such termination or expiration; and, further provided. that Licensee shall, prior to the effective date of said termination, deliver to Licensor a detailed schedule of all inventory of Licensed Items in Licensee’s possession (constructive or otherwise). After the expiration of the aforesaid Selloff Period, Licensee shall destroy all Licensed Items and packaging and promotional material remaining in Licensee’s possession which are identified in any manner by or with the Trademarks. Notwithstanding the above, during the Selloff Period Licensor shall have the right to purchase such excess stock of Licensed Items, in whole or in part. prior to any sale or offer of sale by Licensee to any third party, for an amount equal to the wholesale cost of such Licensed Items. It is specifically understood and agreed that the Licensee’s right to dispose of stock shall be conditioned upon the absence of harm to the Trademarks and/or the reputation of the Licensor arising from the Licensee’s use of the Trademarks, as reasonably determined by the Licensor in its sole discretion.

 

12

 

 

23.2 Continuation of Agreement Terms. Licensee shall continue to abide by the terms of this Agreement with respect to such Licensed Items during the Selloff Period. Neither Licensee nor any creditor (judgment or otherwise), assignee, transferee, trustee, or receiver of Licensee, or similar person or officer, or purchaser other than in the regular course of Licensee’s business may sell or transfer any Licensed Item until and unless all sums due Licensor from Licensee have been paid. After the expiration of the aforesaid Selloff Period, Licensee shall destroy all Licensed Items and packaging and promotional material remaining in Licensee’s possession which are identified in any manner by or with the Trademarks.

 

23.3 Licensee’s Obligations The termination of this Agreement for any reason shall not relieve Licensee of any accrued obligations to Licensor nor shall such action relieve Licensee of any obligation or duty which accrued on or after the termination or expiration of this Agreement.

 

23.4 No Right in Licensee. It is understood and agreed that except for the right to use the Trademarks as specifically provided for in this Agreement, Licensee shall have no right, title or interest in or to the Trademarks. Upon and after the termination of this Agreement, all rights granted to Licensee hereunder, together with any interest in and to the Trademarks that Licensee may acquire, shall forthwith and without further act or instrument be assigned to and revert to the Licensor. In addition, Licensee shall execute any instruments requested by Licensor to accomplish or confirm the foregoing. Any such assignment, transfer or conveyance shall be without consideration other than the mutual agreements contained herein. However, Licensor and Licensee agree that Licensee owns all right, title and interest in and to the designs and products that underlie, preexist and are severable from the Trademarks, and all intellectual property associated therewith and that Licensee’s use thereof in or on or in connection with the Trademarks does not and shall not grant Licensor any rights to such designs and products. Nothing herein shall be deemed a waiver by Licensee of any intellectual property right. design or idea not derived from or based upon the Trademarks.

 

23.5 Survival of Terms. The provisions of this Article 23 shall survive the termination (or expiration) of this Agreement.

 

ARTICLE 24: ADDITIONAL RIGHTS PRIOR TO TERMINATION

 

During the final Contract Year of the Contract Term hereof, and subject to Extension Period(s) thereof. Licensor shall have the right to design and manufacture merchandise of the types covered by this Agreement and to negotiate and conclude such Agreements as it desires pursuant to which it may grant licenses to any party or parties of any or all of the rights herein granted to Licensee; provided, however, that no merchandise herein identified as Licensed Items shall be shipped by Licensor or any third party other than Licensee prior to the expiration or termination of this Agreement (exclusive of the Selloff Period).

 

13

 

 

ARTICLE 25: GOODWILL

 

Licensee acknowledges and recognizes that the Trademarks are of substantial significance and value to Licensor and that said Trademarks have acquired valuable secondary meaning, value and goodwill. Except as may be otherwise specified in this Agreement, Licensee shall not use any of the Trademarks or any name or symbol similar thereto as part of its name or symbol or as part of the name or symbol of any corporation partnership. joint venture, proprietorship or other entity or person which it controls or with which it is affiliated.

 

ARTICLE 26: INSURANCE

 

During the Contract Term of this Agreement and any agreed upon extensions, Licensee shall maintain or shall cause its supplier of Licensed Items to maintain comprehensive general liability, product liability and advertising liability insurance in an amount no less than $1 million per incidence or occurrence plus excess liability insurance to a minimum limit of $5 million and shall have Licensor named as an additional insured party therein. Said insurance may be carried by Licensee under a blanket or an umbrella policy. Licensee shall also submit to Licensor upon the signing of this Agreement. and each year upon renewal of insurance, a certificate of insurance for said insurance coverage naming Licensor as an additional insured party and stating that thirty days’ written notice will be given Licensor by Licensee’s insurance carrier in the event any modification is made to the policy or the policy is canceled.

 

ARTICLE 27: AGENTS, FINDERS AND BROKERS

 

Each of the parties to this Agreement shall be responsible for the payment of any arid all agent, brokerage and/or finder commissions, fees and related expenses incurred by it in connection with this Agreement or the transactions contemplated hereby and agrees to indemnify the other and hold it harmless from any and all liability (including. without limitation, reasonable attorney’s fees and disbursements paid or incurred in connection with any such liability) for any agent, brokerage and/or finder commissions, fees and related expenses claimed by its agent, broker or finder, if any, in connection with this Agreement or the transactions contemplated hereby. Licensor’s sole agent/finder/broker in connection with this Agreement is Leveraged Marketing Corporation of America (“LMCA”) with offices at 156 West 56th Street, Suite 1400, New York, New York 10019. Any and all commissions, fees and/or other monies due LMCA in connection with this Agreement shall be borne exclusively by Licensor.

 

ARTICLE 28: RESERVED RIGHTS

 

Rights not herein specifically granted to Licensee are reserved by Licensor and may be used by Licensor without limitation. Any use by Licensor of such reserved rights, including but not limited to, the use or authorization of the use of the Trademarks in any manner whatsoever not inconsistent with Licensee’s right hereunder, shall not be deemed to be interference with or infringement of any of Licensee’s rights.

 

14

 

 

ARTICLE 29: APPLICABLE LAW

 

This Agreement shall be construed and governed, in all respects, by the law of the State of Texas applicable to contracts made and to be performed in that state without reference to any provisions relating to conflicts of law Any legal action or proceeding of any sort, shall be brought in a court of competent jurisdiction in Tarrant County, Ft. Worth, Texas.

 

ARTICLE 30: NON-AGENCY OF PARTIES

 

This Agreement does not constitute or appoint Licensee as the agent or legal representative of Licensor, or Licensor as the agent or legal representative of Licensee, for any purpose whatsoever. Licensee is not granted any right or authority to assume or to create any obligation or responsibility, express or implied, on behalf of or in the name of, Licensor or to bind Licensor in any manner or thing whatsoever; nor is Licensor granted any right or authority to assume or create any obligation or responsibility, express or implied, on behalf of or in the name of Licensee, or to bind Licensee in any manner or thing whatsoever. No joint venture or partnership between the parties hereto is intended or shall be inferred

 

ARTICLE 31: AMENDMENTS AND WAIVERS BY LICENSOR

 

This Agreement may be amended or modified by Licensor, and Licensor may waive any of its rights hereunder or performance by Licensee of any of its obligations hereunder, only by instrument in writing. In the event Licensor shall at any time waive any of its rights under this Agreement or the performance by Licensee of any of its obligations hereunder, such waiver shall not be construed as a continuing waiver of the same rights or obligations, or a waiver of any other rights or obligations.

 

ARTICLE 32: ENTIRE AGREEMENT

 

This Agreement constitutes the entire Agreement between the parties as to the Licensed Items, and supersedes all prior agreements and understandings relating to this subject matter hereof.

 

ARTICLE 33: SEPARABILITY OF PROVISIONS

 

If any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws, such provisions shall be fully severable The Agreement shall be construed and enforced as if such illegal, invalid or unenforceable provisions had never comprised a part of this Agreement, and the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid, or unenforceable provision or by its severance from this Agreement. Furthermore, in lieu of such illegal, invalid or unenforceable provision, there shall be added automatically as part of this Agreement, a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible and be legal. valid or enforceable.

 

15

 

 

ARTICLE 34: COUNTERPARTS, HEADINGS

 

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. The headings herein are set out for convenience of reference only and shall not be deemed a part of this Agreement.

 

ARTICLE 35: BINDING EFFECT

 

This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and. subject to the provisions of Article 16 of this Agreement, their respective permitted successors and assigns

 

ARTICLE 36: INDEMNIFICATION

 

Licensee shall indemnify, defend and hold harmless Licensor from and against all demands, claims (including without limitation, claims for product liability, alleged product defects, negligence, false advertising, breach of warranty, fraud and misrepresentation) actions or causes of action. assessments, losses, damages. liabilities, costs and expenses (including. without limitation, interest, penalties, attorneys’ fees and expenses) (“Damages”) asserted against, resulting to or imposed upon or incurred by Licensor, including any Damages for loss of, or damage to, property, or for personal injury, sickness and disease (including death) sustained by any person, including, but not limited to, the ultimate user of the Licensed Items or other person affected by the use of the Licensed Items, if such loss, damages or injury is caused by. arises out of, or is in any way connected with the Licensed Items hereunder.

 

ARTICLE 37: CONFIDENTIALITY

 

37.1 Exchange of Information. in performing the rights and obligations under this Agreement, it is anticipated that the parties may disclose confidential information. “Confidential Information” shall include any and all information that is not publicly known, including, but not limited to customer lists, market share, sources of product supply, sales prices, financial data and the terms of this Agreement. Confidential Information includes all information exchanged between the parties except information that

 

37.1.1 can be demonstrated to have been in the public domain prior to the date of the disclosure:
37.1.2 can be demonstrated to have been in the receiving party’s possession prior to its disclosure to the receiving party;
37.1.3 becomes part of the public domain by publication or otherwise not due to any unauthorized act or omission on the part of receiving party: or
37.1.4 is given to the receiving party as a matter of right by a third party which is under no obligation to hold such information confidential.

 

37.2 Non-disclosure or use. Each party agrees that it shall not, at any time during or subsequent to the termination or expiration of this Agreement, without the express permission of the disclosing party, publish, disclose or use any Confidential Information of the other party except as may be required in any legal proceedings Notwithstanding the foregoing, the parties may disclose Confidential Information to Licensor’s broker named in Article 27 above.

 

16

 

 

37.3 The parties acknowledge that in the performance of their respective rights and obligations under this Agreement, the Licensor may obtain information regarding the Licensee’s suppliers. The Licensor acknowledges that any direct dealings between the Licensor and the Licensee’s suppliers without the express written consent of the Licensee would cause irreparable harm to the Licensee. Therefore throughout the term of this Agreement (and any renewal period) and for a period of two (2) years thereafter, Licensor shall not directly or indirectly acquire any Items from any of the Licensee’s suppliers. For the purposes of this section 37.3, the expression “Licensee’s suppliers” shall include any affiliates or successors in title to the Licensee’s suppliers.

 

ARTICLE 38: ADDRESSES FOR NOTICE

 

All notices, statements, consents, instructions or other documents required or authorized to be given hereunder shall be in writing, and shall be delivered personally to an officer. partner or authorized representative of the other party or by certified mail, return receipt requested. addressed to the parties concerned as follows:

 

to Licensee at:

 

5005 Jean Talon Boulevard Suite 10, Montreal, Quebec, H4P1W7, Canada

 

and to Licensor at:

 

4700 Amon Carter Boulevard Fort Worth, TX 76155

 

with a copy to:

 

Leveraged Marketing Corporation of America

Attn President

156 West 56th Street

Suite 1400

New York, NY 10019

 

and shall be deemed to have been given upon receipt

 

17

 

 

ARTICLE 39 LIMITS ON LIABILITY

 

Except as otherwise provided, and notwithstanding anything else in this Agreement or otherwise, neither party shall be liable or obligated under any section of this Agreement or under contract, negligence, strict liability or other legal or equitable theory for any indirect, special, incidental, consequential or punitive damages, or lost profits.

 

IN WITNESS WHEREOF, this Agreement is executed on the day and year first written above.

 

Uniden America Corporation (Licensor)

 

/s/ Rex Holloway  
     
     
By: Rex Holloway  

 

 

Signifi Mobile (Licensee)

 

 

/s/ Stephen Ari Schachter  
             
     
By: Stephen Ari Schachter  

 

18

 

 

 

19

 

 

Appendix B

 

Distribution Guidelines

Prohibited Distribution

 

Neither Licensee nor any third party may present to, sell to or otherwise distribute to any mass retailers and warehouse clubs, including their physical stores and corn business. Examples of mass retailers include, but are not limited to:

 

Wal-Mart

Wal-Mart Canada

Best Buy

Target

Target Canada

Costco

Sams

PriceMart

 

Other Prohibited Distribution

Amazon.com

 

20

 

 

Appendix C

 

Payment Instructions

Beneficiary LMCA

JP Morgan Chase

1370 Avenue of the Americas

NY NY 10019

a/c #2963410408

routing #021000021

 

21

 

 

Appendix D

Licensor QA SAMPLE STAGES

 

Licensor Engineering and QA

 

1. Engineering Pre-Production (EPP) Sample

 

At this stage. the product should be basically final and should meet the following conditions:

 

Quantity: 2 units should be sent to Licensor, at Licensee’s expense, to confirm with the product plan

Hardware – The Printed Circuit Boards should be the final version.

 

a. Software – This version should have the final microcontroller installed.
b. Mechanical – The tooling should be completed at this stage
c. Documentation – The Licensee shall submit a document package that includes:

 

· Schematics.
· PCB Layout (with component identification).
· Electrical, Mechanical, and Software comments
· Test Data (including temperature, ESD, and Drop test data).

 

d. Accessories – All accessories must be included at this stage.

 

2. Factory Pre-Production (FPP) Sample

 

At this final evaluation stage, the samples must be final and must be in the condition for retail sale. The following conditions must be met:

 

Quantity: 4 units should be submitted to Licensor, at Licensee’s expense

Hardware – The Printed Circuit Boards must be the final version.

 

a. Software – Sample must have the final microcontroller installed.
b. Mechanical –The tooling must be complete at this stage.
c. Documentation – The document package must include:

 

· Product and Regulatory Labels correct with supporting certification.

 

If required by Licensor, the Licensee shall submit the following additional documentation that includes

 

· Final Schematics.
· Final PCB Layout (with component identification).
· Bill Of Materials (BOM) in MS Excel format.
· Test Data (including all customer documentation, labels, protection film that is specified in the product plan)
· Alignment procedures.

 

d. Display Box, Owners Manual and Shipping Carton – These items must be complete at this stage. These items are verified with Licensor Marketing, as to color, size, and wording.

 

22

 

 

e. Test Jigs – If any special test jigs are required for Licensor IQC They must be provided by Licensee at Licensor’s expense with Licensor’s advance written acceptance The jigs must be received at this time (with set-up and operation documentation)

 

Testing and acceptance required prior to shipment. Each sample stage must be accompanied by the appropriate test reports and data as requested by Licensor. Each stage requires written acceptance and approval by Licensor before proceeding to the next stage. Written approval from Licensor of the FPP sample and release of the Products is required prior to mass production.

 

23

 

 

Appendix E

 

UNIDEN AMERICA CORPORATION
TRADEMARK USAGE GUIDELINES

 

The purpose of these Trademark Usage Guidelines is to provide Uniden America Corporation’s authorized dealers, suppliers, licensees and agents (“Third Party TM Users”) a guide to the proper and legal use of Uniden America Corporation (“UAC”) logos and trademarks, including advertising, product brand labeling, point of purchase displays, trade show displays, truck/vehicle identification, outdoor signs, brochures, stationary, packaging, uniforms, promotional clothing, instruction manuals, and sales aid items

 

The use of UAC trademarks has tremendous value to the merchantability and image of UAC The consistent, correct use of these marks not only protects UAC’s right to their use, but contributes to our strength and recognition in the marketplace. Furthermore, Third Party TM Users benefit by identifying themselves with UAC’s well-known, respected trademarks.

 

Third Party TM Users are required to strictly follow these guidelines as they will be enforced. Misuse or improper use of any UAC trademark may result in termination of permission to use UAC’s trademarks and/or other legal action by UAC

 

Questions regarding these standards should be addressed to the UAC Legal Department. Any existing materials in violation of these standards must be corrected as soon as possible.

 

PROPER TRADEMARK USAGE GUIDELINES

 

1. Trademarks are not nouns: they function exclusively as proper adjectives Trademark rights may be lost if misused. Some examples of trademarks which have become “lost” or become generic include escalator, corn flakes, and aspirin The first and most important rule is to always use the generic description of the product in association with the trademark whenever possible.

 

EXAMPLE: Dealers sell a UNIDEN TRUNKTRACKER scanning radio receiver - not just the “TRUNKTRACKER.”

 

NOTE: Uniden dealers must never refer to competitors’ products as “their trunktrackers”.

 

2. Since trademarks are not nouns, they should never be used in the plural form. Instead pluralize the generic product name that the mark describes.

 

EXAMPLE:

 

CORRECT UNIDEN TRUNKTRACKER scanning radio receivers

 

INCORRECT Two trunktrackers

 

Trademarks should never be used in the possessive form. Never use a trademark as a verb

 

3. Whenever possible. proper trademark notice (i.e. ® or TM) should follow the trademark. Circle R (®) should follow any trademark which has been registered with and accepted by the United States Patent and Trademark Office (“USPTO”). The TM symbol should follow any trademark which has not been formally registered and accepted by the USPTO. As a minimum requirement, the notice should be used at least once in each piece of printed matter and preferably the first time the trademark appears.

 

24

 

 

4. If it is not possible or desirable to utilize a ® or TM, an asterisk or other such symbol may be placed next to the trademark, directing a reader to a footnote indicating that the mark is either “Reg. U.S. Patent and Trademark Office,” or if not registered, “[trademark] is a trademark of Uniden America Corporation”.

 

5. Generally, the mark should be distinguished in print with some form of special typographical treatment At a bare minimum, the mark should be capitalized. The trademark may also appear in all capital letters, in quotation marks, in italics, in bold-face, underscored, set larger than body copy, or set in a different type face or ink color. The product description following the trademark is not set off in any distinguishing manner. If the mark uses a particular logo or design, whenever possible, use the mark in the unique type style or form, at least once in every advertisement or piece of printed material.

 

6. Never embellish or make additions to a trademark or change its presentation in any manner. Do not change the spelling, insert or delete hyphens, make one word into two, or combine two words into one. Mutilation of a trademark is prohibited, since it risks dilution of the strength of UAC marks which may result in the loss of the mark.

 

7. All Web pages. manuals, advertisements, promotional and marketing materials should include a variation of the trademark credit line included below. The credit line may appear anywhere on the collateral, but typically is displayed on a copyright page, at the end of a document or Web page. The credit line should be similar to the following: “the Uniden trademark is owned by Uniden America Corporation & its affiliates and is used under license by__________________.”

 

8. In the United States, Uniden’s corporate name representing the entity under which it does business is Uniden America Corporation. UAC has also registered the trademark UNIDEN, in several forms, both as a word mark and as a logo, to identify the family of products and services offered by our company Use of the name Uniden as a trademark is not the same as a corporate designation

 

9. Third Party TM Users may not use UAC trademarks or logos on company checks in any form whatsoever

 

10. Third Party TM Users may not use any of UAC’s trademarks in such a manner that implies that any non-UAC materials, including but not limited to goods, services, Web sites or publications, are endorsed, sponsored, licensed by or affiliated with UAC. The trademarks may not be displayed as a primary or prominent feature on any materials that do not originate from UAC

 

11. Third Party TM Users may not incorporate UAC trademarks into their own product names, service names, trademarks or logos, or adopt marks or logos that are confusingly similar to UAC’s trademarks.

 

25

 

 

UNAUTHORIZED USE OF UAC TRADEMARKS

 

Each of us has a responsibility to protect UAC’s valuable marks. If you become aware of any unauthorized use of a UAC trademark, e.g , that someone other than a UAC employee or authorized Third Party TM User is using a UAC trademark, please contact the UAC Legal Department as quickly as possible.

 

 

26

 

Exhibit 10.3

 

PATENT LICENSE AGREEMENT

 

This Patent License Agreement (“Agreement”) is made this 30 day of November, 2017 (“Agreement Date”), by and between Wilson Electronics, LLC, a limited liability company existing under the laws of the State of Delaware, having its principal place of business at 3301 E. Deseret Drive, St. George, Utah 84790 (“Wilson”); and Signifi Mobile, Inc. a corporation organized and existing under the laws of Ontario, Canada, having its principal place of business at 1001 Rue Lenoir, Suite A-414, Montreal, Quebec, H4C2Z6, Canada (“Licensee”). Where appropriate, Wilson and. Licensee shall hereinafter be referred to collectively as “Parties” and individually as a “Party”.

 

WHEREAS Wilson owns, controls or is otherwise entitled to grant rights under certain patents and patent applications relating to Licensed Products (as hereinafter defined) and Licensee manufactures, sells and distributes certain Licensed Products;

 

WHEREAS Licensee markets and sells Licensed Products that are directly competitive with products marketed and sold by Wilson; and

 

WHEREAS Wilson is willing to grant a license and Licensee is willing to obtain a license under the Licensed Patents on the terms and conditions set forth in this Agreement.

 

NOW THEREFORE, in consideration of the premises and mutual covenants herein contained, the Parties hereby agree as follows:

 

1. Definitions

 

The following capitalized terms used in this Agreement shall have the respective meanings ascribed to them below in this Section unless otherwise expressly defined in this Agreement.

 

1.1 “Affiliate” of an entity means an entity that at any time controls, is controlled by, or is under common control with such entity.. Such entities shall only be deemed to be Affiliates hereunder for as long as such control exists. Control, in this context, exists where one entity owns more than 20% whether directly or indirectly of the right to exercise voting power with respect to the election of directors or similar managing authority of an entity (whether through direct or indirect beneficial ownership of shares or securities of such entity or otherwise) or, if the entity in question does not have outstanding voting shares or securities, more than 20% of the equity interest in such entity.

 

1.2. “Auditor” has the meaning set forth in Section 5.2.

 

1.3. “Average Selling Price” of a specific model or type of Licensed Product means the average selling price charged by Licensee and its Affiliates for all such Licensed Product during the immediately preceding calendar quarter.

 

1.4. “Confidential Information” has the meaning set forth in Section 10.1.

 

CONFIDENTIAL Page 1

 

 

1.5. “Effective Date” means January 1, 2018.

 

1.6. “End User Device” means a stand-alone cell phone radio signal booster having as its primary function to receive and amplify digital cellular 2G, 3G and/or 4G, 5G, etc., radio signals and which is designed for use in home, office or civilian ground-based vehicular environments. End User Devices exclude all other products and applications, including, without limitation, any chip-based radio signal booster that is intended to constitute a component of a larger device or product, such as a smart phone, tablet, game player, laptop computer or vehicle.

 

1.7. “Have Made” means the right to have a Third Party make Licensed Products for the use and benefit of the Licensee and its Affiliates when (a) the Licensed Products are made under contract by a Third Party manufacturer for Licensee or its Affiliates and are units supplied by such Third Party manufacturer solely to Licensee or its Affiliates (or directly to their customers on behalf of Licensee or its Affiliates) and to no other Third Party; and (b) such Licensed Products are not re-Sold back to, or on behalf of, such Third Party manufacturers or its Affiliates.

 

1.8. “Wilson Licensed Patents” shall mean all Patents throughout the Territory owned, controlled or licensable (without the obligation to pay any Third Party) by Wilson or its Affiliates, the practice of which is necessary to implement either a mandatory or optional portion of a normative clause of the Standard when, at the time of the Standard’s approval, there was no commercially and technically feasible non-infringing alternative implementation method for such mandatory or optional portion of the normative clause. The term Wilson Licensed Patents shall also mean certain Patents throughout the Territory owned, controlled or licensable (without the obligation to pay any Third Party) by Wilson or its Affiliates that are not necessary to implement the Standard, but which Wilson is willing to license to Licensee. For the avoidance of doubt, the Wilson Licensed Patents include those Patents listed in Appendix A hereto and the existing and future patent priority related family members that provide priority date to or derive a priority date from a Patent listed in Appendix A, and all foreign counterparts thereof throughout the Territory.

 

1.9. “Licensed Product” means an End User Device that is branded primarily with a brand owned by or licensed to Licensee and/or its Affiliates, A list of Licensees anticipated Licensed Products by name and SKU is provided in Exhibit B which shall be updated by Licensee in January and July of each year for the duration of the Term.

 

1.10. “Net Selling Price” shall mean the Selling Price of a Licensed Product, less sales tax, import tax, export tax and other taxes and/or customs duties levied or imposed directly upon the Sale of such Licensed Products and collected by Licensee.

 

CONFIDENTIAL Page 2

 

 

1.11. “Patent” shall mean patent claims (including claims of licensable patent applications, whether or not divisionals, continuations, continuations-in-part, reissues, renewals, or extensions therefor and any counterparts claiming priority therefrom), and like statutory rights other than design patents.

 

1.12. “Royalty” has the meaning set forth in Section 3.2.

 

1.13. “Sale”, “Sell” or “Sold” or any similar variation of such term, means the delivery of Licensed Products in the Territory to a Third Party for compensation, including lease, rent or similar transaction, or the putting into use of the Licensed Products by the Licensee and/or its Affiliates and/or End-Users for any purpose other than routine testing, quality control or certification, with a Sale being deemed to have occurred upon invoicing or putting into use, whichever shall first occur.

 

1.14. “Selling Price” shall mean with respect to each Licensed Product Sold by Licensee or any of its Affiliates, one of the following, whichever is applicable:

 

  (a) With respect to Sales to an entity that is not an Affiliate of Licensee, the Selling Price will be the selling price charged by Licensee or its Affiliate to such unrelated buyer.

 

  (b) With respect to Sales to an entity that is an Affiliate of Licensee, the Selling Price will be (a) the selling price charged by the final vendee Affiliate to a non-Affiliate buyer of such Licensed Product, or (b) if no further Sale of such Licensee Product is made by the Affiliate to a non-Affiliate, then the Selling Price for each such Licensed Product shall be the Average Selling Price of the Licensed Product.

 

  (c) In the event that a Licensed Product is Sold to a non-Affiliate as part of a combination or bundle including both Licensed Products arid other products (e.g., an End User Device sold together with a smart phone or wireless router), the Selling Price of the Licensed Product shall be, at Licensee’s sole discretion, either the Net Sales Price of the combination or bundle, or the greater of (x) the Average Selling Price: of such Licensed Product, and (y) the portion of the aggregate sale price of such combination or bundle which is allocable to the Licensed Product using reasonable and standard accounting practices in the. industry.

 

1.15. “Standard” means FCC Part 20 §20.21(e).

 

1.16. “Term” has the meaning set forth in Section 5.1.

 

1.17. “Territory” means world-wide.

 

1.18. “Third Party” means any entity that is not a Party or an Affiliate of a Party.

 

CONFIDENTIAL Page 3

 

 

2. Licenses

 

2.1. License Grant by Wilson. Wilson, hereby grants to Licensee an irrevocable (except upon Termination for Material Breach), non-exclusive, nontransferable (except as expressly provided herein), royalty-bearing license under the Wilson Licensed Patents in the Territory during the Term to make, Have Made, use, import, Sell and offer for Sale Licensed Products.

 

2.2. Limitations. The foregoing license does not include any right or license to manufacture or sell products that are based on a Third Party design and which are sold by Licensee or its Affiliates to or on behalf of such Third Party as the Third Party’s own product and not a Licensed Product.

 

2.3. Sublicenses. The licenses granted under this Article 2 shall include the right of Licensee to grant sublicenses to its Affiliates. No such sublicense shall be broader in any respect than the license held by Licensee. Any sublicensed Affiliate will be bound in all respects to all of the obligations of Licensee contained in this Agreement and Licensee shall be responsible for compliance by its sublicensed Affiliates with such obligations and jointly and severally liable with such Affiliates for all actions and omissions of such Affiliates. Any sublicense granted hereunder shall indicate that Wilson is a third party beneficiary and entitled to enforce the terms and conditions of the sublicense. Licensee shall enforce all sublicenses at its costs and shall be responsible for the acts and omissions of its sublicensees with respect to such sublicenses. Any sublicense granted under this Agreement shall immediately terminate when an Affiliate ceases to be an Affiliate of Licensee and otherwise upon termination of this Agreement

 

2.4. Licensee Liability. Notwithstanding any sublicense agreement, Licensee shall remain primarily liable to Licensor for all of Licensee’s duties and obligations contained in this Agreement, including the payment of all Royalties. Any act or omission of a sublicensee that would be a breach of this Agreement if committed or omitted by Licensee will be a breach by Licensee. Each sublicense agreement shall contain a right of termination by Licensee for the sublicensee’s: (a) breach of any payment or reporting obligations affecting Wilson; or (b) breach of any other terms or conditions of the sublicense agreement that is also set forth, in substance, in this Agreement, which breach would constitute a breach of this Agreement if Licensee failed to comply therewith.

 

2.5. Reservation of Rights. All rights not expressly granted, herein are expressly reserved. Nothing in this Agreement shall be construed as conveying, whether explicitly, by implied license, or otherwise, any license rights not explicitly granted herein. Nothing in this Agreement shall be construed as conveying, whether explicitly, by implied license, or otherwise, any rights to any Third Party user or purchaser of the Licensed Products, under any Licensed Patent covering any combination of the Licensed Products with any other product (not licensed hereunder) where the patent claim is infringed by the combination and not by the Licensed Product alone.

 

CONFIDENTIAL Page 4

 

 

2.6. Marking. Licensee shall mark all Licensed Products manufactured, used or sold under this Agreement as agreed by the Parties using a Licensee website used to promote and educate end users about the Licensed Products in order to preserve Wilson’s rights under and comply with applicable laws.

 

2.7. Voluntary Standard. Nothing in this Agreement shall be construed as a requirement that Licensee or its Affiliates implement or adopt the Standard or any other standard in any product or refrain from engaging in any competitive activity or promotion of any competitive standard.

 

2.8. Acknowledgement. Licensee understands that the licenses granted hereunder with respect to certain of the Wilson Licensed Patents have been granted in connection with Wilson’s commitment, contained in a Letter of Assurance submitted to IEEE on June 8, 2015, to grant such licenses under reasonable rates and other reasonable terms and conditions. Licensee hereby acknowledges that the Royalties and other terms and conditions of this Agreement are reasonable and fairly reflect the value that Licensee will obtain from the licenses and other rights granted hereunder, that Licensee has willingly entered into this Agreement without coercion or other pressure from Wilson, and that Wilson has fully, and in good faith, complied with any commitment it may or may not have to grant a license under the Wilson Licensed Patents to Licensee on reasonable terms. Accordingly, Licensee hereby releases and waives any claim that it may have under contract, antitrust, competition, estoppel, or any other legal or equitable theory with respect to any commitment Wilson may or may not have to grant a license under the Wilson Licensed Patents to Licensee on reasonable terms.

 

2.9. Return License to Wilson. Licensee agrees that if, as of the Effective Date, Licensee owns, controls or is otherwise entitled to grant rights under any Patents throughout the Territory owned, controlled or licensable (without the obligation to pay any Third Party) by Licensee or its current Affiliates as of the Effective Date, the practice of which is necessary to implement either a mandatory or optional portion of a normative clause of the Standard, Licensee hereby grants to Wilson a non-exclusive, non-transferable, non-royalty-bearing license in the Territory during the Term to make, Have Made, use, import, Sell and offer for Sale products pursuant to any such Patents.

 

3. Payment

 

3.1. Royalties. Licensee shall pay to Wilson a running royalty equal to four and one half percent (4.5%) of the Net Selling Price of each Licensed Product Sold by Licensee or its Affiliates in the Territory during the Term (the “Royalty”). Royalties shall be due and payable hereunder on a quarterly basis with respect to all Sales of Licensed Products during a calendar quarter no later than forty-five (45) days following the end of each calendar quarter during the Term.

 

CONFIDENTIAL Page 5

 

 

3.2. Remittance Details. All payments hereunder shall be made by wire transfer in U.S. Dollars to the following bank account of Wilson, or as may be otherwise notified by Wilson to Licensee in writing at least ten (10) days prior to the due date of any such payment:

 

Wilson Electronics, LLC

Acct # 039013297

Routing # 124000054

S.W.I.F.T. Code: ZFNBUS55

Zions Bank

One South Main Street

Salt Lake City, Utah 84133

 

3.3. Quarterly Reporting. Licensee, on behalf of itself and its Affiliates, shall submit to Wilson a written report (“Sales Report”) within forty-five (45) days of the end of each calendar quarter during the Term. Each Such Sales Report shall list each type or model of Licensed Products Sold and the aggregated Net Selling Price for the total of all of Licensed Product Sold by Licensee and its Affiliates during such calendar quarter. Licensee warrants that each such Sales Report shall be complete and accurate and shall be certified by a duly authorized financial officer of Licensee.

 

3.4. Taxes. All payments required by this Agreement are exclusive of taxes, customs or any other duties, and Licensee agrees to bear and be responsible for the payment of all such taxes, customs or other duties including, but not limited to, all sales, use, rental receipt, personal property or other taxes and their equivalents which may be levied or assessed in connection with this Agreement (excluding only taxes based on Wilson’s net income).

 

3.5. Currency Conversion. For any currency conversion from the currency of one country in which the Licensed Products are sold into U.S. Dollars required in determining the royalties due hereunder, such conversion shall be calculated at the conversion rate as reported in the Wall Street. Journal (New York Edition) on the last business day of the applicable quarterly period in which the royalties are determined, or such other method agreed to by the Parties in writing.

 

3.6. Overdue Amounts. All overdue amounts hereunder shall bear interest at an annual rate of ten percent (10%). Such interest shall commence on the date such payment becomes due until such payment is made. If at any time such interest rate exceeds the maximum legal rate in the jurisdiction where a claim therefore is being asserted, the interest rate shall be reduced to such maximum legal rate.

 

CONFIDENTIAL Page 6

 

 

4. Records and Audit

 

4.1. Recordkeeping. Licensee shall, and shall cause its Affiliates to, keep accurate and complete books and records which relate to the Licensed Products in sufficient detail (consistent with generally accepted accounting practices for the industry) to enable the Royalties payable hereunder to be determined. Such books and records, shall be kept by Licensee for a period of three (3) years after the calendar quarter to which the books and records apply.

 

4.2. Audit. Wilson shall have the right during the Term and for two (2) years thereafter, upon at least thirty (30) days’ notice, to appoint, at its own expense, a Third Party independent auditor (“Auditor”) to examine and audit any and all books and records of Licensee and its Affiliates to the extent relevant to the determination of Royalties payable hereunder and Licensee’s and its Affiliates’ compliance with this Agreement. The audit shall be conducted during Licensee’s normal business hours and without undue interference with Licensee’s normal business. Any such audit shall take place no more than once per calendar year, and any particular calendar quarter shall be audited only once. Licensee shall assemble in a single location, or otherwise make available in electronic form, all books and records necessary for such audit to be carried out, and shall make such personnel available as may be reasonably necessary to respond to any inquiries by the Auditor. The Auditor shall sign a non-disclosure agreement on reasonable terms to be agreed between the Auditor and Licensee in advance of the commencement of any audit.

 

4.3. Reporting and Use of Audit Results. The Auditor is authorized to report to Wilson whether Licensee is or is not (and if not, in what manner) in compliance with its obligations under this Agreement as well as the particulars of such non-compliance, if any. The auditor shall furnish Licensee with a copy of all audit reports furnished to Wilson. Wilson shall use, the information resulting from such audits exclusively for the administration and enforcement of this Agreement. The contents of any such audit report shall be treated by Wilson as Confidential Information of Licensee.

 

4.4. Reconciliation. In the event that the audit identifies an overpayment of Royalties by Licensee, Wilson will credit the amount overpaid to Licensee against the next payment due under this Agreement. To the extent that no further payment is due under this Agreement, Wilson shall within sixty (60) days after such determination, pay Licensee the amount by which Royalties were determined to be overpaid. In the event that the audit identifies any underpayment of royalties by Licensee, then Licensee shall within thirty (30) days after such determination, pay Wilson the shortfall plus any applicable interest. In the event that any underpayment for the audit period exceeds five percent (5%) of the Royalty amount actually due, Licensee shall reimburse Wilson in full for the actual cost of the audit and related attorneys’ fees.

 

CONFIDENTIAL Page 7

 

 

5. Term and Termination

 

5.1. Term. This Agreement shall come into force on the Agreement Date and shall remain in force until the last to expire of the Wilson Licensed Patents, unless earlier terminated as set forth in this Section 5 (“Term”).

 

5.2. Termination for Material Breach. After notice and expiration of the cure period, a Party may terminate this Agreement by written notice if the other Party (or an Affiliate) at any time commits a material breach of any of its significant obligations under this Agreement (which shall expressly include any non-payment) and fails to provide a commercially reasonable cure to the noticed breach within sixty (60) days after receipt of a notice specifying the nature of such breach and requiring remedy of the same. The Parties agree that the failure to identify in this Agreement the breach of any particular obligation as a “material breach” does not preclude any Party from contending in the future that such breach is “material.”

 

5.3. Challenge to Licensed Patents Deemed a Material Breach. A material breach is deemed to have occurred if during the Term of this Agreement and not in response to a court order, subpoena, administrative order or similar, Licensee institutes or actively participates as an adverse party in, or otherwise provides material support to, any action, suit or other proceeding in the Territory to invalidate or limit the scope of any Wilson Licensed Patent or obtain a ruling that any Wilson Licensed Patent is unenforceable or not patentable (“Licensed Patent Challenge”).

 

5.4. Corporate Events. A Party shall provide written notice to the other Party immediately upon the occurrence of any of the following events: (i) its insolvency, bankruptcy or liquidation or filing of any application therefor, or other commitment of an affirmative act of insolvency; (ii) attachment, execution or seizure of substantially all of the assets of the notifying Party or filing of any application therefor; (iii) assignment or transfer of that portion of the business to which this Agreement pertains to a trustee for the benefit of creditors; (iv) termination of its business or dissolution; or (v) in the case of Licensee, within ninety (90) days after the closing of a merger, acquisition, consolidation, transfer or otherwise wherein more than fifty percent (50%) of the ownership or control of Licensee is acquired by an entity then engaged in the manufacture or sale of End User Devices and such acquiring entity was an adverse party to Wilson in infringement or validity or damages, or similar litigation arising from one or more, Licensed Patents at the time of the acquisition closing date. The other Party shall have the right to terminate this Agreement with immediate effect by giving written notice of termination at any time upon such occurrence.

 

5.5. Effects of Termination. Upon any termination of this Agreement, all licenses and rights granted hereunder shall be terminated, except that the Parties’ rights and obligations under the following Sections of this Agreement shall survive in accordance with their terms: 1, 2.7, 4, 5, 7.1, 8.3, 8.4, 9, 10, 11, and 12.

 

CONFIDENTIAL Page 8

 

 

6. Assignment and Transfer

 

6.1. Transfer of Licensed Patents. Nothing contained herein shall prohibit Wilson from selling or assigning any Licensed Patent, provided that Wilson shall procure from its buyer or assignee that any such sale or assignment of any such Licensed Patent shall be subject to the licenses, covenants and releases granted to Licensee herein. If Wilson or any of its Affiliates transfers its business in whole or in part through divestiture, merger or otherwise to a Third Party, Wilson shall procure, prior to the divestiture, that the license, covenant and release granted to Licensee under this Agreement shall continue (as if no such divestiture occurs) for the Term.

 

6.2. Transfer of Licensees Rights and Obligations. Subject to Section 5.4, Licensee may sell, assign, transfer or otherwise divest this Patent License Agreement and all its rights and obligations hereunder in a transaction wherein more than fifty percent (50%) of the ownership or control of Licensee is acquired by a single entity provided that the rights granted herein apply only to Signify branded products. The acquiring entity shall be subject to the licenses, covenants and releases granted to Licensee herein and it shall be expressly understood that the rights assigned and obligations delegated shall not extend beyond those possessed by Licensee at the time of the acquisition and shall expressly exclude the acquiring entity’s business at the time of acquisition and thereafter.

 

6.3. No Other Assignment. Save as otherwise set out herein, neither Party may grant or assign any rights or delegate any obligations under this Agreement to any Third Party (save to an Affiliate) without the prior written consent of the other Party, and any attempted assignment without such consent shall be null and void.

 

7. Representations, Warranties and Liability

 

7.1. Wilson. Wilson hereby represents and warrants that (i) it has received all necessary corporate approvals and that the signatory below is duly authorized to execute this Agreement on behalf of Wilson; (ii) Wilson and/or its Affiliates own, control or have the right to license the Wilson Licensed Patents on the terms set forth herein; and (iii) it has not made and shall not make any agreements, assignments or encumbrances inconsistent with the provisions of this Agreement.

 

7.2. Licensee. Licensee hereby represents and warrants that (i) it has received all necessary corporate approvals and that the signatory below is duly authorized to execute this Agreement on behalf of Licensee; (ii) it has not made and shall not make any outstanding agreements, assignments or encumbrances inconsistent with the provisions of this Agreement; and (iii) the information that Licensee has provided to Wilson is true, accurate, and complete.

 

CONFIDENTIAL Page 9

 

 

7.3. General Disclaimers. Nothing contained in this Agreement shall be construed as:

 

  (a) a warranty or representation, either expressed or implied, as to the validity, enforceability or scope of any Wilson Licensed Patent herein;

 

  (b) an agreement to bring or prosecute actions or suits against Third Parties for infringement;

 

  (c) conferring any right to use, in advertising, publicity or otherwise, any name, trade name, trademark, or any contraction, abbreviation or simulation thereof of the other Party;

 

  (d) a warranty or representation that the manufacture, sale, lease, use or importation of Licensed Products will be free from infringement of patents, copyrights or other intellectual property rights of Third Parties;

 

  (e) an obligation to furnish any manufacturing or technical information or assistance;

 

(f) an obligation to file any patent application, or to secure any patent or patent rights, or to maintain any patent in force, or to provide copies of patent applications to the other Party or its Affiliates, or to disclose any inventions described or claimed in such patent applications; or

 

(g) an obligation upon either Party to make any determination as to the applicability of any Patent to any product of the other Party.

 

7.4. EXPRESS DISCLAIMER. WILSON EXPRESSLY DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, WHETHER WRITTEN, ORAL, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, CONCERNING THE VALIDITY, ENFORCEABILITY AND SCOPE OF THE WILSON LICENSED PATENTS, THE ACCURACY, COMPLETENESS, SAFETY, USEFULNESS FOR ANY PURPOSE OR, LIKELIHOOD OF SUCCESS (COMMERCIAL, REGULATORY OR OTHER) OF THE LICENSED PRODUCTS, AND ANY TECHNICAL INFORMATION, TECHNIQUES, MATERIALS, METHODS, PRODUCTS, PROCESSES OR PRACTICES AT ANY TIME MADE AVAILABLE BY LICENSOR INCLUDING ALL IMPLIED WARRANTIES OF MERCHANTABILITY, QUALITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT AND WARRANTIES ARISING FROM A COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OR TRADE PRACTICE, WITHOUT LIMITATION TO THE FOREGOING, WILSON SHALL HAVE NO LIABILITY WHATSOEVER TO LICENSEE OR ANY OTHER PERSONS FOR OR ON ACCOUNT OF ANY INJURY, LOSS OR DAMAGE, OF ANY KIND OR NATURE, SUSTAINED BY, OR ANY DAMAGE ASSESSED OR ASSERTED AGAINST, OR ANY OTHER LIABILITY INCURRED BY OR IMPOSED ON LICENSEE OR ANY OTHER PERSON, ARISING OUT OF OR IN CONNECTION WITH OR RESULTING FROM (A) MANUFACTURE, USE, OFFER FOR SALE, SALE, OR IMPORT OF A LICENSED PRODUCT, OR THE PRACTICE OF THE WILSON LICENSED PATENTS; (B) THE USE OF OR ANY ERRORS OR OMISSIONS IN ANY KNOW-HOW, TECHNICAL INFORMATION, TECHNIQUES, OR PRACTICES DISCLOSED BY WILSON; OR (C) ANY ADVERTISING OR OTHER PROMOTIONAL ACTIVITIES CONCERNING ANY OF THE FOREGOING.

 

CONFIDENTIAL Page 10

 

 

7.5. Indemnification. Licensee agrees to indemnify Wilson and its Affiliates against any and all out-of-pocket costs, or damages arising out of or in connection with the manufacture, commercialization, marketing, sale or use of Licensed Products, including, but not limited to, any actual or alleged injury, damage, death, liability or other consequence occurring to any legal or natural person or property as a result, directly or indirectly, of the possession, use, manufacture, sale or import of any Licensed Products, claimed by reason of breach of warranty, negligence, product defect, infringement of intellectual property rights (other than the Licensed Patents) or other cause of action, regardless of the form in which any such claim is made. In the event of any such claim is brought, Wilson shall promptly notify Licensee in writing of the claim and Licensee shall manage and control, at its sole expense, the defense of the claim and its settlement. Wilson shall cooperate with Licensee and may, at Wilson’s option, be represented in any such action or proceeding at its own expense.

 

7.6. Indemnification.

 

Wilson agrees to indemnify Licensee and its Affiliates against any and all out o f- pocket costs, or damages arising out of or in connection with any and all court or administrative proceedings involving a challenge to the validity or misuse of the Licensed Patents, third-party infringement of the licensed patents, or the value of the Licensed Patents (hereinafter “Indemnified Claims”). For the avoidance of doubt, Indemnified Claims do not include anything enumerated in Section 7.4 above.

 

In the event Licensee receives written communication regarding any Indemnified Claims, Licensee shall promptly notify Wilson in writing of the communication and Wilson shall manage and control, at its sole expense, the response to such communication as agreed by the Parties and any and all resulting actions or agreements resulting therefrom. Licensee shall cooperate with Wilson and may, at Licensee’s option, be represented by its own counsel in any such action or proceeding at its own expense.

 

CONFIDENTIAL Page 11

 

 

8. Governing Law and Dispute Resolution

 

8.1. Governing Law. This Agreement, including, without limitation, all matters relating to performance under this Agreement, shall be construed, interpreted, applied and governed in all respects in accordance with the laws of the United States of America and the State of Utah without reference to its conflict of laws principles.

 

8.2. Dispute Resolution. Any controversy, difference, claim or other dispute arising out of or relating to this Agreement, including the validity, interpretation, performance, breach or termination of this Agreement, or the amount of Royalties due hereunder, shall be referred to and finally resolved in the federal or state courts of the State of Utah.

 

8.3. Injunctive Relief. Notwithstanding the foregoing, either Party may seek interim or injunctive relief from any court of competent jurisdiction pending resolution of the controversy, difference, claim or other dispute.

 

9. Notices

 

Any and all notices, requests, demands, consents, agreements and other communications required or permitted to be given or made under this Agreement shall be given in writing and in the English language and shall be (i) delivered personally; or (ii) sent by facsimile; or (iii) mailed by registered mail; or (iv) delivered by courier to the following addresses of the Parties or to such other address as the Party concerned may subsequently notify in writing to the other Party in accordance with this Section 10.

 

  If to Wilson: Bruce Lancaster
    Wilson Electronics, LLC
    2890 E. Cottonwood Pkwy, #325
    Cottonwood Heights, UT 84121
     
  With Copy to: Jed H. Hansen
    Thorpe North & Western, LLP
    175 South Main St. Suite 900
    Salt Lake City, Utah 84111
     
  If to Licensee: Signifi Mobile, Inc.
    Marc Seelenfreund, CEO
    1001 Rue Lenoir, Suite A-414
    Montreal, Quebec, H4C2Z6
    Canada
     
  With Copy to: Craig M Carothers, Esq.
    16811 Holland Rd.
    Pearland, TX 77584

 

CONFIDENTIAL Page 12

 

 

Unless otherwise specifically provided in this Agreement, such notice shall be deemed given: (i) if delivered personally or by courier, upon delivery; (ii) if mailed by registered mail, unless actually received earlier, seven (7) days after the date of mailing; or (iii) on the day of the receipt of sender’s facsimile confirmation of the transmission in case of facsimile.

 

10. Confidentiality

 

10.1. Confidential Information. For purposes of this Agreement, “Confidential Information” means confidential, proprietary or secret information of a Party or its Affiliates which is so designated by such Party in writing, whether by letter or by the use of a proprietary stamp or legend, and which is disclosed by such Party to the other Party or its Affiliates hereunder. For the avoidance of doubt, the information contained in Licensee’s Sales Reports shall constitute the Confidential Information of Licensee. The Parties entered into a prior Confidentiality Agreement dated July 20, 2017, in an effort to facilitate discussions related to this Agreement. The Parties agree and acknowledge that any and all Confidential Information as defined by this Agreement disclosed between the Parties after the July 20, 2017, agreement but prior to the Effective Date of this Agreement shall be treated as Confidential Information as if it was disclosed pursuant to this Agreement.

 

10.2. Restrictions. All Confidential Information disclosed by a disclosing Party hereunder shall be held in strict confidence by the receiving Party and shall be used only in connection with the performance of the receiving Party’s obligations or the exercise of its rights under this Agreement. Except as expressly permitted herein, the receiving Party shall not, without the prior written consent of the disclosing Party, disclose any such Confidential Information to any Third Party and the receiving Party shall take, all reasonably appropriate measures to prevent the unauthorized disclosure of such Confidential Information. Notwithstanding the foregoing, each Party may disclose Confidential Information of the other Party to its directors, officers, employees, Affiliates and agents in connection with its activities pursuant to this Agreement. Each receiving Party shall ensure that each of the entities or persons to whom it discloses Confidential Information of the other Party as permitted under this Section 10.1 is aware of the receiving Party’s duty of confidentiality and non-use under this Agreement.

 

10.3. Exceptions. The confidentiality and non-use obligations under this Section 10 shall not apply to any information that (a) is or becomes a part of the public domain through no wrongful act or omission or breach of this Agreement on the part of the receiving Party, (b) is disclosed to the receiving Party by a Third Party having no obligation of confidentiality with respect thereto, or (c) is independently developed by the receiving Party without reference to the Proprietary Information of the disclosing Party. In addition, the receiving Party may disclose Proprietary Information as required (but only to the extent required) to comply with applicable laws, provided that the disclosing Party is given, if commercially reasonable, advance notice of such disclosure and, if commercially reasonable, the opportunity to limit its scope or seek a protective order or other relief.

 

CONFIDENTIAL Page 13

 

 

10.4. Terms of Agreement. Licensee acknowledges that Wilson is committed to grant licenses under the Wilson Licensed Patents to Third Parties on terms that do not discriminate against such Third Parties. Accordingly, Wilson shall be permitted to disclose the terms of this Agreement to any Third Party (including its financial and legal representatives) with which Wilson is negotiating a license to the Wilson Licensed Patents, provided that Wilson shall not disclose the name or other identifying information of Licensee when disclosing the terms of this Agreement. Notwithstanding the foregoing, either Party may publicly disclose that Licensee has been granted a. license under the Wilson Licensed Patents without further detail.

 

11. Miscellaneous

 

11.1. Waiver. Neither this Agreement nor any provision hereof may be waived without the prior written consent of the Party against whom such waiver is asserted. No delay or omission by either Party to exercise or assert any right or power shall impair any such right or power to be construed to be a waiver thereof. Consent by either Party to, or waiver of, a breach by the other Party shall not constitute consent to, waiver of, or excuse for any other different or subsequent breach.

 

11.2. Force Majeure. Neither Party shall be in default or liable for any loss or damage resulting from delays in performance or from failure to perform or comply with terms of this Agreement due to any unforeseeable, unavoidable and unpreventable causes, which causes include but are not limited to Acts of God; riots and insurrections; natural catastrophe; social unrest; war; fire; and military action.

 

11.3. Entire Agreement. This Agreement, and its Appendices, constitutes the entire and only agreement between the Parties with respect to the subject matter hereof and merges and supersedes all prior and contemporaneous oral or written discussions, negotiations, understandings, representations, warranties and agreements of the Parties.

 

11.4. Amendment. Any amendment or modification of any of, the provisions of this Agreement or any right, power or remedy hereunder shall not be effective unless made in writing and signed by duly authorized representatives of both Parties.

 

11.5. Drafting. This Agreement is considered to be jointly drafted and neither Party shall benefit from who actually drafted the Agreement.

 

CONFIDENTIAL Page 14

 

 

11.6. Severability. If any of the provisions of this Agreement is or becomes invalid, illegal or unenforceable, the validity, legality, and enforceability of any other provision of this Agreement shall in no way be affected or impaired thereby, and such invalid or unenforceable term, Section or provision shall be deemed deleted from this Agreement, and this Agreement shall continue in full force and effect. Should such case arise, the Parties shall negotiate in good faith a replacement but legally valid, term, Section or provision that best meets the intent of the Parties.

 

11.7. Independent Contractors. The relationship between Wilson and Licensee is that of independent contractors. Wilson and Licensee are not joint ventures, partners, principal and agent, master and servant, employer or employee, and have no other relationship other than independent contracting parties. Each Party is executing this Agreement solely on behalf of itself and its Affiliates and is not acting on behalf of, and does not represent, any other company or entity or any government agency. Nothing in this Agreement shall be construed as creating a partnership, joint venture, or other formal business organization of any kind.

 

11.8. Registration. Each Party agrees, upon reasonable request by the other Party, to consent to the registration of this Agreement to the extent required by the laws of the applicable jurisdiction requiring registration and subject always to the terms herein.

 

11.9. Counterparts. This Agreement may be executed in counterparts and each such counterpart shall be deemed an original thereof. Facsimile signatures or signatures delivered by e-mail in .pdf or similar format will be deemed original signatures for purposes of this Agreement.

 

11.10. Headings. The headings and sub-headings of the Sections are inserted for convenience or reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement.

 

11.11. Construction. The words “hereof,” “herein” and “hereunder” and words of like import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement, and Section references are to this Agreement unless otherwise specified. For the purpose of the construction and interpretation of this Agreement, the word “including” (and variations thereof such as “include” and “includes”) and the phrase “such as” will not be deemed to be terms of limitation, but rather will be deemed to be followed by the words “without limitation”.

 

[Remainder of page intentionally blank]

 

CONFIDENTIAL Page 15

 

 

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be signed by their duly authorized representatives and executed on the Date.

 

WILSON ELECTRONICS, LLC.   LICENSEE:  
         
Name: Bruce Lancaster   Name: Marc Seelenfreund
Signature: /s/ Bruce Lancaster   Signature: /s/ Marc Seelenfreund
Date: 11/30/17   Date: 11/30/17

 

[Signature Page to Patent License Agreement]

 

CONFIDENTIAL Page 16

 

 

APPENDIX A

 

WILSON LICENSED PATENTS

 

U.S. 7,409,186

 

U.S. 7,486,929

 

U.S. 7,221,967

 

U.S. 7,729,669

 

U.S. 7,783,318

 

U.S. 8,849,187

 

U.S. 8,538,033

 

U.S. 8,583,034

 

U.S. 8,639,180

 

U.S. 8,755,399

 

U.S. 8,874,029

 

U.S. 8,874,030

 

CONFIDENTIAL Page 17

 

 

EXHIBIT B

 

LICENSED PRODUCTS

 

SKU   Name
2003CPAL   Uniden® U2 4G Cellular Booster
003   Uniden® U2 Cellular Booster
004   Uniden® U4 Cellular Booster
2005CPAL   Uniden® U60 4G Cellular Booster
005   Uniden® U60 Cellular Booster
2005CP   Uniden® U60 Cellular Booster
2005VCPAL   Uniden® U60v 4G Cellular Booster
2006CPAL   Uniden® U65 4G Cellular Booster
006   Uniden® U65 Cellular Booster
2006CP   Uniden® U65 Cellular Booster
2006VCPAL   Uniden® U65v 4G Cellular Booster
2020CPALF   Uniden® U70 4G Cellular Booster
020   Uniden® U70 Cellular Booster
2020CP   Uniden® U70 Cellular Booster
2020CPAL   Uniden® U70i 4G Cellular Booster
2020VCPAL   Uniden® U70v 4G Cellular Booster
2080CPAL   Uniden® U80i 4G Cellular Booster
023   Uniden® UL20 Cellular Booster
2021CPAL   Uniden® UM50 4G Cellular Booster
021   Uniden® UM50 Cellular Booster
2021CP   Uniden® UM50 Cellular Booster
022   Uniden® UP20 Cellular Booster

 

 

CONFIDENTIAL Page 18

 

Exhibit 10.4

 

SIYATA MOBILE INC.

 

 

 

 

INCENTIVE STOCK OPTION PLAN

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Approved by the shareholders: June 17, 2015

 

Re-approved by the shareholders: September 16, 2016

 

 

 

 

SIYATA MOBILE INC.

 

STOCK OPTION PLAN

 

 

 

1. PURPOSE OF THE PLAN

 

The purpose of the Plan is to provide Eligible Persons with an opportunity to purchase Shares and to benefit from the appreciation in the value of the Shares. The Plan will provide an increased incentive for those individuals to contribute to the future growth, success and prosperity of the Company, thus enhancing the value of the Shares for the benefit of all of the Company’s shareholders and increasing the ability of the Company and any Affiliate to attract and retain skilled and motivated individuals.

 

2. INTERPRETATION

 

2.1. Definitions

 

In the Plan, the following terms shall have the following meanings:

 

“Associate” means an associate as defined in Exchange Policy 1.1 — Interpretation.

 

“Affiliate” has the meaning set out in the Corporations Act;

 

“Blackout Period” means an interval of time (i) when any trading guidelines of the Company, as amended from time to time, restrict Participants from trading in any securities of the Company because they may be in possession of confidential information; or (ii) when the Company has determined that one or more Participants may not trade any securities of the Company because they may be in possession of confidential information;

 

“Board” means the board of directors of the Company and any committee of the board of directors to which any or all authority, rights, powers and discretion with respect to the Plan has been delegated;

 

“Business Day” means a day that is not a Saturday, Sunday or a statutory or public holiday and any other day on which the banks are not regularly open for business in the jurisdiction where the Company has its head office;

 

“Cause” means any act, omission or course of conduct recognized as cause under applicable law, including, without limitation, embezzlement, theft, fraud, wilful failure to follow any lawful directive of the Company and wilful misconduct detrimental to the interests of the Company;

 

“Company” means Siyata Mobile Inc. and its successors;

 

“Consultant” means a person, company, partnership or other entity, other than an Employee, Officer or Director, that is engaged to provide on an ongoing basis, consulting, technical, management or other services (other than services in relation to a distribution) to the Company or an Affiliate of the Company under a written contract with the Company or an Affiliate of the Company, and otherwise meets the definition of “consultant” contained in NI 45-106 and Exchange Policy 4.4 — Incentive Stock Options, and includes, for an individual consultant, a company, partnership or other entity of which the individual consultant is an employee, shareholder or partner;

 

 

 

 

“Corporations Act” means the British Columbia Business Corporations Act, as amended or replaced from time to time;

 

“Director” means a director of the Company or an Affiliate of the Company;

 

“Disability” means any disability with respect to a Participant which the Board, in its sole and unfettered discretion, considers likely to permanently prevent the Participant from:

 

(a) being employed or engaged by the Company, an Affiliate of the Company or another employer, in a position the same as or substantially similar to that in which the Participant was last employed or engaged by the Company or an Affiliate of the Company;

 

(b) acting as a director or officer of the Company or an Affiliate of the Company or another company; or

 

(c) engaging in any substantial gainful activity by reason of any medically determinable mental or physical impairment that can be expected to result in death or that has lasted or can be expected to last a continual period of not less than 12 months;

 

“Disinterested Shareholders” means the shareholders of the Company, including holders of any non-voting and subordinate voting shares of the Company, but excluding:

 

(a) Insiders to whom Options may be issued under the Plan; and

 

(b) Associates of those Insiders;

 

“Discounted Market Price” means the “Market Price” as defined in Exchange Policy 1.1 — Interpretation, less the allowable discount under the policies of the Exchange;

 

“Eligible Person” means a bona fide Director, Officer, Employee, Consultant, and any “permitted assign” within the meaning of NI 45-106;

 

“Employee” means an employee (whether full-time or part-time) of the Company or an Affiliate of the Company within the meaning of Exchange Policy 4.4 — Incentive Stock Options, or a Management Company Employee;

 

“Exchange” means the TSX Venture Exchange or, if the Shares are not listed and posted for trading on the TSX Venture Exchange, the most senior stock exchange in Canada on which the Shares are listed and posted for trading;

 

2

 

 

“Exchange Hold Period” means the “Exchange Hold Period” as defined in Exchange Policy 1.1 — Interpretation;

 

“Expiry Date” means the date set by the Board under Section 3.1 of the Plan, as the last date on which an Option may be exercised by the Participant;

 

“Grant Date” means the date specified in an Option Agreement as the date on which an Option is granted;

 

“Insider” means:

 

(a) an insider as defined in the Securities Act, other than a person who is an insider solely by virtue of being a director or senior officer of an Affiliate; and

 

(b) an Associate of any person who is an insider under section (a);

 

“Investor Relations Activities” means investor relations activities as defined in Exchange Policy 1.1 — Interpretation;

 

“Management Company Employee” means an individual employed by a person providing management services to the Company which are required for the ongoing successful operation of the business enterprise of the Company, but excludes a person engaged in Investor Relations Activities;

 

“NI 45-106” means Canadian National Instrument 45-106 — Prospectus and Registration Exemptions;

 

“Officer” means an executive officer (as that term is defined in NI 45-106) of the Company or an Affiliate of the Company;

 

“Option” means an option to purchase Shares granted pursuant to the Plan;

 

“Option Agreement” means an agreement, in the form attached hereto as Schedule A, whereby the Company grants an Option to a Participant;

 

“Option Price” means the per Share exercise price specified in an Option Agreement to be paid to acquire Option Shares, adjusted from time to time in accordance with the provisions of Section 5;

 

“Option Shares” means the aggregate number of Shares which a Participant may purchase under an Option;

 

“Participant” means an Eligible Person granted an Option pursuant to the Plan and his or her heirs, executors and administrators and, subject to the policies of the Exchange, a Participant may also be a company wholly-owned by an individual eligible for an Option grant pursuant to the Plan;

 

3

 

 

“Plan” means this Siyata Mobile Inc. Stock Option Plan, as amended from time to time in accordance with the provisions hereof;

 

“Securities Act” means the Securities Act (British Columbia), as amended or replaced from time to time;

 

“Shares” means the Common Shares in the capital of the Company as constituted on the date of the Plan provided that, in the event of any adjustment pursuant to Section 5, “Shares” shall thereafter mean the shares or other property resulting from the events giving rise to the adjustment;

 

“Unissued Option Shares” means the number of Shares, at a particular time, which have been allotted for issuance upon the exercise of an Option but which have not been issued, as adjusted from time to time in accordance with the provisions of Section 5, such adjustments to be cumulative; and

 

“Vested” means that an Option has become exercisable in respect of a number of Option Shares by the Participant pursuant to the terms of the Option Agreement and the Plan.

 

2.2. Number and Gender

 

The Plan shall be read with all changes in number and gender required by the context.

 

2.3. Sections

 

A reference to a Section includes all subsections and paragraphs in that Section, unless the context otherwise requires.

 

2.4. Currency

 

Unless the context otherwise requires or the Board determines otherwise, all references to currency shall be to the lawful money of Canada.

 

3. GRANT OF OPTIONS AND ADMINISTRATION OF THE PLAN

 

3.1. Option Terms

 

The Board may from time to time authorize the grant of Options to Eligible Persons on the terms and subject to the conditions set out herein and any additional terms and conditions as are set out in the Option Agreement, all as determined by the Board in its sole and unfettered discretion. Notwithstanding the foregoing, if the Shares are, at the time of grant, listed and posted for trading on the Exchange:

 

(a) the Option Price under each Option shall be not less than the Discounted Market Price on the Grant Date or such other minimum price as may be required by the Exchange;

 

(b) the Expiry Date for each Option shall be set by the Board at the time of issue of the Option and shall not be more than ten years after the Grant Date, subject to extension in connection with a Blackout Period, as provided in Section 4.5; and

 

4

 

 

(c) Options shall not be assignable or transferable by the Participant, except to the extent necessary to enable Options that have Vested at the time of death of a Participant to be exercised by the legal personal representatives or beneficiary(ies) of the Participant as contemplated in Section 4.4(a).

 

For greater certainty, the Board shall not be permitted to amend the Option Price, and Options may not be re-priced, except as set out in Section 5 of the Plan 

   

3.2. Option Price at the Discounted Market Price

 

If required by the Exchange, the Option Price of an Option is the Discounted Market Price, such Option shall be subject to the Exchange Hold Period and any Option Shares issued under such Option prior to the expiry of the Exchange Hold Period shall be legended with the Exchange Hold Period commencing on the Grant Date of such Option, as follows (or with such other legend as may be required by the Exchange):

  

“Without prior written approval of the Exchange and compliance with all applicable securities legislation, the securities represented by this certificate may not be sold, transferred, hypothecated or otherwise traded on or through the facilities of the TSX Venture Exchange or otherwise in Canada or to or for the benefit of a Canadian resident until [insert the date immediately following the date which is four months after the Grant Date].”

 

3.3. Limits on Shares Issuable on Exercise of Options

 

Subject to Section 5.1,

 

(a) the maximum number of Shares that may be issuable pursuant to Options granted under the Plan shall be shall be a number equal to 10% of the number of issued and outstanding Shares;

 

(b) unless approved by a majority of the Disinterested Shareholders,

 

(i) the aggregate number of Shares issuable pursuant to Options granted to Insiders pursuant to the Plan and all of the Company’s other previously established and outstanding or proposed share compensation arrangements and grants may not exceed 10% of the issued and outstanding Shares on a non-diluted basis at any time;

 

(ii) the aggregate number of Shares issued to Insiders pursuant to the Plan and all of the Company’s other previously established and outstanding or proposed share compensation arrangements and grants within any 12 month period may not exceed 10% of the issued and outstanding Shares on a non-diluted basis; and

 

5

 

 

(iii) the aggregate number of Shares issuable to any one Participant pursuant to the Plan and all of the Company’s other previously established and outstanding or proposed share compensation arrangements and grants within any 12 month period may not exceed 5% of the issued and outstanding Shares on a non-diluted basis;

 

(c) the aggregate number of Shares issuable pursuant to Options granted to any one Consultant pursuant to the Plan and all of the Company’s other previously established and outstanding or proposed share compensation arrangements and grants within any 12 month period may not exceed 2% of the issued and outstanding Shares on a non-diluted basis; and

 

(d) the aggregate number of Shares issuable pursuant to Options granted to all Participants performing Investor Relation Activities pursuant to the Plan and all of the Company’s other previously established and outstanding or proposed share compensation arrangements and grants within any 12 month period may not exceed 2% in aggregate of the issued and outstanding Shares on a non-diluted basis.

 

3.4. Option Agreements

 

Each Option will be evidenced by the execution of an Option Agreement. Each Participant shall have the option to purchase from the Company the Option Shares at the time and in the manner set out in the Plan and in the Option Agreement applicable to that Participant. In the case of Options granted to Employees, Consultants or Management Company Employees, each Option Agreement will contain a representation of the Company and the Participant that the Participant is a bona fide Employee, Consultant or Management Company Employee, as the case may be. The execution of an Option Agreement shall constitute conclusive evidence that the grant of Options to the

Participant has been completed in compliance with the Plan.

 

3.5. Authority of the Board

 

Subject only to the express provisions of the Plan, the Board shall have, and hereby is specifically granted, the sole and unfettered authority to:

 

(a) grant Options to Eligible Persons;

 

(b) determine the terms, limitations, restrictions and conditions respecting Options;

 

(c) interpret the Plan and adopt, amend and rescind such administrative guidelines and other rules and regulations relating to the Plan, as it may from time to time deem advisable;

 

(d) authorize any officer or director to execute and deliver any Option Agreement, notice, commitment or document and to do any other act as contemplated by the Plan for and on behalf of the Company;

 

6

 

 

(e) make all other determinations and perform all other actions as the Board deem necessary or advisable to implement and administer the Plan; and

 

(f) subject to applicable law, delegate to the compensation committee or any other committee of the Board, on such terms as the Board in its discretion determines, all or any part of the authority of the Board hereunder to administer and implement the Plan.

  

3.6. Discretion of the Board

 

The determinations of the Board under the Plan (including, without limitation, determinations of who may receive grants of Options and the terms, limitations, restrictions and conditions respecting Options) need not be uniform and may be made by the Board selectively among Eligible Persons who receive, or are eligible to receive, grants of Options under the Plan, whether or not such Eligible Persons are similarly situated as to office, length of service, salary or any other factor. The Board may, in its discretion, authorize the grant of additional Options to a Participant before an existing Option has terminated.

 

3.7. Interpretation of the Plan

 

Except as set out in Section 5.4, the interpretation and construction of any provision of the Plan by the Board shall be final and conclusive. Administration of the Plan shall be the responsibility of the appropriate officers of the Company and the Company shall pay all costs in respect thereof. All guidelines, rules, regulations, decisions and interpretations of the Board respecting the Plan, any Option Agreement or the Options shall be binding and conclusive on the Company and on all Participants and their respective legal personal representatives.

 

3.8. Overriding Restrictions on Issue and Exercise

 

Notwithstanding anything else in this Plan or the terms of any Option, no Option may be offered, issued or exercised if to do so:

 

(a) would contravene the constating documents of the Company, the Securities Act, the Corporations Act or any policy of the Exchange; or

 

(b) would contravene the local laws or customs of a Participant’s country of residence or in the opinion of the Board would require actions to comply with those local laws or customs which are impractical.

 

4. EXERCISE OF OPTIONS

 

4.1. When Options May be Exercised

 

Subject to this Section 4, an Option may be exercised to purchase any number of Option Shares up to the number of Unissued Option Shares that have Vested at any time after the Grant Date up to 5 p.m. in the location where the Company has its head office on the Expiry Date, provided the Expiry Date is a Business Day and if the Expiry Date is not a Business Day, then the Expiry Date shall be deemed to fall on the next day that is a Business Day, and shall not be exercisable thereafter.

 

7

 

 

4.2. Manner of Exercise

 

The Options shall be exercisable by delivering, prior to the Expiry Date, to the Company at its head office, a written notice specifying the number of Option Shares in respect of which the Options are exercised together with payment in full of the Option Price for each such Option Share. All Option Shares subscribed for upon exercise of the Options shall be paid in full at the time of subscription. No fractional Shares may be purchased or issued hereunder.

 

4.3. Vesting of Options

 

With the exception of Options granted to a Consultant who performs Investor Relations Activities, all Options granted to a Participant under the Plan will become vested on the Grant Date, or at such other time as may be established by the Board at the time of the grant in compliance with requirements of the Exchange. For Options granted to a Consultant who performs Investor Relations Activities, the Board will, at the time of grant, determine the vesting date for such Options, provided that such Options must vest in stages over 12 months with no more than one-quarter of the Options vesting in any three month period.

 

4.4. Termination of Employment or Affiliation

 

If a Participant ceases to be an Eligible Person, the Participant’s Options shall be exercisable as follows:

 

(a) Death, Disability or Retirement. If the Participant ceases to be an Eligible Person due to his or her death, Disability or retirement in accordance with the Company’s retirement policy in force from time to time, or, in the case of a Participant that is a company, the death, Disability or retirement of the person who provides management or consulting services to the Company or to an Affiliate of the Company, the Options then held by the Participant shall be exercisable to acquire Unissued Option Shares that have Vested at the time of death, Disability or retirement at any time up to but not after the earlier of:

 

(i) 365 days after the date of death, Disability or retirement; and

 

(ii) the Expiry Date.

 

(b) Termination For Cause. If the Participant ceases to be an Eligible Person as a result of termination for Cause, any outstanding Options held by such Participant on the date of such termination, whether in respect of Option Shares that are Vested or not, shall be cancelled as of the date of delivery of written notice of termination (and specifically without regard to the date on which any period of reasonable notice, if any, would expire).

 

8

 

 

(c) Early Retirement, Voluntary Resignation or Termination Other than For Cause. If the Participant ceases to be an Eligible Person due to the Participant’s retirement or, in the case of a Participant that is a company, the retirement of the person who provides management or consulting services to the Company or to an Affiliate of the Company, at the request of his or her employer earlier than the normal retirement date under the Company’s retirement policy then in force, or due to the Participant’s voluntary resignation or due to the termination of the Participant’s employment by the Company for reasons other than Cause, the Options then held by the Participant shall be exercisable, subject to section (d), to acquire Unissued Option Shares that have Vested at the time of retirement, resignation or termination for reasons other than Cause, at any time up to but not after the earlier of:

 

(i) the Expiry Date;

 

(ii) twelve months after the Participant ceases active employment or engagement with the Company or an Affiliate of the Company; and

 

(iii) twelve months after the date of delivery of written notice of retirement, resignation or termination (and specifically without regard to the date any period of reasonable notice, if any, would expire),

 

provided that the Board shall have the discretion to increase the twelve-month period referred to in clause (ii) or (iii), above, as applicable, at any time for any period of time up to the Expiry Date.

 

(d) For greater certainty, unless the Board determines otherwise, an Option that had not become Vested in respect of any Unissued Option Shares at the time that the relevant events referred to in Sections 4.4(a) or 4.4(c) occurred, shall not be or become exercisable in respect of such Unissued Option Shares and shall be cancelled.

 

4.5. Blackout Periods

 

(a) No Option may be exercised during a Blackout Period.

 

(b) If the Expiry Date of an Option, or the deadline for exercising any Option set out in Section 4.4(a) or Section 4.4(c) falls within a Blackout Period or within two Business Days after the expiry of a Blackout Period, such Expiry Date or deadline shall be deemed to be extended by ten Business Days after the last day of the Blackout Period.

 

9

 

 

4.6. Effect of a Take-Over Bid

 

Notwithstanding Section 4.3, if:

 

(a) a bona fide takeover offer (an “Offer”) is made to the shareholders of the Company to acquire their Shares and the Board becomes aware that more than 50% of the issued Shares have or will become vested in the offeror and related and associated parties, then the Board shall notify each Participant in writing that all Options issued to the Participant have become Vested and may be exercised by the Participant with effect from the date of such notice and shall be exercisable by a date specified in the notice. Upon receipt of such notice, the Participant shall be entitled to exercise all or any of the Options, and any Participant who exercises any such Options shall tender the Shares that have been issued as a result to the Offer. If for any reason if Shares are taken up and paid for by the offeror under the Offer as and when required, then the Shares that have been issued in pursuance of this paragraph (a) shall be returned by the relevant Participant to the Company and reinstated as authorized but Shares, the Option with respect to such returned Shares shall be reinstated as if it had not been exercised and the terms for the vesting of the Options shall be reinstated, and the Corporation shall immediately refund the exercise price paid for the issuance of any Shares upon the exercise of any Option under this paragraph (a) to the Option holder, without interest;

 

(b) the Board concludes that there has been such a change in the control of issued Shares of the Company that the replacement of the majority of the Board is imminent or the Board becomes aware that any person or corporation who is not already so entitled has become entitled to more than 50% of the issued Shares, then the Board shall notify each Participant in writing that all Options issued to the Participant have become Vested and may be exercised by the Participant with effect from the date of the notice and shall be exercisable by a date specified in the notice. Upon receipt of such a notice, the Participant shall be entitled to exercise all or any of the Options.

 

4.7. Acceleration of Expiry Date

 

If at any time when an Option granted under the Plan remains unexercised with respect to any Unissued Option Shares an Offer is made by an offeror, the Board may, upon notifying each Participant of full particulars of the Offer, declare that all Options granted under the Plan have become Vested and accelerate the Expiry Date for the exercise of all unexercised Options granted under the Plan so that all Options will either be exercised or expire prior to the date upon which Shares must be tendered pursuant to the Offer.

 

4.8. Exclusion from Severance Allowance, Retirement Allowance or Termination Settlement

 

If the Participant retires, resigns or is terminated from employment or engagement with the Company or an Affiliate, the loss or limitation, if any, pursuant to the Option Agreement with respect to the right to purchase Option Shares which were not Vested at that time or which, if Vested, were cancelled, shall not give rise to any right to damages and shall not be included in the calculation of nor form any part of any severance allowance, retiring allowance or termination settlement of any kind whatsoever in respect of such Participant.

 

10

 

 

4.9. Shares Not Acquired

 

Any Unissued Option Shares not acquired by a Participant under an Option which have expired or have been cancelled may be made the subject of a further Option grant pursuant to the provisions of the Plan.

 

4.10. Right to Participate in New Issues

 

To the extent that shareholders of the Company are entitled to participate in new issues of Shares, a Participant, with respect to Vested Options held by such Participant, shall not be entitled to participate in respect of such Vested Options, unless such Participant first exercises the Vested Options in accordance with the terms of the Plan prior to the record date of such offering, whereby the Participant will be entitled to participation by virtue of the Shares held by such Participant.

 

4.11. Quotation or Listing

 

(a) The Company will not seek the official quotation or listing of any Options.

 

(b) The Company will apply to the Exchange for official quotation or listing of Shares issued on the exercise of Options.

 

5. ADJUSTMENT OF OPTION PRICE AND NUMBER OF OPTION SHARES

 

5.1. Share Reorganization

 

If the Company issues Shares to all or substantially all holders of Shares by way of a stock dividend or other distribution, or subdivides all outstanding Shares into a greater number of Shares, or combines or consolidates all outstanding Shares into a lesser number of Shares (each of such events being a “Share Reorganization”), then effective immediately after the effective date for such Share Reorganization for each Option:

 

  (a) the Option Price will be adjusted to a price per Option Share which is the product of:

 

(i) the Option Price in effect immediately before the effective date for the Share Reorganization; and

 

(ii) a fraction the numerator of which is the total number of Shares outstanding on the effective date of the Share Reorganization before giving effect to the Share Reorganization, and the denominator of which is the total number of Shares that are or would be outstanding on the effective date of the Share Reorganization after giving effect to the Share Reorganization; and

 

(b) the number of Unissued Option Shares will be adjusted by multiplying (i) the number of Unissued Option Shares immediately before the effective date of the Share Reorganization by (ii) a fraction which is the reciprocal of the fraction described in section 5.1(a)(ii). Subject to any provisions with respect to rounding of entitlements as sanctioned by the meeting, if any, of shareholders approving a Share Reorganization, in all other respects the terms for the exercise of Options shall remain unchanged notwithstanding the reorganization.

 

11

 

  

5.2. Special Distribution

 

Subject to the prior approval of the Exchange if the Company is listed on the Exchange at the relevant time, if the Company issues by way of a dividend or otherwise distributes to all or substantially all holders of Shares:

 

(a) shares of the Company, other than Shares;

 

(b) evidences of indebtedness;

 

(c) any cash or other assets, excluding cash dividends (other than cash dividends which the Board has determined to be outside the normal course); or

 

(d) rights, options or warrants,

 

then to the extent that such dividend or distribution does not constitute a Share Reorganization (any of such non-excluded events being a “Special Distribution”), and effective immediately after the record date at which holders of Shares are determined for purposes of the Special Distribution, for each Option the Option Price will be reduced, and the number of Unissued Option Shares will be correspondingly increased, by such amount, if any, as is determined by the Board in its sole and unfettered discretion to be appropriate in order to properly reflect any diminution in value of the Shares as a result of such Special Distribution.

 

5.3. Corporate Reorganization

 

Whenever there is:

 

(a) a reclassification of outstanding Shares, a change of Shares into other shares or securities, or any other capital reorganization of the Company, other than as described in sections 5.1 or 5.2;

 

(b) a consolidation, merger or amalgamation of the Company with or into another Company resulting in a reclassification of outstanding Shares into other shares or securities or a change of Shares into other shares or securities; or

 

(c) a transaction whereby all or substantially all of the Company’s undertaking and assets become the property of another Company,

 

(any such event being a “Corporate Reorganization”)

 

the Participant will have an option to purchase (at the times, for the consideration and subject to the terms and conditions set out in the Plan and the Option Agreement) and will accept on the exercise of such option, in lieu of the Unissued Option Shares which the Participant would otherwise have been entitled to purchase, the kind and amount of shares or other securities or property that the Participant would have been entitled to receive as a result of the Corporate Reorganization if, on the effective date thereof, the Participant had been the holder of all Unissued Option Shares or, if appropriate, as otherwise determined by the Board.

 

12

 

 

5.4. Determination of Option Price and Number of Unissued Option Shares

 

If any questions arise at any time with respect to the Option Price or number of Unissued Option Shares deliverable upon exercise of an Option following a Share Reorganization, Special Distribution or Corporate Reorganization, such questions shall be conclusively determined by the Board in its sole and unfettered discretion, and in arriving at a decision, the Board may consult such professional advisors as it deems necessary.

 

5.5. Compliance with Regulatory Authorities

 

Notwithstanding Sections 5.1, 5.2 or 5.3, in the event of any reorganization (including, without limitation, consolidation, sub-division, reduction or return of the issued capital of the Company) on or prior to the Expiry Date, the rights of the Participant will be changed to the extent necessary at the time of such reorganization, in such manner as determined by the Board, to ensure compliance with the policies of the Exchange that apply to a reorganization of capital at the time of such reorganization. For greater certainty, any adjustment to the Option Price or the number of Unissued Option Shares purchasable under the Plan pursuant to the operation of any one of Sections 5.1, 5.2 or 5.3 is subject to the approval of the Exchange, if applicable, and any other governmental authority having jurisdiction.

 

6. MISCELLANEOUS

 

6.1. No Right to Employment

 

Neither the Plan nor any of the provisions hereof shall confer upon any Participant any right with respect to employment, engagement or appointment or continued employment, engagement or appointment with the Company or any Affiliate or interfere in any way with the right of the Company or any Affiliate to terminate such employment, engagement or appointment.

 

6.2. Related Rights and Other Benefit Plans

 

No Participant shall have any of the rights of a shareholder of the Company with respect to any Option Shares (including, without limitation, voting rights or any right to receive dividends, warrants or rights under any rights offering) until the Participant has made full payment to the Company upon exercise of the Option and such Option Shares have been issued to such Participant. Participation in the Plan shall not affect an Eligible Person’s eligibility to participate in any other benefit plan or incentive plan of the Company. The grant of any Option pursuant to the Plan shall not obligate the Company to make any benefit available to an Eligible Person under any other plan of the Company unless otherwise specifically provided for in such plan.

 

13

 

 

6.3. Necessary Approvals

 

If required by the Exchange, the Plan shall be subject to the approval of the shareholders of the Company at each annual general meeting of the Company. The obligation of the Company to sell and deliver Option Shares in accordance with the Plan is subject to the approval of the Exchange, if applicable, and any other regulatory body having authority over the Company, the Plan or the shareholders of the Company. If any Option Shares cannot be issued to any Participant for any reason, including, without limitation, the failure to obtain such approval, then the obligation of the Company to issue such Option Shares shall terminate and the Company shall immediately refund to the Participant any Option Price paid by the Participant to the Company.

 

6.4. Income Taxes

 

As a condition of and prior to participation in the Plan, each Participant authorizes the Company to withhold from any amount otherwise payable to the Participant any amounts required by any taxing authority to be withheld for taxes of any kind as a consequence of the Participant’s participation in the Plan or issuance of Option Shares. The Company may, prior to and as a condition of issuing any Option Shares, require the Participant to pay to the Company in cash or such other consideration as the Board, in its discretion, may accept, such amount as the Company is obliged to remit in accordance with applicable tax laws and the requirements of any taxing authority having jurisdiction in respect of any such issuance of Option Shares. The Company shall also have the right in its sole discretion to satisfy any such liability for withholding or other required deduction amounts to require the Participant to complete a sale in respect of such number of Option Shares that have been issued and would otherwise be delivered to the Participant under the Plan, and any amount payable from such sale will first be paid to the Company to satisfy any liability for withholding. The Company may require a Participant, as a condition of participation in the Plan, to pay or reimburse the Company for any cost incurred by the Company as a result of the participation by the Participant in the Plan.

 

6.5. Amendments to the Plan

 

(a) The Board may from time to time, subject to applicable law and to the prior approval, if required, of the Exchange or any other regulatory body having authority over the Company, the Plan or the shareholders of the Company, suspend, terminate or discontinue the Plan at any time.

 

(b) The Board may amend or revise the terms of the Plan or of any Option granted under the Plan and the Option Agreement relating thereto at any time without the consent of the Participants provided that such amendment shall:

 

(i) not adversely alter or impair any Option previously granted except as permitted by the adjustment provisions of Section 5;

 

14

 

  

(ii) be subject to any regulatory approvals including, where required, the approval of the Exchange; and

 

(iii) be subject to shareholder approval where required by law or the requirements of the Exchange, provided that shareholder approval shall not be required for the following amendments and the Board may make any changes which may include but are not limited to:

 

A. amendments of a typographical, grammatical, clerical or administrative nature or which are required to comply with regulatory requirements;

 

B. a change to the vesting provisions of the Plan or any Option;

 

C. a change to the termination provisions of any Option that does not entail an extension beyond the original Expiry Date (as such date may be extended by virtue of Section 4.5); and

 

D. a change to the Eligible Persons of the Plan.

 

(c) Notwithstanding this Section 6.5, the Board shall not be permitted to amend the Option Price except as set out in Section 5. If the Plan is terminated, the provisions of the Plan and any administrative guidelines and other rules and regulations adopted by the Board and in force on the date of termination will continue in effect as long as any Option or any rights pursuant thereto remain outstanding and, notwithstanding the termination of the Plan, the Board shall remain able to make such amendments to the Plan or the Options as they would have been entitled to make if the Plan were still in effect.

 

(d) Without obtaining the prior approval of the shareholders of the Company and of the Exchange or any other regulatory body having authority over the Company, the Board will not be entitled to:

 

(i) increase the maximum percentage of Shares issuable by the Company pursuant to the Plan;

 

(ii) extend the Expiry Date;

 

(iii) make a change to the class of eligible participants which would have the potential of broadening or increasing participation by Insiders;

 

(iv) provide any form of financial assistance to Participants for the purchase of Option Shares; or

 

(v)

add a deferred or restricted share unit or any other provision which results in a Participant receiving Shares

when no cash consideration is received by the Company.

 

15

 

 

(e) Without obtaining the prior approval of the Disinterested Shareholders and of the Exchange or any other regulatory body having authority over the Company, the Board will not be entitled to amend the terms of Options held by an Insider (including, for greater certainty, to effectively reduce the Option Price).

 

6.6. Form of Notice

 

Any notice to be given to the Company pursuant to the provisions of the Plan shall be addressed to the Company to the attention of its President at the Company’s head office, and any notice to be given to a Participant shall be delivered personally or addressed to the Participant at the address set out in the Option Agreement, or at such other address as such Participant may hereafter designate in writing to the Company. Any such notice shall be deemed duly given when made in writing and delivered to the Company or the Participant, as the case may be, or if mailed, then on the fifth business day following the date of mailing such notice in a properly sealed envelope addressed as aforesaid, registered or certified mail, postage prepaid.

 

6.7. No Representation or Warranty

 

The Company makes no representation or warranty as to the future market value of the Shares or with respect to any income tax matters affecting the Participant resulting from the grant or exercise of an Option and/or transactions in the Option Shares. Neither the Company, nor any of its directors, officers or employees are liable for anything done or omitted to be done by such person or any other person with respect to the price, time, quantity or other conditions and circumstances of the purchase or sale of Option Shares hereunder, with respect to any fluctuations in the market price of Shares or in any other manner related to the Plan.

 

6.8. Compliance with Applicable Law

 

If any provision of the Plan or any Option Agreement contravenes any law applicable or any order, policy, by-law or regulation of the Exchange or any other regulatory body having authority over the Company, the Plan or the shareholders of the Company, then such provision shall be deemed to be amended to the extent required to bring such provision into compliance therewith.

 

6.9. No Assignment

 

No Option shall be assignable or transferable by the Participant and any purported assignment or transfer of an Option shall be void and shall render the Option void, provided that in the event of death of the Participant, a Participant’s legal personal representative may exercise the Option in accordance with Section 4.4.

 

6.10. Other Incentive Schemes

 

The Company is not restricted to using the Plan as the only method of providing incentive rewards to Eligible Persons. The Company may approve other incentive schemes. Participation in the Plan does not affect, and is not affected by, participation in any other incentive or other scheme of the Company unless the terms of that incentive or scheme provide otherwise.

 

16

 

  

6.11 . Conflict

 

In the event of any conflict between the provisions of the Plan and an Option Agreement, the provisions of the Plan shall govern.

 

6.12. Governing Law

 

The laws of the Province of British Columbia shall govern the Plan and each Option Agreement issued pursuant to the Plan.

 

6.13. Time of Essence

 

Time is of the essence of the Plan and of each Option Agreement. No extension of time will be deemed to be, or to operate as, a waiver that time is to be of the essence.

 

6.14. Entire Agreement

 

The Plan and the Option Agreement sets out the entire agreement between the Company and the Participants relative to the subject matter hereof and supersedes all prior agreements, undertakings and understandings, whether oral or written.

 

 

17

 

Exhibit 10.5

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 
 

 

 

 

Exhibit 10.6

 

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

 

THIS AMENDED AND RESTATED AGREEMENT dated as of the 1st day of July, 2018.

 

BETWEEN:

 

SIYATA MOBILE INC., a corporation incorporated under the laws of the Province of British Columbia having its head office at Suite A-414, 1001 St. Lenoir Street, Montreal, QC H4C 2Z6

 

(“Siyata” or the “Company”)

 

AND:

 

GERALD BERNSTEIN, of 6080 David Lewis, Montreal, QC H3X 4A3

 

(“Employee”)

 

WHEREAS:

 

A. Siyata and the Employee entered into an employment effective June 6, 2016 (the “Original Employment Agreement”) whereby Siyata employed the Employee as its Chief Financial Officer;

 

B. Siyata and the Employee wish to make certain amendments to the terms of the Original Employment Agreement pursuant to the terms of this Agreement, which Agreement shall restate and supersede all prior agreements relating to the subject matter hereof;

 

NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the promises, covenants, agreements and payments herein contained, the parties hereto agree as follows:

 

Position

 

1. Subject to any approval of the TSX Venture Exchange, Siyata wishes to employ Employee as the Company’s Chief Financial Officer, and Employee agrees to serve Siyata in such capacities, upon the terms and subject to the conditions contained herein.

 

Duties

 

2. Employee shall diligently and faithfully devote such time and effort to the provision of services to Siyata hereunder as are necessary to efficiently and competently perform the services required by this Agreement and the discharge of his duties hereunder. Employee shall report to the Chief Executive Officer, or such other person as may be determined by Siyata from time to time.

 

 

 

 

Remuneration

 

3. Unless otherwise agreed by the parties, Siyata shall pay to Employee and he shall be entitled to receive a gross annual salary of $140,000 (the “Annual Salary”). The Annual Salary shall be payable in arrears in equal bi-weekly instalments, subject to deductions required by law. This remuneration shall commence on the hiring date. The hiring date shall be defined as of June 6th, 2016.

 

4. The Board will undertake a review of the Annual Salary at least once every year. Increases in the Annual Salary will not be automatic but will be made solely at the discretion of the Board in consultation with the Chief Executive Officer. Increases to the Annual Salary, if any, will be based on such factors as the Board and the Chief Executive Officer considers relevant.

 

Change of Control

 

5. If this Agreement is terminated by the Company, other than pursuant to Section 14(c) of this Agreement, or if the Contractor is constructively dismissed at any point within 6 (six) months of the occurrence of a Change of Control (as that term is defined in Section 6) then, in such circumstance:

 

(a) the Company shall pay the Employee an amount equal to two (2) years’ Annual Salary (as defined above); and

 

(b) if the Employee holds any options, rights, warrants, or other entitlements for the purchase or acquisition of securities in the capital of the Company (collectively, the “Options”), regardless of whether such Options are then exercisable in accordance with the terms thereof and notwithstanding the terms and conditions of such Options or of any plan or other document affecting such Options, all of such Options shall thereupon be immediately fully vested and any unexercised portion of such Options shall thereafter be exercisable by the Employee.

 

6. For the purposes of this agreement, a “Change of Control” means any of the following:

 

(a) at least 50% of the fair-market value of all the assets of the Company are sold;

 

(b) there is direct or indirect acquisition by a person or group of persons (excluding the Employee or any person associated with the Employee) acting jointly or in concert of voting securities of the Company (as defined in the Securities Act (British Columbia) and as the same may be amended from time to time and any successor legislation thereto) that when taken together with any voting securities owned directly or indirectly by such person or group of persons at the time of the acquisition, constitute 20% or more of the outstanding voting securities of the Company;

 

(c) a majority of the then-incumbent Board of Directors’ nominees for election to the Board of Directors of the Company are not elected at any annual or special meeting of shareholders of the Company;

 

(d) a liquidation, dissolution or winding-up of the Company; or

 

(e)

the amalgamation, merger or arrangement of the Company with or into another entity where the shareholders of the Company immediately prior to the transaction will hold less than 51% of the voting securities of the resulting entity upon completion of the transaction;

 

but does not include any transaction that may occur between the Company, any affiliate or subsidiary of the Company or, as applicable, any person associated with the Company or any affiliate or subsidiary of the Company, which, but for such relationship the transaction would otherwise constitute a Change of Control hereunder.

 

- 2 -

 

 

Incentive Stock Options and Bonuses

 

7. Employee shall be eligible for an annual bonus, to be determined by the compensation committee of the Board, in its sole discretion.

 

8. Upon execution of this agreement the Employee will receive a grant of 360,000 stock options under the Company’s security based compensation arrangements. The options will vest quarterly in twelve equal tranches of 30,000 options over three years from the date of the grant. Notwithstanding the forgoing, if at any time the Employee is terminated by the Company in accordance with section 14(c), 60,000 stock options will vest immediately. All stock options are governed by the terms of the Company’s stock option plan.

 

Expenses

 

9. Siyata shall reimburse Employee for all reasonable business related expenses incurred by Employee in the course of performing his duties hereunder, provided that such expenses are supported by proper statements or vouchers supplied to Siyata including but not limited to travel and entertainment expenses. Any expenditures (in excess of $1,000) including all related expenses must be approved in advance by the CEO.

 

Benefits

 

10. Siyata may establish employee benefit plans for its employees and, in that event, Employee shall be entitled to participate in such benefit plans on the same basis as the other employees at his level, subject to the terms and conditions of the benefit plan policies.

 

11. Employee is entitled to a reimbursement of car expenses incurred for business purposes. Said reimbursement of car expenses shall not exceed $1,000 per month based on an average to be calculated semi-annually (i.e. It is possible that in any given month expenses may exceed $1,000 however a semi-annual reconciliation shall be performed to ensure the cumulative amount does not exceed $6,000 in a six momth period).

 

12. Siyata will pay the Employee’s licensing and insurance fees in connection with his membership as a certified public accountant. The Company will also pay for training courses which are reasonably required to allow the Employee to remain a certified public accountant in good standing.

 

Vacation

 

13. Employee shall be entitled to 4 (four) weeks’ vacation with pay in each year, in addition to statutory holidays. All such vacation time shall be taken by Employee at times mutually agreeable to Siyata and Employee. Any unused vacation in any year may not be carried forward, but unused vacation pay shall be paid out on the next payroll date following the year end.

 

- 3 -

 

 

Termination

 

14. Siyata may terminate Employee’s employment hereunder as follows:

 

(a) at any time for Just Cause without any prior notice or compensation;

 

(b) in the event of the death of Employee, immediately and without any notice or compensation; or

 

(c) at any time upon payment by Siyata to Employee of a lump sum reflecting the greater of: (i) payments equal to 90 days and benefits; and (ii) such amounts Employee is entitled to under applicable legislation.

 

“Just Cause” as used herein, shall mean: (i) a material violation by the Employee of the Employee’s obligations hereunder, or a written directive from either the Chairman of the Board, the Board or the Company’s Chief Executive Officer which directive is lawful and consistent with the position and duties of the Employee as herein described, (A) which is willful and deliberate on the Employee’s part, and (B) which either has not been cured by the Employee or does not cease within fifteen (15) days after receipt by the Employee of notice to the Employee specifying the nature of such violations, or is, in the reasonable discretion of the Board, not curable; (ii) an act or acts of dishonesty on the Employee’s part which are intended to, or do, result in either the Employee’s personal enrichment or material adverse affects upon the Company’s assets, business, prospects, or reputation, provided however, as a matter of clarity, no act of the Employee conducted in good faith which is consistent with his position and duties but which coincidentally negatively affects the Company’s assets, business, prospects or reputation shall constitute an act of “dishonesty” under this subpart (ii); or (iii) a conviction of a felony or a misdemeanor involving fraud, breach of trust, or misappropriation.

 

15. The Employee may terminate his employment hereunder at any time on thirty days notice in writing to Siyata.

 

Confidential Information

 

16. For the purposes of this Agreement, the term “Confidential Information and Materials” includes all information and material presently belonging to, used by, or in the possession of Siyata and any of its subsidiaries (the “Subsidiaries”) relating to any its business, products or intellectual property in which it or its Subsidiaries have an interest, or relating to the business and affairs of Siyata and the Subsidiaries. The term “Confidential Information and Materials” also includes any confidential commercial, financial or technical information relating to the business of Siyata and any of its Subsidiaries.

 

17. Employee acknowledges that all of the Confidential Information and Materials are, and will continue to be, the exclusive property of Siyata, whether or not prepared in whole or in part by Employee and whether or not disclosed or entrusted to the custody of Employee or obtained by Employee.

 

18. Employee will not disclose, except as required by law, any Confidential Information and Materials, in whole or in part, to any person or other entity, for any reason or purpose whatsoever, unless first authorized to do so by Siyata. Subject to section 17, Employee will not use the Confidential Information and Materials of Siyata for his own purpose or for the benefit of any other person or entity except Siyata, whether such consists of duplication, removal, oral use or disclosure, the transfer of any Confidential Information and Materials in any manner, or any other unauthorized use.

 

- 4 -

 

 

Return of Siyata Property

 

19. Upon termination of this Agreement, for whatever reason, Employee will immediately surrender to Siyata all of Siyata’s property, documents (whether in written or electronic form) and all copies thereof, including, without limiting the foregoing, all financial accounts, records, plans, libraries, data bases or any other property or things of value in his possession or in the possession of any person or other entity under his control which in any way relate, directly or indirectly, to any Confidential Information and Materials or to the business or operations of Siyata and its Subsidiaries.

 

20. The provisions of sections 16, 17, 18, and 19 will continue to be binding upon Employee for a period of twelve months following the date of termination of this Agreement.

 

Notice

 

21. Any notice, demand or other communication (in this section, a “notice”) required or permitted to be given or made pursuant to the terms and conditions of this Agreement shall be in writing and shall be sufficiently given or made if:

 

(a) delivered in person during normal business hours on a business day and left with a receptionist or other responsible employee of the addressee at the applicable address set forth above; or

 

(b) sent by facsimile transmission, charges prepaid and confirmed by prepaid first class mail

 

in each case addressed to the relevant party as set forth on the first page of this Agreement. Each notice sent in accordance with this section shall be deemed to have been received on the day of delivery, if delivered as aforesaid and, if sent by facsimile transmission, on the date of sending if sent during normal business hours of the addressee on a business day and, if not, on the first business day thereafter. Any party may change its address for notice by giving notice to the other party in accordance with this section.

 

Successors and Assigns

 

22. This Agreement enures to the benefit of and is binding upon the parties hereto and their respective heirs, personal representatives and successors, and permitted assigns.

 

Waiver

 

23. The waiver by Employee or by Siyata of the breach of any provision of this Agreement will not operate or be construed as the waiver of any subsequent breach by Employee or by Siyata.

 

- 5 -

 

 

Severability

 

24. Each provision of this Agreement constitutes a separate covenant. If any provision of this Agreement is held by a Court to be unenforceable or invalid, such unenforceability or invalidity will not affect the enforceability or validity of the remaining provisions of this Agreement and this Agreement will be interpreted as if such unenforceable or invalid provisions were not contained herein.

 

Entire Agreement

 

25. This Agreement contains the entire agreement between Employee and Siyata, supersedes any prior agreements and any other representations or discussions and may only be amended in writing signed by the parties.

 

Governing Law

 

26. This Agreement shall be governed by and construed in accordance with the laws of the Province of British Columbia and the parties irrevocably attorn to the jurisdiction of the Courts of British Columbia.

 

Time

 

27. Time is of the essence of this Agreement.

 

Execution in Counterparts

 

28. This Agreement may be signed in counterparts, each of which so signed shall be deemed to be an original, and such counterparts together shall constitute one and the same instrument.

 

Independent Legal Advice

 

29. Siyata and Employee acknowledge that they understand the terms of this Agreement and acknowledge that the terms are mutually fair and equitable and that they have executed this Agreement voluntarily and of their own free will. Employee acknowledges that Siyata’s solicitors have prepared this Agreement but that he has been provided with the opportunity to obtain and has obtained independent legal advice before executing this Agreement.

 

Currency

 

30. All dollar amounts in this agreement refer to Canadian Dollars.

 

- 6 -

 

 

IN WITNESS WHEREOF the parties hereto have executed this Agreement as of the day and year first above written.

 

SIYATA MOBILE INC.    
       
Per:    
       

SIGNED BY GERALD BERNSTEIN in the presence of

   
     
/s/ Sean Timstt   /s/ Gerald Bernstein
Witness Signature   GERALD BERNSTEIN
     
Name: SEAN TIMSTT    
(please Print) 11 Hillside Ave    
Address: #208 Montreil,    
  Qubec. H32IV8    

 

 

 

 

 

Exhibit 10.7

 

CONSULTING AGREEMENT

 

THIS AGREEMENT made this 26th day of November, 2018.

 

AMONG:

 

SIYATA MOBILE INC., of Suite A-414, 1001 Lenoir Street, Montreal, QC H4C 2Z6

 

(the “Company”)

 

AND:

 

GLENN KENNEDY SALES AGENCY

 

(the “Consultant”)

 

AND:

 

GLENN KENNEDY, of 134 Don Head Village Boulevard, Richmond Hill, ON L4C 7P4

 

(the “Service Provider”)

 

WHEREAS the Company desires to retain the Consultant to assist in the ongoing business operations of the Company, and to have the Consultant, through the Service Provider, serve as the Company’s Vice President of Sales, North America under this Consulting Agreement.

 

AND WHEREAS the Consultant and the Company wish to confirm the terms and conditions of the Consultant’s retainer.

 

THEREFORE in consideration of the covenants and agreements herein, and for other good and valuable consideration given by each party hereto to the other, the receipt and sufficiency of which are hereby acknowledged by each of the parties, the parties hereby agree as follows:

 

1. CONSULTING ARRANGEMENT

 

1.1 Position. As of the Effective Date (as defined in section 1.3), the Company shall engage the Consultant for the Term (as defined in Section 1.3), to render services in such capacities as the Company may reasonably request. The Consultant shall have such responsibilities, powers and duties relating to all sales activities in North America of the Company’s overall product line and such other duties as determined by the Company, from time to time. In this role, the Consultant will make available to the Company, the services of the Service Provider, as Vice President of Sales, North America. The Service Provider will report directly to the CEO. The Consultant through the Service Provider, shall devote his full working time and efforts to the business and affairs of the Company. The Company shall act in good faith with respect to the Consultant and the Company’s obligations hereunder and shall in no way create obstacles to the Consultant’s ability to perform its duties.

 

 

 

 

1.2 Independent Contractor. The Consultant’s relationship with the Company shall be that of an independent contractor and not that of an employee. Accordingly, the Consultant will not be eligible for any employee benefits, other than as specifically provided for herein, nor will the Company make deductions from payments, if any, made to the Consultant for taxes, all of which will be the Consultant’s responsibility. The Consultant agrees to indemnify and hold the Company harmless from any liability for, or assessment of, any such taxes imposed on the Company by relevant taxing authorities. The Consultant shall have no authority to enter into contracts that bind the Company or create obligations on the part of the Company or direct employees or officers of the Company or otherwise manage or direct the business or affairs of the Company. The Consultant does not have any supervisory, management or fiduciary obligations whatsoever.

 

1.3 Term. The term of this Agreement (the “Term”) shall commence on January 1, 2019 (the “Effective Date”) and shall continue for 2 years, or until this Agreement is terminated in accordance with Section 3. The Company recognizes the Effective Date as the Consultant’s start date for services rendered for calculating all entitlements pursuant to this Agreement. The Term can be extended by mutual agreement.

 

2. COMPENSATION

 

2.1 Fee. As compensation for the services to be rendered to the Company pursuant to this Agreement, the Company shall pay to the Consultant during the Term a per annum fee (the “Base Fee”) and certain commissions (the “Commissions”) as more fully described in Schedule “A” attached hereto.

 

2.2 Business Expenses. The Company shall pay for and/or reimburse the Consultant for reasonable pre-approved: (i) International Travel Expenses (as defined herein) actually incurred or paid by the Consultant in the performance of the Consultant’s services under this Agreement, and which expenses are standard and customary within the industry and consistent with the Company’s policies in effect from time to time with respect to such International Travel and other business expenses, upon presentation of expense statements or vouchers or such other supporting documentation as it reasonably imposes on all executive level employees. “International Travel Expenses” shall include any expenses incurred by the Consultant in performance of the Consultant’s services under this Agreement when outside of Canada. Effective as of the Effective Date and during the Term of this Agreement, the Company shall pay the Consultant a monthly allowance of up to $2,000 per month (the “Monthly Allowance”) to be used for Canadian travel expenses and business expenses incurred by the Consultant in carrying out its responsibilities under this Agreement. For greater certainty, such business expenses shall include home office expenses, supply expenses and telecom expenses. The Monthly Allowance may be reduced by any payments made directly by the Company regarding any of the aforementioned expenses.

 

2.3 Temporary Suspension of Services. The Consultant shall be entitled to temporarily suspend its provision of services hereunder for not more than thirty (30) days per every twelve (12) month period commencing on the Effective Date without any diminution in the Base Fee. Unused suspension of service time may not be brought forward from year to year.

 

3. TERMINATION OF AGREEMENT

 

3.1 Termination by Consultant. The Consultant may terminate this Agreement by giving not less than 90 calendar days’ written notice of termination. At the time the Consultant provides the Company with notice of termination, or at any time thereafter, the Company shall have the right to elect to terminate the Consultant’s services at any time prior to the effective date of the Consultant’s termination. Upon the effective date of the termination, the Company shall not be obligated to make any further payment or provide any further benefit to the Consultant, except for amounts which were payable up to and including the date of termination.

 

2

 

 

3.2 Termination by the Company for Cause. The Company may terminate this Agreement at any time, without notice, as a result of actions taken by the Consultant or the Service Provider, which would constitute cause under applicable employment law. If this Agreement is terminated for cause, no notice, payments or allowances shall be provided to the Consultant thereafter or as a result of such termination except for those amounts which were payable up to and including the date of effective termination, and the Consultant will have no claim for any other form of compensation or damages. Stock Options shall immediately expire, notwithstanding section 2.2 above.

 

3.3 Termination by the Company without Cause. In addition to section 3.2 above, the Company may terminate the Agreement without cause, by giving not less than 90 calendar days’ written notice of termination. in which case no notice, payments or allowances shall be provided to the Consultant thereafter or as a result of such termination except for those amounts which were payable up to and including the date of effective termination, and the Consultant will have no claim for any other form of compensation or damages.

 

3.4 Termination by Death or Permanent Incapacity. The Company’s obligation to the Consultant and the Consultant’s obligations to the Company pursuant to this Agreement shall terminate upon the death or permanent incapacity of the Service Provider. For the purposes of this section, the Service Provider shall be deemed to have suffered permanent incapacity when he suffers from any illness or injury that prevents him from performing its usual duties for a period of two consecutive months. Where the obligations of the Consultant are terminated under this section, the Company shall be under no obligation to provide the Consultant with any further notice of termination or pay in lieu of notice or any other form of pay or damages. The Consultant acknowledges and agrees that given the nature of the Company’s business and the critical importance of the Consultant’s position to the operations of the Company, it would constitute undue hardship for the Company to operate without the services of the Consultant for a period in excess of two months.

 

3.5 Termination by Dissolution or Insolvency. In the event of the dissolution or insolvency of the Consultant, during the Term, the Company’s obligation to the Consultant and the Consultant’s obligations to the Company pursuant to this Agreement shall terminate as of the date of dissolution or insolvency, as applicable, and its Base Fee for the month in which the dissolution or insolvency occurs shall be paid to the Consultant, on a pro rata basis.

 

3.6 No Additional Payments. The Consultant acknowledges and agrees that unless otherwise expressly agreed in writing between the Consultant and the Company, the Consultant shall not be entitled, howsoever arising to any remuneration, compensation or other benefits other than expressly provided for in this Agreement,

 

4. CONFIDENTIALITY, INTELLECTUAL PROPERTY, NONCOMPETE AND NONSOLICITATION

 

4.1 Nondisclosure and Nonuse of Confidential Information. The Consultant and the Service Provider will not disclose or use at any time during or after the Term any Confidential Information (as defined below) of which the Consultant is or becomes aware, whether or not they develop such information, except to the extent that such disclosure or use is directly related to and required by the Consultant’s performance of duties assigned to the Consultant pursuant to this Agreement. Under all circumstances and at all times, the Consultant will take all appropriate steps to safeguard Confidential Information in its possession and to protect it against disclosure, misuse, espionage, loss and theft. For purposes hereof, “Confidential Information” means information that is not generally known to the public, that the Consultant becomes aware of during the course of the Term hereunder and that was or is used, developed or obtained by the Company or its subsidiaries or affiliates in connection with their business. It shall not include information (a) required to be disclosed by court or administrative order, (b) lawfully obtainable from other sources or which is in the public domain through no fault of the Consultant; or (c) the disclosure of which is consented to in writing by the Company.

 

3

 

 

4.2 Ownership of Intellectual Property. In the event that the Consultant, as part of their activities on behalf of the Company generates, authors or directly contributes to any invention, design, new development, device, product, method of process (whether or not patentable or reduced to practice or comprising Confidential Information), any copyrightable work (whether or not comprising Confidential Information) or any other form of Confidential Information relating directly to the business of the Company as now or hereinafter conducted during the Term (collectively, “Intellectual Property”), the Consultant acknowledges that such Intellectual Property is the sole and exclusive property of the Company and hereby assigns all right title and interest in and to such Intellectual Property to the Company. The Consultant will promptly and fully disclose all Intellectual Property and will cooperate with the Company, at the Company’s expense, to protect the Company’s interests in and rights to such Intellectual Property (including providing reasonable assistance in securing patent protection and copyright registrations and executing all documents as reasonably requested by the Company, whether such requests occur prior to or after termination of this Agreement).

 

4.3 Delivery of Materials upon Termination of Employment. As requested by the Company, from time to time and upon the termination of this Agreement for any reason, the Consultant will promptly deliver to the Company all copies and embodiments, in whatever form or medium, of all Confidential Information and Intellectual Property in the Consultant’s possession, or within their control, (including written records, notes, photographs, manuals, notebooks, documentation, program listings, flow charts, magnetic media, disks, diskettes, tapes and all other materials containing any Confidential Information or Intellectual Property) irrespective of the location or form of such material and, if requested by the Company, will provide the Company with written confirmation that all such materials have been delivered to the Company.

 

4.4 Noncompetition. The Consultant and Service Provider acknowledges that during the Term, the Consultant will become familiar with trade secrets and other Confidential Information concerning the Company, its subsidiaries and affiliates and their respective predecessors, and that their services will be of special, unique and extraordinary value to the Company. In addition, the Consultant and the Service Provider hereby agrees that at any time during the Term, the Consultant and the Service Provider will not directly or indirectly own (except in accordance herewith), manage, control, participate in, consult with, render services for or in any manner engage in any business competing with the businesses of the Company or its subsidiaries or affiliates as such businesses exist during the Term, within any province in which the Company or its subsidiaries or affiliates have operating locations or leases. It shall not be considered a violation of this section for the Consultant, to be a passive owner of not more than 5% of the outstanding stock of any class of a corporation which is publicly or privately traded, so long as the Consultant and the Service Provider do not actively participate in the business of such corporation.

 

4.5 Nonsolicitation. The Consultant hereby agrees that (a) during the Term (the “Nonsolicitation Period”), the Consultant will not, directly or indirectly induce or attempt to induce any employee of the Company or its subsidiaries to leave the employ of the Company or its subsidiaries, or in any way interfere with the relationship between the Company or its subsidiaries and any employee thereof who was an employee of the Company or its subsidiaries at any time during such Nonsolicitation Period or within the 12 month period prior thereafter and (b) during the Nonsolicitation Period, the Consultant will not induce or attempt to induce any customer, supplier, client, insurer, reinsurer, broker, licensee or other business relation of the Company or its subsidiaries to cease doing business with, or reduce its business with, the Company or its subsidiaries. Notwithstanding the foregoing, should the Consultant depart from the Company for any reason, the Nonsolicitation Period shall be for 12 months from the date of the termination of this Agreement. For the avoidance of doubt, general solicitation through advertising or responding to unsolicited inquiries from an employee, contractor, and/or subcontractor of the Company shall not constitute a violation of this provision.

 

4

 

 

4.6 Enforcement of Noncompete and Nonsolicitation. If, at the enforcement of Sections 4.4 and 4.5, a court holds that the duration, scope or area restrictions stated herein are unreasonable under circumstances then existing, the parties agree that the maximum duration, scope or area reasonable under such circumstances will be substituted for the stated duration, scope or area and that the court will be permitted to revise the restrictions contained in Sections 4.4 or 4.5 to cover the maximum duration, scope and area permitted by law.

 

5. NOTICE

 

Any Notice or other communication required or which may be given hereunder shall be in writing and shall be delivered personally, sent by overnight delivery service with delivery signature required, or sent with return receipt requested by certified, registered, or express mail, postage prepaid to the parties at the following addresses or at such other addresses as shall be specified by the parties by like notice, and shall be deemed given when so delivered personally, telecopied or if mailed, two days after the date of mailing, as follows:

 

if to the Company, to:

 

Siyata Mobile Canada Inc.

 

Suite 2200, 885 West Georgia Street

 

Vancouver, British Columbia V6C 3E8

 

if to the Consultant or the Service Provider, to:

 

Glenn Kennedy

 

134 Don Head Village Boulevard

 

Richmond Hill, Ontario L4C 7P4

 

6. SEVERABILITY

 

The invalidity or unenforceability of any particular term of this agreement will not affect or limit the validity or enforceability of the remaining terms.

 

7. ENTIRE AGREEMENT

 

On the Effective Date, this Agreement (including the documents referred to herein) will constitute the entire agreement among the parties and supersedes and nullifies any prior understanding, agreements or representations by or among the parties, written or oral, that may have related in any way to the subject matter hereof including, without limitation, any prior employment agreement or separation agreement.

 

5

 

 

8. WAIVERS AND AMENDMENTS

 

This Agreement may be amended, modified, superseded, cancelled, renewed or extended, and the terms and conditions hereof may be waived, only by a written instrument signed by the parties making specific reference to this Agreement, or, in the case of a waiver, by the party waiving compliance. No delay on the part of any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any waiver on the part of any party of any right, power or privilege hereunder, nor any single or partial exercise of any right, power or privilege hereunder preclude any other or further exercise of any other right, power or privilege hereunder.

 

9. GOVERNING LAW

 

The laws of British Columbia and the laws of Canada applicable in that province, excluding any rule or principle of conflicts of law that may provide otherwise, govern this Agreement.

 

10. ASSIGNMENT

 

This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors, heirs and permitted assigns. No rights or obligations of the Consultant under this Agreement may be assigned or transferred by the Consultant, other than the Consultant’s right to compensation and various benefits hereunder, which may be transferred by will or operation of law subject to the limitations of this Agreement. No rights or obligations of the Company under this Agreement may be assigned or transferred by the Company except that such rights or obligations may be assigned or transferred pursuant to a merger or consolidation or amalgamation or scheme of arrangement in which the Company is not the continuing entity, or the sale or liquidation of all or substantially all of the assets of the Company, provided that the assignee or transferee is the successor to all or substantially all of the assets of the Company and such assignee or transferee assumes by operation of law or in writing duly executed by the assignee or transferee all of the liabilities, obligations and duties of the Company, as contained in this Agreement.

 

11. CURRENCY

 

All dollar amounts in this agreement refer to Canadian Dollars.

 

12. ACKNOWLEDGEMENTS

 

The Consultant acknowledges that he has read this entire agreement, has had the opportunity to consult with an attorney, and fully understands the terms of this Agreement. The Consultant is satisfied with the terms of this Agreement.

 

13. COUNTERPARTS

 

This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument. The execution of this Agreement by any of the parties may be evidenced by way of a facsimile transmission (including by .pdf or other electronic means) of such party’s signature, or a photocopy of such facsimile transmission, and such facsimile signature shall be deemed to constitute the original signature of such party hereto.

 

14. HEADINGS

 

The headings in this Agreement are for reference purposes only and shall not in any way affect or limit the validity or enforceability of the remaining terms.

 

6

 

 

15. NONDISPARAGEMENT

 

For the Term of this Agreement and for 2 years thereafter, neither party, or any of their affiliates or agents, shall make any statements, comments, or take any actions whatsoever which would in any way disparage the other.

 

[Signature page follows]

 

7

 

 

IN WITNESS WHEREOF the parties hereto have duly executed this agreement as of the day and year first above written.

 

  SIYATA MOBILE INC.
     
  Per:  
    Authorized Signatory
     
  GLENN KENNEDY SALES AGENCY
     
  Per: /s/ Glenn Kennedy
    Authorized Signatory

 

/s/ Carol Kennedy   /s/ Glenn Kennedy
Witness signature   GLENN KENNEDY
                  
Name:                                                                     
  Carol Kennedy    
  (please print)    
       
Address: 134 Don Head Village Blvd    
  Richmond Hill, ON, L4C 7P4    

 

8

 

 

Schedule “A”

Consultant Compensation

 

Base Fee: During the term of this Agreement, the Company shall pay to the Consultant an annual fee of $150,000, plus applicable taxes. Payment will be made as to 1/12 of the Base Fee on the 15th of each month following the Effective Date, with the first payment commencing on January 15, 2019.

 

Commission: During the term of this Agreement, the Company shall pay to the Consultant a commission of 1.5%, for all North American sales of the Company’s products exceeding $5,000,000 but less than $18,500,000 and a commission of 0.75% on sales exceeding $18,500,000 on a quarterly basis following the Effective Date and subject to such sales maintaining a gross profit margin of not less than 40%, unless otherwise agreed by the parties in accordance with approved budgets. For greater certainty, any sale by the Consultant with a gross profit margin lower than 40% must be pre-approved by the Company at its sole discretion. If such approval is granted by the Company such sales revenue shall be attributed to the Consultant’s commission.

 

 

9

 

 

Exhibit 10.8

 

LTE STANDARD

PATENT LICENSE AGREEMENT

 

AN AGREEMENT BETWEEN

 

LICENSEE

Siyata Mobile Inc.

(“Licensee”)

of 1001 Lenoir St Suite A-414

Montreal, Quebec

H4C 2Z6 Canada

telephone: (888) 316-3747

 

and

 

LICENSE ADMINISTRATOR

Via Licensing Corporation (hereinafter “Via”)

of 1275 Market Street

San Francisco, CA 94103-1410 United States
telephone: (415) 645-4700 facsimile: (415) 645-4400

  

LTE Patent License Agreement  
Siyata Mobile Inc. Page 1

 

 

LICENSEE

 

Each of the persons executing this Agreement represents that he/she is authorized to execute on behalf of, and to therefore bind, the respective Parties below.

 

Signature: /s/ Gerry Bernstein  
   
Printed Name: Gerry Bernstein
   
Title: C.F.O. Siyata Mobile Inc., a Canada corporation
   
Place Montreal, Quebec Canada
   
Date June 5, 2018

 

LICENSE ADMINISTRATOR

 

Signature: /s/ Jane Bu  
   
Printed Name: Jane Bu
   
Title: Director, Legal Via Licensing Corporation, a Delaware corporation
   
Place 1275 Market Street, San Francisco, CA 94103-1410, U.S.A.
   
Date June 5, 2018

  

LTE Patent License Agreement  
Siyata Mobile Inc. Page 2

 

 

TABLE OF CONTENTS

 

TITLE PAGE AND SIGNATURE BLOCK 1 - 2
   
TABLE OF CONTENTS 3 - 5
   
DEFINITIONS 6
   
Affiliate 6
Agreement 6
Bilateral reconciliation letter 6
CONFIDENTIAL INFORMATION 7
Country of final sale 7
Country of initial sale 7
Country of manufacture 7
Data terminal product 7
Effective date 7
Essential lte patent(s) 7
External model number 7
Femtocell product 7
Finished product 7
General terminal product 7
Initial fee 7
License administrator 7
License fees 8
Licensed patents 8
Licensed product 8
Licensee 8
Licensors 8
Listed licensed patents 8
Lte Standard 8
Otherwise Supply or Otherwise Supplied 8
Partially Licensed Products 8
Parties 8
Patent Evaluator 8
Quarterly Report 8
Sale, Sell, Selling or Sold 8
Small Entity 8
Term 9
Terminal Product 9
Via Administration System 9
Viasecure 9
   
GRANT OF LICENSES 9
   
License Grant 9
Scope of License Grant 9
Limitation of License 9
No Other Products 9
License Contingent on Reporting and Payment Obligations 9
No Sublicensing 9
Have Made Requirements 9
Individual Licensors option To Withdraw Patents 10
Guaranty By Licensee Regarding Its Affiliates 11
Grantback 11
Express License Only 12
Statement of Vias Intellectual Property Ownership 13

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 3

 

 

PUBLICITY AND ANNOUNCEMENTS 13
   
PAYMENTS, REPORTS & RECORDS 13
   
Initial Fee 13
Quarterly Reports 13
License Fees 14
Taxes 15
Payment Procedure 16
Fee Applicability 16
When Sold or Otherwise Supplied 16
Other Licensee Fee Payment 17
Sales Prior to Effective Date 17
Sales By New Affiliates 17
Books And Records 17
   
CONFIDENTIALITY 18
   
Reproduction 18
Disclosure 18
Use 18
Property 18
Exclusions 18
Exceptions 19
No Implied Assurances 19
   
TERM AND TERMINATION 19
   
Term 19
Termination For Breach 19
Other Terminations 19
Termination For Convenience 19
Effect of Termination 20
Effect of Termination on Payments And Reporting 20
Effect of Expiration or Termination On License 20
Survival 20
   
REPRESENTATIONS AND WARRANTIES 20
   
Negation of Representations And Warranties By Via And Licensors 20
Representations And Warranties By Licensee 20
Representations And Warranties By Each Party 21
Warranty Disclaimer 22
Waiver Of Consequential Damages And Other Indirect Damages 22
Limitation Of Remedies And Limitation of Liability 22
Failure of Essential Purpose 22
Express Allocation of Risks And Benefits 22
   
RIGHT TO INDEPENDENT NEGOTIATION 22
   
Acknowledgements 22
Independent Negotiations 22
   
FURTHER ACKNOLWEDGEMENT 22
   
GENERAL 23
   
Section Titles 23
Assignment 23
Compliance With Laws 23
Costs 23
Assertion Of Unenforceability 23

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 4

 

  

Modification And Waiver 24
Calendar Days 24
Notices 24
Dispute Resolution 24
Relationship Of The Parties 25
Controlling Language 25
Third Party Beneficiary 25
Counterparts 25
Agreement Negotiated 25
Entire Agreement 25
Appendix A: Lte Standard; Licensors 26
Appendix B: Schedule Of Fees 29
Appendix C: Declaration Of Small Entity Status 31

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 5

 

 

LTE PATENT LICENSE AGREEMENT

 

This LTE Patent License Agreement is entered into by and between Via Licensing Corporation, as an agent acting on behalf of Licensors, having a principal place of business at 1275 Market Street, San Francisco, California, 94103 (hereinafter “Via”), and the Party identified as Licensee on the title page of this Agreement.

 

WHEREAS, the 3rd Generation Partnership Project (“3GPP”) in collaboration with its Organizational Partners such as the European Telecommunications Standards Institute (“ETSI”), has developed and published specifications for wireless mobile broadband networks known as Long Term Evolution or “LTE” that are designed to supersede current 3rd Generation (“3G”) technologies such as Universal Mobile Telecommunications System (“UMTS”) (see “LTE Standard,” defined below);

 

WHEREAS, each of the Licensors owns and/or has rights to license certain Essential LTE Patents and each of the Licensors has gone to considerable effort to develop what it believes represents significant advancements relating to the field of wireless broadband communications, including the development and implementation of LTE products and services;

 

WHEREAS, each of the Licensors executed an agreement whereby it appointed Via with limited authority to act as its agent to license, on behalf of Licensors, Licensed Patents as set forth herein (the “LTE Commercialization Agreement”);

 

WHEREAS, each of the Licensors has agreed to make its Licensed Patents available on reasonable and non-discriminatory terms to each entity willing to grant licenses to all Essential LTE Patents it may own;

 

WHEREAS, in order to hasten the acceptance and commercial viability of the LTE Standard, each Licensor desires to make its Licensed Patents available for license on a nonexclusive basis through Via as agent pursuant to the terms and conditions of this Agreement and by which the Licensors and the Parties may achieve economies of scale, reduce transaction costs, integrate complementary technologies and promote the LTE Standard;

 

WHEREAS, Via desires to license, on behalf of the Licensors, Licensors’ Licensed Patents to all entities desiring such a license on the terms and conditions herein;

 

WHEREAS, Licensee desires to obtain a non-exclusive license to Licensors’ Licensed Patents to make, have made, use, import, Sell or Otherwise Supply products compliant with the LTE Standard;

 

NOW THEREFORE, for and in consideration of the payments made and to be made by Licensee hereunder and the other covenants herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby covenant and agree as follows:

 

1. Definitions.

 

1.1. Affiliate” means a separate corporation, company, or other entity that now or hereafter, directly or indirectly, controls, is controlled by, or is under common control of or with a party. The term “control” as used in this definition means ownership of more than fifty percent of the outstanding shares or securities (representing the right to vote for the election of directors or other managing authority) of such corporation, company, or other entity. In jurisdictions where percentage of foreign ownership is restricted to less than or equal to fifty percent, then whatever percentage of ownership represents the maximum interest allowed in that jurisdiction. Such corporation, company or other entity shall be deemed to be an Affiliate only so long as such “control” exists.

 

1.2. Agreement” means this LTE Patent License Agreement (also known as the “LTE PLA”).

 

1.3. Bilateral Reconciliation Lettermeans a document provided by Licensee which contains evidence reasonably satisfactory to Via (and subject to confirmation by applicable Licensors) to establish the existence of effective bilateral or other licenses or agreements with one or more Licensors covering Partially Licensed Products, a sample, approved form of which is available for download from ViaSecure.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 6

 

  

1.4. Confidential Information” means information that is marked “confidential” and is disclosed by one Party (“Discloser”) to the other Party (“Recipient”) pursuant to this Agreement.

 

1.5. Country of Final Sale” means the country where a Licensed Product is first Sold or Otherwise Supplied by Licensee or any other entity to an end user.

 

1.6. Country of Initial Sale” means the country where a Licensed Product is first Sold or Otherwise Supplied by Licensee or an Affiliate of Licensee to an entity that is neither the Licensee nor an Affiliate of the Licensee.

 

1.7. Country of Manufacture” means the country where a Licensed Product is manufactured.

 

1.8. Data Terminal Product” means a Terminal Product that is limited solely to one of the device categories listed and defined in Appendix B. For the avoidance of doubt, unless a product fits squarely within one of the device categories listed and defined in Appendix B, it shall be deemed a General Terminal Product. In the event there is any question regarding the classification of a terminal product as a Data Terminal Product, Via shall, in the reasonable exercise of its sole discretion, determine its classification.

 

1.9. Effective Date” means the date on which this Agreement is executed by Via, after having been executed by Licensee.

 

1.10. Essential LTE Patent(s)” means any patent(s) having one or more claims that would be necessarily and unavoidably infringed (in the absence of a license) by the implementation of the LTE Standard.

 

1.11. External Model Number” means the model number designation marked on a Licensed Product and/or the Licensed Product’s packaging or associated marketing materials presented to customers, and not a model number designation used solely for Licensee’s or Licensee’s suppliers’ internal purposes.

 

1.12. Femtocell Product” means a product that: (i) is capable of providing LTE network connectivity to Terminal Products, (ii) interfaces with LTE network infrastructure and (iii) provides a transmission power of 200mW or less per antenna.

 

1.13. Finished Product” means a standalone, add-on, or add-in product that contains all or substantially all of the hardware functionality that implements the LTE Standard. For the purposes of this definition a product is considered a Finished Product only if it includes enabled LTE baseband functionality and enabled LTE RF functionality. For an add-in or add-on module to be considered a Finished Product, it must incorporate a standardized physical interface and not be permanently affixed to the host products. It is not a requirement that add-in or add-on modules contain an antenna, drivers, or other software to qualify as a Finished Product. Modules such as USB dongles, PC-cards and similar modules that connect to a device to enable LTE functionality are considered Finished Products.

 

1.14. General Terminal Product” means a Terminal Product that is not a Data Terminal Product.

 

1.15. Initial Fee” means the non-refundable fee defined in Section 4 (“Payments, Reports & Records”) below.

 

1.16. License Administrator” means Via or its successor, if any, in either event the entity designated by Licensors to administer the terms of this Agreement and other LTE Patent License Agreements, and act as an independent agent with limited authority to negotiate, receive, accept, execute, enforce, and terminate this Agreement and other LTE Patent License Agreements on behalf of Licensors.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 7

 

  

1.17. License Fees” means the amounts calculated pursuant to Appendix B of this Agreement and due and payable by Licensee to Via under this Agreement.

 

1.18. Licensed Patents” means any and all Essential LTE Patents that are owned and licensable, or licensed to and sublicensable by, the Licensors and their Affiliates in accordance with the terms of this Agreement, now or at any time during the Term, including without limitation the Listed Licensed Patents, but excluding patents that, if licensed, would require a payment of fees by a Licensor to any party that is not an Affiliate of such Licensor. References herein to a particular Licensor’s Licensed Patents shall mean those Licensed Patents owned and licensable, or licensed to and sublicensable by, such Licensor or its Affiliates, subject to the exclusions in the previous sentence.

 

1.19. Licensed Product” means a Data Terminal Product, General Terminal Product or Femtocell Product that is a Finished Product, the making, using, importing, Sale or Otherwise Supplying of which would, in the absence of a license, infringe directly or indirectly a Licensed Patent.

 

1.20. Licensee” means the Party identified as such on the title page and signature page of this Agreement.

 

1.21. Licensors” (individually, “Licensor”) means the entities listed in Appendix A (such list is subject to additions and/or deletions by Via from time to time).

 

1.22. Listed Licensed Patents” means those patents listed for access or download in the LTE License Program area of the Licensee portal on ViaSecure (which list may be updated by Via from time to time) which the Patent Evaluator has determined to be Essential LTE Patents, such list being a representative list of the Licensed Patents.

 

1.23. LTE Standard” means the following standard defined by the 3rd Generation Partnership Project: 3GPP Releases 8 through 12 (but does not include portions of standards related to Enhanced Voice Services - EVS), as further described in Appendix A to this Agreement. The LTE Standard may be further updated as provided in Section 2.2.

 

1.24. Otherwise Supply,” “Otherwise Supplying” or “Otherwise Supplied” means to offer for sale, distribute, rent, lend, lease or otherwise transfer without compensation, consideration, or money; provided that Licensed Products that are replaced without charge for maintenance or warranty purposes shall not be considered Otherwise Supplied.

 

1.25. Partially Licensed Products” means Licensed Products that are already licensed to some or all of those Licensed Patents practiced by such products through another licensing program or other means, whether a patent pool or a bilateral agreement, at least to the same extent as would otherwise be licensed pursuant to the licenses granted hereunder.

 

1.26. Parties” (individually, “Party”) means the entities listed on the title page that have executed the signature page of this Agreement.

 

1.27. Patent Evaluator” means the independent patent evaluator for the Via-administered LTE licensing program.

 

1.28. Quarterly Report” means a report due from Licensee each calendar quarter, in written form or such other formats as reasonably designated by Via, as further described in Section 4 (“Payments, Reports & Records”) below.

 

1.29. Sale,” “Sell,” “Selling” or “Sold” means to sell, directly or through distribution channels, offer for sale, distribute, rent, lend, lease or otherwise transfer for money or any other form of compensation or consideration.

 

1.30. Small Entity” means an organization that, in combination with its Affiliates, has no more than twenty-five (25) employees, has annual gross revenues of US $2 million or less and, such organization has executed the Declaration of Small Entity Status set forth in Exhibit C.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 8

 

 

1.31. Term” means the term of this Agreement as described in Section 6 (“Term and Termination”) below.

 

1.32. Terminal Product” means a network-capable terminal product that contains LTE functionality and requires connectivity to LTE network equipment to enable its LTE functionality.

 

1.33. Via Administration System” means Via’s proprietary systems, technologies and related databases used by Via to manage information relating to patent licensing programs, and includes ViaSecure.

 

1.34. ViaSecure” means Via’s online accounting and reporting portal accessible at [https://www.viasecure.com/].

 

2. Grant of Licenses.

 

2.1. License Grant. On the condition that Licensee and all Affiliates remain in compliance with all terms and conditions of this Agreement and, solely during the Term and subject to the terms and conditions hereof, including but not limited to Licensee’s payment of the Initial Fee and License Fees and compliance with the grantback obligations set forth in Section 2.6, Via hereby grants to Licensee and its Affiliates, on behalf of Licensors, a limited, non-exclusive, non-transferable (subject to Section 9.2 (“Assignment”) below), fee-bearing, worldwide license under the Licensed Patents to make, have made (subject to Section 2.3.4), use, import, Sell and Otherwise Supply Licensed Products.

 

2.2. Scope of License Grant. The patent license granted herein may only be used for the implementation of the LTE Standard in compliance and in accordance with the specifications set forth on Appendix A. The LTE Standard shall further include any additional 3GPP releases that are approved by the Licensors, effective upon ninety (90) days’ notice provided by Via to Licensee from time to time in accordance with Section 9.8. Any update to the definition will include all predecessor releases that were previously included in the definition.

 

2.3. Limitation of License.

 

2.3.1. No Other Products. No license is granted hereunder to utilize the inventions claimed in the Licensed Patents in any products other than Licensed Products for which License Fees have been paid.

 

2.3.2. License Contingent on Reporting and Payment Obligations. Any products for which Licensee must report under Section 4.2 and pay License Fees under Section 4.3 shall not be licensed hereunder unless and until Licensee satisfies its reporting and payment obligations with respect to such products.

 

2.3.3. No Sublicensing. No rights to sublicense are granted or implied hereunder.

 

2.3.4. Have Made Requirements. Any exercise of the right to have made granted pursuant to Section 2.1 above shall only constitute a valid exercise of the have made right (and thereby be licensed hereunder) to the extent that the applicable manufacturer is manufacturing Licensed Products for Licensee or one of its Affiliates in accordance with the designs and/or specifications provided by Licensee to such have-made manufacturer. If any Licensed Products are made for Licensee by a third party pursuant to the foregoing have made right, such third party may Sell or Otherwise Supply such Licensed Products to Licensee only; provided however, at Licensee’s instruction, such third party may ship such Licensed Products to Licensee’s customer, authorized distributor or other designated representative to whom Licensee has Sold or Otherwise Supplied such Licensed Products but to no other person or entity.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 9

 

  

2.4. Individual Licensor’s Option to Withdraw Patents. In the event that Licensee or any of its Affiliates directly or indirectly initiates or otherwise causes an action or files a suit or counterclaim, directly or indirectly, against a Licensor, any of its Affiliates and/or any supplier manufacturing Licensed Products for Licensor or one of its Affiliates on a “have made” basis from designs owned or controlled and/or specifications provided by Licensor or its Affiliate, over a patent alleged, or believed in such Licensor’s reasonable judgment, to be an Essential LTE Patent (“Asserted Licensee Patent”), then, if such Licensor desires to withdraw its Licensed Patents from this Agreement and the licenses granted hereunder, such Licensor shall provide notice to Via and the applicable Licensee simultaneously of its intention to withdraw its Licensed Patents pursuant to this Section. Such notice shall also identify the Asserted Licensee Patent(s). For the avoidance of doubt, Licensor is not obligated to provide such notice before filing a complaint or counterclaim for infringement of its Licensed Patents. Upon issuance of such notice, one or more of the following may be applicable:

 

2.4.1. In the event that Licensee has not formally withdrawn in writing such claim or counterclaim, or dismissed the applicable suit, within ten (10) days following the effective date of notice from Licensor, Licensor’s Licensed Patents shall be deemed withdrawn from this Agreement and the licenses granted hereunder.

 

2.4.2. If Licensee disputes that the Asserted Licensee Patent is an Essential LTE Patent, Licensee may submit such patent to the Patent Evaluator for evaluation provided it pays the applicable fees for such evaluation and reasonably cooperates with the Patent Evaluator, provided further that such submission must be made within thirty (30) days following the effective date of notice from Licensor. Licensee acknowledges that Licensor, in its sole discretion, may provide the Patent Evaluator claim charts and other materials to support its belief that the Asserted Licensee Patent is an Essential LTE Patent.

 

2.4.3. If the final determination of the Patent Evaluator is that the Asserted Licensee Patent is not an Essential LTE Patent, then the applicable Licensor shall reimburse Licensee for the fees paid to the Patent Evaluator and the withdrawal of such Licensor’s Licensed Patents shall be deemed to be retroactively void and without effect and such patents shall be deemed to have been continuously licensed hereunder; provided that nothing in this Section 2.4 shall supersede or limit the terms, conditions and restrictions set forth elsewhere in this Agreement.

 

2.4.4. If the final determination of the Patent Evaluator is (or if Licensee does not dispute) that the Asserted Licensee Patent is an Essential LTE Patent, then the Asserted Licensee Patent is subject to the grantback provisions provided under Section 2.6, and Licensee shall fulfill its grantback obligations in accordance with Section 2.6. Upon Licensee’s compliance with the applicable election, the withdrawal of Licensor’s and its Affiliates’ Essential LTE Patents shall be deemed to be retroactively void and without effect and such patents shall be deemed to have been continuously licensed hereunder; provided that nothing in this Section 2.4 shall supersede or limit the terms, conditions and restrictions set forth elsewhere in this Agreement.

 

2.4.5. The submitting Licensee shall not use or disclose the results of the evaluation by the Patent Evaluator for any purpose whatsoever (including without limitation, in any judicial, legislative or other governmental action), except in connection with resolving the dispute between the submitting Licensee and the Licensor concerning whether the Asserted Licensee Patent is an Essential LTE Patent or, if applicable, for purposes of complying with the terms of Section 2.6 below.

 

2.4.6. If a Licensor withdraws one or more of its Licensed Patents pursuant to this Section 2.4, License Administrator will provide Licensee with a list of such withdrawn patents, which shall be deemed to be removed from the Licensed Patents effective as of the date of the Licensor’s notice described in this Section 2.4.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 10

 

 

2.4.7. Licensee expressly waives all claims against License Administrator, whether based on contract or any other legal theory, based on or otherwise arising out of a Licensor withdrawing its Licensed Patents and the licenses granted hereunder pursuant to this Section.

 

2.5. Guaranty by Licensee Regarding its Affiliates.

 

2.5.1. Licensee unconditionally and irrevocably guarantees performance under this Agreement by all of its Affiliates. Such performance includes, without limitation, obligations under Section 4.7 (“Books and Records”), and the obligation to comply with the terms of the Grantback License (pursuant to Section 2.6) Licensee warrants that it has all necessary authority to bind its Affiliates to the obligations imposed on Affiliates in this Agreement; alternatively, if Licensee lacks such authority with respect to one or more Affiliates, Licensee shall provide Via with a written undertaking from such Affiliate(s) stating that the Affiliate(s) understands and agrees to comply with such obligations, and acknowledging Via and Licensors as third-party beneficiaries to such undertaking.

 

2.5.2. If any of Licensee’s Affiliates breaches or does not perform a duty or obligation pursuant to this Agreement, Licensee shall, as soon as reasonably practicable, cure such breach or perform such duty or obligation, and Licensee agrees that the Licensors and Via, individually or collectively in their sole discretion, shall have the right to proceed directly against Licensee and/or the Affiliate for such breach or non-performance. Licensee’s liability shall not be relieved by the insolvency or bankruptcy of any of such Affiliates, and any liability will be reinstated against Licensee if any payment by any of such Affiliates is returned for any reason, including but not limited to the insolvency or bankruptcy of any such Affiliates.

 

2.6. Grantback.

 

2.6.1. In partial consideration of the rights granted to Licensee and its Affiliates hereunder and subject to this Section 2.6, if Licensee or any of its Affiliates owns and has the right to license or has a license under and the right to sublicense one or more Essential LTE Patents, Licensee agrees to either (i) become a Licensor in the LTE essential patent licensing program administered by License Administrator by executing the LTE Commercialization Agreement (or by execution of a separate addendum or acknowledgment as provided therein), or (ii) license to all Licensors and their Affiliates and all other parties that are licensees pursuant to an effective LTE Patent License Agreement administered by License Administrator that request a license, all such Essential LTE Patents that are licensable or sublicensable by Licensee or any of its Affiliates, on terms and conditions no less favorable than the terms of this Agreement (“Grantback License”). Such obligation to license does not include patents that, if licensed, would require a payment of license fees by Licensee to any party that is not an Affiliate of Licensee, to make, have made, use, import, Sell and Otherwise Supply Licensed Products. Each such Grantback License shall be granted on a non-exclusive basis under reasonable and non-discriminatory (“RAND”) terms and shall include a license grant to such Licensor and its Affiliate(s) or such other licensee and its Affiliate(s) for activity prior to the effective date of the Grantback License. The Licensee’s obligation to grant a Grantback License shall continue until the later of (a) five (5) years after the Effective Date of this Agreement, and (b) the actual Term of this Agreement, including all renewal periods. If Licensee agrees to become a Licensor as set forth clause (i) above and its obligations under the LTE Commercialization Agreement terminate before the expiration of the last such Essential LTE Patent, then Licensee hereby agrees to the requirements of the Grantback License as set forth in clause (ii) above and the remainder of this Section 2.6.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 11

 

  

2.6.2. Only with respect to Grantback License negotiations between Licensee and either a Licensor or a Licensor’s Affiliate, such Licensor may provide ninety (90) days’ written notice to Licensee and to License Administrator, and upon expiration of such notice and the negotiation period described below in this sentence, if later, withdraw the grant of license to its Licensed Patents from the license granted hereunder if a Grantback License agreement is not executed within twelve (12) months after written request for a Grantback License, and (a) Licensee’s proposed Grantback License or negotiations are alleged by Licensor and/or its Affiliate to not be reasonable, or (b) Licensee is seeking to negotiate a royalty rate on a per-patent basis for each of Licensee’s Essential LTE Patents that is greater than the Licensors’ per-patent share of License Fees (calculated by dividing the applicable per unit royalties as set forth on Appendix B by the number of Listed Licensed Patents). The exercise of the right to withdraw shall not affect any other remedies the affected Licensor, other Licensors, License Administrator or Licensee may have. Upon expiration of such 90-day period, License Administrator shall notify Licensee in accordance with this Agreement and provide Licensee with a revised list of Listed Licensed Patents applicable to Licensee, and, with immediate effect from the date of such notice from License Administrator, the Licensed Patents under this Agreement will cease to include the Licensed Patent(s) of such affected Licensor. Upon execution of a Grantback License agreement between Licensee and the affected Licensor or Licensor’s Affiliate, any withdrawn patents, unless otherwise licensed by Licensor to Licensee, shall immediately be reinstated, effective from the date such patents were withdrawn.

 

2.6.3. In the event that any other licensee pursuant to an effective LTE Patent License Agreement administered by License Administrator or any of such licensee’s Affiliates (together, an “Asserting Party”) makes a claim, raises a counterclaim, or files a suit, directly or indirectly, against Licensee and/or any of its Affiliates over a patent alleged, or believed in Licensee’s reasonable judgment, to be an Essential LTE Patent, then Licensee will have no obligation to offer a Grantback License to such Asserting Party under this Section 2.6 until such claim or suit is withdrawn or otherwise fully resolved.

 

2.6.4. In the event that Licensee or its Affiliates sells, assigns, or grants an exclusive license to, or otherwise transfers any Essential LTE Patent during the Term of this Agreement (collectively, “Transferred Patents”), Licensee shall bind the purchaser, assignee, or exclusive licensee to the foregoing grantback obligations until the expiration or termination hereof by making any such sale, assignment, exclusive license, or other transfer subject to the grantback obligations set forth in Section 2.6. If the purchaser, assignee or exclusive licensee is not so bound, then effective immediately prior to such sale, assignment, exclusive license, or other transfer, Licensee agrees it is deemed to have granted, and hereby grants to each Licensor and its Affiliates and all other parties that are licensees pursuant to an effective LTE Patent License Agreement, a royalty-free, non-exclusive, non-transferable, worldwide license under all of Licensee’s and its Affiliates’ Transferred Patents to make, have made, use, import, Sell and Otherwise Supply Licensed Products.

 

2.7. Express License Only. No license is granted herein by implication, estoppel or otherwise, and no implied or express license, authority to infringe, immunity or other waiver from infringement liability shall be deemed to arise or exist as a matter of law or otherwise:

 

2.7.1. under any patent that is not a Licensed Patent;

 

2.7.2. to make, have made, use, import, Sell, or Otherwise Supply any products other than Licensed Products;

 

2.7.3. for any field of use other than to comply with the LTE Standard;

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 12

 

 

2.7.4. to any person acquiring from Licensee or its Affiliates any product other than a Licensed Product.

 

2.8. Statement of Via’s Intellectual Property Ownership. Via shall own all right, title and interest, including without limitation all intellectual property rights, in and to the Via Administration System, ViaSecure, the Via trademarks, trade names, trade dress, service marks and the associated names and logos used by Via from time to time.

 

3. Publicity and Announcements.

 

3.1. No rights or licenses of any kind or nature whatsoever are created hereunder to use any of Via’s, Licensee’s, or the Licensors’ trade names, trademarks or service marks (or any confusingly similar names or marks).

 

3.2. Licensee shall make no statements that any of its or its Affiliates’ Licensed Products have been approved, tested or certified by Via or by any of the Licensors.

 

3.3. Neither Party shall make any public disclosures inconsistent with the rights and obligations created hereunder. The Parties agree that Via and the Licensors may disclose to third parties the identity of Licensee as a licensee under this Agreement, and Licensee may disclose to third parties its identity as a licensee under this Agreement.

 

4. Payments, Reports & Records.

 

4.1. Initial Fee. Within thirty (30) days following the Effective Date, Licensee shall pay to Via an upfront, one-time, initial fee of USD 15,000 or, in the case of a Small Entity, USD 2,500 (the “Initial Fee”). The Initial Fee is an administrative fee for services provided in the United States, paid to Via. The Initial Fee is non-recoupable and non-refundable, and shall not be credited against the License Fees. The Initial Fee shall be paid in full to Via regardless of any tax treaties or obligations. Failure to remit the Initial Fee shall be a material breach of this Agreement.

 

4.1.1. Small Entity Initial Fee. If Licensee qualifies as a Small Entity, Licensee shall be eligible for the USD 2,500 Initial Fee after providing Via with an executed Declaration of Small Entity Status, attached as Appendix C hereto.

 

4.2. Quarterly Reports. Within thirty (30) days following the end of every calendar quarter following the Effective Date, Licensee shall deliver to Via in electronic form, paper form, or as otherwise reasonably required by Via, a written report summarizing such calendar quarter’s transactions involving Licensed Products as specified below.

 

4.2.1. Quarterly Reports shall include:

 

4.2.1.1. the quantity and description, including product name and/or External Model Number, of Licensed Products Sold or Otherwise Supplied to an entity that is neither the Licensee nor its Affiliate pursuant to this Agreement by Licensee and/or its Affiliates during the calendar quarter for which the Quarterly Report is due; whether the Licensed Products are Data Terminal Products, General Terminal Products or Femtocell Products; the Country of Manufacture; the Country of Initial Sale; and, if reasonably known to Licensee, the Country of Final Sale (by way of example only, not a country of intermediate distribution); if no Licensed Products were Sold or Otherwise Supplied by Licensee and/or its Affiliates during the calendar quarter, the Quarterly Report should so state;

 

4.2.1.2. if Licensee or any of its Affiliates has Sold or Otherwise Supplied Partially Licensed Products during the calendar quarter for which the Quarterly Report is due, Licensee may provide a Bilateral Reconciliation Letter to Via to establish the existence of effective licenses covering such Partially Licensed Products. The Bilateral Reconciliation Letter from Licensee and acknowledged by the affected Licensor must be received by Via at least thirty (30) days prior to the due date for Licensee’s Quarterly Report under this Section 4.2, in order for any reduction of Licensee Fees to be applied for such quarter. The Bilateral Reconciliation Letter will remain in effect for the duration specified therein and need not be resubmitted each quarter; provided that Licensee must continue to submit Quarterly Reports in accordance with Section 4.2.2. Nothing herein shall excuse failure to or delay in submitting reports and making payments as they become due hereunder.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 13

 

  

4.2.1.3. such other information and in such form as Via may reasonably request.

 

4.2.2. Quarterly Reports shall include Partially Licensed Products, even if Licensee has provided Via with a Bilateral Reconciliation Letter pursuant to Section 4.2.1.2 above, and all applicable Licensors that have granted rights to Licensed Patents under other licensing agreements have confirmed the existence of such licenses or have given their approval for Via to reconcile Licensee’s reports to exclude payment of License Fees on such products. So long as Licensee has provided a timely Bilateral Reconciliation Letter to Via for any Partially Licensed Products it or any of its Affiliates has Sold or Otherwise Supplied during a calendar quarter, Via will invoice Licensee only for the net amount of License Fees after deducting the amount of License Fees that would have otherwise been due for such Partially Licensed Products. For the avoidance of doubt, Via will reduce the quarterly License Fees invoice to account for Essential LTE Patents of Licensors with which Licensee has bilateral licenses, and no License Fees are due from Licensee pursuant to this Agreement for the portion of License Fees that would otherwise have been owed for such Partially Licensed Products based on such Licensors’ Licensed Patents, provided that Licensee has submitted a Bilateral Reconciliation Letter in accordance with this Section.

 

4.2.3. Except as may be required under Section 4.4 (“Taxes”) below and as required by law, Via shall not disclose Licensee-specific details of Quarterly Reports to Licensors. To the extent that Licensee has provided evidence to Via of licenses applicable to Partially Licensed Products, Via shall be permitted to disclose Licensee-specific information to Licensors as needed to confirm that the Licensed Products are licensed with respect to those Licensed Patents practiced by such products.

 

4.3. License Fees. Unless Licensee qualifies for the semi-annual payment election set forth in Section 4.3.1, Licensee shall pay to Via all License Fees due hereunder within thirty (30) days after its Quarterly Report is due certifying the amounts due. In accordance with Appendix B (the “Schedule of Fees”), upon the Sale or Otherwise Supplying of Licensed Products to an entity that is neither the Licensee nor its Affiliate, Licensee shall pay to Via the amounts for each Licensed Product (except those returned and refunded) made or had made in, or Sold or Otherwise Supplied under this Agreement within or to any jurisdiction in which any Licensed Patent remains unexpired.

 

4.3.1. If the License Fees due for a calendar quarter total less than US $25,000, Licensee may elect to defer payment of such License Fees until the following quarter, so long as this election is made not more than once every other calendar quarter (payments must be made at least on a semi-annual basis). Such an election does not excuse Licensee’s obligation to provide a Quarterly Report each quarter.

 

4.3.2. If Licensee Sells or Otherwise Supplies Licensed Products for resale to a customer who also has executed an LTE Patent License Agreement with the License Administrator (“Other Licensee”), Licensee may agree with such Other Licensee that, as an exception to Section 4.3, the payment of License Fees for specific Licensed Products will not be made by Licensee under this Agreement but by the Other Licensee under the Other Licensee’s LTE Patent License Agreement. If Licensee executes such an agreement with an Other Licensee, Licensee remains responsible for reporting the Licensed Products in its own Quarterly Reports (referencing the agreement with the Other Licensee) and also remains responsible for payment of the License Fees due for such Licensed Products if the Other Licensee fails to report and pay License Fees that are due. If Licensee and an Other Licensee enter into such an agreement for the reporting and payment of License Fees, both Licensee and the Other Licensee shall provide Via with written notice of such agreement prior to initiating reporting and payment under this Section.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 14

 

  

4.3.3. Reports and payments required hereunder shall be consolidated by Licensee to include reporting and payment of License Fees due with regard to Licensee’s Affiliates and have-made manufacturers.

 

4.3.4. All fees due by Licensee under this Agreement are non-refundable and non-recoupable. With respect to (i) License Fees for Partially Licensed Products that are reduced under a Bilateral Reconciliation Letter pursuant to Section 4.2.2 above, or (ii) License Fees for Licensed Products that are paid by the Other Licensee pursuant to Section 4.3.2 above, the reduction of License Fees applies on a go-forward basis after the receipt of the applicable Bilateral Reconciliation Letter or notice of the Other Licensee, and cannot be retroactively applied to License Fees already paid.

 

4.4. Taxes. Except as provided in Section 4.4.1 below, in addition to the Initial Fee and the License Fees set forth in this Agreement and Appendix B, Licensee shall pay any and all fees, duties, charges of any kind, and taxes, including, without limitation, sales, use, excise, value added, withholding and similar taxes, based on payments to be made hereunder in any jurisdiction(s) where such taxes are required, and shall not deduct such amounts from any payments of fees hereunder. Licensee shall pay any such taxes and fees which are necessary to ensure that the net amounts received by Via on behalf of Licensors after all taxes and fees are paid are equal to the amounts to which Licensors are otherwise entitled under this Agreement as if such taxes and fees did not exist. Licensee shall timely provide to Via documentation and proof of payment of taxes and fees paid on behalf of Licensors under this Section. If any taxing authority makes a claim against Via for any taxes owed by Licensee, Licensee shall be obligated to pay all of Via’s expenses and costs incurred in defending such claim by the taxing authority. Via shall reasonably cooperate and provide such information as may be required by Licensee for any purpose or reason relating to Licensee’s payment of taxes as may be required under this Section 4.4.

 

4.4.1. Notwithstanding Section 4.4 (“Taxes”), if applicable law and/or tax treaty requires Licensee to withhold any income taxes levied by Licensee’s country of residency or any other jurisdiction(s) on payments to be made pursuant to this Agreement (“Withholding Tax”), Licensee shall timely remit to the appropriate governing authority any Withholding Tax that may be levied upon License Fees paid to Via for the benefit of Licensors. Licensee shall use Via’s calculation of Withholding Tax, and shall deduct such Withholding Tax from License Fees.

 

4.4.1.1. Licensee shall provide to Via by the required filing or submission deadline as communicated by Via, all relevant documentation and proof of payment (in original form) of the Withholding Tax to allow Licensor to provide evidence to Licensor’s tax authorities of payment of Withholding Taxes. If Licensee cannot provide such documentation and proof of payment by such deadline, Licensee shall remit the amount of Withholding Tax to Via for distribution to affected Licensors.

 

4.4.1.2. If a Licensor is eligible for a Withholding Tax rate exemption or a reduction pursuant to an applicable tax treaty then in force (as determined by (i) the country listed as Licensee’s address on the title page of this Agreement, from which the Licensee is paying the License Fee and (ii) the country in which the Licensor is receiving its share of the License Fees from Licensee), Licensee must cause any Withholding Tax that is payable by the Licensor to be avoided or reduced accordingly. Via shall reasonably cooperate with Licensee for purpose of reducing or eliminating any Withholding Taxes.

 

4.4.1.3. Via shall reasonably cooperate with Licensee by furnishing necessary information, completed certificates, forms and other documents required by Licensee for the purpose of reducing or eliminating any Withholding Taxes. Licensee shall file all necessary tax forms required or desirable in order to apply for the application of rates under tax treaties. Nothing in this Section 4.4.1.3 shall require Via or Licensee to take any action inconsistent with any applicable law or government regulation.

 

4.4.1.4. If any taxing authority makes a claim against a Licensor or Via for failure to timely remit all required Withholding Taxes, then Licensee shall be obligated to pay all deficiencies and any interest or penalties owed to such taxing authority as a result of such failure.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 15

 

  

4.5. Payment Procedure.

 

4.5.1. Payments to Via shall be made by wire transfer to the bank and account set forth in the invoice from Via, or to such other bank and account as Via may notify Licensee in writing, or by check drawn upon a nationally-recognized U.S. bank and sent to Via to the address set forth below in Section 9.8 (“Notices”).

 

4.5.2. Via will credit payments from Licensee against any prior outstanding amounts owed by Licensee under this Agreement (crediting the oldest outstanding amounts first) before applying them to current License Fees or other amounts owed.

 

4.5.3. Excess payment amounts shall be applied to immediately subsequent payment obligations and not refunded.

 

4.5.4. Any fees or payments that are made hereunder later than the date on which they are due shall bear interest, compounded monthly at the statutory rate of ten percent (10%) per annum or the highest rate permitted under applicable law, whichever is lower. A payment is considered late if received more than thirty (30) days after the due date.

 

4.5.5. Time is of the essence with respect to all payments required hereunder.

 

4.5.6. Licensee shall pay all amounts due hereunder in United States dollars. All dollar amounts in this Agreement refer to United States dollars unless otherwise indicated.

 

4.5.7. Notwithstanding any requirement for written documents, communication or notice in this Agreement, Quarterly Reports, tax, withholding, financial and payment information and communications may be exchanged by the Parties electronically through the Via Administration System, ViaSecure, or as otherwise requested by Via by notice through such systems.

 

4.6. Fee Applicability.

 

4.6.1. When Sold or Otherwise Supplied. For the purpose of timing the payment of License Fees, a Licensed Product shall be considered Sold or Otherwise Supplied on the earlier of the following events: (i) when delivered to a party that is not an Affiliate of Licensee; (ii) when otherwise disposed of, or (iii) when invoiced to a party that is not an Affiliate of Licensee. For the avoidance of doubt, License Fees are payable only when Licensed Products are Sold or Otherwise Supplied under this Agreement and this Section, and not for Licensed Products that are made or have made but not Sold or Otherwise Supplied during the applicable quarter.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 16

 

 

4.6.2. Other Licensee Fee Payment. Licensee shall have no obligation to pay License Fees for a particular Licensed Product on which a third party that is a licensee under an LTE Patent License Agreement with Via has paid Via the required License Fees as set forth in Appendix B provided that Licensee documents the payment by such third party to Via’s reasonable satisfaction. Notwithstanding the foregoing, Licensee remains responsible for reporting such Licensed Products in its own Quarterly Reports.

 

4.6.3. Sales Prior to Effective Date. Not later than thirty (30) days following the Effective Date of this Agreement, Licensee shall submit to Via a written report, identical in form and to the content requirements set forth in Section 4.2 (“Quarterly Reports”), for any Licensed Products Sold or Otherwise Supplied during the entire period prior to the Effective Date of this Agreement. Except as specifically provided in this Section, Licensee shall pay to Via all License Fees for such Licensed Products and interest thereon, compounded monthly at the statutory rate of ten percent (10%) per annum or the highest rate permitted under applicable law, whichever is lower; or if no Licensed Products were Sold or Otherwise Supplied during the entire period prior to the Effective Date of this Agreement, a statement to that effect. Upon receipt of such reports and payments, the license grant set forth in Section 2.1 will be extended to include Licensed Products Sold or Otherwise Supplied prior to the Effective Date for which a report and payment has been received.

 

4.6.4. Sales By New Affiliates. Not later than thirty (30) days following the date that an entity that is not already a licensee under an LTE Patent License Agreement becomes an Affiliate of Licensee (“New Affiliate”) for the first time (for example where an entity acquires ownership of Licensee or one of Licensee’s parents, or where an entity is acquired by Licensee or one of Licensee’s Affiliates) (“Date of Affiliation”), Licensee shall submit to Via a written report, identical in form and including the equivalent content as set forth in Section 4.2 (“Quarterly Reports”), for any Licensed Products Sold or Otherwise Supplied by any New Affiliates during the entire period prior to the date of such report, together with payment for fees and interest thereon, compounded monthly at the statutory rate of ten percent per annum or the highest rate permitted under applicable law, whichever is lower; or if no Licensed Products were Sold or Otherwise Supplied by all such New Affiliates during the entire period prior to the Affiliation Date, a written statement to that effect. Upon receipt by Via of such reports and full payment for such Licensed Products, the license grant set forth in Section 2.1 will be extended to include Licensed Products Sold or Otherwise Supplied by such New Affiliate prior to the Date of Affiliation.

 

4.7. Books and Records. Licensee and its Affiliates shall keep true, correct, and complete books and records of all sales, licenses, leases, uses, returns or other transfers of Licensed Products under this Agreement for at least six (6) years from the date of their creation in order to confirm the accuracy of all of Licensee’s reports and amounts paid or payable hereunder. Via may select an independent and professionally licensed accountant in its sole discretion (“Auditor”) to audit, inspect and make abstracts of such books and records, at Licensee’s facility (or elsewhere as determined by Auditor) as necessary to verify their accuracy and that of all other written reports and statements provided for herein, and verify or determine fees paid or payable under this Agreement (“Audit”). Such Audit shall be performed during regular business hours upon at least ten days’ notice and not more often than once annually unless an underpayment of five percent (5%) or more is found, in which case Via may conduct more frequent Audits to the extent reasonably necessary to verify consistently accurate reporting. The Auditor may provide to Via information sufficient to support its findings provided that it shall not reveal any information to Via beyond what is required of Licensee in accordance with this Agreement. If the Audit shows an underpayment, then Licensee shall immediately report the discrepancy pursuant to Section 4.2.1 and pay to Via the amounts due, plus accrued interest, plus the cost of the Audit if applicable, after receiving notice of the results of the applicable Audit, Licensee will pay the cost of the Audit if, for the period audited, an underpayment of five percent (5%) or more is found, based on and compared to payments or reports received by Via prior to Via’s notice informing Licensee of the Audit. Amounts payable after notice of the audit results will be subject to additional interest pursuant to Section 4.5.4 if they are not received by Via within ten (10) days after the date of such notice. Upon initiation of an Audit, Via, in its discretion, may disable Licensee’s ability to report under Section 4.2 electronically until the completion of such Audit and agreement by the Parties on the results of such Audit. Following an Audit, Via will apply any subsequent payments received from Licensee hereunder first to the costs of the Audit and then to accrued interest before applying any remainder to outstanding License Fees. Via may report the results of any Audit to Licensors; provided, however, that Via shall not disclose in its report to Licensors any Confidential Information of the Licensee, or any other Licensee-specific information other than discrepancies in Licensee’s reporting of Licensed Products and payments of License Fees under this Agreement for the period that was the subject of the Audit.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 17

 

  

5. Confidentiality.

 

5.1. Reproduction. Recipient shall not reproduce Discloser’s Confidential Information except and only to the extent necessary to exercise its rights and obligations under this Agreement. Reproductions of Confidential Information shall include any trade secret legends, proprietary notices and/or copyright notices present in the Confidential Information.

 

5.2. Disclosure. Recipient shall restrict disclosure of Confidential Information to its and its Affiliates’ employees, contractors, attorneys and accountants with a need to know such information to accomplish the purposes of this Agreement, and Recipient shall advise such Affiliates, employees, contractors, attorneys and accountants, in advance of such disclosure, of the obligations of this Section 5 and shall require such Affiliates, employees, attorneys, and accountants to be bound, in writing, by confidentiality obligations substantially similar to those herein. Recipient shall not disclose Confidential Information to any other third party without prior written approval of Discloser. All tax credit payments and related documents shall be deemed Confidential Information and shall be disclosed only on a need-to-know basis. Except for books and records specified in Section 4.7 (“Books and Records”) above, Recipient’s obligation to maintain confidentiality of Confidential Information as provided under this Section 5 shall expire three (3) years from the date of disclosure. Recipient shall take reasonable steps to prevent unauthorized disclosure or use of the Discloser’s Confidential Information and to prevent it from falling into the public domain or into the possession of unauthorized persons, but in no event will the Recipient use less care than it would in connection with its own Confidential Information of like kind or importance.

 

5.3. Use. All Confidential Information that is disclosed for the purposes set forth in this Agreement shall be used only to the extent necessary to accomplish the purposes of this Agreement, shall be subject to the restrictions of this Section 5 and shall not be used for any other purpose.

 

5.4. Property. All Confidential Information that is owned by Discloser shall remain the property of Discloser. Recipient’s duty to protect Confidential Information commences upon receipt of the Confidential Information.

 

5.5. Exclusions. The foregoing restrictions on the use and disclosure of Confidential Information shall not apply to any Confidential Information:

 

5.5.1. that is independently developed by Recipient without reference to or use of the Discloser’s Confidential Information, or lawfully received free of restriction from another source having the right to furnish the Confidential Information;

 

5.5.2. after it has become generally available to the public without breach of this Agreement by Recipient;

 

5.5.3. that, at the time of disclosure to Recipient, was known to Recipient or its Affiliates free of restriction as evidenced by documentation in Recipient’s possession; or

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 18

 

 

5.5.4. that Discloser agrees in writing is free of such restrictions.

 

5.6. Exceptions. Nothing in this Agreement shall prevent Recipient from disclosing Confidential Information to the extent Recipient is legally compelled to do so by any governmental, investigative or judicial agency pursuant to proceedings over which such agency has jurisdiction, provided that Recipient first gives Discloser reasonable notice of the required disclosure sufficient to permit Discloser to take appropriate steps to seek a protective order or equivalent. In no event shall Recipient’s cooperation with Discloser require Recipient to take any action which, on the advice of Recipient’s counsel, could result in the imposition of any sanctions or other penalties against Recipient.

 

5.7. No Implied Assurances. None of the Confidential Information which may be disclosed by Discloser shall constitute any representation, warranty, guarantee, inducement or other assurance by Discloser with respect to the non-infringement of any intellectual property rights, or any other rights of any third persons or of Discloser.

 

6. Term and Termination.

 

6.1. Term. This Agreement shall commence on the Effective Date and continue thereafter for a period of five (5) years unless earlier terminated pursuant to this Section 6. Licensee shall have the option to renew this Agreement for additional periods of five (5) years (or until the expiration of all Licensed Patents if shorter), provided that any renewal shall be subject to delivery of written notice to Via by Licensee setting forth Licensee’s election to renew at least thirty (30) days prior to the expiration of the then-current term and provided further that such renewal shall be according to the terms of this Section 6.1. Any renewal of this Agreement shall be conditioned upon compliance with and acceptance of any amendments or changes to the terms and conditions of this Agreement as set forth in notice from Via to Licensee after Licensee’s election to renew provided that such amended or changed terms and conditions shall be no less favorable than the terms of the then-current LTE Patent License Agreement being offered by Via. In any event, such renewal shall include only the Licensed Patents of the Licensors that are parties to an effective LTE Commercialization Agreement on the first date that such renewal becomes effective.

 

6.2. Termination for Breach. Failure to pay or perform any obligation hereunder within the time prescribed shall constitute an event of material default. Failure to cure any event of material default within sixty (60) days after receipt of notice describing the non-performance, or thirty (30) days with respect to non-payment of amounts due, shall entitle the Party giving such notice to terminate, or suspend, any or all portions of this Agreement.

 

6.3. Other Terminations. In addition to other rights to terminate set forth in this Agreement, this Agreement may be terminated by Via, upon thirty (30) days’ written notice to Licensee, without any right of Licensee to cure, upon the occurrence of any of the following events:

 

6.3.1. If Licensee files a petition in bankruptcy or the equivalent thereof, or is the subject of an involuntary petition in bankruptcy that is not dismissed within sixty (60) days after the filing date thereof, or is or becomes insolvent, or admits of a general inability to pay its debts as they become due; or

 

6.3.2. Upon the de facto or de jure nationalization or expropriation of Licensee by governmental or military action, whether or not with valid authority.

 

6.4. Termination for Convenience. Licensee may terminate this Agreement at will by providing Via with at least sixty (60) days’ prior written notice.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 19

 

  

6.5. Effect of Termination.

 

6.5.1. Effect of Termination on Payments and Reporting. Upon expiration or termination of this Reports shall automatically be accelerated so that they shall all become due, payable, and deliverable on or before thirty (30) days after the effective date of expiration or termination of this Agreement.

 

6.5.2. Effect of Expiration or Termination on License. Upon expiration or termination of this Agreement, all licenses granted to Licensee hereunder shall terminate and revert to the Licensors.

 

6.6. Survival. The definitions and the Parties’ rights, duties and obligations under Sections 4.7 (“Books and Records”), 5 (“Confidentiality”), 6.5 (“Effect of Termination”), 6.6 (“Survival”), 7 (“Representations and Warranties”), and 9 (“General”) shall survive the expiration or termination of this Agreement. Without limiting the foregoing, Licensee’s obligation to grant a Grantback License pursuant to Section 2.6 (“Grantback”) shall continue until the later of (a) five (5) years after the Effective Date of this Agreement, and (b) the actual Term of this Agreement, including all renewal periods.

 

7. Representations and Warranties.

 

7.1. Negation of Representations and Warranties by Via and Licensors. Via and Licensors, individually and collectively, make no representation, warranty, covenant or claim regarding:

 

7.1.1. the scope, validity, enforceability or infringement of the Licensed Patents;

 

7.1.2. any ongoing maintenance or prosecution of any of the Licensed Patents;

 

7.1.3. any defense of Licensee against any actions or suits of any nature brought by any third parties;

 

7.1.4. any obligation to bring or prosecute any actions or suits against any third parties for infringement; or

 

7.1.5. any sufficiency, adequacy or completeness of the Licensed Patents for any purpose including but not limited to making, using, importing, Selling, or Otherwise Supplying any Licensed Products.

 

7.2. Representations and Warranties by Licensee. Licensee represents, warrants and covenants that:

 

7.2.1. Licensee enters this Agreement for its own convenience to acquire non-exclusive rights from multiple Licensors hereto in a single transaction rather than in multiple transactions for rights to the Licensed Patents which it believes are necessary to make, use, import, Sell, or Otherwise Supply Licensed Products; and by doing so Licensors and Licensee may achieve economies of scale, reduce transaction costs, integrate complementary technologies, and promote the LTE Standard;

 

7.2.2. Licensee is aware that the Licensed Patents may not comprise all the technology, or include licenses to all of the patents or other licenses or rights required to make, use, import, Sell, or Otherwise Supply a Licensed Product;

 

7.2.3. Licensee acknowledges that Via and Licensors, individually and collectively, make no representation, warranty, covenant or claim that the Licensed Patents hereunder include all Essential LTE Patents throughout the world;

 

7.2.4. Licensee acknowledges that Via and Licensors do not, individually or collectively, make any representation, warranty, covenant or claim that making, using, importing, Selling, or Otherwise Supplying of the Licensed Product will not infringe, directly, indirectly, by inducement or otherwise, any patent not licensed hereunder;

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 20

 

 

7.2.5. Licensee acknowledges and agrees that (i) the terms of this Agreement require the payment of the same specified License Fees regardless of the number of Licensed Patents licensed under this Agreement; (ii) it is not required by this Agreement to utilize all or a specific subset of the Licensed Patents; and (iii) the License Fees payable hereunder represent the value to Licensee of making, using, importing, Selling or Otherwise Supplying Licensed Products and not the value of a specific subset of Licensed Patents at any given time; notwithstanding the foregoing, Licensee acknowledges and agrees that Via may offer other program offerings on standards or technology that may be related to the LTE Standard as defined above, which, if offered, will be available through separate patent license agreements or optional amendments to this Agreement;

 

7.2.6. Licensee shall defend, indemnify, and hold Via and the Licensors, individually and collectively, harmless and free from and against any claim, loss, damage, costs, attorneys’ fees or other liability based on or otherwise arising out of Licensee’s or Licensee’s Affiliates’ conduct, including without limitation claims related to Licensee’s violation of any applicable laws or government regulations, including any applicable laws or government regulations relating to export, import, and royalty withholding; any infringement of third party intellectual property rights in connection with Licensed Products; any breach by Licensee or its Affiliates of this Agreement; costs of enforcement actions or proceedings brought by Via or any Licensors relating to Licensee’s or its Affiliates’ breach of this Agreement including, without limitation, costs of proceedings before the U.S. International Trade Commission (ITC) or actions of the U.S. Customs Service or actions or proceedings before similar foreign agencies for seizure of products made, used, imported, Sold or Otherwise Supplied in violation of this Agreement; provided, however, that notwithstanding the foregoing, Licensee shall not be obligated to defend, indemnify and hold Via or the Licensors harmless from and against a claim, loss, damage or liability based on or otherwise arising out of the willful misconduct or gross negligence of Via or the Licensors;

 

7.2.7. Licensee acknowledges that Via and the Licensors have not investigated Licensee’s particular Licensed Product(s) and that to the extent such Licensed Product(s) include features not necessarily and unavoidably required by the implementation of the LTE Standard, such features may infringe patents and/or intellectual property rights owned by the Licensors which are not included in the Licensed Patent(s) and that a separate license for same would, in such case, be required;

 

7.2.8. Neither Licensee nor its Affiliates have, in contemplation of signing this Agreement, made an assignment of, or granted an exclusive license to, any Essential LTE Patent to any third party.

 

7.3. Representations and Warranties by Each Party. Each Party represents, covenants and warrants that:

 

7.3.1. this Agreement does not violate any of that Party’s existing agreements;

 

7.3.2. such Party has the authority, power and right to convey the rights or accept the obligations created hereunder subject to the terms, conditions and limitations set forth herein.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 21

 

 

7.4. WARRANTY DISCLAIMER. THE FOREGOING REPRESENTATIONS AND WARRANTIES ARE IN LIEU OF ALL OTHER REPRESENTATIONS AND WARRANTIES, AND EXCEPT FOR THE EXPRESS REPRESENTATIONS AND WARRANTIES SET FORTH ABOVE IN THIS SECTION 7, VIA AND THE LICENSORS MAKE NO WARRANTY OF ANY TYPE OR OF ANY KIND WHATSOEVER ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, AND HEREBY DISCLAIM AND EXCLUDE ALL OTHER WARRANTIES, WHETHER STATUTORY, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION THE IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT OF THIRD-PARTY RIGHTS.

 

7.5. WAIVER OF CONSEQUENTIAL DAMAGES AND OTHER INDIRECT DAMAGES. VIA AND THE LICENSORS SHALL NOT BE LIABLE FOR ANY CONSEQUENTIAL, INCIDENTAL, SPECIAL, PUNITIVE OR OTHER INDIRECT DAMAGES OF ANY TYPE OR OF ANY KIND WHATSOEVER ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, REGARDLESS OF THE FORM OF THE ACTION, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT PRODUCT LIABILITY OR OTHERWISE, EVEN IF ANY REPRESENTATIVE OF VIA OR ANY OF THE LICENSORS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

 

7.6. LIMITATION OF REMEDIES AND LIMITATION OF LIABILITY. IN ALL EVENTS, LICENSEE’S SOLE REMEDY UNDER THIS AGREEMENT FOR ANY CLAIM OF BREACH SHALL BE TO TERMINATE THIS AGREEMENT. IN NO EVENT SHALL VIA’S AND LICENSORS’ AGGREGATE CUMULATIVE LIABILITY TO LICENSEE FOR DAMAGES UNDER THIS AGREEMENT EXCEED THE AMOUNTS DUE TO VIA BUT UNPAID BY LICENSEE OR THE AMOUNTS PAID BY LICENSEE TO VIA IN THE TWELVE MONTH PERIOD IMMEDIATELY PRIOR TO THE FIRST EVENT GIVING RISE TO THE LIABILITY, WHICHEVER IS LESS.

 

7.7. FAILURE OF ESSENTIAL PURPOSE. THE PARTIES AGREE THAT THE LIMITATIONS SPECIFIED IN SECTION 7.6 (“LIMITATION OF REMEDIES AND LIMITATION OF LIABILITY”) SHALL APPLY EVEN IF THIS AGREEMENT OR ANY LIMITED REMEDY SPECIFIED HEREIN IS FOUND TO HAVE FAILED OF ITS ESSENTIAL PURPOSE.

 

7.8. Express Allocation of Risks and Benefits. All of the terms and conditions in Sections 7 (“Representations and Warranties”), 7.4 (“Warranty Disclaimer”) and 7.6 (“Limitation of Remedies and Limitation of Liability”) have been expressly accepted by the Parties and represent the bargained for allocations of risks and benefits under this Agreement which are reflected in the financial terms between the Parties in this Agreement. This allocation is an essential element of the basis of the bargain between the Parties.

 

8. Right to Independent Negotiation.

 

8.1. Acknowledgements. Licensee understands and acknowledges that the Licensed Patents are offered to be licensed for the convenience of Licensee, and Licensee is free to negotiate licenses and/or fees for the Licensed Patents directly with each of the Licensors independently and individually on mutually acceptable terms and conditions which may be different from those set forth in this Agreement.

 

8.2. Independent Negotiations. Licensee also understands and acknowledges that Licensee is free to conduct the negotiations described in this Section 8 (“Right to Independent Negotiation”) simultaneously with any or all of the Licensors independently, individually and directly.

 

8.3. Further Acknowledgement. Licensee also understands and acknowledges that this Agreement has been entered into freely and at the option of Licensee. Furthermore, Licensee understands and acknowledges that each Licensor may hold patents or other intellectual property that are infringed by making, importing, Selling or Otherwise Supplying Licensed Products and which are not licensed to Licensee hereunder.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 22

 

 

9. General.

 

9.1. Section Titles. Section titles are intended only to aid and assist the reader as an index device and are not intended to be substantive or fully descriptive of the contents of the section or to be used for construction or interpretation.

 

9.2. Assignment. Licensee shall not assign this Agreement or delegate any of its rights, duties or obligations hereunder without the prior written consent of Via, except in connection with Licensee’s merger with another entity, or sale to another entity of its entire business, or substantially all of the assets used to carry out the business related to practice of the technology to which this Agreement pertains, provided that such entity shall promptly agree in writing with Via to perform all Licensee’s obligations and duties hereunder. Any attempt to do so without such consent is void. Via may assign the administration and management of this Agreement or its rights, interests and obligations under this Agreement to a successor in connection with a merger with or acquisition by or sale of all of Via’s assets, or in the event that a different license administrator (“New Administrator”) or the Licensors succeed to Via’s obligations and rights under this Agreement.

 

9.2.1. In the event that a New Administrator succeeds to Via’s obligations and rights under this Agreement, Via shall notify Licensee that Via will no longer administer this Agreement, and Licensee shall have thirty (30) days from receipt of Via’s notice to decide whether to terminate this Agreement or permit Via to assign this Agreement to the New Administrator. If Via does not receive a notice of termination from Licensee during the 30-day period, then Via shall assign this Agreement to the New Administrator and shall further transfer to the New Administrator copies of invoices, financial reports, agreements, and other documents and information that are related to Licensee and this Agreement.

 

9.2.2. In the event that Licensors succeed to Via’s obligations and rights under this Agreement, Via shall notify Licensee that it will no longer administer this Agreement, and Licensee shall have thirty (30) days from receipt of Via’s notice to decide whether to terminate this Agreement or permit Via to assign this Agreement to the Licensors. If Via does not receive a notice of termination from Licensee during the 30-day period, Via shall assign this Agreement to the Licensors, and provide each Licensor copies of this Agreement and those invoices, financial reports, agreements, and other documents and information that are related to Licensee and this Agreement applicable to that Licensor. The Licensors shall immediately notify Licensee, and provide contact information for notices, reports, payments and any additional information necessary to achieve the successful transfer of this Agreement from Via to the Licensors.

 

Subject to the foregoing, this Agreement shall be binding on and inure to the benefit of the Parties and their respective successors and permitted assigns.

 

9.3. Compliance with Laws. Licensee will comply with all applicable laws and regulations, including any applicable laws and regulations relating to export, import, and applicable royalty withholding laws and regulations, and will defend and hold Via and all Licensors harmless from any expense or damage resulting from Licensee’s violation or alleged violation of any such law or regulation as set forth in Section 7.2.6. Licensee shall not export or re-export any data acquired from Licensors under this Agreement, or the direct product thereof, to any country in contravention of applicable law.

 

9.4. Costs. Any covenant requiring a Party to perform or provide an act or service shall be construed to impose upon such Party the burden of the cost thereof unless otherwise provided for herein.

 

9.5. Assertion of Unenforceability. In the event that any provision of this Agreement shall be unenforceable or invalid under any applicable law or be so held by applicable court decision, such unenforceability or invalidity shall not render this Agreement unenforceable or invalid as a whole, and the unenforceable or invalid provision shall be amended to achieve as closely as possible the economic effect of the original provision.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 23

 

  

9.6. Modification and Waiver. No provision of this Agreement shall be deemed modified by any act or omission of a Party or its agents, or by failure to object to any acts of a Party which may be inconsistent with the terms of this Agreement. No waiver of a breach committed by a Party in one instance shall constitute a waiver or permission to commit or continue breaches in other or like instances. This Agreement shall not be amended or modified other than by a duly executed written amendment signed by representatives of the Parties, except that Via may provide updates to the lists of Licensors, Listed Licensed Patents on ViaSecure, and the Parties may provide updates to contact information, addresses and other administrative matters via written notice, email, as provided in Section 4.5.7 above, or other electronic means.

 

9.7. Calendar Days. All references to days under this Agreement are a reference to calendar days; thus, for example, when action is required “within thirty (30) days” then in all cases such action is required within thirty (30) calendar days.

 

9.8. Notices. All notices and communication shall be in written English, to the addresses below, or to such other contact information as either Party may designate pursuant to proper notice and, except to the extent an alternate means is specified below or elsewhere in this Agreement, sent by an internationally-recognized courier service that provides proof of delivery. All notices so provided shall be deemed effective upon receipt as indicated by such proof, and in no case later than ten (10) days after sending. Notwithstanding the foregoing, Via may send notices updating contact information and addresses and other administrative matters, and any updates to the lists of Licensors, Listed Licensed Patents pursuant to Section 2.4 or otherwise, via email, as provided in Section 4.5.7 above, or by other electronic means. The parties may agree on additional procedures for electronic communication; such agreement may be entered into by electronic means. If and when so entered into, such procedures will be deemed to be incorporated into the notice procedures set forth in this Section 9.8. All fees payable to Via shall be paid by check tendered or wire transfer at the applicable following address (or such other payment addresses or bank account as Via shall designate in writing):

 

Via Licensing Corporation

Attention: LTE License Administrator

1275 Market Street

San Francisco, CA 94103

Telephone: (415) 645-4700

 

Notices to Licensee shall be sent to the address on page 1, or to the following if specified:

 

Company:

Attn:

Address:

Fax:

Email: gerry@siyatamobile.com

 

9.9. Dispute Resolution. This Agreement shall be governed by, and construed in accordance with, the substantive law of the State of California. This Agreement shall be deemed to have been made and entered into in San Francisco, California. The sole jurisdiction and venue for any action, dispute, claim or controversy related to or arising out of this Agreement, whether in contract or in tort (“Action”), shall be the United States District Court for the Northern District of California, San Francisco Division or the Superior Court of the State of California, San Francisco County. In the event that such courts do not have, or decline, subject matter jurisdiction, personal jurisdiction or venue, such Action may be brought in any court approved by Via that has the requisite jurisdiction and venue. The Parties hereby consent and submit to jurisdiction of such courts, and waive any venue objections thereto, and further agree that process may be served as authorized by California law. In the event that any action is brought to resolve any dispute under this Agreement, the prevailing Party shall be entitled to recover from the other Party all costs and expenses incurred in that action as well as any appeal therefrom, including all reasonable attorney’s fees and costs. Licensee shall not object to any enforcement action brought by Via under this Agreement on the basis that the Licensors should be required to seek, maintain, or be joined to such action.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 24

 

  

9.10. Relationship of the Parties. The Parties are independent contractors. There is no relationship of partnership, joint venture, employment, franchise or other agency between Via and Licensee, and neither Via nor Licensee has the authority to bind the other or incur any obligation on behalf of the other.

 

9.11. Controlling Language. This Agreement and the Appendices hereto are prepared and executed in the English language only, which language shall be controlling in all respects. Any translations of this Agreement into any other language are for reference only and shall have no legal or other effect. Any notice which is required or permitted to be given by one Party to the other under this Agreement shall be in the English language and shall be in writing. All proceedings related to this Agreement shall be conducted in the English language.

 

9.12. Third Party Beneficiary. Licensee acknowledges and agrees that each Licensor is a direct and intended third party beneficiary of those provisions of this Agreement expressly or implicitly referencing Licensor and Licensor shall be entitled to enforce the terms of such provisions directly against Licensee.

 

9.13. Counterparts. This Agreement may be executed, whether in person or by facsimile transmission, simultaneously in counterpart, each of which shall be deemed to be an original, but all of which together shall constitute one and the same Agreement. Without limiting the foregoing, in territories where electronic or digital signatures are binding and legally enforceable, the Parties may execute this Agreement and any amendments hereto using such electronic or digital means.

 

9.14. Interpretation. Each Party hereby acknowledges and agrees that it is sophisticated and has consulted legal counsel with respect to this transaction. As a consequence, the Parties expressly waive any presumption of any statutory or common law rule relating to the interpretation of contracts against the drafter. The terms “including,” “such as,” “by way of example” or any variation thereof means “including the following by way of example only, without limitation” and shall not be construed to limit any general statement that it follows to the specific or similar items immediately following it.

 

9.15. Entire Agreement. This Agreement, together with the Appendices attached hereto and incorporated by this reference, contains the entire agreement between Via and Licensee, and supersedes all other prior or contemporaneous representations, discussions, negotiations and agreements, whether written or oral between them relating to the subject matter hereof.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 25

 

 

APPENDIX A

LTE STANDARD; LICENSORS

 

The patent license granted herein may only be used solely for the implementation of the following LTE specifications implemented in accordance with the LTE Forum Specifications:

 

LTE Standard  

3rd Generation Partnership Project:

 

3GPP Releases 8 through 12
(but does not include portions of
standards related to Enhanced
Voice Services - EVS)

 
   
Document identification  
Ref No. Description
TS 22.011 Service accessibility
TS 22.016 International Mobile Equipment Identities (IMEI)
TS 22.022 Personalization of Mobile Equipment (ME); Mobile functionality specification
TS 22.024 Description of Charge Advice Information (CAI)
TS 22.030 Man-Machine Interface (MMI) of the User Equipment (UE)
TS 22.038 (U)SIM Application Toolkit (USAT/SAT); Service description; Stage 1
TS 22.053 Tandem Free Operation (TFO); Service description; Stage 1
TS 22.057 Mobile Execution Environment (MExE) service description; Stage 1
TS 22.101 Service aspects; Service principles
TS 22.105 Services and service capabilities
TS 22.220 Service Requirements for Home Node B (HNB) and Home eNode B (HeNB)
TS 23.107 Quality of Service (QoS) concept and architecture
TS 23.110 Universal Mobile Telecommunications System (UMTS) access stratum; Services and functions
TS 23.140 Multimedia Messaging Service (MMS) Stage 2
TS 23.204 Support of Short Message Service (SMS) over generic 3GPP Internet Protocol (IP) access; Stage 2
TS 23.207 End-to-end Quality of Service (QoS) concept and architecture
TS 23.221 Architectural requirements
TS 23.401 General Packet Radio Service (GPRS) enhancements for Evolved Universal Terrestrial Radio Access Network (E-UTRAN) access

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 26

 

 

TS 23.402 Architecture enhancements for non-3GPP accesses
TS 24.301 Non-Access-Stratum (NAS) protocol for Evolved Packet System (EPS); Stage 3
TS 26.244 Transparent end-to-end packet switched streaming service (PSS); 3GPP file format (3GP)
TS 26.245 Transparent end-to-end Packet switched Streaming Service (PSS); Timed text format
TS 33.102 3G security; Security architecture
TS 33.105 Cryptographic algorithm requirements
TS 33.110 Key establishment between a UICC and a terminal
TS 33.320 Security of Home Node B (HNB) / Home enhanced Node B (HeNB)
TS 33.401 3GPP System Architecture Evolution (SAE); Security architecture
TS 35.201 Specification of the 3GPP confidentiality and integrity algorithms; Document 1: f8 and f9 specification
TS 35.202 Specification of the 3GPP confidentiality and integrity algorithms; Document 2: Kasumi specification
TS 35.215 Specification of the 3GPP Confidentiality and Integrity Algorithms UEA2 & UIA2; Document 1: UEA2 and UIA2 specifications
TS 35.216 Specification of the 3GPP Confidentiality and Integrity Algorithms UEA2 & UIA2; Document 2: SNOW 3G specification
TS 36.101 Evolved Universal Terrestrial Radio Access (E-UTRA); User Equipment (UE) radio transmission and reception
TS 36.104 Evolved Universal Terrestrial Radio Access (E-UTRA); Base Station (BS) radio transmission and reception
TS 36.133 Evolved Universal Terrestrial Radio Access (E-UTRA); Requirements for support of radio resource management
TS 36.211 Evolved Universal Terrestrial Radio Access (E-UTRA); Physical channels and modulation
TS 36.212 Evolved Universal Terrestrial Radio Access (E-UTRA); Multiplexing and channel coding
TS 36.213 Evolved Universal Terrestrial Radio Access (E-UTRA); Physical layer procedures
TS 36.214 Evolved Universal Terrestrial Radio Access (E-UTRA); Physical layer—measurements
TS 36.300 Evolved Universal Terrestrial Radio Access (E-UTRA) and Evolved Universal Terrestrial Radio Access Network (E-UTRAN); Overall description; Stage 2
TS 36.302 Evolved Universal Terrestrial Radio Access (E-UTRA); Services provided by the physical layer
TS 36.304 Evolved Universal Terrestrial Radio Access (E-UTRA); User Equipment (UE) procedures in idle mode
TS 36.314 Evolved Universal Terrestrial Radio Access Network (E-UTRAN); Layer 2—measurements

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 27

 

  

TS 36.321 Evolved Universal Terrestrial Radio Access (E-UTRA); Medium Access Control (MAC) protocol specification
TS 36.322 Evolved Universal Terrestrial Radio Access (E-UTRA); Radio Link Control (RLC) protocol specification
TS 36.323 Evolved Universal Terrestrial Radio Access (E-UTRA); Packet Data Convergence Protocol (PDCP) specification
TS 36.331 Evolved Universal Terrestrial Radio Access (E-UTRA); Radio Resource Control (RRC); Protocol specification
TS 36.401 Evolved Universal Terrestrial Radio Access Network (E-UTRAN); Architecture description
TS 36.413 Evolved Universal Terrestrial Radio Access (E-UTRA) ; S1 Application Protocol (S1AP)
TS 36.423 Evolved Universal Terrestrial Radio Access Network (E-UTRAN); X2 Application Protocol (X2AP)

 

Licensors:

 

· AT&T Intellectual Property, LLC
· China Mobile Communications Corporation
· Conversant Wireless Licensing S.a.r.l
· Deutsche Telekom AG
· Dolby Laboratories, Inc.
· Google Inc.
· HP Inc.
· Innovative Sonic Limited
· KDDI Corporation
· Lenovo PC (HK) Limited (including Motorola Mobility LLC, a wholly-owned subsidiary of Lenovo)
· MediaTek Inc.
· NTT DOCOMO, INC.
· Siemens AG
· SK Telecom Co., Ltd.
· Technology In Ariscale, LLC
· Telecom Italia S.p.A.
· Telefonica, S.A.
· Verizon Wireless

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 28

 

 

APPENDIX B

SCHEDULE OF FEES

 

Pursuant to Section 4, Licensee shall calculate and pay License Fees to Via for each Licensed Product Sold or Otherwise Supplied during each calendar quarter in accordance with the following tables.

 

General Terminal Products

 

Volume
(per unit / annual reset*)
  Per Unit Fee  
For the first 1 to 500,000 units   $ 3.00  
For units 500,001 to 2,500,000   $ 2.55  
For units 2,500,001 to 5,000,000   $ 2.40  
For units 5,000,001 to 10,000,000   $ 2.25  
For units 10,000,001 or more   $ 2.10  

 

General Terminal Products that are mobile phones and/or Mobile Computer Tablets (as defined below)

 

Volume
(per unit / annual reset*)
  Per Unit Fee  
For the first 1 to 100,000 units     No Fee  
For units 100,001 to 1,000,000   $ 1.00  
For units 1,000,001 to 2,500,000   $ 1.50  
For units 2,500,001 or more   $ 2.10  

 

In the event Licensee executes this Agreement within six (6) months of becoming aware of the above rate table for General Terminal Products that are mobile phones and/or Mobile Computer Tablets, then Licensee shall receive a 50% discount off the 100,001 to 1,000,000 volume tier such that the effective per unit fee for that tier equals $0.50 per unit.

 

Data Terminal Products (limited to product categories defined below)

 

Volume
(per unit / annual reset*)
  Per Unit Fee  
For the first 1 to 250,000 units   $ 1.50  
For units 250,001 to 500,000   $ 1.28  
For units 500,001 to 1,000,000   $ 1.20  
For units 1,000,001 to 5,000,000   $ 1.13  
For units 5,000,001 or more   $ 1.05  

  

LTE Patent License Agreement  
Siyata Mobile Inc. Page 29

 

 

Femtocell Products

 

Volume
(per unit / annual reset*)
  Per Unit Fee  
For the first 1 to 50,000 units   $ 2.00  
For units 50,001 to 250,000   $ 1.90  
For units 250,001 to 500,000   $ 1.80  
For units 500,001 to 1,000,000   $ 1.70  
For units 1,000,001 or more   $ 1.60  

 

* For each annual reset, the cumulative volumes for determining the applicable fee shall be reset to zero at the end of each four calendar quarter period measured from the first calendar quarter for which Licensed Products that have been Sold or Otherwise Supplied are to be reported hereunder.

 

Mobile Computer Tablets

 

A wireless, portable personal tablet computer with a touchscreen interface that has a flat, rectangular form, runs a general-purpose operating system, designed to run general-purpose applications and is not a general purpose laptop, desktop, server and large format tablet microprocessor-based computers, or is not designed to be used in conjunction with, or to provide services to, a host device. In the event there is any question regarding the classification of a hardware product as a Mobile Computer Tablets, Via shall, in the reasonable exercise of its sole discretion, determine its classification.

 

Data Terminal Products

 

Data Terminal Products are limited to the following categories of Terminal Products (as such list may be supplemented as provided below):

 

Modem Device” means an add-in or add-on Terminal Product that is designed with the following features and product limitations, such that it: (i) only provides data connectivity, (ii) does not have other primary or secondary functions or applications, and (iii) provides LTE data connectivity only to the product to which it is attached.

 

M2M Device” means a Terminal Product that is designed with the following features and product limitations, such that it: (i) performs a dedicated function, (ii) primarily communicates to a system or application (software program) that captures the device communication and translates the communication into meaningful information for a specific set of purposes, (iii) does not provide a general purpose application environment and (iv) the primary function is not to communicate with generic Terminal Products. Examples include automatic meter reading (AMR), vending machine monitoring, point of sale terminal reporting.

 

Mobile Hotspot” means a Terminal Product that is designed with the following features and product limitations, such that it: (i) primarily provides LTE data connectivity for up to 10 devices via a non-LTE wireless network connection, (ii) does not provide a general purpose application environment, (iii) does not provide advanced network or application layer security features and (iv) is not the endpoint for data communication.

 

Additional Data Terminal Products

 

Additional categories of products will be added to the above list of Data Terminal Products if and when a new product is approved as such by the Licensors, effective for Products Sold or Otherwise Supplied during the calendar quarter in which notice is provided by Via to Licensee in accordance with Section 9.8.

 

LTE Patent License Agreement  
Siyata Mobile Inc. Page 30

 

 

Appendix C

Declaration of Small Entity Status

 

On behalf of [Licensee Company Name], the undersigned hereby declares that, at the time of executing this Declaration of Small Entity Status and Agreement, it is a Small Entity as defined in Section 1.30 and confirms that:

 

[Licensee Company Name], together with its Affiliates, has no more than twenty-five (25) employees; and [Licensee Company Name]’s, together with its Affiliates, combined annual gross revenues do not exceed US $2 million.

 

The undersigned hereby represents and warrants that all statements herein are accurate and true, and that the undersigned has the authority to execute this form on behalf of [Licensee Company Name].

 

     
DATE   SIGNATURE
     
Name: _______________________    
     
Title: _______________________    
     
Company:    

 

 

LTE Patent License Agreement  
Siyata Mobile Inc.  Page 31

 

Exhibit 10.9

 

AAC Patent License Agreement  
Siyata Mobile Inc. Page 1

 

AAC

PATENT LICENSE AGREEMENT

 

AN AGREEMENT BETWEEN

 

LICENSEE

Siyata Mobile Inc.

(“Licensee”)

of 1001 Lenoir St Suite A-414

Montreal, Quebec

H4C 2Z6 Canada

telephone: (888) 316-3747

 

and

 

LICENSE ADMINISTRATOR

Via Licensing Corporation (hereinafter “Via”)
of 1275 Market Street

San Francisco, CA 94103-1410 United States of America
telephone: (415) 645-4700 facsimile: (415) 645-4400

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 2

 

LICENSEE

 

Each of the persons executing this Agreement represents that he/she is authorized to execute on behalf of, and to therefore bind, the respective Parties below.

 

Signature: /s/ Gerry Bernstein  
     
Printed Name: Gerry Bernstein  
     
Title: C.F.O. Siyata Mobile Inc., a Canada corporation
     
Place Montreal Quebec Canada  
     
Date June 5, 2018  

 

LICENSE ADMINISTRATOR

 

Signature: /s/ Jane Bu  
     
Printed Name: Jane Bu  
     
Title: Director, Legal Via Licensing Corporation, a Delaware corporation
     
Place 1275 Market Street, San Francisco, CA 94103-1410, U.S.A.
     
Date June 5, 2018  

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 3

 

TABLE OF CONTENTS

 

TITLE PAGE AND SIGNATURE BLOCK   1
TABLE OF CONTENTS   3
DEFINITIONS   6
AAC Standard   6
Affiliate   7
Agreement   7
Channel   7
Effective Date   7
End-User   7
Essential AAC Patent(s)   7
External Model Number   7
Initial Fee   7
Internal Use Licensed Product   7
License Administrator   7
License Fees   7
Licensed Patents   7
Licensed Product   8
Licensee   8
Licensors   8
Otherwise Supply or Otherwise Supplied   8
Parties   8
Products Subject to Other Licenses   8
Professional Product   8
Quarterly Report   8
Sell or Sold   8
Small Entity   8
Term   8
Trial Period   8
Via Administration System   8
GRANT OF LICENSES   9
License Grant   9
Scope of License Grant   9
Limitation of License   9
No Other Products   9
No Sublicensing   9
Guaranty by Licensee Regarding its Affiliates   9
Limitation of Have-made Rights   9
Grantback   10
Express License Only   11
Statement of Via’s Intellectual Property Ownership   11
PUBLICITY AND ANNOUNCEMENTS   11
PAYMENTS, REPORTS & RECORDS   11

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 4

 

Initial Fee   11
Quarterly Reports   11
License Fees   13
Taxes   13
Payment Procedure   14
Fee Applicability   15
When Sold or Otherwise Supplied   15
When First Used   15
Software Installations   15
Hosted Services   15
Other Licensee Fee Payment   16
Sales Prior to Effective Date   16
Books and Records   16
Trial Period Rules   16
CONFIDENTIALITY   17
Confidential Information   17
Reproduction   17
Disclosure   17
Use   17
Property   17
Exclusions   17
Exceptions   18
No Implied Assurances   18
Injunctive Relief   18
TERM AND TERMINATION   18
Term   18
Termination for Breach   18
Individual Licensor’s Option to Withdraw Patents   18
Termination for Convenience   18
Effect of Termination   19
Effect of Termination on Payments and Reporting   19
Effect of Termination on License   19
Survival   19
REPRESENTATIONS AND WARRANTIES   19
Negation of Representations And Warranties by Via And Licensors   19
Representations and Warranties by Licensee   19
Representations and Warranties By Each Party   20
Warranty Disclaimer   20
Waiver of Consequential Damages and Other Indirect Damages   21
Limitation of Remedies and Limitation Of Liability   21
Failure of Essential Purpose   21
Express Allocation of Risks and Benefits   21
RIGHT TO INDEPENDENT NEGOTIATION   21

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 5

 

Acknowledgements   21
Independent Negotiations   21
GENERAL   21
Section Titles   21
Assignment   21
Compliance With Laws   22
Costs   22
Assertion of Unenforceability   22
Modification and Waiver   22
Calendar Days   22
Notices   22
Dispute Resolution   23
Relationship of the Parties   23
Controlling Language   23
Third Party Beneficiary   23
Counterparts   23
Review by Counsel   23
Entire Agreement   23
APPENDIX A: AAC STANDARD, LICENSORS, AND LICENSED PATENTS   24
APPENDIX B: SCHEDULE OF FEES   41
APPENDIX C: DECLARATION OF SMALL ENTITY STATUS   44

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 6

 

AAC PATENT LICENSE AGREEMENT

 

This AAC Patent License Agreement is entered into by and between Via Licensing Corporation, as an agent acting on behalf of Licensors, having a principal place of business at 1275 Market Street, San Francisco, California, 94103 (hereinafter “Via”), and the Party identified as Licensee on the title page and signature page of this Agreement.

 

WHEREAS, the International Organization for Standardization (“ISO”) and the International Electrotechnical Commission (“IEC”) issued standards for the coding of audio information namely ISO/IEC 13818-7:2006 “Information Technology – Generic coding of moving pictures and associated audio information – Part 7: Advanced Audio Coding (AAC), and ISO/IEC 14496-3:2009 “Information Technology—Coding of audio-visual objects—Part 3: Audio”;

 

WHEREAS, each of the Licensors owns and/or has rights to license Essential AAC Patents and each of the Licensors has gone to considerable effort to develop what it believes represents significant advancements;

 

WHEREAS, each of the Licensors has appointed Via with limited authority to act as its agent to license, on behalf of Licensors, all Essential AAC Patents owned and licensable or licensed and sublicensable by each of the Licensors;

 

WHEREAS, each of the Licensors agrees to make its Essential AAC Patents available on fair, reasonable, nondiscriminatory, and reciprocal terms to entities willing to grant licenses to any essential patents they may own;

 

WHEREAS, in order to hasten the acceptance and commercial viability of the AAC Standard, each Licensor desires to make its Essential AAC Patents available for license through Via as agent in this Agreement and by which the Licensors and the Parties can achieve economies of scale, reduce transaction costs, integrate complementary technologies and promote the AAC Standard;

 

WHEREAS, in response to requests received from Licensees and potential Licensees of previous MPEG-2 AAC and MPEG-4 Audio patent licensing programs, the Licensors wish to offer a license focused on those portions of the MPEG-2 AAC and MPEG-4 Audio standards that are in common practice;

 

WHEREAS, Via desires to license, on behalf of the Licensors, Licensors’ Essential AAC Patents to all entities desiring such a license on the terms and conditions herein;

 

WHEREAS, Licensee desires to obtain a non-exclusive license to Licensors’ Essential AAC Patents to manufacture, have made, Sell, or Otherwise Supply products compliant with the AAC Standard;

 

NOW THEREFORE, for and in consideration of the payments made and to be made by Licensee hereunder and the other covenants herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, it is covenanted and agreed by and between the Parties hereto that:

 

1. Definitions.

 

1.1. AAC Standard” means standards defined by the International Organization for Standardization (“ISO”) and the International Electrotechnical Commission (“IEC”) for the coding of audio information, namely ISO/IEC 13818-7:2006 “Information Technology – Generic coding of moving pictures and associated audio information – Part 7: Advanced Audio Coding (AAC), and ISO/IEC 14496-3:2009 “Information Technology—Coding of audio-visual objects—Part 3: Audio”, specifically limited to the following Profiles and Audio Object Types (“AOT”): MPEG-4 AAC Profile (including MPEG-2 AAC LC), MPEG-4 High Efficiency AAC Profile (including MPEG-2 AAC LC in combination with SBR), MPEG-4 High Efficiency AAC v2 Profile, MPEG-4 Low Delay AAC Profile, MPEG-4 Low Delay AAC v2 Profile (ISO/IEC 14496-3:2009/Amd. 3: 2012), MPEG-4 ER AAC Scalable (AOT 20), MPEG-4 ER AAC ELD (AOT 39), the Extended HE-AAC Profile (xHE-AAC, as defined and specified in the MPEG-D Standard, specifically ISO/IEC 23003-3:2012 “Information Technology – MPEG audio technologies – Part 3: Unified Speech and Audio Coding or as additionally described in Appendix A to this Agreement.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 7

 

1.2. Affiliate” means a separate corporation, company, or other entity that now or hereafter, directly or indirectly, controls, is controlled by, or is under common control of or with a party. The term “control” as used in this definition means ownership of more than fifty percent (50%) of the outstanding shares or securities (representing the right to vote for the election of directors or other managing authority) of such corporation, company, or other entity. In jurisdictions where percentage of foreign ownership is restricted to less than or equal to fifty percent (50%), then whatever percentage of ownership represents a controlling interest in that jurisdiction. Such corporation, company or other entity shall be deemed to be an Affiliate only so long as such “control” exists.

 

1.3. Agreement” means this AAC Patent License Agreement (also known as the “AAC PLA”).

 

1.4. Channelor Channels” means an audio channel. As examples: A monaural product utilizes one Channel; a stereo product utilizes two Channels (left and right), a multichannel product utilizes three or more Channels.

 

1.5. Effective Date” means the date on which this Agreement is executed by Via.

 

1.6. End User” means any person or entity that purchases or otherwise obtains a decoding and/or encoding device or software for personal or commercial use and not to re-Sell or Otherwise Supply.

 

1.7. Essential AAC Patent(s)” means any patent(s) having one or more independent claims that would be necessarily and unavoidably infringed (in the absence of a license) by the practice of the AAC Standard.

 

1.8. External Model Number” means the model number designation marked on a Licensed Product and/or the Licensed Product’s packaging or associated marketing materials presented to End Users, and not a model number designation used for a Licensee’s or a Licensee’s suppliers’ internal purposes.

 

1.9. Initial Fee” means the non-refundable fee defined in Section 4 (“Payments, Reports & Records”) below.

 

1.10. Internal Use Licensed Product” means a Licensed Product made by Licensee or its Affiliates, or made on behalf of Licensee or its Affiliates, that is used by Licensee or its Affiliates, and is not intended for Sale or Otherwise Supply to any unaffiliated third party.

 

1.11. License Administrator” means Via Licensing Corporation (“Via”), the entity designated by Licensors to administer the terms and act as an independent agent with limited authority to negotiate, receive, accept, execute, enforce, and terminate the AAC PLA on behalf of Licensors.

 

1.12. License Fees” means the amounts calculated pursuant to Appendix B of this Agreement and due and payable by Licensee to Via under this Agreement.

 

1.13. Licensed Patents” means any and all Essential AAC Patents that are owned and licensable, or licensed and sublicensable, by the Licensors and their Affiliates in accordance with the terms of this Agreement, now or at any time during the Term, including without limitation those patents listed in Appendix A (which list shall be updated by Via from time to time). Licensed Patents do not include any patents that, if licensed, would require a payment of fees by a Licensor to any party that is not an Affiliate of such Licensor.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 8

 

1.14. Licensed Product” means (a) a complete (or substantially complete), ready-to-use End User decoding and/or encoding device or software, the making, using, importing, Sale or Otherwise Supplying of which would, in the absence of a license, infringe directly or indirectly a Licensed Patent, or (b) a component decoding and/or encoding device or software, the making, using, importing, Sale, or supplying of which would, in the absence of a license, infringe directly or indirectly a Licensed Patent, that is Sold or Otherwise Supplied directly to an End User. (By way of example only, and without limitation, such components may be in the form of software libraries, DSP code modules, subassemblies or integrated circuits).

 

Notwithstanding the foregoing, to the extent that Licensee or an Affiliate Sells or Otherwise Supplies components or software, the making, using, importing, Selling, or supplying of which would, in the absence of a license, infringe directly or indirectly a Licensed Patent, for inclusion in Professional Products sold by Licensee’s customer, such components shall be considered Licensed Products, provided that Licensee reports each customer’s name along with the quantity and product name and/or model number of the product(s) incorporating such component or software as part of Licensee’s quarterly reports, and pays the applicable Professional Product License Fees for such component or software as set forth herein.

 

1.15. Licensee” means the Party identified as such on the title page and signature page of this Agreement.

 

1.16. Licensors” (individually, “Licensor”) means the entities listed in Appendix A (such list is subject to additions and/or deletions by Via from time to time).

 

1.17. Otherwise Supply” or “Otherwise Supplied” means to offer for sale, distribute, dispose, rent, lend, lease, commercialize, exploit, or otherwise transfer without compensation, consideration, or money.

 

1.18. Parties” (individually, “Party”) means the entities listed on the cover page that have executed the signature page of this Agreement.

 

1.19. Products Subject to Other Licenses” means products that would be Licensed Products but that are licensed to those AAC Essential Patents practiced by such products through another licensing program or other means, whether a pool or a bi-lateral agreement, to the same extent that would otherwise be licensed pursuant to the licenses granted hereunder.

 

1.20. Professional Product” means a Licensed Product intended primarily for an End User’s direct revenue-generating use or intended to serve as a main resource to generate revenue for End Users, including monitoring and testing equipment.

 

1.21. Quarterly Report” means reports due from Licensee each calendar quarter , in electronic form, paper form, or as otherwise reasonably required by Via, as further described in Section 4 (“Payments, Reports & Records”) below.

 

1.22. Sell” or “Sold” means to sell, directly or through distribution channels, offer for sale, distribute, dispose, rent, lend, lease, commercialize, exploit or otherwise transfer for money or any other form of compensation or consideration.

 

1.23. Small Entity” means an organization that, together with its Affiliates, has no more than fifteen (15) employees, and has annual gross revenues of US $1 million or less and has executed the Declaration of Small Entity Status set forth in Appendix C.

 

1.24. Term” means the period of time described in Section 6 (“Term and Termination”) below.

 

1.25. Trial Period” means an evaluation or testing period provided to End Users for a Licensed Product as further described in Section 4.8 (“Trial Period Rules”).

 

1.26. Via Administration System” means Via’s proprietary systems, technologies and related databases used by Via to manage information relating to patent licensing programs and that is protected by intellectual property rights owned solely and exclusively by Via.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 9

 

2. Grant of Licenses.

 

2.1. License Grant. On the condition that Licensee and all Affiliates remain in compliance with all terms and conditions of this Agreement then, solely during the Term and subject to the terms and conditions hereof, including but not limited to Licensee’s payment of the Initial Fee, Via hereby grants to Licensee and its Affiliates, pursuant to authority granted by the Licensors, a limited, non-exclusive, non-transferable (subject to Section 9.2 (“Assignment”) below), fee-bearing, worldwide license under the Licensed Patents to make, have made (subject to Section 2.5), use, import, Sell and Otherwise Supply Licensed Products solely for the purpose of encoding or decoding data in accordance with the AAC Standard.

 

2.2. Scope of License Grant. The patent license granted herein may only be used for the practice of the AAC Standard.

 

2.3. Limitation of License.

 

2.3.1. No Other Products. No license is granted hereunder to utilize the inventions claimed in the Licensed Patents in any products other than Licensed Products for which License Fees have been paid.

 

2.3.2. No Sublicensing. No rights to sublicense are granted or implied hereunder.

 

2.4. Guaranty by Licensee Regarding its Affiliates.

 

2.4.1. Licensee unconditionally and irrevocably guarantees performance under this Agreement by all its Affiliates. Such performance includes, without limitation, obligations under Section 4.7 (“Books and Records”), and the obligation to provide a Grantback License (pursuant to Section 2.6) to all Essential AAC Patents that are owned or licensable by Licensee or any and all of its Affiliates, on terms and conditions no less favorable than the terms of this Agreement.

 

2.4.2. If any of Licensee’s Affiliates breaches or does not perform a duty or obligation pursuant to this Agreement, Licensee shall, as soon as reasonably practicable, cure such breach or perform such duty or obligation, and Licensee agrees that the Licensors and Via, individually or collectively in their sole discretion, shall have the right to proceed directly against Licensee and/or the Affiliate for such breach or nonperformance. Licensee’s liability shall not be relieved by the insolvency or bankruptcy of any of such Affiliates, and any liability will be reinstated against Licensee if any payment by any of such Affiliates is returned for any reason, including but not limited to the insolvency or bankruptcy of any such Affiliates.

 

2.5. Limitation of Have-Made Rights.

 

2.5.1. If any Licensed Products are made for Licensee by a third party, such third party may Sell or Otherwise Supply such Licensed Products to Licensee only; however, at Licensee’s instruction such third party may ship such Licensed Products to Licensee’s authorized distributor or other designated representative to whom Licensee has Sold or Otherwise Supplied such Licensed Products, and to no other person or entity.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 10

 

2.5.2. If a third party providing Licensed Products for Licensee pursuant to Section 2.5.1. (a “have-made manufacturer”) makes a claim, raises a counterclaim, or files a suit directly or indirectly against a Licensor and/or any of such Licensor’s Affiliate(s) over a patent alleged, or believed, in such Licensor’s reasonable judgment, to be an Essential AAC Patent, then such Licensor shall have the right to instruct Via to revoke Licensee’s have-made right for that Licensor’s and its Affiliates’ Essential AAC Patents under this AAC PLA with regard to such have-made manufacturer only. Upon notice to Licensee from Via of such revocation, such have-made manufacturer shall no longer be entitled to enjoy the benefit of any rights under such Licensor’s and its Affiliates’ Essential AAC Patents with respect to the manufacture of Licensed Products for Licensee or any of Licensee’s Affiliates and all Licensed Products manufactured by such have-made manufacturer thereafter shall be deemed unlicensed products with respect to such Licensor’s and its Affiliates’ Essential AAC Patents.

 

2.6. Grantback.

 

2.6.1. If Licensee or any of its Affiliates has the right to license or control the licensing of one or more Essential AAC Patents, Licensee agrees to either (i) become a Licensor in the AAC licensing program, or (ii) license to all Licensors that request a license and all other AAC licensees (having a substantially similar, reciprocal obligation to license Essential AAC Patents), all Essential AAC Patent(s) that are owned or controlled and licensable, or licensed and sublicensable, by Licensee or any of its Affiliates on terms and conditions no less favorable than the terms of this Agreement (“Grantback License”). Such obligation to license does not include patents that, if licensed, would require a payment of license fees by Licensee to any party that is not an Affiliate of Licensee. Each such patent license shall be granted on a non-exclusive basis under fair, reasonable, and non-discriminatory terms and shall include a license grant to such Licensor or AAC licensee, as applicable, and their Affiliate(s) for activity prior to the effective date of the Grantback License. For purposes of this subsection, the Licensors’ per-patent share of License Fees payable under Section 4.3 (“License Fees”) shall be presumed to be a fair and reasonable per-patent royalty rate for each of Licensee’s Essential AAC Patents; the amount of such per-patent share shall be disclosed to the Licensee upon request as necessary to conclude grantback negotiations.

 

2.6.2. Only with respect to Grantback License negotiations between Licensee and either a Licensor or a Licensor Affiliate that is an AAC licensee, if a license agreement is not executed within twelve (12) months after written request for a license, and Licensee’s proposed license or negotiations are alleged by Licensor and/or its Affiliate to not be fair or reasonable, then in addition to other remedies either party may have, the affected Licensor may provide ninety (90) days’ written notice to Licensee and to Via, and upon expiration of such notice, withdraw the grant of license to its and its Affiliates’ Essential AAC Patents from the license granted hereunder. Upon expiration of such 90-day period, Via shall notify Licensee in accordance with this Agreement and provide Licensee with a revised Appendix A to this Agreement, and, with immediate effect from the date of such notice from Via, the Licensed Patents under this Agreement will cease to include the Essential AAC Patent(s) of such affected Licensor and its Affiliates. Upon execution of a Grantback License agreement between Licensee and the affected Licensor or Licensor Affiliate, any withdrawn patents, unless otherwise licensed by Licensor to Licensee, shall immediately be reinstated, effective from the date such patents were withdrawn

 

2.6.3. During the 12-month period described above, and for ninety (90) days thereafter, neither Licensor nor Licensee shall commence, or join or assist in, any legal or administrative proceeding in any jurisdiction asserting against the other any claims, or seeking a declaratory judgment, related to either party’s practice of the AAC Standard or challenging the enforceability or validity of any Essential AAC Patents owned, controlled, or sublicensable by the other party, including but not limited to reexamination proceedings.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 11

 

2.7. Express License Only. No license is granted herein by implication, estoppel or otherwise, and no implied or express license, authority to infringe, immunity or other waiver from infringement liability shall be deemed to arise or exist as a matter of law or otherwise:

 

2.7.1. under any patent that is not a Licensed Patent;

 

2.7.2. to make, use, import, lease, Sell, or Otherwise Supply any products other than Licensed Products;

 

2.7.3. for any field of use other than to comply with the AAC Standard; or

 

2.7.4. to any person acquiring from Licensee or its Affiliates any product other than a Licensed Product.

 

2.8. Statement of Via’s Intellectual Property Ownership. Via shall own all right, title and interest, including without limitation all intellectual property rights, in and to the Via Administration System, Via trademarks, trade names, trade dress, service marks and the associated names and logos used by Via from time to time.

 

3. Publicity and Announcements.

 

3.1. No rights or licenses of any kind or nature whatsoever are created hereunder to use any of Via’s, Licensee’s, or the Licensors’ trade names, trademarks or service marks (or any confusingly similar names or marks).

 

3.2. Licensee shall make no statements that any of its or its Affiliates’ Licensed Products have been approved, tested or certified by Via or by any of the Licensors.

 

3.3. Neither Party shall make any public disclosures inconsistent with the rights and obligations created hereunder. The Parties agree that Via and the Licensors may disclose to third parties the identity of Licensee as a licensee under this Agreement, and Licensee may disclose to third parties its identity as a licensee under this Agreement.

 

4. Payments, Reports & Records.

 

4.1. Initial Fee. Within thirty (30) days following the Effective Date, Licensee shall pay to Via an upfront, one-time initial fee of USD 15,000 or, in the case of a Small Entity, USD 1,000 (the “Initial Fee”). The Initial Fee is an administrative fee for services provided in the United States, paid to Via. The Initial Fee is non-recoupable and non-refundable, and is not credited against the “License Fees.” The Initial Fee shall be paid in full to Via regardless of any tax treaties or obligations. Notwithstanding the foregoing, the Initial Fee shall be waived to the extent that Licensee is a licensee under an existing and effective AAC Patent License Agreement administered by Via applicable to MPEG-2 AAC, MPEG-4 AAC or MPEG-4 HE AAC.

 

4.1.1. Small Entity Initial Fee. A Licensee that qualifies as a Small Entity shall be eligible for the USD 1,000 Initial Fee after providing Via with an executed Declaration of Small Entity Status, attached as Appendix C hereto.

 

4.2. Quarterly Reports. Within thirty (30) days following the end of every calendar quarter following the Effective Date, Licensee shall deliver to Via in electronic form, paper form, or as otherwise reasonably required by Via, a written report summarizing the previous quarter’s transactions involving Licensed Products as specified below.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 12

 

4.2.1. Quarterly Reports shall include:

 

4.2.1.1. the quantity and description, including product name and/or External Model Number, of Licensed Products Sold or Otherwise Supplied pursuant to this Agreement by Licensee and/or its Affiliates during the calendar quarter for which the Quarterly Report is due;

 

4.2.1.2. the quantity and description, including product name and/or model number, of Internal Use Licensed Products;

 

4.2.1.3. the number of such Licensed Products that are multichannel products (a multichannel product is one which provides three or more Channels);

 

4.2.1.4. if Licensee or any Affiliate has Sold or Otherwise Supplied Products Subject to Other Licenses, Licensee shall provide evidence reasonably satisfactory to Via (and subject to confirmation by Licensors) of the licenses, or confirming the existence of ongoing good-faith negotiations toward the execution of such license agreements. This requirement to provide evidence of existing licenses shall apply only once per category of Licensed Product; and

 

4.2.1.5. such other information and in such form as Via may reasonably request.

 

4.2.1.6. If Licensee has elected the Alternative Rate Structure (as described in Appendix B), the information required by this Section 4.2.1 shall be reported separately for each country/region in which R2 Products are Sold or Otherwise Supplied for use by an End User.

 

4.2.1.7. In the event that Licensee or an Affiliate Otherwise Supplies components or software, the making, using, importing, Selling, or supplying of which would, in the absence of a license, infringe directly or indirectly a Licensed Patent, for inclusion in Professional Products sold by Licensee’s customer, and Licensee elects to have such components or software be Licensed Products hereunder, in addition to the information cited in Section 4.2.1.1 above, Licensee shall report each customer’s name along with the quantity and product name and/or model number of the product(s) incorporating such components or software and shall pay the applicable fees set forth in Section 4.3.3 below.

 

4.2.2. Quarterly Reports need not include:

 

4.2.2.1. component decoding and/or encoding devices or software Sold or Otherwise Supplied to an intermediate market prior to being incorporated in a Licensed Product; or

 

4.2.2.2. Products Subject to Other Licenses, so long as Via has been provided evidence of a license applicable to such products pursuant to Section 4.2.1.4 above, and all Licensors have confirmed the existence of such licenses or have given their approval for Via to accept Licensee’s reports excluding such products.

 

4.2.3. Except as may be required under Section 4.4 (“Taxes”) below or as required by law, Via shall not disclose Licensee-specific details of Quarterly Reports to Licensors. To the extent that Licensee has provided evidence to Via of licenses applicable to Products Subject to Other Licenses, Via shall be permitted to disclose Licensee-specific information to Licensors as needed to fulfill its obligations hereunder.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 13

 

4.3. License Fees. Unless Licensee qualifies for the semi-annual payment election set forth in Section 4.3.1, Licensee shall pay to Via all License Fees due hereunder within fifteen (15) days after its Quarterly Report is due. In accordance with Appendix B (the “Schedule of Fees”), Licensee shall pay to Via the amounts for each Licensed Product Sold or Otherwise Supplied under this Agreement (except those returned and refunded) within, to, or from a jurisdiction in which any Licensed Patent remains unexpired, and the amounts for each Internal Use Licensed Products used by Licensee or its Affiliates in a jurisdiction in which any Licensed Patent remains unexpired.

 

4.3.1. If the License Fees due for a calendar quarter total less than US $25,000, Licensee may elect to defer payment of such License Fees until the following quarter, so long as this election is made not more than once every other calendar quarter (payments must be made at least on a semi-annual basis). Such an election does not excuse Licensee’s obligation to provide a Quarterly Report each quarter.

 

4.3.2. If Licensee Sells or Otherwise Supplies Licensed Products for resale to a customer who also has executed an AAC Patent License Agreement administered by License Administrator (“Other Licensee”), Licensee may agree with such Other Licensee that, as an exception to Section 4.2 and 4.3, the reporting and payment of License Fees for specific Licensed Products will not be made by the Licensee under this Agreement but by the Other Licensee under the Other Licensee’s AAC Patent License Agreement. If Licensee executes such an agreement with an Other Licensee, Licensee remains responsible for the License Fees due for such Licensed Products if the Other Licensee fails to report and pay License Fees that are due. If Licensee and an Other Licensee enter into such an agreement for the reporting and payment of License Fees, both the Licensee and the Other Licensee shall provide Via with written notice of such agreement prior to initiating reporting and payment under this Section.

 

4.3.3. In the event that Licensee or an Affiliate has elected to report and pay for certain Professional Products of Licensee’s customers pursuant to Section 4.2.1.7, Licensee shall pay the applicable License Fees for each such Professional Product incorporating Licensee’s components or software.

 

4.3.4. Licensee shall consolidate all reports and payments required hereunder to include reporting and payment of License Fees due with regard to Licensee and all of its Affiliates.

 

4.3.5. All fees due by Licensee under this Agreement are non-refundable and non-recoupable.

 

4.4. Taxes. Except as provided in Section 4.4.1 below, in addition to the Initial Fee and the License Fees set forth in this Agreement and Appendix B, Licensee shall pay any and all fees, duties, charges of any kind, and taxes, including, without limitation, sales, use, excise, value added, withholding and similar taxes, based on payments to be made hereunder in any jurisdiction(s) where such taxes are required, and shall not deduct such amounts from any payments of fees hereunder. Licensee shall pay any such taxes and fees which are necessary to ensure that the net amounts received by Via on behalf of Licensors after all taxes and fees are paid are equal to the amounts to which Licensors are otherwise entitled under this Agreement as if such taxes and fees did not exist. Upon request by Via, Licensee shall timely provide to Via documentation and proof of payment of taxes and fees paid on behalf of Licensors under this Section. If any taxing authority makes a claim against Via for any taxes owed by Licensee, Licensee shall be obligated to pay all of Via’s expenses and costs incurred in defending such action by the taxing authority. Via shall reasonably cooperate and provide such information as may be required by Licensee for any purpose or reason relating to Licensee’s payment of taxes as may be required under this Section (“Taxes”).

 

4.4.1. Notwithstanding Section 4.4 (“Taxes”), if applicable law and/or tax treaty requires Licensee to withhold any income taxes levied by Licensee’s country of residency or any other jurisdiction(s) on payments to be made pursuant to this Agreement (“Withholding Tax”), Licensee shall timely remit to the appropriate governing authority any Withholding Tax that may be levied upon License Fees paid to Via for the benefit of Licensors. Licensee shall use Via’s calculation of Withholding Tax, and shall deduct such Withholding Tax from License Fees.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 14

 

4.4.1.1. Licensee shall provide to Via all relevant documentation and proof of payment of the Withholding Tax to allow Licensor to provide evidence to Licensor’s tax authorities of payment of Withholding Taxes. If Licensee cannot provide such documentation and proof of payment in a timely manner, Licensee shall remit the amount of Withholding Tax to Via for distribution to affected Licensors.

 

4.4.1.2. If a Licensor is eligible for a Withholding Tax rate exemption or a reduction pursuant to an applicable tax treaty then in force, Licensee must cause any Withholding Tax that is payable by the Licensor to be avoided or reduced accordingly. Via shall reasonably cooperate with Licensee for purpose of reducing or eliminating any Withholding Taxes.

 

4.4.1.3. Via shall reasonably cooperate with Licensee by furnishing necessary information, completed certificates, forms and other documents required by Licensee for purposes of reducing or eliminating any Withholding Taxes. Licensee shall file all necessary tax forms required in order to apply for the application of rates under tax treaties. Nothing in this Section 4.4.1.3 shall require Licensee to take any action inconsistent with any applicable law or government regulation.

 

4.4.1.4. If any foreign taxing authority makes a claim against a Licensor or Via for failure to timely remit all required Withholding Taxes, then Licensee shall be obligated to pay all deficiencies and any interest or penalties associated with such failure owed to such taxing authority.

 

4.5. Payment Procedure.

 

4.5.1. Payments to Via shall be made by wire transfer to the bank and account set forth in the applicable invoice from Via, or by check drawn upon a nationally-recognized U.S. bank tendered to the address set forth in Section 9.8 (“Notices”) below (or to such other payment addresses or bank account as Via shall designate in writing).

 

4.5.2. Via will credit payments from Licensee against any prior outstanding amounts owed by Licensee under this Agreement (crediting the oldest outstanding amounts first) before applying them to current License Fees or other amounts owed.

 

4.5.3. Excess payment amounts shall be applied to immediately subsequent payment obligations and not refunded.

 

4.5.4. Any fees or payments that are made hereunder later than the date on which they are due shall bear interest, compounded monthly at the statutory rate of ten percent (10%) per annum or the highest rate permitted under applicable law, whichever is lower. A payment is considered late if received more than thirty (30) days after becoming due.

 

4.5.5. Time is of the essence with respect to all payments required hereunder.

 

4.5.6. Licensee shall pay all amounts due hereunder in United States dollars. All dollar amounts in this Agreement refer to United States dollars unless otherwise indicated. Any conversion to United States dollars shall be at the prevailing rate for bank cable transfers as quoted by the Wall Street Journal for the last day of the applicable quarterly period (or business day thereafter if such last day shall be a Sunday or other non-business day).

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 15

 

4.5.7. Notwithstanding any requirement for written documents, communication or notice in this Agreement, Quarterly Reports, tax, withholding, financial and payment information and communications may be exchanged by the Parties electronically through the Via Administration System, ViaSecure, or as otherwise requested by Via by notice through such systems.

 

4.6. Fee Applicability.

 

4.6.1. When Sold or Otherwise Supplied. For the purpose of timing the payment of License Fees, a Licensed Product shall be considered Sold or Otherwise Supplied on the earlier of when delivered or otherwise disposed of or when invoiced; or, for Licensed Products provided on a trial basis, when the applicable Trial Period is exceeded. Licensed Products shipped on a consignment basis shall be considered Sold or Otherwise Supplied when any payment for such shipment is agreed upon between Licensee and its customer.

 

4.6.2. When First Used. For the purpose of timing the payment of License Fees for Internal Use Licensed Products, a first use shall be considered to be when the Internal Use Licensed Products are first used to achieve their intended purpose. For the avoidance of doubt, the first use of an encoder Internal Use Licensed Product is when Licensee initially uses the encoder to create bit-streams in AAC format. For an encoder Internal Use Licensed Product in software form, Licensee shall report the highest number of simultaneously-running encoder instances that occur in the calendar quarter as the unit number of Licensed Products for that quarter. For subsequent quarters, the highest number of simultaneously-running encoder instances shall be compared to the highest number from previous quarters. If the highest number of instances for the current quarter is greater than the number from previous quarters, Licensee shall report the difference between the two values as the unit number of Internal Use Licensed Products for the current quarter and pay License Fees for such reported products. For the avoidance of doubt, License Fees will only be due for Internal Use Licensed Products in software form if the highest number of simultaneously-running encoder instances for the current reporting quarter is greater than the highest number from previous quarters.

 

4.6.3. Software Installations. For encoder and decoder Licensed Products in software form, each computer or workstation which has the Licensed Product installed on it, or is capable of using or executing the Licensed Product, shall be considered a separate Licensed Product. By way of example only, if the Licensed Product is installed on a network server, each computer or workstation connected to the network server and capable of executing the Licensed Product shall be considered a separate Licensed Product.

 

4.6.4. Hosted Services. For Professional Products which are hosted on servers that provide encoding or decoding services (often referred to as “cloud computing” environments), as an alternative to reporting and paying for the total number of encoder/codec or decoder instances as the number of units of Licensed Products Sold or Otherwise Supplied, Licensee may elect to track the average number of simultaneously-running encoder/codec or decoder instances that occur each calendar month, and report the highest monthly average for the applicable quarter as the unit number of professional encoder/codec or decoder Licensed Products for that quarter. The highest monthly average for subsequent quarters shall be compared to the highest monthly average from previous quarters. If the highest monthly average for the current quarter is greater than the highest monthly average from previous quarters, Licensee shall report the difference between the two values as the unit number of professional encoder/codec or decoder Licensed Products for the current quarter and pay License Fees for such reported products. For the avoidance of doubt, License Fees will only be due for professional encoder/codec or decoder Licensed Products if the highest monthly average for the current reporting quarter is greater than the highest monthly average from previous quarters.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 16

 

4.6.5. Other Licensee Fee Payment. Licensee shall have no obligation to pay License Fees for a particular Licensed Product on which another licensee under an AAC Patent License Agreement administered by Via has paid Via the required License Fees as set forth in Appendix B, provided that Licensee documents the payment of such other licensee to Via’s reasonable satisfaction.

 

4.6.6. Sales Prior to Effective Date. Not later than thirty (30) days following the Effective Date of this Agreement, Licensee shall submit to Via a written report, identical in form and to the content requirements set forth in Section 4.2 (“Quarterly Reports”), for any Licensed Products Sold or Otherwise Supplied during the entire period prior to the Effective Date of this Agreement, together with payment for fees and interest thereon, compounded monthly at the statutory rate of ten percent (10%) per annum or the highest rate permitted under applicable law, whichever is lower; or if no Licensed Products were Sold or Otherwise Supplied during the entire period prior to the Effective Date of this Agreement, a statement to that effect. Upon receipt of such reports and payments, the license grant set forth in Section 2.1 will be extended to include Licensed Products Sold or Otherwise Supplied prior to the Effective Date for which a report and payment has been received. If the Effective Date is less than six (6) months after the commencement of discussions leading to execution of this Agreement between Via and Licensee, then interest on such past practice may be waived, at Via’s sole discretion.

 

4.7. Books and Records. Licensee and its Affiliates shall keep true, correct, and complete books and records of all sales, licenses, leases, uses, returns, disposals, or other transfers of Licensed Products under this Agreement for at least five (5) years from the date of their creation in order to confirm the accuracy of all of Licensee’s reports and amounts paid or payable hereunder. Via may select an independent and professionally licensed accountant (“Auditor”) to audit, inspect and make abstracts of such books and records, at Licensee’s facility (or elsewhere as determined by Auditor) as necessary to verify their accuracy and that of all other written reports and statements provided for herein, and verify or determine fees paid or payable under this Agreement (“Audit”). Such Audit shall be performed during regular business hours upon at least ten (10) days’ notice and not more often than once annually unless an underpayment of five percent (5%) or more is found, in which case Via may conduct more frequent Audits to the extent reasonably necessary to verify consistently accurate reporting. The Auditor may provide Via information sufficient to support its findings. If the Audit shows an underpayment, then Licensee shall immediately pay the amounts due, plus accrued interest, plus the cost of the Audit if applicable, after receiving notice of the results of the applicable Audit. Licensee will pay the cost of the Audit if, for the period audited, an underpayment of five percent (5%) or more is found, based on and compared to payments or reports received by Via prior to Via’s notice informing Licensee of the Audit. Following an Audit, Via will apply any subsequent payments received from Licensee hereunder first to the costs of the Audit and then to accrued interest before applying any remainder to outstanding License Fees. Via may report the results of any Audit to Licensors; provided, however, that Via shall not disclose in its report to Licensors any Licensee Confidential Information, or any other Licensee-specific information other than discrepancies in Licensee’s payments of License Fees for the period that was the subject of the Audit.

 

4.8. Trial Period Rules. No amounts shall accrue or become payable with respect to a Licensed Product Sold solely to the extent the Licensed Product is provided on terms that allow the End User to evaluate the Licensed Product as provided below:

 

4.8.1. at the end of the Trial Period, the Licensed Product is automatically disabled such that the Licensed Product would not, in the absence of a license, directly or indirectly infringe a Licensed Patent; such Trial Period not to exceed thirty (30) days;

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 17

 

4.8.2. the Licensed Product is altered in a manner that renders the Licensed Product unusable for commercial or personal purposes by compromising the audio output, such as by periodically inserting an interval of silence or periodically inserting an audible tone or beep in the audio output; or

 

4.8.3. the Licensed Product is subject to an agreement between Licensee and an End User obligating that End User to return or destroy all copies of the Licensed Product unless that End User purchases such Licensed Product prior to the expiration of the Trial Period; such Trial Period not to exceed thirty (30) days.

 

For the avoidance of doubt, there shall be only one Trial Period per End User, and if the End User retains the Licensed Product for any period of time after the expiration of the Trial Period, or if the output of the Licensed Product is no longer compromised, License Fees shall be due for such Licensed Product as specified in Appendix B.

 

5. Confidentiality.

 

5.1. Confidential Information.Confidential Information” shall include any non-public information that is marked “confidential” or, if disclosed orally, is identified as confidential prior to, during, or immediately after such oral disclosure, which is disclosed by one Party (“Discloser”) to the other Party (“Recipient”) pursuant to this Agreement.

 

5.2. Reproduction. Recipient shall not reproduce Confidential Information except and only to the extent necessary to exercise its rights and obligations under this Agreement. Reproductions of Confidential Information shall include any trade secret legends, proprietary notices and/or copyright notices present in the Confidential Information.

 

5.3. Disclosure. Recipient shall restrict disclosure of Confidential Information to employees, attorneys and accountants with a need to know such information to accomplish the purposes of this Agreement, and Recipient shall advise such employees, attorneys and accountants, in advance of such disclosure, of the obligations of this Section 5 (“Confidentiality”) and shall require such employees, attorneys, and accountants to be bound, in writing, by confidentiality obligations substantially similar to those herein. Recipient shall not disclose Confidential Information to any other third party without prior written approval of Discloser. All tax credit payments and related documents shall be deemed Confidential Information and shall be disclosed only on a need-to-know basis. Except for books and records specified in Section 4.7 (“Books and Records”) above, Recipient’s obligation to maintain confidentiality of Confidential Information shall expire three (3) years from the date of disclosure.

 

5.4. Use. All Confidential Information that is disclosed for the purposes set forth in this Agreement shall be used only to the extent necessary to accomplish the purposes of this Agreement, shall be subject to the restrictions of this Section 5 (“Confidentiality”) and shall not be used for any other purpose. The fact that a discussion involving the disclosure of Confidential Information will occur or has occurred shall also be considered Confidential Information.

 

5.5. Property. All Confidential Information that is owned by the Discloser shall remain the property of Discloser. Recipient’s duty to protect Confidential Information commences upon receipt of the Confidential Information.

 

5.6. Exclusions. The foregoing restrictions on the use and disclosure of Confidential Information shall not apply to any Confidential Information:

 

5.6.1. independently developed by Recipient or lawfully received free of restriction from another source having the right to furnish the Confidential Information;

 

5.6.2. after it has become generally available to the public without breach of this Agreement by Recipient;

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 18

 

5.6.3. that, at the time of disclosure to Recipient, was known to Recipient free of restriction as evidenced by documentation in Recipient’s possession; or

 

5.6.4. that Discloser agrees in writing is free of such restrictions.

 

5.7. Exceptions. Nothing in this Agreement shall prevent a Recipient from disclosing Confidential Information to the extent the Recipient is legally compelled to do so by any governmental, investigative or judicial agency pursuant to proceedings over which such agency has jurisdiction, provided that the Recipient first gives Discloser notice of the required disclosure. In no event shall Recipient’s cooperation with Discloser require Recipient to take any action which, on the advice of Recipient’s counsel, could result in the imposition of any sanctions or other penalties against Recipient.

 

5.8. No Implied Assurances. None of the Confidential Information which may be disclosed by Discloser shall constitute any representation, warranty, guarantee, inducement or other assurance by Discloser of any kind, and, in particular, with respect to the non-infringement of any intellectual property rights, or any other rights of any third persons or of Discloser.

 

5.9. Injunctive Relief. The Parties agree that in the case of the breach of any provision of this Section 5 (“Confidentiality”), the aggrieved Party may suffer immediate and irreparable harm and that immediate injunctive relief may therefore be appropriate.

 

6. Term and Termination.

 

6.1. Term. This Agreement shall commence on the Effective Date and continue thereafter for a period of five (5) years. Unless terminated earlier pursuant to this Section 6, Licensee shall have the option to renew this Agreement for additional periods of five (5) years each subject to providing Via with written notice of Licensee’s election to renew at least thirty (30) days prior to the expiration of the then-current term. As determined by Via in its reasonable discretion, certain terms and conditions of this Agreement may be subject to change upon renewal. Furthermore, if Licensors generally increase the License Fees, Licensors have the option to increase the License Fees herein upon any renewal by the same percentage as the general price increase, but in no event more than twenty-five percent (25%) of the Schedule of Fees.

 

6.2. Termination for Breach. Failure to pay or perform any obligation hereunder within the time prescribed shall constitute an event of material default. Failure to cure any event of material default within sixty (60) days after receipt of written notice describing the non-performance, or thirty (30) days with respect to non-payment of funds, shall entitle the Party giving such notice to terminate, or suspend, any or all portions of this Agreement.

 

6.3. Individual Licensor’s Option to Withdraw Patents. In the event Licensee or any of its Affiliates makes a claim, raises a counterclaim, or files a suit, directly or indirectly, against a Licensor and/or any of its Affiliates over a patent alleged, or believed in such Licensor’s reasonable judgment, to be an Essential AAC Patent, then such Licensor may withdraw the grant of license under its and its Affiliates’ Essential AAC Patent(s) from this Agreement. Upon such withdrawal, Via will promptly notify Licensee, and as of the date of the filing of such claim, counterclaim, or suit (“Claim Date”), Licensee’s Licensed Patent(s) under this Agreement will cease to include the Essential AAC Patents of such Licensor and its Affiliates. Via will provide Licensee with a revised Appendix A to this Agreement, which shall be effective as of the Claim Date.

 

6.4. Termination for Convenience. Licensee may terminate this Agreement at will by providing Via with written notice at least sixty (60) days prior to the effective date of such termination (the “Termination Date”), with such notice becoming effective only if (i) Licensee has fully performed all of its payment and other obligations under this Agreement; and (ii) either (a) Licensee certifies to Via in writing prior to the Termination Date that it has ceased to make, use, import, Sell and Otherwise Supply Licensed Products as of the Termination Date; or (b) prior to the Termination Date, Via has received written confirmation that Licensee has entered into bilateral agreements with each of the Licensors covering the practice of the Licensed Patents for making, having made, using, importing, Selling and Otherwise Supplying Licensed Products for the purpose of encoding or decoding data in accordance with the AAC Standard.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 19

 

6.5. Effect of Termination.

 

6.5.1. Effect of Termination on Payments and Reporting. Upon expiration or termination of this Agreement, the payment date of all monies due and the reporting date of all Quarterly Reports shall automatically be accelerated so that they shall all become due, payable, and deliverable no later than thirty (30) days after the effective date of expiration or termination of this Agreement.

 

6.5.2. Effect of Termination on License. Upon expiration or termination, all licenses granted to Licensee hereunder shall revert to Licensors, except that for a period of six (6) months after the Term of this Agreement, Licensee shall be entitled to fill orders for Licensed Products received prior to expiration or termination and to make, or have made for it, and to Sell Licensed Products for which commitments to vendors had been made prior to notice of such expiration or termination (“Sell Off Period”), except when this Agreement is terminated for material breach the foregoing Sell Off Period shall not apply, but rather the termination provisions set forth in Section 6.2 above (“Termination for Breach”) shall apply. Any expiration or termination of this Agreement pursuant to the terms in this Section 6 (“Term and Termination”) shall not relieve Licensee of its obligation to account for and make payments pursuant to the terms of this Agreement for all Licensed Products Sold or Otherwise Supplied by Licensee either prior or subsequent to the expiration or termination date.

 

6.6. Survival. The definitions and the Parties’ rights, duties and obligations which, by their nature, would continue beyond the expiration or termination of this Agreement, including but not limited to Sections 4.7 (“Books and Records”), 5 (“Confidentiality”), and 7 (“Representations and Warranties”) shall survive the expiration or termination of this Agreement.

 

7. Representations and Warranties.

 

7.1. Negation of Representations and Warranties by Via and Licensors. Via and Licensors, individually and collectively, make no representation, warranty, covenant or claim regarding:

 

7.1.1. the scope, validity, enforceability or infringement of the Licensed Patents;

 

7.1.2. any ongoing maintenance or prosecution of any of the Licensed Patents;

 

7.1.3. any defense of Licensee against any actions or suits of any nature brought by any third parties;

 

7.1.4. any obligation to bring or prosecute any actions or suits against any third parties for infringement; or

 

7.1.5. any sufficiency, adequacy or completeness of the Licensed Patents for any purpose including but not limited to make, use, import, Sell, or Otherwise Supply Licensed Products.

 

7.2. Representations and Warranties by Licensee. Licensee represents, warrants and covenants that:

 

7.2.1. Licensee enters into this Agreement for its own convenience to acquire non-exclusive rights from multiple Licensors hereto in a single transaction rather than in multiple transactions for rights to the Licensed Patents which it believes are necessary to make, use, import, Sell, or Otherwise Supply Licensed Products; and by doing so Licensors and Licensee can achieve economies of scale, reduce transaction costs, integrate complementary technologies, and promote the AAC Standard;

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 20

 

7.2.2. Licensee is aware that the Licensed Patent(s) may not comprise all the technology, or include licenses to all of the patents required to make, use, import, Sell, or Otherwise Supply a Licensed Product;

 

7.2.3. Licensee acknowledges that Via and Licensors, individually and collectively, make no representation, warranty, covenant or claim that the Licensed Patents hereunder include all applicable Essential AAC Patents throughout the world;

 

7.2.4. Licensee acknowledges that Via and Licensors, individually and collectively, make no representation, warranty, covenant or claim that making, using, importing, Selling, or Otherwise Supplying Licensed Products will not infringe, directly, indirectly, by inducement or otherwise, any patent not licensed hereunder;

 

7.2.5. Licensee shall defend, indemnify, and hold Via and the Licensors, individually and collectively, harmless and free from and against any claim, loss, damage or other liability based on or otherwise arising out of Licensee’s conduct; provided, however, that notwithstanding the foregoing, Licensee shall not be obligated to defend, indemnify and hold Via or the Licensors harmless from and against a claim, loss, damage or liability based on or otherwise arising out of conduct by Via or the Licensors;

 

7.2.6. Licensee acknowledges that Via and the Licensors have not investigated Licensee’s particular Licensed Product(s) and that to the extent such Licensed Product(s) include features not necessarily and unavoidably required by the practice of the AAC Standard such features may infringe patents and/or intellectual property rights owned by the Licensors which are not included in the Licensed Patent(s);

 

7.2.7. Licensee has not, in contemplation of signing this Agreement, made an assignment of, or granted an exclusive license to, any Essential AAC Patent to any third party. During the Term, any assignment made or exclusive license granted by Licensee of any Essential AAC Patent may only be assigned or licensed under the condition that such Essential AAC Patent continues to be subject to the obligation to offer a license to all Licensors and all other licensees under an AAC Patent License Agreement administered by License Administrator pursuant to the terms and conditions of this Agreement.

 

7.3. Representations and Warranties by Each Party. Each Party represents, covenants and warrants that:

 

7.3.1. this Agreement does not violate any of that Party’s existing agreements;

 

7.3.2. such Party has the authority, power and right to convey the rights or accept the obligations created hereunder.

 

7.4. WARRANTY DISCLAIMER. THE FOREGOING REPRESENTATIONS AND WARRANTIES ARE IN LIEU OF ALL OTHER REPRESENTATIONS AND WARRANTIES, AND EXCEPT FOR THE EXPRESS REPRESENTATIONS AND WARRANTIES SET FORTH IN THIS SECTION 7 (“REPRESENTATIONS AND WARRANTIES”), VIA AND THE LICENSORS MAKE NO WARRANTY OF ANY TYPE OR OF ANY KIND WHATSOEVER ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, AND HEREBY DISCLAIM AND EXCLUDE ALL OTHER WARRANTIES, WHETHER STATUTORY, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION THE IMPLIED WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT OF THIRD-PARTY RIGHTS.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 21

 

7.5. WAIVER OF CONSEQUENTIAL DAMAGES AND OTHER INDIRECT DAMAGES. VIA AND THE LICENSORS SHALL NOT BE LIABLE FOR ANY CONSEQUENTIAL, INCIDENTAL, SPECIAL, PUNITIVE OR OTHER INDIRECT DAMAGES OF ANY TYPE OR OF ANY KIND WHATSOEVER ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, REGARDLESS OF THE FORM OF THE ACTION, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT PRODUCT LIABILITY OR OTHERWISE, EVEN IF ANY REPRESENTATIVE OF VIA OR ANY OF THE LICENSORS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

 

7.6. LIMITATION OF REMEDIES AND LIMITATION OF LIABILITY. IN ALL EVENTS, LICENSEE’S SOLE REMEDY UNDER THIS AGREEMENT FOR ANY CLAIM OF BREACH SHALL BE TO TERMINATE THIS AGREEMENT. IN NO EVENT SHALL VIA’S AND LICENSORS’ AGGREGATE CUMULATIVE LIABILITY TO LICENSEE FOR DAMAGES UNDER THIS AGREEMENT EXCEED THE AMOUNTS DUE TO VIA BUT UNPAID BY LICENSEE OR THE AMOUNTS PAID BY LICENSEE TO VIA IN THE TWELVE MONTH PERIOD IMMEDIATELY PRIOR TO THE FIRST EVENT GIVING RISE TO THE LIABILITY, WHICHEVER IS LESS.

 

7.7. FAILURE OF ESSENTIAL PURPOSE. THE PARTIES AGREE THAT THE LIMITATIONS SPECIFIED IN SECTION 7.6 (“LIMITATION OF REMEDIES AND LIMITATION OF LIABILITY”) SHALL APPLY EVEN IF THIS AGREEMENT OR ANY LIMITED REMEDY SPECIFIED HEREIN IS FOUND TO HAVE FAILED OF ITS ESSENTIAL PURPOSE.

 

7.8. Express Allocation of Risks and Benefits. All of the terms and conditions in this Section 7 (“Representations and Warranties”) have been expressly accepted by the Parties and represent the bargained for allocations of risks and benefits under this Agreement which are reflected in the financial terms between the Parties in this Agreement. This allocation is an essential element of the basis of the bargain between the Parties.

 

8. Right to Independent Negotiation.

 

8.1. Acknowledgements. Licensee understands and acknowledges that the Licensed Patents are offered to be licensed for the convenience of Licensee, and Licensee is free to negotiate licenses and/or fees for the Licensed Patents directly with the Licensors independently, individually and directly on mutually acceptable terms and conditions which may be different from those set forth in this Agreement.

 

8.2. Independent Negotiations. Licensee also understands and acknowledges that Licensee is free to conduct the negotiations described in this Section 8 (“Right to Independent Negotiation”) simultaneously with any or all of the Licensors independently, individually and directly.

 

9. General.

 

9.1. Section Titles. Section titles are intended only to aid and assist the reader as an index device and are not intended to be substantive or fully descriptive of the contents of the section or to be used for construction or interpretation.

 

9.2. Assignment. Licensee shall not assign this Agreement or delegate any of its rights, duties or obligations hereunder without the prior written consent of Via, except in connection with Licensee’s merger with another entity, or sale to another entity of its entire business, or substantially all of the assets used to carry out the business related to practice of the technology to which this Agreement pertains, provided that such entity shall promptly agree in writing with Via to perform all Licensee’s obligations and duties hereunder. Any attempt to do so without such consent is void. Via may assign the administration and management of this Agreement or its rights, interests and obligations under this Agreement to a successor in connection with a merger with or acquisition by or sale of all of Via’s assets, or in the event the Licensors designate a different license administrator. Subject to the foregoing, this Agreement shall be binding on and inure to the benefit of the Parties and their respective successors and permitted assigns.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 22

 

9.3. Compliance with Laws. Licensee will comply with all applicable laws and regulations, including any applicable laws and regulations relating to export, import, and applicable royalty withholding laws and regulations, and will defend and hold Via and all Licensors harmless from any expense or damage resulting from Licensee’s violation or alleged violation of any such law or regulation. Licensee shall not export or re-export any data acquired from Licensors under this Agreement, or the direct product thereof, to any country in contravention of applicable law.

 

9.4. Costs. Any covenant requiring a Party to perform or provide an act or service shall be construed to impose upon such Party the burden of the cost thereof unless otherwise provided for herein.

 

9.5. Assertion of Unenforceability. In the event that any provision of this Agreement shall be unenforceable or invalid under any applicable law or be so held by applicable court decision, such unenforceability or invalidity shall not render this Agreement unenforceable or invalid as a whole, and the unenforceable or invalid provision shall be amended to achieve as closely as possible the economic effect of the original provision.

 

9.6. Modification and Waiver. No provision of this Agreement shall be deemed modified by any act or omission of a Party or its agents, or by failure to object to any acts of a Party which may be inconsistent with the terms of this Agreement. No waiver of a breach committed by a Party in one instance shall constitute a waiver or permission to commit or continue breaches in other or like instances. This Agreement shall not be amended or modified other than by a duly executed amendment signed by authorized representatives of the Parties, except that Via may provide updates to Appendix A, and the Parties may provide updates to contact information, addresses and other administrative matters via written notice, email, facsimile, or as provided in Section 4.5.7 above.

 

9.7. Calendar Days. All references to days under this Agreement are a reference to calendar days; thus, for example, when action is required “within thirty (30) days” then in all cases such action is required within thirty (30) calendar days.

 

9.8. Notices. All notices and communication shall be in written English, to the addresses below, or to such other contact information as either Party may designate pursuant to proper notice, and, except to the extent an alternative means is specified below or elsewhere in this Agreement, sent by an internationally-recognized courier service that provides proof of delivery. All notices so provided shall be deemed effective upon receipt as indicated by such proof, and in no case later than ten (10) days after sending. Notwithstanding the foregoing, Via may send notices updating contact information, addresses and other administrative matters, and any updates to the list of Licensors and Licensed Patents in Appendix A pursuant to Sections 2.6.2 or 6.3 or otherwise, via email, facsimile, as provided in Section 4.5.7 above, or other electronic means. The parties may agree on additional procedures for electronic communication; such agreement may be entered into by electronic means. If and when so entered into, such procedures will be deemed to be incorporated into the notice procedures set forth in this Section 9.8 (“Notices”). All fees payable to Via shall be paid by check tendered to the following address or wire transfer to the bank and account set forth in the applicable invoice from Via (or such other payment addresses or bank account as Via shall designate in writing):

 

Via Licensing Corporation

Attention: AAC License Administrator

1275 Market Street

San Francisco, CA 94103

Telephone: (415) 645-4700

 

Notices to Licensee shall be sent to the address on page 1, or to the following if specified:

 

Company:

Attn:

Address:

Fax:

Email: gerry@siyatamobile.com

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 23

 

9.9. Dispute Resolution. This Agreement shall be governed by, and construed in accordance with, the substantive law of the State of California and applicable federal law of the United States, but without regard to choice of law provisions thereof. This Agreement shall be deemed to have been made and entered into in San Francisco, California. The Parties hereby submit to the jurisdiction of, and waive any venue objections against, the United States District Court for the Northern District of California, San Francisco Division and the Superior Court of the State of California, San Francisco County, in any litigation arising out of or relating to this Agreement. In the event that any action is brought to resolve any dispute under this Agreement, the prevailing Party shall be entitled to recover from the other Party all costs and expenses incurred in that action as well as any appeal therefrom, including all reasonable attorney’s fees and costs. Licensee shall not object to any enforcement action brought by Via under this Agreement on the basis that the Licensors should be required to seek, maintain, or be joined to such action. Each Party expressly waives the defense of sovereign immunity and any other defense based on the fact or allegation that it is an agency or instrumentality of a sovereign state.

 

9.10. Relationship of the Parties. The Parties are independent contractors. There is no relationship of partnership, joint venture, employment, franchise or other agency between Via and Licensee, and neither Via nor Licensee has the authority to bind the other or incur any obligation on behalf of the other.

 

9.11. Controlling Language. This Agreement and the Appendices hereto are prepared and executed in the English language only, which language shall be controlling in all respects. Any translations of this Agreement into any other language are for reference only and shall have no legal or other effect. Any notice which is required or permitted to be given by one Party to the other under this Agreement shall be in the English language and shall be in writing. All proceedings related to this Agreement shall be conducted in the English language.

 

9.12. Third Party Beneficiary. Licensee acknowledges and agrees that each Licensor is a direct and intended third party beneficiary of those provisions of this Agreement expressly or implicitly referencing Licensor and Licensor shall be entitled to enforce the terms of such provisions directly against Licensee. Nothing in this Agreement, express or implied, is intended to or shall confer upon Licensee or any other third party any right, benefit or remedy of any nature whatsoever under or by reason of any separate agreement between any of Via, the Licensors or any third party. Except for each Licensor and the Parties, nothing in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.

 

9.13. Counterparts. This Agreement may be executed, whether in person or by facsimile transmission, simultaneously in counterpart, each of which shall be deemed to be an original, but all of which together shall constitute one and the same Agreement.

 

9.14. Review by Counsel. Each Party hereby acknowledges and agrees that it is sophisticated and has consulted legal counsel with respect to this transaction. As a consequence, the Parties expressly waive any presumption of any statutory or common law rule relating to the interpretation of contracts against the drafter.

 

9.15. Entire Agreement. This Agreement, together with the Appendices attached hereto and incorporated by this reference, contains the entire agreement between Via and Licensee, and supersedes all other prior or contemporaneous representations, discussions, negotiations and agreements, whether written or oral between them relating to the subject matter hereof.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 24

 

APPENDIX A

 

AAC STANDARD, LICENSORS, AND LICENSED PATENTS

 

The patent license granted herein may only be used for the practice of the following Audio Object Types (AOTs) and/or Profiles as defined in the AAC Standard:

 

MPEG-4 AAC Profile, including MPEG-2 AAC LC

MPEG-4 High Efficiency AAC Profile, including MPEG-2 AAC LC in combination with SBR

MPEG-4 High Efficiency AAC v2 Profile

MPEG-4 Low Delay AAC Profile

MPEG-4 Low Delay AAC v2 Profile

MPEG 4 Error Resilient AAC Scalable (AOT 20)

MPEG-4 Error Resilient AAC Enhanced Low Delay (AOT 39)

MPEG-D Extended HE-AAC Profile

 

Licensors:

 

Dolby International AB Apollo Building, 3E, Herikerbergweg 1-35, 1101 CN Amsterdam Zuidoost, The Netherlands and Dolby Laboratories Licensing Corporation 1275 Market Street San Francisco CA 94103-1410 USA (together, “Dolby”)
Electronics and Telecommunications Research Institute (ETRI) 218 Gajeong-ro, Yuseong-gu, Daejeon, Korea
Fraunhofer Gesellschaft zur Foerderung der angewandten Forschung e.V (Fraunhofer) Hansastrasse 27c Munich 80686 Federal Republic of Germany
JVC KENWOOD Corporation 3-12, Moriyacho, kanagawa-ku, Yokohama-shi, Kanagawa, 221-0022 Japan
Koninklijke Philips N.V. (Philips) PO Box 220 5600 AE Eindhoven Netherlands
Microsoft Corporation, One Microsoft Way, Redmond, WA, 98052-6399 USA
NEC Corporation 7-1 Shiba 5-chome Minato-ku Tokyo 108-8001 Japan
NTT DOCOMO, INC. Sanno Park Tower, 11-1, Nagata-cho 2 chome, Chiyoda-ku, Tokyo 100-6150 Japan
ORANGE SA Orange Gardens, Room 1E-4-86, 44, avenue de la Republique, Chatillon 92320 France
Panasonic Corporation 7F & 8F OBP Panasonic Tower, 2-1-61 Shiromi, Chuo-ku, Osaka City 540-6207 Japan
Sony Corporation 1-7-1- Konan, Minato-ku, Tokyo 108-0075 Japan
Telefonaktiebolaget LM Ericsson (publ) (Ericsson) Torshamnsgatan 23, SE-164 83 Stockholm Sweden
VoiceAge Corporation 750 Chemin Lucerne, Mont-Royal, QC H3R 2H6, Canada

 

List of Licensed Patents:

 

Patent Holder(s)   Country   Patent Number
Dolby   AR   061807
Dolby   AU   2003270114
Dolby   AU   2006235812
Dolby   AU   2006235813
Dolby   AU   2006336954
Dolby   AU   2010215469
Dolby   AU   2010257205
Dolby   BR   122015007138-0
Dolby   BR   122015007141-0
Dolby   BR   122015007146-1
Dolby   BR   PI0009138-3
Dolby   BR   PI0014642-0

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 25

 

Patent Holder(s)   Country   Patent Number
Dolby   BR   PI0111362-3
Dolby   BR   PI9805989-0
Dolby   CA   2496665
Dolby   CA   2640431
Dolby   CA   2688871
Dolby   CA   2688916
Dolby   CN   ZL00813602.5
Dolby   CN   ZL01809978.5
Dolby   CN   ZL01818972.5
Dolby   CN   ZL01820576.3
Dolby   CN   ZL02806796.7
Dolby   CN   ZL02811036.6
Dolby   CN   ZL02813646.2
Dolby   CN   ZL02820840.4
Dolby   CN   ZL03822145.4
Dolby   CN   ZL200410045997.9
Dolby   CN   ZL200410100078.7
Dolby   CN   ZL200480011462.8
Dolby   CN   ZL200510107590.9
Dolby   CN   ZL200510109957.0
Dolby   CN   ZL200510109958.5
Dolby   CN   ZL200510109959.X
Dolby   CN   ZL200510109960.2
Dolby   CN   ZL200510116027.8
Dolby   CN   ZL200580007351.4
Dolby   CN   ZL200580018659.9
Dolby   CN   ZL200610008886.X
Dolby   CN   ZL200610008887.4
Dolby   CN   ZL200680053841.2
Dolby   CN   ZL200710089097.8
Dolby   CN   ZL200780032661.0
Dolby   CN   ZL200910009864.9
Dolby   CN   ZL200910009865.3
Dolby   CN   ZL200910158611.8
Dolby   CN   ZL200910158612.2
Dolby   CN   ZL200910165019.0
Dolby   CN   ZL201010162942.1
Dolby   CN   ZL201010183360.1
Dolby   CN   ZL201010212976.7
Dolby   CN   ZL201010222389.6
Dolby   CN   ZL201010576370.1
Dolby   CN   ZL201110402525.4
Dolby   CN   ZL201110402529.2
Dolby   CN   ZL98800792.4
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,NL,PT)   0940015
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,NL,PT,SE)   1216474
Dolby   EP (DE,FI,FR,GB,NL,SE)   1285436
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,NL,PT,SE,TR)   1334484
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,NL,PT,SE)   1342230
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,NL,PT)   1367566
Dolby   EP (DE,ES,FI,FR,GB,IT,NL,SE,TR)   1374399
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,NL,PT,SE,TR)   1408484

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 26

 

Patent Holder(s)   Country   Patent Number
Dolby   EP (DE,ES,FI,FR,GB,IT,NL,SE,TR)   1410687
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,NL,PT,SE)   1423847
Dolby   EP (DE,FR,GB,NL)   1444688
Dolby   EP (DE,ES,FI,FR,GB,IT,NL,SE,TR)   1527517
Dolby   EP (CH,DE,FR,GB,LI,NL,SE)   1600945
Dolby   EP (CH,DE,ES,FI,FR,GB,IT,LI,NL,SE)   1603117
Dolby   EP (DE,ES,FI,FR,GB,IT,NL,SE,TR)   1603119
Dolby   EP (DE,FR,GB)   1616461
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,NL,PT,SE)   1617418
Dolby   EP (DE,ES,FI,FR,GB,IT,NL,SE,TR)   1635461
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IT,LI,NL,SE)   1643642
Dolby   EP (DE,ES,FI,FR,GB,IT,NL,PL,SE,TR)   1695338
Dolby   EP (DE,ES,FI,FR,GB,IT,NL,PL,SE,TR)   1735775
Dolby   EP (AT,CH,DE,DK,ES,FI,FR,GB,IT,LI,NL,PL,SE,TR)   1768454
Dolby   EP (DE,FR,GB)   1807824
Dolby   EP (DE,FR,GB)   1909265
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,NL,PT,SE)   1914728
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,GR,IE,IT,LI,LU,NL, PT,SE)   1914729
Dolby   EP (CH,DE,FR,GB,LI,NL,SE)   1977510
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IT,LI,NL,SE)   1986321
Dolby   EP (AT,BE,CH,CZ,DE,DK,ES,FI,FR,GB,GR,IE,IT,LI,LU, NL,SE,TR)   2015292
Dolby   EP (DE,FR,GB,LT,LV,SI)   2024967
Dolby   EP (CH,DE,ES,FR,GB,IT,LI,NL,SE,TR)   2036201
Dolby   EP (DE,ES,FR,GB,IT,SE)   2216776
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IT,LI,NL,SE)   2239847
Dolby   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IT,LI,NL,SE)   2249336
Dolby   EP (DE,FR,GB)   2337223
Dolby   EP (AT,BE,CH,DE,DK,ES,FR,GB,IE,IT,LI,NL,PL,SE,TR)   2337224
Dolby   EP (AT,CH,CZ,DE,ES,FI,FR,GB,IT,LI,NL,PL,SE,TR)   2975764
Dolby   HK   1030843
Dolby   HK   1049401
Dolby   HK   1056429
Dolby   HK   1057815
Dolby   HK   1058096
Dolby   HK   1060450
Dolby   HK   1062349
Dolby   HK   1062350
Dolby   HK   1062624
Dolby   HK   1067954
Dolby   HK   1077413
Dolby   HK   1080206
Dolby   HK   1080208
Dolby   HK   1080979
Dolby   HK   1081715
Dolby   HK   1082093
Dolby   HK   1093594
Dolby   HK   1093812
Dolby   HK   1094077
Dolby   HK   1099882
Dolby   HK   1106862
Dolby   HK   1120938
Dolby   HK   1124156

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 27

 

Patent Holder(s)   Country   Patent Number
Dolby   HK   1124950
Dolby   HK   1129169
Dolby   HK   1131473
Dolby   HK   1140572
Dolby   HK   1141149
Dolby   HK   1142454
Dolby   HK   1144043
Dolby   HK   1145728
Dolby   HK   1150687
Dolby   ID   0022349
Dolby   ID   0032438
Dolby   IN   224775
Dolby   IN   230121
Dolby   IN   234014
Dolby   IN   238265
Dolby   IN   242206
Dolby   IN   255436
Dolby   IN   263883
Dolby   IN   264129
Dolby   IN   267905
Dolby   IN   269029
Dolby   IN   270243
Dolby   IN   285130
Dolby   IN   286020
Dolby   JP   3870193
Dolby   JP   3926726
Dolby   JP   3954495
Dolby   JP   3977744
Dolby   JP   4035631
Dolby   JP   4220461
Dolby   JP   4289815
Dolby   JP   4328720
Dolby   JP   4334526
Dolby   JP   4377302
Dolby   JP   4447317
Dolby   JP   4474347
Dolby   JP   4511443
Dolby   JP   4519783
Dolby   JP   4519784
Dolby   JP   4527716
Dolby   JP   4589962
Dolby   JP   4602375
Dolby   JP   4603037
Dolby   JP   4628921
Dolby   JP   4700467
Dolby   JP   4786987
Dolby   JP   4834153
Dolby   JP   4852122
Dolby   JP   4852123
Dolby   JP   4878384
Dolby   JP   4991397
Dolby   JP   5090390
Dolby   JP   5132627

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 28

 

Patent Holder(s)   Country   Patent Number
Dolby   JP   5133397
Dolby   JP   5185337
Dolby   JP   5186444
Dolby   JP   5186543
Dolby   JP   5326020
Dolby   JP   5427270
Dolby   JP   5452936
Dolby   JP   5557467
Dolby   JP   5577187
Dolby   JP   5689820
Dolby   JP   5933965
Dolby   KR   KR10-0517229
Dolby   KR   KR10-0551862
Dolby   KR   KR10-0565821
Dolby   KR   KR10-0648760
Dolby   KR   KR10-0649299
Dolby   KR   KR10-0666813
Dolby   KR   KR10-0666814
Dolby   KR   KR10-0666815
Dolby   KR   KR10-0679376
Dolby   KR   KR10-0697255
Dolby   KR   KR10-0717604
Dolby   KR   KR10-0717607
Dolby   KR   KR10-0848365
Dolby   KR   KR10-0848367
Dolby   KR   KR10-0890201
Dolby   KR   KR10-0890203
Dolby   KR   KR10-0935961
Dolby   KR   KR10-0959971
Dolby   KR   KR10-1004834
Dolby   KR   KR10-1495064
Dolby   KR   KR10-1657506
Dolby   KR   KR10-1667244
Dolby   MX   257664
Dolby   MX   284090
Dolby   MX   284332
Dolby   MX   287155
Dolby   MX   307488
Dolby   MX   312884
Dolby   MX   313059
Dolby   MY   151651
Dolby   MY   144430-A
Dolby   MY   154144-A
Dolby   MY   157026-A
Dolby   NO   335321
Dolby   NO   336926
Dolby   NO   336930
Dolby   NO   339847
Dolby   NO   340225
Dolby   NO   340385
Dolby   RU   2236046
Dolby   RU   2251795
Dolby   RU   2256293

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 29

 

Patent Holder(s)   Country   Patent Number
Dolby   RU   2402872
Dolby   RU   2453986
Dolby   RU   2484579
Dolby   RU   2507678
Dolby   SE   0512719
Dolby   SG   110461
Dolby   SG   144562
Dolby   TW   I313857
Dolby   TW   I325685
Dolby   TW   I330826
Dolby   TW   I334736
Dolby   TW   I338461
Dolby   TW   I351022
Dolby   TW   I458258
Dolby   TW   I458365
Dolby   UA   79301
Dolby   UA   91890
Dolby   US   6978236
Dolby   US   7003451
Dolby   US   7050972
Dolby   US   7139702
Dolby   US   7181389
Dolby   US   7191121
Dolby   US   7283955
Dolby   US   7308401
Dolby   US   7382886
Dolby   US   7433817
Dolby   US   7469206
Dolby   US   7483758
Dolby   US   7487097
Dolby   US   7509254
Dolby   US   7548864
Dolby   US   7564978
Dolby   US   7577570
Dolby   US   7590543
Dolby   US   7680552
Dolby   US   7711552
Dolby   US   7783496
Dolby   US   7986789
Dolby   US   8014534
Dolby   US   8019612
Dolby   US   8027479
Dolby   US   8036880
Dolby   US   8036881
Dolby   US   8036882
Dolby   US   8059826
Dolby   US   8081763
Dolby   US   8108209
Dolby   US   8112284
Dolby   US   8116460
Dolby   US   8145475
Dolby   US   8223976
Dolby   US   8243936

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 30

 

Patent Holder(s)   Country   Patent Number
Dolby   US   8255212
Dolby   US   8255233
Dolby   US   8315859
Dolby   US   8346566
Dolby   US   8412365
Dolby   US   8447621
Dolby   US   8498876
Dolby   US   8538031
Dolby   US   8543232
Dolby   US   8543385
Dolby   US   8605911
Dolby   US   8606587
Dolby   US   8738369
Dolby   US   8818541
Dolby   US   8880572
Dolby   US   8935156
Dolby   US   8948405
Dolby   US   9218818
Dolby   US   9245533
Dolby   US   9245534
Dolby   US   9318118
Dolby   US   9349382
Dolby   US   RE43189
Dolby   VN   6033
Dolby   VN   12967
Dolby   ZA   20050873
Dolby   AU   2003237295
Dolby   AU   2003239126
Dolby   AU   2003243441
Dolby   AU   2005219956
Dolby   AU   2005280392
Dolby   AU   2007243586
Dolby   AU   2011200680
Dolby   CA   2475460
Dolby   CA   2489441
Dolby   CA   2489443
Dolby   CA   2556575
Dolby   CA   2589623
Dolby   CA   2648237
Dolby   CA   2736060
Dolby   CA   2736065
Dolby   CN   ZL03805096.X
Dolby   CN   ZL03813967.7
Dolby   CN   ZL03813969.3
Dolby   CN   ZL200580006783.3
Dolby   CN   ZL200580027587.4
Dolby   CN   ZL200710137399.8
Dolby   CN   ZL200780014742.8
Dolby   CN   ZL200910138855.X
Dolby   CN   ZL201110236398.5
Dolby   EP (DE,ES,FR,GB,IT,NL)   1914722
Dolby   EP (AT,BE,DE,FR,GB,TR)   2065885
Dolby   EP (BG,DE,EE,FR,GB,IE,SI,SK,TR)   2194528

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 31

 

Patent Holder(s)   Country   Patent Number
Dolby   EP (DE,DK,FR,GB,NL,SI)   2207169
Dolby   EP (CH,DE,FR,GB,IE,LI,SE)   2207170
Dolby   EP (DE,FR,GB,HU,IS,SE)   2224430
Dolby   HK   1070728
Dolby   HK   1070729
Dolby   HK   1092580
Dolby   HK   1114233
Dolby   HK   1119820
Dolby   HK   1126902
Dolby   HK   1146145
Dolby   HK   1146146
Dolby   ID   0021495
Dolby   ID   0021855
Dolby   ID   0025322
Dolby   ID   0025693
Dolby   ID   0025846
Dolby   ID   0036215
Dolby   IL   165648
Dolby   IL   165650
Dolby   IL   177094
Dolby   IL   181407
Dolby   IL   194430
Dolby   IL   201469
Dolby   IL   216068
Dolby   IL   216069
Dolby   IN   236328
Dolby   IN   236917
Dolby   IN   247787
Dolby   IN   259090
Dolby   IN   261624
Dolby   IN   262071
Dolby   JP   4345890
Dolby   JP   5038138
Dolby   JP   5253564
Dolby   JP   5253565
Dolby   JP   5292498
Dolby   KR   KR10-0986152
Dolby   KR   KR10-0986153
Dolby   KR   KR10-0991448
Dolby   KR   KR10-1005731
Dolby   KR   KR10-1139880
Dolby   KR   KR10-1253699
Dolby   MX   254933
Dolby   MX   257474
Dolby   MX   269371
Dolby   MX   281100
Dolby   MX   286694
Dolby   MX   299092
Dolby   MX   305432
Dolby   MY   136521-A
Dolby   MY   140567-A
Dolby   MY   141426-A
Dolby   MY   145083-A

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 32

 

Patent Holder(s)   Country   Patent Number
Dolby   MY   151318-A
Dolby   MY   159022-A
Dolby   NO   339346
Dolby   PL   207861
Dolby   PL   208344
Dolby   RU   2417514
Dolby   SG   101112
Dolby   SG   108044
Dolby   SG   125013
Dolby   SG   129669
Dolby   SG   146885
Dolby   SG   149871
Dolby   SG   173224
Dolby   SG   177013
Dolby   TW   I352969
Dolby   TW   I393120
Dolby   TW   I397902
Dolby   TW   I455481
Dolby   TW   I498882
Dolby   UA   93243
Dolby   US   6778709
Dolby   US   7337118
Dolby   US   7945449
Dolby   US   8032387
Dolby   US   8050933
Dolby   US   8126709
Dolby   US   8144881
Dolby   US   8170882
Dolby   US   8255211
Dolby   US   8983834
Dolby   US   9165562
Dolby   US   9311922
Dolby   US   9324328
Dolby   VN   9166
Ericsson   EP (DE,FR,GB,IT)   1141946
Ericsson   US   6182030
ETRI   US   8954321
Fraunhofer   AR   063394
Fraunhofer   AR   063400
Fraunhofer   AU   711082
Fraunhofer   AU   716982
Fraunhofer   AU   723582
Fraunhofer   AU   726762
Fraunhofer   AU   747694
Fraunhofer   AU   754723
Fraunhofer   AU   754877
Fraunhofer   AU   2004306509
Fraunhofer   AU   2005204715
Fraunhofer   AU   2005299068
Fraunhofer   AU   2005299070
Fraunhofer   AU   2005324210
Fraunhofer   AU   2006233511
Fraunhofer   AU   2006233512

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 33

 

Patent Holder(s)   Country   Patent Number
Fraunhofer   AU   2006233513
Fraunhofer   AU   2006272127
Fraunhofer   AU   2006340728
Fraunhofer   AU   2007308415
Fraunhofer   AU   2007308416
Fraunhofer   AU   2007312667
Fraunhofer   AU   2007312696
Fraunhofer   CA   2267219
Fraunhofer   CA   2284220
Fraunhofer   CA   2286068
Fraunhofer   CA   2301663
Fraunhofer   CA   2341864
Fraunhofer   CA   2356869
Fraunhofer   CA   2363955
Fraunhofer   CA   2540851
Fraunhofer   CA   2554002
Fraunhofer   CA   2557993
Fraunhofer   CA   2582485
Fraunhofer   CA   2583146
Fraunhofer   CA   2593290
Fraunhofer   CA   2604521
Fraunhofer   CA   2605316
Fraunhofer   CA   2614384
Fraunhofer   CA   2645618
Fraunhofer   CA   2646961
Fraunhofer   CA   2664466
Fraunhofer   CA   2667059
Fraunhofer   CA   2667505
Fraunhofer   CN   ZL00804929.7
Fraunhofer   CN   ZL00805534.3
Fraunhofer   CN   ZL200480028776.9
Fraunhofer   CN   ZL200580002802.5
Fraunhofer   CN   ZL200580007036.1
Fraunhofer   CN   ZL200580035701.8
Fraunhofer   CN   ZL200580035950.7
Fraunhofer   CN   ZL200580046256.5
Fraunhofer   CN   ZL200680011585.0
Fraunhofer   CN   ZL200680012093.3
Fraunhofer   CN   ZL200680025974.9
Fraunhofer   CN   ZL200680054008.X
Fraunhofer   CN   ZL200780009735.9
Fraunhofer   CN   ZL200780038753.X
Fraunhofer   CN   ZL200780038756.3
Fraunhofer   CN   ZL200780039899.6
Fraunhofer   CN   ZL201110219357.5
Fraunhofer   CN   ZL97199177.4
Fraunhofer   CN   ZL99811774.9
Fraunhofer   EP (AT,BE,CH,DE,FI,FR,GB,IE,IT,LI,LU,NL,SE)   0911981
Fraunhofer   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,GR,IE,IT,LI,NL,PT,SE)   0931386
Fraunhofer   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,NL,SE)   0954909
Fraunhofer   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,LU,NL,SE)   0962015
Fraunhofer   EP (AT,BE,CH,DE,FI,FR,GB,IE,IT,LI,LU,NL,SE)   1025646
Fraunhofer   EP (AT,BE,CH,DE,FI,FR,GB,IE,IT,LI,LU,NL,SE)   1112621

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 34

 

Patent Holder(s)   Country   Patent Number
Fraunhofer   EP (AT,BE,CH,DE,FI,FR,GB,IE,IT,LI,LU,NL,SE)   1155498
Fraunhofer   EP (AT,BE,CH,DE,ES,FI,FR,GB,IE,IT,LU,MC,NL,PT,SE)   1458103
Fraunhofer   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,IE,IT,LI,LU,NL,PT,SE)   1668959
Fraunhofer   EP (AT,BE,CH,DE,ES,FI,FR,GB,IE,IT,LU,NL,PT,SE)   1706865
Fraunhofer   EP (AT,BE,CH,DE,ES,FI,FR,GB,IE,IT,NL,PT,SE)   1721489
Fraunhofer   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,GR,IE,IT,LI,LU,MC,NL,PL,PT,SE,TR)   1803117
Fraunhofer   EP (AT,BE,CH,DE,ES,FI,FR,GB,IE,IT,LI,LU,MC,NL,PL,PT,SE,TR)   1803325
Fraunhofer   EP (AT,BE,CH,DE,ES,FI,FR,GB,IE,IT,LI,LU,MC,NL,PL,PT,SE,TR)   1854218
Fraunhofer   EP (BE,DE,ES,FR,GB,IT,NL,PL,TR)   1869775
Fraunhofer   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,GR,IE,IT,LI,LU,MC,NL,PL,PT,SE,TR)   1994530
Fraunhofer   EP (BE,DE,ES,FR,GB,IT,NL,PL,TR)   1999997
Fraunhofer   EP (BE,DE,ES,FR,GB,IT,NL,PL,TR)   2057625
Fraunhofer   EP (BE,DE,ES,FR,GB,IT,NL,PL,TR)   2074615
Fraunhofer   EP (BE,DE,ES,FR,GB,IT,NL,PL,PT,TR)   2076901
Fraunhofer   EP (BE,DE,ES,FR,GB,IT,NL,PL,TR)   2378516
Fraunhofer   EP (BE,DE,ES,FI,FR,GB,IT,NL,PL,PT,SE,TR)   2884490
Fraunhofer   HK   1040327
Fraunhofer   HK   1044641
Fraunhofer   HK   1044865
Fraunhofer   HK   1069264
Fraunhofer   HK   1092001
Fraunhofer   HK   1104412
Fraunhofer   HK   1106861
Fraunhofer   HK   1110708
Fraunhofer   HK   1110709
Fraunhofer   HK   1119824
Fraunhofer   HK   1120699
Fraunhofer   HK   1126567
Fraunhofer   HK   1128058
Fraunhofer   HK   1163332
Fraunhofer   IL   174286
Fraunhofer   IL   176776
Fraunhofer   IL   182235
Fraunhofer   IL   182236
Fraunhofer   IL   184340
Fraunhofer   IL   185656
Fraunhofer   IL   186312
Fraunhofer   IL   186315
Fraunhofer   IL   188425
Fraunhofer   IL   193786
Fraunhofer   IL   194064
Fraunhofer   IL   197561
Fraunhofer   IL   197757
Fraunhofer   IL   197976
Fraunhofer   IL   226224
Fraunhofer   IN   235547
Fraunhofer   IN   255634
Fraunhofer   IN   255688
Fraunhofer   IN   257008

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 35

 

Patent Holder(s)   Country   Patent Number
Fraunhofer   IN   257622
Fraunhofer   IN   259275
Fraunhofer   IN   259305
Fraunhofer   IN   262770
Fraunhofer   IN   263033
Fraunhofer   IN   263754
Fraunhofer   IN   268919
Fraunhofer   IN   272357
Fraunhofer   JP   3366903
Fraunhofer   JP   3417479
Fraunhofer   JP   3420250
Fraunhofer   JP   3472268
Fraunhofer   JP   3577324
Fraunhofer   JP   3580777
Fraunhofer   JP   3878952
Fraunhofer   JP   3902642
Fraunhofer   JP   3926399
Fraunhofer   JP   3978194
Fraunhofer   JP   4168000
Fraunhofer   JP   4418493
Fraunhofer   JP   4547380
Fraunhofer   JP   4625084
Fraunhofer   JP   4664371
Fraunhofer   JP   4800379
Fraunhofer   JP   4832507
Fraunhofer   JP   4936569
Fraunhofer   JP   5027799
Fraunhofer   JP   5083779
Fraunhofer   JP   5156386
Fraunhofer   JP   5222279
Fraunhofer   JP   5265358
Fraunhofer   JP   5266234
Fraunhofer   JP   5520994
Fraunhofer   JP   5700714
Fraunhofer   KR   KR10-0304055
Fraunhofer   KR   KR10-0308427
Fraunhofer   KR   KR10-0331166
Fraunhofer   KR   KR10-0346066
Fraunhofer   KR   KR10-0391935
Fraunhofer   KR   KR10-0397806
Fraunhofer   KR   KR10-0433201
Fraunhofer   KR   KR10-0717598
Fraunhofer   KR   KR10-0737302
Fraunhofer   KR   KR10-0803344
Fraunhofer   KR   KR10-0895609
Fraunhofer   KR   KR10-0922419
Fraunhofer   KR   KR10-0924576
Fraunhofer   KR   KR10-0946688
Fraunhofer   KR   KR10-0954180
Fraunhofer   KR   KR10-0954181
Fraunhofer   KR   KR10-0954182
Fraunhofer   KR   KR10-0957711
Fraunhofer   KR   KR10-1001835

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 36

 

Patent Holder(s)   Country   Patent Number
Fraunhofer   KR   KR10-1056253
Fraunhofer   KR   KR10-1183962
Fraunhofer   KR   KR10-1209410
Fraunhofer   MX   262173
Fraunhofer   MX   262786
Fraunhofer   MX   272383
Fraunhofer   MX   273092
Fraunhofer   MX   273098
Fraunhofer   MX   276040
Fraunhofer   MX   276041
Fraunhofer   MX   276043
Fraunhofer   MX   278269
Fraunhofer   MX   278278
Fraunhofer   MX   283408
Fraunhofer   MX   284130
Fraunhofer   MX   289673
Fraunhofer   MX   298082
Fraunhofer   MX   304790
Fraunhofer   MY   141054-A
Fraunhofer   MY   141958-A
Fraunhofer   MY   142520-A
Fraunhofer   MY   142581-A
Fraunhofer   MY   143234-A
Fraunhofer   MY   147067-A
Fraunhofer   MY   148715-A
Fraunhofer   MY   149198-A
Fraunhofer   MY   149613-A
Fraunhofer   MY   153289-A
Fraunhofer   NO   317596
Fraunhofer   NO   337395
Fraunhofer   RU   2327304
Fraunhofer   RU   2329548
Fraunhofer   RU   2339088
Fraunhofer   RU   2367087
Fraunhofer   RU   2368074
Fraunhofer   RU   2379832
Fraunhofer   RU   2382418
Fraunhofer   RU   2383939
Fraunhofer   RU   2384014
Fraunhofer   RU   2393646
Fraunhofer   RU   2411645
Fraunhofer   RU   2413312
Fraunhofer   RU   2420815
Fraunhofer   RU   2426178
Fraunhofer   SG   131461
Fraunhofer   SG   131462
Fraunhofer   SG   133828
Fraunhofer   SG   135892
Fraunhofer   SG   136310
Fraunhofer   SG   136435
Fraunhofer   SG   139281
Fraunhofer   SG   146291
Fraunhofer   SG   148222

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 37

 

Patent Holder(s)   Country   Patent Number
Fraunhofer   SG   151560
Fraunhofer   SG   151603
Fraunhofer   SG   151624
Fraunhofer   TW   I289025
Fraunhofer   TW   I314024
Fraunhofer   TW   I318079
Fraunhofer   TW   I319937
Fraunhofer   TW   I321316
Fraunhofer   TW   I325234
Fraunhofer   TW   I330827
Fraunhofer   TW   I339028
Fraunhofer   TW   I355647
Fraunhofer   TW   I355648
Fraunhofer   TW   I355649
Fraunhofer   TW   I357065
Fraunhofer   US   6370507
Fraunhofer   US   6424939
Fraunhofer   US   6441755
Fraunhofer   US   6502069
Fraunhofer   US   6766293
Fraunhofer   US   6975254
Fraunhofer   US   7103554
Fraunhofer   US   7394903
Fraunhofer   US   7433825
Fraunhofer   US   7447317
Fraunhofer   US   7526432
Fraunhofer   US   7720230
Fraunhofer   US   7788106
Fraunhofer   US   7805313
Fraunhofer   US   7903824
Fraunhofer   US   7991610
Fraunhofer   US   8116459
Fraunhofer   US   8126721
Fraunhofer   US   8180061
Fraunhofer   US   8204261
Fraunhofer   US   8386268
Fraunhofer   US   8438015
Fraunhofer   US   8452605
Fraunhofer   US   8494865
Fraunhofer   US   8682681
Fraunhofer   US   8775193
Fraunhofer   US   9043200
Fraunhofer   US   RE45277
Fraunhofer   US   RE45339
Fraunhofer   US   RE45526
Fraunhofer   ZA   200809187
Fraunhofer   ZA   200810308
Fraunhofer   ZA   200810394
Fraunhofer   ZA   200901650
Fraunhofer   ZA   200902199
JVC KENWOOD   EP (DE,FR,GB)   1298643
JVC KENWOOD   US   6836739
Microsoft   US   6266644

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 38

 

Patent Holder(s)   Country   Patent Number
Microsoft   US   7143030
Microsoft   US   7801735
Microsoft   US   7930171
Microsoft   US   8069052
NEC/Panasonic   CA   2469674
NEC/Panasonic   CN   ZL03801779.2
NEC/Panasonic   EP (CZ,DE,ES,FI,FR,GB,HU,IT,NL,SE)   1543307
NEC/Panasonic   HK   1074877
NEC/Panasonic   IN   225035
NEC/Panasonic   JP   3646939
NEC/Panasonic   KR   KR10-0728428
NEC/Panasonic   TW   I313856
NEC/Panasonic   US   7069212
NTT DOCOMO   EP (DE,FR,GB,IT)   1018807
NTT DOCOMO   JP   3362051
NTT DOCOMO   JP   3457335
NTT DOCOMO   JP   4932917
NTT DOCOMO   KR   KR10-0363580
NTT DOCOMO   KR   KR10-0493261
NTT DOCOMO   US   6434718
NTT DOCOMO   US   7191369
Orange   CN   ZL01808263.7
Orange   CN   ZL200780020028.X
Orange   EP (AT,BE,CH,DE,DK,ES,FI,FR,GB,GR,IE,IT,LI,LU,MC,PT,SE,TR)   1275109
Orange   EP (DE,ES,FR,GB,IT)   1600042
Orange   EP (DE,ES,FR,GB,IT,PL)   2000002
Orange   JP   4928703
Orange   KR   KR10-0754033
Orange   KR   KR10-1325644
Orange   US   7742927
Orange   US   8239208
Orange   US   8605909
Panasonic   AU   2002343212
Panasonic   AU   2011263191
Panasonic   CA   2430923
Panasonic   CN   ZL02810590.7
Panasonic   EP (DE,ES,FI,FR,GB,IT,NL,SE)   1374230
Panasonic   ID   0018609
Panasonic   IN   243038
Panasonic   JP   3913664
Panasonic   JP   5243620
Panasonic   KR   KR10-0587517
Panasonic   MX   244624
Panasonic   MX   318521
Panasonic   MY   130392-A
Panasonic   PH   12003500445
Panasonic   SG   97499
Panasonic   SG   178320
Panasonic   TW   204681
Panasonic   US   7260540
Panasonic   US   8311841
Panasonic   ZA   201200919
Panasonic/NEC   CA   2453814

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 39

 

Patent Holder(s)   Country   Patent Number
Panasonic/NEC   CA   2464408
Panasonic/NEC   CN   ZL03801492.0
Panasonic/NEC   CN   ZL03817248.8
Panasonic/NEC   EP (DE,FI,FR,GB,IT,NL,SE)   1439524
Panasonic/NEC   EP (CZ,DE,ES,FI,FR,GB,HU,IT,NL,SE)   1527442
Panasonic/NEC   EP (DE,FI,FR,GB,IT,NL,SE)   2019391
Panasonic/NEC   HK   1073525
Panasonic/NEC   HK   1082092
Panasonic/NEC   IN   209397
Panasonic/NEC   IN   219698
Panasonic/NEC   JP   3579047
Panasonic/NEC   JP   3646938
Panasonic/NEC   KR   KR10-0602975
Panasonic/NEC   KR   KR10-0723753
Panasonic/NEC   TW   I268665
Panasonic/NEC   TW   I303410
Panasonic/NEC   US   7058571
Panasonic/NEC   US   7555434
Panasonic/NEC   US   7941319
Philips   CN   ZL03808908.4
Philips   CN   ZL03808978.5
Philips   CN   ZL200480003949.1
Philips   CN   ZL200480009976.X
Philips   EP (AT,CH,DE,ES,FR,GB,IT,LI,NL,TR)   1500082
Philips   EP (DE,ES,FR,GB,IT)   1500084
Philips   EP (DE,ES,FR,GB,IT)   1500086
Philips   EP (DE,ES,FR,GB,IT,TR)   1595247
Philips   EP (AT,CH,DE,ES,FR,GB,IT,PL,TR)   1618763
Philips   EP (AT,DE,ES,FR,GB,IT,PL,TR)   1621047
Philips   EP (DE,ES,FR,GB,IT)   1881486
Philips   IN   247097
Philips   IN   248604
Philips   IN   251053
Philips   JP   4401173
Philips   JP   4431568
Philips   JP   4597967
Philips   JP   4714416
Philips   JP   4834539
Philips   JP   5101579
Philips   KR   KR10-0978018
Philips   KR   KR10-1016982
Philips   KR   KR10-1021076
Philips   KR   KR10-1049751
Philips   KR   KR10-1169596
Philips   KR   KR10-1200776
Philips   US   7181019
Philips   US   7933415
Philips   US   8311809
Philips   US   8331572
Philips   US   8798275
Philips/Dolby International   CN   ZL200480032342.6
Philips/Dolby International   EP (DE,ES,FI,FR,GB,IT,NL,PL,SE,TR)   1683133

 

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 40

 

Patent Holder(s)   Country   Patent Number
Philips/Dolby International   IN   271540
Philips/Dolby International   JP   5192424
Philips/Dolby International   JP   5335015
Philips/Dolby International   JP   5889828
Philips/Dolby International   KR   KR10-1106026
Philips/Dolby International   KR   KR10-1217649
Philips/Dolby International   RU   2374703
Philips/Dolby International   US   7519538
Sony   CN   ZL201180018948.4
VoiceAge   AU   2003233722
VoiceAge   CA   2483790
VoiceAge   CN   ZL03812588.9
VoiceAge   HK   1078978
VoiceAge   IN   237351
VoiceAge   MX   261878
VoiceAge   MY   140905-A
VoiceAge   NO   332045
VoiceAge   NZ   536237
VoiceAge   RU   2327230
VoiceAge   US   7529660
VoiceAge   ZA   200409647

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 41

 

APPENDIX B

SCHEDULE OF FEES

 

These License Fees will not be increased for any reason during the initial Term, including but not limited to the addition of Licensors and/or Licensed Patents to Appendix A after the Effective Date.

 

(1)  Standard Rate Structure - Worldwide Rates:

 

Licensee shall pay Via for each Licensed Product Sold or Otherwise Supplied in accordance with the following table.

 

Volume

(per unit* / annual reset)

  Per Unit Fee  
For the first 1 to 500,000 units   $ 0.98  
For units 500,001 to 1,000,000   $ 0.78  
For units 1,000,001 to 2,000,000   $ 0.68  
For units 2,000,001 to 5,000,000   $ 0.45  
For units 5,000,001 to 10,000,000   $ 0.42  
For units 10,000,001 to 20,000,000   $ 0.22  
For units 20,000,001 to 50,000,000   $ 0.20  
For units 50,000,001 to 75,000,000   $ 0.15  
For units 75,000,001 and more   $ 0.10  
* Licensed Products with more than two Channels count as 1.5 units.

 

(2)  Alternative Rate Structure Country/Region-Based Rates:

 

As an alternative to the Standard Rate Structure described above, Licensee may elect the bifurcated rate structure described below, which includes a different rate table for those Licensed Products that are Sold or Otherwise Supplied for use by an End User within certain countries/regions.

 

The first table below (R1 Rate Table) applies to those Licensed Products Sold or Otherwise Supplied for use by an End User within the countries/regions listed on the R1 Country/Region List below in which any Licensed Patent remains unexpired (i.e., “R1 Products”).

 

The second table below (R2 Rate Table) applies to those Licensed Products Sold or Otherwise Supplied for use by an End User within countries/regions that are not listed on the R1 Country/Region List in which any Licensed Patent remains unexpired (i.e., “R2 Products”).

 

If any Licensed Product is Sold or Otherwise Supplied for use by an End User in a country/region in which there is no unexpired Licensed Patent, but is manufactured in a country/region in which a Licensed Patent remains unexpired, then the identity of the country/region of manufacture shall determine the applicable R1 or R2 rate.

 

The volume of units of R1 Products may not be aggregated with the volume of units of R2 Products for purposes of determining the applicable rate under either the R1 or R2 Rate Tables.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 42

 

R1 Rate Table:

 

Volume

(per unit* / annual reset)

  Per Unit Fee  
For the first 1 to 500,000 units   $ 0.98  
For units 500,001 to 1,000,000   $ 0.78  
For units 1,000,001 to 2,000,000   $ 0.68  
For units 2,000,001 to 5,000,000   $ 0.45  
For units 5,000,001 to 10,000,000   $ 0.42  
For units 10,000,001 to 20,000,000   $ 0.22  
For units 20,000,001 to 50,000,000   $ 0.20  
For units 50,000,001 to 75,000,000   $ 0.15  
For units 75,000,001 and more   $ 0.10  
* Licensed Products with more than two Channels count as 1.5 units.

 

R2 Rate Table:

 

Volume

(per unit* / annual reset)

  Per Unit Fee  
For the first 1 to 500,000 units   $ 0.64  
For units 500,001 to 1,000,000   $ 0.51  
For units 1,000,001 to 2,000,000   $ 0.44  
For units 2,000,001 to 5,000,000   $ 0.29  
For units 5,000,001 to 10,000,000   $ 0.27  
For units 10,000,001 to 20,000,000   $ 0.14  
For units 20,000,001 to 50,000,000   $ 0.13  
For units 50,000,001 to 75,000,000   $ 0.10  
For units 75,000,001 and more   $ 0.07  
* Licensed Products with more than two Channels count as 1.5 units.

 

R1 Country/Region List:

 

Andorra

American Samoa

Australia

Austria

Belgium

Bermuda

Bulgaria

Canada

Croatia

Cyprus

Czech Republic

Denmark

Latvia

Lichtenstein

Lithuania

Luxembourg

Malta

Monaco

Netherlands

New Zealand

Norway

Poland

Portugal

Puerto Rico

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 43

 

R1 Country/Region List (continued)

 

Estonia
Finland
France
Germany
Greece
Guam
Hong Kong
Hungary
Iceland
Israel
Italy
Ireland
Japan
Romania
San Marino
Singapore
Slovakia
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
United States and its Territories
United States Virgin Islands

 

Procedures For Electing the Alternative Rate Structure

 

The Standard Rate Structure shall apply unless Licensee has elected to use the Alternative Rate Structure in accordance with this section.

 

Notice and Timing of Election: Licensee may elect the Alternative Rate Structure by providing written notice to Via of its election prior to the Effective Date of this Agreement. During the Term of this Agreement, Licensee may elect to change to the Standard Rate Structure or the Alternative Rate Structure by providing written notice to Via of its election to change, and making the administrative fee payment described below. Upon such election and fee payment after the Effective Date, the Standard Rate Structure or Alternative Rate Structure, as appropriate, will apply to Licensed Products Sold or Otherwise Supplied after the end of the calendar quarter in which notice was provided. When changing to the Standard Rate Structure or the Alternative Rate structure after the Effective Date of this Agreement, the Licensee’s annual unit volume count will be reset to zero and the applicable tier rate(s) will apply beginning with the quarter in which the Standard Rate Structure takes effect.

 

Fee: At the time that Licensee provides notice of an election to change to the Alternative Rate Structure or the Standard Rate Structure after the Effective Date, Licensee shall pay to Via an administrative fee of fifteen thousand dollars (US $15,000) for each such election to change.

 

Eligibility: Notwithstanding the above, Licensee may make an election to change to the Standard Rate Structure only if Licensee is in good standing, i.e. Licensee has fully complied with all obligations under the Agreement, including all payment and reporting obligations.

 

Via Confidential
© 2017 Via Licensing Corporation

AAC Patent License Agreement  
Siyata Mobile Inc. Page 44

 

Appendix C

Declaration of Small Entity Status

 

On behalf of [Licensee Company Name], the undersigned hereby declares that, at the time of executing this Declaration of Small Entity Status and Agreement, it is a Small Entity as defined in Section 1.23 and confirms that:

 

[Licensee Company Name], together with its Affiliates, has no more than fifteen (15) employees; and [Licensee Company Name]’s, together with its Affiliates, combined annual gross revenues do not exceed US $1 million.

 

The undersigned hereby represents and warrants that all statements herein are accurate and true, and that the undersigned has the authority to execute this form on behalf of [Licensee Company Name].

 

     
DATE   SIGNATURE
     
    Name:
    Title:
    Company:

 

 

Via Confidential
© 2017 Via Licensing Corporation

 

 

Exhibit 10.10

 

LOAN AGREEMENT

 

THIS AGREEMENT dated for reference this 1st day of April, 2019, is between:

 

SIYATA MOBILE INC., a company existing under the laws of the Province of British Columbia and having an office at Suite A-414, 1001 Lenoir Street, Montreal, Quebec, H4C 2Z6

 

(the “Lender”)

 

AND:

BSD CAPITAL LTD., a company existing under the laws of the State of Israel and having a principal place of business at 4a Nachshon Street, Raanana, Israel

 

(the “Borrower”)

 

WHEREAS the Lender desires to advance a loan to the Borrower, in the principal amount of USD$200,000.00, on the terms and subject to the conditions of this agreement (the “Agreement”).

 

FOR GOOD AND VALUABLE CONSIDERATION, the receipt and sufficiency of which each party acknowledges, the parties agree as follows:

 

1. Definitions. In this Agreement:

 

(a) Business Day” means a day which is not a Saturday, Sunday or a statutory holiday in the Province of British Columbia;

 

(b) Default” means an Event of Default or any event or circumstance which would (with the expiry of a grace period, the giving of notice, the making of any determination or any combination of any of the foregoing) be an Event of Default;

 

(c) Event of Default” has the meaning set forth in Section 9 below;

 

(d) Borrower” means BSD Capital Ltd.;

 

(e) Maturity Date” has the meaning set forth in subsection 4(a) below;

 

(f) Lender” means Siyata Mobile Inc.;

 

(g) Principal Amount” means the principal amount of the loan provided herein, being USD$200,000.00; and

 

(h) Promissory Note” has the meaning set forth in Section 6 below.

 

2. Loan Advance. Immediately upon execution of this Agreement, the Lender shall, directly or indirectly through its wholly-owned subsidiary, Siyata Mobile Israel Ltd., deliver the Principal Amount to Borrower, or to such third-party as the Borrower may direct. Following delivery of the Principal Amount, the Borrower shall immediately execute the Promissory Note, attached as Schedule “A” hereto and shall deliver the Promissory Note to the Lender.

 

 

 

3. Use of Proceeds. The Borrower will use the proceeds of the loan facility provided herein at the sole discretion of the Borrower.

 

4. Term and Prepayment.

 

(a) Subject to the rights of the Lender under Section 10 to accelerate payment of all monies owing hereunder, the Principal Amount, will be immediately due and payable in full by the Borrower to the Lender on April 1, 2024. (the “Maturity Date”).

 

(b) Upon written notice, the Borrower may prepay the Principal Amount in its entirety at any time prior to the Maturity Date.

 

5. Interest. Interest shall accrue on the Principal Amount at rate of 7.0% per annum, compounded and payable quarterly. Interest shall continue to accrue on the Principal Amount in the event it is not repaid in full on the Maturity Date.

 

6. Security. As security for the Borrower’s obligations hereunder the Borrower will execute and deliver to the Lender the promissory note in the form attached as Schedule “A” hereto (the “Promissory Note”) in the Principal Amount.

 

7. Representations and Warranties. The Borrower represents and warrants to the Lender as follows:

 

(a) this Agreement been executed and delivered hereunder by the Borrower and has been duly authorized by all necessary action of the Borrower;

 

(b) each of this Agreement, and the Promissory Note, constitutes or will constitute a legal, valid and binding obligation, enforceable against the Borrower in accordance with their terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium and other similar laws affecting the rights and remedies of creditors and to the general principles of equity;

 

(c) the Borrower has not committed any act of bankruptcy, or proposed a compromise or arrangement to its creditors generally, had a petition or receiving order in bankruptcy filed against it, made a voluntary assignment in bankruptcy, taken any proceedings with respect to a compromise or arrangement, taken any proceedings to have a receiver appointed for any of its property or had any execution or distress become enforceable or become levied upon any of its property; and

 

(d) no bankruptcy, insolvency or receivership proceedings have been instituted or threatened or are pending against the Borrower, nor have they sought, nor do they intend to seek, relief from creditors under the Bankruptcy and Insolvency Act (Canada), the Companies’ Creditors Arrangement Act (Canada) or other applicable legislation for the relief of debtors.

 

8. Positive Covenants of the Borrower. The Borrower covenants and agrees that so long as any monies will be outstanding under this Agreement, it will:

 

(a) at all times maintain its corporate existence;

 

- 2 -

 

 

(b) duly perform its obligations under this Agreement and all other agreements and instruments executed and delivered hereunder or thereunder; and

 

(c) furnish and give to the Lender notice that an Event of Default has occurred and, if applicable, is continuing or notice in respect of any event which would constitute an Event of Default hereunder with the passage of time and specifying the nature of same.

 

9. Events of Default. Each and every one of the events set forth in this Section will be an event of default (“Event of Default”):

 

(a) if the Borrower fails to make any payment when due hereunder, provided that the Lender shall be required to provide written notice to the Borrower of its failure to make any payment when due hereunder and the Borrower shall not have remedied such failure for a period of forty-five (45) calendar days of the Lender having sent the written notice;

 

(b) if the Borrower defaults in observing or performing any term, covenant or condition of this Agreement or the Promissory Note, other than the payment of monies as provided for in subsection (a) hereof, on its part to be observed or performed and such failure continues for five (5) Business Days;

 

(c) if any of the Borrower’s representations, warranties or other statements in this Agreement or any other collateral document delivered hereunder were at the time given false or misleading in any material respect;

 

(d) if the Borrower ceases to carry on business;

 

(e) if the Borrower petitions or applies to any tribunal for the appointment of a trustee, receiver or liquidator or commences any proceedings under any bankruptcy, insolvency, readjustment of debt or liquidation law of any jurisdiction, whether now or hereafter in effect; or

 

(f) if any petition or application for appointment of a trustee, receiver or liquidator is filed, or any proceedings under any bankruptcy, insolvency, readjustment of debt or liquidation law are commenced, against the Borrower which is not opposed by the Borrower in good faith, or an order, judgment or decree is entered appointing any such trustee, receiver, or liquidator, or approving the petition in any such proceeding.

 

10. Effect of Event of Default. If any one or more of the Events of Default occur or occurs and is or are continuing, the Lender may without limitation, subject to any other rights it may have in law or pursuant to this Agreement or any other document or instrument delivered hereunder, demand immediate payment of all monies owing hereunder.

 

11. Lender’s Expenses. The Lender shall be responsible for all of their expenses incurred in furtherance of the transactions contemplated herein.

 

12. Notices. In this Agreement:

 

(a) Any notice or communication required or permitted to be given under this Agreement will be in writing and will be considered to have been given if delivered by hand, transmitted by facsimile transmission, emailed, mailed by prepaid registered post, or delivered by courier to the address of each party set forth above or to such other address, facsimile number or email address as any party may designate.

 

- 3 -

 

 

(b) Notice or communication will be considered to have been received:

 

  (i) if delivered by hand or by courier during business hours on a Business Day, upon receipt by a responsible representative of the receiver, and if not delivered during business hours, upon the commencement of business on the next Business Day;

 

  (ii) if sent by email or facsimile transmission during business hours on a Business Day, upon such Business Day, and if not transmitted during business hours, upon the commencement of business on the next Business Day; and

 

  (iii) if mailed by prepaid registered post upon the fifth Business Day following posting; except that, in the case of a disruption or an impending or threatened disruption in postal services every notice or communication will be delivered by hand, courier, facsimile transmission, or email.

 

13. Assignment. The Lender agrees that it will not, without the prior written consent of the Borrower, assign all or part of the Promissory Note or any collateral agreements, documents or instruments delivered hereunder any assignee.

 

14. Enurement. This Agreement will enure to the benefit of and be binding upon the parties hereto and their respective successors and permitted assigns.

 

15. Waivers. No failure or delay on the Lender’s part in exercising any power or right hereunder will operate as a waiver thereof.

 

16. Remedies are Cumulative. The Lender’s rights and remedies hereunder are cumulative and not exclusive of any rights or remedies at law or in equity.

 

17. Time. Time is of the essence of this Agreement and all documents or instruments delivered hereunder.

 

18. Withholding Taxes, etc.

 

(a) All payments hereunder will be made free and clear without deduction or withholdings for any taxes, duties, fees or other charges unless those deductions or withholdings are required by law.

 

(b) If the Borrower is required by law to make a deduction or withholding, the Borrower shall make that deduction or withholding within the time allowed and in the minimum amount required by law.

 

(c) Within thirty days of making a deduction or withholding the Borrower shall deliver to the Lender evidence reasonably satisfactory to that Lender that the deduction or withholding has been made or (as applicable) any appropriate payment paid to the relevant taxing authority.

 

19. Invalidity. If at any time any one or more of the provisions hereof is or becomes invalid, illegal or unenforceable in any respect under any law, the validity, legality and enforceability of the remaining provisions hereof will not in any way be affected or impaired thereby to the fullest extent possible by law.

 

- 4 -

 

 

20. Governing Laws. This Agreement will be governed by and interpreted in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein. The Parties submit to the non-exclusive jurisdiction of the Courts of the Province of British Columbia and agree to be bound by any suit, action or proceeding commenced in such Courts and by any order or judgment resulting from such suit, action or proceeding.

 

21. Amendment. This Agreement supersedes all prior agreements and discussions between the parties with respect to the subject matter set forth herein. This Agreement may be varied or amended only by or pursuant to an agreement in writing signed by the parties hereto.

 

22. Schedules. All Schedules attached hereto will be deemed fully a part of this Agreement.

 

23. Currency. All references herein to “dollars”, “USD$” or “$” are to Unites States of America dollars, unless otherwise indicated.

 

24. Independent Advice. The Borrower hereby acknowledges that this Agreement has been prepared by Cassels Brock & Blackwell LLP, and that they have been advised to seek independent legal advice in connection with the entering into of this Agreement. Cassels Brock & Blackwell LLP in no way represents the interests of the Borrower, and by executing this Agreement, the Lender confirms that they have either sought the requisite independent advice, or have waived their right thereto.

 

25. Counterparts. This Agreement may be signed in one or more counterparts, originally or by facsimile, each such counterpart taken together will form one and the same agreement.

 

TO EVIDENCE THEIR AGREEMENT each of the parties has executed this Agreement on the date first above written.

 

  SIYATA MOBILE INC.
     
  Per:
    Authorized Signatory
     
  BSD CAPITAL LTD.
     
  Per:
    Authorized Signatory

 

- 5 -

 

 

SCHEDULE “A”

PROMISSORY NOTE

 

All capitalized terms which are not expressly defined herein have the meaning ascribed to them in the loan agreement between Siyata Mobile Inc., and BSD Capital Ltd., dated for reference April 1, 2019 (the “Agreement”).

 

Principal Amount: USD$200,000.00 (the “Principal Amount”)

 

For value received, BSD CAPITAL LTD. (the “Borrower”) hereby promises to pay to or to the order of SIYATA MOBILE INC. (the “Lender”), or as the Lender may direct, the Principal Amount on April 1, 2024 (the “Maturity Date”). No interest shall accrue on the Principal Amount

 

INTEREST

 

Interest shall accrue on the Principal Amount at rate of 7.0% per annum, compounded and payable monthly. Interest shall continue to accrue on the Principal Amount in the event it is not repaid in full on the Maturity Date.

 

PREPAYMENT

 

Prior to the Maturity Date, upon written notice by the Borrower to the Lender, the Borrower may prepay the Principal Amount.

 

TRANSFERABILITY

 

This Promissory Note is non-transferable except as permitted under the Agreement.

 

GOVERNING LAW, AMENDMENT

 

This Promissory Note shall be governed by the terms and conditions set out in the Agreement with respect to the governing law and amendment.

 

DEFAULT, REMEDIES, ACTIONS IN CONCERT

 

This Promissory Note may be declared due prior to its expressed Maturity Date if an Event of Default has occurred and is continuing.

 

This Promissory Note is executed as of the date first above written.

 

  BSD CAPITAL LTD.
     
Per:
    Authorized Signatory

 

 

- 6 -

 

Exhibit 10.11

 

ASSIGNMENT AND AMENDING AGREEMENT

 

THIS AGREEMENT (the “Agreement”) is made effective as of January 1, 2020

 

AMONG:

 

SIYATA MOBILE INC., a company existing under the laws of the Province of British Columbia and having an office at Suite A-414, 1001 Lenoir Street, Montreal, Quebec, H4C 2Z6

 

(“Siyata”)

 

AND:

 

BSD CAPITAL LTD., a company existing under the laws of the State of Israel and having a principal place of business at 4a Nachshon Street, Raanana, Israel

 

(“BSD”)

 

AND:

 

BASAD PARTNERS LTD., a company existing under the laws of the State of Israel and having a principal place of business at 4a Nachshon Street, Raanana, Israel

 

(“Basad”)

 

AND:

 

MARC SEELENFREUND, a businessman, domiciled and residing at 4a Nachshon Street, Raanana, Israel

 

(“Marc Seelenfreund”)

 

(collectively, the “Parties”, and each a “Party”)

 

WHEREAS:

 

A. Siyata and BSD entered into a loan agreement dated April 1, 2019 (the “Loan Agreement”) and a promissory note dated April 1, 2019 (the “Promissory Note”);

 

B. Siyata, BSD and Marc Seelenfreund entered into a consulting agreement dated July 1, 2018 (the “Consulting Agreement”);

 

C. Siyata, BSD, Marc Seelenfreund and Basad entered in an assignment agreement dated July 1, 2019 (the “Assignment Agreement”) pursuant to which BSD assigned all of its rights, title and interest in and to the Consulting Agreement, together will all benefits and advantages to be derived therefrom and all obligations and liabilities arising therefrom, to Basad;

 

 

 

D BSD wishes to assign all of its right, title and interest in and to the Loan Agreement to Basad, and Basad wishes to accept such assignment;

 

E. BSD wishes to assign all of its right, title and interest in and to the Promissory Note to Basad, and Basad wishes to accept such assignment; and

 

F. Siyata and Basad wish to amend certain terms of the Loan Agreement and the Promissory Note.

 

NOW THEREFORE in consideration of the premises, covenants and agreements herein contained and other good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged by each Party), the Parties agree and confirm as follows:

 

1. BSD agrees to assign to Basad, effective as of January 1, 2020, all of BSD’s right, title and interest in and to the Loan Agreement, together with all benefits and advantages to be derived therefrom and all obligations and liabilities arising therefrom, and each of Siyata and Basad accepts such assignment.

 

2. BSD agrees to assign to Basad, effective as of January 1, 2020, all of BSD’s right, title and interest in and to the Promissory Note, together with all benefits and advantages to be derived therefrom and all obligations and liabilities arising therefrom, and each of Siyata and Basad accepts such assignment.

 

3. Siyata and Basad agree that Section 5 of the Loan Agreement shall be amended to reflect an interest rate of 12.5% per annum, compounded and payable quarterly, effective as of January 1, 2020;

 

4. Siyata and Basad agree that the Section entitled “Interest” of the Promissory Note shall be amended to reflect an interest rate of 12.5% per annum, compounded and payable quarterly, effective as of January 1, 2020;

 

5. Siyata, Basad and Marc Seelenfreund agree that the Loan Agreement shall be amended to include that in the event that any payments are due to Basad upon termination of the Consulting Agreement, Siyata shall be authorized to offset such amounts against any amounts owing by Basad to Siyata under the Loan Agreement;

 

6. Except as expressly amended and modified hereby, the Loan Agreement and Promissory Note shall be unmodified and shall continue to be in full force and effect in accordance with its terms (as amended hereby) and all provisions of the Loan Agreement and Promissory Note, as amended and modified hereby, are confirmed;

 

7. This Agreement shall enure to the benefit of and shall be binding upon each of the Parties hereto and each of their respective successors and permitted assigns;

 

8. The Agreement shall be interpreted, construed, and enforced in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein. The Parties irrevocably attorn to the exclusive jurisdiction of the courts of the Province of British Columbia; and

 

9. This Agreement may be executed and delivered in any number of counterparts, including by electronic transmission, all of which taken together will be deemed to constitute one and the same instrument.

 

 

 

IN WITNESS WHEREOF the undersigned Parties have executed and delivered this Agreement effective as of the date first written above.

 

SIYATA MOBILE INC.   BSD CAPITAL LTD.
         
Per:   Per:  
Name:  GERRY BERNSTEIN   Name:  MARC SEELENFREUND
Title: CFO   Title: PRESIDENT
         
BASAD PARTNERS LTD   MARC SEELENFREUND
         
Per:     Per:  
Name: KEREN SEELENFREUND      
Title: PRESDIENT      

 

 

 

 

 

Exhibit 21.1

Siyata Mobile Inc.
List of subsidiaries

 

Name   Jurisdiction  
1. Siyata Mobile (Canada) Inc.   British Columbia, Canada  
2. Siyata Mobile   (Israel) Ltd. Israel  
3. Queensgate Resources Corp.   British Columbia, Canada  
4. Signifi Mobile Inc.   Quebec, Canada  

Exhibit 23.1

 

CONSENT OF Independent Registered Public Accounting Firm

  

We consent to the use in this Registration Statement on Form F-1 of our report dated August 6, 2020, relating to the consolidated financial statements of Siyata Mobile Inc., which is part of this Registration Statement.

 

We also consent to the reference to us under the caption “Experts” in the Prospectus.

  

  /s/ DAVIDSON & COMPANY LLP
   
  DAVIDSON & COMPANY LLP”
   
Vancouver, Canada Chartered Professional Accountants
   
August 21, 2020